Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.7930916204420804,-1.944128403004297,0.0,0.21548988022137514,0.182,11/13,17.66%,CNOT1;CNOT7;PRR5L;PNPT1;MOV10;GTPBP1;NUDT21;CNOT8;ZC3HAV1;UPF1;ZC3H12A
prerank,focal adhesion assembly (GO:0048041),-0.6477369521836734,-1.9252369885283422,0.0,0.14518174133558748,0.247,12/21,16.50%,PIP5K1A;PTPRK;SORBS1;TAOK2;TESK2;ARHGEF7;PEAK1;FERMT2;BCR;RCC2;ACTN1;WHAMM
prerank,membrane repolarization (GO:0086009),-0.7432896414445904,-1.9191238552028314,0.0,0.10409256925947782,0.261,6/15,8.30%,ATP1B3;ATP1B1;ATP1A1;ATP1A2;KCNJ2;KCND3
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.9377256212139868,1.8721090328264018,0.0,0.2329552630914189,0.168,1/14,0.07%,ACE2
prerank,cellular potassium ion homeostasis (GO:0030007),-0.7594287738256376,-1.864476073271302,0.0,0.16481323466083989,0.46,9/13,23.20%,ATP1B3;ATP1B1;ATP1A1;ATP1A2;KCNJ2;ATP1A3;KCNMA1;SLC12A2;ATP1B2
prerank,blood circulation (GO:0008015),0.7617043411155904,1.799958770631977,0.0011210762331838565,0.9287558515355253,0.712,5/49,4.50%,CXCL12;ACE2;ITGB1BP1;SGCG;MYOF
prerank,neuromuscular junction development (GO:0007528),0.8026766989830145,1.7637916733919214,0.0025412960609911056,1.0,0.923,6/24,7.47%,MUSK;LRRK2;DVL1;PPFIBP2;DCTN1;NEDD4
prerank,regulation of multicellular organism growth (GO:0040014),-0.6684767458762159,-1.7552477788493623,0.0033333333333333335,0.5064012185202316,0.887,10/15,28.09%,APP;GHR;IGF1;PTCH1;PPIB;STAT5B;BBS2;STAT5A;SOD1;MBD5
prerank,sterol transport (GO:0015918),0.8415110272258347,1.7506558677577844,0.0013333333333333333,1.0,0.956,4/19,2.58%,LCAT;CD36;LDLRAP1;OSBP
prerank,development of primary male sexual characteristics (GO:0046546),0.7636565740663377,1.7462075951041118,0.0012165450121654502,1.0,0.966,9/34,11.11%,WNT4;WNT2B;CSDE1;TGFB2;AR;KITLG;MAMLD1;LHFPL2;NR5A1
prerank,neuromuscular process controlling balance (GO:0050885),-0.7114361540854426,-1.7452647556842698,0.0030120481927710845,0.4749603927760677,0.913,7/12,19.47%,PCDH15;NRXN1;CLN3;CDH23;TPP1;MYO7A;TIFAB
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.8164493170773953,1.7443192998623922,0.002554278416347382,1.0,0.969,4/20,1.78%,BMP5;WNT4;BRCA1;FBXW7
prerank,negative regulation of signaling receptor activity (GO:2000272),0.7847101185294595,1.7394667581589116,0.0025220680958385876,0.992687183135802,0.979,7/25,11.44%,ACE2;TSG101;SOCS4;EPHB2;PPARG;SOCS5;CBL
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.8575267798391956,1.7359671173361018,0.006858710562414266,0.9279895513279878,0.982,3/16,2.53%,BMP5;IGFBP3;IGFBP2
prerank,positive regulation of calcium ion import (GO:0090280),0.9016551352155343,1.7236400877347278,0.0014367816091954023,1.0,0.99,2/12,5.17%,CXCL12;PDGFB
prerank,epidermis development (GO:0008544),0.7286539469861499,1.7214063566928457,0.0010976948408342481,0.9668665151903936,0.99,2/56,2.36%,POU2F3;FLOT2
prerank,pharyngeal system development (GO:0060037),0.8523923815508581,1.720313769442961,0.007122507122507123,0.8960603760139227,0.993,4/15,4.03%,ISL1;BMP5;TGFB2;BMPR1A
prerank,male gonad development (GO:0008584),0.7501517321575404,1.7150288667202211,0.0035971223021582736,0.8988701434415604,0.995,7/34,6.88%,WNT4;WNT2B;CSDE1;TGFB2;AR;KITLG;MAMLD1
prerank,chemokine-mediated signaling pathway (GO:0070098),0.7363747050434056,1.7128458822459716,0.003444316877152698,0.8620287873099469,0.996,4/42,7.28%,CXCL12;CX3CL1;RBM15;CCL25
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.5750831483039796,-1.7109703649119503,0.004366812227074236,0.598858377782284,0.966,8/24,10.71%,PLCG2;RYR2;PTPRC;ITPR2;ITPR1;IBTK;ERO1A;FGF2
prerank,positive regulation of positive chemotaxis (GO:0050927),0.843786313845734,1.7075168824511417,0.004285714285714286,0.8708819406234027,0.997,3/15,3.19%,CXCL12;IL16;VEGFC
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.7975936169289177,1.7041031553778085,0.008951406649616368,0.8590055037561064,0.997,1/21,0.03%,EVC
prerank,sensory perception of chemical stimulus (GO:0007606),0.8231561005317672,1.700429941881299,0.01092896174863388,0.8538500062487286,0.997,4/15,3.53%,C5AR1;CD36;ADCY3;BBS4
prerank,mesonephric tubule development (GO:0072164),-0.6538091285248622,-1.6882870258198293,0.006493506493506494,0.6732917391026969,0.986,5/15,9.42%,SLIT2;SALL1;FGFR2;PKD1;NPNT
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.6931073715359092,1.68734406935072,0.0010626992561105207,0.9691443801210345,0.998,19/72,14.08%,FGF22;FGF18;POLR2D;HNRNPM;FGF1;GRB2;POLR2A;MAPK1;SPRED2;FLRT2;GALNT3;KIF16B;SETX;CBL;GTF2F2;FRS2;SPRED1;HNRNPH1;SHOC2
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.5466323137291922,-1.6864956142999967,0.0,0.6094386584226933,0.987,16/25,28.94%,CSNK2A1;TAF1;CSNK2A2;RPL5;PML;EPHA4;RPL11;RPL23;PSME3IP1;RPS7;SGTA;PSMF1;GABARAPL2;TRIM39;PRKCG;PDCL3
prerank,negative regulation by host of viral transcription (GO:0043922),0.8724271129831691,1.6859142215090785,0.0106544901065449,0.934886253195826,0.998,4/12,4.24%,POU2F3;TFAP4;TARDBP;JUN
prerank,postsynaptic membrane organization (GO:0001941),0.8168193676315909,1.6837758872864554,0.009296148738379814,0.9123543383215635,0.999,1/17,0.01%,MUSK
prerank,positive regulation of calcium ion transport (GO:0051928),0.7388695960475905,1.6803906920138039,0.003472222222222222,0.906533145516936,1.0,4/36,5.17%,CXCL12;WFS1;CACNA1D;PDGFB
prerank,modulation by host of symbiont process (GO:0051851),0.7530565504690786,1.679836512030138,0.011083743842364532,0.8694953021526206,1.0,8/31,7.41%,POU2F3;SMARCA4;SP1;TFAP4;TARDBP;JUN;EP300;RRP1B
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.8318893406398685,1.6773451957658168,0.0070921985815602835,0.8582097900052491,1.0,1/15,0.08%,LCAT
prerank,regulation of blood circulation (GO:1903522),0.7343762888900393,1.6772055828070862,0.010428736964078795,0.8223622864890058,1.0,3/34,8.39%,ACE2;TPM1;CAMK2D
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.489761510983983,-1.6746136248761962,0.0,0.6162462718703647,0.991,10/41,10.71%,PLCG2;RYR2;CACNA2D1;PTPRC;GRIN2B;ITPR2;ITPR1;IBTK;ERO1A;FGF2
prerank,motor neuron axon guidance (GO:0008045),-0.6354437319318711,-1.6739379597440422,0.014598540145985401,0.5639592627981597,0.991,10/15,28.73%,SLIT2;RAC1;TMEFF1;CHN1;EPHA4;SEMA3A;SLIT1;RHOH;RHOG;RAC2
prerank,neuron fate commitment (GO:0048663),0.8438479175161242,1.6715324884575404,0.008571428571428572,0.8559147595857048,1.0,1/14,0.09%,ISL1
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.6672984467453877,-1.6679367624128256,0.0033222591362126247,0.5505188147604693,0.995,4/14,12.90%,CSF1;TYROBP;ATP6AP1;TRAF6
prerank,vascular process in circulatory system (GO:0003018),0.8435806658388885,1.6669931091265242,0.01272984441301273,0.8356602006813466,1.0,2/13,3.16%,ACE2;ITGB1BP1
prerank,regulation of tube diameter (GO:0035296),0.8435806658388885,1.6669931091265242,0.01272984441301273,0.8356602006813466,1.0,2/13,3.16%,ACE2;ITGB1BP1
prerank,cholesterol homeostasis (GO:0042632),0.6906210807140867,1.6657613184474587,0.002129925452609159,0.8175760979678535,1.0,11/64,9.50%,LCAT;RORA;INSIG1;LDLRAP1;EHD1;SOAT1;HDAC9;LRP5;TTC39B;IL18;ABCG1
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.8138746693305412,1.664969001133645,0.01226158038147139,0.7967697634086985,1.0,2/17,1.05%,CXCL12;PLA2G7
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.8172917789676137,1.6648427469431533,0.011019283746556474,0.7703871419777626,1.0,1/16,0.05%,CXCL12
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.7688542118589332,1.6633724628238724,0.006377551020408163,0.7592161878412149,1.0,2/22,4.00%,ALDH1A2;VKORC1L1
prerank,regulation of transmembrane transport (GO:0034762),0.7396835231209468,1.6621071913808347,0.008464328899637243,0.7475794110695477,1.0,4/31,7.47%,ACE2;KCNJ6;PRKCB;NEDD4
prerank,regulation of cytoplasmic translation (GO:2000765),-0.6568713421204062,-1.6610262594251162,0.018726591760299626,0.5439925431272981,0.997,5/14,6.15%,CPEB3;DHX9;PKM;CPEB4;FMR1
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.6764843476128845,1.6580838523600137,0.0020768431983385254,0.7633307942333541,1.0,22/87,14.08%,FGF22;FGF18;POLR2D;HNRNPM;FGF1;GRB2;ITGB1BP1;POLR2A;MAPK1;SPRED2;FLRT2;GALNT3;KIF16B;CD44;SETX;CBL;GTF2F2;FRS2;ZFP36L1;SPRED1;HNRNPH1;SHOC2
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.8569123775870024,1.6527396419442681,0.010574018126888218,0.7915029699187974,1.0,3/11,6.15%,CXCL12;GAS6;AXL
prerank,mesenchyme morphogenesis (GO:0072132),0.7822043873907325,1.6501302371140123,0.015047879616963064,0.7948786976304336,1.0,4/17,6.38%,ISL1;TGFB2;BMPR1A;ACVR1
prerank,cholesterol transport (GO:0030301),0.7003882614799558,1.6492476525577493,0.003374578177727784,0.7801665922453848,1.0,14/45,14.69%,LCAT;CD36;LDLRAP1;OSBP;VPS4A;SOAT1;CEL;ABCA7;STARD5;ABCG1;RELCH;ABCA1;LIMA1;ABCA5
prerank,blood vessel diameter maintenance (GO:0097746),0.7301434087332322,1.6481312682412104,0.009259259259259259,0.7693086453893764,1.0,2/34,3.16%,ACE2;ITGB1BP1
prerank,antibacterial humoral response (GO:0019731),0.8050814368702581,1.6479674583316468,0.009735744089012517,0.749759168823508,1.0,3/16,4.23%,ANG;RNASE6;PLA2G6
prerank,endocardial cushion morphogenesis (GO:0003203),0.7780678361791941,1.646338961577803,0.013850415512465374,0.7451664544454737,1.0,4/18,6.38%,ISL1;TGFB2;BMPR1A;ACVR1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.7510683353469261,1.6461882063704312,0.010025062656641603,0.7272647439741102,1.0,3/24,0.58%,ISL1;BRCA1;RORA
prerank,sterol homeostasis (GO:0055092),0.6808876112069415,1.6457531550566162,0.0021253985122210413,0.7132466898357117,1.0,16/65,15.44%,LCAT;RORA;INSIG1;LDLRAP1;EHD1;SOAT1;HDAC9;LRP5;TTC39B;IL18;ABCG1;ABCA1;ABCD1;LIMA1;ABCA5;GRAMD1B
prerank,reverse cholesterol transport (GO:0043691),0.825898282611367,1.645470275699444,0.010071942446043165,0.6981430996476359,1.0,1/13,0.08%,LCAT
prerank,regulation of steroid biosynthetic process (GO:0050810),0.8463447418249852,1.6443688601566133,0.01188707280832095,0.6909838442824419,1.0,2/11,0.22%,BMP5;WNT4
prerank,pancreas development (GO:0031016),0.8291542617323253,1.6438465320046831,0.01951951951951952,0.6792627607093423,1.0,1/12,0.09%,ISL1
prerank,receptor clustering (GO:0043113),0.7514665759270672,1.6424531887425209,0.006097560975609756,0.6738333158280296,1.0,6/27,7.48%,MUSK;DVL1;ITGB1BP1;FLNA;ITGA4;DLG1
prerank,gonad development (GO:0008406),0.7055586602723387,1.6402951612825662,0.00922722029988466,0.6758200200697938,1.0,7/41,6.88%,WNT4;WNT2B;CSDE1;TGFB2;AR;KITLG;MAMLD1
prerank,negative regulation of heart contraction (GO:0045822),-0.701731343329451,-1.6400580563695524,0.0058309037900874635,0.6211639283378865,1.0,7/11,22.21%,PDE4D;PIK3CG;GRK2;ATP1A2;ZC3H12A;SRI;SPTBN4
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.7935283249600689,1.638254748160876,0.009971509971509971,0.6782090010710702,1.0,3/16,3.64%,WNT4;RGCC;RUNX1
prerank,heart trabecula morphogenesis (GO:0061384),0.7886993926865395,1.63688097772669,0.01828410689170183,0.6736267952047217,1.0,4/18,4.03%,BMP5;S1PR1;TGFB2;BMPR1A
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.8534367009027238,1.6312939153885646,0.007911392405063292,0.7045066102464083,1.0,3/11,4.03%,ISL1;TGFB2;BMPR1A
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.7384002620804815,1.6289048605556393,0.014814814814814815,0.7090414219621025,1.0,3/29,3.74%,CXCL12;PLA2G7;GAS6
prerank,metanephric mesenchyme development (GO:0072075),0.8368215390896728,1.6242564210281774,0.0189873417721519,0.7314590914348544,1.0,1/10,0.22%,WNT4
prerank,regulation of collagen biosynthetic process (GO:0032965),0.7726192857098039,1.6242325666094046,0.015089163237311385,0.7173371302245739,1.0,3/19,3.64%,WNT4;RGCC;RUNX1
prerank,endocardial cushion development (GO:0003197),0.7490403559798209,1.6148010011298533,0.017173051519154558,0.7790129314933777,1.0,4/21,6.38%,ISL1;TGFB2;BMPR1A;ACVR1
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.7314461238637815,1.6129691003216182,0.01371571072319202,0.780122528262202,1.0,3/26,0.58%,ISL1;BRCA1;RORA
prerank,positive regulation of T cell migration (GO:2000406),0.7643590023931093,1.612533655483618,0.013333333333333334,0.7694789343243847,1.0,2/20,2.59%,CXCL12;DOCK8
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.6839010878365399,-1.6110373736228434,0.025806451612903226,0.7606062297644302,1.0,6/11,17.04%,RAPGEF6;TJP1;F11R;TJP2;RAP2C;RAP2B
prerank,regulation of cellular localization (GO:0060341),0.6788352044718284,1.6108802267825537,0.016853932584269662,0.7687152142522259,1.0,11/46,10.08%,STXBP2;LRRK2;DVL1;UNC13D;ADCY5;LRP5;HSP90AA1;REEP5;CAMK2D;LYN;EPHA5
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.8434364895758668,1.6103228984656572,0.01812688821752266,0.7597136748013464,1.0,4/10,9.65%,CXCL12;GAS6;AXL;LYN
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.708485318546848,1.6097497839864277,0.013414634146341463,0.7506336255167942,1.0,3/29,4.91%,ISL1;S1PR1;TPM1
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.645769394453839,-1.6091898690562447,0.019867549668874173,0.7256233652051868,1.0,6/13,16.16%,GLUD1;GLUL;ASPA;GOT1;MTHFS;GOT2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.7405901218837958,1.6089313288232197,0.02111801242236025,0.7443329349214854,1.0,1/24,0.05%,CXCL12
prerank,retinoic acid metabolic process (GO:0042573),0.8039472905186507,1.6082115746360113,0.027941176470588237,0.7364967576579657,1.0,1/14,0.31%,ALDH1A2
prerank,response to chemokine (GO:1990868),0.7974686413684203,1.6066736060444669,0.026239067055393587,0.7366529039526089,1.0,2/13,2.59%,CXCL12;DOCK8
prerank,positive regulation of vasculature development (GO:1904018),0.6535128919238472,1.605892458659334,0.0020964360587002098,0.7298360424706928,1.0,18/94,10.13%,FGF18;ISL1;BRCA1;VASH2;SP1;FGF1;VEGFC;RUNX1;SASH1;ADAM12;THBS1;PRKCB;PRKCA;IL1A;AGO2;ITGB8;MTDH;F3
prerank,regulation of endothelial cell proliferation (GO:0001936),0.6438340518732696,1.6014317546698902,0.0010309278350515464,0.7511719582790787,1.0,12/88,5.26%,FGF18;ANG;RGCC;VASH2;ATP5F1A;NRAS;VEGFC;NF1;THBS1;NRP1;PDGFB;PRKCA
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.6933366570611343,-1.6009698165149426,0.013736263736263736,0.7375640666001803,1.0,3/10,1.98%,ANO6;RAB31;APPL2
prerank,rRNA transcription (GO:0009303),0.7661676594235329,1.6003237804083807,0.0214190093708166,0.7473413727732996,1.0,4/17,1.87%,ANG;CAVIN1;SIRT7;GTF3A
prerank,cellular response to heat (GO:0034605),0.6934903620197717,1.5998144061490795,0.0178359096313912,0.7396393461503177,1.0,11/35,7.60%,POLR2D;HSBP1;FGF1;BAG3;HIKESHI;THBS1;YWHAE;PRKACA;IL1A;HSP90AA1;MAPT
prerank,positive regulation of collagen metabolic process (GO:0010714),0.7659151451328622,1.5991950504262165,0.02247191011235955,0.7326144363631417,1.0,3/17,3.64%,WNT4;RGCC;RUNX1
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.7747095844748723,1.5981826290693668,0.019943019943019943,0.7296106824494002,1.0,1/15,0.08%,FGF18
prerank,regulation of monocyte chemotaxis (GO:0090025),0.7391474767984405,1.598001678445375,0.02518891687657431,0.7197884536472225,1.0,2/24,1.05%,CXCL12;PLA2G7
prerank,T cell activation involved in immune response (GO:0002286),-0.663352554309075,-1.5966793128176688,0.012422360248447204,0.7237274296417983,1.0,6/12,19.82%,FCER1G;EIF2AK4;SLC11A1;ICAM1;LILRB1;CD74
prerank,homologous chromosome segregation (GO:0045143),0.7446602348246505,1.5947069643056742,0.02860858257477243,0.7328835082912183,1.0,2/20,1.00%,MAJIN;SIRT7
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.8019588167633367,1.5936186576040978,0.019230769230769232,0.7309245322562629,1.0,1/13,0.10%,BMP5
prerank,negative regulation of interferon-beta production (GO:0032688),-0.7194475229854144,-1.591057476451186,0.01977401129943503,0.7182195048859169,1.0,7/10,14.22%,REL;PTPRS;RELB;NLRC3;PYCARD;SIRPA;LILRB1
prerank,ncRNA transcription (GO:0098781),0.7956108445879012,1.588657665754349,0.019005847953216373,0.7574695099078436,1.0,4/13,1.87%,ANG;CAVIN1;SIRT7;GTF3A
prerank,chordate embryonic development (GO:0043009),0.6674219028427507,1.587639868690333,0.013230429988974642,0.7541113572880914,1.0,6/55,4.15%,ISL1;BMP5;ALDH1A2;BRCA1;DVL1;MBNL1
prerank,regulation of feeding behavior (GO:0060259),-0.6747939722932852,-1.586806284708516,0.020114942528735632,0.7087882183128918,1.0,5/11,23.31%,SGIP1;EIF2AK4;CFAP20;AGRP;STAT3
prerank,regulation of calcium ion import (GO:0090279),0.748515188135155,1.5857361552989289,0.01913265306122449,0.7572465124929518,1.0,2/21,5.17%,CXCL12;PDGFB
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.6759855821336399,1.5853911755479853,0.0145413870246085,0.7494206084455018,1.0,7/51,5.62%,CXCL12;PLA2G7;VEGFC;GAS6;THBS1;CMKLR1;MAPK1
prerank,regulation of presynapse assembly (GO:1905606),-0.5738245414662322,-1.5838544656284412,0.01984126984126984,0.6608300987836546,1.0,5/18,3.90%,IL1RAPL1;APP;LRFN5;EIF4G1;IL1RAPL2
prerank,regulation of presynapse organization (GO:0099174),-0.5738245414662322,-1.5838544656284412,0.01984126984126984,0.6608300987836546,1.0,5/18,3.90%,IL1RAPL1;APP;LRFN5;EIF4G1;IL1RAPL2
prerank,positive regulation of cellular senescence (GO:2000774),-0.6827494742188606,-1.5821139720394468,0.026954177897574125,0.6395618957933592,1.0,5/10,14.17%,B2M;ABI3;YPEL3;SIRT1;CGAS
prerank,male meiosis I (GO:0007141),-0.5945586067866112,-1.5815258346572758,0.03942652329749104,0.6159190803149439,1.0,5/16,18.16%,FOXJ3;FOXJ2;BRDT;ZSCAN21;ING2
prerank,cell chemotaxis (GO:0060326),0.6628924662768307,1.5813425626610687,0.011995637949836423,0.7685369757109151,1.0,7/60,7.28%,CXCL12;CX3CL1;PLEKHG5;NRP1;PDGFB;ARRB2;CCL25
prerank,cellular response to chemokine (GO:1990869),0.6720517066455164,1.5798966741422544,0.022701475595913734,0.7689158455792904,1.0,3/46,2.59%,CXCL12;CX3CL1;DOCK8
prerank,serine family amino acid biosynthetic process (GO:0009070),0.8193022611776057,1.57909616414363,0.017991004497751123,0.7645256175832646,1.0,6/12,10.40%,CBS;SERINC5;SEPHS1;PSAT1;SERINC3;SRR
prerank,establishment of spindle localization (GO:0051293),0.8050017191820027,1.579040505596383,0.025899280575539568,0.7549947914886963,1.0,4/14,3.39%,LLGL2;CFL1;KPNB1;LLGL1
prerank,regulation of extracellular matrix organization (GO:1903053),0.7874597881158026,1.5788629583930773,0.023224043715846996,0.7464549970346663,1.0,3/15,3.64%,DDR1;DDR2;RUNX1
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.687429692324671,1.576660846426696,0.0332541567695962,0.7525262038071402,1.0,2/32,0.81%,ANG;RNASE6
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.5077207506498209,-1.5759904913773304,0.02843601895734597,0.6198073334502943,1.0,9/26,10.71%,PLCG2;RYR2;PTPRC;ITPR2;ITPR1;SLC8B1;IBTK;ERO1A;FGF2
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.5448380644117992,-1.5754093856236884,0.03076923076923077,0.5991644143508607,1.0,12/20,27.11%,BCL2L1;APPL1;GSK3B;MCL1;DCC;BAX;CASP9;CASP2;GSK3A;CASP3;ITGAV;BCL2L2
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.6192042644600857,-1.5733492888720468,0.02464788732394366,0.5879640705475249,1.0,7/15,15.30%,PRKN;OPA1;BCL2L1;IGF1;GHITM;AKT1;HGF
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.6668084050876211,1.5726705237291971,0.01997780244173141,0.7714471905981896,1.0,15/49,12.31%,ISL1;PRKCZ;RIOK3;SMAD6;PMEPA1;IMPACT;EP300;PYDC1;LDLRAD4;CDC42;PPM1A;HMGB1;RAF1;AIDA;SORL1
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.7993334746591073,1.5724516146434862,0.024216524216524215,0.7636260405581718,1.0,3/14,1.44%,SMPDL3A;AK4;AK3
prerank,glutathione metabolic process (GO:0006749),-0.47900846544323533,-1.5724361673204534,0.013888888888888888,0.5717917009384975,1.0,17/38,33.05%,GCLC;CNDP2;GSR;CTNS;HAGH;GSTZ1;GCLM;GLRX2;GGT5;SOD1;GSS;ETHE1;GGT7;CHAC2;PARK7;GPX1;OPLAH
prerank,cellular response to glucagon stimulus (GO:0071377),0.7455472663725635,1.5704365390061186,0.02924791086350975,0.7677829672887324,1.0,6/17,7.05%,ADCY8;ADCY3;PRKAR2A;ADCY5;PRKACA;ADCY9
prerank,L-serine metabolic process (GO:0006563),0.830119427900799,1.5701358963377061,0.0144,0.7606252774865611,1.0,5/10,10.40%,CBS;SERINC5;PSAT1;SERINC3;SRR
prerank,detection of calcium ion (GO:0005513),-0.6324925603672079,-1.567619785472406,0.01773049645390071,0.5749335495093966,1.0,4/13,1.83%,RYR2;STIM1;CALM2;SYT1
prerank,positive regulation of lymphocyte migration (GO:2000403),0.8001192692242125,1.5604659049106477,0.030791788856304986,0.821413005003478,1.0,2/12,2.59%,CXCL12;DOCK8
prerank,Golgi inheritance (GO:0048313),-0.6787011224067185,-1.5601967170992246,0.0223463687150838,0.5896144010802937,1.0,8/11,20.36%,STX5;GBF1;VRK1;PDCD10;GOLGA2;STK25;PLK3;YWHAZ
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.6899653525258329,1.5590540964291333,0.024764150943396228,0.8218464547380497,1.0,9/32,10.80%,PLK1;BRCA1;BLM;CDK5RAP3;MRE11;NBN;BABAM2;TAOK1;FOXN3
prerank,response to copper ion (GO:0046688),0.7231216980143963,1.5556911692782702,0.0311284046692607,0.8372750515659249,1.0,10/20,11.35%,IL1A;MT1F;MT1M;MT1H;MT1X;MT1A;MT1E;MT1G;MT1B;PRNP
prerank,negative regulation of intracellular protein transport (GO:0090317),0.7159085124808685,1.5542733105701552,0.044642857142857144,0.8383735312717847,1.0,5/22,3.91%,LMAN1;LRRK2;INSIG1;ITGB1BP1;GDI1
prerank,positive regulation of transporter activity (GO:0032411),0.7876715080052494,1.5536835815472179,0.029957203994293864,0.8332353696050477,1.0,1/13,0.11%,SGK2
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.7461645859010567,1.5506970371440116,0.03968253968253968,0.8452606993344663,1.0,4/18,6.35%,ISL1;KLF9;BCL2L11;NR3C1
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.6446336728217379,1.5472645405192276,0.01847826086956522,0.8618890630555811,1.0,13/55,13.46%,ACE2;EIF6;BRCA1;PID1;GRB2;THBS1;PDGFB;ALOX5;TGFBR2;PARL;MAPK14;TP53;COQ7
prerank,regulation of vasoconstriction (GO:0019229),0.7039035692538796,1.5463573260061707,0.03288672350791717,0.8593228774195945,1.0,1/27,0.07%,ACE2
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.6977166880652763,1.545654057608146,0.029339853300733496,0.8552021374120286,1.0,2/29,1.00%,MAJIN;SIRT7
prerank,leukotriene biosynthetic process (GO:0019370),0.7603854173592383,1.5452319247700093,0.03467406380027739,0.8488299159106398,1.0,4/14,8.48%,GGTA1;MGST3;PLA2G4A;ALOX5
prerank,regulation of developmental growth (GO:0048638),0.6966371374144987,1.5436477286465473,0.025119617224880382,0.8517019200286633,1.0,2/29,3.85%,MUSK;OLFM1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.8238280145479895,1.5434828106426335,0.02047244094488189,0.8351820817484387,1.0,1/10,4.37%,CEP250
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.8238280145479895,1.5434828106426335,0.02047244094488189,0.8351820817484387,1.0,1/10,4.37%,CEP250
prerank,secondary alcohol metabolic process (GO:1902652),0.6595572552236193,1.543055663429833,0.023755656108597284,0.8296582246968534,1.0,11/42,14.69%,LCAT;GBA2;LDLRAP1;SOAT1;ABCG1;IDH2;ABCA1;RXRA;PPARD;OSBPL1A;ABCA5
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.7962515621603403,1.5427241113067025,0.02245508982035928,0.82374665846997,1.0,3/12,11.13%,ISL1;IL18;PAEP
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.6602627437441257,-1.542500473020319,0.017543859649122806,0.6599009399234128,1.0,8/11,31.85%,PRKN;NONO;FBXO7;RACK1;REST;ATF4;PINK1;PARK7
prerank,neurotransmitter uptake (GO:0001504),-0.6407014172926042,-1.542343649464758,0.02108433734939759,0.639935320938133,1.0,3/12,6.96%,SNAP25;GLUL;ATP1A2
prerank,positive regulation of embryonic development (GO:0040019),0.7399276300338983,1.5420496389422127,0.03504043126684636,0.820441768328701,1.0,5/19,11.33%,WNT4;CFL1;TENM4;B4GALT5;NR2C2
prerank,sensory perception of smell (GO:0007608),0.7879702710083853,1.5409699124140661,0.041728763040238454,0.8198901353846891,1.0,2/11,3.53%,ADCY3;BBS4
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.7444607232475744,1.540845295946039,0.031746031746031744,0.8125412405230962,1.0,4/18,5.09%,RGCC;DDR2;RUNX1;SMAD3
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.7673609387068857,1.5394486293912677,0.02556818181818182,0.8142115002519694,1.0,4/14,14.08%,ISL1;IL18;PAEP;CD84
prerank,cranial nerve development (GO:0021545),0.8051936282342399,1.5388282858565632,0.03298350824587706,0.8104926661081749,1.0,2/11,1.97%,ISL1;TMEM126A
prerank,regulation of T cell migration (GO:2000404),0.740442301415393,1.5386253824637188,0.03208556149732621,0.8041043511094151,1.0,2/18,2.59%,CXCL12;DOCK8
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.7065321905868782,1.5372317986982305,0.02509907529722589,0.8060991643480845,1.0,3/23,4.91%,ISL1;HOPX;TPM1
prerank,regulation of dendritic spine development (GO:0060998),-0.5488624611632991,-1.5363746204181032,0.056451612903225805,0.6516438327033393,1.0,6/19,8.27%,CPEB3;PPFIA2;GRIN3A;FMR1;PTPRS;KIF1A
prerank,regulation of mast cell degranulation (GO:0043304),0.7655962525511661,1.5363015787046004,0.02014388489208633,0.8050296947562531,1.0,2/14,2.71%,STXBP2;UNC13D
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.5845218689203696,-1.5355398725956588,0.014760147601476014,0.6367210331715583,1.0,5/16,14.22%,FCGR2B;VSIR;TYROBP;CD274;LILRB1
prerank,atrial septum development (GO:0003283),0.7805646860862236,1.5337169636544368,0.03143712574850299,0.8155248501525919,1.0,3/13,3.69%,ISL1;DAND5;TGFB2
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.5263597498257682,-1.5332492320687048,0.008403361344537815,0.6296687347485606,1.0,6/23,9.85%,TGFB1;MAML1;AKAP6;ATP11A;NIBAN2;IGF1
prerank,maturation of 5.8S rRNA (GO:0000460),0.7342048690099359,1.533186881380661,0.04341926729986431,0.8117295111992334,1.0,4/17,5.51%,EIF6;C1D;MPHOSPH6;PRKDC
prerank,cell differentiation in spinal cord (GO:0021515),0.8060123751043157,1.5326020308577366,0.03755868544600939,0.8087068392060629,1.0,2/10,2.70%,ISL1;SOX13
prerank,cardiac atrium morphogenesis (GO:0003209),0.746366530068841,1.5310744016662219,0.03730272596843615,0.8117301992353344,1.0,2/16,3.69%,ISL1;TGFB2
prerank,platelet degranulation (GO:0002576),0.6136341015053066,1.5302478203827685,0.003048780487804878,0.8097929220194238,1.0,27/118,12.08%,STXBP2;HABP4;VCL;FAM3C;CD36;ENDOD1;SELENOP;VEGFC;TGFB2;GAS6;SCG3;THBS1;FLNA;ALDOA;PDGFB;QSOX1;FERMT3;LHFPL2;PHACTR2;F13A1;LYN;CD63;ACTN4;CYRIB;TMSB4X;APOOL;WDR1
prerank,positive regulation of cell aging (GO:0090343),-0.63135098047768,-1.526918726112516,0.04411764705882353,0.6433245435422504,1.0,5/11,14.17%,B2M;ABI3;YPEL3;SIRT1;CGAS
prerank,establishment of spindle orientation (GO:0051294),0.680796315768207,1.524863496999732,0.04767726161369193,0.8395366130865092,1.0,6/28,11.05%,PLK1;LLGL2;NDEL1;LLGL1;DCTN1;FBXW11
prerank,outflow tract septum morphogenesis (GO:0003148),0.6999780850600518,1.5243664444394667,0.03717948717948718,0.8354887525296262,1.0,6/24,6.38%,ISL1;SMAD6;TGFB2;BMPR1A;NRP1;ACVR1
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.6826183954146218,1.5242146007405861,0.036855036855036855,0.8292085251598563,1.0,3/28,2.93%,CXCL12;GBA2;PLEKHG2
prerank,DNA replication initiation (GO:0006270),0.6632555458765633,1.5234165001414701,0.03125,0.827533147019868,1.0,9/37,9.38%,POLE4;POLE2;ORC4;POLA1;CDK2;NOC3L;POLA2;PRIM2;ORC2
prerank,cellular response to copper ion (GO:0071280),0.7330380217301548,1.5218133542472176,0.04951856946354883,0.831506189565155,1.0,9/16,11.35%,MT1F;MT1M;MT1H;MT1X;MT1A;MT1E;MT1G;MT1B;PRNP
prerank,renal water homeostasis (GO:0003091),0.6971631556597412,1.5215209800948093,0.04516129032258064,0.8265475594669256,1.0,7/23,7.05%,WFS1;ADCY8;ADCY3;PRKAR2A;ADCY5;PRKACA;ADCY9
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.659175898769768,1.5205787690362667,0.03409090909090909,0.8259504010937913,1.0,6/38,8.61%,ISL1;CACNA1D;AKAP9;YWHAE;CAMK2D;TRPM4
prerank,serine family amino acid catabolic process (GO:0009071),0.8017710117710636,1.5205637532466274,0.04276315789473684,0.8192328773355348,1.0,1/10,0.33%,CBS
prerank,DNA double-strand break processing (GO:0000729),0.7383927583078932,1.5182629781806993,0.03994673768308921,0.8281150909455921,1.0,8/18,9.23%,BRCA1;BLM;RAD50;UBE2V2;RBBP8;MRE11;NBN;EXD2
prerank,superoxide anion generation (GO:0042554),-0.5983792431433073,-1.51744458229876,0.04983388704318937,0.67452873294673,1.0,4/13,7.60%,NCF2;NCF1;CYBA;CYBB
prerank,cAMP biosynthetic process (GO:0006171),0.788772209689041,1.516728880670811,0.05705229793977813,0.8320880303135969,1.0,4/10,7.05%,ADCY8;ADCY3;ADCY5;ADCY9
prerank,sensory perception of taste (GO:0050909),0.8018311491144979,1.5167272922192738,0.03571428571428571,0.8252676366225018,1.0,1/10,1.63%,CD36
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.4430823817169046,-1.5166459337919616,0.044585987261146494,0.6605745202013631,1.0,8/34,4.82%,PDE4D;RYR2;CALM2;ASB3;SMAD7;PIK3CG;ATP1B1;PDE4B
prerank,negative regulation of histone modification (GO:0031057),0.7594867986648456,1.5162213452359379,0.03927068723702665,0.8216399580266163,1.0,5/14,10.74%,BRCA1;THAP7;SET;CTBP1;NOC2L
prerank,positive regulation of insulin secretion (GO:0032024),0.6649633130162583,1.5142731462303975,0.03571428571428571,0.8282881264763265,1.0,10/36,12.47%,ISL1;ADCY8;NNAT;PSMD9;PLA2G6;IRS2;TRPM4;TM7SF3;GCK;TCF7L2
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.664637528386802,1.513560741987749,0.038869257950530034,0.8262064925620187,1.0,9/33,9.43%,RELA;SMARCA4;TGFB2;JUN;SMAD3;PDGFB;TEAD1;NR3C1;PPARG
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.7719456841022563,1.512383733165911,0.04302670623145401,0.8276934231065239,1.0,5/12,8.30%,INSIG1;TAPT1;INSIG2;KDELR2;ANKRD13C
prerank,myotube cell development (GO:0014904),0.790818674949793,1.5105160519711145,0.049924357034795766,0.834555230747522,1.0,1/10,0.70%,SELENON
prerank,negative regulation of DNA binding (GO:0043392),0.6789016327986704,1.5076136883046736,0.03233830845771144,0.8477196045884282,1.0,6/28,7.33%,MDFI;HABP4;TFAP4;JUN;ILRUN;SUMO3
prerank,lymphocyte migration (GO:0072676),0.6610233937575177,1.5066010251353505,0.043010752688172046,0.8486329275102025,1.0,5/32,8.96%,S1PR1;CX3CL1;MSN;CCL25;MYO1G
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.6692174545937514,1.5061575865878405,0.052568697729988054,0.845240918147893,1.0,4/30,9.66%,CXCL12;PTTG1IP;THOC5;CD44
prerank,regulation of epithelial cell proliferation (GO:0050678),0.6131962001619238,1.505641408007968,0.021119324181626188,0.8423920632600705,1.0,16/85,12.68%,FGF18;BMP5;C5AR1;FGF1;NUPR1;TGFB2;PRKDC;SGPP2;CDK6;DUSP10;LIMS1;DEAF1;LAMC1;ZFP36L1;TCF7L2;TGFA
prerank,sterol metabolic process (GO:0016125),0.6306279817205398,1.5044526523626036,0.02467811158798283,0.8441299912425136,1.0,13/60,14.69%,LCAT;INSIG1;GBA2;LDLRAP1;INSIG2;SOAT1;LIPA;ABCG1;ABCA1;RXRA;PPARD;OSBPL1A;ABCA5
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.7138435123029742,1.5036637496343908,0.05423280423280423,0.8428687706305636,1.0,4/20,11.56%,WNT4;EP300;NCOR1;GCK
prerank,mitochondrion morphogenesis (GO:0070584),0.7596846780876236,1.5027752322734744,0.057863501483679525,0.8426481078169016,1.0,4/11,3.80%,NUBPL;PID1;SLIRP;WASF1
prerank,muscle organ development (GO:0007517),0.6309018939023969,1.5024987419486464,0.02869757174392936,0.8384118952157636,1.0,6/54,10.73%,EVC;CHODL;SGCG;MEF2A;TCF12;FKTN
prerank,response to glucagon (GO:0033762),0.7013579951556308,1.501980103241947,0.043882978723404256,0.8359133224693569,1.0,6/19,7.05%,ADCY8;ADCY3;PRKAR2A;ADCY5;PRKACA;ADCY9
prerank,mesenchyme development (GO:0060485),0.7290797331377559,1.5013992497715034,0.05049088359046283,0.8337495416199924,1.0,1/15,0.09%,ISL1
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.7392460896676131,1.4998828915070879,0.05722070844686648,0.8376142519723621,1.0,3/15,6.35%,ISL1;BCL2L11;NR3C1
prerank,activation of protein kinase A activity (GO:0034199),0.7232260940902605,1.49960626304962,0.04231311706629055,0.8332274342965981,1.0,6/16,7.05%,ADCY8;ADCY3;PRKAR2A;ADCY5;PRKACA;ADCY9
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.6294927610477441,1.499264771359568,0.03662597114317425,0.8294944313191598,1.0,15/54,13.90%,FGF18;RGCC;ATP5F1A;SP1;NF1;THBS1;PDGFB;PRKCA;MECP2;PPARG;TMSB4X;HMGB1;MAPK14;NUS1;PRKD2
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.6672380330913721,1.4988800325825031,0.04201680672268908,0.8265100271539179,1.0,7/29,14.70%,BMP5;SPRED2;LDLRAD4;USF3;SPRED1;ADIPOR1;PTEN
prerank,positive regulation of lipid transport (GO:0032370),-0.6203750464988624,-1.498542130118541,0.03278688524590164,0.7361868528553802,1.0,4/12,19.80%,ABCA3;SPP1;ABCB4;DBI
prerank,modulation by host of viral genome replication (GO:0044827),-0.6145884849334654,-1.4983221883642601,0.029585798816568046,0.7186952742467981,1.0,11/13,24.55%,PRKN;EIF2AK4;FMR1;NUCKS1;TBC1D20;ZC3H12A;CCNK;PPIB;VAPA;FBXL2;IFI27
prerank,positive regulation of angiogenesis (GO:0045766),0.6063173534434818,1.4955171650032213,0.009355509355509356,0.8436641496168473,1.0,18/108,10.13%,FGF18;ISL1;BRCA1;VASH2;SP1;FGF1;VEGFC;RUNX1;SASH1;ADAM12;THBS1;PRKCB;PRKCA;IL1A;AGO2;ITGB8;MTDH;F3
prerank,positive regulation of exosomal secretion (GO:1903543),0.7282897146237665,1.4950162450958828,0.0676056338028169,0.8410082259059796,1.0,8/15,14.59%,TSG101;SMPD3;VPS4A;SDCBP;HGS;VPS4B;PDCD6IP;RAB7A
prerank,response to purine-containing compound (GO:0014074),-0.5580743789309429,-1.493739023438266,0.03308823529411765,0.7250178845191058,1.0,3/17,1.85%,RYR2;P2RX7;NDUFS4
prerank,response to interleukin-6 (GO:0070741),0.7833879860572173,1.4924356895746236,0.03816793893129771,0.8517568714225844,1.0,3/10,8.51%,RELA;PID1;PTPRT
prerank,skeletal muscle tissue development (GO:0007519),0.6530185762337353,1.4921474151935852,0.05339805825242718,0.8478838746903887,1.0,6/32,16.32%,SELENON;SVIL;LEMD2;ZBTB18;MEF2C;CFLAR
prerank,monoacylglycerol metabolic process (GO:0046462),0.7567517553815756,1.4914865148989664,0.043348281016442454,0.8468002192937683,1.0,4/13,10.19%,MOGAT3;ABHD6;PLA2G4A;ABHD16A
prerank,positive regulation of kinase activity (GO:0033674),0.5965736986676463,1.491463081635658,0.007186858316221766,0.8411925860973557,1.0,13/107,8.16%,MUSK;CAMKK1;ROR2;DDR1;DDR2;RAD50;GAS6;EPHB2;RAP1A;AXL;MRE11;MAPT;NBN
prerank,spliceosomal snRNP assembly (GO:0000387),0.6501820393119789,1.4911554661822946,0.04377880184331797,0.8373590186743561,1.0,9/38,9.48%,SNRPD2;SNRPD1;GEMIN8;SART1;PRPF3;GEMIN2;TGS1;PRPF6;SNRPD3
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.6048632490451331,1.4910608422970373,0.019128586609989374,0.8324660303789934,1.0,21/74,15.19%,BMP5;RGCC;TGFB2;OLFM1;SMAD3;SPRED2;SDCBP;MCRIP1;LDLRAD4;EZH2;DAB2;TGFBR2;USF3;MTOR;TGFBR1;SPRED1;ADIPOR1;PTEN;DAG1;CLASP1;SMAD4
prerank,peptidyl-proline hydroxylation (GO:0019511),0.7648704848214828,1.4904274587729396,0.0490506329113924,0.8310236259555347,1.0,6/11,12.46%,CRTAP;P4HTM;EGLN3;EGLN2;EGLN1;P4HA1
prerank,"base-excision repair, gap-filling (GO:0006287)",0.6586616990891895,1.4902445791313468,0.035545023696682464,0.8267042865899932,1.0,6/35,6.74%,POLG;MPG;RFC2;PARG;POLD3;POLB
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.788543519870512,1.4868124650210266,0.044753086419753084,0.8438511329266926,1.0,5/10,8.59%,DNAJB1;BAG3;IMPACT;JUN;NCK1
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.7735434837928674,1.4860512785847473,0.0618705035971223,0.8430103642607342,1.0,2/11,9.50%,PLA2G7;ABCG1
prerank,potassium ion homeostasis (GO:0055075),-0.5065740456834433,-1.4859704876909963,0.04265402843601896,0.7483664393523403,1.0,7/23,8.21%,ATP1B3;ATP1B1;ATP1A1;ATP1A2;KCNJ2;SLC12A9;ATP1A3
prerank,sodium ion import across plasma membrane (GO:0098719),0.7232234365326808,1.4858877481241388,0.04845222072678331,0.8386575241038362,1.0,5/17,8.80%,SLC9A9;SLC9A1;TRPM4;SLC9A7;SLC9A6
prerank,regulation of histone acetylation (GO:0035065),0.6484947086735864,1.4833287792972032,0.03618817852834741,0.8500428125832153,1.0,10/33,12.73%,BRCA1;THAP7;HDAC5;SET;RPS6KA5;TADA2A;CTBP1;GLYR1;NOC2L;BRD7
prerank,regulation of cellular protein catabolic process (GO:1903362),0.7173835835875535,1.4829787446593008,0.05371900826446281,0.8467355310313126,1.0,9/18,12.69%,CDK5RAP3;MSN;NELL1;HSP90AA1;EZR;PTTG1IP;VPS35;FAF1;VPS11
prerank,negative regulation of histone acetylation (GO:0035067),0.7823732420223112,1.4829385679208962,0.038980509745127435,0.8415831018118256,1.0,5/11,10.74%,BRCA1;THAP7;SET;CTBP1;NOC2L
prerank,cell part morphogenesis (GO:0032990),0.7402434967461287,1.482588464798428,0.04354136429608128,0.8386104937880686,1.0,5/13,6.28%,NUBPL;PID1;SLIRP;WASF1;PACSIN2
prerank,negative regulation of leukocyte migration (GO:0002686),0.8004472290019308,1.4819863535487312,0.05642633228840126,0.8372560724568893,1.0,1/10,0.10%,BMP5
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.7867349407069929,1.4817328033689552,0.04754601226993865,0.8336069090996114,1.0,1/10,0.10%,BMP5
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.6515904783471906,1.4817092301148633,0.05581395348837209,0.8286132654076354,1.0,11/37,12.02%,DFFB;RNASE6;RNASEH2A;NUDT5;PPP1R8;EXOSC7;NUDT9;PABPC4;ENTPD1;XRN2;RNASE3
prerank,positive regulation of transferase activity (GO:0051347),0.5920474324117678,1.481543239333789,0.0030181086519114686,0.8246840842550537,1.0,26/142,11.25%,MUSK;PLK1;ROR2;DDR1;DDR2;SERINC5;RFC2;FBXW7;RAD50;TCP1;EPHB2;MAPK1;AXL;DCUN1D4;POLG2;HSP90AA1;HNRNPA2B1;MRE11;PKIB;NBN;NEK7;HMBOX1;EPHA5;UBE2I;SERINC1;IGF1R
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.618802532340771,1.4810106262789708,0.028047464940668825,0.8233355088740388,1.0,9/56,8.83%,BMP5;SMAD6;PMEPA1;TGFB2;BMPR1A;SDCBP;ACVR1;LDLRAD4;DAB2
prerank,DNA replication (GO:0006260),0.5975797343704365,1.4796209303762282,0.011235955056179775,0.826750702771196,1.0,21/105,9.38%,POLG;BRCA1;PCLAF;BLM;RFC2;POLE2;RNASEH2A;RAD50;ORC4;POLA1;WRN;CDK2;CDK2AP1;POLA2;POLG2;POLB;RBBP8;MRE11;NBN;SET;ORC2
prerank,negative regulation by host of viral process (GO:0044793),-0.6689811322805939,-1.478834730697551,0.04065040650406504,0.770862596747769,1.0,6/10,25.74%,PRKN;EIF2AK4;ZC3H12A;CCNK;VAPA;PSMC3
prerank,regulation of cell motility (GO:2000145),0.5915395311892379,1.4777935925806647,0.01006036217303823,0.8334993174543107,1.0,19/121,12.03%,FGF22;FGF18;SGK3;MGAT3;CAVIN1;PLXNA1;NRG2;MINK1;FGF1;FLNA;CDK6;CAMSAP3;PKN2;TBCCD1;DIAPH1;CYRIB;TMSB4X;ABL1;RAF1
prerank,DNA strand elongation (GO:0022616),0.7111851914631013,1.4775576794862424,0.056833558863328824,0.8298631171218225,1.0,5/18,8.16%,RAD50;POLA1;POLD3;MRE11;NBN
prerank,nuclear membrane disassembly (GO:0051081),0.7458296580741244,1.4768032332861603,0.052704576976421634,0.8296293368646784,1.0,5/14,7.27%,PLK1;PRKCB;PRKCA;CTDNEP1;DCTN1
prerank,natural killer cell mediated immunity (GO:0002228),0.7233766916657979,1.4762962477621284,0.05454545454545454,0.827756267832539,1.0,2/15,3.27%,TUBB4B;RAET1E
prerank,positive regulation of translational initiation (GO:0045948),0.7140974745619008,1.4750984366574058,0.0504774897680764,0.8305364182285807,1.0,3/18,1.67%,POLR2D;HABP4;RPS6KB2
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.7077121318988434,1.4740979482785506,0.06089309878213803,0.8319015155004837,1.0,11/18,17.42%,CTSC;MSN;HSP90AA1;EZR;PTTG1IP;VPS35;FAF1;VPS11;CD81;RDX;VGLL4
prerank,positive regulation of MAP kinase activity (GO:0043406),0.6082925550240283,1.4739412390108542,0.035752979414951244,0.8279985774637444,1.0,8/66,5.17%,FGF18;TNFRSF11A;LRRK2;TPD52L1;FGF1;SASH1;MAP3K11;PDGFB
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.673346103578945,1.4738577043875563,0.05368289637952559,0.8236479765574661,1.0,7/25,6.24%,ANG;GLMN;ITGA6;AR;THBS1;NRP1;SDCBP
prerank,regulation of kinase activity (GO:0043549),0.5968216135359469,1.4729592379722904,0.025906735751295335,0.8245213053865431,1.0,12/89,8.16%,MUSK;ROR2;DDR1;DDR2;RAD50;ANKRD54;EPHB2;AXL;IRS2;MRE11;MAPT;NBN
prerank,regulation of phospholipase activity (GO:0010517),-0.6606746374160328,-1.4729467519170814,0.05390835579514825,0.784554161368385,1.0,4/10,11.78%,FGFR2;SNCA;RGS2;PDPK1
prerank,atrial septum morphogenesis (GO:0060413),0.7831960714005597,1.4715453600950366,0.04777070063694268,0.828614213686134,1.0,3/10,6.38%,ISL1;TGFB2;ACVR1
prerank,B cell mediated immunity (GO:0019724),-0.6373841673723489,-1.471339523621921,0.06666666666666667,0.7762099696787651,1.0,6/10,26.08%,FCER1G;FCGR2B;MSH2;CD74;CARD9;TLR8
prerank,cellular response to alcohol (GO:0097306),0.6314620557488636,1.47013019560481,0.04719101123595506,0.8325961226353832,1.0,9/42,7.03%,BRCA1;BLM;ADCY8;ADCY3;KLF9;ADAM15;ADCY5;CTNNA1;GOLPH3
prerank,ovarian follicle development (GO:0001541),0.7437478451562043,1.4700043274194925,0.06408345752608048,0.8286201524460146,1.0,1/13,0.24%,ANG
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.7831689030605926,1.4658627718727362,0.04420731707317073,0.850070818549126,1.0,5/10,10.74%,BRCA1;THAP7;SET;CTBP1;NOC2L
prerank,response to estrogen (GO:0043627),0.6642402325560947,1.4647581524930586,0.048507462686567165,0.8520913903230034,1.0,6/31,6.00%,BRCA1;PELP1;AR;WBP2;EP300;ESR1
prerank,negative regulation of nervous system development (GO:0051961),-0.5348414796965505,-1.4633220183995606,0.06463878326996197,0.8038590345730499,1.0,7/17,21.22%,PCM1;B2M;APPL2;NOTCH1;TLR2;REST;SLIT1
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.7288533790905979,1.4622936130245314,0.06648575305291723,0.8625714872420578,1.0,5/14,10.28%,ITGB1BP1;FLNA;LIMS1;CD63;LOXL3
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.7577874475659439,1.4620186653452216,0.054441260744985676,0.8594993416676305,1.0,4/12,6.77%,PLK1;PRKCB;PRKCA;CTDNEP1
prerank,nucleocytoplasmic transport (GO:0006913),0.6348388774963746,1.4612631417894941,0.05096262740656852,0.8595940825281573,1.0,10/40,9.48%,SNRPD2;SNRPD1;GEMIN8;PHAX;ATXN1;NUP205;GEMIN2;RGS14;NUP98;SNRPD3
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.6199633599619632,1.459702241256381,0.05073280721533258,0.8648806591445921,1.0,6/45,8.83%,BMP5;TGFB2;BMPR1A;SDCBP;ACVR1;DAB2
prerank,activation of protein kinase B activity (GO:0032148),0.6450071143248493,1.4592714754189777,0.0728395061728395,0.8628065761152436,1.0,9/29,13.60%,ANG;FGF1;ITGB1BP1;GAS6;PDGFB;MAPKAP1;IL18;MTOR;INSR
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.65994128011508,1.4572354122486342,0.07202881152460984,0.8709668206670949,1.0,9/27,12.18%,RNASE6;ZC3H12D;CSTF3;RNASE4;XRN1;POP1;ZC3H12B;CPSF3;ERN1
prerank,sulfur amino acid catabolic process (GO:0000098),0.7648369272983211,1.4569672301246466,0.056818181818181816,0.8678936656828122,1.0,1/10,0.33%,CBS
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.6726563639653416,1.4567470203384234,0.08311688311688312,0.8645569230373785,1.0,4/21,7.05%,ADCY8;ADCY3;ADCY5;ADCY9
prerank,regulation of protein localization to cell periphery (GO:1904375),0.7095985701585281,1.4563449402072735,0.06495263870094722,0.8623868774110421,1.0,7/18,9.89%,PLK1;LDLRAP1;VPS4A;AR;STX7;SPTBN1;CDK5
prerank,sulfation (GO:0051923),0.7542587527860483,1.4547472560594135,0.06607929515418502,0.8679463974778107,1.0,1/11,1.12%,UST
prerank,cellular response to cAMP (GO:0071320),0.6501072317869567,1.4546582342226324,0.04945717732207479,0.8638676583004399,1.0,9/30,15.36%,HCN3;RAPGEF1;AKAP9;RAP1A;EZR;RAP1B;ZFP36L1;PKD2;HCN1
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.5289016702602671,-1.4543130595364349,0.05533596837944664,0.8370534600809746,1.0,7/18,14.16%,PRKN;NONO;PPIA;SOD2;TRAP1;AKT1;SIRT1
prerank,lipoprotein catabolic process (GO:0042159),-0.6293555456995694,-1.4536695200597332,0.04643962848297214,0.8233813537695976,1.0,9/11,35.27%,CTSD;PPT1;ABHD17B;ABHD17C;LYPLA1;ABHD10;LYPLA2;LYPLAL1;ABHD17A
prerank,cholesterol metabolic process (GO:0008203),0.6023687944517792,1.4533433501479054,0.025477707006369428,0.8675862735654217,1.0,14/68,14.69%,LCAT;INSIG1;GBA2;LDLRAP1;INSIG2;SOAT1;GGPS1;CEL;ABCG1;ABCA1;RXRA;PPARD;OSBPL1A;ABCA5
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.619067311616585,1.4531617148153175,0.04783599088838269,0.8642849956804279,1.0,18/43,16.09%,TSG101;DUSP3;GRB2;SOCS4;AREG;PTPRJ;RNF115;PTPN3;HGS;SOCS5;MVP;CDC42;CBL;TGFA;EPS15;RAB7A;SH3KBP1;SH3GL2
prerank,response to fatty acid (GO:0070542),0.6920536117737848,1.45262654824911,0.06310013717421124,0.8632052546157497,1.0,3/17,4.54%,CD36;PID1;IRS1
prerank,lipoprotein transport (GO:0042953),0.7774275903602605,1.4526194815606834,0.061514195583596214,0.8587856280949454,1.0,4/10,11.09%,CD36;PRKCB;PPARG;MIA3
prerank,acylglycerol biosynthetic process (GO:0046463),0.6705068148105648,1.4504033447778215,0.06405228758169934,0.8678152350309403,1.0,5/23,11.56%,ANG;MOGAT3;GPAM;PLA2G4A;GK
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.7006677232081943,1.4500410092068938,0.07282913165266107,0.8656074747748914,1.0,3/16,3.27%,TUBB4B;VAMP7;RAET1E
prerank,signal release from synapse (GO:0099643),0.6234570556092704,1.4491419625224216,0.04262672811059908,0.8668314966692757,1.0,7/43,9.89%,STXBP2;PDZD11;DVL1;GAD2;SYN3;VAMP2;CDK5
prerank,peptidyl-lysine dimethylation (GO:0018027),0.6999794250476716,1.4490288282819568,0.07862068965517241,0.8632248659366278,1.0,7/18,8.35%,EHMT1;SUV39H1;SETD1A;EHMT2;SETD2;SETD3;ASH1L
prerank,membrane depolarization (GO:0051899),-0.44016206456457474,-1.4486886243674029,0.037267080745341616,0.834846257678816,1.0,12/32,22.11%,P2RX7;CACNB4;CACNA1E;SCN2A;SCN3A;SCN8A;CACNA1B;ATP5IF1;SCN1B;P2RX4;SCN9A;CACNG2
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.48581469032953895,-1.4485700693370873,0.04608294930875576,0.818642402590153,1.0,6/22,14.13%,CACNB4;NOS1AP;PDE4B;FMR1;AHNAK;STAC
prerank,neurotrophin signaling pathway (GO:0038179),0.6791797903353748,1.4483511512896916,0.06265984654731457,0.8632255731818587,1.0,4/21,4.54%,RAPGEF1;ZFYVE27;GRB2;RAP1A
prerank,regulation of neuroblast proliferation (GO:1902692),0.7053233424048637,1.4477972405551254,0.07905686546463246,0.8624099132990068,1.0,3/15,4.01%,LRRK2;CX3CL1;NF1
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.6449570467854285,1.4458336981218909,0.06090133982947625,0.8703944277294647,1.0,8/29,9.30%,ISL1;BRCA1;UBA5;RUNX1;WBP2;ESR1;GPAM;CNOT9
prerank,positive regulation of phosphorylation (GO:0042327),0.57495050173462,1.4456378278406086,0.001001001001001001,0.8672078388465382,1.0,34/240,10.08%,MUSK;FGF22;FGF18;ANG;ROR2;DDR1;LRRK2;DDR2;RAD50;GLMN;FGF1;ITGA6;VEGFC;GAS6;NIBAN1;EPHB2;AR;THBS1;NRP1;AKTIP;CDK2AP1;AXL;SDCBP;HSP90AA1;MRE11;NBN;NPTN;DAB2;KRAS;FNIP1;FXR2;MAVS;LYN;EPHA5
prerank,AMP metabolic process (GO:0046033),0.7316343614541235,1.4450107988934644,0.0856353591160221,0.8668802710813538,1.0,3/13,2.57%,AK4;AK3;ADSS1
prerank,positive regulation of nuclear division (GO:0051785),0.6595539112841042,1.4448908302380299,0.06132665832290363,0.8633447678103486,1.0,7/25,15.29%,RGCC;PDGFB;LRP5;IL1A;TGFA;INSR;PHIP
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.7441165080184386,1.4442509007695343,0.0723781388478582,0.8629041186681797,1.0,1/12,0.10%,BMP5
prerank,negative regulation of centrosome duplication (GO:0010826),0.7540051567722248,1.4441054178688826,0.07007299270072993,0.8596617391641873,1.0,3/11,3.49%,BRCA1;TMEM67;MDM1
prerank,cellular response to ketone (GO:1901655),0.6369882703671405,1.4430479623106722,0.07192575406032482,0.8614751893009167,1.0,13/35,14.41%,ADCY8;ADCY3;KLF9;ADAM15;MSN;AR;ADCY5;NR3C1;GOLPH3;DCPS;GNG2;ROCK2;GNB1
prerank,sister chromatid segregation (GO:0000819),0.6236325558685374,1.4426631727026782,0.08262454434993925,0.8598554676578002,1.0,2/31,0.85%,PLK1;ZWINT
prerank,regulation of striated muscle contraction (GO:0006942),-0.4549818664531315,-1.442445507503019,0.06153846153846154,0.8368584231727747,1.0,6/27,6.96%,RYR2;CALM2;ASB3;SMAD7;GRK2;ATP1A2
prerank,regulation of angiogenesis (GO:0045765),0.5754624826384953,1.4415118506232678,0.006036217303822937,0.86310455490899,1.0,29/192,10.13%,FGF18;ISL1;THBS2;RGCC;BRCA1;VASH2;SP1;FGF1;VEGFC;RUNX1;TGFB2;SASH1;NF1;ADAM12;THBS1;CEMIP2;PRKCB;PRKCA;IL1A;PDE3B;MECP2;AGO2;EGLN1;ALOX5;ITGB8;PPARG;MTDH;HGS;F3
prerank,cardiac ventricle morphogenesis (GO:0003208),0.6200090461290475,1.441363500092404,0.058823529411764705,0.8598499413266455,1.0,5/41,4.91%,ISL1;TGFB2;BMPR1A;CPE;TPM1
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.5854842522774266,1.44041325909865,0.030271398747390398,0.8618566270679604,1.0,19/83,10.46%,TUBB4B;PLK1;CETN2;ALMS1;MAPRE1;AKAP9;CEP250;YWHAE;PRKACA;CDK2;PCNT;HSP90AA1;DCTN1;TUBA1A;DCTN2;CCP110;ODF2;CEP152;CNTRL
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.6644114483183511,1.4401186548997726,0.06108897742363878,0.8596072451302401,1.0,9/22,11.58%,TSG101;VPS4A;RNF115;NEDD4;PTPN23;PLAA;VPS37C;VPS37A;VPS4B
prerank,negative regulation of cell division (GO:0051782),0.7505846244922236,1.439909153618509,0.07882534775888717,0.8568392999828492,1.0,2/11,2.78%,BLM;VPS4A
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.5822138465491142,1.438895883775242,0.016597510373443983,0.859014138124642,1.0,23/95,10.46%,TUBB4B;PLK1;CETN2;CEP89;NPHP4;ALMS1;TMEM67;MAPRE1;IQCB1;AKAP9;CEP250;YWHAE;PRKACA;PCNT;HSP90AA1;DCTN1;TUBA1A;DCTN2;CCP110;ODF2;AHI1;CEP152;CNTRL
prerank,regulation of smoothened signaling pathway (GO:0008589),0.6190660344613451,1.438111733410772,0.04955947136563876,0.8596121779806407,1.0,4/50,4.29%,EVC;RORA;GAS1;HERC4
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.6099578215301349,1.4376658354649599,0.059684684684684686,0.8583512774290509,1.0,12/43,14.37%,RELA;SMARCA4;TGFB2;JUN;SMAD3;PDGFB;TEAD1;NR3C1;PPARG;TP53;DDX5;PPARD
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.6115725799811371,1.4373016146428659,0.043673012318029114,0.8564871196172608,1.0,14/46,12.40%,MTAP;CFL1;TCP1;MSN;RPLP0;HNRNPA2B1;HSPA9;RAP1B;PAK2;ANXA2;CDC42;ARF1;TALDO1;PITPNA
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.6167641903314522,1.4366261116935468,0.058426966292134834,0.8569849509917769,1.0,9/43,10.80%,PLK1;BRCA1;BLM;CDK5RAP3;MRE11;NBN;BABAM2;TAOK1;FOXN3
prerank,heterocycle biosynthetic process (GO:0018130),0.7199540233161721,1.4358445578509416,0.0746054519368723,0.8578391026654897,1.0,4/14,8.48%,PYCR2;LIAS;NFS1;ALOX5
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.5695018861197105,1.4313804345599632,0.02556237218813906,0.8810842806337366,1.0,24/113,13.90%,BMP5;ANG;VASH2;NRAS;C5AR1;FGF1;VEGFC;AREG;NRP1;PDGFB;PRKCA;F3;NOTCH2;SOX11;LAMC1;TCF7L2;TGFA;TGFBR1;AGGF1;RTN4;PPP1R16B;RREB1;NRP2;PRKD2
prerank,heart morphogenesis (GO:0003007),0.6049523883575924,1.4297361763355632,0.056433408577878104,0.8872130917996254,1.0,7/50,8.95%,ISL1;TGFB2;OLFM1;BMPR1A;FLRT2;ACVR1;CHD7
prerank,canonical Wnt signaling pathway (GO:0060070),0.5887124076568007,1.428322472938588,0.0481283422459893,0.892093645527846,1.0,13/68,14.70%,WNT4;LRRK2;WNT2B;DVL1;LRP5;DIXDC1;APC;TCF7L2;LRP6;CSNK1A1;FZD9;FZD3;PTEN
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.5853446115708357,1.427558997461426,0.0412262156448203,0.8930458016239101,1.0,22/75,14.70%,PLK1;CDK5RAP3;TFAP4;PRKAR2A;SMPD1;NF1;LRP5;PTPRJ;IPO7;RGS14;PKIB;PTPN1;APC;LYN;IPO5;PKIA;ABL1;SORL1;SH2B3;LRP6;HEG1;PTEN
prerank,regulation of actin filament-based movement (GO:1903115),-0.6312860124826709,-1.4274070957056308,0.06166219839142091,0.9058933279514947,1.0,2/10,4.82%,PDE4D;PDE4B
prerank,muscle cell migration (GO:0014812),0.7520096979269192,1.4271066572187463,0.0633693972179289,0.8916939539046055,1.0,2/10,3.16%,DDR1;ITGB1BP1
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.6811945649035455,1.4267763589735984,0.0739247311827957,0.8898205028954025,1.0,3/17,5.27%,GJC1;GJD3;PRKACA
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.617637248332919,1.426428139967692,0.06334841628959276,0.8880000330901943,1.0,3/41,4.56%,ACE2;KCNJ6;FLNA
prerank,positive regulation of protein secretion (GO:0050714),0.5840164421720221,1.426093715493773,0.046637744034707156,0.8861504641854724,1.0,18/69,12.94%,ISL1;ANG;NNAT;PPID;TGFB2;PSMD9;IL1A;IRS2;EZR;GOLPH3;TM7SF3;ABCG1;PTPN23;WLS;CD2AP;GCK;TCF7L2;FRMD4A
prerank,negative regulation of cellular component organization (GO:0051129),0.5837698090398235,1.4257034045479535,0.04148936170212766,0.8846367641094862,1.0,16/74,12.31%,ISL1;DNAJB1;PRKCZ;RIOK3;SACS;IMPACT;AR;EP300;TERF2;SYT11;ABCA7;CDC42;SCAMP5;RAF1;AIDA;SORL1
prerank,regulation of MAP kinase activity (GO:0043405),0.5731210616207906,1.4216937346479608,0.03954214360041623,0.9057041072807113,1.0,15/92,10.01%,FGF18;LRRK2;CDK5RAP3;TSG101;TPD52L1;FGF1;SMPD1;NF1;PDGFB;PTPRJ;RGS14;PTPN1;EZH2;LYN;HGS
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.6403044833474405,1.4205709139099143,0.0784557907845579,0.9089324348130252,1.0,10/26,12.69%,ISL1;BRCA1;SMARCA4;CLOCK;ZBTB7A;DAB2;NCOR1;CNOT9;NCOR2;VPS11
prerank,regulation of inclusion body assembly (GO:0090083),0.7363161655158783,1.4205308455117884,0.08144796380090498,0.9051804590636306,1.0,2/11,2.09%,DNAJB1;SACS
prerank,positive regulation of dendrite development (GO:1900006),0.7577074563501538,1.4193334819464387,0.10490693739424704,0.9087457958997393,1.0,1/10,0.10%,BMP5
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.5767989006692003,1.4190946149284933,0.05876068376068376,0.9063966207673173,1.0,17/74,13.04%,BMP5;BRCA1;EYA2;RELA;ITGA6;AR;THBS1;ACVR1;IL1A;RNF34;BIRC6;TRAF2;ZMYND11;MAP2K5;TCF7L2;TGFBR1;BCL2
prerank,gas transport (GO:0015669),-0.6327860531223604,-1.4188633689245052,0.04477611940298507,0.9400892464054826,1.0,1/10,2.94%,CA2
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.5247361677266734,-1.4187148284302546,0.09012875536480687,0.9235087333781091,1.0,3/17,1.51%,XIAP;SLIT2;CASK
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.700334836028243,1.417788926980272,0.10245310245310245,0.9103821870457834,1.0,4/14,6.71%,TYSND1;IRS1;ABCD2;IRS2
prerank,regulation of DNA recombination at telomere (GO:0072695),0.674261206187765,1.4170428577783816,0.09441489361702128,0.9073429237504332,1.0,5/19,13.42%,POLR2D;POLR2A;TERF2;ATRX;TERF1
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.674261206187765,1.4170428577783816,0.09441489361702128,0.9073429237504332,1.0,5/19,13.42%,POLR2D;POLR2A;TERF2;ATRX;TERF1
prerank,cellular response to organic cyclic compound (GO:0071407),0.5717678894984287,1.416765233797415,0.016112789526686808,0.9051737202900051,1.0,40/141,16.27%,HCN3;BRCA1;RORA;URI1;LRRK2;BLM;INSIG1;RIOK3;RAPGEF1;ADCY8;ADCY3;IMPACT;MSN;AR;AKAP9;ADCY5;RAP1A;PDGFB;CTNNA1;ESR1;NR3C1;EZR;GOLPH3;RAP1B;IL18;NCOA3;GABRG2;DIAPH1;ZFP36L1;LCOR;PKD2;GNG2;ROCK2;GNB1;P2RY12;SPIDR;HCN1;ARL6IP5;EPG5;MEF2C
prerank,positive regulation of ruffle assembly (GO:1900029),0.7210193848764139,1.4146940342943009,0.07566765578635015,0.9143006920650699,1.0,6/13,15.93%,FAM98A;NDEL1;EPS8L1;EPS8;P2RY12;PLEKHM1
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.5611684409545642,1.4144108701369449,0.014155712841253791,0.9122750308255158,1.0,33/150,15.24%,FGF22;FGF18;NRG2;CX3CL1;FGF1;GRB2;ITGB1BP1;GAS6;AREG;IRS1;THBS1;PDGFB;KITLG;PTPRJ;ESR1;AXL;IRS2;HSP90AA1;IL18;MTDH;F3;IGF1R;FRS2;TCF7L2;TGFA;TGFBR1;RTN4;INSR;FYN;P2RY12;PIK3AP1;VAV1;HIP1
prerank,striated muscle tissue development (GO:0014706),0.6296656949006105,1.414053990725678,0.08801955990220049,0.9104928976353832,1.0,4/29,8.91%,BMP5;SVIL;SGCG;NDUFV2
prerank,eye photoreceptor cell differentiation (GO:0001754),0.7194873382166901,1.4139591354654408,0.08853410740203194,0.9072696451608472,1.0,1/12,0.17%,SDK2
prerank,icosanoid biosynthetic process (GO:0046456),0.7394225616051531,1.413264421655054,0.09615384615384616,0.9079947333263335,1.0,4/10,9.99%,MGST3;PLA2G4A;ALOX5;FADS1
prerank,establishment of mitotic spindle localization (GO:0040001),0.6376852157154962,1.413106501648597,0.08004926108374384,0.9053277531794596,1.0,5/28,11.05%,PLK1;KPNB1;NDEL1;DCTN1;FBXW11
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.5981744295954976,1.4129889676550698,0.06411698537682789,0.9022370289899045,1.0,11/47,13.36%,ACE2;CD36;PID1;GRB2;THBS1;PDGFB;MAPT;TGFBR2;MAPK14;TP53;SYK
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.5926768809014139,1.4118718052916193,0.08156424581005586,0.9053313522952788,1.0,11/46,14.65%,ANG;IGFBP3;CX3CL1;THBS1;PDGFB;PRKDC;IL18;PPARG;TCF7L2;NDRG4;AIF1
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.617815876668766,1.4118702243942305,0.08004640371229699,0.9016528036509723,1.0,12/34,13.90%,GAS1;RELA;ITGB1BP1;VEGFC;NRP1;MT1G;SEMA6A;ERN1;MAPK14;MAPKAPK2;NUS1;PRKD2
prerank,B cell activation involved in immune response (GO:0002312),-0.5777985867170216,-1.4113901995394649,0.08387096774193549,0.9498156415427823,1.0,8/13,29.85%,FCGR2B;GPR183;RNF168;MSH2;CD180;RNF8;BATF;MSH6
prerank,regulation of mononuclear cell migration (GO:0071675),0.6557954096459802,1.4098925812463874,0.0913907284768212,0.9098205526403288,1.0,6/23,9.65%,BMP5;MSN;THBS1;CMKLR1;MAPK1;LYN
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.5912002563888348,1.409817356570806,0.05837837837837838,0.9065879551134265,1.0,13/57,10.80%,PLK1;BRCA1;BLM;CDK5RAP3;CDK2;PRKDC;MRE11;NBN;BABAM2;CHEK2;RFWD3;TAOK1;FOXN3
prerank,establishment of mitotic spindle orientation (GO:0000132),0.6464502059692131,1.4072454658274012,0.08883248730964467,0.9191400198990057,1.0,4/23,11.05%,PLK1;NDEL1;DCTN1;FBXW11
prerank,negative regulation of transposition (GO:0010529),0.689320268930038,1.4069426259966131,0.106703146374829,0.9171762039549577,1.0,2/16,3.35%,SIRT7;TUT4
prerank,substrate-dependent cell migration (GO:0006929),0.7009410824431564,1.4066368844110788,0.08356545961002786,0.9154160975227115,1.0,7/14,14.62%,ITGB1BP1;VEGFC;NRP1;SDCBP;ANKS1A;CD2AP;P2RY12
prerank,water-soluble vitamin metabolic process (GO:0006767),0.5795883506800824,1.4064090828321225,0.06309148264984227,0.9130797713271475,1.0,14/68,12.20%,PDZD11;BTD;PDXK;ALDH1L1;SLC2A3;MMADHC;TPK1;MCCC2;MTHFD2L;MTHFR;LMBRD1;MTR;PCCA;SLC25A32
prerank,endocrine system development (GO:0035270),0.6705516609116288,1.4055486007903024,0.09293193717277487,0.914435363001014,1.0,2/21,4.01%,WNT4;NF1
prerank,response to interferon-alpha (GO:0035455),0.6882253922558259,1.405248659404539,0.08207934336525308,0.9126988838139477,1.0,6/16,10.94%,IFITM3;EIF2AK2;GAS6;AXL;ADAR;IFNAR2
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.5904286837273045,1.4042110982407332,0.07295173961840629,0.9156543304019304,1.0,17/46,15.19%,DUSP3;CNKSR3;ITGB1BP1;EPHB2;SPRED2;EZR;DLG1;RGS14;RANBP9;DUSP10;PTPN1;LYN;SEMA6A;SPRED1;PTEN;TLR4;SMAD4
prerank,hepaticobiliary system development (GO:0061008),0.6507737220274084,1.4042009743083939,0.09244791666666667,0.9121076038894153,1.0,4/20,5.16%,WNT4;CDK5RAP3;NF1;ARID5B
prerank,protein import into mitochondrial matrix (GO:0030150),0.6649672156594069,1.4041843044054565,0.09324324324324325,0.9086205153530931,1.0,4/18,6.70%,TIMM17A;TOMM40;DNAJC15;TIMM23
prerank,cellular response to zinc ion (GO:0071294),0.6929678753548448,1.4034745374021664,0.10056657223796034,0.9094264009049281,1.0,9/15,10.61%,HVCN1;MT1F;MT1M;MT1H;MT1X;MT1A;MT1E;MT1G;MT1B
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.6725842635240072,1.402274238479251,0.09102730819245773,0.91332292177442,1.0,5/20,9.84%,PLK1;TFAP4;IPO7;APC;IPO5
prerank,negative regulation of neuron differentiation (GO:0045665),-0.4732778058056457,-1.4022724718655046,0.07462686567164178,0.987917399571194,1.0,4/22,9.40%,B2M;EIF2AK4;GSK3B;CALR
prerank,central nervous system neuron development (GO:0021954),0.6920792997650026,1.4019725355576955,0.07596685082872928,0.9117453676492863,1.0,7/15,14.70%,GBA2;ATP7A;HSP90AA1;MAPT;B4GALT5;ARHGAP35;PTEN
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.5932803436323082,1.4010767098609431,0.07469342251950947,0.9134062689168498,1.0,13/48,13.90%,FGF18;ATP5F1A;SP1;THBS1;HDAC9;PDGFB;PRKCA;TMSB4X;HMGB1;MAPK14;PIK3C2A;NUS1;PRKD2
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.6786796510126344,1.4010420311263945,0.09002770083102493,0.9100867036951851,1.0,3/16,4.94%,BLM;SSBP1;WRN
prerank,presynapse organization (GO:0099172),0.7453547013641416,1.4010299794748917,0.09782608695652174,0.9066637870281448,1.0,2/10,1.89%,C5AR1;DVL1
prerank,telomere capping (GO:0016233),0.6876322733982153,1.4006399268699474,0.10256410256410256,0.9056328156153045,1.0,8/16,15.16%,RAD50;DCLRE1A;TERF2;PRKDC;MRE11;NBN;TERF1;CTC1
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.6887632928333836,1.398872542861948,0.0937062937062937,0.9124235945869975,1.0,2/16,5.26%,PDE6H;PRKCA
prerank,microtubule bundle formation (GO:0001578),0.6060947263362653,1.3987398485784663,0.08823529411764706,0.90986341874592,1.0,5/42,7.32%,PLK1;RSPH4A;NAV1;NCKAP5L;CCDC66
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.6115798017910311,1.3974962231096348,0.07276995305164319,0.9139560786049878,1.0,7/39,12.47%,ISL1;NNAT;PSMD9;IRS2;TM7SF3;GCK;TCF7L2
prerank,neurotransmitter secretion (GO:0007269),0.5988755466420737,1.3972441633303092,0.07394766780432309,0.9120637091870667,1.0,7/44,9.89%,STXBP2;PDZD11;DVL1;GAD2;SYN3;VAMP2;CDK5
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),-0.6222907112163094,-1.39642426207282,0.08516483516483517,1.0,1.0,8/10,32.14%,CPEB3;NUDT21;HSF1;NCBP1;CDC73;NCBP2;PAF1;LEO1
prerank,nuclear membrane organization (GO:0071763),0.658289156427777,1.3954589966352005,0.1091644204851752,0.9194382510020835,1.0,4/19,7.27%,PLK1;VPS4A;TARDBP;DCTN1
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.6324581518520448,1.3953986301584609,0.10401002506265664,0.9163241262355479,1.0,2/26,0.41%,EIF6;BRCA1
prerank,positive regulation of cell junction assembly (GO:1901890),0.5918161663569503,1.394886652212876,0.06616052060737528,0.9159690446156763,1.0,10/56,11.90%,ACE2;NPHP4;EPHB2;NRP1;CLSTN3;PTPRJ;IL1RAP;LIMS1;CLSTN1;ABL1
prerank,activation of adenylate cyclase activity (GO:0007190),0.6108575240167907,1.3945264862234956,0.07793764988009592,0.9148851579880188,1.0,5/35,7.05%,RXFP1;ADCY8;ADCY3;ADCY5;ADCY9
prerank,regulation of programmed necrotic cell death (GO:0062098),0.6589711357875946,1.3937813281306997,0.09879839786381843,0.9159428613006694,1.0,9/20,13.31%,FLOT2;NUPR1;PELI1;SDCBP;BIRC3;HSP90AA1;ASAH1;CYLD;PDCD6IP
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.6545074185480231,1.393552201505787,0.0888030888030888,0.9138490201478715,1.0,6/22,7.60%,RAPGEF1;EHD1;STMN2;WASF1;RAP1A;MAPT
prerank,cellular response to interleukin-12 (GO:0071349),0.588463693564872,1.3935438188639804,0.07142857142857142,0.9105771969771524,1.0,14/48,12.40%,MTAP;CFL1;TCP1;MSN;RPLP0;HNRNPA2B1;HSPA9;RAP1B;PAK2;ANXA2;CDC42;ARF1;TALDO1;PITPNA
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.6738733350677348,1.3934494612812176,0.10518934081346423,0.9078530395713734,1.0,3/15,6.66%,BRCA1;TGFB2;CAMSAP3
prerank,regulation of centriole replication (GO:0046599),0.6705778561791729,1.3927695671295488,0.09375,0.9088616616065067,1.0,3/18,3.49%,BRCA1;ALMS1;MDM1
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.5742871777946033,-1.3925970950706614,0.08974358974358974,1.0,1.0,7/12,33.05%,GCLC;CNDP2;HAGH;GCLM;GSS;CHAC2;OPLAH
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.6424762380976106,1.3922744756818262,0.07888040712468193,0.9087269219233522,1.0,7/23,13.69%,UACA;RELA;IFI35;TMSB4X;PPM1A;CYLD;ADIPOR1
prerank,nuclear transport (GO:0051169),0.6865954115979995,1.3920609664023054,0.10758620689655173,0.9067996048217153,1.0,5/16,7.61%,BANF1;PSIP1;NUP205;RGS14;NUP98
prerank,negative regulation of cartilage development (GO:0061037),0.7124135992285927,1.39155387557329,0.08746355685131195,0.9063656031776537,1.0,1/13,0.64%,ADAMTS12
prerank,positive regulation of neuron projection development (GO:0010976),0.5653814952688169,1.3914162310937683,0.04583333333333333,0.903935022908523,1.0,20/85,11.34%,BMP5;ROR2;CX3CL1;RAPGEF1;ITGA6;CAMK1D;STMN2;RAP1A;EP300;SERPINI1;SNX3;ARSB;TWF2;NPTN;LRP8;LYN;SETX;ARHGAP35;RIT2;DBNL
prerank,regulation of phosphate metabolic process (GO:0019220),0.6757251264804082,1.391298106239711,0.08713692946058091,0.901434476639026,1.0,4/16,7.16%,SMG6;PGAM1;IGBP1;IKBKB
prerank,homocysteine metabolic process (GO:0050667),0.7304740018731543,1.390835695200233,0.08742331288343558,0.9009190454149055,1.0,2/11,6.57%,CBS;MTHFR
prerank,megakaryocyte differentiation (GO:0030219),0.7328783818524707,1.3908301392988023,0.1050228310502283,0.8977572480871506,1.0,4/11,17.53%,UBA5;TAL1;SH2B3;MED1
prerank,intracellular cholesterol transport (GO:0032367),0.6852501996197141,1.390262489896352,0.09957325746799431,0.8980426831235622,1.0,7/15,13.13%,LDLRAP1;OSBP;VPS4A;ABCG1;RELCH;ABCA1;LRP6
prerank,regulation of B cell apoptotic process (GO:0002902),0.7017855702702018,1.388881225332301,0.10014306151645208,0.9030655250456345,1.0,6/12,10.74%,BCL6;BTK;IRS2;FNIP1;LYN;NOC2L
prerank,positive regulation of histone acetylation (GO:0035066),0.6250681396809004,1.3886396365978217,0.10408921933085502,0.9013691037920152,1.0,7/23,15.19%,BRCA1;WBP2;RPS6KA5;TADA2A;GLYR1;BRD7;SMAD4
prerank,heart contraction (GO:0060047),-0.3950340947212337,-1.3883964901744974,0.046153846153846156,1.0,1.0,7/41,7.08%,SGCZ;RYR2;ATP1B1;GRK2;SGCD;ATP1A2;PIK3CA
prerank,negative regulation of cell communication (GO:0010648),0.6387678019607332,1.386900851474027,0.11282051282051282,0.9087733053570893,1.0,4/21,10.11%,IGFBP3;ACVR1;PTPN1;SOCS5
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.69610344598498,1.3866116643130404,0.10806916426512968,0.9072426827461376,1.0,3/14,6.60%,RGCC;THBS1;ITGA4
prerank,regulation of viral life cycle (GO:1903900),0.648311358083275,1.3860570378042147,0.09727626459143969,0.9072994457244736,1.0,5/21,10.54%,TSG101;VPS4A;AXL;KPNA6;TRIM5
prerank,cellular response to sterol (GO:0036315),0.7170745860098081,1.385851004038973,0.10334788937409024,0.9053898608394835,1.0,3/13,3.75%,RORA;INSIG1;INSIG2
prerank,protein O-linked glycosylation via serine (GO:0018242),0.7453563880056964,1.3857981779899262,0.1,0.9025805111131082,1.0,3/10,7.26%,POGLUT3;GALNT1;GALNT3
prerank,positive regulation by host of viral transcription (GO:0043923),0.6887804875673614,1.3854596097520255,0.11031518624641834,0.9013684920633952,1.0,6/15,7.41%,SMARCA4;SP1;TFAP4;JUN;EP300;RRP1B
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.6704566461639384,1.3854320262726585,0.11528150134048257,0.8984281477587146,1.0,9/16,17.50%,NRP1;PDGFB;PTPRJ;RGS14;PTPN1;ABL1;PIK3C2A;PDGFC;FER
prerank,positive regulation of cell adhesion (GO:0045785),0.5685686070284846,1.384530953542429,0.06376195536663125,0.9007415840844583,1.0,9/74,8.94%,CXCL12;RSU1;TGFB2;TPM1;PDGFB;PRKCA;PTPRJ;STX3;LIMS1
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.6549581771812556,1.3837947741368313,0.09448818897637795,0.8956853963388539,1.0,4/20,9.63%,PLK1;ZWINT;BUB3;APC
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.6549581771812556,1.3837947741368313,0.09448818897637795,0.8956853963388539,1.0,4/20,9.63%,PLK1;ZWINT;BUB3;APC
prerank,spindle assembly checkpoint signaling (GO:0071173),0.6549581771812556,1.3837947741368313,0.09448818897637795,0.8956853963388539,1.0,4/20,9.63%,PLK1;ZWINT;BUB3;APC
prerank,epithelial cell-cell adhesion (GO:0090136),0.7256179338923665,1.383720188572088,0.11275964391691394,0.8931494638161626,1.0,3/11,7.03%,VCL;CAMSAP3;ITGB5
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.6472920035308716,1.3837029093077988,0.09610389610389611,0.8902511882644739,1.0,4/21,9.63%,PLK1;ZWINT;BUB3;APC
prerank,positive regulation of interleukin-13 production (GO:0032736),0.7239529657784828,1.3823324981324203,0.10318664643399089,0.8952668295767838,1.0,3/10,14.00%,PRKCZ;IL18;LGALS9
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.652766272728944,1.3820202602242313,0.09045226130653267,0.891137785276761,1.0,9/23,15.19%,ZEB2;THBS1;EP300;SDCBP;STK11;GIPC1;DAB2;HIPK2;SMAD4
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.652766272728944,1.3820202602242313,0.09045226130653267,0.891137785276761,1.0,9/23,15.19%,ZEB2;THBS1;EP300;SDCBP;STK11;GIPC1;DAB2;HIPK2;SMAD4
prerank,mRNA destabilization (GO:0061157),0.5992849912539475,1.3817618628506771,0.08342989571263036,0.8896534655878661,1.0,11/38,12.05%,POLR2D;ZC3H12D;TUT4;TARDBP;FTO;RC3H2;METTL3;YTHDF1;PUM1;DCPS;ZFP36L1
prerank,cellular response to decreased oxygen levels (GO:0036294),0.572314185199039,1.3813293510698579,0.07036247334754797,0.8893283614713888,1.0,18/65,14.87%,RGCC;RORA;AK4;SUV39H1;UBQLN1;EGLN3;EGLN2;HP1BP3;BNIP3L;EGLN1;BNIP3;MTOR;ZFP36L1;HIPK2;TP53;FMN2;NDRG1;TSC1
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.590272662718139,1.3810136137445634,0.09101251422070535,0.8881578527807813,1.0,17/39,16.49%,TSG101;DUSP3;GRB2;AREG;PTPRJ;RNF115;PTPN3;HGS;MVP;CDC42;CBL;TGFA;EPS15;PTPN18;SH3KBP1;SH3GL2;LGMN
prerank,mesenchymal cell differentiation (GO:0048762),0.5918882716059354,1.381002591200434,0.05941704035874439,0.8853288341096712,1.0,10/51,14.30%,ISL1;WNT4;TGFB2;LIMS1;LOXL3;TGFBR1;LRP6;DDX5;RBPJ;ROCK2
prerank,maturation of LSU-rRNA (GO:0000470),0.6189103267507872,1.3809274330139016,0.10709838107098381,0.8827844953282883,1.0,3/26,1.18%,EIF6;ZNHIT3;BOP1
prerank,regulation of telomere capping (GO:1904353),0.6397601511563337,1.3804115169179783,0.110397946084724,0.8828242815200921,1.0,8/23,9.59%,RAD50;SMG6;TERF2;MAPK1;PKIB;NBN;TNKS2;NEK7
prerank,calcium ion homeostasis (GO:0055074),0.5676846619172866,1.3784649145531833,0.04569055036344756,0.8909748540325084,1.0,4/95,1.09%,CXCL12;WFS1;SELENON;SLC24A5
prerank,positive regulation of DNA binding (GO:0043388),-0.43279868001416116,-1.3770729309023062,0.06626506024096386,1.0,1.0,9/31,15.48%,PRKN;TGFB1;SIRT2;CEBPG;NIBAN2;IGF1;PINX1;TRAF6;PLAUR
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.5066261741395639,-1.3769431865419783,0.08561643835616438,1.0,1.0,9/17,17.35%,VCP;NPLOC4;FAF2;HM13;UFD1;DERL2;OS9;HERPUD1;AUP1
prerank,metal ion export (GO:0070839),-0.4237341297713581,-1.3765346408649697,0.0755813953488372,1.0,1.0,9/31,9.60%,KCNT2;ATP1B3;ATP1B1;SLC11A1;ATP1A1;ATP1A2;ATP1A3;KCND3;SLC40A1
prerank,monocyte chemotaxis (GO:0002548),0.615911414401561,1.3756389012749857,0.09212121212121212,0.9041254797035762,1.0,4/32,7.28%,TNFRSF11A;CX3CL1;PDGFB;CCL25
prerank,lipoprotein localization (GO:0044872),0.7240696665075685,1.3755591304849226,0.10648148148148148,0.9016946947960317,1.0,4/11,11.09%,CD36;PRKCB;PPARG;MIA3
prerank,negative regulation of protein processing (GO:0010955),0.7029310895409036,1.375031617160422,0.11475409836065574,0.9016831856564098,1.0,5/12,11.35%,GAS1;LRRK2;THBS1;CTSZ;PRNP
prerank,liver development (GO:0001889),0.6092261483567301,1.3748506728210768,0.10475030450669914,0.8997817060952553,1.0,4/32,5.16%,WNT4;CDK5RAP3;NF1;ARID5B
prerank,regulation of synapse assembly (GO:0051963),0.5957639508741667,1.3747902920236277,0.07374301675977654,0.8972220285578331,1.0,6/46,10.25%,MUSK;EPHB2;CLSTN3;IL1RAP;VPS35;CLSTN1
prerank,regulation of axon regeneration (GO:0048679),-0.5641290633631068,-1.374347750121878,0.09287925696594428,1.0,1.0,5/12,17.08%,RTN4RL1;GRN;PTPRS;EPHA4;CERS2
prerank,mitochondrial fission (GO:0000266),-0.5296288544800057,-1.3741906527226944,0.11824324324324324,1.0,1.0,9/16,26.54%,PRKN;OPA1;DNM2;SLC25A46;DNM1;MIEF1;GDAP1;FIS1;MTFR1
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.5322130144388714,-1.3730712727743424,0.09666666666666666,1.0,1.0,11/15,29.23%,VCP;NPLOC4;FAF2;UFD1;DERL2;OS9;HERPUD1;AUP1;SELENOS;SYVN1;HSP90B1
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.6237909561467785,1.3726500998772173,0.10899873257287707,0.9063815072748096,1.0,5/23,14.29%,FNTB;METAP1;NMT1;NMT2;CALM1
prerank,collagen fibril organization (GO:0030199),0.5619098840379274,1.372581627022581,0.055036344755970926,0.9038624114602861,1.0,13/88,12.97%,COL14A1;CRTAP;DDR2;ADAMTS2;ITGA6;TGFB2;NF1;ATP7A;COL11A1;LOXL3;PXDN;P4HA1;TGFBR1
prerank,defense response to virus (GO:0051607),0.5541477254164342,1.3722027431576334,0.04024767801857585,0.9031061478485266,1.0,28/100,15.14%,RNASE6;SERINC5;IFITM3;RELA;IRF1;EIF2AK2;TTC4;TLR7;FLNA;IRF3;EXOSC5;AKAP1;NT5C3A;SETD2;TLR3;BNIP3L;ZDHHC1;SERINC3;MAVS;TRIM5;BNIP3;IFNAR2;ZMYND11;BCL2;TRIM56;RNF135;G3BP1;ATG7
prerank,positive regulation of interleukin-12 production (GO:0032735),0.612245311564694,1.3701053433662966,0.09928229665071771,0.9121799908617884,1.0,8/31,14.85%,ISL1;IL16;TLR3;HMGB1;MAPK14;SYK;LGALS9;TLR4
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.6850585120927728,1.3700209919390687,0.12536023054755044,0.9098585841396146,1.0,5/13,15.94%,RELA;PDGFB;PPARG;PPARD;NFIB
prerank,mesoderm formation (GO:0001707),-0.514132807446487,-1.369555127957553,0.10227272727272728,1.0,1.0,2/17,2.27%,BMPR2;SMAD2
prerank,response to glucocorticoid (GO:0051384),0.6240803801354066,1.36902383069789,0.11015911872705018,0.9125996888266084,1.0,3/26,6.35%,ISL1;BCL2L11;NR3C1
prerank,ureteric bud development (GO:0001657),-0.49785749239790844,-1.3687309697348715,0.10431654676258993,1.0,1.0,4/17,9.42%,SLIT2;SALL1;FGFR2;NPNT
prerank,glutamate receptor signaling pathway (GO:0007215),-0.4004097818323462,-1.3686580363169174,0.09375,0.9913367015891988,1.0,13/37,13.22%,APP;GRIK1;GRIN2B;PTK2B;GRIN3A;GRM1;CLN3;CPEB4;FMR1;DAGLA;GRIK4;GRM3;GRIK2
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.6577853833032726,1.368262547582354,0.11481975967957277,0.9143178962234157,1.0,5/17,10.54%,CD36;CX3CL1;SASH1;PRKCA;TRIM5
prerank,defense response to symbiont (GO:0140546),0.5513042073085518,1.367342773397599,0.05394190871369295,0.9166537025021992,1.0,25/92,15.14%,RNASE6;SERINC5;IFITM3;RELA;IRF1;EIF2AK2;TTC4;TLR7;FLNA;IRF3;EXOSC5;NT5C3A;SETD2;TLR3;BNIP3L;SERINC3;MAVS;TRIM5;BNIP3;IFNAR2;ZMYND11;BCL2;TRIM56;G3BP1;ATG7
prerank,glutathione biosynthetic process (GO:0006750),-0.5743079069427846,-1.367286563660028,0.12312312312312312,0.9848035738267328,1.0,7/11,33.05%,GCLC;CNDP2;HAGH;GCLM;GSS;CHAC2;OPLAH
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.6976612107165452,1.3666274908940534,0.10601719197707736,0.9179881078556167,1.0,1/14,0.64%,ADAMTS12
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.6901592778581022,1.3655220829882513,0.12573099415204678,0.9216825537350861,1.0,5/14,9.28%,DDX60;PUM2;ZDHHC5;TLR3;PUM1
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.7047768741244467,1.3645458804031654,0.13513513513513514,0.9244299886203595,1.0,6/12,13.74%,PTPRJ;IFT20;HGS;F3;CBL;NDRG4
prerank,regulation of ossification (GO:0030278),0.6012003782430447,1.3644742512771886,0.10012062726176116,0.9219986194396113,1.0,11/36,14.21%,S1PR1;DDR2;SMAD6;CHSY1;TGFB2;ACVR1;TXLNG;SOX11;BMP2K;LRP6;RBPJ
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.648982294016904,1.3641959548804696,0.11820652173913043,0.920725712765407,1.0,5/17,10.28%,MID1;EIF2AK2;TGFB2;LYN;TAOK1
prerank,response to alcohol (GO:0097305),-0.4278822802078947,-1.3636040062730093,0.10294117647058823,0.9913056257447715,1.0,12/27,25.51%,SLIT2;GRIN2B;TGFB1;SMAD2;GRIN3A;GLRA1;TGFBR3;GOT2;ABCA2;SLIT3;GRIN1;SOD1
prerank,cellular response to nitrogen compound (GO:1901699),0.6423555699921326,1.363568318016148,0.1283068783068783,0.9213732031946147,1.0,7/20,15.96%,BLM;RIOK3;RTF2;ATRX;ROCK2;SPIDR;EPG5
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.7162374214189171,1.362171900216413,0.11214953271028037,0.9264732551726476,1.0,1/10,0.38%,RGCC
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.6784606009769197,1.36154787470562,0.11225997045790251,0.9270065197486214,1.0,4/13,11.44%,TSG101;SOCS4;SOCS5;CBL
prerank,positive regulation of translation (GO:0045727),0.5514726519913076,1.3613251604145737,0.060950413223140494,0.9254529664516777,1.0,18/94,9.11%,POLR2D;EIF6;HABP4;EIF4A3;COA3;RPS6KB2;EIF3C;EIF3E;NIBAN1;THBS1;PYM1;RBM3;PRKDC;METTL3;LARP4B;AGO2;YTHDF1;FXR2
prerank,response to cAMP (GO:0051591),0.5905963413306095,1.361242908209545,0.09425287356321839,0.9230870765062715,1.0,9/37,15.36%,HCN3;RAPGEF1;AKAP9;RAP1A;EZR;RAP1B;ZFP36L1;PKD2;HCN1
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.5506562654429358,1.3609235957600763,0.06569343065693431,0.9221406633575435,1.0,17/75,14.95%,ANG;VASH2;NRAS;SP1;VEGFC;NRP1;PDGFB;PRKCA;ITGA4;F3;HMGB1;TGFBR1;AGGF1;PPP1R16B;NRP2;PRKD2;ARNT
prerank,RNA methylation (GO:0001510),0.5607376604264733,1.3605521416606656,0.07939914163090128,0.9215425346118784,1.0,11/60,6.76%,WDR6;NSUN6;TRMO;TFB2M;METTL8;TARBP1;RBM15;TGS1;METTL3;CBLL1;NSUN3
prerank,positive regulation of vascular permeability (GO:0043117),-0.5655562955157494,-1.3604395713562325,0.11455108359133127,0.9943451037811103,1.0,8/12,33.45%,TJP1;TGFB1;TJP2;PDE3A;ANGPT1;VEGFA;TRPV4;BMP6
prerank,chromosome condensation (GO:0030261),0.5944373137283774,1.360438210804568,0.10550458715596331,0.9194199512956348,1.0,6/36,9.00%,PLK1;DFFB;BANF1;NCAPD3;SET;ACIN1
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.6410488549929722,1.3603636675417088,0.1310615989515072,0.917142754342724,1.0,3/20,6.60%,RGCC;THBS1;ITGA4
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.5896895400546381,1.3599775078727685,0.09662398137369034,0.9166648318415201,1.0,11/34,16.70%,RGCC;PDGFB;CDC23;LRP5;IL1A;CDC16;TGFA;INSR;PHIP;RB1;NSMCE2
prerank,negative regulation of blood pressure (GO:0045776),-0.5515274855430492,-1.359499888784932,0.11635220125786164,0.9855440831946639,1.0,2/13,9.69%,BMPR2;SCPEP1
prerank,GTP metabolic process (GO:0046039),0.6661247602167615,1.3593406288410697,0.11732605729877217,0.9175742165545335,1.0,3/15,1.44%,LRRK2;AK4;AK3
prerank,cellular response to inorganic substance (GO:0071241),0.637306911984789,1.358343193334611,0.12483912483912483,0.9206874713759263,1.0,6/21,14.72%,BLM;CDK2;RTF2;MTR;ATRX;SPIDR
prerank,synapse organization (GO:0050808),0.5562474599508663,1.3582790823166264,0.04060913705583756,0.9182951024279243,1.0,18/125,11.46%,MUSK;SDK2;PCDHB16;LRRK2;C5AR1;CX3CL1;DVL1;PPFIBP2;FARP1;PPFIA1;DCTN1;NEDD4;MAPT;CDK5;CDC42;C1QB;DBNL;ARHGAP39
prerank,regulation of mitochondrion organization (GO:0010821),0.575365773620113,1.3577408555002322,0.1019036954087346,0.9185654820112429,1.0,13/47,12.32%,MIEF2;SIRT7;LRRK2;FBXW7;PID1;INF2;EP300;SQSTM1;GOLPH3;MAPT;VPS35;CYRIB;PARL
prerank,endothelial cell differentiation (GO:0045446),0.6737829821032455,1.3571250906203498,0.1590909090909091,0.9193660599086617,1.0,1/12,0.19%,SCUBE1
prerank,establishment of epithelial cell polarity (GO:0090162),0.6594683484547794,1.3568189675654476,0.10700132100396301,0.9184134051970592,1.0,8/19,11.78%,SIPA1L3;MSN;CAMSAP3;EZR;GOLPH3;MYO9A;CDC42;CYTH1
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.6478822088676345,1.3565650531990918,0.11096774193548387,0.9170742286043422,1.0,5/22,9.84%,PLK1;TFAP4;IPO7;APC;IPO5
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.564408374304951,1.3564348922345046,0.07692307692307693,0.9151890061220778,1.0,12/66,8.48%,RGCC;ATP5F1A;FBXW7;NUPR1;KLF9;TGFB2;NF1;THBS1;CDK6;BRCA2;DUSP10;ALOX5
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.5722552557156138,1.3564271046264709,0.10810810810810811,0.912564622102275,1.0,9/47,14.30%,WNT4;BRCA1;FBXW7;EP300;ACADL;GCK;SLC27A1;FYN;ROCK2
prerank,regulation of mRNA processing (GO:0050684),-0.4103890302274945,-1.3562721115168386,0.060240963855421686,0.9896298951262469,1.0,10/32,9.82%,DHX9;TIA1;AHCYL1;SRSF10;SAFB;CDK11B;METTL16;YTHDC1;SRPK1;CWC22
prerank,negative regulation of inclusion body assembly (GO:0090084),0.7143185363627707,1.3554166947199862,0.12933753943217666,0.915794262626475,1.0,2/10,2.09%,DNAJB1;SACS
prerank,negative regulation of binding (GO:0051100),0.5555448569551826,1.355117943131199,0.06875,0.9148273910582909,1.0,15/81,10.38%,MDFI;HABP4;LRRK2;DVL1;TFAP4;ITGB1BP1;JUN;ILRUN;STYX;PDGFB;USP33;SUMO3;MAPK8;DAB2;CTSZ
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.686257005128403,1.3545868800155214,0.12965722801788376,0.9151337126026801,1.0,3/13,4.54%,PRKCZ;SNX5;IRS1
prerank,protein kinase A signaling (GO:0010737),0.6921106392441596,1.354515498576067,0.14245014245014245,0.9129131421019774,1.0,4/12,16.82%,PRKACA;EZR;RDX;PRKACB
prerank,intraciliary retrograde transport (GO:0035721),-0.5647220296987465,-1.3544186576198185,0.0967741935483871,0.986547319820179,1.0,9/12,35.88%,TTC21B;IFT140;DYNC2I1;IFT43;WDR35;IFT122;DYNLT2B;DYNC2I2;WDR19
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.39408280678614577,-1.3543421118027172,0.07857142857142857,0.9737464180715268,1.0,15/37,27.35%,IL1RAPL1;CADM1;ICAM1;ALCAM;FAT4;HMCN1;CADM3;CD164;TENM1;TENM3;ADGRL1;NECTIN3;NECTIN1;PVR;NECTIN4
prerank,iron-sulfur cluster assembly (GO:0016226),0.6111535824592084,1.3543302053964623,0.12516129032258064,0.9112844978958656,1.0,6/24,7.64%,NUBPL;NFU1;NFS1;ABCB7;HSPA9;GLRX3
prerank,glycerophospholipid metabolic process (GO:0006650),0.5550175440676631,1.352469227038272,0.07635206786850478,0.9189884265417226,1.0,13/75,12.07%,LCAT;PLA2G7;SERINC5;PLA2G6;FAR1;PIGP;CRLS1;HDHD5;ABHD6;PLA2G4A;PNPLA6;SERINC1;GPCPD1
prerank,nerve growth factor signaling pathway (GO:0038180),0.7255213884110481,1.3522192554998274,0.11526946107784432,0.9177396528957219,1.0,2/10,4.54%,RAPGEF1;RAP1A
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.5724037572934703,1.3511103577507393,0.12311265969802555,0.9214103373050805,1.0,11/40,12.97%,RGCC;TGFB2;OLFM1;SMAD3;SDCBP;EZH2;DAB2;TGFBR2;MTOR;TCF7L2;TGFBR1
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.6165092881459111,1.3504042328956662,0.11316113161131611,0.9227463310347237,1.0,8/27,9.22%,PRKCZ;PID1;PIP4K2A;IRS1;PRKCB;PTPN1;NCK1;PIP4K2B
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.6642809436309189,1.3495558901270082,0.14064697609001406,0.9248066789303879,1.0,2/14,1.18%,ZNHIT3;BOP1
prerank,apoptotic nuclear changes (GO:0030262),0.6245339611130194,1.3488719294323677,0.12422360248447205,0.9260169185808532,1.0,5/24,12.01%,DFFB;CDK5RAP3;KPNB1;ACIN1;HMGB1
prerank,synaptic membrane adhesion (GO:0099560),-0.5332448610859282,-1.3484608055556717,0.14035087719298245,0.9932165983508509,1.0,8/14,26.97%,LRFN5;NTNG1;PTPRS;LRRC4C;LRRC4;SLITRK1;LRRC4B;PTPRF
prerank,regulation of organelle organization (GO:0033043),0.5511259572721441,1.348437444139671,0.07457983193277311,0.9257277527638407,1.0,32/80,16.98%,MIEF2;LMAN1;SIRT7;ZEB2;MSN;AKAP9;EP300;MYO5A;SQSTM1;MAPK1;TMED9;CAMSAP3;EZR;GOLPH3;MAPT;SYT11;PAK2;ARMH3;VPS35;MAVS;TAOK1;CAPN2;DIAPH1;PARL;VPS11;SAR1B;SCARB2;MTM1;DNM1L;RDX;ARL6IP1;MFF
prerank,glutamate metabolic process (GO:0006536),-0.47703046104277,-1.3474321118864208,0.11715481171548117,0.9858080961128857,1.0,7/19,17.16%,GLUD1;GLUL;GCLC;GOT1;MTHFS;GOT2;GCLM
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.5980852512963026,1.3472035601428913,0.09570552147239264,0.9300166537339994,1.0,4/31,4.91%,ISL1;TGFB2;BMPR1A;TPM1
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.6937029090631177,1.3471802649801032,0.14198473282442747,0.9275240949056317,1.0,3/12,4.54%,PRKCZ;SNX5;IRS1
prerank,regulation of response to external stimulus (GO:0032101),0.5365073684224573,1.3467961071164545,0.05583756345177665,0.9271142850706249,1.0,27/121,14.86%,ACE2;ADAMTS12;FNTB;CD36;RELA;CX3CL1;IRF1;METAP1;EPHB2;BCL6;BIRC3;LACC1;ALOX5;AREL1;LRP8;NMT1;TRIM5;CYRIB;TMSB4X;NMT2;ERAP1;CYLD;NR1D2;RNF135;CALM1;P2RY12;PIK3AP1
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.6010322707017687,1.3465469353924953,0.11163337250293771,0.9259390279365474,1.0,6/35,9.43%,RGCC;ATP5F1A;NF1;THBS1;ALOX5;PPARG
prerank,high-density lipoprotein particle assembly (GO:0034380),0.715282187298326,1.3464303176929417,0.13043478260869565,0.9240581286838075,1.0,4/10,16.82%,PRKACA;ABCA7;ABCA1;PRKACB
prerank,mRNA polyadenylation (GO:0006378),-0.42764342992626636,-1.3461904477159035,0.11224489795918367,0.9673119269259337,1.0,15/26,22.48%,APP;TENT2;TENT4B;WDR33;AHCYL1;PABPC1;MTPAP;PNPT1;PAPOLG;SYMPK;CPSF2;GRSF1;CDC73;TUT1;PCF11
prerank,RNA polyadenylation (GO:0043631),-0.42764342992626636,-1.3461904477159035,0.11224489795918367,0.9673119269259337,1.0,15/26,22.48%,APP;TENT2;TENT4B;WDR33;AHCYL1;PABPC1;MTPAP;PNPT1;PAPOLG;SYMPK;CPSF2;GRSF1;CDC73;TUT1;PCF11
prerank,regulation of cellular senescence (GO:2000772),-0.42759981803377944,-1.346015777272812,0.08196721311475409,0.9561678615288921,1.0,13/28,19.73%,AKT3;MAP3K3;B2M;ABI3;YBX1;YPEL3;PNPT1;RBL1;SIRT1;CGAS;RSL1D1;ING2;NEK4
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.6846327269950471,1.3459754505575523,0.15283842794759825,0.9241131389228252,1.0,5/13,8.59%,WFS1;BFAR;PTPN1;ABCA7;NCK1
prerank,stress granule assembly (GO:0034063),0.6359864125443806,1.3458808230526458,0.1227390180878553,0.9221439754069274,1.0,12/20,16.59%,RPS23;ATXN2L;CSDE1;MAPT;YTHDF1;PRRC2C;ATXN2;LSM14A;EIF2S1;BICD1;G3BP1;YTHDF3
prerank,positive regulation of glycolytic process (GO:0045821),-0.48467556210095253,-1.3456345479492942,0.11688311688311688,0.934906720416827,1.0,7/20,15.18%,APP;P2RX7;PFKFB4;PRKAA1;IGF1;PRKAA2;PRXL2C
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.48467556210095253,-1.3456345479492942,0.11688311688311688,0.934906720416827,1.0,7/20,15.18%,APP;P2RX7;PFKFB4;PRKAA1;IGF1;PRKAA2;PRXL2C
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.6800812650350903,1.3454825287933134,0.11318051575931232,0.9218717119661715,1.0,3/13,1.44%,LRRK2;AK4;AK3
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.5401584864414304,1.3447244308823838,0.04276985743380855,0.9237418400050071,1.0,27/129,11.05%,TUBB4B;PLK1;CETN2;CCDC57;TPD52L1;ALMS1;MAPRE1;AKAP9;CEP250;PPP2R2A;YWHAE;CDK7;PRKACA;CDK2;PCNT;HSP90AA1;MNAT1;DCTN1;TUBA1A;DCTN2;CCP110;PPP1R12B;CHEK2;ODF2;CEP152;CNTRL;FBXW11
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.689622785336179,1.3444312043606712,0.15195369030390737,0.9229697296786112,1.0,1/13,0.29%,GJC1
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.5865287306734912,-1.3444171828952525,0.11331444759206799,0.9296383928030981,1.0,3/10,15.06%,PRKN;SNCA;OXA1L
prerank,axoneme assembly (GO:0035082),0.5936808938068566,1.3443285353874348,0.11421628189550426,0.9209280983766863,1.0,4/31,10.67%,RSPH4A;SPAG1;DNAI4;CFAP74
prerank,detection of visible light (GO:0009584),0.6634834865613124,1.3432661087992706,0.12205270457697642,0.9241608117324893,1.0,2/16,9.87%,CEP250;GNAQ
prerank,protein localization to phagophore assembly site (GO:0034497),0.6900119474210633,1.3427153218983228,0.13383458646616542,0.9246771790921717,1.0,5/11,11.84%,WDR45;WDR45B;STX17;TRAPPC8;PACS2
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.5414569503528128,1.3396482630230835,0.0698869475847893,0.9390803048693379,1.0,28/101,12.87%,PLK1;EIF6;EIF4A3;EIF3C;EIF3E;NIBAN1;MSN;THBS1;PYM1;RBM3;PRKDC;METTL3;HSP90AA1;EZR;PTTG1IP;LARP4B;VPS35;YTHDF1;FXR2;FAF1;ASPSCR1;FBXW11;MTOR;CYFIP2;PLD1;TBC1D10A;VPS11;SAMD4A
prerank,positive regulation of lipid localization (GO:1905954),-0.5796794206827165,-1.3388765862062,0.1094224924012158,0.9459966609173535,1.0,4/11,20.73%,IKBKE;LPL;ZC3H12A;VSTM2A
prerank,embryonic hemopoiesis (GO:0035162),0.6830879056793565,1.3386807201393915,0.15119760479041916,0.9420356492339779,1.0,5/12,12.90%,KITLG;THOC5;TAL1;TGFBR2;SH2B3
prerank,placenta development (GO:0001890),0.6831295811239123,1.3376882422329226,0.12121212121212122,0.9452074018021607,1.0,2/12,9.43%,ANG;PPARG
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.5786610941263015,1.3373146295903418,0.10760233918128655,0.9446758234915856,1.0,13/35,13.71%,PMEPA1;AR;WBP2;PADI2;ESR1;NR3C1;EGLN2;KDM3A;NEDD4;UBE3A;UBR5;PPARGC1B;DDX5
prerank,positive regulation of type I interferon production (GO:0032481),0.5353595497084733,1.3372972632252023,0.10242872228088701,0.9422720828557092,1.0,17/73,10.15%,POLR1C;POLR3G;RIOK3;RELA;IRF1;POLR3H;TLR7;IRF3;EP300;PRKDC;HSP90AA1;MRE11;SETD2;TLR3;CRCP;MAVS;POLR3A
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.7019036068819136,1.3368186837589973,0.13414634146341464,0.9425424798493841,1.0,2/10,6.16%,BRCA1;HDAC5
prerank,glucan catabolic process (GO:0009251),-0.5261894517085884,-1.3366791532117666,0.12030075187969924,0.9460822154026286,1.0,8/15,25.29%,PHKA2;PHKB;PYGB;PGM2L1;PHKG2;PYGL;GAA;PGM2
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.6121926001086181,1.3361578084399874,0.1394422310756972,0.943665593845145,1.0,3/23,2.78%,ZWINT;CDK5RAP3;VPS4A
prerank,sphingolipid catabolic process (GO:0030149),0.6571658338912286,1.3354603152253433,0.15091678420310295,0.9451143727645066,1.0,6/15,12.30%,SMPDL3A;SMPD1;ACER3;PDXDC1;ASAH1;SGPL1
prerank,DNA alkylation (GO:0006305),0.6374121977038921,1.3352744979147868,0.12649800266311584,0.9412419189591295,1.0,6/19,12.96%,EHMT1;DMAP1;EHMT2;KMT2E;DNMT3A;ATRX
prerank,DNA methylation or demethylation (GO:0044728),0.6374121977038921,1.3352744979147868,0.12649800266311584,0.9412419189591295,1.0,6/19,12.96%,EHMT1;DMAP1;EHMT2;KMT2E;DNMT3A;ATRX
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.7062596793394109,1.3352490348386863,0.15184049079754602,0.9389303925109979,1.0,4/10,11.89%,KDM1B;MECP2;PCGF5;DNMT3A
prerank,mitotic nuclear division (GO:0140014),0.5440974268821424,1.334736954526019,0.0906183368869936,0.9392372911018094,1.0,12/71,11.55%,TOGARAM2;PLK1;ZWINT;KPNB1;NDEL1;CCDC61;FLNA;KIF11;STAG2;CHEK2;EPS8;LSM14A
prerank,termination of RNA polymerase I transcription (GO:0006363),0.5932481538734629,1.3346809734361438,0.12317073170731707,0.9370973485863249,1.0,6/30,8.81%,CAVIN1;POLR1C;CDK7;POLR1A;MNAT1;UBTF
prerank,female gonad development (GO:0008585),0.6297484886407402,1.3341152200230322,0.14496644295302014,0.9376727994050533,1.0,1/19,0.24%,ANG
prerank,negative regulation of MAPK cascade (GO:0043409),0.5378384982396958,1.333722517518846,0.08428720083246619,0.9375438193732619,1.0,26/87,15.19%,CDK5RAP3;DUSP3;CNKSR3;ITGB1BP1;SMPD1;IGBP1;NF1;EPHB2;SPRED2;PTPRJ;EZR;DLG1;RGS14;RANBP9;DUSP10;PTPN1;ABCA7;LYN;SEMA6A;SORL1;SH2B3;SPRED1;PTEN;TLR4;DAG1;SMAD4
prerank,copper ion transport (GO:0006825),0.7042475464448094,1.3334694948469048,0.13622291021671826,0.9364940975589279,1.0,4/11,11.64%,STEAP3;COX17;ATP7A;SLC31A1
prerank,protein localization to Golgi apparatus (GO:0034067),0.5914367620768205,1.3334504250104824,0.14017521902377972,0.9342068530118235,1.0,11/27,14.38%,RIPOR1;SYS1;ARL5A;IFT20;VPS13A;GOLPH3;VPS13C;RAB6A;SORL1;VPS13D;OPTN
prerank,sulfur compound biosynthetic process (GO:0044272),0.5399830708330788,1.333372196987497,0.06332992849846783,0.9322885808556214,1.0,15/104,9.84%,CBS;GGTA1;MGST3;UST;B4GALT3;CHSY1;TPK1;UGDH;DSE;LIAS;GLCE;MAT2B;B4GALT5;B4GALT1;BGN
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.552632549559164,1.3326191725515713,0.08898305084745763,0.9338802385643918,1.0,11/75,10.93%,WNT4;THBS2;RGCC;TGFB2;THBS1;PDE3B;MECP2;ALOX5;PPARG;HGS;SEMA6A
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.6665479988477517,1.332366728413614,0.14469914040114612,0.9328506253640381,1.0,6/14,13.91%,MDFI;G3BP2;KEAP1;FAF1;TMSB4X;PKD2
prerank,regulation of transposition (GO:0010528),0.6792938196301185,1.3315449881216037,0.1595900439238653,0.9350426409932825,1.0,1/13,1.00%,SIRT7
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.6580369774831645,1.3313466551502715,0.1388888888888889,0.9336721320866824,1.0,2/15,1.19%,DDR1;DDR2
prerank,potassium ion export across plasma membrane (GO:0097623),-0.5482330325687477,-1.331051563518669,0.12693498452012383,0.9646824510757747,1.0,2/13,8.30%,KCNT2;KCND3
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.5378176642916132,1.3294594007120852,0.10706638115631692,0.9417998110749972,1.0,3/62,1.07%,CXCL12;URI1;LRRK2
prerank,regulation of inflammatory response (GO:0050727),0.5253751556261639,1.328675428429499,0.03009027081243731,0.9437792156043124,1.0,27/190,11.88%,ACE2;ISL1;RORA;ADAMTS12;PLA2G7;TNFAIP8L2;RELA;CX3CL1;IFI35;IL16;TLR7;FEM1A;VAMP3;BCL6;BIRC3;TLR3;LACC1;ALOX5;VPS35;IL18;AREL1;PPARG;PROC;VAMP2;NFKBIZ;TMSB4X;IL17RA
prerank,muscle cell differentiation (GO:0042692),0.5869518737815697,1.3285308456064908,0.13214285714285715,0.9421983568596692,1.0,4/32,6.05%,RORA;GLMN;NEBL;MRTFB
prerank,regulation of mitochondrial fission (GO:0090140),0.609167557178457,1.328289233012999,0.13089005235602094,0.9411273212169126,1.0,11/24,17.12%,MIEF2;LRRK2;INF2;MAPT;VPS35;BNIP3;CYRIB;DNM1L;STAT2;MFF;RALBP1
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.5821031910078384,1.3280139549293355,0.1386946386946387,0.940323518990012,1.0,7/33,12.68%,PDE6H;FBXW7;AREG;CNOT9;DGKD;CBL;TGFA
prerank,response to nitric oxide (GO:0071731),0.6653535307965545,1.3276973644731118,0.1470160116448326,0.9397234832444088,1.0,3/13,9.04%,CDK2;EGLN1;MTR
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.6981639999052166,1.327242863839345,0.15236686390532544,0.940068996932805,1.0,3/10,7.65%,UBAC2;INSIG1;ERLEC1
prerank,regulation of membrane depolarization (GO:0003254),0.6331101426103413,1.3267337284877239,0.14785992217898833,0.9405554733513406,1.0,5/18,12.94%,LRRK2;GPD1L;CAMK2D;PTPN3;ABCD1
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.5836325937276596,-1.3264552104220417,0.13355048859934854,0.9769042495132281,1.0,2/11,4.37%,NOS1AP;AKAP6
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.5385164220193974,-1.3263112519705644,0.14193548387096774,0.9665501407155979,1.0,7/12,28.34%,RIMS2;SYT1;RIMS1;UNC13B;SYT2;SYT7;UNC13A
prerank,dorsal/ventral pattern formation (GO:0009953),0.6293580965737694,1.32598395350572,0.14267515923566879,0.9422595099190977,1.0,3/20,6.38%,MDFI;BMPR1A;ACVR1
prerank,regulation of insulin secretion (GO:0050796),0.5375285029858535,1.3257859045503881,0.07510288065843622,0.9411282088979185,1.0,19/101,12.47%,ISL1;EIPR1;NNAT;CLOCK;CACNA1D;PSMD9;ADCY5;IRS1;RAP1A;PRKCA;LRP5;IRS2;ALOX5;RAPGEF4;TM7SF3;CACNA1A;EPHA5;GCK;TCF7L2
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.5210577848589424,-1.325357647633324,0.16049382716049382,0.9602041929955696,1.0,8/16,25.29%,PHKA2;PHKB;PYGB;PGM2L1;PHKG2;PYGL;GAA;PGM2
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.686869633815065,1.3251436188989438,0.14626865671641792,0.9420839112507827,1.0,3/12,8.61%,ADCY8;PLA2G6;TRPM4
prerank,regulation of cell division (GO:0051302),0.5478213269479351,1.324061332336131,0.09584664536741214,0.9455904895104986,1.0,14/72,9.73%,PLK1;CETN2;BLM;FGF1;BBS4;PIK3R4;KIF13A;AHCTF1;PRPF40A;SETD2;CCP110;BIRC6;NCOA3;TAL1
prerank,aminoglycan metabolic process (GO:0006022),-0.5888359043384153,-1.3240431193922726,0.14511041009463724,0.956525489508073,1.0,8/10,36.14%,XYLT1;B3GAT3;CHST9;XYLT2;B4GALT7;B3GAT1;B3GAT2;CLN6
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.6270017198604304,1.323435411598145,0.135752688172043,0.9466412228818947,1.0,9/19,18.14%,FLOT2;RTN3;ABCA7;PRNP;SORL1;RTN4;GGA3;BIN1;ROCK1
prerank,cell cycle G2/M phase transition (GO:0044839),0.5320483185754966,1.3231937036879327,0.0560081466395112,0.9457412314018617,1.0,27/130,11.05%,TUBB4B;PLK1;CETN2;CCDC57;TPD52L1;ALMS1;MAPRE1;AKAP9;CEP250;PPP2R2A;YWHAE;CDK7;PRKACA;CDK2;PCNT;HSP90AA1;MNAT1;DCTN1;TUBA1A;DCTN2;CCP110;PPP1R12B;CHEK2;ODF2;CEP152;CNTRL;FBXW11
prerank,positive regulation of protein phosphorylation (GO:0001934),0.5262366225761523,1.322601033748162,0.004,0.9466311812133132,1.0,43/348,9.66%,MUSK;FGF22;FGF18;BMP5;PLK1;CAMKK1;LRRK2;DDR2;CX3CL1;RAD50;FGF1;VEGFC;BRAF;TGFB2;GAS6;NIBAN1;BMPR1A;AKAP9;RAP1A;NRP1;PDGFB;AKTIP;CDK2AP1;MAPK1;PTPRJ;SDCBP;ACVR1;HSP90AA1;MRE11;PAK2;NBN;RPS6KA5;CDK9;NPTN;DAB2;KRAS;FNIP1;FXR2;LRP8;CNOT9;MAVS;LYN;CD44
prerank,cellular macromolecule catabolic process (GO:0044265),0.5648631264688408,1.3225468997199266,0.11521252796420582,0.94462145094244,1.0,13/49,14.35%,DFFB;RNASE6;FBXO17;RNASEH2A;RAB12;PPP1R8;EXOSC7;PABPC4;CHEK2;XRN2;RNASE3;HTRA2;MTREX
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.6005139608030363,1.3212895849217594,0.1382842509603073,0.9490335256452268,1.0,7/26,9.86%,CACNA1D;AKAP9;YWHAE;NEDD4;DLG1;NETO1;VAMP2
prerank,positive regulation of exocytosis (GO:0045921),0.5820455661392323,1.3205862067546617,0.12559241706161137,0.9505627790960105,1.0,12/35,15.10%,TSG101;SMPD3;UNC13D;VPS4A;CADPS;SDCBP;HGS;STXBP5;VPS4B;PDCD6IP;RAB7A;CLASP1
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.5091946021435961,-1.3205387019526131,0.12359550561797752,0.9638847492003043,1.0,4/17,8.32%,NOS1AP;KCNAB1;AKAP6;SUMO1
prerank,protein trimerization (GO:0070206),-0.518002221342299,-1.3202169803322317,0.1299638989169675,0.9447269571104956,1.0,4/14,9.61%,SLC1A2;CLYBL;DISP1;PNPT1
prerank,protein homotrimerization (GO:0070207),-0.518002221342299,-1.3202169803322317,0.1299638989169675,0.9447269571104956,1.0,4/14,9.61%,SLC1A2;CLYBL;DISP1;PNPT1
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.5277743277769963,1.3200873969871711,0.08932238193018481,0.9509487983227539,1.0,24/102,12.05%,INSIG1;RELA;ADCY8;ADCY3;RAB8B;PRKAR2A;INSIG2;RAB12;ADCY5;IRS1;HDAC9;PRKACA;MYO5A;PRKDC;HDAC5;PDE3B;IRS2;ADCY9;PPARG;VAMP2;KAT2B;GCK;TBC1D4;ZFP36L1
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.7046647871819791,1.3200332660735723,0.14175654853620956,0.9489233391605333,1.0,4/10,10.43%,CDK5RAP3;NELL1;ANXA2;FURIN
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.639392382704921,1.31909210192448,0.16870748299319727,0.9517399218504926,1.0,3/15,9.14%,PLK1;CDC23;CDC16
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.5554962640141562,-1.3190866084490938,0.13114754098360656,0.9406117729659402,1.0,6/13,25.51%,TOX;CLPTM1;CAMK4;ADAM8;ZC3H8;SOD1
prerank,response to zinc ion (GO:0010043),0.6038373938113011,1.3190301659478507,0.16020025031289112,0.9498035639025569,1.0,10/25,10.61%,D2HGDH;HVCN1;MT1F;MT1M;MT1H;MT1X;MT1A;MT1E;MT1G;MT1B
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.5433407310673801,1.318621190050638,0.09619450317124736,0.9497063027223696,1.0,9/66,5.09%,PLK1;CDK5RAP3;PARP9;DMAP1;BAG3;NMD3;TCP1;FLNA;SMAD3
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.5233421230984475,1.3185785377779806,0.0537525354969574,0.9476566982212,1.0,21/138,13.79%,MUSK;ROR2;DDR1;DDR2;RAPGEF1;EPHB2;LIFR;YES1;ABI1;AXL;PTPRT;AHI1;LYN;EPHA5;IGF1R;FRS2;ACVR1B;SYK;PTPRU;INSR;FYN
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.46349165027520434,-1.318394340460796,0.14410480349344978,0.933670939098332,1.0,9/19,22.77%,DLG2;SYNJ2BP;PATJ;PRKCI;PARD3B;FSCN1;DLG3;MTCL1;SCRIB
prerank,UV-damage excision repair (GO:0070914),0.6699692955848682,1.318293213540311,0.16114457831325302,0.9469637311079252,1.0,3/12,6.62%,ACTR5;POLA1;POLD3
prerank,positive regulation of protein modification process (GO:0031401),0.5272480712893653,1.318185482970496,0.028084252758274825,0.9453133007294157,1.0,32/203,14.30%,MUSK;FGF22;FGF18;LRRK2;FGF1;RAB3GAP1;VEGFC;SMPD1;GAS6;NIBAN1;AKTIP;CDK2AP1;SPPL3;HSP90AA1;NPTN;DAB2;KRAS;FNIP1;FXR2;MAVS;LYN;ASPSCR1;TAOK1;RAMP1;ABL1;RB1CC1;ERP29;PPP1R16B;INSR;CAMKK2;CALM1;ROCK2
prerank,myelin maintenance (GO:0043217),0.7040538504604219,1.3180510974207076,0.17384370015948963,0.9437437105153315,1.0,5/10,14.70%,DEGS1;ABCD2;EPB41L3;ABCD1;PTEN
prerank,pulmonary valve morphogenesis (GO:0003184),0.642045829510753,1.317377311194054,0.15020297699594046,0.9452564852997309,1.0,4/17,11.19%,SMAD6;TGFB2;NFATC1;NOTCH2
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.6677463579780517,1.3171450314423567,0.1849112426035503,0.9443118668070225,1.0,4/12,12.94%,IRS1;ABCD2;IRS2;ABCD1
prerank,sympathetic nervous system development (GO:0048485),0.6684055854647867,1.317070524260502,0.15877437325905291,0.9424514297127925,1.0,6/15,17.61%,NF1;NRP1;SOX11;NRP2;FZD3;CTNNB1
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.6281079190547879,1.3162465898467255,0.15299026425591097,0.9447011611999155,1.0,8/18,14.25%,ADCY8;CAMK1D;CRTC1;RPS6KA5;LRP8;EPHA5;PRKD2;RELN
prerank,protein localization to cilium (GO:0061512),0.5818589382709338,1.3161934401168505,0.13701923076923078,0.9427716325863301,1.0,8/32,10.70%,NPHP4;ARL6;EHD1;BBS4;RABEP1;IFT20;SNX10;TULP3
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.6778598657879801,1.3159071994198153,0.1656891495601173,0.9419712322664547,1.0,6/12,9.96%,BRCA1;RLIM;RBM15;METTL3;PCGF5;SMCHD1
prerank,base-excision repair (GO:0006284),0.5524419203313962,1.3153422846345306,0.1273532668881506,0.942830411475372,1.0,7/48,6.74%,POLG;MPG;RFC2;PARG;WRN;POLD3;POLB
prerank,protein localization to chromatin (GO:0071168),0.6286244220676306,1.3141286819495208,0.15567282321899736,0.9469823377802272,1.0,4/18,7.70%,PLK1;PPHLN1;ESR1;LEMD2
prerank,diacylglycerol metabolic process (GO:0046339),0.6008397996730467,1.313781118180768,0.14470284237726097,0.9465992739282881,1.0,5/23,10.16%,ANG;LIPE;GPAM;DGKI;DGKD
prerank,central nervous system neuron differentiation (GO:0021953),0.5787532961280042,1.31296511000297,0.14736842105263157,0.9488317289106722,1.0,4/33,7.60%,ISL1;GBA2;ATP7A;MAPT
prerank,cellular response to cadmium ion (GO:0071276),0.6002145144378259,1.3120256496927667,0.14358322744599747,0.951885909153295,1.0,11/24,10.61%,JUN;MAPK1;MAPK8;MT1F;MT1M;MT1H;MT1X;MT1A;MT1E;MT1G;MT1B
prerank,negative regulation of MAP kinase activity (GO:0043407),0.5618498577480319,1.3114750350238231,0.1345496009122007,0.9525915721884994,1.0,11/44,12.90%,CDK5RAP3;SMPD1;NF1;PTPRJ;RGS14;DUSP10;PTPN1;LYN;AIDA;SORL1;SH2B3
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.5252625536565433,1.311062924703954,0.04939516129032258,0.9525459629824651,1.0,43/166,14.50%,POLR2D;CAVIN1;RORA;POLR1C;POLR3H;TFB2M;POLR2A;AR;HDAC9;CDK7;TEAD1;ESR1;POLR1A;HDAC5;NR3C1;MAML3;MAML2;MNAT1;CDK9;UBTF;TAF4;CRCP;NCOR1;PPARG;NR6A1;GTF2E1;GTF2E2;GTF2B;NR5A1;NOTCH2;KAT2B;NR2C2;GTF2F2;NCOR2;BRF1;NRBP1;NR1D2;RXRA;MED27;GTF2H1;RBPJ;PPARD;TBL1XR1
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.6551923678321653,1.310459923522251,0.1688125894134478,0.9535081722177063,1.0,3/14,5.28%,AK4;AK3;NMNAT3
prerank,regulation of protein kinase B signaling (GO:0051896),0.5195979208502106,1.3098821197867596,0.030181086519114688,0.9546162815278275,1.0,40/193,15.24%,FGF22;FGF18;NRG2;CX3CL1;FGF1;GRB2;ITGB1BP1;GAS6;AREG;IRS1;THBS1;PDGFB;KITLG;PTPRJ;ESR1;ARRB2;AXL;IRS2;HSP90AA1;IL18;PHLPP1;MTDH;F3;IGF1R;FRS2;TCF7L2;BANK1;TGFA;SH2B3;TGFBR1;RTN4;INSR;FYN;PPP2R5C;P2RY12;PTEN;PIK3AP1;VAV1;DAG1;HIP1
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.5465995907081114,1.3097557452559985,0.11670480549199085,0.9531157618026598,1.0,10/45,12.45%,RGCC;GAS1;ZWINT;BCL6;SMAD3;PTPN3;TOM1L2;PRCC;ZFP36L1;HECA
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.5916066996378105,1.3090120141550359,0.15519399249061328,0.9548346082552018,1.0,6/26,10.08%,ADCY8;PLA2G6;ADCY5;LRP5;TRPM4;EPHA5
prerank,histone lysine demethylation (GO:0070076),0.5854837144555197,1.3089170160755463,0.16832917705735662,0.9532098091477514,1.0,7/25,11.95%,KDM1B;KDM5A;KDM3A;KDM5B;JMJD1C;KDM4B;KDM4C
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.6536342072499137,1.3082775514250873,0.15736766809728184,0.9545784811562672,1.0,7/13,18.59%,AR;ESR1;NR3C1;NR3C2;MED1;PLPP1;PGR
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.6104782527778779,1.3079936059508839,0.14104193138500634,0.9539880274600803,1.0,5/23,9.99%,ACSBG1;HPGD;GPX4;ALOX5;FADS1
prerank,positive regulation of RNA metabolic process (GO:0051254),0.5582292228604733,1.3074649726975676,0.12788018433179724,0.9546606213631216,1.0,14/45,13.71%,HABP4;SIRT7;RELA;NMD3;POLR2A;SLC38A2;LIN28B;SETX;U2AF2;HEATR1;ERN1;TP53;MAP2K2;DDX5
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.586879436589868,1.3073697848080024,0.13532934131736526,0.9529630786044043,1.0,2/30,0.41%,BMP5;BRCA1
prerank,cAMP metabolic process (GO:0046058),0.6601359823904495,1.3066099418795385,0.16251830161054173,0.9548273565648846,1.0,4/13,7.05%,ADCY8;ADCY3;ADCY5;ADCY9
prerank,positive regulation of interferon-beta production (GO:0032728),0.5668804089489773,1.3054322371043858,0.14268292682926828,0.9591892456637063,1.0,12/33,14.85%,POLR3G;RIOK3;IRF1;TLR7;IRF3;HSP90AA1;TLR3;MAVS;POLR3A;TRIM56;RNF135;TLR4
prerank,response to interleukin-1 (GO:0070555),0.5295764783559105,1.3052116010932548,0.09763948497854077,0.9582208120249023,1.0,11/73,10.87%,ADAMTS12;TNFRSF11A;RELA;CX3CL1;SMPD1;IGBP1;PRKCA;CCL25;IRAK2;YTHDC2;TANK
prerank,activation of protein kinase activity (GO:0032147),0.5232646353119567,1.305209370137208,0.09548254620123203,0.9560906619281657,1.0,23/106,11.90%,ANG;MINK1;ADCY8;ADCY3;FGF1;ITGB1BP1;PRKAR2A;TGFB2;GAS6;ADCY5;PDGFB;PRKACA;STK11;ADCY9;TLR3;PAK2;MAPKAP1;IL18;TAOK1;TRAF2;TGFBR2;MTOR;ABL1
prerank,regulation of interleukin-12 production (GO:0032655),0.556594245415465,1.3044976074832781,0.12768361581920903,0.9577232565470796,1.0,12/47,15.45%,ISL1;IL16;THBS1;CMKLR1;TLR3;MAST2;HMGB1;MAPK14;SYK;LGALS9;TLR4;CD47
prerank,N-glycan processing (GO:0006491),0.6338065929947818,1.3044400856380092,0.16415868673050615,0.9558933698971009,1.0,9/18,16.30%,MAN1B1;ST8SIA5;ST8SIA4;GANAB;MAN2A2;PRKCSH;MGAT4B;MAN1A2;MGAT4A
prerank,neurotransmitter transport (GO:0006836),0.5316002987559938,1.3044295490922002,0.12008501594048884,0.9538326987131466,1.0,8/73,7.93%,STXBP2;PDZD11;DVL1;GAD2;SLC38A2;PPFIA1;APBA1;SYN3
prerank,positive regulation of biosynthetic process (GO:0009891),0.5595967719026047,1.3038667602998233,0.1554524361948956,0.9547374019795324,1.0,4/40,3.64%,WNT4;RGCC;CD36;RUNX1
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.6061961368048627,1.3034140956453977,0.17709720372836218,0.9550218814133982,1.0,6/21,11.10%,CGNL1;TGFB2;EPHB2;MAPKAP1;CD2AP;CYRIB
prerank,organelle fission (GO:0048285),-0.43721686991082565,-1.302527006374474,0.12796208530805686,1.0,1.0,13/24,32.22%,PRKN;OPA1;DNM2;CORO1C;TMCC1;DNM1;PEX19;MIEF1;GDAP1;FIS1;MTFR1;ACOT8;MTFR1L
prerank,negative regulation of cell cycle process (GO:0010948),0.5462653261817891,1.3024361781981524,0.132821075740944,0.9582052884198893,1.0,15/61,13.42%,BRCA1;EHMT1;VPS4A;MAX;APAF1;TERF2;EHMT2;RBBP8;EZH2;CCP110;TOM1L2;PHC3;RBBP7;EPC1;TERF1
prerank,relaxation of muscle (GO:0090075),-0.5362303551453066,-1.3021987998400184,0.1715210355987055,0.9932095383556488,1.0,7/13,17.46%,ATP1B1;ATP1A1;ATP1A2;KCNJ2;PIK3CA;RGS2;P2RX4
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.5772134442767822,1.3018236126584593,0.1524822695035461,0.9592883192601347,1.0,8/33,16.27%,ANG;IGFBP3;TPM1;PPARG;NDRG4;AIF1;PTEN;MEF2C
prerank,cell-cell junction maintenance (GO:0045217),-0.565470069530287,-1.301714771059308,0.14540059347181009,0.9854320171105811,1.0,3/11,12.04%,TJP1;CSF1R;FERMT2
prerank,regulation of interleukin-13 production (GO:0032656),0.6451951099081098,1.3015228520859459,0.18634423897581792,0.9587282044400343,1.0,3/13,14.00%,PRKCZ;IL18;LGALS9
prerank,response to organophosphorus (GO:0046683),-0.49951237629607004,-1.3009091254776188,0.18796992481203006,0.9794256702819838,1.0,8/16,38.50%,P2RX7;NDUFS4;P2RX4;DGKQ;TRPC3;TYMS;RFC3;VGF
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.5380730145106783,1.3008194572863725,0.12736842105263158,0.9604183656052091,1.0,19/65,16.09%,PDE6H;TSG101;DUSP3;GRB2;AREG;PTPRJ;RNF115;PTPN3;CNOT9;HGS;DGKD;MVP;CDC42;CBL;TGFA;EPS15;HIP1;SH3KBP1;SH3GL2
prerank,ribonucleoprotein complex assembly (GO:0022618),0.5223846125134847,1.3006045251067904,0.06376518218623482,0.9593764908226841,1.0,28/132,12.74%,POLR2D;EIF6;SNRPD2;SNRPD1;BOP1;DENR;GEMIN8;SART1;EIF4B;GEMIN2;RPLP0;PRKDC;TRAF7;TGS1;RPL38;RBM5;HSP90AA1;LUC7L;SRSF5;PRPF6;SNRPD3;SETX;SCAF11;DDX23;SF1;EIF3A;SRSF9;SRPK2
prerank,body fluid secretion (GO:0007589),-0.4951216387201213,-1.3005264476781946,0.156794425087108,0.9714119443691287,1.0,6/15,30.94%,ERBB4;GPAT4;PRLR;SLC22A4;VEGFA;ZBTB7B
prerank,cellular response to growth factor stimulus (GO:0071363),0.5169047291149571,1.3002932287114983,0.057459677419354836,0.9588891679387093,1.0,36/151,13.90%,WNT4;ADAMTS12;GAS1;URI1;DUSP3;RELA;RAPGEF1;ITGB1BP1;EHD1;STMN2;BMPR1A;RAP1A;NRP1;SMAD3;PDGFB;NR3C1;ACVR1;MAPT;TWF2;LIMS1;CD44;SETX;MT1G;SEMA6A;TGFBR2;MAP2K5;ZFP36L1;ERN1;MAPK14;SOX6;MAPKAPK2;TGFBR1;ACVR1B;WWOX;HTRA2;PRKD2
prerank,positive regulation of cellular metabolic process (GO:0031325),0.5281895677840925,1.3002452002426406,0.10248447204968944,0.9570453797212133,1.0,19/98,14.37%,ACE2;PID1;GRB2;VAMP3;THBS1;PDGFB;IL10RB;ARRB2;AHI1;PPARG;CD63;ANXA2;TGFBR2;TBC1D5;MAPK14;TP53;INSR;ACACA;PPARD
prerank,defense response to Gram-positive bacterium (GO:0050830),0.5672467859018405,1.299972058177663,0.13557358053302435,0.9564406029694967,1.0,3/40,7.47%,ANG;RNASE6;GSDMD
prerank,positive regulation of lipid catabolic process (GO:0050996),0.6077748752054836,1.299880376931002,0.16733601070950468,0.954845597152152,1.0,4/19,12.94%,IRS1;ABCD2;IRS2;ABCD1
prerank,negative regulation of defense response (GO:0031348),0.5321746218881063,1.2997642068373452,0.11263157894736842,0.9533528138008959,1.0,10/77,10.06%,ISL1;RORA;TNFAIP8L2;FEM1A;ILRUN;ALOX5;VPS35;PPARG;PROC;MAPKBP1
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.5776805553857324,-1.2991487916382507,0.14488636363636365,0.9684478284508461,1.0,5/10,34.05%,WHRN;IFT88;PLS1;SOD1;ADGRV1
prerank,regulation of DNA metabolic process (GO:0051052),0.5619292035895823,1.2990386295956058,0.1431818181818182,0.955234675157018,1.0,9/44,8.29%,SIRT7;KDM1B;SMG6;PARG;UBE2V2;TERF2;USP1;NBN;CDK9
prerank,response to cadmium ion (GO:0046686),0.5901308129053132,1.2989119957831659,0.15298507462686567,0.9538776990880311,1.0,11/26,10.61%,JUN;MAPK1;MAPK8;MT1F;MT1M;MT1H;MT1X;MT1A;MT1E;MT1G;MT1B
prerank,peptidyl-lysine trimethylation (GO:0018023),0.5922812371615037,1.2987604308811453,0.15527950310559005,0.9526344706462648,1.0,7/26,9.33%,CTR9;SUV39H1;SETD1A;SETD2;KMT5B;SETD3;KMT5C
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.6400243245955879,1.2986232040274626,0.17158931082981715,0.9513065010837921,1.0,3/15,11.69%,ZFYVE27;GRB2;FRS2
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.5151575702407069,1.2980924990896585,0.009,0.9521285560057697,1.0,63/348,14.30%,MUSK;FGF22;FGF18;RGCC;BRCA1;WFS1;CD36;SP1;PID1;FGF1;FAM98A;PPHLN1;BRAF;GAS6;HCFC1;OLFM1;MSN;RBMS3;VAMP3;EPHB2;AR;SMAD3;TERF2;PDGFB;MAPK1;SLC38A2;TNRC6B;ARRB2;IL1A;EZR;TLE1;MAPK8;TLR3;AGO2;PTPN1;ITGB8;VPS35;KRAS;LIMS1;AHI1;DTNBP1;CD63;HGS;F3;ANXA2;NR5A1;SOX11;MTOR;MAP2K5;TASOR;TBC1D5;MAPK14;ERP29;UBR5;SRPK2;TP53;TGFBR1;FUBP3;FN1;INSR;LGALS9;RBPJ;ROCK2
prerank,regulation of dendrite development (GO:0050773),0.5665105784253941,1.2979309596545263,0.13609467455621302,0.9509298775266551,1.0,10/37,12.22%,BMP5;CAMK1D;NEDD4;HECW1;ADGRB3;LRP8;SDC2;BCL11A;LZTS1;CDKL5
prerank,regulation of mitochondrial translation (GO:0070129),0.6034339269053473,1.2975268298979739,0.18340026773761714,0.9510200381921294,1.0,4/21,6.76%,COA3;MALSU1;MTG2;NSUN3
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.50486115434547,-1.2974841270685105,0.15,0.9664728289440148,1.0,2/13,3.22%,TPR;DYNC1LI1
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.5338202532212519,1.2964134561395009,0.12763713080168776,0.954743613229102,1.0,15/78,14.70%,PLK1;RGCC;BLM;CDK5RAP3;TFAP4;CDK7;PDGFB;IPO7;MNAT1;APC;IPO5;CCNI;GTF2H1;PKD2;PTEN
prerank,regulation of cytokinesis (GO:0032465),0.5369836708950172,1.2957985580201186,0.10326659641728135,0.9559404872667515,1.0,21/78,15.16%,PLK1;CETN2;SVIL;VPS4A;BBS4;PIK3R4;KIF13A;AHCTF1;PRPF40A;KIF20B;GIPC1;SETD2;PKN2;CCP110;BIRC6;CDC42;UVRAG;SH3GLB1;CALM1;PKP4;BECN1
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.6927815681020739,1.2957920409854469,0.18085106382978725,0.9539542753451682,1.0,3/10,8.07%,ATP5F1A;ATP5MC3;ATP5MC2
prerank,negative regulation of telomere maintenance (GO:0032205),0.640351965711641,1.295717547549964,0.17414965986394557,0.9523336534013421,1.0,6/15,8.76%,RAD50;SMG6;TERF2;ERCC4;NBN;TNKS2
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5653222631710635,1.295537576430967,0.1559074299634592,0.9511648673297315,1.0,8/33,12.01%,RGCC;ITGB1BP1;THBS1;HDAC5;MECP2;PPARG;MAP2K5;HMGB1
prerank,phospholipid metabolic process (GO:0006644),0.5337954857553094,1.2953445048783108,0.11275026343519494,0.9501820795606262,1.0,11/71,10.71%,LCAT;SMPD3;SMPD1;PIP4K2A;GPX4;GPAM;PLA2G4A;PIP4K2B;FADS1;PLAA;AGPAT4
prerank,postreplication repair (GO:0006301),0.551587683190781,1.2949328740486654,0.13864628820960698,0.9503628286154265,1.0,7/45,6.62%,BRCA1;PCLAF;RFC2;RAD18;UBE2V2;UBE2A;POLD3
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.5416938881134988,-1.2945924174171168,0.13479623824451412,0.9704136592197241,1.0,5/12,23.20%,ATP1B3;ATP1B1;WNK2;WNK3;ATP1B2
prerank,divalent inorganic cation homeostasis (GO:0072507),0.5905307651397287,1.2945333002409833,0.1592920353982301,0.9504526652548241,1.0,2/25,0.70%,WFS1;SELENON
prerank,natural killer cell activation (GO:0030101),-0.45281654795953136,-1.2944021681653137,0.12254901960784313,0.9617851376601516,1.0,11/23,24.57%,ELF4;PTPRC;IL21R;PRDX1;TOX;SNX27;PBX1;ULBP1;CASP8;SLAMF7;BAG6
prerank,striated muscle cell development (GO:0055002),0.643844380516106,1.29417450683234,0.17372262773722627,0.9502422453351319,1.0,2/14,4.80%,TMOD1;TMOD3
prerank,metal ion homeostasis (GO:0055065),0.5602577440977642,1.2936682023425616,0.1413793103448276,0.9508171749441591,1.0,5/40,8.66%,WFS1;SELENON;LETM1;LETM2;SLC7A8
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.5188532689312962,1.2933188918481104,0.08620689655172414,0.9506772634572054,1.0,21/125,11.83%,PLK1;NUDC;PMF1;ZWINT;SBDS;KPNB1;NDEL1;MAPRE1;AHCTF1;PCNT;DYNLL2;BUB3;KIF11;SETD2;NUP98;DCTN2;MECP2;CENPP;TAOK1;EML4;EML1
prerank,regulation of hormone secretion (GO:0046883),0.6390272554333516,1.2933186682903293,0.1752136752136752,0.9486966858250027,1.0,3/15,11.42%,VAMP3;VAMP2;SOX11
prerank,glycoprotein catabolic process (GO:0006516),0.6082842268484112,1.2932228645011339,0.20433017591339647,0.9472192788506092,1.0,2/17,1.05%,ADAMTS12;FBXO17
prerank,regulated exocytosis (GO:0045055),0.5178939316756935,1.2929665474901537,0.05823293172690763,0.9464856853829505,1.0,32/173,12.08%,STXBP2;HABP4;VCL;FAM3C;CD36;VAMP7;ENDOD1;SELENOP;VEGFC;TGFB2;GAS6;SCG3;THBS1;FLNA;ALDOA;PDGFB;QSOX1;FERMT3;SYT12;SYT11;LHFPL2;PHACTR2;F13A1;LYN;VAMP2;CDK5;CD63;ACTN4;CYRIB;TMSB4X;APOOL;WDR1
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.5306072246625748,1.2928492498858557,0.13191489361702127,0.9451205124203027,1.0,18/69,11.97%,POLR2D;SNAPC5;RPRD1B;SP1;PHAX;INTS12;INTS2;POLR2A;CDK7;RPRD2;RPRD1A;CDK9;INTS4;GTF2E1;GTF2E2;GTF2B;GTF2F2;RPAP2
prerank,regulation of cell adhesion (GO:0030155),0.5138800281549968,1.2925676903375298,0.09959349593495935,0.9446644971663877,1.0,26/129,14.97%,CXCL12;PLXNA1;MINK1;ITGB1BP1;RSU1;EPHB2;TPM1;PRKCA;PTPRJ;CBLL1;PDE3B;STX3;LPXN;IL18;LYN;MIA3;CYTH1;ABL1;ADAM10;PLXNC1;ADAM22;ATXN3;PRKD2;ROCK2;PKP4;ARHGDIB
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.5568668827893811,1.2923899289699645,0.15635939323220538,0.9435741488821073,1.0,9/38,9.28%,POLR3G;RIOK3;IFI35;DDX60;SASH1;PRKCA;PUM2;AKIRIN2;PUM1
prerank,ether lipid metabolic process (GO:0046485),0.6408471433811657,1.2923612626375867,0.18832116788321168,0.9417924155600533,1.0,4/14,5.02%,PLA2G7;LIPE;PLA2G6;FAR1
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.5876118709169514,1.2923528301150398,0.16319018404907976,0.9399089026053943,1.0,8/28,9.22%,PRKCZ;PID1;PIP4K2A;IRS1;PRKCB;PTPN1;NCK1;PIP4K2B
prerank,regulation of mitotic spindle assembly (GO:1901673),0.6079988205683229,1.2921898503727398,0.16754617414248021,0.9387805657259347,1.0,3/19,2.90%,PLK1;EML3;CHMP5
prerank,metallo-sulfur cluster assembly (GO:0031163),0.5913755630854556,1.2914838949319571,0.175,0.9404107187683666,1.0,5/22,7.55%,NUBPL;NFU1;NFS1;ABCB7;HSPA9
prerank,cell-cell junction organization (GO:0045216),0.5297249872673524,1.2913310898942523,0.10729166666666666,0.9392984742547361,1.0,7/79,5.31%,SDK2;ANG;GJC1;TLN2;TGFB2;SMAD3;CTNNA1
prerank,ribosomal subunit export from nucleus (GO:0000054),0.6678169417880626,1.2905365071893218,0.17956204379562044,0.9415160765799796,1.0,2/13,2.84%,EIF6;NMD3
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.6639350117870624,1.2903624350269858,0.18436578171091444,0.940453870692867,1.0,1/12,0.18%,PLK1
prerank,amyloid fibril formation (GO:1990000),-0.3488993464852133,-1.290239837076909,0.05357142857142857,0.97251330810319,1.0,15/51,12.33%,USP9X;APP;PRKN;TSPAN14;CST3;B2M;H3-3A;TSPAN5;SIAH1;RIPK1;SNCA;NCSTN;GGA2;UBC;FKBP1A
prerank,DNA-dependent DNA replication (GO:0006261),0.5150407048204292,1.2902244260730718,0.07164480322906155,0.9392135955442732,1.0,27/128,12.95%,POLG;SIRT7;BLM;RFC2;POLE4;POLE2;SSBP1;PSMD9;ORC4;PSMB8;POLA1;WRN;CDK2;CDK2AP1;NOC3L;POLA2;POLD3;POLG2;POLB;PSMC5;PRIM2;ORC2;DDX23;REV3L;PSMD12;SRPK2;PSMA2
prerank,relaxation of cardiac muscle (GO:0055119),-0.525841446672707,-1.2896843695078657,0.18006430868167203,0.9663018985286695,1.0,7/13,17.46%,ATP1B1;ATP1A1;ATP1A2;KCNJ2;PIK3CA;RGS2;P2RX4
prerank,negative regulation of hormone secretion (GO:0046888),-0.5735544260850853,-1.2896417355404886,0.1592920353982301,0.9574587783525293,1.0,2/10,5.34%,RAB11FIP5;RAB11FIP3
prerank,regulation of fatty acid metabolic process (GO:0019217),0.6186343931632681,1.2893116018456718,0.18922651933701656,0.942003227592956,1.0,5/17,14.37%,EIF6;NCOR1;PPARG;ADIPOR1;PPARD
prerank,T cell migration (GO:0072678),0.6426484028344688,1.2886041210428243,0.18820224719101122,0.9436979315418941,1.0,3/13,8.96%,S1PR1;MSN;MYO1G
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.488411972893362,-1.2877098247081231,0.16842105263157894,0.9576144371137114,1.0,9/16,35.81%,BMPR2;KLK3;PLCB3;GSK3A;DDAH1;GPR37L1;SLC2A5;KLK1;PRCP
prerank,7-methylguanosine RNA capping (GO:0009452),0.5731132635418624,1.2873872108913933,0.15840386940749698,0.946063648845408,1.0,7/31,13.65%,POLR2D;POLR2A;CDK7;MNAT1;RNGTT;GTF2F2;GTF2H1
prerank,7-methylguanosine mRNA capping (GO:0006370),0.5731132635418624,1.2873872108913933,0.15840386940749698,0.946063648845408,1.0,7/31,13.65%,POLR2D;POLR2A;CDK7;MNAT1;RNGTT;GTF2F2;GTF2H1
prerank,regulation of protein processing (GO:0070613),0.6049915169882374,1.2871409696466485,0.17113665389527458,0.945394926992365,1.0,3/21,3.64%,GAS1;LRRK2;RUNX1
prerank,response to tumor necrosis factor (GO:0034612),0.5193687490387048,1.286720857106756,0.11958762886597939,0.9455990993837657,1.0,16/91,12.66%,BRCA1;ADAMTS12;TNFRSF11A;RELA;CX3CL1;PID1;SMPD1;IGBP1;IKBKB;CCL25;ZFAND6;YTHDC2;ASAH1;TANK;ZFP36L1;ADAM10
prerank,mitotic spindle organization (GO:0007052),0.5135995636614652,1.2866640791263777,0.0655241935483871,0.9440042039319129,1.0,26/153,11.83%,TOGARAM2;PLK1;NUDC;PMF1;ZWINT;SBDS;KPNB1;NDEL1;CCDC61;MAPRE1;FLNA;AHCTF1;PCNT;DYNLL2;BUB3;KIF11;NUP98;DCTN2;MECP2;STAG2;CHEK2;CENPP;TAOK1;LSM14A;EML4;EML1
prerank,Wnt signaling pathway (GO:0016055),0.5230978692812199,1.286496372270451,0.10743801652892562,0.9429948616460435,1.0,21/92,14.70%,WNT4;LRRK2;WNT2B;DVL1;ARL6;CPE;USP34;LRP5;DIXDC1;SNX3;CSNK1G1;VPS35;NXN;APC;WLS;TCF7L2;LRP6;CSNK1A1;FZD9;FZD3;PTEN
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.553989023798037,1.2861741308965904,0.1553973902728351,0.9429237552398254,1.0,10/36,12.73%,DUSP3;IGBP1;EZR;DLG1;DUSP10;NCOR1;FKTN;ZMYND11;AIDA;CYLD
prerank,cellular response to fatty acid (GO:0071398),0.652372694315414,1.2851471200343905,0.1887905604719764,0.946096884992777,1.0,2/12,4.54%,PID1;IRS1
prerank,DNA modification (GO:0006304),0.5961933520578302,1.2850764358955535,0.170076726342711,0.944608940485112,1.0,4/22,8.24%,MPG;EXOSC5;TERF2;PARP2
prerank,regulation of DNA binding (GO:0051101),0.5482058345074285,1.2847526634529511,0.1541095890410959,0.9444177126749266,1.0,9/44,9.43%,MDFI;HABP4;TFAP4;JUN;ZBTB7A;ILRUN;SUMO3;MAPK8;PPARG
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.5154539474716553,1.2846480126841309,0.09100204498977506,0.943066179785377,1.0,16/110,14.41%,RXFP1;S1PR1;ADGRE1;ADCY8;ADCY3;ADCY5;GPR65;ADCY9;ADGRB3;ADGRE5;GNAQ;RAMP1;ABCA1;CALCRL;GNG2;GNB1
prerank,regulation of cellular component biogenesis (GO:0044087),0.5582150092987634,1.2843872528937614,0.16435185185185186,0.9424777137659613,1.0,12/39,14.30%,CD36;RAPGEF1;HCFC1;MSN;RAP1A;SPTY2D1;HSP90AA1;EZR;RAP1B;TRAF2;VPS11;ROCK2
prerank,filopodium assembly (GO:0046847),0.6184201378279837,1.283974400559972,0.19508867667121418,0.9426276954499259,1.0,4/16,7.01%,FGD6;FGD3;FGD1;EZR
prerank,regulation of sprouting angiogenesis (GO:1903670),0.566867911749994,1.2839732637807628,0.16626794258373206,0.9407777819689043,1.0,6/33,10.93%,FGF18;FGF1;THBS1;CEMIP2;ALOX5;SEMA6A
prerank,gastrulation (GO:0007369),0.6268838951209795,1.2825193797212964,0.19444444444444445,0.9463897716054486,1.0,5/15,13.37%,UGDH;LRP5;LMBRD1;TASOR;GPC3
prerank,positive regulation of gene expression (GO:0010628),0.5103671930114942,1.282414681708412,0.006,0.9450635997225478,1.0,78/442,13.49%,MUSK;FGF22;FGF18;EIF6;RGCC;BRCA1;HABP4;ELAVL4;POLR1C;EIF4A3;CD36;SP1;EIF2AK2;EIF3C;PID1;GLMN;FGF1;FAM98A;EIF3E;BRAF;GAS6;HCFC1;OLFM1;NIBAN1;MSN;POLR2A;RBMS3;EPHB2;AR;WBP2;THBS1;PYM1;RBM3;EP300;SMAD3;TERF2;PDGFB;PRKDC;MAPK1;SLC38A2;TNRC6B;POLR1A;METTL3;IL1A;EZR;TLE1;MAPK8;LARP4B;TLR3;AGO2;ITGB8;VPS35;YTHDF1;KRAS;LIMS1;FXR2;DTNBP1;SETX;HGS;F3;U2AF2;NR5A1;KAT2B;SOX11;MTOR;SCAMP5;ERN1;PLD1;MAPK14;ERP29;UBR5;SRPK2;SAMD4A;TP53;TGFBR1;MAP2K2;FUBP3;FN1
prerank,cellular response to estrogen stimulus (GO:0071391),0.6424583876194918,1.2820638660798425,0.19540229885057472,0.9449878460358131,1.0,3/14,4.50%,PELP1;AR;WBP2
prerank,neural tube development (GO:0021915),0.6335224588846744,1.2820105620503037,0.1876750700280112,0.9434206167807471,1.0,2/15,1.89%,ALDH1A2;DVL1
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.5388857412161207,1.2819662386178285,0.15899122807017543,0.941797863628013,1.0,13/52,12.87%,POLR2D;CNOT10;LSM7;TUT4;EXOSC5;DCP1B;RC3H2;EXOSC7;CNOT9;DCP1A;CNOT3;DCPS;SAMD4A
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.6155486612874134,1.2814252687045196,0.1767180925666199,0.9427506260700754,1.0,3/15,7.52%,CD36;EIF2AK2;PYDC1
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.5507834848260058,-1.2810369953707148,0.16463414634146342,0.980376755639402,1.0,3/11,14.22%,PTPRC;SMAD7;LILRB1
prerank,positive regulation of cell cycle (GO:0045787),0.5341196561161075,1.2810288512839239,0.14935064935064934,0.9427749871152823,1.0,15/62,13.91%,RGCC;CCDC57;DUSP3;NUPR1;TGFB2;HCFC1;USP19;PDGFB;PRKCA;RPS15A;PKN2;TAL1;SRPK2;LRP6;PKD2
prerank,regulation of fibroblast migration (GO:0010762),-0.4493841666657124,-1.2809978835960079,0.14937759336099585,0.9716136548502295,1.0,13/20,10.71%,PRKCE;PTK2;TGFB1;RFFL;APPL2;CORO1C;RAC1;APPL1;CLN3;PRR5L;GNA12;ARHGEF7;FGF2
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.5218809372847197,1.2804976324521988,0.11134020618556702,0.9435403566356891,1.0,17/86,15.19%,BMP5;ZEB2;TGFB2;BMPR1A;THBS1;EP300;SDCBP;ACVR1;STK11;GIPC1;DAB2;SOX11;HIPK2;TGFBR1;ACVR1B;RBPJ;SMAD4
prerank,snRNA transcription (GO:0009301),0.5245657619509141,1.2802133878558204,0.14012738853503184,0.9431567725528529,1.0,18/70,11.97%,POLR2D;SNAPC5;RPRD1B;SP1;PHAX;INTS12;INTS2;POLR2A;CDK7;RPRD2;RPRD1A;CDK9;INTS4;GTF2E1;GTF2E2;GTF2B;GTF2F2;RPAP2
prerank,inositol phosphate dephosphorylation (GO:0046855),0.6667222185071302,1.2801005106595933,0.17682020802377416,0.9400754810114841,1.0,5/11,15.36%,INPP1;INPP5A;OCRL;PTEN;SYNJ2
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.6667222185071302,1.2801005106595933,0.17682020802377416,0.9400754810114841,1.0,5/11,15.36%,INPP1;INPP5A;OCRL;PTEN;SYNJ2
prerank,regulation of secretion (GO:0051046),-0.5147458917729975,-1.2789576882252682,0.17940199335548174,0.972402608832217,1.0,8/13,36.87%,MYO6;SGK1;ACSL3;OAS2;FGF10;GPLD1;ERBB3;POFUT2
prerank,regulation of pH (GO:0006885),0.6725663263808491,1.278908729325546,0.20294117647058824,0.9442407048655742,1.0,3/11,8.79%,SLC9A1;LACC1;SLC9A7
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.5840390140797516,1.2786896168710464,0.17783191230207065,0.9435377140318821,1.0,7/25,15.24%,PDE6H;CNOT9;DGKD;CBL;RTN4;RBPJ;HIP1
prerank,regulation of dephosphorylation (GO:0035303),0.6392323368877703,1.2784902748843583,0.18384401114206128,0.9426518193525163,1.0,4/15,4.09%,CDK5RAP3;SMG6;IGBP1;MTMR1
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.5274324615988134,1.2783996769163806,0.1327713382507903,0.9412623388921307,1.0,21/80,12.87%,EIF6;EIF4A3;RELA;SP1;EIF3C;SMPD3;EIF3E;NIBAN1;PLA2G6;THBS1;PYM1;RBM3;PRKDC;METTL3;LARP4B;YTHDF1;FXR2;ABCG1;MTOR;PLD1;SAMD4A
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.6601056904464766,1.2783524238529953,0.18413173652694612,0.9397341359056063,1.0,2/11,2.65%,UQCRH;UQCRC1
prerank,regulation of mitochondrial depolarization (GO:0051900),0.6688256916880402,1.2782800607591784,0.19365079365079366,0.9383477157302541,1.0,5/10,14.50%,LRRK2;MLLT11;ABCD1;BCL2;FZD9
prerank,telomere maintenance via telomere trimming (GO:0090737),0.6716844762447698,1.2782224453423365,0.21231766612641814,0.9333372355110241,1.0,4/10,13.42%,BLM;WRN;NBN;TERF1
prerank,t-circle formation (GO:0090656),0.6716844762447698,1.2782224453423365,0.21231766612641814,0.9333372355110241,1.0,4/10,13.42%,BLM;WRN;NBN;TERF1
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.6716844762447698,1.2782224453423365,0.21231766612641814,0.9333372355110241,1.0,4/10,13.42%,BLM;WRN;NBN;TERF1
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.6495048169198133,1.2779515756079607,0.19562043795620437,0.9329295369426166,1.0,1/13,1.34%,PARP9
prerank,DNA catabolic process (GO:0006308),0.6700620661437533,1.2775959831907213,0.1873156342182891,0.9328985868696832,1.0,2/11,10.81%,DFFB;XRN2
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.62401901708858,1.277134919195087,0.19515477792732167,0.9332921951199958,1.0,2/16,2.15%,BRCA1;CTR9
prerank,peptidyl-lysine monomethylation (GO:0018026),0.6744251760647574,1.2769272369706037,0.20285261489698891,0.9324958182770032,1.0,3/10,7.97%,EHMT1;SETD2;SETD3
prerank,intestinal lipid absorption (GO:0098856),0.6640626155675358,1.2765155018664462,0.19938176197836166,0.9327413779582489,1.0,3/11,13.71%,CD36;CEL;LIMA1
prerank,glycoprotein metabolic process (GO:0009100),0.5292658670111151,1.2763874997200388,0.16648648648648648,0.9315804197771405,1.0,16/53,17.11%,MAN1B1;FBXO17;ST8SIA5;ST8SIA4;ERP44;GOLPH3;GANAB;B4GALT5;MAN2A2;PRKCSH;MGAT4B;PCSK6;MAN1A2;MGAT4A;LARGE1;ST3GAL2
prerank,artery morphogenesis (GO:0048844),0.5632995820797129,1.2763345361969738,0.1798298906439854,0.9300558931811489,1.0,5/30,4.64%,HPGD;TGFB2;NF1;BMPR1A;NRP1
prerank,atrioventricular valve morphogenesis (GO:0003181),0.6166734845857531,1.2763301839553194,0.1835883171070932,0.9283391668789127,1.0,6/19,11.20%,SMAD6;TGFB2;OLFM1;BMPR1A;ACVR1;TGFBR2
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.5628897735083911,1.2759274218206025,0.16766467065868262,0.9285260564299193,1.0,6/32,8.81%,CAVIN1;POLR1C;CDK7;POLR1A;MNAT1;UBTF
prerank,positive regulation of hemostasis (GO:1900048),0.6647846778937672,1.2749370999691185,0.1885245901639344,0.9298873269036919,1.0,2/10,4.93%,THBS1;ENPP4
prerank,positive regulation of coagulation (GO:0050820),0.6647846778937672,1.2749370999691185,0.1885245901639344,0.9298873269036919,1.0,2/10,4.93%,THBS1;ENPP4
prerank,regulation of steroid metabolic process (GO:0019218),0.600765134139975,1.2747610688691506,0.17412935323383086,0.9290429190193101,1.0,6/23,11.42%,RORA;TTC39B;ABCG1;ASAH1;NR5A1;ACADL
prerank,icosanoid secretion (GO:0032309),-0.5232990279028977,-1.274722039600103,0.1574074074074074,0.9840693659958122,1.0,2/12,10.26%,PNPLA8;ABCC4
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.6477281868845397,1.274057853269912,0.18577648766328012,0.9307107182396248,1.0,3/14,7.10%,BRCA1;CTR9;KMT2E
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.5428142499852289,1.2740201344216082,0.16928251121076232,0.9291792218159329,1.0,9/43,9.22%,PRKCZ;PID1;SNX5;PIP4K2A;IRS1;PRKCB;PTPN1;NCK1;PIP4K2B
prerank,regulation of hydrolase activity (GO:0051336),0.527866807895193,1.2735714785859789,0.12937433722163308,0.9296273302029211,1.0,21/71,15.08%,PLXNA1;CDK5RAP3;FGD6;FGD3;FGD1;ITGB1BP1;RAB3GAP1;NF1;TBC1D15;WRN;VAV3;TBC1D10B;EPHA5;FBXW11;OCRL;VAV2;RABGAP1;ARHGAP15;PLXNC1;SCARB2;VAV1
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.6562110456763055,1.2732982879708659,0.18463810930576072,0.9292864031165238,1.0,2/12,8.16%,BLM;NBN
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.5057589637090755,1.2731432045060143,0.0888661899897855,0.9284096597445742,1.0,33/122,15.24%,EIF6;RGCC;EIF4A3;EIF3C;NMD3;EIF3E;DYRK2;TGFB2;NIBAN1;HSPH1;AR;IRS1;THBS1;PYM1;RBM3;PDGFB;PRKDC;METTL3;IRS2;LARP4B;YTHDF1;FXR2;FAF1;GCK;MTOR;PLD1;SAMD4A;INSR;PRKD2;LDB1;TLR4;CTC1;NPM1
prerank,positive regulation of axon extension (GO:0045773),0.5873094682595591,1.2729920422636833,0.18528252299605782,0.9275006321827765,1.0,9/22,16.16%,ZFYVE27;NRP1;MAPT;TWF2;DBNL;CDKL5;RUFY3;MACF1;GOLGA4
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.5265998522558881,-1.2726400555970057,0.18018018018018017,0.9848795770549754,1.0,3/11,4.45%,CACNA2D1;NOS1AP;SESTD1
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.48678099972419286,-1.2724569578686311,0.1708185053380783,0.9770892985506079,1.0,9/16,18.61%,SIK3;CLEC16A;GPR137B;PIP4P1;FLCN;KLHL22;RRAGD;SEH1L;RRAGB
prerank,import into nucleus (GO:0051170),0.5265115514070785,1.2722897491476557,0.13219616204690832,0.9292480735666444,1.0,18/73,13.36%,SNRPD2;SNRPD1;GEMIN8;KPNB1;EIF4ENIF1;HIKESHI;HEATR3;GEMIN2;RANBP6;IPO7;IPO9;PTTG1IP;CSE1L;SNRPD3;IPO5;BACH2;IPO11;SYK
prerank,response to UV-B (GO:0010224),0.6441887447555646,1.2717341536689402,0.2002820874471086,0.9301498013969598,1.0,2/12,6.79%,RELA;STK11
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.5602538585788259,1.2717042757835373,0.17894736842105263,0.9285775125781348,1.0,10/36,13.26%,BRCA1;EHMT1;MAX;APAF1;EHMT2;RBBP8;EZH2;PHC3;RBBP7;EPC1
prerank,cardiac muscle tissue development (GO:0048738),0.5313617174965938,1.2716467157744789,0.16129032258064516,0.92716113120042,1.0,6/50,11.19%,BMP5;BMPR1A;SGCG;NDUFV2;AKAP13;NOTCH2
prerank,gland development (GO:0048732),0.529051460169942,1.2712012650552629,0.15135135135135136,0.9275915934907399,1.0,10/59,13.91%,WNT4;CDK5RAP3;NF1;MSN;ARID5B;EZR;ARHGAP35;PRKCSH;TGFBR1;PKD2
prerank,vasodilation (GO:0042311),-0.5165923422860074,-1.271150074826764,0.14335664335664336,0.974976578920543,1.0,6/13,37.36%,SOD2;KCNMA1;SOD1;ADRB1;ADRB2;KLF2
prerank,regulation of cell cycle (GO:0051726),0.504567769920103,1.2709597366635472,0.03803803803803804,0.9271317939528237,1.0,61/271,13.91%,PLK1;WDR6;RGCC;BRCA1;PCLAF;BOP1;CDK5RAP3;RPRD1B;IRF1;NUPR1;TFAP4;HPGD;TGFB2;HCFC1;TARDBP;RASSF1;JUN;THBS1;CDK7;EP300;SMAD3;PRKACA;LIN9;MAP3K20;RPS15A;KIF20B;SDCBP;CDK6;METTL3;BIRC3;JUND;STK11;MAP2K6;NBN;CDK9;GRK5;PUM1;NEK7;APC;CTBP1;TXLNG;CDK5;HBP1;LIN52;NOTCH2;KAT2B;PRCC;ABL1;ERN1;TCF7L2;ADAM10;CYLD;SRPK2;HIPK2;TP53;TGFBR1;RNF20;LRP6;TTC28;HTRA2;PKD2
prerank,cell-substrate junction assembly (GO:0007044),-0.37490524214549614,-1.2704094468050413,0.1346153846153846,0.9701295213969755,1.0,13/33,16.82%,PIP5K1A;PTPRK;SORBS1;TAOK2;TESK2;ARHGEF7;PEAK1;FERMT2;BCR;RCC2;ACTN1;WHAMM;PLEC
prerank,cellular response to BMP stimulus (GO:0071773),0.521900255850653,1.2701965805197717,0.14696485623003194,0.9292833169010025,1.0,8/66,7.45%,BMP5;ADAMTS12;SMAD6;TGFB2;BMPR1A;SMAD3;ACVR1;SLC33A1
prerank,regulation of cellular component organization (GO:0051128),0.514726126947287,1.2701895466115545,0.08173562058526741,0.9276347060066595,1.0,24/135,11.90%,SGK3;SGK2;URI1;CD36;RAPGEF1;SETD1A;HCFC1;RAP1A;STON2;PACSIN2;EGLN2;CAMSAP3;STK11;HSP90AA1;RAB5B;NRG3;NEDD4;RAP1B;CAMK2D;PTPN1;TRAF2;RIT2;MTOR;ABL1
prerank,regulation of cytokine production (GO:0001817),0.5108838601199971,1.270052884790025,0.08664627930682976,0.926609475894269,1.0,22/126,14.00%,ACE2;RGCC;EIF2AK2;GLMN;IRF3;BCL6;HDAC9;POLA1;IL1A;SYT11;RPS6KA5;ALOX5;NPTN;MAST2;ICOSLG;LYN;PLD4;SCAMP5;MAPK14;MAPKAPK2;TRIM56;LGALS9
prerank,phagolysosome assembly (GO:0001845),-0.520774558357102,-1.269841719883111,0.1751592356687898,0.964132254184727,1.0,6/12,16.54%,ARL8B;CLN3;RAB14;CORO1A;RAB39A;RAB20
prerank,lamellipodium organization (GO:0097581),0.5583989166509652,1.2695482773525133,0.17454545454545456,0.9275305049439393,1.0,10/29,15.12%,VCL;S1PR1;WASF1;PARVB;ABLIM3;GOLPH3;SNX1;PTPRO;P2RY12;ABLIM1
prerank,heart development (GO:0007507),0.511121419833421,1.26873771890931,0.07894736842105263,0.9297318085501431,1.0,30/150,14.84%,ISL1;BMP5;SCUBE1;DAND5;TGFB2;NF1;SGCG;PDLIM2;HDAC9;PDGFB;FLRT2;ACVR1;MEF2A;NDUFV2;CHD7;MICAL2;CACYBP;AKAP13;TGFBR2;KAT2B;TGFBR1;GPC3;FN1;INSR;NDRG4;HEG1;PKD2;PTEN;CACNA1C;SMG9
prerank,regulation of coagulation (GO:0050818),0.6480003699310021,1.2686970985504271,0.2169230769230769,0.9283062156355748,1.0,2/11,9.62%,EPHB2;PROC
prerank,positive regulation of behavior (GO:0048520),-0.559331624672421,-1.2686299129748546,0.19047619047619047,0.9612157939966604,1.0,3/10,15.26%,SGIP1;CFAP20;AGRP
prerank,microtubule nucleation (GO:0007020),0.590543107960026,1.2684630824934386,0.195822454308094,0.9277578367414229,1.0,6/20,8.66%,CCDC57;NDEL1;AKAP9;TUBGCP6;RANBP9;TUBGCP2
prerank,cilium movement (GO:0003341),0.5354734233353995,1.2684342746122113,0.16777041942604856,0.9262424961311241,1.0,3/48,10.04%,RSPH4A;CAMSAP3;DNAI4
prerank,ESCRT III complex disassembly (GO:1904903),0.6704605221609715,1.2671983292882252,0.20610687022900764,0.928810295600004,1.0,4/10,14.18%,VPS4A;CHMP5;VPS4B;IST1
prerank,ESCRT complex disassembly (GO:1904896),0.6704605221609715,1.2671983292882252,0.20610687022900764,0.928810295600004,1.0,4/10,14.18%,VPS4A;CHMP5;VPS4B;IST1
prerank,glutathione derivative metabolic process (GO:1901685),0.597422056384481,1.267041278678034,0.18848167539267016,0.9262874154687673,1.0,1/20,0.99%,MGST3
prerank,glutathione derivative biosynthetic process (GO:1901687),0.597422056384481,1.267041278678034,0.18848167539267016,0.9262874154687673,1.0,1/20,0.99%,MGST3
prerank,regulation of programmed cell death (GO:0043067),0.5050260836847754,1.2665232654547682,0.07777777777777778,0.9272647703307526,1.0,40/161,15.24%,WFS1;GAS1;LRRK2;IGFBP3;STEAP3;DDX42;HS1BP3;TNFRSF25;BCL2L11;TARDBP;ZBTB7A;IRF3;BCL6;WRN;APAF1;ACER3;BIRC3;HSP90AA1;PSMC5;BNIP3L;PHLPP1;DAPK1;TM7SF3;LRP8;FBXO11;CDK5;ACTN4;ASAH1;BNIP3;TRAF2;ABL1;DCPS;RAF1;DNAJA3;TP53;RTN4;NDRG1;ANP32A;ANP32B;HIP1
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.6012895149321615,1.2663235029798843,0.2032828282828283,0.926542996380073,1.0,4/20,6.83%,AK4;AK3;ADSS1;HPRT1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.4331470058314051,-1.2652617127093606,0.1440677966101695,0.9680240634827114,1.0,14/23,46.35%,FGF2;SMO;ITGAX;VEGFA;GJA1;PAX8;PAX2;MDK;SOX8;AGT;WNT5B;SOX9;SIRT6;EGF
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.5664941767677223,1.264794599295712,0.18615751789976134,0.9320926752091926,1.0,6/28,7.60%,GBA2;MAP1A;STMN2;MAPRE1;CAMSAP3;MAPT
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.5218066138950879,-1.2646532336046352,0.16451612903225807,0.9626127742600893,1.0,9/13,31.85%,TPR;NUP153;SUFU;CHP1;RANGAP1;RAB23;UFM1;CABP1;PARK7
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.5236990654786531,1.264458522168287,0.1655773420479303,0.9319611142665262,1.0,14/58,8.48%,BRCA1;RAD50;XRCC4;ZBTB7A;POLA1;UBE2V2;DCLRE1A;PRKDC;POLB;MRE11;ERCC4;SMC5;NBN;BABAM2
prerank,regulation of protein localization to nucleus (GO:1900180),0.5427363275457522,1.2640804002221957,0.16666666666666666,0.9320827595710568,1.0,6/43,7.33%,PLK1;CDK5RAP3;PARP9;ILRUN;CTNNA1;SUMO3
prerank,triglyceride catabolic process (GO:0019433),-0.46143176506349937,-1.263312551831515,0.18518518518518517,0.9604452481151253,1.0,3/19,16.92%,LPL;FABP5;LIPH
prerank,calcium ion transport into cytosol (GO:0060402),-0.44659504678723033,-1.2632464044043006,0.2,0.9528421832753365,1.0,11/21,32.00%,RYR2;CACNA2D1;GRIN2B;JPH1;ATP2B4;GRIN1;ADRA1A;TRPM2;JPH4;TRPV4;ITPR3
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.63337382825005,1.262706972854907,0.20266272189349113,0.937137288014465,1.0,1/13,0.26%,MGAT3
prerank,protein-containing complex assembly (GO:0065003),0.49927278319868507,1.2626359217941594,0.04804804804804805,0.9358686893593355,1.0,61/259,14.30%,CXCL12;RSPH4A;LMAN1;PDZD11;LRRK2;BLM;GOSR2;CX3CL1;SMARCA4;ADCY8;TFAP4;PEF1;CTSC;PPID;ITGB1BP1;LLGL1;SLC9A1;NAPG;WASF1;VAMP3;AREG;TLE2;EP300;FARP2;TEAD1;WIPF1;ST13;TRAPPC3;TLE1;MNAT1;GSDMD;FERMT3;RANBP9;REPS2;IL1RAP;LPXN;TUBGCP2;APC;VAMP2;TRAPPC9;CTSZ;TFG;CD2AP;TRAF2;SEC24B;SEC24D;DBNL;LAMC1;TMED2;TCF7L2;ADAM10;TGFA;TP53;LIN7A;NAPA;FN1;FBXL7;CSNK1A1;SAR1B;TRAPPC6B;MDN1
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.6442683254337023,1.262389700713029,0.2088235294117647,0.9354497223420314,1.0,6/12,13.60%,SETX;BNIP3;IGF1R;UVRAG;FYCO1;INSR
prerank,regulation of tau-protein kinase activity (GO:1902947),0.6719242727879291,1.2620885177012677,0.19126506024096385,0.9352796384359323,1.0,4/10,16.57%,C5AR1;HSP90AA1;SORL1;RB1
prerank,positive regulation of JUN kinase activity (GO:0043507),0.5858838592530551,1.2612360975884247,0.18932655654383734,0.9376280531267951,1.0,4/23,10.87%,TNFRSF11A;SASH1;MAP3K11;TRAF2
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.6358517820466391,1.2611772987153453,0.20520231213872833,0.9363177445557398,1.0,7/13,16.92%,UBA5;DESI1;DESI2;UBA6;ATG7;UBA2;SAE1
prerank,DNA geometric change (GO:0032392),0.5738710033588059,1.2607266789734812,0.19293820933165196,0.9368057665984156,1.0,8/24,14.60%,BLM;RAD50;WRN;HNRNPA2B1;MRE11;NBN;HMGB1;RECQL5
prerank,regulation of endocytic recycling (GO:2001135),0.641958902188357,1.2603693010589199,0.19242424242424241,0.9370481566648419,1.0,5/11,15.88%,EIPR1;EHD1;ARHGAP1;SORL1;INPP5F
prerank,intracellular sterol transport (GO:0032366),0.6335071720152081,1.260099757295561,0.21190130624092887,0.936691492372132,1.0,6/13,16.25%,OSBP;VPS4A;ABCG1;RELCH;ABCA1;OSBPL2
prerank,regulation of mRNA metabolic process (GO:1903311),-0.5332296719459716,-1.2594873033439757,0.19648093841642228,0.9613010386312096,1.0,4/11,8.86%,DHX9;SAFB;CDK11B;SRPK1
prerank,phosphatidylcholine catabolic process (GO:0034638),0.6537878809435146,1.2594804006562148,0.22408536585365854,0.937916221832526,1.0,3/10,8.02%,PLA2G7;PLA2G6;PLA2G4A
prerank,extracellular transport (GO:0006858),0.6413680163530535,1.2585266677083458,0.21547799696509864,0.940606906265521,1.0,1/13,1.41%,TSG101
prerank,regulation of exosomal secretion (GO:1903541),0.5884071202633258,1.258499251510732,0.19919786096256684,0.9391259210107245,1.0,8/19,14.59%,TSG101;SMPD3;VPS4A;SDCBP;HGS;VPS4B;PDCD6IP;RAB7A
prerank,negative regulation of signaling (GO:0023057),0.5680555147822336,1.2582729401422756,0.21851851851851853,0.9385841226936058,1.0,5/25,14.38%,IGFBP3;ACVR1;PTPN1;SOCS5;OPTN
prerank,embryonic appendage morphogenesis (GO:0035113),0.6473896978613345,1.2577124256418384,0.20114122681883023,0.9396642574578922,1.0,4/12,15.49%,TGFB2;MBNL1;LRP6;FBXW4
prerank,actin filament capping (GO:0051693),0.604306957907077,1.2574738407739139,0.19678714859437751,0.9375818166107361,1.0,5/18,10.27%,SVIL;CAPZB;TWF2;ADD1;EPS8
prerank,barbed-end actin filament capping (GO:0051016),0.604306957907077,1.2574738407739139,0.19678714859437751,0.9375818166107361,1.0,5/18,10.27%,SVIL;CAPZB;TWF2;ADD1;EPS8
prerank,response to steroid hormone (GO:0048545),0.551485210291025,1.2562386488954318,0.197352587244284,0.941667640154523,1.0,8/31,12.58%,URI1;TGFB2;AR;WBP2;THBS1;NR3C1;UBE3A;PAQR8
prerank,nucleoside phosphate catabolic process (GO:1901292),0.6442542171985323,1.256231190730288,0.2191977077363897,0.9401148185574596,1.0,2/13,8.09%,SMPDL3A;ENTPD1
prerank,histone H2A acetylation (GO:0043968),0.6273851856431208,1.256116248227877,0.18724559023066487,0.9390096161688123,1.0,7/16,15.69%,DMAP1;BRD8;ING3;MORF4L2;EPC1;EP400;TRRAP
prerank,aromatic amino acid family catabolic process (GO:0009074),-0.48174235750705163,-1.2557866749341302,0.18118466898954705,0.9703303713235123,1.0,8/15,44.12%,KYNU;QDPR;GSTZ1;KYAT1;HAAO;KMO;FAH;IL4I1
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.5498312727316421,1.2553446339185537,0.1889400921658986,0.9410028008410748,1.0,4/38,6.99%,BMP5;BRCA1;THBS1;RNF34
prerank,regulation of G0 to G1 transition (GO:0070316),0.5528683358420516,1.2551427119896656,0.18859138533178113,0.9404063808047766,1.0,10/38,13.26%,BRCA1;EHMT1;MAX;APAF1;EHMT2;RBBP8;EZH2;PHC3;RBBP7;EPC1
prerank,tRNA methylation (GO:0030488),0.5467387840764305,1.2548736404950709,0.1793020457280385,0.9402054812130122,1.0,4/34,5.02%,WDR6;NSUN6;TRMO;TARBP1
prerank,inositol phosphate catabolic process (GO:0071545),0.6408285040417769,1.2545931689461507,0.1988388969521045,0.9399053257187194,1.0,5/12,15.36%,INPP1;INPP5A;OCRL;PTEN;SYNJ2
prerank,positive regulation of leukocyte degranulation (GO:0043302),-0.5196472432873462,-1.254379746270162,0.19528619528619529,0.9687110161246592,1.0,5/13,12.30%,FGR;STX4;GAB2;ITGB2;AP1G1
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.5717528297992046,1.2542953449489553,0.19854721549636803,0.9397437880691953,1.0,11/29,11.02%,TUT4;SMAD3;PUM2;METTL3;HNRNPA2B1;AGO2;LIN28B;PUM1;ZC3H7A;ADAR;PRKRA
prerank,muscle contraction (GO:0006936),0.4991491786875836,1.2540911347844808,0.10964467005076142,0.9391534935672116,1.0,8/126,7.03%,GJC1;VCL;TMOD1;MYOF;TMOD3;ALDOA;TPM1;ITGB5
prerank,DNA methylation (GO:0006306),0.5858397568645721,1.25369299284793,0.21045918367346939,0.9395389126214566,1.0,6/23,12.96%,EHMT1;DMAP1;EHMT2;KMT2E;DNMT3A;ATRX
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.5531739133591556,-1.2534998668942152,0.21703296703296704,0.9650447894538708,1.0,2/10,8.32%,KCNAB1;SUMO1
prerank,positive regulation of catabolic process (GO:0009896),-0.3205093062852224,-1.2534317803981594,0.06756756756756757,0.9577623586657563,1.0,20/65,19.01%,SMURF2;PRKN;SMURF1;CSNK2A1;HUWE1;NSF;STX5;VCP;GSK3B;RNF41;IDE;VSIR;DDB1;HECW2;TIPARP;SNF8;CDKN1B;TNFAIP3;SEC22B;OAZ2
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.4972276724633755,1.2528839581176086,0.021,0.9418415721091317,1.0,82/390,14.30%,MUSK;FGF22;FGF18;POLR2D;ROR2;DDR1;DDR2;RAPGEF1;HNRNPM;ACTR3;FGF1;ZFYVE27;GRB2;VEGFC;ITSN1;POLR2A;EPHB2;IRS1;NRP1;PDGFB;DOCK1;YES1;MAPK1;VAV3;SPRED2;PTPRJ;ABI1;AXL;SDCBP;FLRT2;AP2A1;IRS2;HSP90AA1;GALNT3;RGS14;ATP6V0E1;ARPC1A;ARPC4;PAK2;PTPRT;NCK1;ATP6V1E1;AHI1;KALRN;KIF16B;APC;LYN;SETX;ANKS1A;EPHA5;MVP;CDC42;SDC2;PXN;ARPC2;IGF1R;CBL;GTF2F2;CYFIP2;FRS2;VAV2;ANKS1B;MAPK14;NCF4;MAPKAPK2;ATP6V0D2;PIK3C2A;ATP6V1H;WASF2;SYK;NUS1;SPRED1;HNRNPH1;INSR;FYN;ELMO1;NRP2;PRKD2;SHOC2;ATP6V0A2;ARPC3;ROCK2
prerank,response to sterol (GO:0036314),0.6455201102343929,1.2527452599154631,0.22522522522522523,0.9409209741167236,1.0,4/11,12.97%,RORA;INSIG1;TGFBR2;TGFBR1
prerank,regulation of telomere maintenance (GO:0032204),0.5766314467862961,1.2525087237597285,0.2111650485436893,0.9404469402889197,1.0,10/26,16.91%,RAD50;SMG6;TERF2;MRE11;ERCC4;NBN;ATRX;PPP1R10;HNRNPD;YLPM1
prerank,neuron maturation (GO:0042551),0.6027849656289873,1.2518500753819866,0.2024793388429752,0.9420332797981261,1.0,6/18,9.75%,CX3CL1;MTCH1;FARP2;ADGRB3;ANKS1A;B4GALT5
prerank,response to leucine (GO:0043201),-0.5528567503396278,-1.2516066153096799,0.2111111111111111,0.9510249906931988,1.0,7/10,18.86%,UBR1;SESN1;SESN3;UBR2;KLHL22;RRAGD;RPTOR
prerank,cellular response to leucine (GO:0071233),-0.5528567503396278,-1.2516066153096799,0.2111111111111111,0.9510249906931988,1.0,7/10,18.86%,UBR1;SESN1;SESN3;UBR2;KLHL22;RRAGD;RPTOR
prerank,epithelial to mesenchymal transition (GO:0001837),0.5414202255390502,1.2512979506322035,0.17371937639198218,0.9429598187767374,1.0,10/47,14.30%,WNT4;TGFB2;OLFM1;LIMS1;LOXL3;TASOR;TGFBR1;DDX5;RBPJ;ROCK2
prerank,lipoprotein biosynthetic process (GO:0042158),0.6388728855302003,1.2512480788855413,0.23170731707317074,0.9416259611119535,1.0,2/11,5.11%,WDR45;WDR45B
prerank,apoptotic DNA fragmentation (GO:0006309),0.6197077689373036,1.2511725930846291,0.22468793342579751,0.9404490250727652,1.0,2/16,2.43%,DFFB;KPNB1
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.5616613293382284,1.2511353318868141,0.1909307875894988,0.9390628430686961,1.0,4/31,8.48%,PYCR2;LIAS;NFS1;ALOX5
prerank,regulation of chondrocyte differentiation (GO:0032330),0.5805225509032392,1.2509971103285031,0.18734177215189873,0.9381270908779518,1.0,5/24,15.86%,ADAMTS12;TRPS1;SOX6;TGFBR1;MBOAT2
prerank,mammary gland development (GO:0030879),0.5875295618315328,1.2505979430711522,0.21638924455825864,0.9384656928891202,1.0,1/21,0.22%,WNT4
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.585194933424431,1.2502341518907827,0.19869281045751633,0.9385624742903059,1.0,6/20,12.73%,BRCA1;RPS6KA5;TADA2A;GLYR1;DIP2B;BRD7
prerank,cellular response to hydroxyurea (GO:0072711),0.6668764742631366,1.2500202840519379,0.23343373493975902,0.9379615369234436,1.0,4/10,14.72%,BLM;RTF2;ATRX;SPIDR
prerank,positive chemotaxis (GO:0050918),0.5939365583394515,1.249189120902853,0.2011173184357542,0.9403338213925952,1.0,3/17,5.98%,CX3CL1;NRP1;PTPRJ
prerank,intermediate filament organization (GO:0045109),-0.44907883369723517,-1.2490424080220033,0.21033210332103322,0.9550668824309552,1.0,4/17,16.22%,DNAJB6;VIM;NEFL;GFAP
prerank,positive regulation of protein ubiquitination (GO:0031398),0.5167429542874197,1.2486272552637605,0.1588296760710554,0.9413030752615666,1.0,11/80,7.08%,PLK1;BRCA1;WFS1;LRRK2;CDK5RAP3;FBXW7;PEF1;UBQLN1;BIRC3;DCUN1D4;PTTG1IP
prerank,lysosome localization (GO:0032418),0.5466110403208004,1.2480756425511976,0.18445475638051045,0.9423527680384997,1.0,4/37,3.12%,BORCS6;MILR1;FAM98A;NDEL1
prerank,RNA catabolic process (GO:0006401),0.5440342593734095,1.2475603085127602,0.19797525309336333,0.9433072079819249,1.0,11/46,12.18%,RNASE6;CNOT10;ZC3H12D;RNASEH2A;METTL3;PPP1R8;EXOSC7;PABPC4;XRN2;RNASE3;ERN1
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.4951994708365643,1.2471964197607943,0.10606060606060606,0.9435168186653843,1.0,41/166,15.24%,EIF6;RGCC;EIF4A3;CD36;SP1;EIF3C;NMD3;EIF3E;DYRK2;ZEB2;NIBAN1;IRS1;THBS1;PYM1;RBM3;ATP7A;SMAD3;PDGFB;PRKDC;METTL3;IRS2;CTDNEP1;HSP90AA1;GIPC1;LARP4B;YTHDF1;FXR2;FAF1;GCK;MTOR;PLD1;SLC27A1;SAMD4A;INSR;PRKD2;PKD2;LDB1;TLR4;ARNT;CTC1;NPM1
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.4259248293965583,-1.2467064539430635,0.16019417475728157,0.9582315556124262,1.0,6/22,4.75%,CDK13;CCNT2;TCERG1;CCNT1;ERCC6;CDK12
prerank,regulation of lipid metabolic process (GO:0019216),0.5114429500880597,1.2465910766391521,0.15305067218200621,0.944739159881667,1.0,22/88,14.57%,RORA;SP1;BBS4;GGPS1;TGS1;IRS2;GPAM;NCOA1;CHD9;ABCA7;NCOR1;PPARG;SIN3B;NCOR2;ZFP69;NR1D2;RXRA;ADIPOR1;ACACA;PPARD;TBL1XR1;NCOA2
prerank,regulation of spindle assembly (GO:0090169),0.5587714915864508,1.2463249442364064,0.1972361809045226,0.9444789196420522,1.0,3/25,2.90%,PLK1;EML3;CHMP5
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.4619075521555721,-1.2458452179556474,0.20454545454545456,0.954659183342057,1.0,12/17,29.65%,AFG1L;COX10;COX7A2L;COX6B1;COX7B;COX8A;NDUFA4;COX4I1;COX6C;COX6A1;COX5A;COX15
prerank,peptidyl-serine modification (GO:0018209),0.500525959702338,1.2447569509648861,0.0763819095477387,0.9503515846570384,1.0,42/166,14.30%,SGK3;SGK2;PLK1;LRRK2;POGLUT3;PRKCZ;RPS6KB2;DYRK2;CAMK1D;GAS6;GALNT1;PRKCB;PDGFB;PRKCA;PRKACA;CDK2;PRKDC;MAPK1;IKBKB;GALNT3;MAPK8;PKN2;PAK2;RPS6KA5;PARP2;CAMK2D;CSNK1G1;MAST2;CDK5;MAST3;TGFBR2;ULK2;MTOR;MAPK14;SRPK2;HIPK2;MAPKAPK2;TGFBR1;MAST4;PRKD2;CSNK1A1;ROCK2
prerank,regulation of cell cycle process (GO:0010564),0.5047121152707359,1.2443275867897912,0.13422131147540983,0.9508729894542108,1.0,20/104,12.70%,PLK1;CETN2;RPRD1B;BBS4;USP19;CEP250;PIK3R4;KIF13A;AHCTF1;PRPF40A;KIF20B;KIF11;SETD2;CCP110;BIRC6;APC;TXLNG;CDC42;UVRAG;SH3GLB1
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.6276786089839885,1.2442662265125222,0.21480406386066764,0.9496302990444127,1.0,4/13,8.48%,WFS1;NUPR1;USP19;ALOX5
prerank,histone exchange (GO:0043486),0.5355322903731335,1.2438758905793676,0.18997668997668998,0.9498474703872539,1.0,6/37,9.32%,SRCAP;DMAP1;VPS72;ZNHIT1;SPTY2D1;CENPP
prerank,negative regulation of transmembrane transport (GO:0034763),0.6400172038491008,1.2438501982339778,0.24126984126984127,0.948425871486425,1.0,3/10,6.71%,THBS1;PRKCB;IRS2
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.40676373325736637,-1.2431205265209193,0.15942028985507245,0.9588091366712448,1.0,3/25,1.52%,PLCG2;LAPTM5;B2M
prerank,regulation of protein secretion (GO:0050708),0.5012040607290184,1.2431092886217499,0.12873326467559218,0.9502484540284146,1.0,27/119,15.04%,ANG;LLGL2;EIPR1;PPID;LLGL1;CLOCK;CACNA1D;TGFB2;RAP1A;PRKCA;IL1A;EZR;GOLPH3;ALOX5;RAPGEF4;ABCG1;CACNA1A;STXBP5;CD2AP;GCK;DNAJC1;STXBP5L;ERP29;FRMD4A;RFX3;CACNA1C;ENSA
prerank,regulation of oxidative phosphorylation (GO:0002082),0.6087532004233275,1.2430050938466732,0.21686746987951808,0.9492184489316571,1.0,3/16,5.05%,AK4;NUPR1;ATP7A
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.5665272392020925,1.2427821010053972,0.20496894409937888,0.9486886770516549,1.0,11/24,18.36%,DUSP3;NRP1;PTPRJ;LIMS1;ABL1;TSC1;PIK3R1;MAP4K4;IQSEC1;ROCK1;MAPRE2
prerank,cell-cell junction assembly (GO:0007043),0.5157908872101553,1.2425097534269536,0.1751054852320675,0.9484258609225953,1.0,12/63,12.29%,GJC1;GJD3;VCL;TLN2;PRKCA;CTNNA1;PKN2;PAK2;CDH11;WDR1;EPB41L3;CDH20
prerank,microtubule anchoring at centrosome (GO:0034454),0.6532691949802644,1.242136978025409,0.2094081942336874,0.948579118344273,1.0,4/10,11.52%,BBS4;NIN;DCTN1;KIF3A
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.551365439551858,1.2421169387365207,0.19437652811735942,0.9471503208410597,1.0,1/32,0.08%,LCAT
prerank,alpha-amino acid catabolic process (GO:1901606),0.5557068733168906,1.2417283203211789,0.22545454545454546,0.9474892639456302,1.0,2/29,3.78%,CBS;ACAT1
prerank,regulation of protein-containing complex assembly (GO:0043254),0.5010202045498814,1.241170501496283,0.13922764227642276,0.9485267222828639,1.0,26/110,14.02%,ISL1;PRKCZ;CD36;RIOK3;EIF2AK2;IMPACT;BCL2L11;HCFC1;EP300;FARP2;HSP90AA1;SLF1;FNIP1;FAF1;TAL1;CDC42;TRAF2;RAF1;AIDA;SORL1;SH3GLB1;ABCA1;FBLIM1;NAPA;SYK;SAR1B
prerank,regulation of erythrocyte differentiation (GO:0045646),0.5401839205695028,1.2399578345540259,0.19447640966628307,0.9527836473381657,1.0,14/35,17.53%,ANKRD54;PRKDC;CDK6;HSPA9;LYN;TAL1;ZFP36L1;MAPK14;ACVR1B;LDB1;ARNT;FOXO3;NCKAP1L;MED1
prerank,protein homotetramerization (GO:0051289),0.5243212138419762,1.2397899206686893,0.19447513812154696,0.9520611086409535,1.0,12/49,16.25%,ALDH1A2;SSBP1;ALDOA;HPRT1;ACOT13;TRPM4;MCOLN1;PKD2;ACACA;HCN1;GLS;OSBPL2
prerank,response to hydroxyurea (GO:0072710),0.6541750122531519,1.2397830261829001,0.23283582089552238,0.950579822369527,1.0,4/11,14.72%,BLM;RTF2;ATRX;SPIDR
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.6347258145056777,1.239217885931908,0.22693997071742314,0.9517125244195621,1.0,7/11,12.69%,EIPR1;MSN;EZR;DAB2;PTPN23;SORL1;VPS11
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.49910792211200516,1.2391582723424897,0.11234817813765183,0.9504834283520881,1.0,35/138,14.50%,POLR2D;RORA;POLR2A;AR;HDAC9;CDK7;TEAD1;ESR1;HDAC5;NR3C1;MAML3;MAML2;MNAT1;CDK9;TAF4;NCOR1;PPARG;NR6A1;GTF2E1;GTF2E2;GTF2B;NR5A1;NOTCH2;KAT2B;NR2C2;GTF2F2;NCOR2;NRBP1;NR1D2;RXRA;MED27;GTF2H1;RBPJ;PPARD;TBL1XR1
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.5265058951126746,1.2391319060613444,0.19460067491563554,0.9491131685105295,1.0,6/43,6.38%,WNT4;DDR2;BMPR1A;NELL1;LRP5;ACVR1
prerank,positive regulation of secretion by cell (GO:1903532),0.5072911901871835,1.2390144125112859,0.1686358754027927,0.9481366095403336,1.0,14/70,11.42%,ANG;RGCC;UNC13D;PPID;TGFB2;CADPS;IL1A;EZR;GOLPH3;DTNBP1;ABCG1;STXBP5;CD2AP;SOX11
prerank,regulation of catabolic process (GO:0009894),0.5795889511142773,1.238330001742627,0.21751025991792067,0.9497704700151876,1.0,5/18,10.43%,HPGD;CHEK2;FAF1;HGS;FURIN
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.5554666427923656,1.2381224461455647,0.2095115681233933,0.9493028021552139,1.0,7/26,12.68%,TSG101;FBXW7;SOCS4;AREG;SOCS5;CBL;TGFA
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.4816499830029624,-1.2372326307984092,0.19387755102040816,0.9767638942086011,1.0,5/14,10.78%,ACTR2;MMS19;ERCC6;PARP1;WDR48
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.43807733629423357,-1.2370976785295955,0.18326693227091634,0.9701508618780027,1.0,9/20,17.46%,APP;ANO6;P2RX7;C3AR1;SUGT1;NLRP3;PYCARD;TXNIP;P2RX4
prerank,triglyceride biosynthetic process (GO:0019432),0.5992222007804813,1.2364377551749974,0.20164609053497942,0.955732501474857,1.0,3/18,11.56%,MOGAT3;GPAM;GK
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.5349964954871973,-1.2356883844215099,0.2208955223880597,0.9685429533541674,1.0,3/10,5.58%,PRKG1;SERPINE2;CD9
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.5309899510827067,1.2356031688085136,0.21076746849942726,0.9581206993423639,1.0,10/38,15.04%,RORA;RIOK3;ESR1;TLE1;MAPKBP1;TANK;ZMYND11;PPM1A;TRIM59;OTUD7A
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.6418962416098307,1.2346891179128794,0.2672811059907834,0.9608015683394868,1.0,3/10,12.96%,SSBP1;WIZ;ATRX
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.6550175770078636,1.2344296666290233,0.23564954682779457,0.9605172616975503,1.0,1/10,1.00%,SIRT7
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.5513397907781168,1.2342782730483275,0.20853658536585365,0.9596991016604532,1.0,4/28,6.92%,FBXW7;ZBTB7A;METTL3;BEND6
prerank,endoderm development (GO:0007492),0.6319282276785443,1.2342627205066388,0.2511078286558346,0.9582860185793368,1.0,2/13,11.50%,KIF16B;LAMC1
prerank,RNA metabolic process (GO:0016070),0.5032654658056495,1.2339359723128926,0.12410986775178026,0.9582528566256668,1.0,43/127,16.77%,POLR2D;ELAVL4;RNASE6;RNASEH2A;HNRNPM;SYNCRIP;POLR2A;ATXN1;RBM3;FTO;RBM5;METTL3;PPP1R8;EXOSC7;RNASE4;HNRNPA2B1;HNRNPA3;PABPC4;AGO2;SETX;APOBEC1;RNGTT;ADAR;ATXN2;XRN2;RBM6;GTF2F2;RNASE3;DHX8;WTAP;HNRNPH3;HNRNPH1;BICD1;PCBP3;MTREX;RBMS1;HNRNPC;HNRNPK;ALKBH1;HNRNPL;CELF2;DROSHA;HNRNPD
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.587273962211175,1.2332142853065104,0.24625850340136055,0.9601412903199009,1.0,5/19,6.01%,CAMK1D;THBS1;CMKLR1;MAPK1;MPP1
prerank,rRNA processing (GO:0006364),0.4907064403895395,1.2330345316254143,0.11569416498993963,0.9594647985521391,1.0,35/172,12.70%,EIF6;C1D;MPHOSPH6;RPL18;BOP1;UTP3;PELP1;SBDS;RIOK3;SART1;RPL41;RPL31;UTP18;EMG1;RPS17;DDX49;RPL4;UTP20;EXOSC5;RPLP0;PRKDC;RPL38;EXOSC7;MRPL1;RRP36;RRP1B;FCF1;DDX10;UTP6;XRN2;HEATR1;NOP56;RPL21;RPS6;NOL8
prerank,negative regulation of cell cycle (GO:0045786),0.4990014427031069,1.2329550457646492,0.1795142555438226,0.9583419090073775,1.0,11/73,9.84%,PLK1;GAS1;NUPR1;TFAP4;HPGD;SMAD3;IPO7;CDK6;PTPN3;APC;IPO5
prerank,mitotic metaphase plate congression (GO:0007080),0.5155255010654375,1.2324732662300468,0.1811111111111111,0.9589947514946928,1.0,12/51,15.16%,NUDC;EML3;KPNB1;VPS4A;CHMP5;CDC23;DCTN2;VPS4B;EML4;PDCD6IP;RMDN1;BECN1
prerank,leukotriene metabolic process (GO:0006691),0.5930228866118863,1.2323372874896807,0.23311258278145697,0.9581672957619594,1.0,4/19,12.92%,MGST3;PLA2G4A;ALOX5;MAPKAPK2
prerank,early endosome to Golgi transport (GO:0034498),0.6356196654829301,1.2318944541220302,0.2555720653789004,0.9588592674833241,1.0,5/11,12.31%,LMAN1;TMED9;RAB6A;SNX1;SNX8
prerank,superoxide metabolic process (GO:0006801),-0.38640095246264233,-1.2314517891449999,0.14285714285714285,0.979688496644203,1.0,7/29,7.60%,SH3PXD2A;NCF2;NCF1;SH3PXD2B;PRDX1;CYBA;CYBB
prerank,transcription by RNA polymerase I (GO:0006360),0.5375573422813532,1.2311462594296312,0.22025912838633688,0.9608392285810612,1.0,6/34,8.81%,CAVIN1;POLR1C;CDK7;POLR1A;MNAT1;UBTF
prerank,cellular response to calcium ion (GO:0071277),0.509414867102853,1.2310601080062114,0.17584745762711865,0.9597259762831016,1.0,17/67,16.49%,CPNE5;SLC25A24;ADCY8;BRAF;SMPD1;MEF2A;SYT12;SYT11;CAMK2D;ADD1;MCOLN1;CARF;PKD2;IQGAP1;CPNE8;MEF2C;LGMN
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.5999757043111424,1.230983105584026,0.23319027181688126,0.9585676286753174,1.0,6/15,14.37%,LDLRAP1;IRS1;IRS2;PPARG;PPM1K;PPARD
prerank,cortical actin cytoskeleton organization (GO:0030866),0.577026500902913,1.2308450055625069,0.2354533152909337,0.9577424652983224,1.0,10/20,18.67%,LLGL2;LLGL1;IKBKB;DLG1;ROCK2;FMNL3;NCKAP1L;ROCK1;NCKAP1;PLEK
prerank,homeostasis of number of cells (GO:0048872),-0.5162159793237036,-1.2305202128360322,0.20462046204620463,0.9766519055501197,1.0,5/12,26.25%,UBAP2L;LPCAT3;NOTCH1;CARD9;NAPEPLD
prerank,regulation of cell population proliferation (GO:0042127),0.48807338975604475,1.2292141846717342,0.011,0.9637053805938035,1.0,102/691,13.60%,FGF22;ACE2;FGF18;BMP5;SGK3;SGK2;ALDH1A2;WDR6;RGCC;ROR2;TNFRSF11A;IGFBP3;CGRRF1;RPRD1B;CDCA7;RELA;CX3CL1;IRF1;EIF2AK2;SMAD6;GLMN;FGF1;IFI35;NUPR1;COX17;TFAP4;FAM98A;ITGB1BP1;VEGFC;RUNX1;TGFB2;BMPR1A;RERG;EAPP;JUN;AREG;AR;UTP20;IRS1;GID8;THBS1;BCL6;LIFR;PDGFB;KITLG;CDK2;LRP5;PRKDC;ACER3;RPS15A;PTPRJ;KIF20B;ABI1;UBE2A;RBM5;SDCBP;EGLN3;CDK6;DHPS;IL1A;JUND;IRS2;STK11;HP1BP3;MECP2;STX3;SLURP1;EZH2;TRPM4;BIRC6;KRAS;LIMS1;NACC1;GRK5;APC;CTBP1;LYN;HGS;FKTN;PRKRA;TGFBR2;IGF1R;KAT2B;SOX11;KDM4C;RAF1;ZFP36L1;DNAJA3;RPS6;TCF7L2;ADAM10;TGFA;BRD7;SRPK2;SH2B3;TP53;TGFBR1;BCL2;S100B;FN1;PTPRU;INSR
prerank,positive regulation of bone resorption (GO:0045780),0.6351470424591716,1.2290774472017743,0.2511415525114155,0.9629138390385868,1.0,4/11,15.93%,TNFRSF11A;PRKCA;SYK;PLEKHM1
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.5344856376582722,1.2285044775053215,0.2,0.9641479573156163,1.0,7/42,6.11%,SRCAP;ACTR5;DMAP1;SMARCA4;VPS72;ZNHIT1;SPTY2D1
prerank,negative regulation of calcium ion transport (GO:0051926),-0.4787852164381684,-1.2281589665134018,0.21993127147766323,0.979709066763081,1.0,5/15,19.88%,CD33;ATP1A2;INPP5K;LILRB1;TRIM27
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.5980243035806818,1.227616779318031,0.2193877551020408,0.9654390339540153,1.0,3/17,6.71%,SMARCA4;IRS1;IRS2
prerank,cellular response to interleukin-7 (GO:0098761),0.5980243035806818,1.227616779318031,0.2193877551020408,0.9654390339540153,1.0,3/17,6.71%,SMARCA4;IRS1;IRS2
prerank,cellular amide metabolic process (GO:0043603),0.4978459227390203,1.227292072941859,0.1721311475409836,0.9655351653348736,1.0,17/102,12.30%,PDZD11;NLN;BTD;ALDH1L1;SMPD3;CPD;SMPD1;CPE;MCCC2;ACOT9;MTHFD2L;MTHFR;ACOT13;ST6GAL1;PCCA;SLC25A32;SGPL1
prerank,actin cytoskeleton reorganization (GO:0031532),0.505758799831292,1.2269109802388185,0.19155844155844157,0.9658211317706099,1.0,12/63,9.40%,S1PR1;MINK1;GRB2;FLNA;NRP1;GPR65;FARP2;PARVB;EZR;CDC42BPB;PTPN1;DTNBP1
prerank,positive regulation of protein deacetylation (GO:0090312),-0.4937449402309434,-1.2264618954918998,0.20284697508896798,0.9801919830118047,1.0,6/14,18.16%,DYRK1A;AKAP8;NIPBL;FNTA;SAP30BP;ING2
prerank,regulation of JUN kinase activity (GO:0043506),0.5406680899617934,1.2261898437701724,0.22183098591549297,0.9677345257376626,1.0,6/33,12.26%,TNFRSF11A;SASH1;MAP3K11;DUSP10;TRAF2;AIDA
prerank,regulation of response to cytokine stimulus (GO:0060759),0.5857119422195955,1.2260226119753899,0.249667994687915,0.9670546806108868,1.0,7/19,12.90%,PARP9;RUNX1;LIFR;IRAK2;MAVS;MAP2K5;SH2B3
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.6392527943561728,1.22519684475981,0.2412280701754386,0.9693066735621064,1.0,2/11,1.93%,SIRT7;SMARCA4
prerank,positive regulation of cell projection organization (GO:0031346),0.49034598230777837,1.2248994674417042,0.1529888551165147,0.9691919194292067,1.0,27/115,14.25%,ROR2;CHODL;PLXNA1;CX3CL1;DVL1;RAPGEF1;ITGA6;SS18L1;CAMK1D;STMN2;RAP1A;EP300;SERPINI1;CUX1;SNX3;ARSB;TWF2;NPTN;LYN;SETX;ARHGAP35;RIT2;CDKL5;PLXNC1;NDRG4;MAP6;RELN
prerank,regulation of smooth muscle cell migration (GO:0014910),0.5781069989150679,1.22450498395394,0.23421052631578948,0.9695316137300015,1.0,6/20,13.74%,IGFBP3;BMPR1A;NRP1;PDGFB;SORL1;NDRG4
prerank,response to ethanol (GO:0045471),-0.48906717263342836,-1.2241509278914908,0.2268041237113402,0.9828180265523933,1.0,7/14,25.51%,GRIN2B;GRIN3A;GLRA1;GOT2;GLRA2;GRIN1;SOD1
prerank,angiogenesis involved in wound healing (GO:0060055),-0.5234149358186668,-1.2239674484870553,0.24705882352941178,0.9766876911800152,1.0,10/11,46.20%,ADIPOR2;HPSE;CD34;ITGB3;VEGFA;PRCP;MCAM;NDNF;KDR;SRF
prerank,peptidyl-serine phosphorylation (GO:0018105),0.49132393443583827,1.223600418361061,0.10462776659959759,0.9722538239357985,1.0,40/153,14.30%,SGK3;SGK2;PLK1;LRRK2;PRKCZ;RPS6KB2;DYRK2;CAMK1D;GAS6;PRKCB;PDGFB;PRKCA;PRKACA;CDK2;PRKDC;MAPK1;IKBKB;MAPK8;PKN2;PAK2;RPS6KA5;CAMK2D;CSNK1G1;MAST2;CDK5;MAST3;TGFBR2;ULK2;MTOR;ERN1;MAPK14;SRPK2;HIPK2;MAPKAPK2;TGFBR1;MAST4;MAP2K2;PRKD2;CSNK1A1;ROCK2
prerank,protein localization to organelle (GO:0033365),0.4886637972916309,1.2234013023839159,0.14111675126903553,0.9717053721496066,1.0,29/133,11.35%,TRAM1L1;RIPOR1;LRRK2;UBAC2;SYS1;DVL1;ARL6;SEC61G;EHD1;BBS4;ZBTB7A;CEP250;SCG3;YWHAE;COG3;PACSIN2;TMEM30A;UBE2J2;IFT20;CTDNEP1;SNX10;RAB6A;ABCA7;LMBRD1;VPS35;VAMP2;TULP3;DCP1A;PRNP
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.44566595924904256,-1.2230086768704245,0.18067226890756302,0.9736888655611441,1.0,5/19,11.60%,PAPSS1;ENPP1;TPST1;BPNT2;SLC35B3
prerank,positive regulation of phagocytosis (GO:0050766),-0.35365578946295506,-1.2229252551775507,0.16279069767441862,0.9673139335466985,1.0,14/47,13.61%,ANO6;PTPRC;RAB31;APPL2;FCER1G;SLC11A1;FCGR2B;CD300LF;CYBA;RAB27A;CALR;PYCARD;SIRPA;IL15RA
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.6457996398350087,1.2227409332340444,0.25039123630672927,0.9733623889775774,1.0,3/10,12.68%,FBXW7;AREG;TGFA
prerank,regulation of platelet activation (GO:0010543),0.5717205524786203,1.2225008830133794,0.22639068564036222,0.9730167415326799,1.0,6/21,14.85%,PDGFB;PRKCA;PLA2G4A;LYN;SYK;TLR4
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.4382196050541647,-1.2222920058842526,0.17625899280575538,0.9633065148154484,1.0,10/18,28.56%,GRIK1;CDH8;GRIK4;NAPB;SLC17A6;GRIK2;UNC13B;GRIK5;UNC13A;GRIK3
prerank,fatty acid transmembrane transport (GO:1902001),0.5889563332961093,1.2214530693663888,0.24704336399474375,0.9764210187417812,1.0,7/19,14.13%,CD36;ABCD2;SLC25A20;ABCD3;SLC27A1;ABCD1;ACACA
prerank,platelet aggregation (GO:0070527),0.5355585400034595,1.2213337108028774,0.2189695550351288,0.9755001641953166,1.0,5/33,7.73%,VCL;CLIC1;METAP1;FLNA;FERMT3
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.6098033019546456,1.221303416471319,0.2388268156424581,0.9741812472952707,1.0,5/14,15.61%,ELAVL4;TARDBP;MAPK14;MAPKAPK2;HNRNPC
prerank,positive regulation of response to external stimulus (GO:0032103),0.4875060908580918,1.221014172918917,0.1390593047034765,0.9740774683599576,1.0,28/128,15.45%,PLA2G7;POLR3G;RIOK3;CX3CL1;IFI35;IL16;DDX60;TLR7;SASH1;FEM1A;THBS1;PDGFB;PRKCA;PUM2;AKIRIN2;TLR3;STX3;IL18;PUM1;NFKBIZ;IL17RA;SLC15A4;OPTN;P2RY12;LY86;AIF1;TLR4;CD47
prerank,lamellipodium assembly (GO:0030032),0.543103249160562,1.2210120712109866,0.22749391727493917,0.9726419590261653,1.0,5/26,7.03%,VCL;S1PR1;PARVB;ABLIM3;GOLPH3
prerank,heme catabolic process (GO:0042167),0.6073322249631188,1.2204406712757057,0.24859550561797752,0.9723493158284302,1.0,5/14,17.27%,SLCO1B1;HMOX2;SLCO2B1;ABCG2;ABCC1
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.6073322249631188,1.2204406712757057,0.24859550561797752,0.9723493158284302,1.0,5/14,17.27%,SLCO1B1;HMOX2;SLCO2B1;ABCG2;ABCC1
prerank,"DNA-templated transcription, termination (GO:0006353)",0.506266363414573,1.220394604396552,0.2053191489361702,0.9711366986084434,1.0,13/68,11.07%,CAVIN1;POLR1C;CSTF3;CSTF2;POLR2A;CDK7;POLR1A;MNAT1;UBTF;SSU72;SNRPD3;SETX;CPSF3
prerank,ribosomal large subunit biogenesis (GO:0042273),0.5054554690303561,1.22029475630623,0.21444201312910285,0.9702000151408263,1.0,8/54,7.30%,EIF6;BOP1;GTF3A;MALSU1;HEATR3;RPLP0;TRAF7;MRPL1
prerank,regulation of lipid catabolic process (GO:0050994),0.5670470680397077,1.219147078245926,0.24566088117489987,0.9740907728332182,1.0,3/19,12.94%,TYSND1;PDE3B;ABCD1
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.6223191119281727,1.2186672467935025,0.2298325722983257,0.974825384913202,1.0,7/13,15.96%,IRAK4;TLR7;PIK3R4;IRAK2;UNC93B1;PIK3AP1;EPG5
prerank,regulation of organelle assembly (GO:1902115),0.49535336848495354,1.2185679540412153,0.19787234042553192,0.9738289855413417,1.0,29/73,16.52%,TSG101;ATXN2L;ALMS1;MSN;TBC1D15;EVI5;IFT20;TBC1D17;EZR;TBC1D14;TBC1D10B;ATXN2;ATG3;TBC1D12;CDKL5;TBC1D5;TBC1D10A;TBC1D13;VPS11;CYLD;RABGAP1;PDCD6IP;TBC1D24;TBC1D22A;TBC1D8;TBC1D1;NPM1;CEP295;RDX
prerank,cAMP-mediated signaling (GO:0019933),-0.4018887224634191,-1.218486768756701,0.17289719626168223,0.972662631223281,1.0,6/24,7.19%,PDE4D;RIMS2;CAP1;AKAP6;KSR1;ADCY2
prerank,regulation of stress fiber assembly (GO:0051492),0.49849554436998206,1.217967711698596,0.1694915254237288,0.9751871367313298,1.0,24/74,16.41%,RGCC;CGNL1;ALMS1;ITGB1BP1;SLC9A1;NRP1;GPR65;TPM1;PPFIA1;PAK2;CDC42;PXN;ABL1;TGFBR1;WASF2;ROCK2;TMEFF2;TSC1;CLASP1;EVL;CD47;PIK3R1;PAK1;ACTG1
prerank,activation of phospholipase C activity (GO:0007202),0.5480833181047864,1.217936404668403,0.21625,0.9738988507012032,1.0,2/29,1.61%,ANG;C5AR1
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.6361725907229016,1.217855682753131,0.25223880597014925,0.9728678950152642,1.0,4/11,9.18%,SOAT1;AGO2;ABCA7;ITM2B
prerank,lipid oxidation (GO:0034440),0.6217781903473876,1.2176811227705235,0.23388305847076463,0.9722614473803692,1.0,3/12,13.69%,PLA2G7;ALOX5;ADIPOR1
prerank,lipoxygenase pathway (GO:0019372),0.6036349191230048,1.2175719175874673,0.25837988826815644,0.9713444449232898,1.0,3/14,8.48%,HPGD;GPX4;ALOX5
prerank,regulation of biomineral tissue development (GO:0070167),0.5516226273442294,1.2174407469917068,0.2356687898089172,0.9705533696385189,1.0,6/26,14.30%,S1PR1;DDR2;GAS6;TXLNG;BMP2K;ROCK2
prerank,nucleic acid metabolic process (GO:0090304),0.5023386323563312,1.2169289329709,0.20127118644067796,0.9714343614008975,1.0,19/69,16.13%,POLR2D;POLG;RAD50;HNRNPM;POLR2A;WRN;METTL3;HNRNPA2B1;HNRNPA3;EXD2;ATXN2;XRN2;GTF2F2;WTAP;HNRNPH1;RECQL5;HNRNPC;HNRNPK;HNRNPL
prerank,negative regulation of organelle assembly (GO:1902116),0.5340648662201136,1.21668502489337,0.22546728971962618,0.971169642539387,1.0,11/35,15.54%,BRCA1;LRRK2;NUPR1;MDM1;CCP110;KAT2B;FEZ1;ODF2L;TMEM39A;SMAD4;MTM1
prerank,peptidyl-amino acid modification (GO:0018193),0.6543436059236207,1.2163313473168402,0.2467741935483871,0.9712930910346871,1.0,3/10,11.18%,METAP1;ATP7A;TTLL4
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.5356543372640283,1.2159523121138067,0.22355769230769232,0.9716140328923515,1.0,3/33,3.74%,WFS1;NUPR1;GAS6
prerank,regulation of nervous system process (GO:0031644),-0.4421945413277314,-1.2156414049664805,0.20948616600790515,0.9779098723813039,1.0,4/18,3.24%,APP;DLGAP2;DLGAP1;TMEM108
prerank,anterograde axonal transport (GO:0008089),-0.3577051181831594,-1.2155125653601515,0.18,0.9720797359585458,1.0,15/37,14.75%,DLG2;AP3B1;AP3D1;AP3S1;MAPK8IP3;KIF3B;RAB21;KIF5C;TRAK2;TRAK1;KIF1A;AP3S2;RAB27B;KIF1C;NEFL
prerank,positive regulation of viral transcription (GO:0050434),0.5530325652219139,1.2154863523893675,0.24714828897338403,0.9723645625283989,1.0,6/25,13.02%,POLR2D;POLR2A;CDK9;NELFA;GTF2F2;CTDP1
prerank,regulation of protein phosphorylation (GO:0001932),0.4839277547016077,1.2151070535121447,0.06813627254509018,0.9726668409495799,1.0,26/256,9.65%,MUSK;FGF22;FGF18;LRRK2;IGFBP3;CDK5RAP3;PID1;FGF1;VEGFC;IMPACT;GAS6;TARDBP;NIBAN1;ANKRD54;EPHB2;AKTIP;PRKDC;CDK2AP1;HSP90AA1;NPTN;DAB2;KRAS;FNIP1;FXR2;MAVS;LYN
prerank,regulation of cellular pH (GO:0030641),0.551516939250585,1.2146698789466301,0.21916167664670658,0.9731946480313438,1.0,6/29,8.80%,SLC4A3;SLC9A9;SLC9A1;LACC1;SLC9A7;SLC9A6
prerank,peptidyl-lysine methylation (GO:0018022),0.5471277659954839,1.2146664550149968,0.23038605230386053,0.9718139959556101,1.0,5/26,7.97%,EHMT1;SUV39H1;EHMT2;SETD2;SETD3
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.49758973008427626,1.2143415877886243,0.17891373801916932,0.9717859353079933,1.0,20/76,14.85%,UACA;RELA;EIF2AK2;IFI35;TLR7;SASH1;EP300;EZR;DLG1;TLR3;LIMS1;PTP4A3;ACTN4;TRIM44;TMSB4X;PPM1A;CYLD;ADIPOR1;LGALS9;TLR4
prerank,mitotic spindle assembly (GO:0090307),0.5186819966709426,1.2141230054170546,0.2325056433408578,0.9713671200005081,1.0,8/42,11.55%,TOGARAM2;KPNB1;CCDC61;FLNA;KIF11;STAG2;CHEK2;LSM14A
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.5860898585692467,1.2139000508570057,0.26425591098748263,0.9708910347162173,1.0,1/15,0.26%,MGAT3
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.4863752179916676,-1.2131355048491868,0.23404255319148937,0.9756793965329826,1.0,7/15,17.60%,SMAD7;RPL5;RPL11;RPL23;LIMK1;DTX3L;RPS7
prerank,microtubule polymerization (GO:0046785),0.5444153018567104,1.2131287227169245,0.22249388753056235,0.9729078800646753,1.0,7/29,8.66%,CCDC57;NDEL1;AKAP9;TUBGCP6;MAPT;RANBP9;TUBGCP2
prerank,phospholipid catabolic process (GO:0009395),0.5591333947935255,1.2129713244160283,0.2428035043804756,0.9722298149976706,1.0,5/24,12.07%,SMPDL3A;SMPD1;PLA2G4A;PNPLA6;GPCPD1
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.5733050891551101,1.2126055572528454,0.24484536082474226,0.9724429684005728,1.0,3/21,4.56%,CACNA1D;AKAP9;FLNA
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.5039317162548517,1.2124407221208595,0.19463087248322147,0.9718183623921027,1.0,14/51,16.23%,RGCC;CX3CL1;ITGB1BP1;NRP1;GPR65;TPM1;CDC42;PXN;ABL1;TGFBR1;ROCK2;EVL;CD47;PAK1
prerank,retinoid metabolic process (GO:0001523),0.4993563248721437,1.2124070880577869,0.19556025369978858,0.9706062924153608,1.0,8/71,15.11%,ALDH1A2;AKR1B1;ALDH1A1;LRP8;DHRS3;SDC2;GPC3;GPC6
prerank,negative regulation of inflammatory response (GO:0050728),0.4834084119737552,1.2123483661439673,0.11823647294589178,0.9695121530700338,1.0,28/182,14.41%,ISL1;RXFP1;RORA;TNFAIP8L2;ADCY8;ADCY3;PRKAR2A;FEM1A;ADCY5;PRKACA;YES1;ADCY9;ALOX5;VPS35;PPARG;PROC;LYN;FURIN;RAMP1;MAPK14;SYK;FYN;CYSLTR1;CALCRL;CREB1;GNG2;PPARD;GNB1
prerank,regulation of lymphocyte differentiation (GO:0045619),0.5804676337625182,1.2121645165278983,0.2327127659574468,0.96894066336309,1.0,5/18,12.05%,PRKDC;METTL3;PRDM1;ABL1;ZFP36L1
prerank,RNA 3'-end processing (GO:0031123),0.50306985914817,1.2120039724741714,0.21002132196162046,0.9682869705868832,1.0,18/69,12.67%,EIF4A3;RPRD1B;TUT4;CSTF3;DHX38;SARNP;CSTF2;RNPS1;U2AF1;RPRD2;RPRD1A;THOC5;SRSF5;LIN28B;U2AF2;CPSF3;SRSF9;SRSF11
prerank,negative regulation of dephosphorylation (GO:0035305),0.5848170856858677,1.2118481931375253,0.2598105548037889,0.9676235793878967,1.0,7/18,17.30%,URI1;PPP1R8;PPP1R16B;GPATCH2;ENSA;YWHAB;MFHAS1
prerank,spliceosomal complex assembly (GO:0000245),0.5171676665948863,1.2117097459659354,0.2241183162684869,0.9668900049757868,1.0,12/46,12.74%,SNRPD2;SNRPD1;RBM5;LUC7L;SRSF5;PRPF6;SETX;SCAF11;DDX23;SF1;SRSF9;SRPK2
prerank,positive regulation of natural killer cell activation (GO:0032816),0.6133404709212781,1.2113501528285242,0.23857142857142857,0.9671687180891406,1.0,5/13,16.68%,GAS6;AXL;IL18;LAMP1;ZBTB1
prerank,mitotic cell cycle phase transition (GO:0044772),0.48036367138748026,1.2113440433968163,0.11055276381909548,0.9658256689825745,1.0,46/204,15.41%,TUBB4B;PLK1;CETN2;CCDC57;TPD52L1;ALMS1;MAX;MAPRE1;AKAP9;CEP250;PPP2R2A;YWHAE;CDK7;CDC23;PRKACA;CDK2;PCNT;CDK6;ACVR1;USP29;HSP90AA1;MNAT1;DCTN1;TUBA1A;DCTN2;CCP110;PPP1R12B;CHEK2;CDC16;ODF2;CEP152;EPS8;CNTRL;FBXW11;CCNI;CUL4A;CTDP1;ACVR1B;USP37;FBXL7;OPTN;ENSA;CLASP1;PPME1;DYNC1I2;CRLF3
prerank,cellular calcium ion homeostasis (GO:0006874),0.48878569067238714,1.2109303932547126,0.13401015228426397,0.9662816013990221,1.0,9/133,5.27%,CXCL12;WFS1;SLC24A5;TRPC5;ADCY8;MICU1;LETM1;YWHAE;PRKACA
prerank,epiboly involved in wound healing (GO:0090505),0.5927302621746602,1.210915731476834,0.2562326869806094,0.9649937190403591,1.0,6/16,16.13%,DDR1;FLNA;CD44;ARHGAP35;TMEFF2;MRTFA
prerank,positive regulation of immune system process (GO:0002684),0.579457114784329,1.210733449792276,0.26721763085399447,0.9644478399134934,1.0,4/16,17.29%,TGFB2;MIA3;LGALS9;NCKAP1L
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.5242983706750004,1.2103983508406169,0.2226148409893993,0.9646337057278714,1.0,4/39,6.60%,RGCC;GAS6;THBS1;ITGA4
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.5779426417499152,1.2101512430676673,0.23694779116465864,0.964452312786088,1.0,8/18,14.30%,LLGL2;LLGL1;KIF20B;ARFGEF1;RAP1B;CYRIB;RUFY3;ROCK2
prerank,regulation of cell-matrix adhesion (GO:0001952),0.5101442224659133,1.2101369299377462,0.20887445887445888,0.9631741665753296,1.0,12/64,7.28%,VCL;CD36;DUSP3;CX3CL1;MINK1;ADAM15;SLC9A1;NF1;THBS1;CDK6;CAMSAP3;CCL25
prerank,regulation of defense response (GO:0031347),0.4956403989087978,1.2100581640147228,0.20042194092827004,0.9621770709862721,1.0,14/76,13.06%,ACE2;ADAMTS12;RELA;IRF1;BCL6;BIRC3;LACC1;ALOX5;AREL1;LRP8;TMSB4X;ERAP1;CYLD;NR1D2
prerank,skeletal system development (GO:0001501),0.49088633353117284,1.2099486851945143,0.14614614614614616,0.9612708539438091,1.0,19/148,13.43%,EVC;BMP5;TGFB2;TRPS1;ATP7A;PLS3;CMKLR1;ITGB8;CHD7;CD44;CDH11;DEAF1;AKAP13;CREB3L2;ANKRD11;SOX11;SOX6;TGFBR1;WWOX
prerank,regulation of cell death (GO:0010941),0.48586324997592756,1.2098279518212385,0.18181818181818182,0.9604480414150371,1.0,18/94,11.58%,SLC25A24;LRRK2;CD36;NOA1;TMEM109;IMPACT;RAD18;ACER3;BNIP3L;NCK1;VPS35;FAF1;ADNP2;APC;CTSZ;BNIP3;SOX11;VPS4B
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.47298013942344186,-1.2094448608309905,0.2422145328719723,0.9843322062552832,1.0,5/15,8.30%,KCNN2;ATP1B1;ATP1A1;KCNJ2;KCND3
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.5537728177521548,1.2085310629835961,0.24872448979591838,0.9647390135693558,1.0,8/22,15.19%,SLC9A1;PRKCA;MEF2A;MLIP;GLRX3;CAMK2D;ROCK2;SMAD4
prerank,prostanoid metabolic process (GO:0006692),0.6041914078792536,1.2085180937310722,0.2608047690014903,0.963467906550648,1.0,3/13,11.29%,HPGD;PLAA;PTGR2
prerank,primary alcohol metabolic process (GO:0034308),-0.40797372151617534,-1.2084874551590257,0.19680851063829788,0.9816653708367393,1.0,10/25,28.69%,GPD2;IGF1;GDPD1;GDE1;GDPD3;PECR;ALDH3A2;RDH10;NAPEPLD;NAAA
prerank,regulation of cardiac conduction (GO:1903779),0.5087312290076553,1.2080772922291572,0.19806243272335844,0.9640204995371711,1.0,2/54,5.27%,ACE2;PRKACA
prerank,response to insulin (GO:0032868),0.49583116649030096,1.2078679615868924,0.20147679324894516,0.9636754322635352,1.0,20/80,13.60%,EIF6;INSIG1;RAB8B;INSIG2;RAB12;IRS1;HDAC9;MYO5A;PRKDC;HDAC5;PDE3B;IRS2;PPARG;VAMP2;KAT2B;GCK;TBC1D4;ZFP36L1;SLC27A1;INSR
prerank,mRNA processing (GO:0006397),0.4839856376595742,1.2074404701478956,0.092,0.9642515817925342,1.0,73/287,13.71%,POLR2D;SNRPD2;SNRPD1;PLRG1;EIF4A3;ELAVL2;RPRD1B;SART1;HNRNPM;LSM7;DDX42;SYNCRIP;PRPF38A;BCAS2;CSTF3;DHX38;DNAJC8;SARNP;CSTF2;POLR2A;FRG1;RNPS1;CDK7;PRPF3;GEMIN2;CTNNBL1;RBM15;SPEN;PRKACA;PRPF40A;BUD31;U2AF1;RBM5;SNRPN;PRPF40B;METTL3;RPRD2;RPRD1A;MNAT1;HNRNPA2B1;THOC5;HNRNPA3;GPKOW;SRSF5;PRPF6;TRA2A;SNRNP70;PRMT9;SNRPD3;SCAF11;FUS;CDC5L;DDX23;DHX16;RNGTT;U2AF2;RBM17;CPSF3;SF1;RBM6;PSPC1;SF3B2;GTF2F2;PRCC;SRSF9;ERN1;SRSF11;DHX8;HNRNPH3;HNRNPH1;GTF2H1;SRRM2;DDX5
prerank,regulation of cell migration (GO:0030334),0.4800596322378122,1.2073611511637274,0.04504504504504504,0.9632682114794072,1.0,59/382,13.60%,CXCL12;FGF22;FGF18;SGK3;MGAT3;ROR2;SYNE2;VCL;PLXNA1;RIPOR1;DUSP3;CX3CL1;MINK1;SCAI;FGF1;ADAM15;ITGA6;ZMYND8;SASH1;MAPRE1;NF1;EPHB2;ELP3;THBS1;FLNA;TPM1;PDGFB;PRKCA;SEMA6D;PTPRJ;SDCBP;ACVR1;CAMSAP3;CBLL1;FERMT3;LDLRAD4;DUSP10;SLURP1;ARSB;PTPRT;DAB2;TBCCD1;APC;F3;ACTN4;SEMA3D;SEMA6A;MIA3;CYRIB;IGF1R;TMSB4X;SORL1;RUFY3;ADAM10;TGFBR1;RNF20;PLXNC1;PTPRU;INSR
prerank,positive regulation of interferon-gamma production (GO:0032729),0.5063013028797076,1.205865161282448,0.21564245810055865,0.9684811915928508,1.0,6/48,11.10%,ISL1;TLR7;TLR3;IL18;SLAMF6;CYRIB
prerank,DNA dealkylation (GO:0035510),0.6489420101105321,1.2052071936057327,0.2739938080495356,0.9688094909155134,1.0,5/10,16.12%,MPG;FTO;ASCC2;ALKBH5;ALKBH1
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.6489420101105321,1.2052071936057327,0.2739938080495356,0.9688094909155134,1.0,5/10,16.12%,MPG;FTO;ASCC2;ALKBH5;ALKBH1
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.552035794782435,1.2051954205983857,0.24664224664224665,0.9675215444088914,1.0,5/27,6.36%,DDR2;GAS6;S100A6;PDGFB;CDK6
prerank,acylglycerol homeostasis (GO:0055090),0.5745888290151104,1.2049385337925707,0.258732212160414,0.9673846501414817,1.0,2/20,8.68%,RORA;IL18
prerank,regulation of mast cell activation (GO:0033003),0.6352404093102497,1.2048682457450413,0.26881720430107525,0.9663617899535163,1.0,3/10,14.08%,MILR1;LYN;CD84
prerank,response to nutrient levels (GO:0031667),-0.4535574549767989,-1.2048566822846063,0.21011673151750973,0.9897985078667418,1.0,7/17,23.12%,EIF4G1;PRKAA1;PRKAA2;CD68;RPTOR;ATF4;ULK1
prerank,sulfur amino acid metabolic process (GO:0000096),0.55908818528946,1.2048430588827925,0.24540682414698162,0.9651660884088108,1.0,3/24,9.04%,CBS;MTHFR;MTR
prerank,regulation of myeloid cell differentiation (GO:0045637),0.5021548722054269,1.2047190301828563,0.2101293103448276,0.9643773271229663,1.0,14/62,11.25%,EIF6;CTR9;SETD1A;RUNX1;THBS1;PRKCB;EP300;RBM15;TNRC6B;CDK6;KMT2E;HSPA9;LYN;KAT2B
prerank,fatty acid biosynthetic process (GO:0006633),0.4990630792807679,1.2039898709397083,0.21436227224008575,0.9663278461102649,1.0,13/63,14.15%,DEGS1;ACSBG1;HACD1;HPGD;LIAS;GPX4;ALOX5;TECR;FADS1;ABCD3;ABCD1;ACACA;HACD4
prerank,isotype switching (GO:0045190),-0.527152294484359,-1.2038432762387228,0.22408963585434175,0.9876977585720009,1.0,6/10,29.85%,RNF168;HSPD1;MSH2;RNF8;BATF;MSH6
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.5761955721774352,1.2035626198798814,0.25864453665283543,0.9668987220107103,1.0,2/16,1.79%,ST8SIA5;ST8SIA4
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.5781887523491068,1.2033771070494201,0.2391891891891892,0.9663936341396633,1.0,4/18,12.01%,IGFBP2;IL18;ICOSLG;HMGB1
prerank,regulation of tissue remodeling (GO:0034103),0.5798622804275146,1.203009249339334,0.2574931880108992,0.9667524354485667,1.0,3/18,8.68%,DDR2;RUNX1;IL18
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.5001431722475872,1.2029630505019306,0.22354211663066956,0.9656143039175621,1.0,14/62,13.65%,POLR2D;EAF1;CTR9;POLR2A;MLLT1;CDK7;MNAT1;SETD2;CDK9;NELFA;ELOC;GTF2F2;CTDP1;GTF2H1
prerank,cardiocyte differentiation (GO:0035051),0.6283035242166768,1.2027050910714523,0.28177641653905056,0.9655216928441924,1.0,2/10,10.68%,TGFB2;AKAP13
prerank,eosinophil migration (GO:0072677),0.6043022765347985,1.2025947875360463,0.25035360678925034,0.963425944303505,1.0,1/14,1.82%,CX3CL1
prerank,eosinophil chemotaxis (GO:0048245),0.6043022765347985,1.2025947875360463,0.25035360678925034,0.963425944303505,1.0,1/14,1.82%,CX3CL1
prerank,organic hydroxy compound transport (GO:0015850),0.5238758391655378,1.2024233377526927,0.24106113033448673,0.9628250980886758,1.0,7/36,14.57%,OSBP;SLCO1B1;NCOA1;STARD5;RXRA;SLCO2B1;NCOA2
prerank,response to acidic pH (GO:0010447),0.6021513927798778,1.2016962884917506,0.2679083094555874,0.9646689639500681,1.0,3/13,4.83%,IMPACT;SLC9A1;GPR65
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.5961738414932746,1.2015723815488029,0.24821683309557774,0.9639130879028192,1.0,5/16,11.09%,LRRK2;UBAC2;TAPT1;BCAP29;MIA3
prerank,renal system development (GO:0072001),0.5040854294055267,1.2012416446828624,0.21651785714285715,0.9640262053237422,1.0,4/52,8.12%,WNT4;WFS1;TGFB2;C1GALT1
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.5780856665727816,1.2011830385075382,0.26584022038567495,0.9630215414939921,1.0,5/16,11.98%,SART1;PSIP1;SFSWAP;DDX23;DCPS
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.4893438975877184,1.2005094949340036,0.20234291799787008,0.9647419103012599,1.0,16/75,14.30%,PDE6H;FNTB;METAP1;USP33;RGS14;RGS3;RIC8B;GRK5;USP20;NMT1;RNF157;TULP3;NMT2;RPGRIP1L;CALM1;ROCK2
prerank,cellular response to metal ion (GO:0071248),0.4802017309774939,1.2004186758368856,0.18439716312056736,0.9638767507669666,1.0,26/123,11.35%,CPNE5;SLC25A24;LRRK2;ADCY8;BRAF;SMPD1;JUN;HVCN1;MAPK1;MEF2A;MAPK8;SYT12;SYT11;CAMK2D;ADD1;MT1F;MT1M;MT1H;MT1X;MT1A;MT1E;MT1G;MT1B;BNIP3;MCOLN1;PRNP
prerank,regulation of glucose metabolic process (GO:0010906),0.5241793405880473,1.2002144706676439,0.23282887077997672,0.9634743596050273,1.0,4/34,6.71%,RORA;SIRT7;IRS1;IRS2
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.45886917839997293,-1.2001589680449327,0.23344947735191637,0.9966584835442392,1.0,8/16,15.54%,ZFPM2;ERBB4;FGFR2;AKAP6;IGF1;FGF2;TGFBR3;NOTCH1
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.5224245550473112,-1.1999241610953941,0.24104234527687296,0.9911827579695925,1.0,9/11,47.41%,GOPC;GPM6B;LEPROTL1;COMMD1;ACTN2;LEPROT;SNX33;TAX1BP3;NEDD4L
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.49790909300167097,1.1996985945731393,0.22556390977443608,0.9644974809225104,1.0,14/64,13.65%,POLR2D;EAF1;CTR9;POLR2A;MLLT1;CDK7;MNAT1;SETD2;CDK9;NELFA;ELOC;GTF2F2;CTDP1;GTF2H1
prerank,histone methylation (GO:0016571),0.5423516631631893,1.1989191310966105,0.252760736196319,0.9666387990294302,1.0,5/26,8.54%,SIRT7;EHMT1;SUV39H1;EHMT2;EZH2
prerank,cellular response to mechanical stimulus (GO:0071260),0.5017382342316729,1.1988543910436062,0.23777777777777778,0.9656549535165373,1.0,8/46,10.86%,HABP4;IRF1;TLR7;SLC9A1;MAPK8;TLR3;PIEZO2;BNIP3
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.4085627963686629,-1.1986168294084225,0.18385650224215247,0.9900734522817809,1.0,5/21,6.96%,PDE4D;RYR2;CALM2;AKAP6;ATP1A2
prerank,endothelial cell development (GO:0001885),0.549415711352615,1.1983619461113635,0.2420785804816223,0.9665667705291957,1.0,5/25,7.63%,RAPGEF1;MSN;RAP1A;EZR;RAP1B
prerank,sodium ion export across plasma membrane (GO:0036376),-0.4835196256889711,-1.197816271688576,0.2679738562091503,0.9868961938563411,1.0,5/13,8.21%,ATP1B3;ATP1B1;ATP1A1;ATP1A2;ATP1A3
prerank,positive regulation of viral process (GO:0048524),0.49586197672129606,1.1975135260554277,0.21686746987951808,0.9690757603803362,1.0,15/60,14.59%,POLR2D;VPS4A;PPID;POLR2A;AXL;KPNA6;PKN2;CDK9;NELFA;ADAR;GTF2F2;SRPK2;CTDP1;TMEM39A;RAB7A
prerank,protein depolymerization (GO:0051261),0.5446611339280152,1.196285574885468,0.24387254901960784,0.9732472145551665,1.0,10/27,17.40%,CFL1;STMN2;NCKAP5L;TWF2;MICAL2;VPS4B;WDR1;MICAL3;KIF2A;GSN
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.5768993973133367,1.1957701193560915,0.26869806094182824,0.9743410971707056,1.0,3/16,11.42%,BRCA1;NCOR1;ACADL
prerank,serine family amino acid metabolic process (GO:0009069),0.5825151327395318,1.1956378102163459,0.2647482014388489,0.9736622568373968,1.0,1/16,0.33%,CBS
prerank,positive regulation of cellular respiration (GO:1901857),0.6249788686198873,1.1954995093918699,0.2680722891566265,0.9730080899586826,1.0,2/11,5.19%,NUPR1;IL10RB
prerank,ubiquinone biosynthetic process (GO:0006744),0.5922862191646183,1.1954486422635209,0.27800829875518673,0.9719765276269728,1.0,4/15,13.46%,COQ6;NDUFA9;PDSS2;COQ7
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.34455327620106546,-1.1951351832320674,0.14473684210526316,0.991601348900039,1.0,8/36,7.85%,IL10RA;PTPRC;JAK2;NLK;ERBB4;NF2;GHR;DOT1L
prerank,ATP transport (GO:0015867),0.6303015071749584,1.1948569432709355,0.30077519379844964,0.973236842995393,1.0,1/10,0.90%,SLC25A24
prerank,sodium-independent organic anion transport (GO:0043252),0.6365966867964554,1.1945594052881618,0.26766917293233083,0.9732093087192398,1.0,2/10,3.36%,SLCO4C1;SLCO1B1
prerank,regulation of intracellular pH (GO:0051453),0.5308842896448779,1.1945464109866217,0.23940435280641467,0.9720061164600308,1.0,6/34,8.80%,SLC4A3;LRRK2;SLC9A9;SLC9A1;SLC9A7;SLC9A6
prerank,tRNA transport (GO:0051031),-0.3565215801559042,-1.1936182674516338,0.20625,0.9913545209160949,1.0,20/35,24.23%,TPR;NUP153;NUP214;SSB;XPOT;YBX1;NUP155;NUP188;NUP88;TOMM20;NUP35;NUP133;SEH1L;RAE1;NUP50;NUP210;NUP107;NUP42;RANBP2;POM121
prerank,mammary gland epithelium development (GO:0061180),0.5817661740369243,1.1934755560696093,0.28969359331476324,0.9753744535155461,1.0,1/14,0.22%,WNT4
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.4842607084473114,1.1931829266582497,0.19855222337125128,0.9753201921640039,1.0,20/88,14.72%,RGCC;TSG101;CX3CL1;SMPD3;VPS4A;BCL2L11;SMAD3;PRKCA;SDCBP;SLF1;FNIP1;FAF1;TAL1;HGS;VPS4B;SH3GLB1;PDCD6IP;SYK;RAB7A;SPIDR
prerank,purine ribonucleotide transport (GO:0015868),0.5664178889027631,1.1927578633341347,0.2784636488340192,0.9759169941602523,1.0,2/16,5.87%,SLC25A24;ABCC5
prerank,positive regulation of endothelial cell migration (GO:0010595),0.4837938767411136,1.1925594707385152,0.20707596253902186,0.9755291377364099,1.0,10/84,5.26%,FGF18;ATP5F1A;SP1;FGF1;ITGB1BP1;SASH1;THBS1;NRP1;PDGFB;PRKCA
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.505327017222397,-1.1924834365480539,0.2791411042944785,0.989843862142937,1.0,6/11,31.49%,JAK2;CANX;JAK1;STAT3;IL6ST;IL12RB2
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.5195235310478702,1.1922040120710262,0.2661290322580645,0.975794178684667,1.0,12/38,14.53%,LMAN1;LRRK2;FBXW7;RNF31;UBE2J2;ABLIM3;HPS4;PARL;VPS11;SH3GLB1;HTRA2;UBE2D3
prerank,"base-excision repair, AP site formation (GO:0006285)",0.5726941147110249,1.1921497018768765,0.2547945205479452,0.9747630943381317,1.0,2/17,5.11%,MPG;TERF2
prerank,immunoglobulin mediated immune response (GO:0016064),-0.5207681887459368,-1.192085462089234,0.25227963525835867,0.9851703232807363,1.0,5/10,26.08%,FCER1G;FCGR2B;CD74;CARD9;TLR8
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.6198344945901064,1.1913351700217725,0.26436781609195403,0.9770719089499976,1.0,3/12,9.84%,UST;DSE;BGN
prerank,endodermal cell fate commitment (GO:0001711),0.6232591487041881,1.1913307140102711,0.2965722801788376,0.9758298091181442,1.0,1/10,2.15%,CTR9
prerank,regulation of protein kinase A signaling (GO:0010738),0.5585676318763504,1.1909427744635461,0.2454308093994778,0.9762201422832276,1.0,2/20,3.26%,LRRK2;PRKAR2A
prerank,regulation of signal transduction (GO:0009966),0.47667628570743525,1.1909138380248534,0.13039117352056168,0.9750801695580676,1.0,35/190,11.35%,RORA;GAS1;LRRK2;IGFBP3;LLGL2;CD36;CX3CL1;IGFBP2;ITGB1BP1;LLGL1;RUNX1;MTCH1;ANKRD54;LIFR;ESR1;ACVR1;USP33;RGS14;RGS3;SNX3;RIC8B;PTPN1;NCK1;UBTF;IRAK2;GRK5;USP20;DTNBP1;CD63;SOCS5;DHRS3;TRIM5;TULP3;PXN;PRNP
prerank,cell junction assembly (GO:0034329),0.4930468524661543,1.1908886618025667,0.18724279835390947,0.9739378622218098,1.0,21/100,15.73%,SDK2;GJC1;PCDHB16;TLN2;ITGA6;FLNA;FARP1;LIMS1;MYO9A;CDK5;CDH11;CDC42;DBNL;CDH20;FBLIM1;FN1;CDH18;PTEN;PKP4;GPM6A;CAPZA1
prerank,telomere organization (GO:0032200),0.5114366603281819,1.1905277630616076,0.24284077892325315,0.9742724359058209,1.0,9/43,8.16%,BLM;RAD50;WRN;TERF2;PRKDC;POLD3;MRE11;ERCC4;NBN
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.581259974217977,1.1900255859936602,0.2741046831955923,0.9751920641118738,1.0,8/17,19.04%,GMFB;WASF1;ARF1;WASF2;CYFIP1;CTNNA2;NCKAP1;BRK1
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.3517892386068253,-1.1899562948418432,0.15079365079365079,0.9878704968811403,1.0,10/35,8.06%,BCAS3;TJP1;HCK;F11R;ABI3;PTK2B;FES;CSF1R;HCLS1;NTRK3
prerank,DNA metabolic process (GO:0006259),0.47235079884114983,1.18991067975053,0.1,0.9743867112554069,1.0,47/270,12.74%,CBS;POLG;BRCA1;DFFB;MPG;SIRT7;BLM;RFC2;POLE4;POLE2;RNASEH2A;RAD50;PARG;RAD18;ORC4;ASF1A;POLA1;WRN;UBE2V2;TERF2;CDK2;PRKDC;NOC3L;UBE2A;POLA2;POLD3;POLB;MNAT1;PDS5A;RBBP8;MRE11;ERCC4;KMT5B;NBN;PARP2;PRIM2;EXD2;KMT5C;ORC2;PARP4;DDX23;RAD51B;HMGB1;UVRAG;USP3;TCF7L2;SRPK2
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.6381465063678387,1.1895805132854302,0.2673107890499195,0.974568390421113,1.0,1/10,0.73%,ZNHIT3
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.6105473631149255,1.1892896245500926,0.2773613193403298,0.9744951534396031,1.0,4/12,17.19%,BRCA1;ACADL;ERLIN1;PIBF1
prerank,regulation of bone mineralization (GO:0030500),0.492284540661683,1.1891440286831625,0.23076923076923078,0.9738496714406203,1.0,10/55,11.49%,WNT4;S1PR1;DDR2;BMPR1A;NELL1;ACVR1;ALOX5;TRPM4;TXLNG;BMP2K
prerank,protein import into peroxisome membrane (GO:0045046),0.5560268430843692,1.189143271275292,0.2576530612244898,0.9726079777952933,1.0,6/22,15.21%,PXMP2;RAB8B;ABCD2;ABCD3;ABCD1;PEX14
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.556118219404315,1.1889705055488178,0.2607561929595828,0.9720802310440301,1.0,4/21,5.17%,LDLRAP1;BMPR1A;JUN;PDGFB
prerank,stress fiber assembly (GO:0043149),-0.4596529192350699,-1.1884688650613304,0.23487544483985764,0.9817528306943861,1.0,13/15,34.08%,RHOA;SORBS1;PDCD10;CUL3;FAM171A1;KCTD13;SRC;TNFAIP1;ZYX;PHACTR1;ITGB1;PDLIM1;FHDC1
prerank,contractile actin filament bundle assembly (GO:0030038),-0.4596529192350699,-1.1884688650613304,0.23487544483985764,0.9817528306943861,1.0,13/15,34.08%,RHOA;SORBS1;PDCD10;CUL3;FAM171A1;KCTD13;SRC;TNFAIP1;ZYX;PHACTR1;ITGB1;PDLIM1;FHDC1
prerank,positive regulation of RNA splicing (GO:0033120),0.540422882192679,1.1881258787548796,0.25415676959619954,0.9745172512428643,1.0,11/29,15.70%,HABP4;POLR2A;RBM3;SLC38A2;NUP98;TRA2A;SETX;U2AF2;ERN1;SF3B4;PIK3R1
prerank,cellular response to interleukin-6 (GO:0071354),0.5429195860018127,1.1870615410138738,0.2606516290726817,0.9779215685926037,1.0,5/26,11.44%,RELA;CTR9;PID1;PTPRT;CBL
prerank,ribosome assembly (GO:0042255),0.5030417902091874,1.1869716614393118,0.24610244988864144,0.9770584706470778,1.0,5/47,5.60%,EIF6;BOP1;SBDS;RPLP0;TRAF7
prerank,telomere maintenance (GO:0000723),0.5041021835315189,1.185965351838868,0.24122310305775765,0.9801896094857183,1.0,10/50,8.16%,BLM;RAD50;WRN;TERF2;PRKDC;POLD3;MRE11;ERCC4;SMC5;NBN
prerank,RNA processing (GO:0006396),0.4804786417938282,1.1859586436280627,0.16432865731462926,0.9789778883476947,1.0,58/176,16.49%,SNRPD2;SNRPD1;ELAVL4;SYNCRIP;TUT4;BCAS2;CSTF3;TARDBP;MBNL1;ATXN1;RNPS1;RBM3;PRPF3;GEMIN2;PRKACA;U2AF1;RBM5;SNRPN;METTL3;HNRNPA2B1;PABPC4;SRSF5;PRPF6;LIN28B;PRMT9;SNRPD3;SETX;SCAF11;FUS;APOBEC1;DDX23;DHX16;RNGTT;U2AF2;ADAR;XRN2;RBM6;SF3B2;SRSF9;SRSF11;SRPK2;DHX8;HNRNPH3;HNRNPH1;BICD1;RBMS1;SF3B4;IVNS1ABP;RP9;ALKBH5;AKAP8L;HNRNPC;HNRNPK;PPP1R9B;DHX15;HNRNPL;CELF2;DROSHA
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.6015311247831179,1.1859341000491765,0.2954876273653566,0.9778314802243395,1.0,2/13,11.10%,STX7;CYRIB
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.5085704960206959,1.185778868088916,0.24682814302191464,0.9772370465837572,1.0,8/41,8.68%,EIF6;PGAM1;ZBTB7A;NUP205;EP300;NUP98;LACC1;NUP54
prerank,autonomic nervous system development (GO:0048483),0.5890834619239114,1.185444814019897,0.2859078590785908,0.9774783180643947,1.0,4/17,13.49%,NF1;NRP1;SOX11;FN1
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.4013987000807597,-1.1850560682039122,0.2631578947368421,0.9898146362587581,1.0,5/24,5.53%,IL10RA;JAK2;PTK2B;ERBB4;GHR
prerank,exit from mitosis (GO:0010458),0.6083500506618381,1.1850160961061063,0.2938530734632684,0.9781413649527755,1.0,6/12,18.03%,SIRT7;EPS8;CTDP1;CLASP1;PPP2R2D;CLASP2
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.49866623739905497,1.1849938220651561,0.25111607142857145,0.9769837420381924,1.0,8/48,8.68%,EIF6;NOA1;PGAM1;ZBTB7A;NUP205;EP300;NUP98;NUP54
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.4761274711972265,1.1848055709187952,0.13913913913913914,0.9765299505608054,1.0,59/241,13.71%,POLR2D;SNRPD2;SNRPD1;PLRG1;EIF4A3;ELAVL2;SART1;HNRNPM;LSM7;DDX42;SYNCRIP;PRPF38A;BCAS2;CSTF3;DHX38;DNAJC8;CSTF2;POLR2A;FRG1;RNPS1;PRPF3;CTNNBL1;RBM15;SPEN;PRPF40A;BUD31;U2AF1;RBM5;SNRPN;PRPF40B;METTL3;HNRNPA2B1;HNRNPA3;GPKOW;SRSF5;PRPF6;TRA2A;SNRNP70;SNRPD3;FUS;CDC5L;DDX23;DHX16;U2AF2;RBM17;CPSF3;SF1;RBM6;PSPC1;SF3B2;GTF2F2;PRCC;SRSF9;SRSF11;DHX8;HNRNPH3;HNRNPH1;SRRM2;DDX5
prerank,nitric oxide mediated signal transduction (GO:0007263),0.5861579111343067,1.1842394498786566,0.2719891745602165,0.9777759020912531,1.0,1/16,1.63%,CD36
prerank,protein localization to synapse (GO:0035418),-0.49687411861365116,-1.1841960653808818,0.254601226993865,0.9874272605181728,1.0,7/12,36.28%,NRXN1;DLG4;NRXN2;SHANK1;BSN;NLGN2;ZDHHC15
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.5009166553113951,1.1838964231972122,0.25275938189845476,0.97792501436986,1.0,8/49,7.10%,EIF6;SETD1A;RUNX1;THBS1;EP300;RBM15;TNRC6B;KMT2E
prerank,protein autophosphorylation (GO:0046777),0.46653407899456956,1.183391801461568,0.1706827309236948,0.9787835744647991,1.0,29/157,13.90%,MUSK;DDR1;LRRK2;DDR2;MINK1;EIF2AK1;EIF2AK2;MAP3K11;STK11;PAK2;CAMK2D;MAP3K9;GRK5;DAPK1;CHEK2;LYN;TAOK1;IGF1R;ULK2;MTOR;ABL1;ERN1;CDKL5;MAPKAPK2;MAP2K2;ACVR1B;INSR;CAMKK2;PRKD2
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.5125433535115079,-1.1832562989411761,0.2621951219512195,0.985369195260733,1.0,3/10,4.82%,CACNA2D1;NOS1AP;PDE4B
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.5834460752263128,1.1831430056199164,0.27034482758620687,0.9786695254468177,1.0,5/16,9.96%,PARP9;PRKDC;KMT5B;KMT5C;SMCHD1
prerank,regulation of receptor internalization (GO:0002090),0.5127204251424432,1.1828505335917134,0.26215895610913403,0.9786530702288357,1.0,10/35,15.06%,RIN3;ARRB2;SDCBP;AHI1;CD63;ATXN2;ARF1;TBC1D5;INSR;ANKRD13A
prerank,regulation of transforming growth factor beta production (GO:0071634),0.5661539720493594,1.1826071115393535,0.279291553133515,0.9784640228620172,1.0,6/18,15.19%,TGFB2;SMAD3;ITGB8;FN1;LGALS9;SMAD4
prerank,negative regulation of viral genome replication (GO:0045071),0.5095943209035295,1.1820387456021866,0.2315668202764977,0.9796701144913337,1.0,4/40,2.23%,BANF1;IFITM3;EIF2AK2;ILF3
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.5613395556460294,1.1818786515768227,0.2766531713900135,0.9791498961450741,1.0,2/18,2.48%,COA3;COX17
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.4848217663599289,1.1818271016292587,0.23265741728922093,0.9781137383861117,1.0,34/70,17.40%,ACTR3;GRB2;PLA2G6;DOCK1;YES1;MAPK1;WIPF1;VAV3;ABI1;HSP90AA1;ARPC1A;ARPC4;NCK1;MYO1G;LYN;CDC42;ARPC2;CYFIP2;ABL1;VAV2;WASF2;SYK;FYN;ELMO1;WIPF2;ARPC3;WASL;VAV1;PIK3R1;PAK1;ACTG1;CYFIP1;NCKAP1L;FCGR1A
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.4991259360686187,1.1816929338372473,0.26101694915254237,0.977479693540068,1.0,7/43,8.68%,CX3CL1;LDLRAP1;BMPR1A;JUN;THBS1;PDGFB;IL18
prerank,positive regulation of response to wounding (GO:1903036),-0.39630047548339054,-1.181504565754502,0.22815533980582525,0.9864934097452759,1.0,3/24,2.33%,PRKCE;PTK2;GRN
prerank,neuron migration (GO:0001764),-0.3193392677673981,-1.181365717271059,0.17142857142857143,0.9811640446876317,1.0,8/48,2.36%,USP9X;ADGRL3;SDCCAG8;ASTN2;NRCAM;LRP12;RAC1;DISC1
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.6035348200480312,1.1812572785556161,0.29056047197640117,0.9780557690333896,1.0,5/12,14.30%,FLOT2;RANBP9;ABCA7;PRNP;ROCK2
prerank,regulation of TORC1 signaling (GO:1903432),-0.3697448485122989,-1.1811236486800902,0.22727272727272727,0.9762840996619704,1.0,15/33,22.93%,SIK3;SESN1;CLEC16A;GPR137B;PIP4P1;FLCN;SESN3;CASTOR2;KLHL22;RRAGD;SEH1L;RNF152;RRAGB;SMCR8;SZT2
prerank,regulation of blood coagulation (GO:0030193),0.5267840806867288,1.1810271088012656,0.27735368956743,0.9777647954918779,1.0,4/27,9.62%,EPHB2;THBS1;ENPP4;PROC
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.6303392124792867,1.180849976829159,0.29685157421289354,0.9772742537576803,1.0,5/10,10.69%,MSN;CAMSAP3;EZR;MYO9A;CDC42
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.5907396990233239,1.1807886089444497,0.29624277456647397,0.9763443288601258,1.0,6/13,17.03%,INSIG1;TMEM30A;SORL1;SAR1B;CD81;GCC2
prerank,epithelial cell migration (GO:0010631),0.5111874656852162,1.180758952491253,0.2648401826484018,0.9752573760107505,1.0,9/37,11.90%,PLEKHG5;ZEB2;NRP1;GIPC1;PKN2;LPXN;PTP4A3;PXN;ABL1
prerank,negative regulation of signal transduction (GO:0009968),0.47021283132410885,1.180284219953604,0.12625250501002003,0.9760801779906386,1.0,42/249,13.74%,BMP5;MDFI;ADAMTS12;LRRK2;IGFBP3;PRKCZ;FBXW7;CX3CL1;PID1;SMPD1;NFATC1;HERC4;ZBTB7A;PIP4K2A;IRS1;THBS1;PRKCB;PTPRJ;METTL3;ACVR1;BEND6;TLE1;NEDD4;RGS14;PTPN1;PTPRT;EZH2;NCK1;NXN;PIP4K2B;LYN;HGS;SOCS5;RNF157;TULP3;SEMA6A;HMGXB4;BCL2;RPGRIP1L;GPC3;WWOX;NDRG4
prerank,neural crest cell differentiation (GO:0014033),0.5548489516046986,1.179460955170295,0.2784313725490196,0.978376785797439,1.0,5/18,16.27%,TAPT1;PEF1;SOX11;LRP6;MEF2C
prerank,cellular response to pH (GO:0071467),0.5751016705251537,1.1792184401158066,0.276797829036635,0.9782160732333752,1.0,4/17,11.17%,IMPACT;SLC9A1;HVCN1;MCOLN1
prerank,nucleosome organization (GO:0034728),0.4922857238150868,1.1791643810827883,0.25792349726775954,0.9772240250891202,1.0,10/55,9.29%,SRCAP;DMAP1;SMARCA4;VPS72;ASF1A;ZNHIT1;SPTY2D1;SETD2;SET;BRD2
prerank,RNA biosynthetic process (GO:0032774),0.5217247669395265,1.1783436377983103,0.26417370325693607,0.9794303197082677,1.0,8/31,12.06%,POLR2A;POLA1;POLA2;PRIM2;TAF4;SETX;GTF2B;BRF1
prerank,C4-dicarboxylate transport (GO:0015740),-0.4615648056297859,-1.1781397950519934,0.27177700348432055,0.9820712605450211,1.0,7/14,33.54%,SLC1A2;SLC25A13;SLC1A1;SLC25A30;SLC25A11;SLC25A14;SLC25A12
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.47305948518903157,1.1777660901284805,0.12912912912912913,0.9805805902231765,1.0,65/264,13.71%,POLR2D;SNRPD2;SNRPD1;PLRG1;EIF4A3;ELAVL2;GEMIN8;SART1;HNRNPM;LSM7;DDX42;SYNCRIP;PRPF38A;BCAS2;CSTF3;DHX38;DNAJC8;CSTF2;POLR2A;FRG1;RNPS1;PRPF3;GEMIN2;CTNNBL1;RBM15;SPEN;PRPF40A;BUD31;U2AF1;TGS1;RBM5;SNRPN;PRPF40B;METTL3;HNRNPA2B1;HNRNPA3;GPKOW;SRSF5;PRPF6;TRA2A;SNRNP70;SNRPD3;SCAF11;FUS;CDC5L;DDX23;DHX16;U2AF2;RBM17;CPSF3;SF1;RBM6;PSPC1;SF3B2;GTF2F2;PRCC;DCPS;SRSF9;SRSF11;SRPK2;DHX8;HNRNPH3;HNRNPH1;SRRM2;DDX5
prerank,positive regulation of locomotion (GO:0040017),0.5347740865021009,1.1772002807187119,0.27682926829268295,0.9818170479102123,1.0,4/27,8.14%,CAVIN1;THBS1;PDGFB;STX3
prerank,cilium assembly (GO:0060271),0.46766491405512717,1.176900188567884,0.105,0.9818622088922094,1.0,51/297,12.16%,TUBB4B;PLK1;RSPH4A;CETN2;CLUAP1;BBIP1;CCDC57;CEP89;NPHP4;ACTR3;ALMS1;ARL6;EHD4;TMEM67;RAB8B;EHD1;BBS4;MAPRE1;IQCB1;DZIP1;AKAP9;CEP250;FLNA;YWHAE;TTC39C;PRKACA;FNBP1L;EXOC5;PCNT;DYNLL2;IFT52;IFT20;ABLIM3;HSP90AA1;DCTN1;TUBA1A;CCDC66;SNX10;DCTN2;CCP110;ODF2;AHI1;CEP152;PTPN23;CNTRL;CFAP74;POC1B;EXOC4;KIF3A;OCRL;PTPDC1
prerank,bile acid and bile salt transport (GO:0015721),0.5420540036034261,1.1768807984107146,0.2727272727272727,0.9807492111901547,1.0,6/24,14.57%,SLCO1B1;NCOA1;STARD5;RXRA;SLCO2B1;NCOA2
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.575820435569744,1.1766845471854368,0.30381471389645776,0.9803858744834718,1.0,3/16,8.07%,ATP5F1A;ATP5MC3;ATP5MC2
prerank,regulation of interferon-gamma production (GO:0032649),0.47932498981672883,1.1766078241107594,0.24252136752136752,0.9794807460222608,1.0,14/71,15.45%,ISL1;TLR7;GAS6;AXL;TLR3;IL18;SLAMF6;CYRIB;PRNP;HMGB1;LGALS9;HAVCR2;TLR4;CD47
prerank,cardiac myofibril assembly (GO:0055003),0.5873414685817706,1.1765811031425064,0.27285513361462727,0.9784158430337522,1.0,2/15,7.15%,NEBL;MEF2A
prerank,negative regulation of T cell differentiation (GO:0045581),0.6227041919800843,1.1764806555578442,0.29180327868852457,0.9776347909610151,1.0,1/10,1.88%,IRF1
prerank,ribosome biogenesis (GO:0042254),0.46728199863246117,1.1759269152914582,0.16950852557673018,0.9787934527595841,1.0,43/187,15.28%,EIF6;C1D;MPHOSPH6;RPL18;BOP1;UTP3;PELP1;SBDS;GTF3A;RPL41;RPL31;UTP18;EMG1;RPS17;DDX49;MALSU1;RPL4;UTP20;EXOSC5;HEATR3;RPLP0;RPL38;EXOSC7;RRP36;RRP1B;FCF1;DDX10;UTP6;NOC2L;XRN2;CUL4A;HEATR1;NOP56;RPL21;RPS6;NOL8;NVL;MDN1;MTREX;TSC1;RPL35A;NPM1;RPS16
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.5749562990018509,1.1757479676327476,0.2713498622589532,0.9783527624972517,1.0,4/15,8.39%,SLC9A1;PRKCA;MEF2A;CAMK2D
prerank,sodium ion homeostasis (GO:0055078),-0.4129562490986064,-1.1756396124879511,0.23706896551724138,0.9856039532917887,1.0,5/21,8.21%,ATP1B3;ATP1B1;ATP1A1;ATP1A2;ATP1A3
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.6003755923291301,1.1753736558306507,0.2869692532942899,0.9787290407979506,1.0,5/12,13.76%,BBS4;NIN;DCTN1;KIF3A;BICD1
prerank,positive regulation of telomere maintenance (GO:0032206),0.5231913714926012,1.1751530816663733,0.28502415458937197,0.9784641205131983,1.0,12/31,17.17%,RAD50;MAPK1;HNRNPA2B1;MRE11;PKIB;NBN;TNKS2;NEK7;ATRX;PPP1R10;HNRNPD;ATM
prerank,cellular defense response (GO:0006968),0.5067508462403376,1.1747984742460886,0.26804123711340205,0.9787144193838339,1.0,3/40,1.76%,CD5L;C5AR1;RELA
prerank,positive regulation of cellular process (GO:0048522),0.4658093281392322,1.1745263037007354,0.046,0.9786836612687102,1.0,80/565,13.60%,CXCL12;FGF22;FGF18;ISL1;BMP5;TNFRSF11A;RPRD1B;CD36;RELA;CX3CL1;FGF1;NUPR1;COX17;FAM98A;DDX49;ITGB1BP1;VEGFC;CAMK1D;MAP1A;TGFB2;GAS6;HCFC1;RAD18;EAPP;AREG;AR;IRS1;GID8;THBS1;LIFR;TPM1;PDGFB;KITLG;PRKCA;CDK2;LRP5;ACER3;RPS15A;PTPRJ;KIF20B;UBE2A;SDCBP;DHPS;IRS2;MAPT;MAPK8;MECP2;TENM4;SMC5;STX3;ABCA7;EZH2;TRPM4;KRAS;NACC1;GRK5;FXR2;FAF1;ADNP2;APC;LYN;TAL1;ACTN4;COLEC12;CDC42;TGFBR2;IGF1R;SOX11;KDM4C;ZFP36L1;RPS6;ADAM10;TGFA;SRPK2;TGFBR1;BCL2;LRP6;S100B;FN1;INSR
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.48377009715142494,1.1743585431284618,0.259656652360515,0.9782112133997611,1.0,14/60,14.13%,RGCC;RFC2;TCP1;PDGFB;MAPK1;POLG2;HSP90AA1;PKIB;TNKS2;NEK7;HMBOX1;CCT3;PRKD2;NVL
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.5761893571850252,1.1736964481375756,0.30303030303030304,0.9797550252994126,1.0,6/16,13.16%,NAA35;EP300;NAA25;NAA16;KAT2B;NAA15
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.5559696836658639,1.1736866196277536,0.2638700947225981,0.9786066036711737,1.0,4/17,9.62%,VCL;IKBKB;ADD1;PROC
prerank,regulation of vasculature development (GO:1901342),0.5282535112740343,1.1736372106061435,0.26783479349186484,0.9776416858743836,1.0,3/26,8.34%,VASH2;NF1;EGLN1
prerank,regulation of DNA repair (GO:0006282),0.49395622051373667,1.1734086556627752,0.2615558060879369,0.977382757493642,1.0,9/44,9.96%,BRCA1;SIRT7;EYA2;PARG;UBE2V2;USP1;CDK9;BABAM2;SMCHD1
prerank,SNARE complex assembly (GO:0035493),0.6128776842560574,1.173191108798656,0.2996894409937888,0.9770459502482166,1.0,4/10,12.03%,VAMP1;VAMP3;VAMP2;UVRAG
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.47731632754980646,1.1730224610487778,0.23236514522821577,0.9765237354557444,1.0,11/93,6.24%,MID1;UNC5CL;MINK1;EIF2AK2;TPD52L1;SH3RF3;TGFB2;SASH1;MAP3K11;RELL1;SDCBP
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.5005263501512144,1.1726818642899872,0.26944757609921083,0.9767467403812312,1.0,7/48,7.05%,ADCY8;ADCY3;ADSS1;ACAT1;ADCY5;PANK1;ADCY9
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.45570648547664344,-1.1724452159491665,0.28525641025641024,0.9925317788162491,1.0,4/15,7.56%,OSBPL11;PLIN2;OSBPL8;LPL
prerank,actin filament depolymerization (GO:0030042),0.6081624585677536,1.1723665697695635,0.3149847094801223,0.9768824377754203,1.0,6/11,17.40%,CFL1;TWF2;MICAL2;WDR1;MICAL3;GSN
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.5042128740738862,1.172355902434042,0.269804822043628,0.9757678046899443,1.0,9/40,11.90%,SIRT7;PARG;UBE2V2;USP1;MAPT;CDK9;FXR2;RFWD3;ABL1
prerank,regulation of ATP metabolic process (GO:1903578),0.48983819181713417,1.1722686752680131,0.2488938053097345,0.9749423561683501,1.0,9/54,8.68%,EIF6;AK4;PGAM1;ZBTB7A;NUP205;EP300;ATP7A;NUP98;NUP54
prerank,positive regulation of MAPK cascade (GO:0043410),0.46323958056327985,1.1722352747746647,0.13813813813813813,0.9738935824729584,1.0,31/245,11.25%,FGF18;ROR2;MID1;LRRK2;PRKCZ;C5AR1;CD36;FBXW7;CX3CL1;EIF2AK2;TPD52L1;FGF1;BRAF;TGFB2;GAS6;RAP1A;NRP1;PDGFB;PRKCA;TRAF7;PTPRJ;ARRB2;CCL25;ABCA7;EZH2;CD44;TAOK1;TRIM5;RIT2;NOTCH2;IGF1R
prerank,lipid droplet organization (GO:0034389),0.5472416981805571,1.1722157749635094,0.28463476070528965,0.972813248070792,1.0,4/22,11.99%,PPID;RAB3GAP1;CDS1;RAB18
prerank,response to growth factor (GO:0070848),0.502389092709897,1.1720151617004535,0.2681242807825086,0.9725142358004288,1.0,10/41,13.81%,URI1;BMPR1A;PDGFB;ACVR1;TWF2;TGFBR2;MAP2K5;TGFBR1;ACVR1B;HTRA2
prerank,RNA destabilization (GO:0050779),0.5658390829516464,1.1718504108025731,0.2881118881118881,0.9720666781506175,1.0,10/18,19.06%,FTO;METTL3;LIN28B;YTHDF1;PUM1;ROCK2;YTHDF3;ROCK1;CELF1;YTHDF2
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.4734242501182425,1.1717155508423338,0.24472573839662448,0.9714759518361604,1.0,3/69,1.82%,ISL1;WFS1;CX3CL1
prerank,regulation of establishment of protein localization (GO:0070201),-0.4747756031568725,-1.1713203390198257,0.2635135135135135,0.9910676818802039,1.0,5/14,9.26%,GAPVD1;CTSD;CEP120;DNAJA1;CEP135
prerank,plasma membrane repair (GO:0001778),0.5818497158856684,1.1712775918106857,0.29285714285714287,0.9721577394354253,1.0,3/13,7.80%,SMPD1;MYOF;SYT11
prerank,gliogenesis (GO:0042063),0.5661493146089411,1.170888161064876,0.3011204481792717,0.9726335666142205,1.0,5/15,15.94%,TGFB2;CDK6;METTL3;RELN;NFIB
prerank,hemidesmosome assembly (GO:0031581),0.5985382494833378,1.170876634275005,0.29012345679012347,0.9715478908632967,1.0,2/11,11.50%,ITGA6;LAMC1
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.5515618601751286,1.1706604009054893,0.277992277992278,0.9713284873866322,1.0,1/21,0.18%,PLK1
prerank,regulation of protein binding (GO:0043393),0.47265722924647635,1.1705293039331837,0.21602434077079108,0.9707385000126304,1.0,22/114,12.87%,PLK1;LRRK2;DVL1;LDLRAP1;NMD3;ITGB1BP1;STYX;PDGFB;PRKACA;AKTIP;SPPL3;HDAC5;USP33;EPB41;MAPK8;DAB2;ADD1;CTSZ;DERL1;SORL1;TCF7L2;HIPK2
prerank,rRNA metabolic process (GO:0016072),0.4674844960937737,1.170235212209213,0.19234642497482377,0.9708310582193547,1.0,32/160,12.70%,C1D;MPHOSPH6;RPL18;BOP1;UTP3;PELP1;SBDS;RPL41;RPL31;UTP18;EMG1;RPS17;DDX49;RPL4;UTP20;EXOSC5;RPLP0;RPL38;EXOSC7;XRN1;RRP36;RRP1B;MAPT;FCF1;DDX10;UTP6;XRN2;HEATR1;NOP56;RPL21;RPS6;NOL8
prerank,mRNA 3'-end processing (GO:0031124),0.4820430802260629,1.170201955902753,0.24050632911392406,0.9698091079873377,1.0,18/78,12.67%,POLR2D;EIF4A3;RPRD1B;CSTF3;DHX38;SARNP;CSTF2;RNPS1;U2AF1;RPRD2;RPRD1A;THOC5;SRSF5;SSU72;U2AF2;CPSF3;SRSF9;SRSF11
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.5504309051497234,1.1701422134619692,0.2870748299319728,0.9689024184601489,1.0,4/17,11.35%,DUSP3;PTPRJ;EZR;PRNP
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.5619532893200627,1.1701078397664153,0.296551724137931,0.9679103144089235,1.0,8/17,18.14%,RTN3;ABCA7;PRNP;SORL1;RTN4;GGA3;BIN1;ROCK1
prerank,regulation of cell differentiation (GO:0045595),0.4695247575063728,1.1700969038844513,0.18365287588294651,0.9668175246808377,1.0,29/148,15.10%,ISL1;CDK5RAP3;EIF2AK2;HOPX;FLOT2;CASZ1;NREP;RUNX1;NF1;AR;BCL6;TRPS1;PRKCB;PRKACA;CDK6;MCRIP1;CDK9;ALOX5;APC;FADS1;RAF1;ZFP36L1;TGFBR1;NR1D2;DDX5;PLEKHB2;ANP32B;DAG1;CLASP1
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.6159972598916013,1.169736296104205,0.28353658536585363,0.9671330752001348,1.0,2/10,8.37%,IFI35;WDFY1
prerank,regulation of cell junction assembly (GO:1901888),0.5361852686273901,1.1696796861017318,0.2787286063569682,0.9662409274186259,1.0,11/27,18.14%,RAPGEF1;RUNX1;RAP1A;PRKACA;RAP1B;ROCK2;MEF2C;SETD5;RAPGEF2;PRKCH;ROCK1
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.5689146964961771,1.1694205670251834,0.3021680216802168,0.9661517791089707,1.0,6/16,13.71%,AR;PADI2;ESR1;EGLN2;PPARGC1B;DDX5
prerank,actin polymerization or depolymerization (GO:0008154),0.48964870411237527,1.1693411068850226,0.2662266226622662,0.9653188927875861,1.0,14/50,15.33%,ANG;SVIL;CFL1;WASF1;ABI1;TWF2;MICAL2;DIAPH1;WDR1;WASHC5;AIF1;WASL;EVL;MICAL3
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.4653913436253069,1.1691868698155843,0.1898989898989899,0.9647975641716278,1.0,20/152,14.62%,RXFP1;S1PR1;ADGRE1;ADCY8;ADCY3;CACNA1D;ADCY5;GPR65;ADCY9;ADGRB3;GRK5;ADGRE5;GNAQ;MTNR1A;RAMP1;GNAI3;ABCA1;WASF2;CALCRL;P2RY12
prerank,positive regulation of cell motility (GO:2000147),0.4653674979432934,1.16912700316067,0.1676706827309237,0.9639265629622668,1.0,28/205,12.97%,CXCL12;CAVIN1;ROR2;SYNE2;RIPOR1;FGF1;ITGA6;MAPRE1;EPHB2;ELP3;THBS1;PDGFB;PRKCA;SEMA6D;SDCBP;ACVR1;CBLL1;FERMT3;DAB2;APC;F3;ACTN4;SEMA3D;SEMA6A;IGF1R;RUFY3;ADAM10;TGFBR1
prerank,positive regulation of cyclase activity (GO:0031281),0.576383867296189,1.1688651560952434,0.3084648493543759,0.9638916070978754,1.0,5/14,14.79%,CACNA1D;NF1;MAPK8;MAPK14;CACNA1C
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.5159859948351344,-1.1684332644559587,0.2809917355371901,0.9972902962681108,1.0,2/10,1.86%,CST3;TGFB1
prerank,mitotic sister chromatid segregation (GO:0000070),0.47137087051857895,1.1683832431791272,0.2412008281573499,0.9647206372727934,1.0,12/98,8.22%,PLK1;NUDC;ZWINT;EML3;KPNB1;VPS4A;CHMP5;CDC23;PDS5A;NCAPD3;DCTN2;SET
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.5389742842383537,1.168060920715937,0.2915601023017903,0.9648780461599759,1.0,7/24,12.74%,FBXW7;NUPR1;TGFB2;NF1;CDK5;PRNP;SRPK2
prerank,mononuclear cell differentiation (GO:1903131),0.5335898411992285,1.1680174961224976,0.28227848101265823,0.9639387689050021,1.0,7/24,10.60%,GAS6;AXL;IKZF1;THOC5;PPARG;LYN;MT1G
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.42921896336967214,-1.1677815504134141,0.24596774193548387,0.9941452551439852,1.0,3/17,2.38%,PTPRC;CALM2;CD33
prerank,response to endoplasmic reticulum stress (GO:0034976),0.47386477088076945,1.1676994685145208,0.22722620266120777,0.9641806802654562,1.0,25/107,13.04%,WFS1;CDK5RAP3;UBA5;BCL2L11;NIBAN1;USP19;JUN;ERP44;UBQLN1;THBS1;UFC1;PDIA4;TMEM259;ERLEC1;NCK1;TRAF2;CREB3L2;DERL1;SCAMP5;ERN1;AIFM1;ATF6;TP53;EIF2S1;BCL2
prerank,BMP signaling pathway (GO:0030509),0.48242223244549587,1.1670358873401299,0.23896663078579117,0.9658111175249834,1.0,7/62,7.45%,BMP5;SMAD6;TGFB2;BMPR1A;SMAD3;ACVR1;SLC33A1
prerank,regulation of RNA export from nucleus (GO:0046831),-0.49279590108496896,-1.1668757580447502,0.29190751445086704,0.9920313833747698,1.0,5/11,11.74%,DHX9;TPR;NUP153;CPSF6;NSUN2
prerank,adenine nucleotide transport (GO:0051503),0.552878933152772,1.1663366338735877,0.30273972602739724,0.9675274564933379,1.0,2/17,5.87%,SLC25A24;ABCC5
prerank,defense response to fungus (GO:0050832),-0.43459463851069335,-1.1658870252541849,0.2591093117408907,0.9903413822523915,1.0,6/17,33.53%,PLCG2;RNASE7;CARD9;BCL10;GAPDH;FAM3A
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.5283203585438805,1.165775125419278,0.28343558282208586,0.9687130600503558,1.0,3/26,9.14%,PLK1;CDC23;CDC16
prerank,positive regulation of interleukin-1 production (GO:0032732),0.4920148264633329,1.1655841236627966,0.25669642857142855,0.9683774567363155,1.0,5/51,7.52%,ISL1;CD36;IL16;GSDMD;PYDC1
prerank,protein localization to chromosome (GO:0034502),0.5147935848100829,1.1655235821159027,0.265792610250298,0.9674747347490573,1.0,7/34,8.76%,PLK1;XRCC4;TERF2;ESR1;LEMD2;SLF1;TNKS2
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.5427503407969764,1.16542373505784,0.3006535947712418,0.9667537721713534,1.0,6/20,13.04%,WFS1;CAMK2D;RAP1GDS1;THADA;PACS2;BCL2
prerank,negative regulation of glycolytic process (GO:0045820),0.6165124082351146,1.1651063841069298,0.2953846153846154,0.96582298772123,1.0,2/10,8.99%,NUPR1;NCOR1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.6165124082351146,1.1651063841069298,0.2953846153846154,0.96582298772123,1.0,2/10,8.99%,NUPR1;NCOR1
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.5447634631550988,1.1649392452323302,0.29860228716645487,0.9653814318252244,1.0,4/22,8.29%,IRF1;RUNX1;BCL6;DUSP10
prerank,regulation of plasminogen activation (GO:0010755),0.5890741985832486,1.1645634972656702,0.30547112462006076,0.9657814200681412,1.0,4/12,10.38%,RUNX1;THBS1;ENO1;CTSZ
prerank,regulation of autophagosome assembly (GO:2000785),0.5198485784467235,1.164167122904111,0.28795180722891567,0.9663684930364661,1.0,12/33,15.54%,LRRK2;NUPR1;RAB3GAP1;PIP4K2A;IFT20;TBC1D14;PIP4K2B;FEZ1;TBC1D12;SH3GLB1;TMEM39A;MTM1
prerank,positive regulation of stress fiber assembly (GO:0051496),0.4940089781199369,1.1640651934207695,0.26865671641791045,0.9656782250055543,1.0,13/44,16.23%,RGCC;ITGB1BP1;NRP1;GPR65;TPM1;CDC42;PXN;ABL1;TGFBR1;ROCK2;EVL;CD47;PAK1
prerank,protein homooligomerization (GO:0051260),0.47184125421619794,1.1638660926269877,0.22515212981744423,0.9654473889527628,1.0,26/114,16.68%,ALDH1A2;BLM;ADCY8;MICU1;EHD4;EHD1;SSBP1;LETM1;ALDOA;G3BP2;HPRT1;GSDMD;ACOT13;TRPM4;FUS;MCOLN1;GLRA3;PDCD6IP;PKD2;RNF135;ACACA;ATL2;HCN1;GLS;OSBPL2;ZBTB1
prerank,positive regulation of cell population proliferation (GO:0008284),0.46160830319727875,1.1634236228945427,0.074,0.966130587701788,1.0,72/423,15.59%,FGF22;FGF18;BMP5;TNFRSF11A;DDR2;RPRD1B;C5AR1;RELA;CX3CL1;PID1;FGF1;COX17;FAM98A;ITGB1BP1;VEGFC;TGFB2;GAS6;BMPR1A;EAPP;AREG;AR;IRS1;GID8;THBS1;LIFR;S100A6;PDGFB;KITLG;CDK2;LRP5;ACER3;RPS15A;KIF20B;UBE2A;SDCBP;CDK6;DHPS;IRS2;MECP2;STX3;EZH2;TRPM4;IL18;KRAS;NACC1;GRK5;LYN;TGFBR2;IGF1R;SOX11;LAMC1;KDM4C;RPS6;TCF7L2;ADAM10;TGFA;SRPK2;TGFBR1;BCL2;S100B;FN1;INSR;RBPJ;FZD9;TBC1D8;AIF1;PTEN;NPM1;PHIP;CD47;TMEM119;HDAC2
prerank,ncRNA processing (GO:0034470),0.46452509521225316,1.163196448106598,0.1827309236947791,0.965964855621206,1.0,43/200,12.70%,C1D;MPHOSPH6;RPL18;BOP1;UTP3;PELP1;SBDS;RPL41;RPL31;UTP18;EMG1;RPS17;DDX49;INTS12;TUT4;INTS2;RPL4;UTP20;EXOSC5;SMAD3;RPLP0;RPL38;METTL3;EXOSC7;HNRNPA2B1;RRP36;RRP1B;POP1;AGO2;FCF1;AARS1;LIN28B;INTS4;DDX10;ADAR;UTP6;XRN2;PRKRA;HEATR1;NOP56;RPL21;RPS6;NOL8
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.49339007365772786,1.1630933823096805,0.2641509433962264,0.9652944387040209,1.0,12/48,13.81%,BRCA1;TMEM109;DYRK2;BCL2L11;EP300;PRKDC;CHEK2;ABL1;HIPK2;TP53;BCL2;HTRA2
prerank,actin filament-based transport (GO:0099515),0.5438539459967149,1.1630844133486509,0.2875318066157761,0.9642265921296023,1.0,9/21,17.05%,SYNE2;MYO5A;FNBP1L;MYO1G;ACTN4;MYO1E;WASL;MYO1B;MYO1D
prerank,protein prenylation (GO:0018342),0.6133532966088844,1.1629388811644379,0.30385852090032156,0.9637623911750984,1.0,1/10,0.72%,FNTB
prerank,cellular response to amino acid stimulus (GO:0071230),-0.35745211628592755,-1.1628661840689263,0.22,0.9964953153405367,1.0,17/33,24.03%,CPEB3;UBR1;SESN1;CPEB4;SESN3;GLRA1;LAMTOR1;UBR2;LAMTOR3;CASTOR2;KLHL22;RRAGD;RRAGB;RPTOR;NSMF;GLRA2;XBP1
prerank,transition metal ion transport (GO:0000041),0.5200656819555292,1.1626904861213645,0.275175644028103,0.9636533191974737,1.0,4/35,5.05%,CP;TRPC5;COX17;ATP7A
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.37310605532252045,-1.1625664243726619,0.2094240837696335,0.9921361053073681,1.0,16/26,34.26%,GRIN2B;MBP;AIM2;VSIR;NCSTN;USP50;EPHA4;PYCARD;STAT3;GRIN1;PSME1;PSME2;APH1A;TTBK1;PRELID1;PSENEN
prerank,positive regulation of lipid storage (GO:0010884),-0.4086763895067917,-1.1623587505375517,0.2537313432835821,0.9874870676957936,1.0,9/21,20.73%,OSBPL11;PLIN2;IKBKE;MSR1;LPL;SREBF2;SCARB1;ZC3H12A;VSTM2A
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.6262424794321646,1.1623208071407616,0.3008982035928144,0.9640946582405946,1.0,1/10,0.41%,BRCA1
prerank,dermatan sulfate metabolic process (GO:0030205),0.5935441644695051,1.1622814697185888,0.3025210084033613,0.9631588344122288,1.0,3/13,9.84%,UST;DSE;BGN
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.48225016174410024,-1.1617480192983227,0.28134556574923547,0.9842687914646797,1.0,10/12,33.77%,GLUD1;ACLY;ACO2;ACO1;IDH1;IREB2;IDH3B;IDH3G;SIRT4;IDH3A
prerank,cellular response to radiation (GO:0071478),0.49988113683123925,1.1616246037421891,0.2829763246899662,0.9648163594207015,1.0,7/40,14.72%,BLM;GRB2;CLOCK;TANK;MAPK14;TP53;SPIDR
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.5293922993350352,1.1614978927814328,0.29570552147239265,0.9642216419750204,1.0,4/29,6.69%,PLK1;FBXW7;FEM1A;DCUN1D4
prerank,positive regulation of transmembrane transport (GO:0034764),-0.458790492450726,-1.1614564486286638,0.2593856655290102,0.9800528450746158,1.0,5/13,7.87%,ANO6;P2RX7;CA2;AZIN1;ACSL1
prerank,response to unfolded protein (GO:0006986),0.491002228509512,1.1609090899975327,0.2649379932356257,0.9656199541620958,1.0,13/48,15.57%,DNAJB1;BAG3;HSPH1;ERP44;HSP90AA1;HSPA9;PTPN1;TM7SF3;DERL1;ERN1;DNAJB4;OPTN;RHBDD1
prerank,regulation of melanin biosynthetic process (GO:0048021),0.6220852499725249,1.1604125226316717,0.3216,0.966528963827883,1.0,3/10,7.12%,ZEB2;ATP7A;GIPC1
prerank,double-strand break repair (GO:0006302),0.4628516882202809,1.1603955245442825,0.2136409227683049,0.9655164492067767,1.0,33/158,12.76%,BRCA1;ACTR5;BLM;PARP9;RAD50;UBXN1;TDP2;XRCC4;POLA1;WRN;UBE2V2;DCLRE1A;PRKDC;SEM1;POLB;BRCA2;RBBP8;MRE11;MAPK8;ERCC4;SMC5;NBN;PARP2;BABAM2;CHEK2;EXD2;SETX;RFWD3;KDM4B;RAD51B;HMGB1;REV3L;RNF138
prerank,regulation of protein export from nucleus (GO:0046825),0.5296567146080614,1.1603680943047927,0.2970550576184379,0.9645474895118252,1.0,7/23,14.94%,SIRT7;BAG3;GAS6;YWHAE;TCF7L2;TP53;ANP32B
prerank,telomere maintenance via recombination (GO:0000722),0.601764925899572,1.160238216108763,0.31204644412191584,0.964035442555192,1.0,3/11,7.92%,RAD50;ERCC4;SMC5
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.4734742271955436,1.1600490924581996,0.24867724867724866,0.9636675622224887,1.0,34/73,17.40%,ACTR3;GRB2;PLA2G6;DOCK1;YES1;MAPK1;WIPF1;VAV3;ABI1;HSP90AA1;ARPC1A;ARPC4;NCK1;MYO1G;LYN;CDC42;ARPC2;CYFIP2;ABL1;VAV2;WASF2;SYK;FYN;ELMO1;WIPF2;ARPC3;WASL;VAV1;PIK3R1;PAK1;ACTG1;CYFIP1;NCKAP1L;FCGR1A
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.5821356811828752,1.1599966821813135,0.3240223463687151,0.9628147814159533,1.0,4/13,13.83%,PLXNA1;NRP1;PLXNC1;NRP2
prerank,positive regulation of developmental process (GO:0051094),0.46405622792257817,1.1599313137505929,0.19514661274014156,0.9620015791242165,1.0,31/164,15.51%,ISL1;BMP5;MIEF2;DVL1;TAPT1;CFL1;BMPR1A;AR;PDGFB;ACVR1;KMT5B;AGO2;TRPM4;VPS35;NCOA3;LRP8;KMT5C;B4GALT5;BNIP3;NR2C2;SORL1;ZDHHC6;SOX6;ACVR1B;RTN4;INSR;RREB1;RELN;DAG1;CLASP1;TMEM119
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.4258636857191054,-1.1598364648739992,0.2591240875912409,0.9808054849012917,1.0,6/16,12.43%,POGZ;NIPBL;SMC1A;NAA50;RAD21;PDS5B
prerank,positive regulation of signaling receptor activity (GO:2000273),0.5153390620523446,1.158379711335254,0.2925969447708578,0.9672761208965652,1.0,9/36,15.59%,FBXW7;EPHB2;AREG;NRP1;BUD31;NCOA3;TGFA;RELN;HDAC2
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.4749645971339117,1.1583182809327517,0.24786324786324787,0.9664210302239602,1.0,34/71,17.40%,ACTR3;GRB2;PLA2G6;DOCK1;YES1;MAPK1;WIPF1;VAV3;ABI1;HSP90AA1;ARPC1A;ARPC4;NCK1;MYO1G;LYN;CDC42;ARPC2;CYFIP2;ABL1;VAV2;WASF2;SYK;FYN;ELMO1;WIPF2;ARPC3;WASL;VAV1;PIK3R1;PAK1;ACTG1;CYFIP1;NCKAP1L;FCGR1A
prerank,visual perception (GO:0007601),0.4740355125644152,1.1581405644639573,0.2507836990595611,0.9660912264577786,1.0,15/84,16.46%,WFS1;CEP250;ATXN7;CRYBG3;COL11A1;MYO9A;DHRS3;PITPNA;EML2;ATF6;RPGR;ABLIM1;SLC4A10;DRAM2;RP2
prerank,regulation of protein transport (GO:0051223),0.5182493621048574,1.1579048135766759,0.31072749691738594,0.9659780956542687,1.0,9/27,13.37%,LLGL2;NDEL1;LLGL1;SNX3;PTPN1;STXBP5;DNAJC1;STXBP5L;NDFIP1
prerank,positive regulation of intracellular transport (GO:0032388),0.4914051897012931,1.1577704525385528,0.283704572098476,0.9654587933276578,1.0,10/38,12.56%,RIPOR1;EIPR1;EHD1;PCNT;KIF20B;STK11;NEDD4;VAMP2;SORL1;RUFY3
prerank,cellular response to ATP (GO:0071318),-0.468013428030311,-1.1574903839213193,0.2788104089219331,0.9845409836701564,1.0,4/14,17.46%,P2RX7;TAF1;SSH1;P2RX4
prerank,cellular response to topologically incorrect protein (GO:0035967),0.5119370408147667,1.157101325525264,0.30324909747292417,0.9671190568940098,1.0,12/31,17.68%,BAG3;DNAJC18;HSPA9;PTPN1;TM7SF3;UBE2W;ERN1;ATXN3;OPTN;RHBDD1;HSPA5;TMBIM6
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.46504066978036274,1.1570708604012099,0.2099391480730223,0.9661782609315615,1.0,33/148,13.19%,BRCA1;BLM;BOP1;EHMT1;CDK5RAP3;RFC2;RAD50;DYRK2;PIP4K2A;WRN;EP300;CDK2;EHMT2;STK11;RNF34;RBBP8;MRE11;MAP2K6;MAPKAP1;NBN;PHF20;TAF4;CHEK2;PIP4K2B;CDK5;NOC2L;MTOR;PRDM1;MAPK14;BRD7;HIPK2;TP53;RBBP7
prerank,cellular response to type I interferon (GO:0071357),0.4943697400688539,1.1566317642384931,0.275626423690205,0.9658038670264896,1.0,7/41,10.94%,IFITM3;IRF1;IFI35;IRF3;PSMB8;ADAR;IFNAR2
prerank,type I interferon signaling pathway (GO:0060337),0.4943697400688539,1.1566317642384931,0.275626423690205,0.9658038670264896,1.0,7/41,10.94%,IFITM3;IRF1;IFI35;IRF3;PSMB8;ADAR;IFNAR2
prerank,regulation of p38MAPK cascade (GO:1900744),0.5071421416384742,1.1561389978557877,0.3014354066985646,0.9666537010627753,1.0,9/35,14.00%,MINK1;SASH1;RELL1;EZR;DLG1;DUSP10;PHLPP1;CYLD;LGALS9
prerank,activin receptor signaling pathway (GO:0032924),0.5690122286718583,1.1558510951134902,0.3031609195402299,0.9667201343707638,1.0,4/15,13.18%,SMAD3;ACVR1;TGFBR1;ACVR1B
prerank,regulation of neurotransmitter transport (GO:0051588),-0.4347825893094353,-1.155719755723303,0.2702702702702703,0.985983038607225,1.0,8/16,32.29%,FMR1;SYN1;RIMS1;MCTP2;CPLX1;CAMK2A;FLOT1;SNCAIP
prerank,regulation of mitotic nuclear division (GO:0007088),0.48400051876023686,1.1553660934320977,0.27582417582417584,0.9674792174070488,1.0,9/55,15.29%,RGCC;PDGFB;LRP5;KIF20B;IL1A;TOM1L2;TGFA;INSR;PHIP
prerank,recombinational repair (GO:0000725),0.4753959151966657,1.1553598114823969,0.2662473794549266,0.9664350915493217,1.0,18/77,14.72%,BRCA1;BLM;RAD50;WRN;SEM1;BRCA2;RBBP8;MRE11;ERCC4;SMC5;NBN;EXD2;RFWD3;RAD51B;REV3L;RNF138;RECQL5;SPIDR
prerank,transcription by RNA polymerase II (GO:0006366),0.4602879184545559,1.1548395642531528,0.147,0.9675311478456438,1.0,71/305,14.50%,POLR2D;EAF1;RORA;PMF1;SNAPC5;RPRD1B;C5AR1;SP1;CTR9;PHAX;INTS12;CSTF3;INTS2;CSTF2;POLR2A;AR;MLLT1;HDAC9;CDK7;TEAD1;ESR1;ARRB2;HDAC5;NR3C1;RPRD2;RPRD1A;MAML3;MAML2;MNAT1;SETD2;TFCP2;CDK9;TAF4;NCOR1;INTS4;SSU72;PPARG;SNRPD3;NR6A1;SETX;GTF2E1;GTF2E2;DEAF1;RNGTT;NELFA;ELOC;GTF2B;CPSF3;NR5A1;NOTCH2;KAT2B;NR2C2;GTF2F2;NCOR2;GMEB2;RPAP2;MAF;NRBP1;CTDP1;NR1D2;KLF13;RXRA;MED27;NFX1;GTF2H1;DDX5;RREB1;RBPJ;TRIP11;PPARD;TBL1XR1
prerank,phagosome maturation (GO:0090382),-0.3526165038434471,-1.1543849446160255,0.2127659574468085,0.9859008702387854,1.0,14/35,17.48%,ATP6V0A1;RAB31;ATP6V1A;ATP6V1D;RAB14;CORO1A;ATP6V0C;RAB39A;RAB32;ATP6V0B;ATP6V1C1;ATP6V1G1;RAB20;RAB43
prerank,spinal cord development (GO:0021510),0.5975876320739903,1.1541622320822338,0.297029702970297,0.9690885050962055,1.0,5/12,14.25%,NF1;LOXL3;SOX11;PKD2;RELN
prerank,circulatory system development (GO:0072359),0.46891699155108163,1.1541008842236737,0.22676200204290092,0.9682916709514149,1.0,23/118,14.84%,ISL1;FBXW7;TGFB2;NF1;PDLIM2;HDAC9;PDGFB;ACVR1;STK11;MEF2A;NXN;MICAL2;CACYBP;AKAP13;TGFBR2;KAT2B;TGFBR1;FN1;HEG1;PKD2;PTEN;CACNA1C;SMG9
prerank,determination of heart left/right asymmetry (GO:0061371),0.49572320006939496,1.153961884235938,0.29218573046432617,0.9677968305300706,1.0,8/43,16.27%,DAND5;BBS4;AHI1;MICAL2;TGFBR2;NDRG4;PKD2;MEF2C
prerank,myofibril assembly (GO:0030239),0.49561486264302856,1.1539590367428636,0.29036004645760743,0.966751360328976,1.0,4/42,12.08%,TMOD1;TMOD3;TPM1;WDR1
prerank,replication fork processing (GO:0031297),0.5071526462583632,1.1538209396271868,0.2910360884749709,0.966257052209869,1.0,9/38,12.96%,BLM;WRN;BRCA2;BOD1L1;MRE11;CDK9;EXD2;RFWD3;ATRX
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.541222949222705,1.153735286334495,0.3074027603513174,0.9655639444186739,1.0,2/23,2.43%,DFFB;KPNB1
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.4903315688173139,1.153699376119377,0.28040540540540543,0.9646782651945458,1.0,4/45,7.52%,ISL1;CD36;GSDMD;PYDC1
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.5215580982547224,1.1533146953503992,0.3103448275862069,0.9651360304905364,1.0,10/31,13.31%,PDZD11;MSN;CAMSAP3;EZR;DLG1;MYO9A;CDC42;WDR1;LIN7A;PDCD6IP
prerank,protein localization to nucleus (GO:0034504),0.4640382590888227,1.1531460514885317,0.2530737704918033,0.9647725177895783,1.0,18/102,9.84%,PLK1;DVL1;KPNB1;EIF4ENIF1;BBS4;HIKESHI;ZBTB7A;YWHAE;WRN;HEATR3;RANBP6;IPO7;IPO9;CTDNEP1;PTTG1IP;CSE1L;ABCA7;IPO5
prerank,positive regulation of cellular component movement (GO:0051272),0.5298826929328438,1.1526825409284416,0.3075,0.9655315907664683,1.0,5/24,12.97%,CAVIN1;STK11;LYN;ACTN4;TGFBR1
prerank,negative regulation of DNA recombination (GO:0045910),0.491095570293911,1.1525768813668258,0.2816742081447964,0.9648985674110361,1.0,7/43,13.42%,POLR2D;BLM;POLR2A;TERF2;SMCHD1;ATRX;TERF1
prerank,Ras protein signal transduction (GO:0007265),0.4634799259667017,1.152385097576996,0.2436548223350254,0.9646363402975774,1.0,37/137,14.97%,RIPOR1;NRAS;ARHGEF3;RAPGEF1;CFL1;KPNB1;GRB2;PLEKHG5;WASF1;GDI1;NF1;RERG;RASSF1;JUN;RAP1A;FARP2;CDK2;G3BP2;RAP1B;EPS8L1;ARHGAP1;KRAS;EPS8;RIT2;DBNL;PLD1;MAPK14;MYO9B;TP53;RREB1;ELMO1;SHOC2;ROCK2;GNB1;AIF1;G3BP1;ARHGDIB
prerank,regulation of microtubule-based process (GO:0032886),0.5084904975104354,1.1522830820537702,0.2857142857142857,0.9639879303471548,1.0,12/36,15.63%,KLHL42;IGBP1;CAMSAP3;MAPT;APC;TAOK1;DIAPH1;CYLD;BICD1;MAP6;CLASP1;MACF1
prerank,kidney development (GO:0001822),0.4749832634789095,1.152254549099388,0.26254002134471716,0.9630774664646724,1.0,4/65,4.01%,WNT4;WFS1;TGFB2;NF1
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.5237208690596699,1.1517615335299611,0.2871165644171779,0.964010084171474,1.0,6/28,9.96%,SIRT7;PARP9;PRKDC;KMT5B;KMT5C;SMCHD1
prerank,quinone biosynthetic process (GO:1901663),0.5736886194209005,1.1516295078160392,0.31077348066298344,0.963434042549063,1.0,1/14,0.23%,COQ6
prerank,alpha-amino acid metabolic process (GO:1901605),0.4942615723660042,1.151617567171453,0.2996632996632997,0.9624443726824465,1.0,5/45,6.57%,CBS;PYCR2;ATP7A;FOLH1;MTHFR
prerank,cellular zinc ion homeostasis (GO:0006882),0.5254459023726074,1.151521742989209,0.29850746268656714,0.9618161531897348,1.0,9/26,12.50%,MT1F;MT1M;MT1H;MT1X;MT1A;MT1E;MT1G;MT1B;SLC39A10
prerank,Golgi to lysosome transport (GO:0090160),-0.5046058773878543,-1.1512452032595353,0.2934131736526946,0.9923812156561593,1.0,5/11,12.30%,LAPTM5;GAK;CLN3;CCDC91;AP1G1
prerank,protein-containing complex disassembly (GO:0032984),0.4798806564448169,1.1511831039425222,0.28492849284928495,0.9621680819926265,1.0,14/54,14.49%,TSG101;VPS16;DVL1;VAMP7;VPS4A;UBQLN1;PYM1;STX17;APC;UVRAG;VIPAS39;LRP6;CSNK1A1;SNX14
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.5782773103603283,1.151130604642935,0.3094512195121951,0.9613193485499096,1.0,5/12,13.60%,DYRK2;IRS1;IRS2;GCK;INSR
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.505765553931519,1.1511298745122542,0.3006134969325153,0.9602933622990713,1.0,9/30,15.08%,RAPGEF1;GRB2;STK19;IRS2;LYN;NOTCH2;SHOC2;RELN;VAV1
prerank,wound healing (GO:0042060),0.47814695976938865,1.1510303615861912,0.28289473684210525,0.9596591777711863,1.0,15/62,16.32%,FGF1;TGFB2;SMPD1;NF1;MYOF;TPM1;SMAD3;DCBLD2;SYT11;MIA3;RAF1;TGFBR1;MACF1;PAK1;CFLAR
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.5205378436948532,1.1510269223171732,0.3092269326683292,0.9586470410329776,1.0,5/26,7.91%,CD36;IRF1;FLOT2;BIRC3;TLR3
prerank,cellular response to organonitrogen compound (GO:0071417),0.47212402286557653,1.1510073134613177,0.23595505617977527,0.9576896390072651,1.0,22/99,15.36%,HCN3;BRCA1;RELA;RAPGEF1;IMPACT;AKAP9;RAP1A;CTNNA1;EZR;GOLPH3;RAP1B;IPO5;CAPN2;GABRG2;DIAPH1;MTOR;ZFP36L1;SLC38A9;PKD2;LARS1;P2RY12;HCN1
prerank,mitochondrial genome maintenance (GO:0000002),-0.48171433977467953,-1.1509064965573013,0.32047477744807124,0.98824169241959,1.0,7/11,21.88%,AKT3;OPA1;PARP1;TOP3A;MPV17;SLC25A4;SLC25A33
prerank,response to iron ion (GO:0010039),-0.4887154091321961,-1.15082826372692,0.3086816720257235,0.9833191539191845,1.0,4/12,12.60%,B2M;SNCA;SLC11A2;ACO1
prerank,regulation of lipid kinase activity (GO:0043550),-0.4882081992915448,-1.1504515295672852,0.301994301994302,0.9796002825433139,1.0,4/11,12.23%,RBL2;WDR81;WDR91;RBL1
prerank,chloride transmembrane transport (GO:1902476),-0.32301995049580057,-1.1504448123465525,0.23,0.9745505103417387,1.0,22/48,33.82%,GABRB1;ANO6;GABRA2;ANO3;GABRA3;SLC12A9;GLRA1;CLCN3;SLC1A1;SLC12A2;GABRA5;SLC6A1;GLRA2;GABRA4;GABRB3;GABRG1;ANO5;GABRA1;SLC12A7;SLC4A8;SLC12A5;LRRC8A
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.5461888249463366,1.150186441543409,0.32808398950131235,0.9597940182571002,1.0,4/20,14.21%,TGFB2;OLFM1;TGFBR1;RBPJ
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.4863701906607968,-1.149944665393617,0.3081232492997199,0.9714029080630071,1.0,6/11,33.95%,JAK2;TMEM106A;SIRT1;XBP1;TAF7;CIITA
prerank,regulation of protein ubiquitination (GO:0031396),0.46539697380850686,1.1490861971934603,0.25025536261491316,0.9631920988654809,1.0,22/108,13.37%,BRCA1;WFS1;SIRT7;LRRK2;CDK5RAP3;FBXW7;UBXN1;SASH1;UBQLN1;SQSTM1;ARRB2;BIRC3;HSP90AA1;PTTG1IP;RCHY1;NXN;U2AF2;DERL1;UBE3A;CAMLG;TGFBR1;NDFIP1
prerank,neuron remodeling (GO:0016322),0.6050112750256358,1.1489926467335225,0.32,0.9624905261989738,1.0,4/10,9.74%,CX3CL1;FARP2;ADGRB3;ANKS1A
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.576171839274762,1.1488495414777522,0.3023255813953488,0.962047792675802,1.0,6/14,16.27%,IGFBP3;BMPR1A;TPM1;NDRG4;AIF1;MEF2C
prerank,protein-containing complex subunit organization (GO:0043933),0.46075310188296725,1.1483860808435309,0.2484787018255578,0.9627453777274259,1.0,33/109,17.29%,TFAP4;PPID;LLGL1;NAPG;WASF1;VAMP3;NUP205;TEAD1;WIPF1;ST13;MNAT1;NUP98;RANBP9;REPS2;IL1RAP;LPXN;TUBGCP2;NUP54;APC;VAMP2;CD2AP;TRAF2;LAMC1;TP53;LIN7A;MDN1;WASL;PEX14;CAPZA1;DNM1L;TAPBP;SNX9;NCKAP1L
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.4827641243951252,1.1479706174387017,0.312707182320442,0.963405569403933,1.0,12/51,12.11%,LRRK2;MINK1;WASF1;NYAP1;ATP7A;KIF20B;SLC9A6;DTNBP1;TAOK1;DBNL;SNX1;EPB41L3
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.5899435012186396,1.1479533109486224,0.31201248049922,0.9614154958040657,1.0,3/12,11.35%,HOMER2;DYRK2;PRNP
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.5899435012186396,1.1479533109486224,0.31201248049922,0.9614154958040657,1.0,3/12,11.35%,HOMER2;DYRK2;PRNP
prerank,phosphatidylcholine metabolic process (GO:0046470),0.46729088673033414,1.1479039595751506,0.2733050847457627,0.9605912052389013,1.0,5/70,8.02%,LCAT;PLA2G7;PLA2G6;CHKB;PLA2G4A
prerank,establishment of protein localization to extracellular region (GO:0035592),0.5023215326820609,1.1475907342213307,0.29500580720092917,0.9608402371779465,1.0,10/39,13.05%,STEAP3;RAB8B;TVP23B;RAB12;TANGO6;PDIA4;GOLPH3;MIA3;ABCA1;RAB3C
prerank,apical protein localization (GO:0045176),-0.5083857128801863,-1.147579697401235,0.29464285714285715,0.9751312439748541,1.0,6/10,19.15%,GOPC;MAL;JAM3;ATP8B1;INSC;SHROOM2
prerank,positive regulation of cellular component organization (GO:0051130),0.4709162926966404,1.1475084158108877,0.2479591836734694,0.9601341132823072,1.0,27/107,14.72%,LMAN1;RUNX1;TGFB2;SMPD1;BCL2L11;AR;TMED9;ABCB7;TMEM30A;CBLL1;DCTN1;SLF1;DAB2;ADD1;FNIP1;FAF1;TAL1;PTPN23;BNIP3;IGF1R;SH3GLB1;TGFBR1;SYK;GPC3;INSR;RELN;SPIDR
prerank,chemical homeostasis (GO:0048878),0.47610263801458036,1.1472498635325983,0.2943722943722944,0.9601430755564289,1.0,11/61,15.33%,SLC4A3;SLC66A1;FBXW7;ADCK1;TLCD3A;IRS2;PPARG;THADA;NR1D2;ACOX3;SLC4A10
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.5105069975556754,1.1471080589774894,0.32057416267942584,0.9597156759880471,1.0,6/31,9.43%,SMAD6;CRIM1;LRP5;CDK6;TRPM4;PPARG
prerank,response to progesterone (GO:0032570),0.5512634610024361,1.1469953874660785,0.31058495821727017,0.9591715771964776,1.0,4/18,12.10%,TGFB2;WBP2;THBS1;UBE3A
prerank,negative regulation of bone remodeling (GO:0046851),-0.49284880733479264,-1.1468730384075652,0.2990936555891239,0.9725092945088479,1.0,3/11,16.37%,P2RX7;GPR137B;TNFAIP3
prerank,hematopoietic stem cell proliferation (GO:0071425),0.5863647796607339,1.1461407355108093,0.3446153846153846,0.9614621048378248,1.0,2/11,3.64%,WNT2B;RUNX1
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.4864076993503714,-1.1460953316985656,0.2994011976047904,0.9702961078049939,1.0,2/12,2.26%,RYR2;PTK2B
prerank,Golgi localization (GO:0051645),0.5877021454874101,1.1459877223554689,0.33088235294117646,0.9610755788696596,1.0,4/11,12.03%,RIPOR1;TBCCD1;CDC42;UVRAG
prerank,positive regulation of peptidase activity (GO:0010952),-0.40566134023723244,-1.1458609074375945,0.23529411764705882,0.9662374896805728,1.0,14/20,40.24%,GRN;VCP;VSIR;NCSTN;DDRGK1;PSME1;PINK1;PSME2;APH1A;PRELID1;PSENEN;NDUFA13;APH1B;PSME3
prerank,peptide cross-linking (GO:0018149),0.5263784692462843,1.1458106353568958,0.3119496855345912,0.9608060216192017,1.0,4/25,13.49%,THBS1;F13A1;ABCA7;FN1
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.5450015220923687,1.1458012220724825,0.3253968253968254,0.959825792933042,1.0,4/19,6.15%,GAS6;BTK;PRKDC;AXL
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.6051550268362031,1.145671889205113,0.35394126738794435,0.9583260873159989,1.0,2/10,4.23%,SMPD3;PLA2G6
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.6051550268362031,1.145671889205113,0.35394126738794435,0.9583260873159989,1.0,2/10,4.23%,SMPD3;PLA2G6
prerank,negative regulation of cell death (GO:0060548),0.46293954335073356,1.1456037742206435,0.27424400417101147,0.9575721665376296,1.0,21/88,13.81%,WFS1;LRRK2;TMEM109;IMPACT;RAD18;INPP5A;PSMC5;BNIP3L;NCK1;VPS35;TM7SF3;ADNP2;CDK5;BNIP3;TRAF2;SOX11;VPS4B;DCPS;SORL1;FYN;HTRA2
prerank,negative regulation of ATP metabolic process (GO:1903579),0.5465464730110653,1.1446769768547167,0.3166441136671177,0.9600412276874463,1.0,3/17,8.99%,PID1;NUPR1;NCOR1
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.4767499159763299,1.1444549484296123,0.2813852813852814,0.959889870148882,1.0,16/57,15.28%,BOP1;GTF3A;EMG1;RPS17;MALSU1;HEATR3;TGS1;RPL38;RRP36;NOC2L;CUL4A;RPS6;NVL;RPL35A;NPM1;RPS16
prerank,purine ribonucleotide metabolic process (GO:0009150),0.47364930915931946,1.1442702760568213,0.26504751847940866,0.9596694321823385,1.0,9/68,9.42%,LRRK2;AK4;AK3;ADSS1;ACAT1;ACOT9;HPRT1;ACOT13;CROT
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.5393187335595593,1.1441820279180492,0.3195187165775401,0.9590185771985432,1.0,2/19,5.66%,RGCC;DENND6A
prerank,positive regulation of nervous system process (GO:0031646),-0.4160114398778932,-1.1440205671434223,0.26229508196721313,0.9678690524118682,1.0,11/18,32.56%,RIMS2;RNF10;RIMS1;ITGAX;TPPP;UNC13B;ATPSCKMT;MYRF;DICER1;NLGN2;CST7
prerank,cellular protein localization (GO:0034613),0.4553095428120453,1.143857842832319,0.16516516516516516,0.9593204957535825,1.0,74/285,15.30%,STXBP2;WDR45;VCL;LRRK2;ARL5A;TMED4;ARL4A;ARL6;ARF3;COPB2;EHD1;BBS4;NAPG;ITSN1;TBC1D15;CEP250;CPE;FLNA;STX7;KIF13A;WDR45B;COG3;SIL1;EVI5;TMED9;TM9SF1;AP2A1;TBC1D17;RAB5B;VPS45;RAB6A;STX3;TBC1D14;VPS35;STX16;ARL4C;STX17;AHI1;TBC1D10B;CD63;HGS;WLS;ARF1;SNX1;TMED2;TBC1D4;TRAPPC8;PACS2;RAB18;TBC1D12;EPB41L3;SNX8;PIGU;TBC1D5;TBC1D10A;VIPAS39;TBC1D13;ERP29;RABGAP1;TMED5;NAPA;RPGR;PTPRU;BICD1;SAR1B;UNC93B1;TBC1D22A;GGA1;TBC1D8;CLTC;TM9SF2;TBC1D1;NPM1;SNX13
prerank,positive regulation of cellular protein localization (GO:1903829),0.47170941229424707,1.143686045380376,0.26524064171122996,0.9589597870767871,1.0,11/69,9.63%,PLK1;CDK5RAP3;PARP9;MAP1A;CEP250;MAPT;GPD1L;SYT11;STX3;ABCA7;APC
prerank,cGMP-mediated signaling (GO:0019934),0.5749677790208331,1.1435806448923036,0.3431516936671576,0.9583627358633762,1.0,1/13,1.63%,CD36
prerank,positive regulation of viral life cycle (GO:1903902),0.5242972990243183,1.1434672902401812,0.3051948051948052,0.9578348998822626,1.0,4/22,7.43%,TSG101;VPS4A;AXL;KPNA6
prerank,spindle assembly (GO:0051225),0.470946113510915,1.14343218058964,0.275377969762419,0.9569675822636995,1.0,14/67,11.93%,TOGARAM2;KPNB1;CCDC61;MAPRE1;FLNA;TUBGCP6;KIF11;STAG2;TUBGCP2;NCOR1;CHEK2;NEK7;LSM14A;STARD9
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.5702768288739235,1.1432489944026383,0.3250728862973761,0.9567030214834514,1.0,4/14,11.72%,ITGB1BP1;THBS1;HDAC5;MAP2K5
prerank,ubiquinone metabolic process (GO:0006743),0.5654608942494054,1.142829111235162,0.3246930422919509,0.9572923948081367,1.0,1/15,0.23%,COQ6
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.5492870302537012,1.1427881931331838,0.32373113854595337,0.9564516016174731,1.0,3/17,6.35%,URI1;AR;NR3C1
prerank,DNA duplex unwinding (GO:0032508),0.4792677005546311,1.1425950934989295,0.2978021978021978,0.9561979046071083,1.0,11/50,14.70%,CETN2;BLM;RAD50;SSBP1;WRN;MRE11;NBN;CUL4A;GTF2H1;RECQL5;RAD23B
prerank,regulation of cellular metabolic process (GO:0031323),0.4841273321770409,1.142568108319319,0.2941834451901566,0.9553093147876224,1.0,11/45,14.13%,EIF6;PID1;RNF34;VPS35;ABCG1;KIF16B;ARF1;NCOR2;PARL;COQ7;ACACA
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.5309734709507008,1.1415465421844406,0.31800766283524906,0.9583302419325168,1.0,3/21,6.50%,BRCA1;ABCB7;ABCD2
prerank,regulation of mitotic spindle organization (GO:0060236),0.49250069107409983,1.1415369440724985,0.30162412993039445,0.9573833526220625,1.0,7/35,14.68%,PLK1;EML3;CHMP5;DCTN1;VPS4B;PDCD6IP;CLTC
prerank,Rap protein signal transduction (GO:0032486),0.601676222910069,1.1414940157046523,0.34662576687116564,0.9565731014997726,1.0,3/10,7.63%,RAPGEF1;RAP1A;RAP1B
prerank,negative regulation of protein binding (GO:0032091),0.475274805695063,1.1413773978761095,0.2758985200845666,0.9560336161248254,1.0,12/71,10.38%,LRRK2;DVL1;ADAM15;ITGB1BP1;STYX;PDGFB;ARRB2;ITGA4;USP33;MAPK8;DAB2;CTSZ
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.4510824730560101,1.1410785978153484,0.21621621621621623,0.9562061478359564,1.0,42/214,15.19%,ROR2;PRKCZ;C5AR1;CD36;DUSP3;FBXW7;CX3CL1;CNKSR3;ITGB1BP1;BRAF;GAS6;EPHB2;RAP1A;NRP1;STYX;PDGFB;PRKCA;TRAF7;SPRED2;ARRB2;EZR;CCL25;DLG1;RGS14;RANBP9;DUSP10;PTPN1;ABCA7;LYN;CD44;SEMA6A;NOTCH2;HMGB1;SYK;FN1;SPRED1;NDRG4;PRKD2;LGALS9;PTEN;TLR4;SMAD4
prerank,regulation of calcium-mediated signaling (GO:0050848),0.525477457210296,1.140967076958999,0.3233082706766917,0.9556712940064339,1.0,5/25,10.91%,LRRK2;CMKLR1;MAPT;TMBIM4;RIT2
prerank,skeletal muscle organ development (GO:0060538),0.5116444130570744,1.1406144621909562,0.31585518102372034,0.9560607653236944,1.0,5/26,16.67%,SVIL;ZBTB18;MEF2C;CFLAR;LARGE1
prerank,positive regulation of DNA metabolic process (GO:0051054),0.4701511201221296,1.1404949394925081,0.2944325481798715,0.9555334376128521,1.0,14/61,13.90%,RGCC;BRCA1;EYA2;RAD50;WRN;PDGFB;MRE11;MECP2;NBN;BABAM2;SMCHD1;HMGB1;ATRX;PRKD2
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.5755910922787911,1.1404625922696245,0.31917808219178084,0.9546662629199684,1.0,4/14,10.97%,PRKCZ;IL18;SOCS5;NFKBIZ
prerank,ATP synthesis coupled proton transport (GO:0015986),0.5528398362969033,1.1404420160137154,0.3319838056680162,0.9537695200686841,1.0,3/17,8.07%,ATP5F1A;ATP5MC3;ATP5MC2
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.4967359229844055,-1.140403453885992,0.3215339233038348,0.9758988085453504,1.0,7/11,27.98%,RENBP;NAGK;GFPT1;AMDHD2;GNPDA1;UAP1L1;PGM3
prerank,fatty acid beta-oxidation (GO:0006635),0.48606161352088356,1.1394864554782005,0.29768467475192945,0.956515904950972,1.0,14/51,14.48%,ACAT1;ECI2;ACADS;ECHS1;DECR1;ABCD2;CROT;ABCD3;ACADL;ABCD1;HSD17B4;ETFA;PPARD;ACOX3
prerank,negative regulation of viral entry into host cell (GO:0046597),0.585840153953852,1.1392144181387298,0.3404255319148936,0.9565939220681248,1.0,5/12,17.40%,IFITM3;SNX3;TRIM5;TRIM26;GSN
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.35033866533724284,-1.138867324418971,0.25,0.9766120073685387,1.0,6/30,2.93%,SMURF2;XIAP;TGFB1;SMAD7;SMAD2;LATS1
prerank,positive regulation of vacuole organization (GO:0044090),0.5984695949706494,1.1388226306853912,0.3440366972477064,0.9572258701193367,1.0,5/10,12.70%,RAB3GAP1;PIP4K2A;PIP4K2B;ANXA2;SH3GLB1
prerank,cytoplasmic sequestering of protein (GO:0051220),0.5741627401123471,1.1386071031633747,0.3145275035260931,0.9570543349633687,1.0,3/13,6.98%,MDFI;FLNA;KEAP1
prerank,positive regulation of proteolysis (GO:0045862),0.4771313928513227,1.1385405921403093,0.29225736095965105,0.9563343437791254,1.0,11/55,15.59%,PLK1;CTSC;NRDC;FURIN;TANK;FBXW11;CYFIP2;TBC1D10A;IST1;RHBDD1;HDAC2
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.46488278428923,1.138351462580814,0.2644628099173554,0.9560737270912242,1.0,21/95,13.58%,DAND5;SMAD6;PMEPA1;NREP;ZEB2;ZBTB7A;THBS1;EP300;SMAD3;SPRED2;SDCBP;STK11;GIPC1;LDLRAD4;DAB2;TGFBR2;SOX11;PPM1A;HIPK2;TGFBR1;SPRED1
prerank,glucose import (GO:0046323),0.595906924239396,1.1381772448056904,0.3569364161849711,0.9557814834911039,1.0,2/13,12.68%,SLC2A3;SLC27A1
prerank,Golgi to endosome transport (GO:0006895),0.5603391045255219,1.13784614024484,0.3394109396914446,0.9560659826641966,1.0,5/16,9.54%,SYS1;AP2A1;VPS13A;VPS13C;KIF16B
prerank,regulation of viral transcription (GO:0046782),0.49884087326812687,1.1376995901394298,0.305978898007034,0.9556480457826186,1.0,7/39,13.02%,POLR2D;IFITM3;POLR2A;CDK9;NELFA;GTF2F2;CTDP1
prerank,cellular sodium ion homeostasis (GO:0006883),-0.44032790016044426,-1.1375767923863365,0.2905405405405405,0.9765276712182241,1.0,5/15,8.21%,ATP1B3;ATP1B1;ATP1A1;ATP1A2;ATP1A3
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.5240970373191365,1.1369195435056376,0.310126582278481,0.957706694059161,1.0,4/23,11.56%,NUPR1;EP300;NCOR1;GCK
prerank,regulation of cellular component size (GO:0032535),0.5096321618251873,1.1368081358755484,0.31757575757575757,0.9571846336198105,1.0,12/30,16.52%,RIN3;MSN;VAV3;EZR;HP1BP3;EPS8;MTOR;VAV2;LARS1;PTEN;VAV1;RDX
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.44620509179227696,-1.136640439645726,0.3177257525083612,0.9751197336196402,1.0,4/15,9.22%,RNF213;CSNK1D;DAAM2;TIAM1
prerank,protein secretion (GO:0009306),0.47867488571900635,1.13633820407058,0.3164277839029768,0.9579805289454123,1.0,14/56,13.39%,STEAP3;RAB8B;TVP23B;SNX19;RAB12;TANGO6;PDIA4;GOLPH3;WLS;MIA3;ABCA1;CYB5R4;RAB3C;CAMK2G
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.4855751822944045,-1.1361194431412085,0.3,0.9721783575087071,1.0,3/11,6.42%,PCBP2;RASA1;NOVA1
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.48535816433423085,1.1358105684022428,0.30248306997742663,0.9590408193070805,1.0,11/50,11.45%,RELA;EIF2AK2;IFI35;TLR7;SASH1;EP300;TLR3;LIMS1;PTP4A3;ACTN4;TRIM44
prerank,regulation of response to stress (GO:0080134),0.5954068743999523,1.1354499761788723,0.32926829268292684,0.9594665683206698,1.0,2/10,5.63%,ADCY8;SLC38A2
prerank,negative regulation of translation (GO:0017148),0.4626540451662161,1.1351031142283592,0.2695109261186264,0.9597926819620619,1.0,25/87,16.59%,EIF4A3;CNOT10;EIF2AK2;ILF3;EIF4ENIF1;EIF3E;SYNCRIP;MALSU1;FTO;METTL3;AGO2;YTHDF1;DAPK1;FXR2;PUM1;CNOT9;LSM14A;SAMD4A;ROCK2;UNK;EIF4E2;TSC1;CAPRIN1;CPEB2;YTHDF3
prerank,positive regulation of signal transduction (GO:0009967),0.4544630968791902,1.134671956775467,0.20520520520520522,0.960499490716176,1.0,48/238,15.70%,EVC;PDE6H;LRRK2;PRKCZ;SMARCA4;TPD52L1;FGF1;SNX5;ITGB1BP1;TGFB2;GAS6;SASH1;IRS1;FLNA;NRP1;PRKCB;EP300;PRKCA;TRAF7;AXL;ZDHHC5;MAML3;MAML2;UCHL5;NPTN;VPS35;LIMS1;CD63;F3;LOXL3;WLS;KAT2B;TRIM44;BMP2K;ERN1;SORL1;TGFBR1;ARMC9;PRKD2;PKD2;RBPJ;RELN;LY86;PTEN;ARNT;PHIP;MACF1;PIK3R1
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.5053550158242839,1.134660726247761,0.31912302070645554,0.9595783199166944,1.0,7/29,7.94%,COG1;GOSR2;COPB2;NAPG;COG3;TRAPPC3;RAB6A
prerank,vacuolar acidification (GO:0007035),-0.3934258814476024,-1.1344368748270406,0.2610619469026549,0.9734150191281156,1.0,7/21,7.65%,ATP6V0A1;GRN;PPT1;SLC11A1;CLN3;ATP6AP2;DMXL2
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.5869842406717578,1.134346649365007,0.35555555555555557,0.9597853678375282,1.0,2/11,4.60%,RIN3;PADI2
prerank,positive regulation of cell differentiation (GO:0045597),0.45365417393393703,1.1343371450028106,0.1991991991991992,0.9588524138825171,1.0,37/237,12.97%,ISL1;WNT4;RGCC;IGFBP3;DDR2;CD36;IMPACT;TGFB2;OLFM1;BMPR1A;AR;RAP1A;NELL1;SMAD3;KITLG;CTNNA1;LRP5;CMKLR1;SDCBP;ACVR1;BEND6;MEF2A;EZH2;TRPM4;IL18;DAB2;CDS1;PPARG;CDC42;TGFBR2;SOX11;MTOR;ABL1;ZFP36L1;MAPK14;SOX6;TGFBR1
prerank,V(D)J recombination (GO:0033151),0.579099183621754,1.1339433756676838,0.3288888888888889,0.9593361951549603,1.0,3/11,12.01%,XRCC4;PRKDC;HMGB1
prerank,amino sugar biosynthetic process (GO:0046349),-0.47996243553080253,-1.1339264753273288,0.32407407407407407,0.9706175537089906,1.0,7/12,27.98%,RENBP;NAGK;GFPT1;AMDHD2;GNPDA1;UAP1L1;PGM3
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.5547982883616513,1.1336299562660959,0.30659767141009053,0.9595408181646621,1.0,6/16,13.42%,SMG6;TERF2;HNRNPA2B1;ERCC4;TNKS2;TERF1
prerank,phosphatidylinositol-mediated signaling (GO:0048015),-0.30171148483602417,-1.1336136226101985,0.2033898305084746,0.9670671301024141,1.0,21/69,13.71%,PLCL1;RHOA;PIK3R5;NYAP2;PLEKHA1;PIK3CG;SIRT2;PI4KB;PLCL2;EXOC1;CSF1R;PIK3CA;PIK3C3;GAB2;MYO16;PTAFR;PIK3C2B;IGF1;PLCB2;PLCE1;AKT1
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.3899175797901812,-1.1336108991324174,0.275,0.9623953082178613,1.0,9/19,28.15%,PRKCE;RAB11FIP2;ITGB2;IRAK1;LY96;NMI;ITGAM;TIRAP;TICAM2
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.4577967205904278,1.1335085131537357,0.28958333333333336,0.9590216445324289,1.0,28/80,17.03%,LMAN1;GOSR2;SNX5;VAMP3;EVI5;TMED9;TBC1D17;DCTN1;RAB6A;SNX3;TBC1D14;VPS35;STX16;TBC1D10B;HEATR5A;SNX1;SNX8;ANKFY1;TBC1D5;TBC1D10A;GGA1;RAB7A;RAB7B;CLTC;VTI1A;VPS53;TBC1D23;GCC2
prerank,transcription by RNA polymerase III (GO:0006383),0.5142011744775651,1.133227740018422,0.3213399503722084,0.9591332880676937,1.0,8/27,15.12%,SNAPC5;POLR3G;GTF3A;POLR3H;CRCP;BRF1;IVNS1ABP;SNAPC3
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.4553650146277833,1.133036534531346,0.26262626262626265,0.9589520565199694,1.0,19/117,14.41%,RXFP1;ADCY8;ADCY3;PRKAR2A;ADCY5;PRKACA;YES1;ADCY9;LYN;FURIN;RAMP1;MAPK14;SYK;FYN;CYSLTR1;CALCRL;CREB1;GNG2;GNB1
prerank,negative regulation of response to external stimulus (GO:0032102),0.45804614711882774,1.1328707010071055,0.2953846153846154,0.9586275528128021,1.0,11/105,10.06%,ISL1;RORA;DUSP3;TNFAIP8L2;FEM1A;ILRUN;ALOX5;VPS35;PPARG;PROC;MAPKBP1
prerank,axon development (GO:0061564),0.46346796293933823,1.132555710956597,0.2917547568710359,0.9588227036360529,1.0,15/78,13.41%,ISL1;VASH2;NREP;LLGL1;MAP1A;EPHB2;S100A6;MAPT;MTR;CDK5;ARHGAP35;GRM7;GAP43;RTN4;S100B
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.45402288643375033,1.1323681622458452,0.24596774193548387,0.9585213407246261,1.0,27/146,12.95%,TUBB4B;PLK1;CETN2;ALMS1;MAPRE1;PSMD9;AKAP9;CEP250;YWHAE;PSMB8;PRKACA;CDK2;PCNT;HSP90AA1;PSMC5;DCTN1;TUBA1A;DCTN2;MECP2;CCP110;ODF2;CEP152;CNTRL;RAD51B;VPS4B;PSMD12;PSMA2
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.5898433936859051,1.131830821554727,0.3582089552238806,0.9595998157538266,1.0,5/12,15.70%,BCL2L11;PTPN1;ERN1;ATF6;PIK3R1
prerank,peptidyl-threonine modification (GO:0018210),0.46677209970799555,1.131012302328009,0.289247311827957,0.9617739797760912,1.0,19/66,14.30%,LRRK2;DYRK2;GALNT1;PRKCA;PRKDC;MAPK1;ACVR1;GALNT3;CDC42BPB;MAPK8;CAMK2D;CDK5;GALNTL6;TGFBR2;HIPK2;TGFBR1;ACVR1B;PRKD2;ROCK2
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.3646631543178426,-1.13065753071109,0.23728813559322035,0.9687518594640817,1.0,11/27,15.93%,IL1RAPL1;DISC1;NTNG1;FCGR2B;GSK3B;FBXO7;ULK4;CCDC88A;MARK1;AKT1;MBOAT1
prerank,DNA replication checkpoint signaling (GO:0000076),-0.42745604274437027,-1.1303458606357275,0.29965156794425085,0.9653487029355946,1.0,10/16,43.13%,DNA2;NAE1;TOPBP1;TIPIN;RAD9B;RAD9A;HUS1;CLSPN;TIMELESS;ORC1
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.4597761210096783,-1.129512303898812,0.3233333333333333,0.9636432646073949,1.0,6/13,27.39%,JAK2;CANX;JAK1;STAT3;OAS2;IL6ST
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.5504702198710818,1.1291943004719016,0.3247978436657682,0.9676111238312097,1.0,11/18,16.52%,MSN;MAPK1;EZR;SNX3;DAB2;PTPN23;VPS11;MAP2K2;DNAJC13;MAP2K1;RDX
prerank,positive regulation of protein import into nucleus (GO:0042307),0.5068420223362062,1.12912668309526,0.33767772511848343,0.9668870713769981,1.0,7/28,12.71%,DMAP1;BAG3;FLNA;SMAD3;MAVS;IPO5;UBR5
prerank,positive regulation of ossification (GO:0045778),0.4836755065556036,1.129101611526059,0.32781065088757394,0.9660167565444111,1.0,7/39,11.42%,WNT4;TGFB2;BMPR1A;NELL1;ACVR1;ALOX5;SOX11
prerank,pre-miRNA processing (GO:0031054),0.5669498358769842,1.1289252808309087,0.33884297520661155,0.9657141088248741,1.0,5/14,11.02%,TUT4;AGO2;LIN28B;ADAR;PRKRA
prerank,negative regulation of phosphorylation (GO:0042326),0.45812639601087274,1.128815628786171,0.2939330543933054,0.9651859047484078,1.0,14/85,9.65%,LRRK2;IGFBP3;CDK5RAP3;PID1;NUPR1;IMPACT;TARDBP;NIBAN1;EPHB2;PRKDC;IRS2;MAPT;NCOR1;LYN
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.518713734235914,1.1288056713437686,0.33676092544987146,0.9642684069908594,1.0,6/25,14.85%,CD36;SMAD3;HSP90AA1;INSR;PKD2;TLR4
prerank,indolalkylamine catabolic process (GO:0046218),-0.49501335998287493,-1.1287575903677862,0.32558139534883723,0.9620145759220179,1.0,5/10,44.12%,KYNU;KYAT1;HAAO;KMO;IL4I1
prerank,renal absorption (GO:0070293),-0.4898629811560798,-1.1284973811507746,0.32664756446991405,0.95851476822326,1.0,3/10,19.53%,SGK1;SLC15A2;KLHL3
prerank,cell-matrix adhesion (GO:0007160),0.45972600606562014,1.1279829654357196,0.29835390946502055,0.9664108663358919,1.0,14/95,9.92%,ADAMTS12;DDR1;VCL;ADAM15;ITGB1BP1;ITGBL1;SIGLEC1;PPFIA1;ITGA4;ITGB5;FERMT3;ITGB8;CD44;CD63
prerank,protein phosphorylation (GO:0006468),0.44575026710454446,1.1274959325429033,0.143,0.9672988645357299,1.0,96/479,14.30%,MUSK;SGK3;SGK2;PLK1;DDR1;RSKR;LRRK2;IGFBP3;DDR2;PRKCZ;RPS6KB2;MINK1;EIF2AK1;EIF2AK2;ILF3;GMFB;LIPE;DYRK2;NEK3;CAMK1D;TLR7;BRAF;TGFB2;GAS6;BMPR1A;EPHB2;PIK3R4;MAP3K11;CDK7;PRKCB;PDGFB;PRKCA;PRKACA;CDK2;BTK;PRKDC;STK19;MAPK1;MAP3K20;ABI1;CDK6;ACVR1;STK11;IKBKB;MAP2K6;CDC42BPB;MAPK8;TLR3;PKN2;PAK2;RPS6KA5;CDK9;CAMK2D;MAP3K9;CSNK1G1;MAST2;PPP4R1;BIRC6;GRK5;DAPK1;CHEK2;BRD2;NEK7;CTBP1;LYN;CDK5;MAST3;TAOK1;TGFBR2;IGF1R;ULK2;BMP2K;MTOR;ABL1;ERN1;CDKL5;MAPK14;ADAM10;SRPK2;HIPK2;MAPKAPK2;TGFBR1;NRBP1;MAST4;ACVR1B;CDK8;SYK;INSR;GTF2H1;CAMKK2;FYN;PRKD2;CSNK1A1;CREB1;RELN;ROCK2
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.5648635610906749,1.127467788194247,0.3454810495626822,0.9664463574125599,1.0,3/13,11.73%,PID1;ENO1;TMSB4X
prerank,mesenchymal cell development (GO:0014031),0.5407613494326299,1.127334486960057,0.34993270524899056,0.9659903560150496,1.0,3/18,11.42%,TAPT1;PEF1;SOX11
prerank,pseudouridine synthesis (GO:0001522),-0.4597499715823467,-1.1272617076509952,0.3161512027491409,0.9583358136987606,1.0,7/13,35.40%,PUS7;TRUB2;TRUB1;DKC1;PUS1;GAR1;PUS3
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.4821236753806951,1.1272604290810486,0.31185270425776757,0.9653074179508534,1.0,7/41,8.68%,EIF6;PGAM1;ZBTB7A;NUP205;EP300;NUP98;NUP54
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.44044492292559956,-1.1271033749684953,0.33088235294117646,0.9498754848283992,1.0,5/15,6.69%,CPEB3;CNOT1;TNRC6C;PABPC1;CNOT7
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.44044492292559956,-1.1271033749684953,0.33088235294117646,0.9498754848283992,1.0,5/15,6.69%,CPEB3;CNOT1;TNRC6C;PABPC1;CNOT7
prerank,DNA biosynthetic process (GO:0071897),0.552571673279562,1.1270616938018307,0.3379501385041551,0.9651361857587315,1.0,3/16,6.62%,POLA1;WRN;POLD3
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.46201496997109304,-1.1264980028553777,0.3416149068322981,0.9475873263971958,1.0,7/12,42.51%,SMO;VEGFA;PAX8;PAX2;SOX8;AGT;SOX9
prerank,positive regulation of macrophage migration (GO:1905523),0.5344305883474508,1.1261929649687288,0.34615384615384615,0.9675436641319561,1.0,4/19,5.62%,CX3CL1;THBS1;CMKLR1;MAPK1
prerank,phosphatidylserine metabolic process (GO:0006658),0.5020221607034482,1.1259930047291087,0.3206197854588796,0.9673085325611664,1.0,6/32,12.68%,SERINC5;PTDSS2;PLA2G4A;ABHD16A;SERINC1;SLC27A1
prerank,regulation of activated T cell proliferation (GO:0046006),0.49902038327338594,1.125819284046941,0.33133253301320525,0.9670048791156683,1.0,8/30,18.02%,IGFBP2;IL18;ICOSLG;PRNP;HMGB1;LGALS9;PRKAR1A;RC3H1
prerank,response to calcium ion (GO:0051592),0.45842498228199235,1.1257006578554567,0.28789420142421157,0.966513053289517,1.0,24/102,16.49%,CPNE5;SLC25A24;D2HGDH;ADCY8;PEF1;BRAF;SMPD1;THBS1;MEF2A;NEDD4;SYT12;SYT11;CAMK2D;ADD1;MCOLN1;CARF;PKD2;CALM1;KCNMB2;KCNMB3;IQGAP1;CPNE8;MEF2C;LGMN
prerank,cellular response to UV-A (GO:0071492),0.5931812724296751,1.1256810513399989,0.3724247226624406,0.9656609892649416,1.0,1/11,2.94%,PPID
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.5723106592839243,1.1254872823513513,0.34365781710914456,0.9654565228085243,1.0,2/12,10.93%,ADAMTS12;SEMA6A
prerank,methylguanosine-cap decapping (GO:0110156),0.5866310770159893,1.1249275971151784,0.334855403348554,0.9666247248195161,1.0,5/10,16.15%,PNRC2;DCP1B;DCP1A;DCPS;PATL1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.5850783130451788,1.1247745814156698,0.34299516908212563,0.9662038309083542,1.0,3/10,12.92%,TFAP4;HIPK2;TP53
prerank,Rac protein signal transduction (GO:0016601),0.533827382521403,1.1247268149336815,0.3293333333333333,0.9654368832597553,1.0,10/18,19.04%,WASF1;FARP2;EPS8;DBNL;ELMO1;AIF1;CYFIP1;HACE1;NCKAP1;BRK1
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.5748846930150651,1.124545417132806,0.34632683658170915,0.9651857683665531,1.0,5/12,15.59%,AR;AP2A1;CLTC;TMEFF2;HDAC2
prerank,limb morphogenesis (GO:0035108),0.5374143243110071,1.1245023286536446,0.33034571062740076,0.9644093946543799,1.0,6/20,17.13%,TGFB2;MBNL1;IQCE;LRP6;FBXW4;PCSK5
prerank,arachidonic acid secretion (GO:0050482),-0.4893848728781438,-1.1236611308772428,0.3259668508287293,0.9487703445806535,1.0,1/10,2.89%,PNPLA8
prerank,arachidonate transport (GO:1903963),-0.4893848728781438,-1.1236611308772428,0.3259668508287293,0.9487703445806535,1.0,1/10,2.89%,PNPLA8
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.5607924612887578,1.1236072374832218,0.3406754772393539,0.9667215301010138,1.0,5/14,12.16%,SAP18;RNPS1;SFSWAP;U2AF2;SRSF9
prerank,positive regulation of tissue remodeling (GO:0034105),0.5801920191625989,1.1235934743297857,0.3569277108433735,0.9658332969777498,1.0,3/10,18.14%,IL18;ROCK2;ROCK1
prerank,excitatory postsynaptic potential (GO:0060079),0.5394719535968948,1.1235726550262202,0.32808398950131235,0.9649833800304957,1.0,6/19,16.27%,LRRK2;RAB3GAP1;ARRB2;GRIN2A;GRID2;MEF2C
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.5042582570259042,1.1235299078252539,0.33456334563345635,0.9642190986642365,1.0,9/25,17.53%,ANKRD54;PRKDC;TAL1;MAPK14;ACVR1B;ARNT;FOXO3;NCKAP1L;MED1
prerank,RNA splicing (GO:0008380),0.4624557045924653,1.1234700342196282,0.3,0.963513550739635,1.0,28/95,16.08%,SNRPD2;SNRPD1;SYNCRIP;BCAS2;TARDBP;MBNL1;RNPS1;PRPF3;GEMIN2;U2AF1;SNRPN;PRPF6;SNRPD3;SCAF11;FUS;DDX23;DHX16;SF3B2;SRSF11;SRPK2;DHX8;HNRNPH3;SF3B4;IVNS1ABP;RP9;HNRNPC;PPP1R9B;DHX15
prerank,regulation of GTPase activity (GO:0043087),0.44867069255911046,1.1232748373769557,0.24723618090452262,0.963281768736909,1.0,47/177,17.18%,PLXNA1;LRRK2;FGD6;CX3CL1;RAPGEF1;FGD3;DOCK8;FGD1;ITGA6;NDEL1;ITGB1BP1;RAB3GAP1;RSU1;NF1;TBC1D15;RAP1A;EVI5;VAV3;ARFGEF1;CCL25;RRP1B;EZH2;LIMS1;TBC1D10B;RAP1GDS1;EPHA5;LRCH1;TMED2;OCRL;CDKL5;VAV2;RABGAP1;ARHGAP15;PLXNC1;DOCK9;DOCK11;LARS1;PKP4;VAV1;SNX13;MAP4K4;RDX;CPEB2;DOCK10;SNX9;RALBP1;RAPGEF2
prerank,NAD biosynthetic process (GO:0009435),0.5319516476700775,1.1231977911020636,0.3390957446808511,0.9626129701875514,1.0,2/20,5.28%,PARP9;NMNAT3
prerank,regulation of lipid biosynthetic process (GO:0046890),0.504858700188686,1.1230984458711064,0.3349339735894358,0.9620586581143543,1.0,6/32,14.01%,EIF6;ASAH1;NR5A1;MTOR;ADIPOR1;CREB1
prerank,mitochondrion distribution (GO:0048311),0.581401310945182,1.1230907443643463,0.36403508771929827,0.9611592626854389,1.0,3/12,7.60%,LRRK2;MEF2A;MAPT
prerank,monosaccharide transmembrane transport (GO:0015749),-0.4332194338809235,-1.1229235546766532,0.3023255813953488,0.9471648299212567,1.0,6/16,44.82%,SLC2A9;SLC5A3;SLC50A1;SLC2A8;SLC2A6;SLC45A3
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.5812604364989031,1.1228304835746445,0.35135135135135137,0.961150701591094,1.0,2/12,8.39%,GJD3;CAMK2D
prerank,folic acid metabolic process (GO:0046655),0.5370699002246683,1.1227242272384734,0.34506089309878213,0.9606200029767127,1.0,4/18,12.20%,ALDH1L1;MTHFD2L;MTHFR;SLC25A32
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.5861767389574108,1.1221916849374245,0.3548872180451128,0.961692542477543,1.0,5/11,16.80%,ABCB7;ABCD2;ABCD1;FYN;COA8
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.5718918208079676,1.1221150339331138,0.34873323397913564,0.9610555644699178,1.0,4/12,11.85%,ESR1;NCOR1;PPARG;NCOR2
prerank,negative regulation of cellular component movement (GO:0051271),-0.43469343806714994,-1.1217630187824517,0.3125,0.946856391069018,1.0,9/15,42.81%,CD9;TGFBR3;ACTN1;FRMD5;WAS;CRK;PIN1;CCDC125;SP100
prerank,regulation of supramolecular fiber organization (GO:1902903),0.5177422481311361,1.121366264407168,0.3541927409261577,0.9628586574510476,1.0,6/22,11.90%,GBA2;MAP1A;CAMSAP3;MAPT;AKAP13;ABL1
prerank,regulation of osteoblast differentiation (GO:0045667),0.45766600685920117,1.121281786254079,0.3037578288100209,0.9622364486732718,1.0,12/82,9.43%,WNT4;DDR2;SMAD6;BMPR1A;NELL1;PRKACA;CRIM1;LRP5;CDK6;ACVR1;TRPM4;PPARG
prerank,regulation of viral genome replication (GO:0045069),0.469357623780837,1.1206987239778803,0.30339539978094193,0.9634225110199206,1.0,10/56,14.05%,BANF1;IFITM3;EIF2AK2;ILF3;PPID;PKN2;MAVS;ADAR;SRPK2;TMEM39A
prerank,regulation of peptide hormone secretion (GO:0090276),0.4654501169998325,1.1206135555746397,0.31663113006396587,0.9628068074624381,1.0,13/67,15.04%,EIPR1;CLOCK;CACNA1D;RAP1A;PRKCA;ALOX5;RAPGEF4;CHD7;CACNA1A;GCK;RFX3;CACNA1C;ENSA
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.4506263995806853,1.1205524505954718,0.2737373737373737,0.9621084343597748,1.0,19/116,14.41%,RXFP1;ADCY8;ADCY3;PRKAR2A;ADCY5;PRKACA;YES1;ADCY9;LYN;FURIN;RAMP1;MAPK14;SYK;FYN;CYSLTR1;CALCRL;CREB1;GNG2;GNB1
prerank,peptidyl-methionine modification (GO:0018206),0.5730438406281316,1.1203193746507882,0.3417910447761194,0.9620259913373278,1.0,4/12,13.16%,METAP1;NAA25;NAA16;NAA15
prerank,nucleotide-excision repair (GO:0006289),0.4543689704867684,1.119821156358294,0.30578512396694213,0.9629323542518864,1.0,21/101,14.70%,POLR2D;CETN2;RFC2;POLR2A;CDK7;POLA1;EP300;COPS7B;POLD3;POLB;BRCA2;MNAT1;ERCC4;COPS4;CUL4A;TP53;UVSSA;GTF2H1;ATXN3;USP45;RAD23B
prerank,negative regulation of mRNA processing (GO:0050686),0.5493397187662366,1.1196636377676459,0.3467048710601719,0.9626013849645394,1.0,5/15,12.16%,SAP18;RNPS1;SFSWAP;U2AF2;SRSF9
prerank,regulation of translational initiation (GO:0006446),0.4615670211815417,1.119220583043945,0.2988384371700106,0.9633500810567933,1.0,11/63,10.49%,POLR2D;HABP4;RPS6KB2;EIF3E;IMPACT;CSDE1;EIF4B;AGO2;NCK1;YTHDF1;EIF1
prerank,inositol lipid-mediated signaling (GO:0048017),-0.3132553507935025,-1.1187779110929117,0.25287356321839083,0.9529299975845235,1.0,15/50,12.55%,PLCL1;RHOA;PIK3CG;PI4KB;PLCL2;EXOC1;CSF1R;PIK3CA;PIK3C3;GAB2;PTAFR;PIK3C2B;IGF1;PLCB2;PLCE1
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.44817788359466737,1.1187272387267697,0.24647887323943662,0.964210881080853,1.0,45/190,15.09%,RORA;CGNL1;URI1;UACA;RIOK3;DUSP3;RELA;IFI35;NF1;THBS1;PTPRJ;ESR1;ARRB2;EPM2A;PDE3B;RNF34;TLE1;GPD1L;ABCA7;PHLPP1;FNIP1;LYN;MAPKBP1;DGKD;CD2AP;RNF157;NOC2L;TANK;CYRIB;ZMYND11;TMSB4X;PPM1A;BANK1;MAPK14;CYLD;SH2B3;BCL2;SPRED1;ADIPOR1;TRIM59;PPP2R5C;PTEN;TSC1;OTUD7A;DAG1
prerank,negative regulation of interleukin-1 production (GO:0032692),0.5108161466666326,1.118379648556568,0.35145385587863465,0.9645388237819947,1.0,3/23,7.52%,CX3CL1;GAS6;PYDC1
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.43656114884323727,-1.1180464296198493,0.3344370860927152,0.9512986506818147,1.0,3/13,10.46%,ENPP1;TPST1;BPNT2
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.44533239954305126,1.117954481245052,0.138,0.9651537797502289,1.0,112/572,15.19%,ISL1;GLIS1;PLK1;MDFI;WFS1;DNAJB1;URI1;SIRT7;HSBP1;PARP9;KDM1B;THAP7;DMAP1;RELA;SMARCA4;CTR9;SUV39H1;VPS72;BAG3;ZFP90;SOX13;PPID;ZBTB5;IMPACT;TGIF1;ZEB2;RUNX1;MAX;HCFC1;IGBP1;JUN;AR;ATXN1;ZBTB7A;BCL6;HDAC9;TRPS1;N4BP2L2;EP300;SMAD3;SPEN;ARID5B;PDGFB;DPF2;ESR1;HDAC5;SDCBP;NR3C1;EHMT2;EZR;NCOA5;MEF2A;MLIP;NEDD4;DLG1;MECP2;CUX1;EZH2;DAB2;NCOR1;FNIP1;PHF6;ORC2;PPARG;MTDH;NR6A1;SIN3B;CTBP1;HMBOX1;ENO1;DEAF1;HIVEP1;UBE2I;NOC2L;ZNF568;CHD8;NR2C2;SOX11;BCL11A;MAP2K5;PRDM1;PPM1A;NCOR2;DNMT3A;YEATS2;HMGB1;ZFP69;DNAJA3;TCF7L2;MIER3;TP53;ATRX;NR1D2;MYT1L;LCOR;RXRA;EPC1;NFX1;WWOX;DDX5;KCNIP3;RREB1;RBPJ;PPARD;ZMYM5;TBL1XR1;UBE2D3;LDB2;LDB1;CTCF;SMAD4;ZBTB18
prerank,ERAD pathway (GO:0036503),0.4554632315240401,1.1177059899395267,0.31879543094496365,0.9651435007843545,1.0,14/83,8.19%,WFS1;MAN1B1;FBXO17;TMEM67;DNAJC18;UGGT2;UBXN4;USP19;UBQLN1;POMT2;UBE2J2;RHBDD2;ERLEC1;ECPAS
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.4722419834507556,1.1173449311325512,0.3232662192393736,0.965518928789475,1.0,14/46,15.70%,DMAP1;BAG3;GAS6;FLNA;YWHAE;SMAD3;NEDD4;MAVS;IPO5;TCF7L2;UBR5;TP53;ANP32B;PIK3R1
prerank,regulation of Notch signaling pathway (GO:0008593),0.4552322989998716,1.1173403655037593,0.3216931216931217,0.9646179286708845,1.0,11/76,6.97%,LLGL2;FBXW7;ITGB1BP1;LLGL1;TGFB2;ZBTB7A;EP300;METTL3;MAML3;BEND6;MAML2
prerank,endodermal cell differentiation (GO:0035987),0.49635066029117475,1.1170778495028657,0.34149326805385555,0.9647017713746528,1.0,5/31,7.49%,CTR9;ITGA4;ITGB5;COL11A1;SETD2
prerank,regulation of necroptotic process (GO:0060544),0.5168849730207798,1.1167621897823805,0.3436293436293436,0.9649753441121686,1.0,9/23,16.32%,FLOT2;PELI1;SDCBP;BIRC3;HSP90AA1;CYLD;PDCD6IP;FZD9;CFLAR
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.5481253285631638,1.1166807010432063,0.36560693641618497,0.9643460784537449,1.0,5/15,16.49%,FGF1;THBS1;TMSB4X;PRKD2;LGMN
prerank,positive regulation of bone mineralization (GO:0030501),0.481774325125756,1.1163857844717175,0.3376932223543401,0.9645482766717713,1.0,5/35,8.48%,WNT4;BMPR1A;NELL1;ACVR1;ALOX5
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.4927165648407149,1.11618697030804,0.33490011750881316,0.9643579333005818,1.0,5/35,8.48%,GGTA1;HPGD;ACAT1;FAR1;ALOX5
prerank,cellular response to purine-containing compound (GO:0071415),-0.4828679415381093,-1.1161487594581563,0.3488372093023256,0.9538420342275933,1.0,1/10,0.51%,RYR2
prerank,protein methylation (GO:0006479),0.47133814922615036,1.1159783056694965,0.3409090909090909,0.9641468216467997,1.0,8/40,9.48%,EHMT1;FAM98A;ETF1;EHMT2;RAB6A;SETD3;EZH2;SNRPD3
prerank,androgen receptor signaling pathway (GO:0030521),0.5791085747974885,1.115611296465089,0.35435435435435436,0.9646354902982137,1.0,3/11,6.72%,PMEPA1;AR;KDM3A
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.5648626885890272,1.1154484259765263,0.36324167872648333,0.9643449609865288,1.0,3/14,8.09%,NUDT5;NUDT9;ENTPD1
prerank,cognition (GO:0050890),0.47953669756887085,1.1152507140383632,0.3352272727272727,0.964128709600427,1.0,4/42,4.01%,MGAT3;C5AR1;BBS4;NF1
prerank,negative regulation of protein modification process (GO:0031400),0.4510652695148531,1.1151519942503816,0.3130252100840336,0.9635856788211933,1.0,12/79,7.60%,CRTAP;LRRK2;IGFBP3;CDK5RAP3;PID1;IMPACT;TARDBP;NIBAN1;EPHB2;PRKDC;PPP1R8;MAPT
prerank,regulation of lamellipodium organization (GO:1902743),0.5553463380913602,1.1149243996979163,0.35694444444444445,0.9635387603633482,1.0,4/14,10.69%,CAPZB;TWF2;CD44;CDC42
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.512834016635354,1.114779742425357,0.3518987341772152,0.9631729959346236,1.0,3/24,2.33%,WFS1;LRRK2;UBXN1
prerank,regulation of cholesterol storage (GO:0010885),0.5530939361991551,1.114774606223953,0.3631361760660248,0.9622937087356287,1.0,6/15,14.37%,EHD1;TTC39B;PPARG;ABCG1;ABCA1;PPARD
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.4808722800370986,1.1147461409044632,0.3325842696629214,0.9615180447368888,1.0,13/42,18.14%,CD36;CX3CL1;NRP1;PTPRJ;CDK6;CCL25;LIMS1;ABL1;TSC1;MAP4K4;RIN2;UTRN;ROCK1
prerank,regulation of gene expression (GO:0010468),0.4432963728500908,1.1142897108627825,0.08,0.9623645074224944,1.0,149/903,14.30%,MUSK;FGF22;ACE2;FGF18;WNT4;RGCC;BRCA1;C1D;ACTR5;RORA;ZNHIT3;PARP9;ELAVL2;THAP7;CD36;RELA;FBXW7;DVL1;SP1;CTR9;PID1;GLMN;FGF1;FLOT2;CASZ1;SOX13;FAM98A;RLIM;CLOCK;BRAF;RUNX1;TGFB2;GAS6;HCFC1;OLFM1;TARDBP;MSN;BMPR1A;POLR2A;RBMS3;MBNL1;EPHB2;MYCBP;AR;ATXN1;PRDM10;BCL6;NELL1;EP300;SMAD3;TERF2;PDGFB;CDK2;RBAK;MAPK1;SLC38A2;PUM2;TNRC6B;ESR1;SPTY2D1;HDAC5;NR3C1;CDK6;IL1A;BRCA2;PRDM4;EZR;TLE1;PTBP3;RRP1B;HP1BP3;MAPT;MAPK8;MECP2;TLR3;ZBTB11;AGO2;RPS6KA5;EZH2;ITGB8;VPS35;JMJD1C;KRAS;LIMS1;CHD7;SNRNP70;CHEK2;ICOSLG;PUM1;DTNBP1;ADNP2;PTP4A3;ASCC2;MBNL2;LYN;FUS;FADS1;HGS;F3;ZC3H7A;AFF2;TRIM5;TULP3;FOXN3;NFKBIZ;NR5A1;NOTCH2;ZNF711;PSPC1;NR2C2;SOX11;TRIM44;ZBTB38;MTOR;AFF1;PRDM1;ABL1;ZFP36L1;GPBP1;MAPK14;ERP29;SOX6;ADAM10;UBR5;SRPK2;TP53;ATRX;TGFBR1;RNF20;NR1D2;MAP2K2;ACVR1B;HNRNPH3;FUBP3;PPARGC1B;NFX1;NDFIP1;COQ7;CLK1;FN1;HNRNPH1;INSR;RREB1;PCBP3;LGALS9;NSD2;RFX3;RBPJ;ROCK2
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.430901285572921,-1.1142879610845393,0.3416370106761566,0.9560243755311659,1.0,7/15,20.79%,PLCG2;KLHL18;CUL3;STXBP4;DDRGK1;ATAD5;CDC73
prerank,erythrocyte differentiation (GO:0030218),0.47053744696555483,1.1141172070259426,0.3186936936936937,0.9621096507611826,1.0,11/44,12.99%,CDK5RAP3;UBA5;IKZF1;KMT2E;HSPA9;ACIN1;LYN;TAL1;HIPK2;SH2B3;FLVCR1
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.4530877155652372,-1.1140535165295526,0.3501683501683502,0.9525504925650065,1.0,2/13,1.34%,PDE4D;CALM2
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.5145683615754131,1.1138940892824991,0.3620457604306864,0.9620063897810993,1.0,4/20,8.44%,YWHAE;NEDD4;CAMK2D;HECW1
prerank,regulation of ERAD pathway (GO:1904292),0.5818507810481475,1.1138857311878714,0.3712121212121212,0.961137970094938,1.0,3/11,6.98%,UBXN1;USP19;TMEM259
prerank,regulation of transferase activity (GO:0051338),0.5400650934007386,1.1136339965784283,0.3663101604278075,0.9611648242249691,1.0,7/17,17.17%,SMG6;FEM1A;HMBOX1;PARP4;LDB2;LDB1;ATM
prerank,macromolecule catabolic process (GO:0009057),0.5006283453637481,1.1133256868819035,0.35471698113207545,0.9614086758396398,1.0,9/26,12.70%,USE1;UCHL3;PIK3R4;CLPX;NEDD4;KIF16B;MTOR;UVRAG;SH3GLB1
prerank,positive regulation of protein export from nucleus (GO:0046827),0.5407600216379245,1.113062494784488,0.36146272855133615,0.9614541678363959,1.0,6/15,14.94%,BAG3;GAS6;YWHAE;TCF7L2;TP53;ANP32B
prerank,cardiolipin metabolic process (GO:0032048),0.5742633719606047,1.1129925699788326,0.36755952380952384,0.96080990540193,1.0,5/13,12.68%,PLA2G6;CRLS1;PLA2G4A;LCLAT1;SLC27A1
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.5595417750843494,1.1128659456583374,0.35674931129476584,0.9603776088508219,1.0,4/13,8.50%,MAP1A;GPD1L;STX3;ABCA7
prerank,cobalamin metabolic process (GO:0009235),0.542458679122676,1.1128020552735889,0.34776725304465494,0.9597242006497512,1.0,3/17,9.04%,MMADHC;LMBRD1;MTR
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.4497432084547794,1.112784284143964,0.3004073319755601,0.9588993516045098,1.0,17/110,5.94%,RPL18;EIF4A3;RPS23;RPL41;RPL31;SMG6;RPS17;EIF3E;RPL4;PNRC2;RNPS1;PYM1;PPP2R2A;RPLP0;ETF1;RPS15A;RPL38
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.48394085871987397,1.1127282166935355,0.3449074074074074,0.9581966719321252,1.0,10/41,14.25%,FBXW7;GAS6;AREG;PDGFB;PTPN1;LRP8;PRNP;TGFA;FYN;RELN
prerank,regulation of response to oxidative stress (GO:1902882),0.5876168963932424,1.1127011355283605,0.36459909228441756,0.9573992351455654,1.0,3/11,12.94%,SELENON;ALOX5;ABCD1
prerank,organonitrogen compound catabolic process (GO:1901565),0.45777711078958455,1.1126986854155145,0.32641921397379914,0.9565270602845662,1.0,12/57,12.65%,PLA2G7;USE1;UCHL3;PLA2G6;CLPX;PLA2G4A;LNPEP;PDXDC1;NPL;MTOR;SGPL1;ERAP1
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.4917941190809172,1.1126584314796473,0.34834123222748814,0.9557918440156271,1.0,4/31,6.70%,TIMM17A;TOMM40;DNAJC15;TIMM23
prerank,cellular biogenic amine catabolic process (GO:0042402),0.5801059198058217,1.1120817729224637,0.34169278996865204,0.9569868770735086,1.0,3/10,15.17%,ALDH7A1;SMOX;SLC44A1
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.5671174586896668,1.1117491940687114,0.3598130841121495,0.9573109134472555,1.0,3/11,12.92%,TFAP4;HIPK2;TP53
prerank,positive regulation of apoptotic process (GO:0043065),0.44492597577169735,1.1116371607526225,0.214,0.9568432147387738,1.0,56/293,12.97%,IGFBP3;UBE2Z;ARHGEF3;TPD52L1;NUPR1;FGD3;TFAP4;FGD1;PLEKHG2;PPID;ITGA6;PLEKHG5;SAP18;TGFB2;SMPD1;BCL2L11;ITSN1;OLFM1;MTCH1;NF1;JUN;BCL6;RNPS1;TNFAIP8;ARHGEF12;MAP3K11;APAF1;CTNNBL1;SQSTM1;TRAF7;VAV3;MAP3K20;RBM5;ING3;RRP1B;MAPK8;BNIP3L;DAPK1;FAF1;KALRN;APC;CDK5;AKAP13;BNIP3;PRNP;ARHGEF17;ABL1;HMGB1;AIFM1;VAV2;RPS6;ATF6;SRPK2;MLLT11;TP53;TGFBR1
prerank,zinc ion transport (GO:0006829),0.5140790958770582,1.1115898848886197,0.34260429835651074,0.9561403726092875,1.0,2/21,3.50%,SLC30A6;SLC39A11
prerank,secondary palate development (GO:0062009),0.5552811910706834,1.1114586947039062,0.35479041916167664,0.9557298059715453,1.0,4/14,15.19%,TGFB2;CHD7;TGFBR2;SMAD4
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.4534211692126524,1.111286675084924,0.3044838373305527,0.9554181443313611,1.0,21/84,16.03%,EIF4A3;CNOT10;EIF2AK2;ILF3;EIF4ENIF1;SYNCRIP;MALSU1;RTN3;ABCA7;DAPK1;FXR2;CNOT9;PRNP;LSM14A;SORL1;SAMD4A;RTN4;EIF4E2;TSC1;CAPRIN1;GGA3
prerank,folic acid-containing compound metabolic process (GO:0006760),0.5240323189831362,1.110042099562209,0.33378196500672946,0.9589240773781559,1.0,4/19,12.20%,ALDH1L1;MTHFD2L;MTHFR;SLC25A32
prerank,tetrapyrrole metabolic process (GO:0033013),0.5380900323148284,1.1100397125167927,0.3421750663129973,0.9580586116177289,1.0,3/18,9.04%,MMADHC;LMBRD1;MTR
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.4523669147701113,1.1100397022868356,0.3154158215010142,0.9571844705487345,1.0,11/107,10.61%,CXCL12;SLC24A5;NPTN;MT1F;MT1M;MT1H;MT1X;MT1A;MT1E;MT1G;MT1B
prerank,regulation of ATP biosynthetic process (GO:2001169),0.5401243785391683,1.1098094826707912,0.35205479452054794,0.957169732339352,1.0,4/16,11.73%,AK4;PID1;ENO1;TMSB4X
prerank,cellular metal ion homeostasis (GO:0006875),0.45378457814032874,1.1096013967899678,0.3125,0.9570526615063932,1.0,6/102,8.63%,CXCL12;SLC24A5;SLC9A1;LETM1;LETM2;NPTN
prerank,positive regulation of ion transport (GO:0043270),0.47214889331648136,1.1095096414964791,0.3377630121816168,0.9565034960537735,1.0,6/48,7.63%,WFS1;VAMP7;CNKSR3;CACNA1D;DLG1;GPD1L
prerank,positive regulation of protein import (GO:1904591),0.49570225206412666,1.1093554839170499,0.3605600933488915,0.9562024028476798,1.0,7/30,12.71%,DMAP1;BAG3;FLNA;SMAD3;MAVS;IPO5;UBR5
prerank,DNA repair (GO:0006281),0.439669054218664,1.1092667391945272,0.23723723723723725,0.9556447991751268,1.0,63/284,15.69%,BRCA1;CETN2;ACTR5;MPG;BLM;PARP9;RFC2;POLE2;RNASEH2A;RAD50;UBXN1;TDP2;XRCC4;RAD18;ASF1A;POLA1;WRN;UBE2V2;DCLRE1A;FTO;PRKDC;UBE2A;POLD3;POLB;BRCA2;MNAT1;PDS5A;RBBP8;MRE11;USP1;SETD2;MAPK8;ERCC4;KMT5B;NBN;PARP2;BABAM2;CHEK2;EXD2;KMT5C;ASCC2;SETX;RFWD3;PARP4;KDM4B;RAD51B;ABL1;UVRAG;USP3;MLH3;TP53;GTF2H1;ATXN3;APEX2;NSD2;USP45;RECQL5;RAD23B;NPM1;ALKBH5;VCPIP1;BAZ1B;TRRAP
prerank,ncRNA catabolic process (GO:0034661),0.49665076018210624,1.1091826144251484,0.34624697336561744,0.9550770815316342,1.0,8/28,14.35%,TUT4;EXOSC5;EXOSC7;XRN1;POP1;LIN28B;RBM7;MTREX
prerank,regulation of interferon-beta production (GO:0032648),0.4619411835063919,1.1091014753719424,0.3393258426966292,0.9544983511033329,1.0,13/46,14.85%,POLR3G;RIOK3;IRF1;TLR7;IRF3;HSP90AA1;TLR3;MAVS;RNF216;POLR3A;TRIM56;RNF135;TLR4
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.4393327372568488,1.1087409672369892,0.2905811623246493,0.954984974943523,1.0,47/173,15.84%,LMAN1;USE1;COG1;ERGIC1;GOSR2;TMED4;VAMP7;PEF1;CTSC;COPB2;GAS6;AREG;COG3;CAPZB;TMED9;DYNLL2;TRAPPC3;KDELR2;DCTN1;DCTN2;DCTN4;SPTBN1;STX17;RAB2A;PROC;BCAP29;CTSZ;TFG;SEC24B;MIA3;SEC24D;TMED2;TRAPPC8;TGFA;NRBP1;TMED5;NAPA;SAR1B;TRAPPC6B;TRIP11;PROS1;ATL2;DYNC1I2;DYNC1LI2;PGAP1;CAPZA1;VTI1A
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.45366664724962136,1.1085318394596346,0.3273495248152059,0.9548114455605039,1.0,11/69,8.19%,WFS1;MAN1B1;FBXO17;TMEM67;DNAJC18;UBXN4;USP19;UBQLN1;UBE2J2;RHBDD2;ECPAS
prerank,epithelium development (GO:0060429),0.4488335126366472,1.108529547344831,0.319672131147541,0.9539573821703954,1.0,12/107,13.91%,WNT4;ALDH1A2;VCL;DVL1;AHI1;PPARG;LOXL3;SOX11;HNRNPH3;NDRG4;PPP2R3A;PKD2
prerank,regulation of cellular response to heat (GO:1900034),0.4540550838934816,1.107873109628632,0.3248136315228967,0.9554418351555597,1.0,15/77,8.68%,DNAJB1;HSBP1;BAG3;HIKESHI;HSPH1;YWHAE;NUP205;EP300;MAPK1;CHORDC1;HSP90AA1;MAPT;NUP98;CAMK2D;NUP54
prerank,cellular response to oxygen levels (GO:0071453),-0.4763398471799797,-1.1076615137704962,0.35962145110410093,0.9706215939422329,1.0,9/10,39.62%,ATP6V1A;CPEB4;ATP6AP1;ATP6V1G1;NDUFS2;TMEM199;PICK1;ATP6V0D1;CCDC115
prerank,cell junction organization (GO:0034330),0.46055604005354733,1.1072153275848446,0.3333333333333333,0.9569180757692163,1.0,12/71,10.69%,SDK2;DVL1;RAB8B;TGFB2;FLNA;PPFIBP2;SMAD3;PPFIA1;MAPT;LIMS1;MYO9A;CDC42
prerank,positive regulation of defense response (GO:0031349),0.4488901132375026,1.1071731209098679,0.33052631578947367,0.9561924853563473,1.0,17/89,15.45%,PLA2G7;POLR3G;RIOK3;CX3CL1;IFI35;IL16;TLR7;FEM1A;AKIRIN2;TLR3;IL18;NFKBIZ;IL17RA;SLC15A4;OPTN;TLR4;CD47
prerank,cartilage development (GO:0051216),0.4662790151003494,1.1069653021174433,0.3538633818589026,0.9560600714228366,1.0,11/49,16.27%,WNT2B;RUNX1;SNX19;ATP7A;ITGB8;CD44;CREB3L2;SOX6;TRIP11;NFIB;MEF2C
prerank,negative regulation of histone methylation (GO:0031061),0.6033027844360105,1.1067341677907883,0.37652439024390244,0.955982155338885,1.0,1/10,0.41%,BRCA1
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.4456924980561508,-1.1067085526234626,0.3380281690140845,0.9697607750842023,1.0,11/14,37.05%,PLCG2;LAPTM5;CAMK4;SIRT1;LILRB1;CD74;BCL10;GPRC5B;KIT;SEMA7A;TICAM1
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.4416556529911663,1.1063454587010695,0.262,0.9565356122965453,1.0,49/234,15.24%,RGCC;TNFRSF11A;DDR2;PRKCZ;CD36;RELA;CX3CL1;SMARCA4;EIF2AK2;ADCY8;FLOT2;RNF31;CLOCK;CAMK1D;AR;ZBTB7A;PRKCB;EP300;SMAD3;ARID5B;BTK;BUD31;ESR1;HDAC5;CRTC1;IKBKB;RPS6KA5;IL1RAP;IL18;IRAK2;TAB3;LRP8;MAVS;PPARG;MTDH;EPHA5;TRIM5;TRAF2;HIPK2;LRP6;PPARGC1B;PRKD2;LGALS9;RELN;RAB7B;PTEN;TLR4;TRIM26;NPM1
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.38570974430303323,-1.1061877183730602,0.32524271844660196,0.9675498825773824,1.0,10/19,32.41%,PRDX1;ACOX1;CYBA;CAT;SOD1;NOX1;PRDX2;PRDX3;PARK7;GPX1
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.4420084252470873,1.1061026004497574,0.2858575727181545,0.9565308489350539,1.0,34/168,12.28%,POLR2D;RPL18;EIF4A3;CNOT10;RPS23;RPL41;RPL31;SMG6;RPS17;EIF3E;TUT4;CSDE1;RPL4;PNRC2;RNPS1;PYM1;PPP2R2A;EXOSC5;RPLP0;DCP1B;ETF1;RPS15A;RPL38;RC3H2;EXOSC7;XRN1;CNOT9;XRN2;DCP1A;CNOT3;DCPS;ZFP36L1;RPL21;RPS6
prerank,positive regulation of inflammatory response (GO:0050729),0.4488950881370947,1.1060496561527995,0.32778355879292403,0.9558538044160726,1.0,12/86,11.88%,PLA2G7;CX3CL1;IFI35;NUPR1;IL16;VAMP7;TLR7;FEM1A;TLR3;IL18;NFKBIZ;IL17RA
prerank,glycogen catabolic process (GO:0005980),-0.4370637585267821,-1.106007338966562,0.3345724907063197,0.9638869838434425,1.0,8/15,25.29%,PHKA2;PHKB;PYGB;PGM2L1;PHKG2;PYGL;GAA;PGM2
prerank,positive regulation of organelle assembly (GO:1902117),0.4686687822389667,1.10600345467151,0.33295454545454545,0.9551605636194654,1.0,12/44,14.77%,TAPT1;RAB3GAP1;BBS4;PIP4K2A;SDCBP;G3BP2;CCP110;PIP4K2B;ARHGAP35;SH3GLB1;PDCD6IP;G3BP1
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.5294770937905562,1.1059875266295325,0.35319148936170214,0.9543614479565654,1.0,8/15,16.79%,ZFYVE27;REEP2;RTN3;RAB18;RTN4;LNPK;ATL2;ARL6IP1
prerank,regulation of protein targeting to membrane (GO:0090313),0.49442059611156985,1.1055143113559143,0.3589420654911839,0.9551654243102486,1.0,3/28,3.91%,MIEF2;ITGB1BP1;GDI1
prerank,regulation of cilium assembly (GO:1902017),0.454702599162853,1.104955696725784,0.33731019522776573,0.9562841697841198,1.0,22/62,15.01%,TAPT1;BBS4;TBC1D15;EVI5;IFT20;TBC1D17;TBC1D14;CCP110;TBC1D10B;ARHGAP35;ATG3;CDKL5;TBC1D5;TBC1D10A;TBC1D13;CYLD;RABGAP1;ODF2L;TBC1D24;TBC1D22A;TBC1D8;TBC1D1
prerank,positive regulation of neurogenesis (GO:0050769),0.45760562822532846,1.1044957471959123,0.3343915343915344,0.9571142094094623,1.0,14/68,14.51%,CHODL;PLXNA1;CX3CL1;NUMBL;SS18L1;SPEN;RGS14;CUX1;NPTN;SOX11;CDKL5;PLXNC1;MAP6;FZD3
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.47080020259401173,1.1044401131518378,0.36727688787185353,0.9564457446300345,1.0,14/40,15.62%,LDLRAP1;ARRB2;DAB2;AHI1;CD63;ANXA2;DGKD;CBL;TBC1D5;INSR;BICD1;WASL;HIP1;HNRNPK
prerank,ganglion development (GO:0061548),0.5838950447183322,1.1043120339906045,0.37257824143070045,0.956052818428826,1.0,5/11,19.13%,NRP1;NRP2;FZD3;CTNNB1;UNC5C
prerank,respiratory chain complex IV assembly (GO:0008535),0.5111748982370842,1.104017535619652,0.35209424083769636,0.9562033316964162,1.0,2/21,2.48%,COA3;COX17
prerank,phosphate ion transport (GO:0006817),0.5366557581208469,1.1040170388260224,0.3656207366984993,0.9553545889262771,1.0,5/16,14.89%,SLC37A2;XPR1;SLC37A3;SLC20A2;SLC25A3
prerank,base conversion or substitution editing (GO:0016553),0.578354830669114,1.1039883577697307,0.3746268656716418,0.9546037120353243,1.0,3/11,10.36%,METTL3;APOBEC1;ADAR
prerank,cristae formation (GO:0042407),0.5094014004807045,1.1038359681142687,0.3629719853836784,0.9542737619724828,1.0,7/27,13.42%,ATP5F1A;ATP5MC3;LETM1;ATP5MC2;DNAJC11;APOOL;CHCHD6
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.42013047710569096,-1.1036710931106382,0.3174061433447099,0.9676162576616921,1.0,8/15,18.39%,TJP1;SMAD1;PKM;ITGA5;FGF2;PDPK1;BMPER;JAK1
prerank,protein targeting to membrane (GO:0006612),0.4507820234787522,1.1036595226701182,0.3155694879832811,0.9540496564912501,1.0,18/83,12.94%,PXMP2;ZDHHC24;ARL6;SSR2;RAB8B;SIL1;SDCBP;ABCD2;NACA;ZDHHC1;SEC61A1;VPS37C;ABCD3;VPS37A;ATG3;ZDHHC6;SRPRA;ABCD1
prerank,protein transport (GO:0015031),0.4388059239655472,1.1033851129869297,0.234,0.9541650155895393,1.0,91/332,16.16%,STXBP2;NEURL1B;STEAP3;SYS1;ARL5A;CD36;TMED4;ARL4A;ARL6;ARF3;COPB2;RAB8B;EHD1;NAPG;TVP23B;HIKESHI;RAB12;TBC1D15;STX7;KIF13A;PRKCB;SIL1;EVI5;TMED9;TANGO6;SCAMP1;AP2A1;TBC1D17;PDIA4;RAB5B;GOLPH3;VPS45;ATP6V0E1;RAB6A;STX3;SPTBN1;TBC1D14;VPS35;STX16;ARL4C;ARHGAP1;STX17;ATP6V1E1;PPARG;ABCG1;TBC1D10B;VAMP2;WLS;ARF1;MIA3;MCOLN1;SNX1;KIF3A;RAMP1;TMED2;TBC1D4;SCAMP5;RAB18;TBC1D12;SNX8;TBC1D5;TBC1D10A;VIPAS39;TBC1D13;ERP29;RABGAP1;ABCA1;ATP6V0D2;RAB3C;TMED5;ATP6V1H;NAPA;RPGR;CALCRL;SAR1B;UNC93B1;ATP6V0A2;TBC1D22A;GGA1;OPTN;TBC1D8;RAB7A;CLTC;TBC1D1;NPM1;SNX13;MACF1;STX8;ARL6IP5;GGA3;GOLGA4
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.473533290835994,1.1031886861906992,0.3549107142857143,0.9540410410076424,1.0,5/42,6.62%,PCLAF;RFC2;POLA1;WRN;POLD3
prerank,positive regulation of intracellular protein transport (GO:0090316),0.43708738886490456,1.1031811468215702,0.31895687061183553,0.953228588721508,1.0,43/144,16.98%,MIEF2;RIPOR1;DMAP1;FBXW7;BAG3;RNF31;ITGB1BP1;GAS6;FLNA;YWHAE;SMAD3;PCNT;KIF20B;TMEM30A;UBE2J2;ABLIM3;MAPK8;MAVS;IPO5;VAMP2;NMT1;HPS4;PRNP;SORL1;TCF7L2;RUFY3;VPS11;SH3GLB1;UBR5;TP53;BCL2;FYN;HTRA2;SAR1B;UBE2D3;ANP32B;PIK3R1;CD81;CEP290;YWHAB;TFDP2;SAE1;MFF
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.5313890155858928,1.1026586761389385,0.3649732620320856,0.9541689885656737,1.0,2/17,5.17%,RGCC;PDGFB
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.29506292265230044,-1.1020448122387094,0.27941176470588236,0.96909177973868,1.0,31/55,27.92%,PSMD14;PSMA3;PSMB2;USP47;PSMB7;AVEN;PSMC6;PSMD4;PINX1;RBX1;PSMD7;PSMA1;PSMA5;PSMC1;PSMD13;PSMC2;PSMA6;SKP1;PSMA4;PSMD3;PSMF1;FHL1;PSMD2;PSMD5;PSMD1;PSMC3;PSMD8;PSMB3;PSME1;PSMB9;CUL1
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.4395801488795095,1.1018494073137304,0.2848545636910732,0.9561945031164725,1.0,27/185,9.42%,TUBB4B;PLK1;RGCC;CETN2;TFAP4;ALMS1;MAPRE1;PSMD9;AKAP9;CEP250;YWHAE;PSMB8;ANAPC10;CDC23;PRKACA;CDK2;PCNT;HSP90AA1;PSMC5;BUB3;DCTN1;TUBA1A;DCTN2;CCP110;CDC16;ODF2;CEP152
prerank,motile cilium assembly (GO:0044458),-0.45741023732273545,-1.1018038127380854,0.33986928104575165,0.9657254233554844,1.0,8/12,51.04%,SPATA6;BBOF1;E2F4;BBS5;CCDC39;DNAAF3;CCDC40;RSPH9
prerank,protein export from nucleus (GO:0006611),-0.34498552535519494,-1.1016271008573564,0.32222222222222224,0.962242965179983,1.0,11/27,13.66%,SMURF1;TPR;XPO6;TGFB1;XPO4;NUP214;PKD1;CHP1;CALR;XPO5;RANBP3
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.48917822182338155,1.1012394903042881,0.3604368932038835,0.9575250539089672,1.0,5/27,9.16%,DLG1;GPD1L;SLMAP;CAMK2D;PTPN3
prerank,regulation of cellular catabolic process (GO:0031329),0.45556132311295355,1.1012148665100294,0.3566137566137566,0.9567818331181701,1.0,15/62,14.93%,TYSND1;LRRK2;NUPR1;PIP4K2A;EP300;KEAP1;USP33;MAPT;DAPK1;PIP4K2B;ABL1;DCAF12;ABCD1;TPCN2;SCARB2
prerank,response to light stimulus (GO:0009416),0.45772191141026536,1.1010261398639045,0.35223555070883317,0.9566030479074987,1.0,7/55,7.85%,PCLAF;CLOCK;FECH;UBE2A;USP1;MAPK8;ERCC4
prerank,membrane repolarization during action potential (GO:0086011),-0.4408798700803325,-1.1007803926709157,0.3519061583577713,0.9610144718021238,1.0,4/13,8.30%,ATP1B1;ATP1A1;KCNJ2;KCND3
prerank,negative regulation of cellular process (GO:0048523),0.4366031526230682,1.1006954508422433,0.17,0.9569124892933637,1.0,93/521,15.41%,BMP5;ALDH1A2;WDR6;RGCC;ROR2;WFS1;PLXNA1;SIRT7;IGFBP3;BLM;CGRRF1;IRF1;SMARCA4;EIF2AK2;SMAD6;HOPX;GLMN;IFI35;NUPR1;TFAP4;TMEM109;ADAM15;ITGB1BP1;IMPACT;HPGD;TGFB2;MALSU1;VAMP3;RAD18;EPHB2;RERG;AR;UTP20;BCL6;EI24;SMAD3;DCBLD2;PTPRJ;ABI1;RBM5;CDK6;IL1A;CBLL1;PDE3B;STK11;VPS13C;SYT11;BNIP3L;SNX3;LPXN;SLURP1;ALOX5;NCK1;VPS35;ADNP2;APC;CTBP1;LYN;ENO1;HGS;FKTN;BNIP3;PRKRA;MIA3;KAT2B;SOX11;VPS4B;RAF1;DNAJA3;ADAM10;BRD7;SH2B3;TP53;BCL2;ACVR1B;RBBP7;PLXNC1;RTN4;ADAM22;PTPRU;HTRA2;PKD2;PPP2R5C;PTEN;TSC1;ANP32B;CTCF;ARHGDIB;BECN1;SMAD4;NPM1;SMARCA2;CRLF3
prerank,homotypic cell-cell adhesion (GO:0034109),0.4745954064207149,1.1006028124689984,0.37142857142857144,0.9563957243968362,1.0,5/39,7.73%,VCL;CLIC1;METAP1;FLNA;FERMT3
prerank,thyroid hormone generation (GO:0006590),-0.48520507566500204,-1.100569117781175,0.33827893175074186,0.9576555226881015,1.0,1/10,1.91%,CPQ
prerank,regulation of keratinocyte differentiation (GO:0045616),0.5001549082834984,1.1004827439838591,0.3695652173913043,0.9559733252217144,1.0,8/24,18.14%,SGPP1;RUNX1;NCOA3;ZFP36L1;ROCK2;PRKCH;MED1;ROCK1
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.43725541403234136,1.1001505761846864,0.117,0.9562537735697995,1.0,144/834,15.59%,POU2F3;FHL5;ISL1;BMP5;GLIS1;RGCC;BRCA1;IER2;RORA;MED10;SIRT7;PELP1;KDM1B;RPRD1B;RELA;CX3CL1;IRF1;DVL1;SMARCA4;SP1;BRD8;ACTR3;PID1;FGF1;CASZ1;ITGA6;SS18L1;ITGB1BP1;CLOCK;ZEB2;RUNX1;SLC9A1;TGFB2;MAX;HCFC1;BMPR1A;EAPP;NFATC1;JUN;AR;PRDM10;ELK3;WBP2;IRF3;CDK7;PAXBP1;EP300;SMAD3;PDGFB;TEAD1;LRP5;PRKDC;SQSTM1;DPF2;ESR1;MRTFB;HDAC5;NR3C1;ACVR1;JUND;MAML3;PRDM4;CRTC1;MAML2;BCLAF3;MEF2A;IKBKB;MLIP;RRP1B;PHF10;TFCP2;AKIRIN2;TLR3;NCOA1;SETD3;AGO2;PRPF6;RPS6KA5;CDK9;NCK1;IL18;DAB2;NCOA3;PCGF5;MAVS;AHI1;PPARG;SSBP3;MICAL2;GLYR1;SETX;TAL1;CDC5L;HIVEP1;HOXC4;TCF12;CHD8;NR5A1;KAT2B;NR2C2;SOX11;ZBTB38;ECD;MAP2K5;ABL1;HMGB1;TCF7L2;ATF6;HIPK2;TP53;ATRX;NR1D2;LRP6;RXRA;EPC1;CDK8;FUBP3;PPARGC1B;WWOX;RREB1;PRKD2;PKD2;CREB1;RFX3;RBPJ;TET2;PPARD;TBL1XR1;NCOA2;WASL;LDB2;LDB1;TLR4;ARNT;SMAD4;ZBTB18;NPM1;PHIP;SMARCA2;AKAP8L;CRLF3;THAP3;AUTS2;HDAC2
prerank,positive regulation of biomineral tissue development (GO:0070169),0.4679260240961111,1.1000605990427448,0.3569767441860465,0.955733565836356,1.0,5/40,8.48%,WNT4;BMPR1A;NELL1;ACVR1;ALOX5
prerank,multivesicular body assembly (GO:0036258),0.4829679221012131,1.09981781963199,0.36330935251798563,0.9557547140523225,1.0,9/30,14.18%,TSG101;VPS4A;CHMP5;HGS;VPS37C;VPS37A;VPS4B;PDCD6IP;IST1
prerank,defense response to protozoan (GO:0042832),-0.4559312561063875,-1.0996594800633688,0.3264094955489614,0.956619378137299,1.0,9/12,45.43%,LYST;SLC11A1;BATF;GBP7;MYD88;CD40;IRF4;PF4;GBP2
prerank,negative regulation of cell population proliferation (GO:0008285),0.43944248536318664,1.0995872655671444,0.207,0.9557641840620114,1.0,55/351,15.37%,BMP5;ANG;ALDH1A2;WDR6;RGCC;ROR2;IGFBP3;CGRRF1;IRF1;EIF2AK2;SMAD6;GLMN;IFI35;NUPR1;TFAP4;ITGB1BP1;TGFB2;NF1;RERG;AR;UTP20;NELL1;PTPRJ;ABI1;RBM5;CDK6;IL1A;STK11;DUSP10;SLURP1;PPARG;APC;CTBP1;LYN;HGS;FKTN;PRKRA;KAT2B;SOX11;RAF1;DNAJA3;BRD7;SH2B3;TP53;PTPRU;MCC;NDRG4;PKD2;PPP2R5C;AIF1;PTEN;TSC1;CTCF;NPM1;SMARCA2
prerank,regulation of actomyosin structure organization (GO:0110020),0.5589783736385914,1.0995170722316996,0.3626062322946176,0.9551697231375469,1.0,8/13,18.14%,ALMS1;SLC9A1;AKAP13;CDC42;ROCK2;TSC1;ACTG1;ROCK1
prerank,regulation of DNA recombination (GO:0000018),0.48928646823574407,1.0993014104233432,0.3802647412755716,0.9551054942507016,1.0,6/32,14.72%,BLM;RAD50;MRE11;SETD2;PPP4C;SPIDR
prerank,synaptic vesicle cycle (GO:0099504),-0.3523578090051027,-1.0990504071292877,0.2711864406779661,0.9547020009807758,1.0,8/30,12.68%,SNAP25;RAB5A;PIP5K1C;SYNDIG1;SNCA;RIMS1;PLD2;SLC17A6
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.4406502523658827,1.0987405332319125,0.3336766220391349,0.9561827898493611,1.0,5/101,2.34%,FGF18;RGCC;LRRK2;TPD52L1;FGF1
prerank,DNA packaging (GO:0006323),0.5356076568083316,1.0986928467841603,0.37746478873239436,0.9555020711809674,1.0,4/16,12.92%,BANF1;NOC2L;AIFM1;TP53
prerank,keratinocyte differentiation (GO:0030216),-0.3585177363776074,-1.098512312418734,0.3016759776536313,0.9525053238890734,1.0,6/29,16.99%,PIP5K1A;ADAM9;UGCG;BCR;TXNIP;ST14
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.44720978414927387,1.0983604297366347,0.34978991596638653,0.9557996958580812,1.0,24/80,16.64%,TAPT1;ACTR3;FAM98A;NDEL1;BBS4;NRP1;FNBP1L;EPS8L1;CCP110;TWF2;APC;EPS8;ARHGAP35;CDC42;ARPC2;WASF2;DOCK11;P2RY12;WASL;GPM6A;AUTS2;PIK3R1;PLEKHM1;CYFIP1
prerank,intracellular pH reduction (GO:0051452),-0.3403602927838133,-1.0982762191740154,0.2857142857142857,0.9492878607567897,1.0,14/33,16.54%,ATP6V0A1;ATP6V1A;SLC11A1;ATP6V1D;DMXL2;ATP6V0C;RAB39A;ATP6V0B;CLCN3;ATP6V1C1;GPR89B;GPR89A;ATP6V1G1;RAB20
prerank,protein localization to lysosome (GO:0061462),0.48754927240626283,1.0981031561943062,0.3620253164556962,0.955824220505527,1.0,13/28,17.03%,VPS4A;AP3M1;NEDD4;LMBRD1;HGS;SORL1;MFSD1;RTN4;RAB7A;SCARB2;GGA3;CD81;GCC2
prerank,positive regulation of stem cell differentiation (GO:2000738),0.5363179357670442,1.0979468335760205,0.3751763046544429,0.955536308265845,1.0,2/16,12.64%,TGFB2;SOX6
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.5248336324926262,1.0978578188114454,0.38386648122392214,0.9550168062544104,1.0,2/18,1.74%,DUSP3;TNFAIP8L2
prerank,atrioventricular valve development (GO:0003171),0.5522693445808124,1.0978442307075502,0.38930163447251115,0.9542138992419386,1.0,4/14,11.20%,TGFB2;BMPR1A;ACVR1;TGFBR2
prerank,pulmonary valve development (GO:0003177),0.5286329978154505,1.0977730573010167,0.37771739130434784,0.953652064244009,1.0,4/18,11.19%,SMAD6;TGFB2;NFATC1;NOTCH2
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.43551795967640317,1.0976867238705144,0.202,0.9531249076724491,1.0,95/509,15.24%,FGF22;FGF18;ROR2;UNC5CL;NRG2;CDK5RAP3;RELA;CX3CL1;IRAK4;EIF2AK2;TMED4;FGF1;IFI35;NUPR1;GRB2;RNF31;ITGB1BP1;PLEKHG5;DDX60;TLR7;TGFB2;BCL2L11;GAS6;SASH1;PELI1;AREG;IRS1;THBS1;FLNA;PRKCB;EP300;PDGFB;KITLG;TRAF7;PUM2;MIOS;PTPRJ;ESR1;AXL;BIRC3;IRS2;HSP90AA1;GOLPH3;IKBKB;NEDD4;TLR3;IL18;LIMS1;TAB3;FNIP1;PUM1;MAVS;MTDH;PTP4A3;LYN;CANT1;F3;ACTN4;TFG;WLS;TRIM5;AKAP13;TRAF2;RIT2;IGF1R;SOX11;CBL;TRIM44;FRS2;PPM1A;HMGB1;SLC38A9;TCF7L2;TGFA;TP53;TGFBR1;BCL2;RTN4;NDFIP1;S100B;FN1;INSR;FYN;PRKD2;LGALS9;RELN;ROCK2;SCHIP1;LARS1;P2RY12;TLR4;PIK3AP1;VAV1;BECN1;HIP1
prerank,myeloid leukocyte differentiation (GO:0002573),0.456603671792249,1.0976319625795985,0.3396825396825397,0.9524763764911373,1.0,14/65,14.00%,TNFRSF11A;RUNX1;EP300;FARP2;CDK2;SNX10;THOC5;PPARG;MT1G;CDC42;TGFBR2;MAPK14;RXRA;LGALS9
prerank,cellular response to ionizing radiation (GO:0071479),0.4634392797875692,1.0974591775711275,0.3515625,0.9523159307066109,1.0,10/47,14.72%,BLM;GRB2;TMEM109;CLOCK;WRN;MAP3K20;TANK;MAPK14;TP53;SPIDR
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.4540198376692104,1.0973877016127216,0.34146341463414637,0.9517258384780019,1.0,13/72,11.88%,RNASE6;RFC2;RAD50;PNRC2;DCP1B;POLD3;RNASE4;MRE11;ERCC4;EXD2;XRN2;DCP1A;CUL4A
prerank,positive regulation of programmed cell death (GO:0043068),0.4394809642295565,1.0967647267698624,0.2502502502502503,0.9530246763320264,1.0,49/272,12.92%,LRRK2;IGFBP3;UBE2Z;ARHGEF3;FGD3;TFAP4;FGD1;PLEKHG2;PPID;ITGA6;PLEKHG5;SAP18;SMPD1;BCL2L11;ITSN1;OLFM1;MTCH1;NF1;JUN;BCL6;RNPS1;TNFAIP8;ARHGEF12;MAP3K11;APAF1;CTNNBL1;SQSTM1;VAV3;MAP3K20;RBM5;ING3;RRP1B;MAPK8;BNIP3L;DAPK1;FAF1;KALRN;APC;AKAP13;BNIP3;ARHGEF17;ABL1;HMGB1;AIFM1;VAV2;RPS6;ATF6;MLLT11;TP53
prerank,translational termination (GO:0006415),0.4393403381213282,1.0961876143908924,0.34390992835209827,0.954136703468498,1.0,10/95,7.30%,MRPS22;MRPS31;MRPS30;MRPL37;MRPS21;ETF1;MRPL48;MRPS35;MRPS28;MRPL1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.4388565376989396,1.0960595591830655,0.3510204081632653,0.9537733254382543,1.0,23/112,13.43%,WNT4;PRKCZ;SMAD6;ZFYVE9;HPGD;TGFB2;BMPR1A;JUN;SMAD3;ARRB2;NR3C1;ACVR1;ITGB5;LPXN;LIMS1;FURIN;PXN;TGFBR2;CBL;ZFP36L1;SOX6;TGFBR1;WWOX
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.5481085245301911,1.0958327402731693,0.37070254110612855,0.9537270562277416,1.0,5/13,13.60%,DYRK2;IRS1;IRS2;GCK;INSR
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.46953458637825185,-1.0957081503514963,0.36795252225519287,0.9537976250285757,1.0,1/11,0.10%,PLCG2
prerank,gene silencing by miRNA (GO:0035195),0.485126319901259,1.0955244053912363,0.3614595210946408,0.9539627243393298,1.0,8/32,11.02%,EIF6;PUM2;TNRC6B;AGO2;PUM1;ZC3H7A;ADAR;PRKRA
prerank,protein acetylation (GO:0006473),0.49246398342274944,1.0951527435019224,0.362874251497006,0.954415357881977,1.0,9/30,13.16%,CLOCK;NAA35;EP300;MAPT;NAA16;GTF2B;KAT2B;ESCO1;NAA15
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.4804127453806339,1.094934161678648,0.3431952662721893,0.9543290876066928,1.0,8/33,16.20%,DUSP3;RELA;PTPRJ;EZR;PRNP;PRKD2;DGKZ;CD81
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.44982321681905124,1.0948134002629912,0.34994807892004154,0.9539398718843609,1.0,13/76,12.10%,BRCA1;WFS1;LRRK2;CDK5RAP3;FBXW7;UBQLN1;BIRC3;DCUN1D4;PTTG1IP;RCHY1;TANK;DERL1;UBE3A
prerank,organic anion transport (GO:0015711),0.4514435356878495,1.0945739258890288,0.3495248152059134,0.953922625018125,1.0,5/76,5.87%,SLC4A3;SLC25A24;SLCO4C1;SLCO1B1;ABCC5
prerank,nuclear body organization (GO:0030575),0.5652355514389666,1.094506443351326,0.3896296296296296,0.9533221864291844,1.0,5/12,16.05%,HABP4;AFF2;SRPK2;HIPK2;SERBP1
prerank,regulation of intracellular transport (GO:0032386),0.46689315240448204,1.094118436355896,0.37132784958871917,0.9538198707878947,1.0,5/38,8.42%,GAS1;LRRK2;NDEL1;REEP5;PTPN1
prerank,negative regulation of ion transport (GO:0043271),-0.3628451360826962,-1.0938473020670771,0.2930232558139535,0.9560308029028105,1.0,8/24,17.97%,PTK2B;CD33;PXK;GPM6B;SNCA;INPP5K;LILRB1;WNK2
prerank,cytokine-mediated signaling pathway (GO:0019221),0.43313450276905074,1.0936015204253344,0.195,0.9547474588033548,1.0,90/532,13.98%,CXCL12;RORA;MID1;TNFRSF11A;S1PR1;IFITM3;CD36;RELA;CX3CL1;IRAK4;IRF1;SMARCA4;MTAP;CTR9;RAPGEF1;CFL1;IFI35;NUMBL;IL16;GRB2;TCP1;TNFRSF25;BCL2L11;MSN;PELI1;PSMD9;IRS1;IRF3;BCL6;LIFR;PSMB8;PDGFB;IL10RB;PRKACA;RPLP0;SQSTM1;PTPRJ;BIRC3;IL1A;IRS2;HSP90AA1;PSMC5;HNRNPA2B1;IKBKB;CCL25;PYDC1;HSPA9;RAP1B;PAK2;STX3;RPS6KA5;IL1RAP;CAMK2D;F13A1;ALOX5;IL18;LIMS1;IRAK2;TAB3;LRP8;CD44;SOCS5;F3;ANXA2;ACTN4;ADAR;TRIM5;CDC42;TRAF2;IFNAR2;ARF1;FBXW11;TALDO1;CBL;TMSB4X;COMMD7;IL17RA;PITPNA;PSMD12;SLC27A1;SH2B3;TP53;PSMA2;BCL2;SYK;CAMK2G;FN1;ADIPOR1;FYN;MAP3K8
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.5171267837048166,1.0934367581893414,0.3835263835263835,0.9545030136456315,1.0,4/19,7.16%,NPHP4;RUNX1;PRKACA;IKBKB
prerank,response to muscle stretch (GO:0035994),-0.4105064717019083,-1.0934332608656219,0.34459459459459457,0.9535895065483402,1.0,3/15,7.08%,RYR2;PTK2;PIK3CA
prerank,DNA recombination (GO:0006310),0.4748457180936783,1.0934084433521476,0.3654524089306698,0.9537747776156653,1.0,7/37,14.60%,BLM;RAD50;WRN;MRE11;RAD51B;HMGB1;RECQL5
prerank,endothelial cell migration (GO:0043542),0.47462880216802583,1.0933153264696482,0.36310904872389793,0.9532853176660354,1.0,7/37,11.90%,PLEKHG5;NRP1;GIPC1;LPXN;PTP4A3;PXN;ABL1
prerank,cardiac muscle contraction (GO:0060048),-0.33215984605678794,-1.0932122855186104,0.3018867924528302,0.9503679379505858,1.0,5/34,7.08%,RYR2;ATP1B1;GRK2;ATP1A2;PIK3CA
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.3714192276703424,-1.0931784717845925,0.3155339805825243,0.9466077059821856,1.0,6/25,12.90%,NSD1;TGFB1;NIBAN2;DOT1L;IGF1;TRAF6
prerank,pentose-phosphate shunt (GO:0006098),0.5554145397096766,1.0930059086035526,0.375,0.9535566680445463,1.0,5/11,13.26%,RPIA;RBKS;TKT;TALDO1;RPE
prerank,long-chain fatty acid transport (GO:0015909),0.4913876374584883,1.092973898839109,0.36634844868735084,0.9528441803574484,1.0,8/30,14.13%,CD36;ABCD2;SLC25A20;PPARG;ABCD3;SLC27A1;ABCD1;ACACA
prerank,negative regulation of type I interferon production (GO:0032480),-0.3137273941347776,-1.0925502278553463,0.27586206896551724,0.9448198893905478,1.0,15/40,14.22%,PCBP2;TAX1BP1;NPLOC4;REL;NLRC5;OTUD5;PTPRS;IKBKE;UFD1;RELB;IFIH1;NLRC3;PYCARD;SIRPA;LILRB1
prerank,pore complex assembly (GO:0046931),0.5173886920007408,1.09238595058068,0.3718120805369127,0.9540692363962803,1.0,7/19,13.32%,PDZD11;NUP205;AHCTF1;GSDMD;NUP98;ADAM10;RTN4
prerank,regulation of focal adhesion assembly (GO:0051893),0.46570860275820797,1.0923803931731073,0.36911281489594744,0.9532870314899391,1.0,18/54,16.41%,VCL;DUSP3;ITGB1BP1;SLC9A1;THBS1;NRP1;PTPRJ;CAMSAP3;LIMS1;ABL1;ROCK2;PTEN;LDB1;TSC1;CLASP1;MACF1;MAP4K4;ACTG1
prerank,fat cell differentiation (GO:0045444),0.45950933986160514,1.0921260409074283,0.35591397849462364,0.9532983276291879,1.0,11/57,12.65%,SMAD6;PID1;BBS4;ZBTB7A;PSMB8;EP300;PPARG;CTBP1;TMEM120B;TCF7L2;ERAP1
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.3817164759109205,-1.092076049511198,0.3446808510638298,0.9425046910798619,1.0,8/20,14.79%,ATP1B3;ATP1B1;ATP1A1;ATP1A2;KCNJ2;ATP1A3;ATP6AP1;KCNMA1
prerank,positive regulation of axonogenesis (GO:0050772),0.47056930480921544,1.0919669553004179,0.3516609392898053,0.9530185494898269,1.0,12/43,16.16%,CHODL;PLXNA1;ZFYVE27;MAPT;TWF2;DBNL;CDKL5;RUFY3;PLXNC1;MAP6;MACF1;GOLGA4
prerank,regulation of phosphatase activity (GO:0010921),0.500457007509624,1.0913412645752705,0.3734015345268542,0.9543573533431694,1.0,2/24,1.21%,URI1;CDK5RAP3
prerank,negative regulation of biosynthetic process (GO:0009890),0.5358431123984474,1.090816202923939,0.39946018893387314,0.955392915116381,1.0,5/16,17.04%,ABCB7;ABCD2;ABCD1;COA8;ASXL3
prerank,cholesterol efflux (GO:0033344),0.5153163849366257,1.090535593641122,0.37292464878671777,0.9555410444273218,1.0,5/20,14.69%,SOAT1;ABCA7;ABCG1;ABCA1;ABCA5
prerank,regulation of astrocyte differentiation (GO:0048710),-0.45919633475841726,-1.0901096572466078,0.3709677419354839,0.9448439407791988,1.0,3/12,15.54%,SERPINE2;EPHA4;NOTCH1
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.5146521246380915,1.0898521993366435,0.3727735368956743,0.9571011663309488,1.0,5/22,9.65%,RELA;SP1;RANBP9;ABCG1;LYN
prerank,"transcription, DNA-templated (GO:0006351)",0.4360057506466431,1.0897691435164933,0.286,0.9565866292677025,1.0,42/207,13.73%,POLR2D;EAF1;PMF1;POLR1C;POLR3G;GTF3A;CTR9;POLR3H;TFB2M;POLR2A;RNPS1;MLLT1;CDK7;ARRB2;MNAT1;MEF2A;CDK9;UBTF;TAF4;CRCP;SETX;GTF2E1;GTF2E2;DEAF1;POLR3A;RNGTT;NELFA;ELOC;GTF2B;GTF2F2;GMEB2;BRF1;TP53;MAF;CTDP1;KLF13;EPC1;FUBP3;NFX1;GTF2H1;DDX5;RREB1
prerank,histone H3-K4 trimethylation (GO:0080182),0.5578547601980901,1.0894219645231749,0.38763197586727,0.9569529330582273,1.0,2/11,3.61%,CTR9;SETD1A
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.4822286069093572,-1.0893377768699724,0.3581267217630854,0.9435414093140343,1.0,4/10,13.79%,PARP14;PTPN2;NF2;PPP2R1A
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.5042585193978665,1.0890887848335682,0.38051948051948054,0.9572780246025532,1.0,3/22,5.80%,MINK1;SASH1;RELL1
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.5146684623378199,1.0886779302192053,0.37101063829787234,0.957876985323321,1.0,4/19,11.72%,WFS1;PDGFB;MAPK8;MAP2K5
prerank,regulation of myoblast fusion (GO:1901739),0.554943061722868,1.0886237940222467,0.38666666666666666,0.9572557525875047,1.0,3/11,16.32%,EHD1;MAPK14;CFLAR
prerank,glycerophospholipid catabolic process (GO:0046475),0.49294770502946594,1.0885610886099881,0.37392373923739236,0.9566596893344479,1.0,6/27,12.07%,PLA2G7;PLA2G6;PLA2G4A;ABHD16A;PNPLA6;GPCPD1
prerank,cellular response to lipid (GO:0071396),0.4326357450107056,1.088521174016018,0.31827309236947793,0.9559716672748375,1.0,25/191,10.09%,RORA;URI1;INSIG1;RELA;CTR9;ADCY8;ADCY3;PID1;CHMP5;ADAM15;MSN;AR;ADCY5;IRS1;ESR1;AXL;NR3C1;IL1A;MAPK8;TWF2;NCOA3;ADNP2;LYN;SETX;PLAA
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.5119376431566055,1.0882611326712255,0.38491048593350385,0.9560476635285552,1.0,6/21,11.40%,NDST3;UGDH;GLCE;EXTL3;HS6ST2;HS3ST4
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.43228331935826014,1.0882564627837727,0.28128128128128127,0.9552607728714251,1.0,38/260,7.63%,VCL;S1PR1;FGD6;CLUAP1;BBIP1;CCDC57;CEP89;MINK1;ACTR3;FGD3;ARL6;EHD4;FGD1;TMEM67;RAB8B;EHD1;BBS4;IQCB1;DZIP1;CEP250;RAP1A;FLNA;NRP1;TTC39C;FNBP1L;EXOC5;PCNT;DYNLL2;SDCBP;IFT52;IFT20;PARVB;ABLIM3;EZR;GOLPH3;CCDC66;SNX10;RAP1B
prerank,chromatin remodeling (GO:0006338),0.4400468560221693,1.0878359345542823,0.35860655737704916,0.9558369437998864,1.0,28/100,16.68%,SRCAP;ACTR5;SMARCA4;HCFC1;ZBTB7A;KDM5A;ESR1;HDAC5;NUDT5;KDM5B;GATAD1;TADA2A;BAZ2B;KDM4B;CHD8;KAT2B;KDM4C;ATRX;NPM1;SMARCA2;HDAC2;HNRNPC;BAZ1B;ARID1B;PAK1;RB1;SMARCC2;ZBTB1
prerank,branched-chain amino acid catabolic process (GO:0009083),0.5174766354019735,1.087563668840543,0.3949468085106383,0.9551203501747204,1.0,4/20,6.05%,ALDH6A1;ACAT1;ECHS1;MCCC2
prerank,branched-chain amino acid metabolic process (GO:0009081),0.5174766354019735,1.087563668840543,0.3949468085106383,0.9551203501747204,1.0,4/20,6.05%,ALDH6A1;ACAT1;ECHS1;MCCC2
prerank,regulation of ruffle assembly (GO:1900027),0.5047126092212185,1.0875202481803605,0.3870558375634518,0.9544850393922937,1.0,8/23,16.52%,FAM98A;NDEL1;EPS8L1;EPS8;P2RY12;EVL;PLEKHM1;RDX
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.43806515760886844,1.0874118264051424,0.35802469135802467,0.9540553106487002,1.0,33/88,17.72%,SYS1;AP1M1;VAMP7;LLGL1;RABEP1;MYO5A;EXOC5;CCDC93;SCAMP1;AP2A1;VPS13A;VPS13C;PUM1;DTNBP1;KIF16B;VAMP2;HGS;ARF1;EXOC6B;EXOC4;SORL1;NAPA;EPS15;CLINT1;CLTC;SH3GL2;FTH1;RP2;MYO1B;SCAMP2;ARL3;AP1B1;FTL
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.48503911237558234,1.086569910231874,0.3864447086801427,0.956049391535541,1.0,3/31,6.69%,PLK1;FBXW7;DCUN1D4
prerank,regulation of protein localization to membrane (GO:1905475),0.4899116179782075,1.0863783342451079,0.37682926829268293,0.9558676724791284,1.0,10/28,15.78%,LDLRAP1;VPS4A;AR;STX7;SPTBN1;CDK5;GPC3;FYN;GPC6;STX8
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.45810668411280014,1.0861699537691465,0.36670416197975253,0.9558066116325155,1.0,13/47,16.10%,MID1;EIF2AK2;TGFB2;IGBP1;MAPK1;PHLPP1;TAOK1;IGF1R;MAP2K2;LGALS9;MAP4K4;ARL6IP5;MAP2K1
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.4257595952023913,-1.0857460511147292,0.34057971014492755,0.9513876011550308,1.0,5/15,17.66%,VCP;HNRNPA1;ATF3;HSF1;ZC3H12A
prerank,regulation of DNA biosynthetic process (GO:2000278),0.5005459560654225,1.085596954847234,0.37409200968523004,0.956940518155997,1.0,6/27,10.02%,RGCC;SMG6;TERF2;PDGFB;HMBOX1;PARP4
prerank,axonal transport of mitochondrion (GO:0019896),-0.4676131828848892,-1.0855465473630443,0.3333333333333333,0.9481518206031995,1.0,5/11,14.75%,OPA1;TRAK2;TRAK1;ACTR10;NEFL
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.4201457605060043,-1.0854879578809118,0.35106382978723405,0.9445780412060429,1.0,7/15,42.51%,SMO;VEGFA;PAX8;PAX2;SOX8;AGT;SOX9
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.43137582483081294,1.085244520039889,0.154,0.9573166719479012,1.0,143/807,14.53%,ISL1;GLIS1;PLK1;WNT4;BRCA1;MDFI;WFS1;DNAJB1;URI1;SIRT7;EHMT1;HSBP1;PARP9;KDM1B;THAP7;DMAP1;RELA;IRF1;SMARCA4;CD38;CTR9;SUV39H1;ILF3;VPS72;ZFP90;TFAP4;SOX13;PPID;RLIM;ZBTB5;IMPACT;TGIF1;CLOCK;ZEB2;RUNX1;SAP18;MAX;GAS6;HCFC1;IGBP1;ZNF318;JUN;AR;TLE2;ATXN1;ZBTB7A;ELK3;FLNA;BCL6;HDAC9;TRPS1;N4BP2L2;EP300;SMAD3;RBM15;SPEN;ARID5B;PDGFB;CIPC;RBAK;DPF2;ESR1;HDAC5;SDCBP;NR3C1;SCMH1;EHMT2;IKZF1;EZR;TLE1;NCOA5;MEF2A;MLIP;DLG1;PHF10;MECP2;CUX1;SET;RPS6KA5;EZH2;DAB2;LIMS1;NACC1;NCOR1;FNIP1;PHF6;ORC2;PPARG;MTDH;NR6A1;SIN3B;CTBP1;HMBOX1;ENO1;CDK5;DEAF1;HIVEP1;LOXL3;UBE2I;NOC2L;ZNF568;FOXN3;BCL7A;CHD8;FBXW11;PHC3;PSPC1;NR2C2;SOX11;ZBTB38;BCL11A;ZMYND11;MAP2K5;COMMD7;PRDM1;PPM1A;NCOR2;DNMT3A;YEATS2;HMGB1;ZFP69;DNAJA3;TCF7L2;MIER3;BRD7;TP53;NR1D2;MYT1L;LCOR;RXRA;EPC1;NFX1;WWOX;DDX5;KCNIP3;RREB1;CREB1;RFX3;RBPJ;PPARD;ZMYM5;TBL1XR1;UBE2D3
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.44951378860123253,-1.0851072115216391,0.3525423728813559,0.9421884845635622,1.0,7/13,12.90%,RHOA;FUT9;ZDHHC21;ETS1;ITGB2;IRAK1;TRAF6
prerank,fatty acid oxidation (GO:0019395),0.45591778193263005,1.0848159078563413,0.3624454148471616,0.9579970160104836,1.0,13/57,14.37%,ACAT1;ECI2;ACADS;ECHS1;DECR1;ABCD2;CROT;ABCD3;ACADL;ABCD1;HSD17B4;ADIPOR1;PPARD
prerank,myelination (GO:0042552),0.46155169089814874,1.0846511663318357,0.379041248606466,0.9577421192804266,1.0,11/46,14.99%,DEGS1;ACSBG1;NF1;ACER3;SBF2;ABCD2;B4GALT5;EPB41L3;ABCD1;PLP1;BCAS1
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.34004596550285654,-1.0837480007834168,0.30939226519337015,0.9427447670648277,1.0,10/29,8.39%,ACSL4;PPT1;HACD2;HSD17B12;ELOVL6;ELOVL7;ACLY;ACSL3;ACSL1;ELOVL5
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.45330650178805043,1.083746774300047,0.38403451995685006,0.9600156298296949,1.0,9/57,14.62%,ADCY8;ADCY3;ADCY5;FLNA;ADCY9;MTNR1A;GRM7;GNAI3;P2RY12
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.4951967645875107,1.0836773270007953,0.37673830594184576,0.9594316408354331,1.0,5/23,11.44%,TSG101;SOCS4;SOCS5;MVP;CBL
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.4316991106078429,1.083377035546168,0.3246231155778894,0.9596717793990922,1.0,22/151,14.00%,ROR2;TNFRSF11A;PRKCZ;C5AR1;CD36;FBXW7;CX3CL1;BRAF;GAS6;RAP1A;NRP1;PDGFB;PRKCA;ARRB2;CCL25;ABCA7;CD44;NOTCH2;HMGB1;NDRG4;PRKD2;LGALS9
prerank,negative regulation of lymphocyte activation (GO:0051250),0.5045751342682684,1.083215022737348,0.3870094722598105,0.9594443200405399,1.0,5/21,12.53%,DUSP3;TNFAIP8L2;LST1;SOX11;BANK1
prerank,regulation of phagocytosis (GO:0050764),-0.3019188030070818,-1.0829687178836995,0.24705882352941178,0.9416142780913132,1.0,15/53,13.75%,HCK;PTPRC;FCER1G;FGR;SLC11A1;FCGR2B;PIP4P2;CYBA;RAB27A;CALR;PYCARD;SIRPA;RACK1;IL15RA;SCARB1
prerank,cellular response to hormone stimulus (GO:0032870),0.45036141532057755,1.08278904877452,0.3705263157894737,0.9600559744404178,1.0,12/69,12.05%,URI1;PELP1;BRD8;KLF9;AR;WBP2;NR3C1;NCOA1;NCOA3;GCK;RAMP1;ZFP36L1
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.4386733008911832,1.0827852550297188,0.35751295336787564,0.9592698792418016,1.0,16/88,12.87%,CDK5RAP3;EIF4A3;CNOT10;EIF2AK2;ILF3;EIF4ENIF1;SYNCRIP;MALSU1;NELL1;DAPK1;FXR2;CNOT9;CDK5;LSM14A;DNAJC1;SAMD4A
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.45135274623295873,1.0823002098240753,0.3630434782608696,0.9600963458954557,1.0,13/63,13.43%,RELA;ITGA6;AR;THBS1;ACVR1;PAK2;BIRC6;TRAF2;ZMYND11;TCF7L2;CYLD;TGFBR1;WWOX
prerank,positive regulation of innate immune response (GO:0045089),0.48736807072519606,1.0813689491583043,0.38625,0.9623741832210443,1.0,5/30,9.31%,POLR3G;RIOK3;IFI35;AKIRIN2;MAVS
prerank,fibrinolysis (GO:0042730),-0.44107873832085626,-1.0813532584296945,0.37003058103975534,0.9428094046594859,1.0,4/13,39.74%,PLAU;PLAUR;SERPINE1;PLAT
prerank,regulation of amyloid-beta formation (GO:1902003),0.4745196657657266,1.0813161086169727,0.3825581395348837,0.9617494030607211,1.0,13/34,18.14%,RELA;SP1;RTN3;ABCA7;ABCG1;PRNP;SORL1;RTN4;ROCK2;GGA3;BIN1;GSAP;ROCK1
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.45197225927476986,1.0812506521005563,0.37794432548179874,0.9611585594578815,1.0,14/67,13.73%,CD36;CX3CL1;RSU1;FLNA;NRP1;PDGFB;DOCK1;CDK6;CCL25;LIMS1;CDC42;ABL1;FN1;RREB1
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.5554504467009025,1.081197685810411,0.38345864661654133,0.9605256971034688,1.0,2/12,8.68%,NUPR1;IL18
prerank,potassium ion import across plasma membrane (GO:1990573),-0.3016284859528617,-1.0810772104045667,0.3050847457627119,0.9400717490510215,1.0,7/41,8.21%,ATP1B3;ATP1B1;ATP1A1;ATP1A2;KCNJ2;SLC12A9;ATP1A3
prerank,microvillus organization (GO:0032528),0.5480110986638066,1.0808894682462837,0.38666666666666666,0.9607328284838612,1.0,4/13,7.63%,MINK1;RAP1A;EZR;RAP1B
prerank,protein targeting to peroxisome (GO:0006625),0.48827334753892315,1.0807816194557778,0.38181818181818183,0.9602848338252257,1.0,9/29,17.45%,PXMP2;RAB8B;ABCD2;ZFAND6;ABCD3;ABCD1;PEX14;PEX7;ATAD1
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.4433605529112982,1.0807166146454965,0.37189189189189187,0.9597164822525738,1.0,14/62,15.75%,ARHGEF3;RAPGEF1;GRB2;GPR65;STK19;IRS2;LYN;AKAP13;NOTCH2;SHOC2;LPAR6;VAV1;AUTS2;MAP4K4
prerank,amyloid-beta metabolic process (GO:0050435),0.529783929167639,1.080676602104945,0.39373297002724794,0.9590549584256619,1.0,2/16,8.50%,MGAT3;ABCA7
prerank,vesicle coating (GO:0006901),0.44879535218987265,1.0803991851620818,0.3712121212121212,0.9575932140078577,1.0,16/61,14.11%,LMAN1;GOSR2;PEF1;CTSC;AREG;TRAPPC3;TRAPPC9;CTSZ;TFG;SEC24B;SEC24D;TMED2;TGFA;NAPA;SAR1B;TRAPPC6B
prerank,COPII vesicle coating (GO:0048208),0.44879535218987265,1.0803991851620818,0.3712121212121212,0.9575932140078577,1.0,16/61,14.11%,LMAN1;GOSR2;PEF1;CTSC;AREG;TRAPPC3;TRAPPC9;CTSZ;TFG;SEC24B;SEC24D;TMED2;TGFA;NAPA;SAR1B;TRAPPC6B
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.44879535218987265,1.0803991851620818,0.3712121212121212,0.9575932140078577,1.0,16/61,14.11%,LMAN1;GOSR2;PEF1;CTSC;AREG;TRAPPC3;TRAPPC9;CTSZ;TFG;SEC24B;SEC24D;TMED2;TGFA;NAPA;SAR1B;TRAPPC6B
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.3328753382164746,-1.0801042724287975,0.3181818181818182,0.9394302858763843,1.0,9/30,10.61%,PTPRC;SAMSN1;PARP14;PTPN2;NF2;SEMA4D;PTPN6;SH3BP5;SRCIN1
prerank,nucleic acid-templated transcription (GO:0097659),0.4688705100355176,1.0798909053467793,0.38444193912063135,0.9584581500716206,1.0,7/42,13.32%,POLR2D;POLR2A;RNPS1;MEF2A;POLR3A;EPC1;FUBP3
prerank,snRNA 3'-end processing (GO:0034472),0.5177232801179577,1.0793117022709842,0.37667560321715815,0.9595693623650702,1.0,4/19,6.57%,INTS12;INTS2;EXOSC5;EXOSC7
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.41183578597109216,-1.0792185579812186,0.366412213740458,0.9386203784514447,1.0,7/16,22.98%,RIF1;SHLD1;SHLD2;KLHL15;CGAS;UBQLN4;HELB
prerank,regulation of mitochondrial fusion (GO:0010635),0.5537907700501438,1.078913532686811,0.40275650842266464,0.9601361167718507,1.0,4/11,12.38%,ADCK1;PID1;BNIP3;ZDHHC6
prerank,mitochondrial translational elongation (GO:0070125),0.43692805619881825,1.0787889423220327,0.3644859813084112,0.9597470453200044,1.0,9/88,7.30%,MRPS22;MRPS31;MRPS30;MRPL37;MRPS21;MRPL48;MRPS35;MRPS28;MRPL1
prerank,cellular component assembly (GO:0022607),0.43089880723013374,1.0787584813542643,0.306,0.95905476072179,1.0,62/253,17.40%,RSPH4A;DVL1;TFAP4;ZFYVE27;PPID;LLGL1;GAS6;NAPG;WASF1;VAMP3;FLNA;STX7;QSOX1;TEAD1;PLS3;WIPF1;ST13;PARVB;EZR;MNAT1;RANBP9;RTN3;REPS2;SPTBN1;IL1RAP;LPXN;TUBGCP2;YTHDF1;ADD1;LIMS1;APC;MYO9A;VAMP2;EPS8;CD2AP;CFAP74;CDC42;NOC2L;TRAF2;LAMC1;TP53;FBLIM1;LIN7A;RTN4;LIMA1;MDN1;AIF1;WASL;PEX14;VCPIP1;CAPZA1;ACTG1;CEP290;DNM1L;YTHDF3;CYFIP1;ARL6IP1;MYO1B;TAPBP;SNX9;NCKAP1L;GSN
prerank,negative regulation of mRNA catabolic process (GO:1902373),-0.3391548278197633,-1.078689562607649,0.3103448275862069,0.9367872924269359,1.0,8/29,13.91%,HNRNPU;PABPC1;SLC11A1;PAIP1;YBX1;FMR1;TENT5A;LARP1
prerank,sodium ion transport (GO:0006814),-0.2663679266665645,-1.0786864442115465,0.20689655172413793,0.9332088476444845,1.0,11/85,8.85%,SLC24A3;ANO6;ATP1B3;SGK1;SCN2A;ATP1B1;SCN3A;SCN8A;ATP1A2;NALCN;SLC38A7
prerank,intracellular protein transmembrane transport (GO:0065002),0.45613037546059615,1.0785784539964767,0.3690744920993228,0.9588340208788935,1.0,7/42,12.19%,TIMM17A;TOMM40;DNAJC15;SEC61G;TIMM23;SEC61A1;AIFM1
prerank,regulation of telomerase activity (GO:0051972),0.45807336525074166,1.078578141907815,0.3865168539325843,0.9580519376644735,1.0,12/45,14.13%,SMG6;TCP1;MAPK1;HSP90AA1;ERCC4;PKIB;NEK7;HMBOX1;PARP4;TP53;TERF1;NVL
prerank,mesonephros development (GO:0001823),0.5645865346690211,1.0780675128461652,0.4116719242902208,0.9589365466966135,1.0,1/11,2.34%,FGF1
prerank,protein localization to cell periphery (GO:1990778),0.43477850357855147,1.0777860928212142,0.3556231003039514,0.959073383524943,1.0,31/133,14.30%,PDZD11;FLOT2;ZFYVE27;EHD4;ITGB1BP1;RAB8B;EHD1;GAS6;RAB40C;RAB12;RAP1A;FLNA;RABEP1;MYO5A;EZR;PPIL2;IKBKB;DLG1;SLMAP;SPTBN1;EFR3B;RAMP1;TMED2;PACS2;EPB41L3;RAB3C;LRP6;LIN7A;PACS1;KCNIP3;ROCK2
prerank,positive regulation of defense response to virus by host (GO:0002230),0.49032763913958455,1.0776586475176964,0.3898305084745763,0.9587211617394678,1.0,5/24,11.45%,PARP9;HSP90AA1;ZDHHC1;MAVS;TRIM44
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.4284161868452381,1.0774406325682928,0.351460221550856,0.958676032755358,1.0,19/142,14.79%,C5AR1;CD36;TRPC5;ADCY8;ADCY5;YWHAE;SMAD3;PRKACA;CMKLR1;ESR1;SPPL3;TRPM4;NPTN;CACNA1A;ABL1;HMGB1;CYSLTR1;FZD9;CACNA1C
prerank,mitochondrial translational termination (GO:0070126),0.43530909938943635,1.0772868112674758,0.37798546209761164,0.9584317763882717,1.0,9/88,7.30%,MRPS22;MRPS31;MRPS30;MRPL37;MRPS21;MRPL48;MRPS35;MRPS28;MRPL1
prerank,MAPK cascade (GO:0000165),0.42833187872386075,1.0770892506876135,0.301,0.9583413424486151,1.0,52/295,14.38%,FGF22;FGF18;FNTB;NRG2;LRRK2;NRAS;MINK1;FGF1;GRB2;BRAF;NF1;PSMD9;AREG;IRS1;YWHAE;PSMB8;PDGFB;KITLG;MAPK1;MAP3K20;IRS2;PSMC5;MEF2A;IKBKB;DLG1;MAPK8;RANBP9;ARTN;SPTBN1;IL18;KRAS;PTPN3;SETX;TAOK1;RIT2;FBXW11;FRS2;RAF1;ZFP36L1;PSMD12;TGFA;MAPKAPK2;PSMA2;MAP2K2;SPRED1;CAMKK2;FYN;MAP3K8;LGALS9;SHOC2;CALM1;RASAL2
prerank,response to X-ray (GO:0010165),0.5278749649417673,1.0770732748404555,0.38285714285714284,0.9576187901986676,1.0,2/14,3.86%,BLM;XRCC4
prerank,mRNA methylation (GO:0080009),0.5306612713475946,1.0766610187430712,0.40387275242047027,0.9581824418930456,1.0,5/15,12.81%,METTL8;METTL3;CBLL1;ZC3H13;WTAP
prerank,regulation of phosphorylation (GO:0042325),0.43068462953716796,1.076599625569897,0.3532994923857868,0.9576283059947464,1.0,17/120,9.65%,ANG;EIF6;GLMN;PGAM1;ITGA6;AR;ZBTB7A;THBS1;NRP1;NUP205;EP300;SDCBP;IKBKB;NUP98;NUP54;FNIP1;LYN
prerank,positive regulation of chromosome organization (GO:2001252),0.5395396834087516,1.0765784923160802,0.4005524861878453,0.9569246173090421,1.0,5/15,15.25%,RAD50;MRE11;NBN;ATRX;PPP1R10
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.49138137682521354,1.0762732486835351,0.3738796414852753,0.9572289323808337,1.0,6/26,14.85%,CD36;SMAD3;HSP90AA1;INSR;PKD2;TLR4
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.4320080885004548,1.0762139873356609,0.357429718875502,0.9566546261349866,1.0,23/149,10.87%,TNFRSF11A;PRKCZ;CD36;RELA;CX3CL1;EIF2AK2;FLOT2;RNF31;CLOCK;AR;ZBTB7A;PRKCB;EP300;BTK;IKBKB;RPS6KA5;IL1RAP;IL18;IRAK2;TAB3;MTDH;TRIM5;TRAF2
prerank,protein import (GO:0017038),0.43874741155905966,1.0758334926352258,0.3796680497925311,0.9571458620223647,1.0,18/84,13.36%,PXMP2;KPNB1;EIF4ENIF1;RAB8B;HIKESHI;HEATR3;RANBP6;IPO7;ABCD2;IPO9;HSP90AA1;PTTG1IP;CSE1L;IPO5;ABCD3;IPO11;ABCD1;SYK
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.5639756306152501,1.0755918095204366,0.4278996865203762,0.9571559260013287,1.0,2/11,5.29%,TPK1;NT5C3A
prerank,regulation of interleukin-1 beta production (GO:0032651),0.44037560967798095,1.0752528796767908,0.38412017167381973,0.9574895364595768,1.0,5/66,7.52%,ISL1;CD36;CX3CL1;GSDMD;PYDC1
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.3319174464721786,-1.0752208700822348,0.3390804597701149,0.9369585864561435,1.0,18/32,24.23%,TPR;NUP153;NUP214;SSB;XPOT;NUP155;NUP188;NUP88;NUP35;NUP133;SEH1L;RAE1;NUP50;NUP210;NUP107;NUP42;RANBP2;POM121
prerank,tRNA export from nucleus (GO:0006409),-0.3319174464721786,-1.0752208700822348,0.3390804597701149,0.9369585864561435,1.0,18/32,24.23%,TPR;NUP153;NUP214;SSB;XPOT;NUP155;NUP188;NUP88;NUP35;NUP133;SEH1L;RAE1;NUP50;NUP210;NUP107;NUP42;RANBP2;POM121
prerank,peroxisomal membrane transport (GO:0015919),0.49380900264126576,1.074693979455898,0.38480392156862747,0.9585736908510449,1.0,8/27,17.45%,PXMP2;RAB8B;ABCD2;ABCD3;ABCD1;PEX14;PEX7;ATAD1
prerank,autophagy of nucleus (GO:0044804),0.5317969186330382,1.074454354459173,0.38285714285714284,0.9585965556752262,1.0,6/16,15.14%,WDR45;WDR45B;ULK2;ATG3;RB1CC1;ATG7
prerank,positive regulation of histone methylation (GO:0031062),0.49144932373674316,1.0741392709856379,0.40125786163522015,0.9588394999832057,1.0,2/24,2.15%,BRCA1;CTR9
prerank,protein K48-linked deubiquitination (GO:0071108),0.49400581473608174,1.073912001605914,0.39158163265306123,0.9588145157405892,1.0,9/23,15.42%,USP34;USP33;USP20;USP5;MINDY2;USP37;ATXN3;OTUD7A;VCPIP1
prerank,insulin receptor signaling pathway (GO:0008286),-0.27173601399093533,-1.0738625838053784,0.2777777777777778,0.9377010821877741,1.0,23/69,16.45%,ATP6V0A1;GAB1;ATP6V1A;PTPN2;AP3S1;APPL1;SORBS1;GSK3B;GRB14;IDE;ATP6V1D;PIK3CA;GRB10;ATP6V0C;SLC39A14;ATP6AP1;BAIAP2;ATP6V0B;AKT1;RHOQ;ATP6V1C1;SHC1;ATP6V1G1
prerank,regulation of cell killing (GO:0031341),0.5232991376055124,1.0737354283020561,0.40136986301369865,0.9586395096021828,1.0,3/16,7.75%,TGFB2;CFH;MAPK8
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.5417413796282178,1.0737170720925548,0.408955223880597,0.9579461334855207,1.0,4/13,11.45%,GAS6;AXL;MAVS;TRIM44
prerank,miRNA mediated inhibition of translation (GO:0035278),0.564338786739276,1.073543354012796,0.4017991004497751,0.9569660064935535,1.0,2/11,8.04%,EIF6;AGO2
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.564338786739276,1.073543354012796,0.4017991004497751,0.9569660064935535,1.0,2/11,8.04%,EIF6;AGO2
prerank,diol metabolic process (GO:0034311),0.5143219016878483,1.0734771724672632,0.41284403669724773,0.9564227629219055,1.0,5/19,14.29%,SGPP1;SGPP2;HSP90AA1;PTS;CALM1
prerank,microvillus assembly (GO:0030033),0.5390902473316715,1.073331564039402,0.380466472303207,0.9561597107026001,1.0,4/14,7.63%,MINK1;RAP1A;EZR;RAP1B
prerank,regulation of chemotaxis (GO:0050920),0.4757753560463218,1.0731942688152167,0.38164251207729466,0.9558440334192254,1.0,9/30,14.65%,DUSP3;THBS1;PDGFB;ZSWIM6;STX3;YTHDF1;CYRIB;P2RY12;AIF1
prerank,response to glucose (GO:0009749),0.46453726554963654,1.0730735463014227,0.37331838565022424,0.9554685182008332,1.0,10/46,12.47%,ADCY8;GAS6;THBS1;PRKACA;IRS2;VAMP2;IGF1R;GCK;ERN1;TCF7L2
prerank,negative regulation of synaptic transmission (GO:0050805),0.49927432549076084,1.0729897102465689,0.39564660691421255,0.9549901248819308,1.0,4/23,14.70%,LRRK2;SYT11;ARF1;PTEN
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.4481378795968433,-1.0729221311828336,0.39556962025316456,0.9371616983645286,1.0,10/12,51.09%,UPP2;TK2;UCKL1;DCK;UMPS;UCK2;DHODH;UCK1;TK1;CAD
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.48577309535495716,1.072741411358581,0.3857315598548972,0.9550400504203594,1.0,5/26,9.73%,CCDC57;DUSP3;PRKCA;PKN2;TAL1
prerank,positive regulation of phospholipase C activity (GO:0010863),0.46315214015001743,1.0725872324627703,0.3990772779700115,0.9547645035900805,1.0,4/40,9.87%,ANG;C5AR1;ESR1;GNAQ
prerank,negative regulation of angiogenesis (GO:0016525),0.4420648924442014,1.0723971166622719,0.38702928870292885,0.9546446466668659,1.0,10/84,10.93%,THBS2;RGCC;TGFB2;THBS1;PDE3B;MECP2;ALOX5;PPARG;HGS;SEMA6A
prerank,negative regulation of interleukin-12 production (GO:0032695),0.5394522286129042,1.0723674069544604,0.414050822122571,0.9539767528017299,1.0,2/14,5.58%,THBS1;CMKLR1
prerank,oligosaccharide metabolic process (GO:0009311),0.45548449930282575,1.0717416429118347,0.37699316628701596,0.9552779135768652,1.0,4/46,4.71%,MAN1B1;ST8SIA5;ST8SIA4;MPDU1
prerank,regulation of microtubule nucleation (GO:0010968),0.5650826040676223,1.0716948996468696,0.4218009478672986,0.9546689620456528,1.0,4/10,16.23%,DCTN1;MECP2;EML2;PAK1
prerank,negative regulation of cholesterol transport (GO:0032375),-0.45777070106085793,-1.0714082914735423,0.3785900783289817,0.9384422338895598,1.0,3/10,34.40%,SREBF2;ABCA2;APOC1
prerank,cellular response to nutrient levels (GO:0031669),0.44747382878863223,1.0713351783036222,0.37280701754385964,0.9551143099562542,1.0,11/62,11.59%,WDR45;RIPOR1;LRRK2;WRN;WDR45B;EHMT2;USP33;FNIP1;VPS41;FADS1;MTOR
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.4253457435425885,1.0710249812559138,0.306,0.9554528925746707,1.0,38/306,8.22%,POLR2D;BRCA1;RPL18;PCLAF;BLM;RFC2;POLE2;RPS6KB2;RPS23;RNASEH2A;RAD50;MRPL37;RPL41;RPL31;RPS17;RPL4;POLR2A;MRPS21;ORC4;RNPS1;POLA1;WRN;CDK2;RPLP0;HARS1;RPS15A;RPL38;DHPS;POLA2;POLD3;GOLPH3;MEF2A;RBBP8;MRE11;PABPC4;AGO2;NBN;SET
prerank,regulation of cellular protein localization (GO:1903827),0.4548555495310161,1.070972001711487,0.38555555555555554,0.954859810465926,1.0,13/45,15.42%,DVL1;NDEL1;MAP1A;HSP90AA1;CCDC66;SUMO3;SETD2;MAPT;PTPN1;GPC3;SPIDR;GPC6;VCPIP1
prerank,synapse assembly (GO:0007416),0.4526274844251604,1.0706947595839234,0.37713675213675213,0.9549482836292381,1.0,7/67,11.34%,SDK2;PCDHB16;DVL1;FARP1;CDK5;GABRG2;DBNL
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.4253386424279186,1.0703193429855138,0.18,0.9554380411070704,1.0,198/1082,16.13%,POU2F3;FHL5;ISL1;BMP5;GLIS1;WNT4;RGCC;BRCA1;IER2;RORA;ANKRD49;MED10;SIRT7;BLM;PARP9;PELP1;KDM1B;RPRD1B;RELA;CX3CL1;IRF1;DVL1;SMARCA4;CD38;SP1;BRD8;ILF3;ACTR3;PID1;FGF1;ZFP90;CASZ1;TFAP4;ITGA6;SS18L1;SNX5;ITGB1BP1;PCBD2;CLOCK;ZEB2;RUNX1;SLC9A1;MAX;HCFC1;ZNF318;BMPR1A;PSMD9;NFATC1;JUN;AR;PRDM10;KDM5A;ASF1A;ELK3;WBP2;IRF3;PADI2;CDK7;PAXBP1;EP300;SMAD3;PDGFB;TEAD1;LRP5;PRKDC;SQSTM1;DPF2;ESR1;MRTFB;HDAC5;NR3C1;ACVR1;JUND;KDM3A;BRCA2;MAML3;PRDM4;PSMC5;CRTC1;MAML2;BCLAF3;KMT2E;MEF2A;IKBKB;MLIP;RRP1B;THOC5;PHF10;SEC14L2;TFCP2;AKIRIN2;TLR3;NCOA1;SETD3;AGO2;PRPF6;RPS6KA5;CDK9;NCK1;IL18;UBTF;DAB2;NCOA3;CHEK2;PCGF5;ZXDC;MAVS;AHI1;PPARG;SSBP3;GLYR1;SETX;TAL1;CDC5L;DEAF1;HIVEP1;HOXC4;TCF12;NAA16;CHD8;FBXW11;NR5A1;KAT2B;ZNF711;CREB3L2;NR2C2;SOX11;TRIM44;ZBTB38;ECD;MTOR;MAP2K5;PPM1A;ABL1;HEATR1;HMGB1;TP53INP2;TCF7L2;ATF6;BRD7;MLLT11;HIPK2;TP53;ATRX;TGFBR1;RNF20;NR1D2;LRP6;MAP2K2;NAA15;RXRA;EPC1;CDK8;FUBP3;PPARGC1B;WWOX;TRIM56;GTF2H1;CAMKK2;RREB1;PRKD2;PKD2;CREB1;RFX3;EDRF1;RBPJ;TET2;PPARD;HIVEP3;TBL1XR1;NCOA2;WASL;LDB2;LDB1;TLR4;CTCF;ARNT;NPAS3;SMAD4;ZBTB18;NPM1;PHIP;SMARCA2;AKAP8L;CRLF3;THAP3;AUTS2;HDAC2;PIK3R1;FOXK1;NFIB;KMT2C;RGMB;ARID1B;LMO2;MAP2K1;UBP1;MRTFA
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.4407790512546284,1.070251715889771,0.3751328374070138,0.9548980277572808,1.0,24/67,15.01%,TBC1D15;CAPZB;EVI5;IFT20;TBC1D17;TBC1D14;TWF2;FXR2;TBC1D10B;CDC42;ATG3;GAP43;CDKL5;TBC1D5;PLD1;TBC1D10A;TBC1D13;CYLD;RABGAP1;PPP1R16B;TBC1D24;TBC1D22A;TBC1D8;TBC1D1
prerank,apical junction assembly (GO:0043297),0.44786530462998225,1.0701334080730738,0.3787047200878156,0.9545516011158586,1.0,8/53,13.31%,VCL;CTNNA1;DLG1;PKN2;PAK2;APC;WDR1;PDCD6IP
prerank,cellular protein catabolic process (GO:0044257),0.44331120142542846,1.0698139751815359,0.3873390557939914,0.9548471246375928,1.0,17/59,16.49%,ADAMTS12;CTSC;RAB12;AP2A1;CLPX;BNIP3L;CHEK2;CTSZ;CAPN2;MYLIP;BNIP3;HTRA2;RSPRY1;RAB7A;CLTC;UBE2G1;LGMN
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.3623403945578113,-1.0698031294379937,0.32195121951219513,0.9399259674489658,1.0,7/23,15.18%,APP;P2RX7;PFKFB4;PRKAA1;IGF1;PRKAA2;PRXL2C
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.4828897441219014,1.0696226527832156,0.39203860072376356,0.9547025712498468,1.0,12/30,16.87%,SMARCA4;AR;ZBTB7A;EP300;DAB2;NCOR1;NCOR2;KDM4C;DDX5;NCOA2;PKN1;KLK2
prerank,triglyceride homeostasis (GO:0070328),0.4914957204333729,1.069596768035554,0.39184177997527814,0.9540361154950558,1.0,2/26,8.68%,RORA;IL18
prerank,histone H4 acetylation (GO:0043967),0.4610548012550074,1.0695390496960255,0.39120631341600903,0.9534736053056433,1.0,14/47,16.62%,DMAP1;BRD8;HCFC1;EP300;BRCA2;ING3;PHF20;MORF4L2;JADE3;EPC1;EP400;MSL2;TRRAP;KANSL1
prerank,cellular response to estradiol stimulus (GO:0071392),0.5127404583838868,1.0692347232352313,0.4095238095238095,0.9537232617565842,1.0,3/18,13.20%,ESR1;NCOA3;LCOR
prerank,Golgi to plasma membrane transport (GO:0006893),0.45371703551337955,1.0692273902229266,0.4022222222222222,0.9529957390116626,1.0,18/47,17.66%,SYS1;LLGL1;RABEP1;KIF13A;EXOC5;CCDC93;GOLPH3;SPTBN1;VAMP2;EXOC6B;EXOC4;GGA1;OPTN;MACF1;GGA3;GOLGA4;GCC2;ARL3
prerank,negative regulation of protein kinase activity (GO:0006469),0.43844599030828135,1.068672491355191,0.390899689762151,0.9540176937513555,1.0,20/88,13.58%,CDK5RAP3;DUSP3;DVL1;ITGB1BP1;NF1;LRP5;PYDC1;PAK2;DUSP10;PTPN1;PTPRT;DTNBP1;GNAQ;ADAR;MVP;ABL1;SORL1;LRP6;PTPRO;SPRED1
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.4913268388064824,1.068514619771691,0.39762219286657857,0.9537999446973175,1.0,5/22,11.35%,DUSP3;PTPRJ;EZR;LPXN;PRNP
prerank,protein autoprocessing (GO:0016540),-0.39588319804091693,-1.0684582132778573,0.36996336996337,0.940677004268596,1.0,7/17,28.20%,AFG3L2;CTSL;CASP4;OMA1;CASP1;SPRTN;MYRF
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.5043586549011254,1.0676480321248303,0.40261437908496733,0.9558862419553662,1.0,4/21,13.94%,DVL1;APC;LRP6;CSNK1A1
prerank,histone modification (GO:0016570),0.4331010817899091,1.0675941144205088,0.38080495356037153,0.9553041231996379,1.0,19/109,9.60%,SIRT7;EHMT1;EYA2;BRD8;PADI2;HDAC9;EP300;ATXN7;CDK2;HDAC11;UBE2A;HDAC5;EHMT2;RPS6KA5;PARP2;PHF20;EZH2;MORF4L2;SIN3B
prerank,regulation of fibrinolysis (GO:0051917),0.525304795919892,1.067567414667751,0.3841554559043348,0.9546517618353157,1.0,1/13,4.55%,THBS1
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.5048511391652961,1.067358997872076,0.39892183288409705,0.9545787905072759,1.0,7/18,16.10%,ESR1;NCOR1;NCOR2;TP53;MAP2K2;DDX5;MAP2K1
prerank,ERBB signaling pathway (GO:0038127),0.44347932635502546,1.067347361665809,0.39383938393839385,0.9538729372963347,1.0,18/64,15.97%,NRG2;GRB2;BRAF;AREG;PRKCA;MAPK1;HSP90AA1;REPS2;RPS6KA5;KIF16B;DGKD;MVP;CBL;TGFA;PIK3C2A;PTPN18;PIK3R1;IQGAP1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.4766458646666726,1.0669697067896267,0.39657282741738065,0.9543957021433864,1.0,5/28,6.95%,CDK5RAP3;FBXW7;NUPR1;CTSC;PSMC5
prerank,peptide metabolic process (GO:0006518),0.4394812282517028,1.0666545104675584,0.3955928646379853,0.9546594285978092,1.0,9/75,12.65%,MGAT3;NLN;CPD;CPE;SPPL3;LNPEP;FURIN;PARL;ERAP1
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.540608096068461,1.0663405970459028,0.4028985507246377,0.954915576677018,1.0,5/12,11.85%,SMARCA4;ZBTB7A;DAB2;NCOR1;NCOR2
prerank,regulation of Golgi organization (GO:1903358),0.5105880307903385,1.0660360144951404,0.4099462365591398,0.9551625726021236,1.0,6/17,13.15%,AKAP9;MYO5A;MAPK1;CAMSAP3;ARMH3;MAP2K2
prerank,positive regulation of cilium assembly (GO:0045724),0.5085213424163538,1.0659078536304343,0.41361256544502617,0.9548565733125712,1.0,4/18,10.44%,TAPT1;BBS4;CCP110;ARHGAP35
prerank,positive regulation of cell migration (GO:0030335),0.42246148889621715,1.0658703744719855,0.35135135135135137,0.9542268918190366,1.0,41/253,13.73%,CXCL12;ROR2;SYNE2;RIPOR1;DDR2;FGF1;ITGA6;TGFB2;MAPRE1;EPHB2;ELP3;THBS1;NRP1;PDGFB;PRKCA;DOCK1;SEMA6D;KIF20B;SDCBP;ACVR1;CBLL1;FERMT3;AGO2;DAB2;APC;PLAA;F3;ACTN4;SEMA3D;SEMA6A;MIA3;IGF1R;MTOR;RUFY3;ADAM10;TGFBR1;ACVR1B;RTN4;FN1;INSR;RREB1
prerank,negative regulation of response to wounding (GO:1903035),-0.38325717162909817,-1.0656350805010093,0.35968379446640314,0.9463660838219468,1.0,6/19,17.08%,RTN4RL1;CASK;PTPRS;FGF2;EPHA4;CERS2
prerank,negative regulation of JNK cascade (GO:0046329),0.46912671297836206,1.065557098409914,0.38855054811205847,0.9544484426948501,1.0,7/31,12.73%,DUSP3;DUSP10;NCOR1;FKTN;ZMYND11;AIDA;CYLD
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.54325703223494,1.0655291094834454,0.4166666666666667,0.9538049836819164,1.0,4/11,14.16%,RFTN1;TLR3;COLEC12;UNC93B1
prerank,regulation of protein catabolic process (GO:0042176),-0.2627542195569691,-1.0653381895394454,0.17857142857142858,0.9436864102763715,1.0,31/99,19.20%,SMURF2;PRKN;SMURF1;CSNK2A1;HUWE1;EEF1A1;NSF;STX5;SIRT2;VCP;SNX12;GSK3B;AZIN1;RNF41;IDE;ATP13A2;WDR91;MDM4;DDB1;BANP;HECW2;TIPARP;SNF8;CDKN1B;HMGCR;GFAP;TNFAIP3;IRAK3;SEC22B;OAZ2;ZDHHC2
prerank,cellular lipid catabolic process (GO:0044242),-0.3352949800976095,-1.065298463091028,0.31351351351351353,0.9402961119942254,1.0,6/27,8.76%,ENPP2;SIRT2;LPIN2;ACOX1;PLA2G15;LPIN1
prerank,phosphorylation (GO:0016310),0.42191307715982673,1.0650877145530682,0.311,0.9544291873740919,1.0,81/385,14.01%,SGK3;SGK2;PLK1;RSKR;LRRK2;IGFBP3;PRKCZ;MINK1;EIF2AK2;ILF3;GMFB;LIPE;DYRK2;NEK3;BRAF;TGFB2;GAS6;BMPR1A;EPHB2;PIK3R4;MAP3K11;CDK7;PRKCB;PDGFB;PRKCA;PRKACA;CDK2;BTK;PRKDC;STK19;MAPK1;MAP3K20;CDK6;ACVR1;STK11;IKBKB;PI4KA;CDC42BPB;MAPK8;DGKI;PKN2;PAK2;RPS6KA5;CDK9;CAMK2D;MAP3K9;MAST2;PPP4R1;BIRC6;GRK5;DAPK1;CHEK2;BRD2;NEK7;CTBP1;LYN;CDK5;DGKD;TAOK1;TGFBR2;BMP2K;GK;MTOR;ABL1;ERN1;CDKL5;ADAM10;SRPK2;HIPK2;MAPKAPK2;TGFBR1;NRBP1;ACVR1B;CDK8;SYK;INSR;CAMKK2;FYN;PRKD2;CSNK1A1;CREB1
prerank,regulation of actin filament depolymerization (GO:0030834),-0.4397730361831764,-1.0650236012053256,0.40307692307692305,0.937587856795329,1.0,4/12,10.03%,MTPN;PLEKHH2;PIK3CA;CFL2
prerank,glycerolipid metabolic process (GO:0046486),-0.47309142136593213,-1.064778967501594,0.39244186046511625,0.9348693026110746,1.0,6/11,25.36%,PIP5K1A;PLA2G15;DGKA;DGKG;GAL3ST1;DGKQ
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.5502474343384438,1.0647546356544062,0.40816326530612246,0.9547459032255899,1.0,2/11,4.55%,BMPR1A;THBS1
prerank,histone H3-K9 demethylation (GO:0033169),0.5476184722121353,1.0643905286584496,0.4052795031055901,0.9551476026543017,1.0,4/11,11.95%,KDM3A;JMJD1C;KDM4B;KDM4C
prerank,membrane raft organization (GO:0031579),0.5367020032509067,1.0643305166144774,0.40813464235624125,0.9546131455353764,1.0,4/15,10.14%,FLOT2;RFTN1;ABCA7;ANXA2
prerank,aromatic amino acid family metabolic process (GO:0009072),0.5597058943835116,1.0640534566818933,0.4166666666666667,0.9548420618487298,1.0,2/10,7.40%,ATP7A;ASRGL1
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.27792104051968153,-1.0636118385218964,0.2676056338028169,0.9349233213609042,1.0,30/61,27.10%,PSMD14;PANK2;PSMA3;AZIN1;PSMB2;PSMB7;PSMC6;PSMD4;PSMD7;SIRT1;PSMA1;PSMA5;PSMC1;PSMD13;PSMC2;PSMA6;OAZ2;PSMA4;PSMD3;PSMF1;PSMD2;PSMD5;OAZ1;PSMD1;PSMC3;PRKAG2;PSMD8;PSMB3;PSME1;PSMB9
prerank,dendritic cell differentiation (GO:0097028),0.4905543945149443,1.0635466909226081,0.41048593350383633,0.9556715047808014,1.0,5/22,14.00%,GAS6;AXL;LYN;TGFBR2;LGALS9
prerank,sphingoid metabolic process (GO:0046519),0.5400539368349311,1.0633947334400933,0.4161764705882353,0.9554100805303686,1.0,2/12,5.74%,SGPP1;SGPP2
prerank,neuron projection morphogenesis (GO:0048812),0.42647872952189514,1.0627731363275754,0.3695431472081218,0.9566406646431423,1.0,33/137,16.94%,ISL1;LRRK2;DVL1;MINK1;IMPACT;LLGL1;MAP1A;EPHB2;S100A6;NYAP1;ATP7A;KIF20B;FARP1;MEF2A;SLC9A6;DTNBP1;CDK5;TAOK1;CDC42;SDC2;DBNL;EPB41L3;S100B;MAP6;PTEN;WASL;BTBD3;GPM6A;MAP4K4;IQGAP1;PAK1;DOCK10;CTNNA2
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.5144321832104577,1.0625323016377057,0.3961218836565097,0.9566813987542342,1.0,4/18,11.91%,SIRT7;FLNA;UBTF;HEATR1
prerank,dendrite morphogenesis (GO:0048813),0.4682787231168153,1.0620203550256249,0.4099883855981417,0.9575651184031856,1.0,13/35,16.94%,DVL1;MINK1;EPHB2;FARP1;MEF2A;CDC42;SDC2;MAP6;PTEN;WASL;BTBD3;DOCK10;CTNNA2
prerank,negative regulation of receptor internalization (GO:0002091),0.5466004993375692,1.0619655588606214,0.4264487369985141,0.9570017912356859,1.0,4/12,15.06%,RIN3;SDCBP;ATXN2;ANKRD13A
prerank,stem cell development (GO:0048864),0.510836950605728,1.0617063592644544,0.41530054644808745,0.9571458988141631,1.0,3/16,11.42%,TAPT1;PEF1;SOX11
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.5054382106048168,1.0616732829917213,0.41688654353562005,0.9565350684876327,1.0,2/20,5.17%,RGCC;PDGFB
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.3790310607052601,-1.0615806472341343,0.3442622950819672,0.938266079052472,1.0,13/18,45.37%,GSK3B;MPV17L;SLC35F6;BAX;BID;GSK3A;ACAA2;HIP1R;SLC25A5;CHCHD10;BAK1;MUL1;TMEM14A
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.543158060226097,1.0613759153938884,0.43255131964809385,0.9567311061166892,1.0,4/12,11.85%,ESR1;LIN28B;NCOR1;NCOR2
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.4384758899687482,1.0612010621787602,0.39660657476139977,0.9565371255727199,1.0,13/72,13.65%,POLR2D;RFC2;POLR2A;CDK7;EP300;COPS7B;POLD3;MNAT1;ERCC4;COPS4;CUL4A;UVSSA;GTF2H1
prerank,proteasome assembly (GO:0043248),0.5420464680061032,1.0609315105005397,0.4144927536231884,0.9566310010072598,1.0,2/11,5.30%,PSMD9;POMP
prerank,positive regulation of multicellular organismal process (GO:0051240),0.42094131991889594,1.0607962259034016,0.32432432432432434,0.9563003803747376,1.0,53/308,13.73%,RGCC;EHMT1;CD36;EIF2AK2;TAPT1;CFL1;GLMN;ALMS1;VAMP7;TGFB2;GAS6;OLFM1;BMPR1A;SMAD3;PDGFB;CMKLR1;DECR1;SDCBP;ACVR1;IL1A;KDM3A;KMT5B;AGO2;ABCA7;EZH2;TRPM4;IL18;DAB2;NCOA3;KMT5C;APC;B4GALT5;ENO1;CNOT3;TGFBR2;IGF1R;NR2C2;ACADL;SOX11;MTOR;SCAMP5;SORL1;SOX6;SLC27A1;TRPV2;ABCA1;TGFBR1;ACVR1B;RTN4;PPARGC1B;SYK;ADIPOR1;RREB1
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.5571862963714703,1.0606869900259233,0.40858505564387915,0.9559029849725375,1.0,4/10,17.88%,CD36;MIA3;TLR4;TREM2
prerank,negative regulation of growth (GO:0045926),0.42737070853324644,1.0605910147639916,0.3871951219512195,0.9554889994030714,1.0,30/121,15.95%,CGRRF1;SMARCA4;ADAM15;TGFB2;RERG;BCL6;EI24;SMAD3;DCBLD2;PTPRJ;STK11;ENO1;MT1F;MT1M;MT1H;MT1X;MT1A;MT1E;MT1G;MT1B;NOTCH2;TP53;ACVR1B;RBBP7;RTN4;SMAD4;SMARCA2;CRLF3;PPP1R9B;ST7L
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.4762666621398443,1.06057723952292,0.41183574879227053,0.9547959980375357,1.0,3/30,7.63%,GJC1;CACNA1D;GPD1L
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.35697357388395073,-1.06053766580332,0.35714285714285715,0.9380184836933748,1.0,5/23,2.93%,SMURF2;TGFB1;SMAD7;SMAD2;LATS1
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),-0.3245387841364353,-1.060497330396581,0.36363636363636365,0.9347555065829818,1.0,8/32,17.46%,P2RX7;AKAP6;TRPC1;CAPN3;SNCA;PDPK1;PLCG1;P2RX4
prerank,positive regulation of DNA recombination (GO:0045911),-0.342933006127382,-1.0596792208069503,0.38235294117647056,0.9339718797442806,1.0,14/27,26.77%,ACTR2;MMS19;RIF1;ERCC6;SHLD1;SHLD2;PARP1;WDR48;PAXIP1;HMCES;WAS;TFRC;ZCWPW1;PRDM9
prerank,regulation of apoptotic process (GO:0042981),0.4207343158224896,1.0592038244188737,0.266,0.9584571558362326,1.0,138/676,15.76%,PLK1;WFS1;GAS1;IGFBP3;UBE2Z;STEAP3;RELA;ARHGEF3;CX3CL1;CD38;WDR73;SMAD6;CFL1;BAG3;DDX42;NUPR1;FGD3;TFAP4;HS1BP3;FGD1;PLEKHG2;PPID;ITGA6;TNFRSF25;PLEKHG5;BRAF;SAP18;SMPD1;BCL2L11;GAS6;ITSN1;OLFM1;TARDBP;MTCH1;NAA35;NF1;JUN;ZBTB7A;THBS1;FLNA;IRF3;BCL6;RNPS1;TNFAIP8;ARHGEF12;MAP3K11;WRN;APAF1;CTNNBL1;PRKDC;SQSTM1;VAV3;MAP3K20;AXL;RBM5;EGLN3;BIRC3;EGLN2;HSP90AA1;GOLPH3;API5;IKBKB;ING3;MRE11;RRP1B;HSPA9;MAPK8;PAK2;BNIP3L;BFAR;ANKRD13C;BABAM2;DAB2;BIRC6;ZFAND6;GRK5;PHLPP1;DAPK1;AREL1;FAF1;LRP8;AHI1;KALRN;FBXO11;MTDH;PROC;APC;CD44;SETX;TMBIM4;CDK5;ACTN4;RNF157;AKAP13;NAA16;BNIP3;TRAF2;NOTCH2;IGF1R;CBL;RNF144B;ARHGEF17;ABL1;HMGB1;RAF1;AIFM1;VAV2;DNAJA3;RPS6;ATF6;ADAM10;MLLT11;TP53;BCL2;FMN2;NAA15;RTN4;HTRA2;ANXA5;NDRG1;ANP32A;FZD9;SPTLC1;DNAJC3;ANP32B;VAV1;ATG7;NPM1;HIP1;PHIP;RHBDD1;HDAC2;HNRNPK;STK3;PIK3R1;GRID2;MAP4K4;RPS6KA2
prerank,blood vessel morphogenesis (GO:0048514),0.44826029310658605,1.059196546998442,0.40904079382579933,0.9577489076320076,1.0,10/54,14.21%,GLMN;NF1;NRP1;LRP5;ITGB8;TGFBR2;TGFBR1;AGGF1;SYK;RBPJ
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.4319481357827799,-1.059119802706625,0.4090909090909091,0.9322775132897717,1.0,6/13,22.14%,RENBP;NAGK;GFPT1;AMDHD2;GNPDA1;UAP1L1
prerank,regulation of lymphocyte activation (GO:0051249),-0.43063564633516077,-1.0589836771004772,0.402555910543131,0.9293843813484246,1.0,1/12,0.43%,PAG1
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.4311790043719048,1.0587775470924827,0.4179728317659352,0.9583502759248707,1.0,14/78,9.89%,PID1;LDLRAP1;VPS4A;EPHB2;AR;STX7;SQSTM1;ZDHHC5;PPFIA1;DLG1;STX3;SPTBN1;DAB2;CDK5
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.542117729189228,1.0587018419943752,0.4366616989567809,0.9578690293389646,1.0,4/13,18.89%,B3GALNT1;B3GNT2;B3GALT1;B3GALT5
prerank,negative regulation of protein localization to membrane (GO:1905476),0.4871988231331872,1.058667205604939,0.4086161879895561,0.9572476675281938,1.0,5/24,8.83%,PID1;ITGB1BP1;GDI1;PPFIA1;DAB2
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.4768108514487712,1.0586573031126192,0.41405269761606023,0.9565596024446279,1.0,4/27,8.39%,SELENON;YWHAE;PRKACA;CAMK2D
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.5150719815720931,1.058526444251359,0.4428969359331476,0.9562602987310865,1.0,4/17,14.21%,BMPR1A;ACVR1;NOTCH2;RBPJ
prerank,regulation of intracellular protein transport (GO:0033157),0.468345893706585,1.0583943519783088,0.393681652490887,0.9559412636600723,1.0,7/32,9.86%,RIPOR1;SIRT7;NDEL1;PCNT;KIF20B;PTPN1;VAMP2
prerank,regulation of type I interferon production (GO:0032479),0.4270420929693936,1.0582209219846828,0.38189386056191466,0.9557724432108361,1.0,15/84,10.15%,POLR1C;POLR3G;RELA;IRF1;POLR3H;IRF3;POLA1;ILRUN;EP300;PRKDC;MRE11;CRCP;MAVS;RNF216;POLR3A
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.5465801022304271,1.0582102153241075,0.42836041358936483,0.9550837095510951,1.0,2/12,2.99%,BRD8;KLF9
prerank,positive regulation of actin nucleation (GO:0051127),0.5521753146553731,1.05795785818148,0.44461077844311375,0.9551567043768648,1.0,6/11,19.04%,WASF1;WASF2;CYFIP1;GSN;NCKAP1;BRK1
prerank,receptor internalization (GO:0031623),0.4483041449552409,1.0578574827615723,0.39815880322209435,0.9547272362461393,1.0,11/44,14.68%,CD36;LDLRAP1;GRB2;ARRB2;NEDD4;LMBRD1;SNX1;RAMP1;SYK;CALCRL;CLTC
prerank,regulation of chromatin binding (GO:0035561),0.5591435331173205,1.0577125635503863,0.4250386398763524,0.954468578358012,1.0,2/10,9.74%,PARP9;HMBOX1
prerank,mRNA metabolic process (GO:0016071),0.43569470387632764,1.0576176443402587,0.3932238193018481,0.9540364161230732,1.0,27/90,16.08%,CNOT10;ZC3H12D;CSTF3;PRPF3;GEMIN2;PRKACA;U2AF1;METTL3;RNASE4;HNRNPA2B1;SRSF5;PRMT9;SNRPD3;SCAF11;U2AF2;CPSF3;SF3B2;SRSF9;ERN1;SRSF11;TP53;DDX5;PCBP3;SF3B4;ALKBH5;AKAP8L;DHX15
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.460445242453028,1.0574420128167732,0.41284403669724773,0.9538589890976402,1.0,9/37,16.27%,LDLRAP1;BMPR1A;JUN;TPM1;PDGFB;PPARG;ERN1;PTEN;MEF2C
prerank,regulation of cholesterol metabolic process (GO:0090181),0.508406278857974,1.0573690489724776,0.4162371134020619,0.9533723775377818,1.0,5/20,11.42%,KPNB1;LDLRAP1;TTC39B;SEC14L2;ACADL
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.5421295849130153,1.0573371615909468,0.42835595776772245,0.9527415299812672,1.0,4/12,18.89%,B3GALNT1;B3GNT2;B3GALT1;B3GALT5
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.5025011484423063,1.0571509848450271,0.4240506329113924,0.9526009256656988,1.0,9/21,16.41%,VCL;DUSP3;SLC9A1;CAMSAP3;ROCK2;LDB1;CLASP1;MACF1;ACTG1
prerank,multivesicular body organization (GO:0036257),0.46440143967797065,1.056635655682128,0.40843373493975904,0.953511525258457,1.0,9/31,14.18%,TSG101;VPS4A;CHMP5;HGS;VPS37C;VPS37A;VPS4B;PDCD6IP;IST1
prerank,double-strand break repair via homologous recombination (GO:0000724),0.4289184953617465,1.0561367986765169,0.39462809917355374,0.9543484319607557,1.0,18/95,14.72%,BRCA1;BLM;RAD50;WRN;SEM1;BRCA2;RBBP8;MRE11;ERCC4;SMC5;NBN;EXD2;RFWD3;RAD51B;REV3L;RNF138;RECQL5;SPIDR
prerank,central nervous system neuron axonogenesis (GO:0021955),0.5423269253314332,1.0561234068305256,0.4240231548480463,0.9536680079689812,1.0,5/12,14.70%,EPHB2;HSP90AA1;B4GALT5;ARHGAP35;PTEN
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.4419781446983773,1.056121536263513,0.4150326797385621,0.9529548054577641,1.0,8/53,7.46%,FBXW7;GLMN;NUPR1;DESI1;USP19;PRKACA;PSMC5;UCHL5
prerank,regulation of translation (GO:0006417),0.42399959824769573,1.0558840522345374,0.38214643931795383,0.9530057123480589,1.0,32/173,11.59%,EIF6;EIF4A3;CNOT10;EIF2AK2;EIF3C;ILF3;EIF4ENIF1;EIF3E;IMPACT;SYNCRIP;METAP1;CSDE1;MALSU1;EIF4B;NIBAN1;THBS1;MTG2;PYM1;RBM3;PRKDC;ETF1;METTL3;NSUN3;LARP4B;YTHDF1;DAPK1;FXR2;CNOT9;EIF1;ATXN2;LSM14A;MTOR
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.29023771658612635,-1.0558346508228011,0.3302752293577982,0.9355450104011684,1.0,9/42,10.78%,ACTR2;MMS19;RIF1;ERCC6;SHLD1;SHLD2;KLHL15;PARP1;WDR48
prerank,establishment of apical/basal cell polarity (GO:0035089),0.5350826914785358,1.055821063674438,0.42083333333333334,0.9524996519600676,1.0,5/14,10.69%,MSN;CAMSAP3;EZR;MYO9A;CDC42
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.4223514182975391,-1.055206085276984,0.39666666666666667,0.9340775979955978,1.0,7/14,51.80%,DAGLA;ALDH9A1;SLC5A7;CHAT;NOS1;MOXD1;ACHE
prerank,long-term synaptic potentiation (GO:0060291),0.5017330659271837,1.0550278142858043,0.42317380352644834,0.9541244316494245,1.0,5/21,14.33%,PRKCZ;RGS14;NPTN;VAMP2;GRIN2A
prerank,positive regulation of cell cycle process (GO:0090068),0.42800681942601965,1.0542801639938288,0.4074074074074074,0.955703884021284,1.0,17/91,15.29%,RGCC;SVIL;USP19;PDGFB;LRP5;MAP3K20;KIF20B;IL1A;GIPC1;WIZ;PKN2;CDC42;TGFA;ATRX;INSR;PKP4;PHIP
prerank,mitotic chromosome condensation (GO:0007076),0.4807216838607456,1.0542464214963474,0.41697416974169743,0.9550951490560299,1.0,3/26,8.22%,PLK1;NCAPD3;SET
prerank,actin nucleation (GO:0045010),0.4953477263505432,1.0541688045150337,0.41222366710013003,0.9546089239065905,1.0,6/21,14.28%,ACTR3;IQGAP2;ARPC1A;ARPC4;ARPC2;ARPC3
prerank,negative regulation of autophagy (GO:0010507),0.43433241403940054,1.053728789380263,0.3896816684961581,0.9552376277427547,1.0,13/54,15.89%,WDR6;LRRK2;NUPR1;QSOX1;TBC1D14;SNRNP70;TAB3;MTOR;LZTS1;BCL2;TSC1;ATG7;FOXK1
prerank,nucleotide metabolic process (GO:0009117),0.48082519678089364,1.053493358708011,0.40803108808290156,0.9552170720552978,1.0,4/23,6.40%,AK4;REXO2;NMNAT3;NUDT5
prerank,response to ATP (GO:0033198),-0.38998169686545875,-1.0534732300311604,0.3926940639269406,0.9361175435851963,1.0,7/18,32.59%,P2RX7;TAF1;SSH1;P2RX4;DGKQ;HSP90B1;TRPC3
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.33891833153647544,-1.053398658259501,0.36363636363636365,0.9330710522995137,1.0,17/27,33.88%,PPP1CC;USP2;PML;FBXL12;MTA1;PER3;BHLHE40;RBM4;CRY2;CRY1;ID2;PER1;FBXL6;PPP1CA;RBM4B;SIK1;PER2
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.28370477088042273,-1.0530439545223562,0.31958762886597936,0.9308594393198535,1.0,27/50,27.10%,PSMD14;PSMA3;AZIN1;PSMB2;PSMB7;PSMC6;PSMD4;PSMD7;PSMA1;PSMA5;PSMC1;PSMD13;PSMC2;PSMA6;OAZ2;PSMA4;PSMD3;PSMF1;PSMD2;PSMD5;OAZ1;PSMD1;PSMC3;PSMD8;PSMB3;PSME1;PSMB9
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.5414003310427804,1.0528602442110295,0.4264264264264264,0.9564670373328209,1.0,4/11,16.52%,PRKCA;LYN;SYK;RDX
prerank,regulation of cytoplasmic transport (GO:1903649),0.5445676009009403,1.0526447458135504,0.45007451564828616,0.9564036580283731,1.0,5/11,16.10%,LRRK2;MAPK1;MAP2K2;DNAJC13;MAP2K1
prerank,extracellular matrix organization (GO:0030198),0.42002307200929073,1.052368129620755,0.372,0.9565369483958132,1.0,34/276,12.97%,SCUBE1;COL14A1;ADAMTS12;CRTAP;DDR1;DDR2;ADAMTS2;ADAM15;ITGA6;TGFB2;GAS6;NF1;ADAM12;THBS1;ADAMTSL3;ATP7A;PDGFB;QSOX1;FLRT2;ITGA4;ITGB5;COL11A1;ITGB8;ADAMTS10;CD44;BGN;LOXL3;FURIN;CAPN2;PXDN;LAMC1;P4HA1;ADAM10;TGFBR1
prerank,cellular response to virus (GO:0098586),0.46976264852492283,1.0523067695841102,0.4078144078144078,0.9560084257320549,1.0,7/30,14.00%,RIOK3;IRF3;HSP90AA1;RRP1B;ARF1;MAPK14;LGALS9
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.43542897323596863,1.0521301318272476,0.40869565217391307,0.9559044471234905,1.0,19/59,16.83%,LRRK2;DYRK2;PRKCA;PRKDC;MAPK1;ACVR1;CDC42BPB;MAPK8;CAMK2D;CDK5;TGFBR2;HIPK2;TGFBR1;ACVR1B;PRKD2;ROCK2;MAP2K1;TBK1;HIPK1
prerank,urogenital system development (GO:0001655),0.5485323039610376,1.0521010346439854,0.4401244167962675,0.9552874757845937,1.0,1/11,4.17%,EPHB2
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.5202878059347404,1.0515566109821024,0.41838134430727025,0.9563274659420441,1.0,5/14,14.48%,ECI2;CROT;ABCD1;HSD17B4;ACOX3
prerank,ureteric bud morphogenesis (GO:0060675),-0.39236033649633734,-1.0513719592046649,0.3890784982935154,0.9327642540536895,1.0,3/16,10.71%,SALL1;NPNT;FGF2
prerank,organelle assembly (GO:0070925),0.41656536772984,1.0507774289422256,0.364,0.9580012681732665,1.0,94/385,16.60%,WDR45;TSG101;CLUAP1;BBIP1;CCDC57;CEP89;RPS23;ACTR3;ATXN2L;EIF4ENIF1;ARL6;VPS4A;EHD4;CHMP5;TMEM67;RAB8B;EHD1;BBS4;CSDE1;CCDC61;MAPRE1;IQCB1;DZIP1;TMOD1;CEP250;UBQLN1;FLNA;STX7;TMOD3;TTC39C;WDR45B;FARP2;FNBP1L;AMBRA1;EXOC5;PCNT;DYNLL2;TUBGCP6;IFT52;IFT20;ABLIM3;CCDC66;SNX10;MAPT;TUBGCP2;YTHDF1;NCOR1;CDS1;AHI1;NEK7;PRRC2C;PTPN23;HGS;VPS37C;HPS4;ATXN2;POC1B;VPS37A;ULK2;DBNL;EXOC4;ATG3;KIF3A;LSM14A;VPS4B;PACS2;STARD9;OCRL;PTPDC1;RB1CC1;TP53INP2;EIF2S1;PDCD6IP;RPGR;ARMC9;BICD1;RFX3;IST1;RAB7A;G3BP1;ABLIM1;ATG7;BECN1;NPM1;SCLT1;NEK6;PDE6D;GOLGA8B;CEP83;PATL1;CEP290;RP2;YTHDF3;CENPC
prerank,protein N-linked glycosylation (GO:0006487),0.4395659743398488,1.0507209516810962,0.410828025477707,0.9574561741810079,1.0,10/66,13.51%,MGAT3;LMAN1;ALG3;UGGT2;MPDU1;STT3A;B4GALT1;ST6GAL1;MGAT4B;UGGT1
prerank,smooth muscle cell differentiation (GO:0051145),0.5446941512645623,1.0506151761802434,0.4305993690851735,0.9570430164665855,1.0,3/12,16.27%,MRTFB;MRTFA;MEF2C
prerank,negative regulation of protein phosphorylation (GO:0001933),0.42639495626149104,1.0503393073416423,0.4147325933400605,0.9572242734784108,1.0,27/150,11.35%,LRRK2;IGFBP3;CDK5RAP3;PRKCZ;DVL1;SMAD6;PMEPA1;PID1;CNKSR3;ITGB1BP1;IMPACT;TARDBP;NIBAN1;NF1;EPHB2;PRKDC;SPRED2;PYDC1;GPD1L;LDLRAD4;PAK2;NCK1;DTNBP1;LYN;GNAQ;MVP;PRNP
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.5538275150640412,1.049897178755836,0.43815201192250375,0.9579259676825996,1.0,4/10,12.92%,ESR1;PSMC5;HMGB1;TP53
prerank,sphingosine metabolic process (GO:0006670),0.5084796725634776,1.0497546728798288,0.4201909959072306,0.9576525351079929,1.0,5/17,14.77%,SGPP1;SGPP2;ACER3;ASAH1;SPTLC1
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.42815520768506904,-1.0497425439915853,0.43214285714285716,0.9345759326081978,1.0,2/13,3.71%,GLUD1;GLUL
prerank,B cell homeostasis (GO:0001782),0.5529903008045863,1.0493214750143922,0.43098159509202455,0.9583506073810663,1.0,6/10,17.29%,LYN;CAMLG;DOCK11;MEF2C;DOCK10;NCKAP1L
prerank,negative regulation of cell migration (GO:0030336),0.4188208045289547,1.0488515344368141,0.40606060606060607,0.9591307155392538,1.0,30/137,15.64%,VCL;IGFBP3;DUSP3;CX3CL1;SCAI;ADAM15;ITGB1BP1;ZMYND8;NF1;BMPR1A;TPM1;PTPRJ;LDLRAD4;DUSP10;SLURP1;PTPRT;PTPN23;MIA3;RNF20;PTPRU;MCC;ADIPOR1;NDRG4;PTEN;TMEFF2;ARHGDIB;DAG1;CLASP1;EVL;STK24
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.5141198192386632,1.0487806110203994,0.4444444444444444,0.9586472191583494,1.0,4/16,8.39%,SLC9A1;PRKCA;MEF2A;CAMK2D
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.4826718134709034,1.04865591609389,0.4071340713407134,0.9583280646122369,1.0,3/25,6.07%,LRRK2;RAB3GAP1;ARRB2
prerank,negative regulation of cell projection organization (GO:0031345),-0.2912527271717079,-1.0483484033922286,0.35135135135135137,0.9355127976356036,1.0,13/48,15.31%,RTN4RL1;CBFA2T2;GAK;GRIN2B;PRAG1;ITM2C;PTPRS;LPAR1;EPHA4;SEMA3A;SPOCK1;DCC;DPYSL3
prerank,cellular response to hypoxia (GO:0071456),0.4211689063490413,1.0481827324705861,0.39979757085020245,0.9590936541472116,1.0,23/126,13.05%,RGCC;RORA;AK4;SUV39H1;PSMD9;UBQLN1;PSMB8;EP300;EGLN3;EGLN2;PSMC5;HP1BP3;BNIP3L;EGLN1;ELOC;BNIP3;MTOR;ZFP36L1;PSMD12;HIPK2;TP53;PSMA2;FMN2
prerank,negative regulation of proteolysis (GO:0045861),0.4525387708924953,1.048129148439651,0.41824644549763035,0.9585623131575243,1.0,6/34,11.66%,GAS1;LRRK2;PTPN3;CDK5;PRNP;DNAJC1
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.5401299658671814,1.0481166331376843,0.4408284023668639,0.9578895546639196,1.0,1/11,1.16%,BLM
prerank,melanosome transport (GO:0032402),0.5075316064058708,1.047816221241138,0.4396200814111262,0.9573719053640605,1.0,3/18,5.36%,ARL6;BBS4;MYO5A
prerank,pigment granule transport (GO:0051904),0.5075316064058708,1.047816221241138,0.4396200814111262,0.9573719053640605,1.0,3/18,5.36%,ARL6;BBS4;MYO5A
prerank,phosphate ion transmembrane transport (GO:0035435),0.5366930980711937,1.047572948427368,0.4263005780346821,0.9573981751389352,1.0,5/12,14.89%,SLC37A2;XPR1;SLC37A3;SLC20A2;SLC25A3
prerank,Rho protein signal transduction (GO:0007266),0.4388905081448503,1.0473552649545135,0.4234135667396061,0.9573906486201227,1.0,11/53,14.97%,RIPOR1;ARHGEF3;CFL1;PLEKHG5;EPS8L1;ARHGAP1;EPS8;CDC42;MYO9B;ROCK2;ARHGDIB
prerank,regulation of protein metabolic process (GO:0051246),0.44072316291922115,1.047174254335418,0.41857798165137616,0.9572901801243415,1.0,11/44,14.30%,WFS1;MAPK8;ABCA7;VPS35;CHEK2;FAF1;HGS;FURIN;MAP2K5;PARL;ROCK2
prerank,central nervous system myelination (GO:0022010),0.5431209304107298,1.0469102448504575,0.43644716692189894,0.9574123331968714,1.0,4/11,14.70%,TENM4;B4GALT5;PLP1;PTEN
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.49694493997499817,1.0466845982771869,0.4272363150867824,0.9573913394374125,1.0,3/18,9.65%,CAMK1D;MTUS1;LYN
prerank,regulation of cell growth (GO:0001558),0.4192536206437547,1.046640234606792,0.40480961923847697,0.9568400622650645,1.0,30/204,13.32%,SGK3;SGK2;URI1;CGRRF1;SMARCA4;ADAM15;DDX49;TGFB2;RERG;BCL6;EI24;SMAD3;DCBLD2;PTPRJ;SDCBP;EGLN2;STK11;NRG3;CAMK2D;ADNP2;ENO1;CDC42;MTOR;ADAM10;TP53;TGFBR1;BCL2;ACVR1B;RBBP7;RTN4
prerank,secondary alcohol biosynthetic process (GO:1902653),0.4666334803493214,1.0465530706685893,0.42105263157894735,0.956412169779178,1.0,3/30,4.43%,INSIG1;INSIG2;GGPS1
prerank,positive regulation of receptor internalization (GO:0002092),0.4733953547416577,1.0465368070985515,0.42312579415501905,0.9557645728854018,1.0,5/22,13.60%,ARRB2;AHI1;CD63;TBC1D5;INSR
prerank,positive regulation of interferon-alpha production (GO:0032727),0.48684153469857744,1.046369645578561,0.4367666232073012,0.9556045329730284,1.0,5/19,9.31%,TLR7;IRF3;SETD2;TLR3;MAVS
prerank,positive regulation of chemokine production (GO:0032722),0.4484656941166783,1.0462391946669964,0.417607223476298,0.9553015348319652,1.0,11/44,14.85%,EIF2AK2;TLR7;TLR3;IL18;MAVS;IL17RA;HMGB1;SYK;LGALS9;AIF1;TLR4
prerank,anterior/posterior axis specification (GO:0009948),0.507917862536533,1.0461768809453023,0.42701227830832195,0.9547880738058823,1.0,2/15,11.94%,WLS;TASOR
prerank,lipid modification (GO:0030258),0.4524195953405863,1.0461684883910538,0.41824644549763035,0.9541182287640061,1.0,6/37,10.16%,PLA2G7;SGPP1;SGPP2;DGKI;ALOX5;DGKD
prerank,negative regulation of multicellular organismal process (GO:0051241),0.41418859968288274,1.0458397802725388,0.39056224899598396,0.9544696047486867,1.0,34/199,15.32%,BMP5;RGCC;SMAD6;CHSY1;GAS6;HDAC9;SPRED2;NRDC;ALDH1A1;BRCA2;STK11;ACOT13;MAP2K6;ABHD6;SYT11;LDLRAD4;RPS6KA5;LNPEP;DUSP10;NPTN;PROC;PTPN23;PAEP;USF3;PTPRO;SPRED1;MCC;ADIPOR1;RBPJ;ROCK2;PTEN;TLR4;ARHGDIB;EVL
prerank,actin-myosin filament sliding (GO:0033275),0.44387167761818536,1.0457640244191873,0.4223245109321059,0.9533034659413467,1.0,2/38,4.91%,TMOD1;TPM1
prerank,muscle filament sliding (GO:0030049),0.44387167761818536,1.0457640244191873,0.4223245109321059,0.9533034659413467,1.0,2/38,4.91%,TMOD1;TPM1
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.41841571261477906,1.045673843338953,0.42396777442094663,0.9528883677612722,1.0,24/151,15.17%,LCAT;DEGS1;MGST3;SGPP1;HACD1;CERS6;SGPP2;ACER3;NFS1;CHKB;GOLPH3;PLA2G4A;SLC25A2;B4GALT5;CERS4;FURIN;SGPL1;SLC27A1;CERS5;CHKA;PRKD2;HACD4;SPTLC1;SLC44A1
prerank,regulation of neuron apoptotic process (GO:0043523),0.4198572040330763,1.0455746208806775,0.4094650205761317,0.9525258124635968,1.0,12/96,13.04%,ISL1;WFS1;NUPR1;TGFB2;NF1;EGLN3;EGLN2;SET;CDK5;PRNP;SRPK2;BCL2
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.5107010820091935,1.0454740222718002,0.4272363150867824,0.9521319005370122,1.0,5/18,9.40%,LRRK2;RAB3GAP1;RAP1A;RAP1B;DTNBP1
prerank,positive regulation of interleukin-6 production (GO:0032755),0.43288664957439354,1.0453441767129752,0.42071197411003236,0.9518319162817254,1.0,13/68,14.85%,ISL1;IL16;TLR7;IL1A;TLR3;MAVS;IL17RA;HMGB1;SYK;LGALS9;RAB7B;AIF1;TLR4
prerank,negative regulation of phosphatase activity (GO:0010923),0.4773631843109671,1.045277618071288,0.43564356435643564,0.951339125864328,1.0,5/25,14.98%,URI1;TGFB2;BOD1L1;TIPRL;GPATCH2
prerank,rRNA catabolic process (GO:0016075),0.5107605398104897,1.045060708726437,0.4491758241758242,0.9513286918270736,1.0,3/16,7.14%,EXOSC5;EXOSC7;XRN1
prerank,regulation of chromosome segregation (GO:0051983),0.5201930268452166,1.0449871770410017,0.42934782608695654,0.9508754230833463,1.0,4/16,9.28%,RAD18;PUM2;SMC5;PUM1
prerank,regulation of heart contraction (GO:0008016),0.42638184228009446,1.044883918826624,0.43388429752066116,0.9505025981338147,1.0,4/90,5.27%,ACE2;TGFB2;TPM1;PRKACA
prerank,monocarboxylic acid transport (GO:0015718),0.444101971367119,1.0445117705715317,0.3997785160575858,0.9509564101492725,1.0,10/51,15.52%,CD36;SLCO1B1;NCOA1;STARD5;SLC27A1;RXRA;SLCO2B1;NCOA2;SLC16A6;ABCG2
prerank,regulation of RNA splicing (GO:0043484),0.4268014133301658,1.044450036486675,0.4217252396166134,0.9504520143308848,1.0,28/69,18.61%,HABP4;POLR2A;MBNL1;SLC38A2;PTBP3;RRP1B;SNRNP70;MBNL2;SETX;FUS;U2AF2;AFF2;SF1;QKI;ERN1;SRPK2;HNRNPH3;CLK1;HNRNPH1;HNRNPK;PIK3R1;HNRNPL;SRSF3;SON;TMBIM6;KHDRBS1;CELF1;KHDRBS3
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.4254963066349631,1.0442413859194344,0.41596638655462187,0.9503766488292907,1.0,14/75,14.82%,ISL1;DVL1;MINK1;LLGL1;MAP1A;S100A6;FARP1;MEF2A;CDK5;SDC2;S100B;MAP6;UNK;BTBD3
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.5522642327428522,1.0435533671121247,0.4411302982731554,0.9517982648897911,1.0,2/10,5.11%,DCLRE1A;TERF2
prerank,error-prone translesion synthesis (GO:0042276),0.48870874669819236,1.0435074270553004,0.42857142857142855,0.951258282894042,1.0,2/21,1.62%,RFC2;POLE2
prerank,negative regulation of cell differentiation (GO:0045596),0.4176930853415054,1.0433273671723409,0.40826612903225806,0.9510854019075055,1.0,24/181,14.94%,BMP5;RORA;ADAMTS12;SMAD6;CTR9;HOPX;IQCB1;SMAD3;CRIM1;LRP5;SPRED2;CDK6;LDLRAD4;TRPM4;PPARG;ABCG1;USF3;ABCA1;TGFBR1;SPRED1;ADIPOR1;ABCA5;PTEN;ANP32B
prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.2599115842838932,-1.0432624702402318,0.3018867924528302,0.9485448055613152,1.0,18/76,16.41%,BCAS3;PRKCE;HCK;P2RX7;PTK2B;FES;HCLS1;NTRK3;CFL2;NCK2;VASP;BAIAP2;PYCARD;PFN1;SORBS3;LIMK1;DYNC1H1;PFDN2
prerank,intracellular protein transport (GO:0006886),0.4151576027295267,1.0431565492854729,0.38538538538538536,0.9509436421969366,1.0,75/304,15.30%,STXBP2;LMAN1;ARL5A;TMED4;BAG3;ARL4A;KPNB1;EIF4ENIF1;ARL6;ARF3;DESI1;COPB2;EHD1;NAPG;HIKESHI;TBC1D15;STX7;KIF13A;HEATR3;SIL1;EVI5;TMED9;RANBP6;IPO7;AP2A1;IPO9;TBC1D17;CAMSAP3;RAB5B;PTTG1IP;GIPC1;VPS45;RAB6A;STX3;CSE1L;TBC1D14;VPS35;STX16;ARL4C;STX17;TBC1D10B;IPO5;WLS;HPS4;ARF1;SNX1;TMED2;TBC1D4;RAB18;TBC1D12;IPO11;SORL1;SNX8;TBC1D5;TBC1D10A;VIPAS39;SRPRA;TBC1D13;ERP29;RABGAP1;TMED5;NAPA;RPGR;SYK;SAR1B;UNC93B1;TBC1D22A;GGA1;TBC1D8;RAB7A;CLTC;TBC1D1;NPM1;PPP1R10;SNX13
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.3627070813205435,-1.0430956787762515,0.38308457711442784,0.9458408303394518,1.0,12/23,25.85%,DYNC1I1;KIF5C;CCDC186;MYO10;KIF1A;CCDC88B;CCDC88A;KIF1C;HOOK1;KIF5A;TUBA1B;CCDC88C
prerank,protein insertion into ER membrane (GO:0045048),0.45495292687072914,1.0430520207336385,0.42276422764227645,0.9505802577338057,1.0,7/37,12.11%,TRAM1L1;EMC9;SEC61G;UBE2J2;VAMP2;PRNP;CAMLG
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.468792838615197,-1.0429630613410192,0.4314868804664723,0.9429508445110767,1.0,5/10,14.62%,DIP2A;FLCN;PRKAA1;SIRT1;PRKAA2
prerank,nervous system development (GO:0007399),0.41900577255968213,1.042341043946184,0.362,0.9520149712447689,1.0,73/429,14.82%,SDK2;PCDH1;ALDH1A2;PCDHB16;ZIC4;BTD;ST8SIA4;DVL1;GBA2;TRPC5;GMFB;NUMBL;TMEM223;VXN;ZEB2;SMPD1;NF1;MBNL1;EPHB2;ELP3;ATXN1;NELL1;APAF1;EP300;MSI1;TEAD1;CRIM1;NAV1;DPF2;AXL;FARP1;DCTN1;SERPINI1;APBA1;RAPGEF5;ARTN;NDUFV2;CHD7;MTR;ITM2B;AHI1;KALRN;GLRB;APC;RBFOX3;CDK5;TRIM3;FKTN;MYLIP;SEMA6A;SDHA;GDA;NOTCH2;NR2C2;DBNL;CHST8;FEZ1;PTS;SOX6;TGFBR1;MYT1L;ACVR1B;S100B;FN1;ADAM22;ATXN3;PKD2;RELN;FZD9;PTEN;LDB2;LDB1;BTBD3
prerank,regulation of interleukin-6 production (GO:0032675),0.4217763151152122,1.0420472998065082,0.4348279457768509,0.9522337202534672,1.0,18/96,15.45%,ISL1;CX3CL1;IL16;TLR7;GAS6;IL1A;SYT11;TLR3;MAVS;IL17RA;HMGB1;MAPKAPK2;SYK;LGALS9;RAB7B;AIF1;TLR4;CD47
prerank,entry into host (GO:0044409),0.5259829228534538,1.041972727645858,0.44365192582025675,0.951755119074809,1.0,3/13,11.44%,GRB2;CBLL1;CBL
prerank,chromosome organization (GO:0051276),0.4214070554580973,1.04188061598225,0.4157187176835574,0.9513460520622455,1.0,18/99,12.47%,CETN2;EHMT1;SMARCA4;SUV39H1;ZBTB7A;PADI2;COPS7B;HMGN3;HDAC11;HDAC5;MTHFR;GATAD1;EZH2;COPS4;RFWD3;CUL4A;ABL1;TCF7L2
prerank,phosphate-containing compound metabolic process (GO:0006796),0.41233055440983746,1.0418781000054207,0.4024024024024024,0.9506733548926599,1.0,30/198,11.98%,LCAT;INPP1;LRRK2;DUSP3;EPHB2;PIP4K2A;ALDOA;INPP4A;INPP5A;NUDT5;GPX4;PI4KA;PAK2;PLA2G4A;DUSP16;DUSP10;PIP4K2B;CDK5;PLAA;TAOK1;MINPP1;PLD4;IPMK;GK;GCK;MTOR;PLCB4;PFKP;PPM1A;OCRL
prerank,neuron projection organization (GO:0106027),0.5102454014005435,1.041808719520476,0.4291845493562232,0.9502005553152522,1.0,7/15,13.60%,MAP1A;ABCD2;DCTN1;ARF1;PRNP;ABCD1;INSR
prerank,positive regulation of secretion (GO:0051047),-0.4443112497459224,-1.041779616867675,0.41297935103244837,0.9434255899662212,1.0,3/11,33.56%,ACSL3;XBP1;GPLD1
prerank,regulation of fibroblast proliferation (GO:0048145),0.45305183745073974,1.0412109338963393,0.4383408071748879,0.9513326562194002,1.0,6/45,6.36%,DDR2;GAS6;NF1;S100A6;PDGFB;CDK6
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.5156871223996623,1.0409725769573563,0.438957475994513,0.9513632596120802,1.0,3/15,9.98%,ZC3H12D;POP1;ZC3H12B
prerank,regulation of B cell activation (GO:0050864),-0.35291612185719357,-1.0409627847051066,0.365296803652968,0.9425993663572446,1.0,6/25,16.37%,LAPTM5;SAMSN1;FCGR2B;TNIP2;CD22;TNFAIP3
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.5417637152460397,1.0408939616682416,0.4373040752351097,0.9509150641083473,1.0,1/10,1.07%,LRRK2
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.4748739587909458,1.0408694461637429,0.4401008827238335,0.9502997720026842,1.0,4/25,7.55%,DNAJB1;DNAJC18;ST13;HSPA9
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.5367610064010477,1.0407114230849348,0.4370257966616085,0.9501065858961797,1.0,3/11,6.42%,NUPR1;PELI1;BIRC3
prerank,response to ionizing radiation (GO:0010212),0.42650629553437386,1.0406440405071715,0.42430703624733473,0.9496274732490217,1.0,12/70,12.92%,BRCA1;BLM;GRB2;CLOCK;SMPD1;XRCC4;STK11;BABAM2;RFWD3;TANK;MAPK14;TP53
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.4149699960485492,1.040129965141797,0.365,0.9504393092599216,1.0,108/476,17.62%,WNT4;BRCA1;RORA;ANKRD49;BLM;PARP9;RELA;IRF1;SMARCA4;CD38;SP1;ILF3;ZFP90;CASZ1;TFAP4;SS18L1;SNX5;PCBD2;CLOCK;RUNX1;HCFC1;ZNF318;PSMD9;NFATC1;JUN;AR;KDM5A;WBP2;EP300;SMAD3;PDGFB;TEAD1;LRP5;ESR1;ACVR1;KDM3A;BRCA2;PSMC5;KMT2E;IKBKB;SEC14L2;NCOA1;SETD3;CHEK2;ZXDC;PPARG;TAL1;DEAF1;NAA16;CHD8;FBXW11;ZNF711;CREB3L2;SOX11;TRIM44;PPM1A;TP53INP2;BRD7;MLLT11;HIPK2;TP53;TGFBR1;RNF20;NR1D2;LRP6;MAP2K2;NAA15;RXRA;EPC1;FUBP3;TRIM56;GTF2H1;CAMKK2;RREB1;CREB1;RFX3;EDRF1;PPARD;HIVEP3;TBL1XR1;CTCF;NPAS3;SMAD4;NPM1;PHIP;SMARCA2;CRLF3;HDAC2;FOXK1;NFIB;RGMB;ARID1B;MAP2K1;MEF2C;CEP290;SMARCC2;HNRNPD;RORB;TBL1X;NFYA;FOXO3;MAP3K2;MDFIC;MED1;USP21;USP16;CTNNB1;TFEB
prerank,protein tetramerization (GO:0051262),0.4294147480053785,1.0401067276152887,0.4258271077908218,0.9498224714284369,1.0,13/67,16.25%,ALDH1A2;FARSA;SSBP1;ALDOA;HPRT1;ACOT13;TRPM4;MCOLN1;PKD2;ACACA;HCN1;GLS;OSBPL2
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.46867638690881713,1.0397962027713035,0.4138755980861244,0.950067644979294,1.0,6/30,7.46%,UBXN1;MAP1A;STYX;SDCBP;GIPC1;UCHL5
prerank,regulation of fatty acid oxidation (GO:0046320),0.5084056007046165,1.039660761024519,0.4236111111111111,0.949788895090245,1.0,3/16,12.94%,TYSND1;ACADL;ABCD1
prerank,phospholipid homeostasis (GO:0055091),0.5346760813111757,1.0389367062963772,0.4496240601503759,0.951278982067297,1.0,2/11,12.85%,ABCG1;ABCA1
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.44004947924206084,1.0388766476184277,0.43673012318029114,0.9501013883803803,1.0,8/51,7.70%,BANF1;KPNB1;VPS4A;PPP2R2A;NUP205;AHCTF1;NUP98;LEMD2
prerank,mitotic nuclear membrane organization (GO:0101024),0.44004947924206084,1.0388766476184277,0.43673012318029114,0.9501013883803803,1.0,8/51,7.70%,BANF1;KPNB1;VPS4A;PPP2R2A;NUP205;AHCTF1;NUP98;LEMD2
prerank,negative regulation of receptor binding (GO:1900121),0.5453119374897364,1.0387112589003673,0.45788667687595713,0.9498929203359237,1.0,1/10,3.00%,ADAM15
prerank,membrane lipid metabolic process (GO:0006643),-0.35323782041692564,-1.0386275233542277,0.415929203539823,0.9463068497752984,1.0,9/22,23.36%,CERK;TEX2;AGK;AGMO;ST3GAL6;ST6GALNAC4;ARV1;GAL3ST1;B4GALT4
prerank,cellular response to cytokine stimulus (GO:0071345),0.4119056148280092,1.0385085865318306,0.374,0.9498251274022592,1.0,66/416,15.08%,CXCL12;BRCA1;RORA;ADAMTS12;S1PR1;CD36;RELA;CX3CL1;IRAK4;IRF1;RAPGEF1;PID1;LDLRAP1;NUMBL;DOCK8;IL16;GRB2;SYNCRIP;BCL2L11;GAS6;BCL6;LIFR;SMAD3;IL10RB;PRKACA;PTPRJ;AXL;IL1A;HSP90AA1;IKBKB;CCL25;MAPK8;STX3;CDK9;IL1RAP;F13A1;ALOX5;PTPRT;IL18;IRAK2;ZFAND6;DAPK1;LRP8;PTPN23;SOCS5;F3;MT1X;ASAH1;TANK;IFNAR2;LRCH1;CBL;ZFP36L1;SH2B3;TP53;BCL2;SYK;FN1;FYN;HTRA2;LGALS9;AIF1;PTPN9;TLR4;PTPN18;VAV1
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.496400704913231,1.0384846715916372,0.4466145833333333,0.9492288477855947,1.0,2/23,5.62%,PLK1;MAPK1
prerank,regulation of acrosome reaction (GO:0060046),-0.45778481601742876,-1.038401134751413,0.4264705882352941,0.9437030589840044,1.0,1/10,12.13%,GLRA1
prerank,catecholamine biosynthetic process (GO:0042423),0.5474766643908158,1.0382760300214047,0.4582043343653251,0.9491695688039304,1.0,1/11,3.69%,TGFB2
prerank,COPII-coated vesicle budding (GO:0090114),0.4275257233330878,1.0381846383692348,0.4322033898305085,0.9487767757799485,1.0,17/68,14.11%,LMAN1;GOSR2;PEF1;CTSC;AREG;TRAPPC3;TRAPPC9;CTSZ;TFG;SEC24B;MIA3;SEC24D;TMED2;TGFA;NAPA;SAR1B;TRAPPC6B
prerank,negative regulation of myoblast differentiation (GO:0045662),-0.41461407552106977,-1.0379876900494804,0.4262295081967213,0.9416152529667572,1.0,2/13,15.54%,TGFB1;NOTCH1
prerank,positive regulation of protein transport (GO:0051222),0.42476156232480483,1.0379545785211852,0.4312026002166847,0.9487972717467832,1.0,14/67,12.94%,ANG;RIPOR1;PPID;TGFB2;PCNT;KIF20B;IL1A;EZR;GOLPH3;ABCG1;VAMP2;CD2AP;RUFY3;FRMD4A
prerank,positive regulation of interleukin-8 production (GO:0032757),0.44027464933102956,1.0378558573145817,0.423841059602649,0.9484052958597843,1.0,10/49,14.85%,RELA;TLR7;TLR3;MAVS;F3;HMGB1;SYK;PRKD2;LGALS9;TLR4
prerank,neutrophil mediated immunity (GO:0002446),0.4107094968772661,1.0376834658151488,0.398,0.9482530939574896,1.0,74/432,12.95%,STXBP2;TUBB4B;VCL;DEGS1;PDXK;SLC2A3;SLCO4C1;NRAS;C5AR1;CD36;IRAK4;AP1M1;RHOF;KPNB1;PDAP1;VAMP7;UNC13D;PGAM1;CTSC;ACTR1B;COMMD3;ERP44;RAP1A;PADI2;IQGAP2;HMOX2;ALDOA;ENPP4;APAF1;HVCN1;QSOX1;MAPK1;GDI2;STOM;PTPRJ;SCAMP1;SDCBP;TMEM30A;PLEKHO2;OSTF1;HSP90AA1;RAB5B;KMT2E;LAIR1;GSDMD;RAP1B;RAB6A;ARSB;ALOX5;DOK3;ADGRE5;CD44;ATP8B4;B4GALT1;VAMP2;CD63;CANT1;ANXA2;CTSZ;MVP;ASAH1;DIAPH1;DBNL;RAB18;HMGB1;RNASE3;YPEL5;PLD1;PSMD12;MAPK14;ADAM10;FUCA1;NHLRC3;PSMA2
prerank,chemical synaptic transmission (GO:0007268),0.41482981971313804,1.0368487433658313,0.418,0.9500617694505232,1.0,50/284,16.82%,STXBP2;CAMKK1;PCDHB16;PDZD11;DVL1;MINK1;GAD2;PRKAR2A;AKAP9;PRKACA;MAPK1;SDCBP;CEL;GIPC1;DLG1;PDE7B;APBA1;SYN3;GRIA4;GLRB;VAMP2;CDK5;CACNA1A;RIT2;GABRG2;GRM7;EXOC4;GLRA3;SLC12A6;AMPH;LRP6;LIN7A;NAPA;TBC1D24;SPG11;CAMKK2;ATXN3;CALM1;GRIN2A;PLP1;PTEN;GRID2;RPS6KA2;KIF1B;UNC13C;KCND2;ERC2;PRKAR1A;KCNA1;PRKACB
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.38137847500817323,-1.0368409687068278,0.4098939929328622,0.9420186262076682,1.0,6/16,25.23%,PIK3CG;ARHGAP24;GABARAP;SH3BP1;STMN3;CADM4
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.51627229541663,1.0366190475311743,0.4441340782122905,0.9500438871601321,1.0,4/15,17.31%,AK4;ENTPD1;CMPK1;AK8
prerank,bicarbonate transport (GO:0015701),0.47781034932132854,1.0366120186455114,0.4600484261501211,0.9493896934831729,1.0,1/25,0.61%,SLC4A3
prerank,tryptophan catabolic process (GO:0006569),-0.44060360583282215,-1.0363287469949736,0.44680851063829785,0.9403655931232129,1.0,6/11,50.08%,KYNU;KYAT1;HAAO;KMO;IL4I1;AFMID
prerank,cellular response to oxidative stress (GO:0034599),0.4171755854370649,1.0363217769589217,0.4439918533604888,0.949564153467347,1.0,26/118,15.27%,MGAT3;PYCR2;SLC25A24;LRRK2;VKORC1L1;JUN;TPM1;MAPK1;KEAP1;MAPT;MAPK8;DAPK1;ADNP2;SETX;PXN;ABL1;TXNRD2;NCF4;TP53;EIF2S1;CAMKK2;HTRA2;PKD2;AIF1;ARNT;MSRA
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.3266987521612489,-1.0363012907860856,0.3875,0.9372682212051593,1.0,14/30,20.98%,BMPR2;DACH1;TENT4B;HNRNPU;NIBAN2;EXOSC10;DCP2;HNRNPA1;PINX1;STN1;GNL3L;NAT10;TEN1;SRC
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.5283341362664542,1.0361271764389222,0.42771084337349397,0.9494755752074968,1.0,2/13,4.71%,ALG3;MPDU1
prerank,ceramide biosynthetic process (GO:0046513),0.4477060722792812,1.0359058105843124,0.4307511737089202,0.9494739400117866,1.0,8/40,14.77%,DEGS1;ST8SIA4;SMPD1;CERS6;CERS4;ASAH1;CERS5;SPTLC1
prerank,regulation of intracellular signal transduction (GO:1902531),0.41160192258925066,1.0356768667814844,0.378,0.9494844962138046,1.0,93/420,15.08%,BRCA1;LRRK2;BLM;BOP1;EHMT1;RFC2;RELA;ARHGEF3;MINK1;RAD50;FGF1;RHOF;FGD3;FGD1;PLEKHG2;DYRK2;PRKAR2A;PLEKHG5;ITSN1;ANKRD54;PIP4K2A;ARHGEF12;WRN;EP300;CDK2;TAGAP;SQSTM1;CMKLR1;MAPK1;VAV3;FAM13B;BIRC3;EHMT2;STK11;FBXO9;RNF34;EZR;RBBP8;ARHGAP22;MRE11;DLG1;MAP2K6;MAPT;PAK2;MAPKAP1;NBN;PHF20;ARHGAP1;TAF4;ZFAND6;PHLPP1;CHEK2;PIP4K2B;KALRN;LYN;TMBIM4;MYO9A;CDK5;TAOK1;ARHGAP35;AKAP13;CDC42;NOC2L;TRAF2;RIT2;ARHGAP39;ARHGEF17;MTOR;TMSB4X;PRDM1;OCRL;VAV2;MAPK14;BRD7;CYLD;ARHGAP15;ARHGAP32;MYO9B;HIPK2;TP53;RBBP7;ARHGAP45;PPP1R16B;SPRED1;PRKD2;PEX5L;SLC15A4;PPP2R5C;OPTN;PTEN;ARHGAP31;ARHGDIB;VAV1
prerank,positive regulation of protein depolymerization (GO:1901881),0.540493327160119,1.0353362258558783,0.46107784431137727,0.9497866544262616,1.0,2/11,12.08%,STMN2;WDR1
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.49280347933814295,1.0353130404984319,0.4491634491634492,0.9491783517173463,1.0,5/19,8.90%,NDST3;UGDH;GLCE;EXTL3;HS6ST2
prerank,positive regulation of B cell proliferation (GO:0030890),0.4663954404918893,1.0352579277240974,0.4518879415347138,0.9486911049271328,1.0,8/29,17.29%,CD38;EPHB2;VAV3;IRS2;BCL2;CD81;MEF2C;NCKAP1L
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.5162427711355555,1.0349606766831632,0.4417952314165498,0.9488945141392137,1.0,6/15,14.28%,ACTR3;IQGAP2;ARPC1A;ARPC4;ARPC2;ARPC3
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.4283038009071551,1.0349520496279099,0.4340425531914894,0.9482531010117817,1.0,24/67,15.70%,VEGFC;NRP1;DOCK1;VAV3;ABI1;AXL;HSP90AA1;PAK2;NCK1;CDC42;PXN;CYFIP2;VAV2;MAPK14;NCF4;MAPKAPK2;WASF2;FYN;ELMO1;NRP2;PRKD2;ROCK2;VAV1;PIK3R1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.5108214697411082,1.0345655103359537,0.43366619115549215,0.948737847909293,1.0,1/13,1.07%,LRRK2
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.4102500913944759,1.0344439500523155,0.375,0.9484334990436059,1.0,99/497,15.71%,WNT4;BRCA1;EHMT1;EIF4A3;CNOT10;THAP7;DMAP1;RELA;IRF1;SMARCA4;CD38;EIF2AK1;EIF2AK2;SUV39H1;ILF3;TFAP4;EIF4ENIF1;SOX13;RLIM;SYNCRIP;CLOCK;SAP18;GAS6;MALSU1;ZNF318;JUN;TLE2;ATXN1;ZBTB7A;ELK3;BCL6;HDAC9;RBM15;SPEN;ARID5B;PDGFB;CIPC;RBAK;DPF2;HDAC5;NR3C1;SCMH1;IKZF1;TLE1;PDS5A;PHF10;MECP2;SET;RPS6KA5;EZH2;LIMS1;NACC1;NCOR1;DAPK1;FXR2;CNOT9;PPARG;CTBP1;HMBOX1;ENO1;CDK5;DEAF1;LOXL3;UBE2I;ZNF568;FOXN3;BCL7A;CHD8;FBXW11;PHC3;PSPC1;ZBTB38;ZMYND11;LSM14A;COMMD7;NCOR2;YEATS2;TCF7L2;BRD7;SAMD4A;TP53;NR1D2;EPC1;TERF1;RFX3;RBPJ;PPARD;EIF4E2;LDB1;TSC1;CTCF;SMAD4;ZBTB18;PEX14;SMARCA2;PBXIP1;HDAC2;CAPRIN1;CIC
prerank,mitochondrial protein processing (GO:0034982),-0.44949778306268584,-1.0343536590476354,0.43175487465181056,0.9397678460677524,1.0,8/11,35.24%,YME1L1;IMMP1L;AFG3L2;OMA1;SPG7;STOML2;ATP23;PMPCA
prerank,L-glutamate transmembrane transport (GO:0015813),-0.4563505056743884,-1.034018086488142,0.4318840579710145,0.9376457758496946,1.0,2/10,3.26%,SLC1A2;SLC25A13
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.3348275760919797,-1.0333860796000365,0.38235294117647056,0.9363052890096273,1.0,14/25,33.54%,ITGA5;ITGB2;JAM3;ITGAX;JUP;ITGB3;CD200R1;ITGAV;CD200;PARVA;CXADR;ITGB1;NINJ1;PKP2
prerank,positive regulation of cytokine production (GO:0001819),0.41102823973111985,1.0332014357595234,0.412,0.9515527033946539,1.0,48/292,14.95%,ISL1;RGCC;BRCA1;RORA;POLR1C;PRKCZ;POLR3G;RELA;IRF1;EIF2AK2;GLMN;POLR3H;IL16;TLR7;RUNX1;RFTN1;IRF3;EP300;PRKDC;IL1A;MRE11;TLR3;LACC1;SPTBN1;IL18;CRCP;MAVS;SLAMF6;F3;POLR3A;TRAF2;CYRIB;PAEP;SCAMP5;IL17RA;HMGB1;SORL1;MAPK14;SYK;PRKD2;LGALS9;ROCK2;RAB7B;HAVCR2;AIF1;G3BP1;TLR4;ARNT
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.4898952783050265,1.0331055344536482,0.42782152230971127,0.9511577528141757,1.0,8/21,17.30%,YWHAE;PPP1R8;BOD1L1;PPP1R16B;TIPRL;ENSA;YWHAB;MFHAS1
prerank,regulation of cellular response to stress (GO:0080135),0.41397293021324183,1.0323625745564997,0.45510204081632655,0.9526793702098687,1.0,20/115,8.68%,DNAJB1;HSBP1;ADCY8;BAG3;NUPR1;HIKESHI;USP19;HSPH1;YWHAE;NUP205;EP300;MAPK1;SLC38A2;CHORDC1;HSP90AA1;MAPT;NUP98;CAMK2D;ALOX5;NUP54
prerank,negative regulation of viral life cycle (GO:1903901),0.5087300307835095,1.0320701754840027,0.46458923512747874,0.9528818565839782,1.0,5/15,17.40%,IFITM3;SNX3;TRIM5;TRIM26;GSN
prerank,UV protection (GO:0009650),-0.4496244481582692,-1.0320454746358698,0.4252199413489736,0.9372654818052698,1.0,3/10,10.74%,ERCC5;XPA;CAT
prerank,regulation of microtubule depolymerization (GO:0031114),0.47952674896447495,1.0320355816657993,0.44050632911392407,0.9523211382703131,1.0,6/25,10.28%,MAP1A;STMN2;ATXN7;CAMSAP3;APC;TAOK1
prerank,negative regulation of endothelial cell migration (GO:0010596),0.4412131179257129,1.0313453137419468,0.4369158878504673,0.9536462201681154,1.0,5/36,12.01%,RGCC;THBS1;MECP2;PPARG;HMGB1
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.3421219413873837,-1.0309075639027558,0.3854166666666667,0.9374569193470169,1.0,15/26,24.13%,UBE2N;IRAK1;UBC;IFIH1;TAB1;TIFA;TRAF6;RPS27A;TNFAIP3;IKBKG;TAB2;NOD1;CASP8;UBB;AAMP
prerank,innate immune response (GO:0045087),0.411163655757281,1.0308509730275306,0.4194194194194194,0.9544632087874179,1.0,38/217,14.06%,ANG;RNASE6;SERINC5;IFITM3;RELA;IRAK4;TTC4;ADAM15;CYBC1;ANKHD1;SMPD1;AKAP1;BTK;YES1;IKBKB;SETD2;PYDC1;TLR3;ZDHHC1;SERINC3;MAVS;PPARG;LYN;POLR3A;ADAR;COLEC12;TRIM5;HMGB1;RNASE3;CYLD;SRPK2;SYK;S100B;COLEC11;TRIM56;FYN;TRIM59;RNF135
prerank,negative regulation of cellular metabolic process (GO:0031324),0.44570205374396593,1.0308214053787168,0.43157894736842106,0.9538883697310698,1.0,7/37,15.06%,BRCA1;RIN3;SDCBP;NCOR1;ATXN2;OPTN;ANKRD13A
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.40916409134585885,1.0306750280203238,0.324,0.9536809046889538,1.0,288/1667,15.71%,POU2F3;FHL5;ISL1;BMP5;GLIS1;PLK1;RGCC;BRCA1;MDFI;SRCAP;IER2;RORA;WFS1;DNAJB1;MED10;ZIC4;URI1;SIRT7;SP8;HSBP1;PARP9;PELP1;KDM1B;RPRD1B;THAP7;ZBTB8A;DMAP1;RELA;CX3CL1;IRF1;DVL1;SMARCA4;SP1;BRD8;SMAD6;CTR9;SUV39H1;HOPX;PSIP1;ACTR3;VPS72;PID1;FGF1;ZFP90;CASZ1;TFAP4;POU5F2;SOX13;PPID;KLF9;ITGA6;SS18L1;ITGB1BP1;ZBTB5;IMPACT;TGIF1;CLOCK;ZEB2;BBX;RUNX1;SAP18;SLC9A1;MAX;HCFC1;IGBP1;BMPR1A;NFATC1;JUN;AR;ELP3;ATXN1;ZBTB7A;ZNF569;PRDM10;ELK3;WBP2;IRF3;BCL6;HDAC9;CDK7;TRPS1;N4BP2L2;PRKCB;PAXBP1;TARBP1;EP300;SMAD3;SPEN;ARID5B;TEAD1;RBAK;BUD31;LRP5;PRKDC;SQSTM1;LIN9;TNRC6B;ZNF467;DPF2;ESR1;MRTFB;HDAC5;SDCBP;NR3C1;ACVR1;EHMT2;IKZF1;JUND;RPRD1A;KDM3A;MAML3;PRDM4;MAMLD1;PSMC5;CRTC1;MAML2;EZR;NCOA5;BCLAF3;MNAT1;MEF2A;IKBKB;RBBP8;MLIP;RRP1B;DLG1;PHF10;WIZ;MECP2;TFCP2;AKIRIN2;CUX1;DRGX;TLR3;NCOA1;SETD3;AGO2;KDM5B;PRPF6;RPS6KA5;CDK9;CAMK2D;PHF20;EZH2;NCK1;TADA2A;IL18;DAB2;JMJD1C;NACC1;MAFG;NCOR1;NCOA3;FNIP1;PCGF5;ZXDC;PHF6;BAZ2B;BRD2;MAVS;AHI1;SSU72;ORC2;PPARG;MTDH;SSBP3;NR6A1;SIN3B;CTBP1;GLYR1;SETX;TAL1;HMBOX1;ENO1;FUS;CDC5L;DEAF1;HBP1;HIVEP1;HOXC4;ZBTB46;ELOC;TCF12;UBE2I;NOC2L;ZNF568;ARID4B;SP140;CHD8;ZSCAN29;EPC2;NR5A1;KAT2B;CREB3L2;NR2C2;SOX11;ZBTB38;BCL11A;ECD;MAP2K5;TSHZ2;ZNF182;PRDM1;PPM1A;NCOR2;HIVEP2;DNMT3A;GMEB2;ABL1;KDM4C;RPAP2;YEATS2;HMGB1;ZFP69;BACH2;DNAJA3;TCF7L2;MIER3;MAPK14;ZBTB34;ATF6;SOX6;TGFA;BRD7;BRD3;HIPK2;TP53;ATRX;MAF;CTDP1;NR1D2;KLF13;MYT1L;LRP6;LCOR;RXRA;EPC1;CDK8;MED27;FUBP3;PPARGC1B;NFX1;WWOX;SP4;GTF2H1;DDX5;KCNIP3;RREB1;CARF;PRKD2;PKD2;CREB1;RFX3;RBPJ;PHF20L1;TET2;PPARD;ZMYM5;DACH2;HIVEP3;TBL1XR1;UBE2D3;MED15;NCOA2;PTEN;WASL;LDB2;LDB1;TLR4;CTCF;ARNT;NPAS3;SMAD4;ZBTB18;NPM1;PHIP;PIAS1;SMARCA2;AKAP8L;CRLF3;THAP3;ZFHX4;AUTS2;HDAC2;HNRNPK;BAZ1B;PIK3R1;CIC
prerank,positive regulation of histone modification (GO:0031058),0.4531211971220823,1.0301410061931626,0.4507531865585168,0.9545563965721091,1.0,7/33,12.73%,BRCA1;RPS6KA5;CDK9;TADA2A;CTBP1;GLYR1;BRD7
prerank,regulation of muscle cell differentiation (GO:0051147),0.46000404942205786,1.0300646426545323,0.44096385542168676,0.9540917295915282,1.0,11/31,17.61%,HDAC9;CTNNA1;MEF2A;CDK9;CDC42;ABL1;MAPK14;MEF2C;CTNNA2;CAMK1;CTNNB1
prerank,protein localization to microtubule organizing center (GO:1905508),0.4960149357935423,1.029728128213344,0.4479315263908702,0.9544010821190816,1.0,6/15,17.19%,BBS4;SNX10;DCTN2;C2CD3;CEP83;PIBF1
prerank,negative regulation of programmed cell death (GO:0043069),0.4089063115403115,1.029409614322576,0.422,0.954693743589136,1.0,59/355,13.16%,PLK1;WFS1;UBE2Z;RELA;CX3CL1;CD38;WDR73;SMAD6;CFL1;BAG3;NUPR1;BRAF;GAS6;NAA35;THBS1;FLNA;TNFAIP8;PRKDC;SQSTM1;AXL;GPX4;BIRC3;PSMC5;GOLPH3;API5;IKBKB;MRE11;HSPA9;MAPK8;PAK2;BNIP3L;BFAR;BABAM2;DAB2;BIRC6;ZFAND6;GRK5;TM7SF3;AREL1;AHI1;MTDH;PROC;CD44;SETX;TMBIM4;RNF157;NAA16;BNIP3;NOTCH2;IGF1R;CBL;RNF144B;DCPS;RAF1;ADAM10;TP53;BCL2;FMN2;NAA15
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.40811259247621723,1.0291511107444855,0.415,0.9547874476128803,1.0,82/417,15.71%,WNT4;BRCA1;EHMT1;THAP7;DMAP1;RELA;IRF1;SMARCA4;CD38;SUV39H1;ILF3;TFAP4;SOX13;RLIM;CLOCK;SAP18;GAS6;ZNF318;JUN;TLE2;ATXN1;ZBTB7A;ELK3;BCL6;HDAC9;RBM15;SPEN;ARID5B;PDGFB;CIPC;RBAK;DPF2;HDAC5;NR3C1;SCMH1;IKZF1;TLE1;PHF10;MECP2;SET;RPS6KA5;EZH2;LIMS1;NACC1;NCOR1;PPARG;CTBP1;HMBOX1;ENO1;CDK5;DEAF1;LOXL3;UBE2I;ZNF568;FOXN3;BCL7A;CHD8;FBXW11;PHC3;PSPC1;ZBTB38;ZMYND11;COMMD7;NCOR2;YEATS2;TCF7L2;BRD7;TP53;NR1D2;EPC1;RFX3;RBPJ;PPARD;LDB1;CTCF;SMAD4;ZBTB18;PEX14;SMARCA2;PBXIP1;HDAC2;CIC
prerank,neuron differentiation (GO:0030182),0.41047275633665103,1.0291365924023765,0.43259557344064387,0.9541579708316911,1.0,19/165,14.80%,WNT4;IER2;WNT2B;TDP2;UGDH;VXN;RUNX1;TGFB2;TENM4;ADNP2;CDK5;EPHA5;SOX11;TGFBR1;MYT1L;LRP6;MYEF2;FZD3;LDB1
prerank,reticulophagy (GO:0061709),0.5254714713654016,1.029126118742448,0.46348733233979134,0.9535251297907656,1.0,4/12,12.19%,UBA5;UFC1;ULK2;RB1CC1
prerank,inner mitochondrial membrane organization (GO:0007007),0.4454372666541818,1.0289034560571524,0.4593088071348941,0.9535094460012313,1.0,12/47,15.74%,ATP5F1A;MTX1;ATP5MC3;LETM1;HSPA9;ATP5MC2;MICOS10;DNAJC11;APOOL;CHCHD6;TIMM9;ATP5F1B
prerank,negative regulation of RNA splicing (GO:0033119),0.48503769649148165,1.0282034524187438,0.44086021505376344,0.9549080040895934,1.0,6/19,12.16%,SAP18;RNPS1;PTBP3;SFSWAP;U2AF2;SRSF9
prerank,histone H2A ubiquitination (GO:0033522),-0.382445708305572,-1.0277737176922763,0.4169611307420495,0.943843512781619,1.0,8/17,17.30%,BCOR;DDB1;RNF168;UBR2;DDB2;CUL4B;DTX3L;SKP1
prerank,nucleus organization (GO:0006997),0.4347910988883243,1.0276805758379652,0.4400895856662934,0.9557483494501015,1.0,11/47,13.31%,WDR73;VPS4A;CHMP5;NUP205;ATXN7;CTDNEP1;NUP98;LEMD2;NUP54;VPS4B;PDCD6IP
prerank,response to thyroid hormone (GO:0097066),0.5246445726165323,1.0275387955187347,0.46074074074074073,0.9554905106585507,1.0,2/13,2.99%,BRD8;KLF9
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.44899653445389925,-1.027514030230273,0.4502923976608187,0.9414764243108958,1.0,4/10,15.07%,GFPT1;HK3;HK1;PFKL
prerank,telomere maintenance via telomerase (GO:0007004),0.4659392851833331,1.027511821769897,0.4539951573849879,0.9549053407006544,1.0,5/28,7.41%,RAD50;TERF2;CDK2;HSP90AA1;MRE11
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.5193974806048517,1.0274811663162244,0.44352617079889806,0.9543420568144343,1.0,3/15,9.84%,UST;DSE;BGN
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.37219222243071215,-1.0274742575041746,0.421259842519685,0.9384981747527638,1.0,4/17,3.46%,CALM2;EIF4G1;SMAD7;SIRT2
prerank,regulation of cell aging (GO:0090342),-0.4228028164889959,-1.0272859058074186,0.4298780487804878,0.9360598200606143,1.0,6/11,31.11%,PNPT1;RSL1D1;ING2;NEK4;VASH1;LMNA
prerank,cellular response to misfolded protein (GO:0071218),0.4849682731216016,1.026515357933509,0.4434447300771208,0.9565048723841433,1.0,7/20,13.77%,DNAJC18;UGGT2;POMT2;DERL1;UBE2W;UGGT1;ATXN3
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.5223831178401456,1.0264316778195024,0.4698972099853157,0.9561026638869345,1.0,4/13,9.84%,KPNB1;KPNA6;NUP54;IPO5
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.4881929277613085,1.0263584626921787,0.4453227931488801,0.9556834760326517,1.0,3/19,7.65%,POLD3;HPRT1;DGUOK
prerank,cholesterol biosynthetic process (GO:0006695),0.4562033052847187,1.0262210130786324,0.45172824791418353,0.9554078218081075,1.0,3/31,4.43%,INSIG1;INSIG2;GGPS1
prerank,neuron projection extension (GO:1990138),0.4593810171088503,1.0261941609011782,0.45336481700118064,0.9548300170619097,1.0,13/32,17.61%,IMPACT;NRP1;HSP90AA1;SLC9A6;CDK5;ULK2;SPG11;NRP2;AUTS2;IQGAP1;SH3GL2;CYFIP1;CTNNB1
prerank,carboxylic acid transmembrane transport (GO:1905039),0.4418192453359848,1.0261745517903822,0.4490950226244344,0.9542334089379112,1.0,7/40,12.68%,SLC38A2;ABCC5;SLC7A11;SLC7A7;SLC7A8;SLC38A9;SLC27A1
prerank,regulation of macrophage chemotaxis (GO:0010758),0.48620530167541776,1.0261511684955458,0.4470426409903714,0.9536481076040556,1.0,4/21,5.62%,THBS1;MTUS1;CMKLR1;MAPK1
prerank,amino acid import (GO:0043090),-0.35049107703440574,-1.0258985355244048,0.425531914893617,0.9371503341153974,1.0,9/21,28.08%,SLC36A1;SLC7A1;SLC1A1;SFXN1;SLC6A1;SLC25A38;SLC16A2;SFXN2;SLC22A4
prerank,inorganic ion transmembrane transport (GO:0098660),0.528310589727548,1.0257959725758938,0.44163150492264414,0.9540378180725785,1.0,2/12,13.91%,TRPM4;PKD2
prerank,protein deacetylation (GO:0006476),0.44752228663019405,1.0245541254710886,0.45257142857142857,0.9571059910887536,1.0,12/41,16.96%,SIRT7;FLNA;HDAC9;HDAC11;HDAC5;MORF4L2;SIN3B;MIER3;TBL1XR1;HDAC2;RCOR1;TBL1X
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.40673070885917,-1.0243830064601147,0.4225352112676056,0.9385765689681594,1.0,9/14,59.34%,ADAM8;IL6ST;PARK7;TNF;OSM;IL1B;PTGER3;OSMR;IL6
prerank,negative regulation of autophagosome assembly (GO:1902902),0.5193034055612136,1.0242196668017038,0.45809248554913296,0.95745372451726,1.0,5/13,15.54%,LRRK2;NUPR1;FEZ1;TMEM39A;MTM1
prerank,O-glycan processing (GO:0016266),0.4332684601226664,1.0240913299807646,0.4582869855394883,0.9571663227566859,1.0,7/54,11.61%,GALNT1;GALNT12;GALNT3;C1GALT1;B4GALT5;ST6GAL1;B3GNT2
prerank,regulation of cellular component movement (GO:0051270),0.4258342475061751,1.0239482060141198,0.4698133918770582,0.9569239181001803,1.0,15/49,16.23%,NRG2;IGBP1;CDK6;ZSWIM6;PKN2;YTHDF1;LYN;ACTN4;DIAPH1;ABL1;RAF1;TGFBR1;ROCK2;INPP5F;PKN1
prerank,axonogenesis (GO:0007409),0.4086189880987251,1.0239349767013322,0.4663991975927783,0.9563141033981442,1.0,45/237,15.70%,CXCL12;ISL1;GRB2;LLGL1;MAP1A;EPHB2;NRP1;S100A6;PRKCA;SEMA6D;MAPK1;IRS2;HSP90AA1;EZR;USP33;RANBP9;ARTN;SPTBN1;RPS6KA5;NPTN;SLC9A6;B4GALT5;CDK5;EPHA5;ARHGAP35;SEMA3D;SEMA6A;PALLD;NOTCH2;ULK2;FRS2;FEZ1;DOK6;S100B;PTPRO;SPG11;FYN;NRP2;RELN;PTEN;DAG1;EVL;AUTS2;SH3KBP1;PIK3R1
prerank,cell cycle checkpoint signaling (GO:0000075),0.5226334412819182,1.0235054584639587,0.4542635658914729,0.9569377422743114,1.0,1/12,0.85%,ZWINT
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.5081971334568586,1.023397523286405,0.44592592592592595,0.956600005116965,1.0,3/13,5.53%,ADCY8;EPHB2;SQSTM1
prerank,regulation of JNK cascade (GO:0046328),0.4138311995036257,1.023353351163825,0.4682377049180328,0.9560792324502728,1.0,19/101,12.87%,UNC5CL;DUSP3;MINK1;TPD52L1;SH3RF3;MAP3K11;SDCBP;DUSP10;NCOR1;PHLPP1;TAOK1;FKTN;TRAF2;IGF1R;ZMYND11;HMGB1;AIDA;CYLD;HIPK2
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.48712278500504375,1.0232006714251718,0.46264744429882043,0.9558738145563108,1.0,6/19,15.75%,NRP1;PTPRJ;LIMS1;ABL1;TSC1;MAP4K4
prerank,"wound healing, spreading of cells (GO:0044319)",0.4746229894225067,1.0230269906016545,0.46332046332046334,0.9557339223383898,1.0,6/24,16.13%,DDR1;FLNA;CD44;ARHGAP35;TMEFF2;MRTFA
prerank,neutrophil degranulation (GO:0043312),0.40474258983035677,1.0229541290724127,0.442,0.9552959543106349,1.0,72/425,12.95%,STXBP2;TUBB4B;VCL;DEGS1;PDXK;SLC2A3;SLCO4C1;NRAS;C5AR1;CD36;AP1M1;RHOF;KPNB1;PDAP1;VAMP7;UNC13D;PGAM1;CTSC;ACTR1B;COMMD3;ERP44;RAP1A;PADI2;IQGAP2;HMOX2;ALDOA;ENPP4;APAF1;HVCN1;QSOX1;MAPK1;GDI2;STOM;PTPRJ;SCAMP1;SDCBP;TMEM30A;PLEKHO2;OSTF1;HSP90AA1;RAB5B;LAIR1;GSDMD;RAP1B;RAB6A;ARSB;ALOX5;DOK3;ADGRE5;CD44;ATP8B4;B4GALT1;VAMP2;CD63;CANT1;ANXA2;CTSZ;MVP;ASAH1;DIAPH1;DBNL;RAB18;HMGB1;RNASE3;YPEL5;PLD1;PSMD12;MAPK14;ADAM10;FUCA1;NHLRC3;PSMA2
prerank,rRNA methylation (GO:0031167),0.47101852506802144,1.0226488067120632,0.46084724005134786,0.9555531375809299,1.0,3/22,6.76%,EMG1;TFB2M;NSUN3
prerank,fatty acid transport (GO:0015908),0.4953431961102578,1.0226191083705114,0.4613220815752461,0.9549925852401063,1.0,4/17,14.37%,CD36;PPARG;SLC27A1;PPARD
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.4743625638134025,1.0223285423920816,0.4595959595959596,0.9552323197721077,1.0,5/23,15.92%,RAET1E;ARRB2;SLAMF6;LGALS9;LAMP1
prerank,regulation of protein kinase activity (GO:0045859),0.4139014962011284,1.0223255829056586,0.44954128440366975,0.9545918074381322,1.0,19/106,14.25%,CAMKK1;DDR2;C5AR1;DVL1;ITGB1BP1;GAS6;NF1;ANKRD54;RAP1A;PYDC1;PAK2;DTNBP1;GNAQ;UVRAG;LRP6;SPRED1;MMD;CAMKK2;RELN
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.4679278295625514,1.02218063796329,0.4509043927648579,0.9543572605440468,1.0,2/24,3.16%,MIEF2;ITGB1BP1
prerank,mitochondrial translation (GO:0032543),0.4108340427322961,1.02211073636109,0.4533333333333333,0.953906111040247,1.0,11/104,7.30%,MRPS22;MRPS31;MRPS30;MRPL37;NOA1;MRPS21;HARS1;MRPL48;MRPS35;MRPS28;MRPL1
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.4759205850875785,1.0220321828520618,0.46387832699619774,0.9534590230006754,1.0,6/25,10.18%,BCAS2;PRPF3;GEMIN2;PRPF6;SCAF11;DDX23
prerank,cortical cytoskeleton organization (GO:0030865),0.436590272571846,1.0217257977298169,0.4819557625145518,0.9536617293589001,1.0,6/41,7.48%,LLGL2;RHOF;LLGL1;EZR;IKBKB;DLG1
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.44042987170299,1.0213536310079119,0.44657863145258103,0.9541061516985089,1.0,7/33,14.62%,ITGB1BP1;TGFB2;PDE3B;FERMT3;LYN;SYK;P2RY12
prerank,protein localization to membrane (GO:0072657),0.41160820943153276,1.0208937196172583,0.45545545545545546,0.954801446541819,1.0,40/187,13.72%,PDZD11;ARL5A;DVL1;FLOT2;ZFYVE27;EHD4;ITGB1BP1;RAB8B;EHD1;BRAF;GAS6;RAB40C;RAB12;RFTN1;CPE;RAP1A;FLNA;RABEP1;MYO5A;TM9SF1;ITGA4;EZR;PPIL2;IKBKB;DLG1;SLMAP;SPTBN1;NUP54;HGS;EFR3B;RAMP1;TMED2;PACS2;EPB41L3;SH3GLB1;RAB3C;LRP6;LIN7A;PACS1;KCNIP3
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.42401817707516487,1.0206746570032996,0.4470338983050847,0.9547591096112473,1.0,15/73,13.26%,POLR1C;KDM1B;GLMN;PPHLN1;WBP2;EP300;POLR1A;HDAC5;MECP2;EZH2;KAT2B;DNMT3A;TASOR;RBBP7;EPC1
prerank,histone H2A monoubiquitination (GO:0035518),-0.380788745658442,-1.020254170361012,0.4317343173431734,0.948196709419145,1.0,8/17,22.28%,BCOR;PCGF3;DDB1;RNF168;DDB2;CUL4B;SKP1;PCGF6
prerank,neutrophil activation involved in immune response (GO:0002283),0.4034284453084527,1.0201912302586187,0.448,0.9554874301332801,1.0,74/428,13.41%,STXBP2;TUBB4B;VCL;DEGS1;PDXK;SLC2A3;SLCO4C1;NRAS;C5AR1;CD36;AP1M1;RHOF;KPNB1;PDAP1;VAMP7;UNC13D;PGAM1;CTSC;ACTR1B;COMMD3;ERP44;RAP1A;PADI2;IQGAP2;HMOX2;ALDOA;ENPP4;APAF1;HVCN1;QSOX1;MAPK1;GDI2;STOM;PTPRJ;SCAMP1;SDCBP;TMEM30A;PLEKHO2;OSTF1;HSP90AA1;RAB5B;LAIR1;GSDMD;RAP1B;RAB6A;ARSB;ALOX5;DOK3;ADGRE5;CD44;ATP8B4;B4GALT1;VAMP2;CD63;CANT1;ANXA2;CTSZ;MVP;ASAH1;DIAPH1;DBNL;RAB18;HMGB1;RNASE3;YPEL5;PLD1;PSMD12;MAPK14;ADAM10;FUCA1;NHLRC3;PSMA2;SYK;ARHGAP45
prerank,positive regulation of lyase activity (GO:0051349),0.5046668881530407,1.020165226408152,0.4595375722543353,0.9549070063973321,1.0,2/14,4.01%,CACNA1D;NF1
prerank,cardiac muscle cell action potential (GO:0086001),0.45176232049661463,1.0200681271132064,0.45024271844660196,0.9545259383175888,1.0,3/30,4.70%,SLC4A3;CACNA1D;YWHAE
prerank,positive regulation of transport (GO:0051050),0.42013944561214234,1.0200503318035246,0.455761316872428,0.9539359545020217,1.0,9/85,10.14%,SGK2;CAMK1D;SMPD1;GAS6;CBLL1;ABCA7;DAB2;PLAA;ANXA2
prerank,mitochondrion organization (GO:0007005),0.40666192690890623,1.0200060088251552,0.46092184368737477,0.9534181266724026,1.0,21/165,8.06%,MIEF2;LRRK2;TIMM17A;TOMM40;NUBPL;MTX1;ADCK1;PID1;NDUFS1;TFB2M;SLIRP;SSBP1;HCFC1;WASF1;ATP7A;PYROXD2;TIMM23;POLG2;MEF2A;VPS13C;BNIP3L
prerank,establishment of melanosome localization (GO:0032401),0.4883018265741913,1.0199325424680985,0.465954606141522,0.9529846526388137,1.0,3/19,5.36%,ARL6;BBS4;MYO5A
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.4487383586012321,1.0197319980528823,0.4600715137067938,0.952925230761861,1.0,9/34,14.87%,DUSP3;PTPRJ;DUSP16;DUSP10;PTPN1;PTPRT;PTPRO;PTPN9;PTPN18
prerank,negative regulation of hippo signaling (GO:0035331),-0.4326064472578989,-1.0194785468830407,0.45544554455445546,0.9474320451784412,1.0,9/12,31.79%,LIMD1;MARK3;DLG5;CIT;MAP2K3;SHANK2;WWC1;WTIP;WWC2
prerank,keratan sulfate catabolic process (GO:0042340),-0.4305621924290298,-1.0194018736972852,0.44200626959247646,0.9446295303446135,1.0,2/11,10.05%,HEXA;GALNS
prerank,histone H3 deacetylation (GO:0070932),0.49818336331774693,1.0193617948349358,0.4555112881806109,0.9533390909011942,1.0,2/15,4.82%,SIRT7;HDAC9
prerank,extracellular matrix assembly (GO:0085029),0.4805167320390014,1.018971358826927,0.45790816326530615,0.9538160411312547,1.0,4/23,11.03%,GAS6;ATP7A;QSOX1;PXDN
prerank,external encapsulating structure organization (GO:0045229),0.4083865380018331,1.0187086469558777,0.46846846846846846,0.9539374132862978,1.0,23/205,11.50%,COL14A1;ADAMTS12;DDR1;DDR2;ADAMTS2;ADAM15;ITGA6;NF1;ADAM12;THBS1;ADAMTSL3;ATP7A;PDGFB;ITGA4;ITGB5;COL11A1;ITGB8;ADAMTS10;CD44;BGN;FURIN;PXDN;LAMC1
prerank,organic acid transport (GO:0015849),0.41681651372477746,1.0175251638616956,0.4613003095975232,0.9566016804371177,1.0,16/94,15.52%,SFXN5;SLCO1B1;SLC7A2;SLC38A2;SLC7A11;SLC7A7;NCOA1;SLC7A8;STARD5;SLC25A32;SLC27A1;RXRA;SLCO2B1;PPARD;NCOA2;ABCG2
prerank,mitochondrion disassembly (GO:0061726),0.4382264920442016,1.0174112608488166,0.4516509433962264,0.9562832400068279,1.0,10/34,15.16%,WDR45;WDR45B;SQSTM1;AMBRA1;BNIP3;ULK2;ATG3;RB1CC1;ATG7;BECN1
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.41736110576533925,1.017032535324413,0.47439916405433646,0.956702347458779,1.0,17/85,13.94%,PLK1;LRRK2;FBXW7;DVL1;NUPR1;PSMC5;TMEM259;KEAP1;SUMO2;DAB2;RCHY1;USP5;SOCS5;RNF144B;HECTD1;ATXN3;CSNK1A1
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.5304537750876015,1.017016753470966,0.4774494556765163,0.956114849243355,1.0,1/10,1.82%,CX3CL1
prerank,morphogenesis of an epithelium (GO:0002009),0.47002059253538314,1.016822341617008,0.45603015075376885,0.9560079884247998,1.0,5/25,16.41%,VCL;AHI1;LRP6;DAG1;ACTG1
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.4902071763559651,1.0162793929062204,0.4747612551159618,0.9569638730417881,1.0,3/18,9.65%,C5AR1;CMKLR1;LYN
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.4870838778731088,1.0161626593644335,0.44565217391304346,0.9566598661103308,1.0,7/19,15.60%,SS18L1;CUX1;LRP8;DBNL;CDKL5;RELN;CAPRIN1
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.4068396509811614,1.0158337777198496,0.49949238578680205,0.9569671273517684,1.0,34/140,15.08%,CGNL1;ARHGEF3;RHOF;FGD3;FGD1;PLEKHG2;PLEKHG5;ITSN1;ARHGEF12;TAGAP;SQSTM1;VAV3;FAM13B;ARHGAP22;ARHGAP1;KALRN;MYO9A;ARHGAP35;CD2AP;AKAP13;CDC42;CYRIB;ARHGAP39;ARHGEF17;OCRL;VAV2;ARHGAP15;ARHGAP32;MYO9B;ARHGAP45;RELN;ARHGAP31;ARHGDIB;VAV1
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.4389612513786636,1.0158111536939443,0.4827188940092166,0.9564018012717308,1.0,7/40,13.04%,LRRK2;PID1;NDUFS1;MAPT;ABL1;ABCD1;BCL2
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.4712997346663691,1.0153873395368904,0.46464646464646464,0.9569533894027785,1.0,9/24,17.61%,CTNNA1;MEF2A;CDC42;ABL1;MAPK14;MEF2C;CTNNA2;CAMK1;CTNNB1
prerank,response to cytokine (GO:0034097),0.40779473068682454,1.0152225390390404,0.46903553299492384,0.956749315772605,1.0,27/141,14.87%,ALDH1A2;TNFRSF11A;IFITM3;RELA;EIF2AK2;PID1;LDLRAP1;SMPD1;IGBP1;LIFR;SMAD3;PRKCA;SETD2;MAPK8;CDK9;IRAK2;PTPN23;ADAR;YTHDC2;IFNAR2;ADAM10;MAPKAPK2;BCL2;TRIM56;LGALS9;PTPN9;PTPN18
prerank,hexose transmembrane transport (GO:0008645),0.4820973499275758,1.0151209046261433,0.4726810673443456,0.9564274642533956,1.0,1/21,1.39%,SLC2A3
prerank,positive regulation of heart rate (GO:0010460),-0.3786442638979831,-1.0150866405682397,0.42745098039215684,0.9545144489975866,1.0,2/17,0.51%,PDE4D;RYR2
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.41348657997246474,1.0147834913560292,0.4830421377183967,0.9567887775970654,1.0,19/100,12.89%,PLK1;LRRK2;DVL1;GLMN;UBXN1;DESI1;MAP1A;SDCBP;KEAP1;GIPC1;SUMO2;UCHL5;DAB2;RCHY1;USP5;SOCS5;RNF144B;CAMLG;HECTD1
prerank,brain morphogenesis (GO:0048854),0.5243204548717719,1.0146681228312362,0.48254931714719274,0.9565086568414016,1.0,4/12,16.94%,BBS4;FBXW11;PTEN;CTNNA2
prerank,endoplasmic reticulum organization (GO:0007029),0.41805249298267955,1.014581353850028,0.4648936170212766,0.9561212495367076,1.0,19/72,16.44%,TRAM1L1;LMAN1;LRRK2;SEC61G;REEP2;UBE2J2;RTN3;REEP5;VAMP2;SEC61A1;MIA3;PRNP;RAB18;RTN4;LNPK;ATL2;VCPIP1;VAPB;DNM1L
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.4056553997751481,1.0144983435417712,0.4923391215526047,0.9557160859453502,1.0,21/118,12.56%,VASH2;LRRK2;CFL1;PID1;INF2;NF1;BCL6;CAPZB;NEDD4;MAPT;PAK2;EGLN1;HECW1;ADGRB3;CDK5;ARHGAP35;SDC2;CYRIB;LZTS1;ZMYM6;RUFY3
prerank,cytosolic transport (GO:0016482),0.4062627992907879,1.0144883310935118,0.4723360655737705,0.9551140091263608,1.0,36/108,17.05%,SYS1;GOSR2;SNX5;VAMP3;EEA1;AKTIP;EVI5;AP2A1;VPS13A;TBC1D17;DCTN1;VPS13C;RAB6A;VPS35;STX16;KIF16B;TBC1D10B;PTPN23;HEATR5A;SNX1;ANKFY1;TBC1D5;TBC1D10A;EPS15;GGA1;RAB7A;CLTC;BECN1;STX8;VTI1A;LAMP1;VPS53;TBC1D23;HOOK2;GCC2;MYO1D
prerank,positive regulation of blood coagulation (GO:0030194),0.48074142971283973,1.0142722563607036,0.46275071633237824,0.9551040097296144,1.0,3/17,10.13%,THBS1;ENPP4;F3
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.27855579833274197,-1.0137961901945223,0.43157894736842106,0.9554671937290521,1.0,9/57,6.81%,JAK2;PARP14;PTPN2;ERBB4;NF2;GHR;CSF1R;CNOT7;HCLS1
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.45245399211729737,1.0136236095670272,0.4752475247524752,0.9563223999134859,1.0,8/31,15.60%,LRRK2;CFL1;LRP8;CDK5;DBNL;RELN;PTEN;CAPRIN1
prerank,ERBB2 signaling pathway (GO:0038128),0.4440228052807411,1.0136087299724406,0.4511904761904762,0.955726514498307,1.0,4/31,6.93%,NRG2;GRB2;PRKCA;HSP90AA1
prerank,zinc ion homeostasis (GO:0055069),0.4585538827439946,1.0134960826925457,0.4815270935960591,0.9554193894939016,1.0,9/28,12.50%,MT1F;MT1M;MT1H;MT1X;MT1A;MT1E;MT1G;MT1B;SLC39A10
prerank,positive regulation of organelle organization (GO:0010638),0.45491191954952276,1.0134394694504487,0.4878345498783455,0.9549401341767231,1.0,8/32,14.20%,LMAN1;RAB3GAP1;TMED9;ANXA2;UVRAG;FYCO1;HTRA2;LNPK
prerank,polarized epithelial cell differentiation (GO:0030859),0.5144444741604879,1.0133356780709606,0.4666666666666667,0.9545787036181359,1.0,5/13,10.69%,MSN;CAMSAP3;EZR;MYO9A;CDC42
prerank,potassium ion transport (GO:0006813),0.40529635119186297,1.0133148580321454,0.4888211382113821,0.9539989986444307,1.0,21/120,17.25%,HCN3;TMEM175;KCNJ6;SLC9A9;SLC9A1;KCNH8;KCNH7;KCNK2;SLC9A7;SLC9A6;KCNK13;KCNK10;PKD2;KCNMB2;KCNMB3;KCNQ5;HCN1;KCND2;KCNA1;KCNA5;KCNB2
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.2902580496607289,-1.013203530712053,0.3884297520661157,0.9542456564330916,1.0,11/44,21.15%,PRKCE;HCK;PTK2B;NCK2;VASP;BAIAP2;PYCARD;PFN1;WHAMM;TENM1;CDC42EP3
prerank,cellular component maintenance (GO:0043954),0.520945389561282,1.013172939460957,0.45440494590417313,0.9537772264929006,1.0,6/12,17.88%,IGF1R;PRNP;INSR;FYN;LNPK;TREM2
prerank,negative regulation of response to stimulus (GO:0048585),0.4262208565391216,1.0130417501342959,0.46730975348338694,0.9535308749997463,1.0,12/60,12.90%,WFS1;IGFBP3;TERF2;CDK6;ACVR1;VPS13C;PTPN1;ALOX5;LYN;SOCS5;MAP2K5;SH2B3
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.5216101962815356,1.0129137329401934,0.49923195084485406,0.9532774581767273,1.0,4/11,12.97%,TGFB2;ACVR1;TGFBR2;TGFBR1
prerank,digestive tract morphogenesis (GO:0048546),-0.3939229832902662,-1.0127983005692052,0.46996466431095407,0.9524943970802029,1.0,2/14,3.58%,FGFR2;NIPBL
prerank,regulation of innate immune response (GO:0045088),0.42588254491915956,1.012748230923798,0.4885745375408052,0.9531223855985923,1.0,13/57,14.14%,PARP9;POLR3G;RIOK3;IRF1;IFI35;BIRC3;AKIRIN2;PTPN1;LRP8;IFNAR2;ERAP1;RNF135;SLC15A4
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.45421645943291866,1.0127320413868313,0.4652014652014652,0.9519205101276844,1.0,4/29,9.42%,ACAT1;ACOT9;ACOT13;CROT
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.45421645943291866,1.0127320413868313,0.4652014652014652,0.9519205101276844,1.0,4/29,9.42%,ACAT1;ACOT9;ACOT13;CROT
prerank,negative regulation of macroautophagy (GO:0016242),0.45409764432090816,1.0125172806455893,0.4547677261613692,0.9519167100049164,1.0,9/26,15.54%,LRRK2;NUPR1;QSOX1;MTOR;FEZ1;LZTS1;TMEM39A;TSC1;MTM1
prerank,negative regulation of transport (GO:0051051),-0.27470724501280563,-1.0122795617106943,0.3739130434782609,0.9510508698034167,1.0,16/51,19.55%,PRKN;PXK;MTMR2;SNX12;FCGR2B;PIP4P2;SNCA;SIRPA;EPHA3;PRKD1;RACK1;LILRB1;LRSAM1;TLR2;CTTNBP2NL;BST2
prerank,translesion synthesis (GO:0019985),0.43375304834522743,1.0122509135713968,0.46524663677130046,0.9520561986061301,1.0,5/42,8.93%,PCLAF;RFC2;POLE2;POLD3;RCHY1
prerank,cellular response to tumor necrosis factor (GO:0071356),0.4013369236323938,1.0122478297902067,0.4737903225806452,0.9514460993746925,1.0,26/175,12.95%,BRCA1;ADAMTS12;TNFRSF11A;RELA;CX3CL1;PID1;TNFRSF25;PSMD9;PSMB8;BIRC3;PSMC5;IKBKB;CCL25;PYDC1;LIMS1;ZFAND6;ACTN4;ASAH1;TANK;TRAF2;TMSB4X;COMMD7;ZFP36L1;PSMD12;TP53;PSMA2
prerank,cellular component disassembly (GO:0022411),0.4215263905529207,1.0119357423573663,0.46916299559471364,0.9517007252889668,1.0,7/53,12.66%,SCUBE1;ADAM15;CD44;FURIN;CAPN2;LAMC1;ADAM10
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.44079521765486757,1.0116708427418486,0.4730195177956372,0.9518420861725496,1.0,7/42,8.31%,NARS2;TARS1;FARSA;WARS2;HARS1;TARS2;AARS1
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.5246332408066657,1.0113159873941884,0.4689863842662632,0.9509805583379464,1.0,3/11,11.12%,ACAT1;PANK1;SLC25A16
prerank,coenzyme A biosynthetic process (GO:0015937),0.5246332408066657,1.0113159873941884,0.4689863842662632,0.9509805583379464,1.0,3/11,11.12%,ACAT1;PANK1;SLC25A16
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.5246332408066657,1.0113159873941884,0.4689863842662632,0.9509805583379464,1.0,3/11,11.12%,ACAT1;PANK1;SLC25A16
prerank,response to lipid (GO:0033993),0.4131883478873525,1.0110054924600897,0.48673469387755103,0.9512179951271157,1.0,17/105,14.85%,OVCA2;TNFRSF11A;CD36;SMAD6;PELI1;LIAS;ESR1;PPARG;ABCG1;SRR;VPS4B;PAQR8;MAPKAPK2;RXRA;LGALS9;PPARD;TLR4
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.4559292064120071,1.0108539299619355,0.4735576923076923,0.9510155237961992,1.0,9/30,14.53%,FBXW7;RNF31;UBE2J2;ABLIM3;HPS4;VPS11;SH3GLB1;HTRA2;UBE2D3
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.41306149322332203,1.0107406128656726,0.4699170124481328,0.9506915069877732,1.0,32/84,18.61%,SAP18;MBNL1;ZBTB7A;RNPS1;RBM3;RBM15;RBM5;NUP98;SFSWAP;TRA2A;FXR2;MBNL2;RBFOX3;U2AF2;SF1;RBM7;QKI;SRSF9;SRPK2;WTAP;DDX5;SF3B4;HNRNPK;HNRNPL;NSRP1;CELF2;SRSF3;SON;KHDRBS1;NCL;CELF1;KHDRBS3
prerank,extracellular structure organization (GO:0043062),0.40473959254119307,1.0106746925289884,0.4774774774774775,0.9502541643891768,1.0,23/204,11.50%,COL14A1;ADAMTS12;DDR1;DDR2;ADAMTS2;ADAM15;ITGA6;NF1;ADAM12;THBS1;ADAMTSL3;ATP7A;PDGFB;ITGA4;ITGB5;COL11A1;ITGB8;ADAMTS10;CD44;BGN;FURIN;PXDN;LAMC1
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.4039685983597736,1.0106031710179797,0.4760935910478128,0.9498379983859667,1.0,22/128,13.71%,BMP5;PRKCZ;SMAD6;ZFYVE9;HPGD;TGFB2;BMPR1A;JUN;SMAD3;ARRB2;ACVR1;ITGB5;SLC33A1;LPXN;HIVEP1;FURIN;PXN;TGFBR2;CBL;TGFBR1;ACVR1B;DDX5
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.5210226250364587,1.010600809493563,0.4741506646971935,0.9492270616744677,1.0,4/12,14.69%,PPARG;ABCG1;ABCA1;ABCA5
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.4349164170683604,-1.0100549287435407,0.4732394366197183,0.9548193269610691,1.0,4/11,8.30%,ATP1B1;ATP1A1;KCNJ2;KCND3
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.4266185725091487,1.0100152825690354,0.47651006711409394,0.950214912924511,1.0,17/52,16.92%,FBXW7;RNF31;YWHAE;UBE2J2;ABLIM3;MAPK8;NMT1;HPS4;VPS11;SH3GLB1;TP53;BCL2;HTRA2;UBE2D3;YWHAB;TFDP2;SAE1
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.44217144281992127,1.0100017658560998,0.4563986409966025,0.949639024983536,1.0,7/41,12.99%,DEGS1;GPX4;PLA2G4A;ALOX5;FADS1;ABCD1;HSD17B4
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.46639266520275724,1.0094444734439885,0.47215189873417723,0.9505888600010278,1.0,5/22,16.68%,STX7;TRAF2;CYRIB;FBXO38;ZBTB1
prerank,phospholipid translocation (GO:0045332),-0.3277288606363279,-1.0093494503326734,0.417910447761194,0.9539013736376231,1.0,10/28,15.68%,ATP8A2;ANO6;P2RX7;ATP9B;ATP11A;ATP9A;ATP10A;ABCB4;ATP8B1;ATP8A1
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.48082419477881755,1.009125137277958,0.46963562753036436,0.950829140609195,1.0,5/17,14.21%,EP300;MAML3;MAML2;KAT2B;RBPJ
prerank,integrated stress response signaling (GO:0140467),0.5012990326960143,1.0084728129215703,0.47707736389684813,0.9520173421301135,1.0,2/14,3.20%,EIF2AK1;IMPACT
prerank,cellular response to organic substance (GO:0071310),0.40656227722605787,1.008471470386929,0.48416751787538304,0.9514100150112085,1.0,25/116,14.87%,URI1;LRRK2;PID1;LDLRAP1;BMPR1A;SMAD3;PDGFB;ACVR1;MAPK8;NCOA1;CDK9;TWF2;IL18;NCOA3;PTPN23;TGFBR2;RAMP1;MAP2K5;DCPS;TGFBR1;ACVR1B;HTRA2;NCOA2;PTPN9;PTPN18
prerank,B cell receptor signaling pathway (GO:0050853),0.44604853183387694,1.0083533442652033,0.48383233532934133,0.9511023890223876,1.0,10/32,17.29%,CD38;RFTN1;PRKCB;BTK;VAV3;BCL2;SYK;SH2B2;MEF2C;NCKAP1L
prerank,osteoclast differentiation (GO:0030316),0.47109220129153406,1.0082564270906453,0.48578811369509045,0.9507607947956983,1.0,5/22,12.55%,TNFRSF11A;FARP2;SNX10;ANXA2;MAPK14
prerank,carbohydrate homeostasis (GO:0033500),0.41319004737868603,1.0080756610919124,0.4841101694915254,0.9506468408730236,1.0,13/67,13.69%,WFS1;ADCY8;IRS1;STK11;ALOX5;PPARG;IGF1R;GCK;RPS6;TCF7L2;CYB5R4;INSR;ADIPOR1
prerank,inner ear morphogenesis (GO:0042472),0.4665708323317719,1.0079839678250473,0.48659003831417624,0.950283541086813,1.0,3/22,8.95%,EPHB2;TTC39C;CHD7
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.4481116807315487,1.0073698097125354,0.4814385150812065,0.9514450656856239,1.0,11/33,16.87%,UBA5;RUNX1;AR;EP300;ESR1;GPAM;KDM4C;DDX5;NCOA2;PKN1;KLK2
prerank,heart looping (GO:0001947),0.4361689975527067,1.006861493270521,0.46774193548387094,0.9522438592731411,1.0,7/40,16.27%,BBS4;AHI1;MICAL2;TGFBR2;NDRG4;PKD2;MEF2C
prerank,negative regulation of lymphocyte migration (GO:2000402),0.5323943659343852,1.0068575584451374,0.48130841121495327,0.9516371508337069,1.0,5/10,17.54%,PADI2;MIA3;LRCH1;WASL;APOD
prerank,fatty acid catabolic process (GO:0009062),0.4231036864624354,1.0063970364623716,0.48764769065520946,0.9523386745891427,1.0,15/67,14.37%,AIG1;ACAT1;ECI2;ACADS;ECHS1;DECR1;ABCD2;CEL;CROT;ABCD3;ACADL;PCCA;ABCD1;HSD17B4;PPARD
prerank,myeloid cell differentiation (GO:0030099),0.42528826094678046,1.006328371194167,0.49503858875413453,0.9519129536646579,1.0,11/47,14.26%,UBA5;RUNX1;IKZF1;KMT2E;HSPA9;ACIN1;LYN;TAL1;HIPK2;FLVCR1;TET2
prerank,negative regulation of immune effector process (GO:0002698),-0.4097648707632441,-1.0060910452000709,0.45569620253164556,0.9607989536316368,1.0,4/13,14.22%,GRN;APPL1;RPS19;LILRB1
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.4853214520966801,1.006012760467953,0.48247978436657685,0.9521689363835842,1.0,2/18,4.54%,PSMD9;IRS1
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.4636300863507678,1.0057560676296888,0.4879807692307692,0.9522728082154627,1.0,9/26,18.73%,IFI35;TLR3;WDFY1;HMGB1;RTN4;SLC15A4;MFHAS1;DDX3X;PJA2
prerank,zinc ion transmembrane transport (GO:0071577),0.4664838001052861,1.0055777461530533,0.4784263959390863,0.9521381858030533,1.0,2/22,3.50%,SLC30A6;SLC39A11
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.46204523000658426,1.005392577009469,0.48891625615763545,0.9520601711846639,1.0,5/27,9.05%,CD36;IRAK4;BTK;IRAK2;TAB3
prerank,positive regulation of developmental growth (GO:0048639),0.4268944743395396,1.005359178724794,0.48123620309050774,0.9515343465364751,1.0,12/49,16.16%,CPNE5;ZFYVE27;MAPT;TWF2;PLAA;RNF157;DBNL;CDKL5;RUFY3;INSR;MACF1;GOLGA4
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.4139133079302871,1.0050319440003983,0.4973319103521878,0.9518323506653992,1.0,17/70,16.07%,EIF2AK2;SETD1A;RUNX1;PSMD9;PSMB8;N4BP2L2;PRKDC;METTL3;PSMC5;TAL1;TCF12;ABL1;PSMD12;PSMA2;LDB1;PSMB1;LMO2
prerank,positive regulation of sodium ion transport (GO:0010765),0.5142331022335294,1.004821611966191,0.4679300291545189,0.9518110084633284,1.0,2/12,7.63%,CNKSR3;GPD1L
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.40251644057862634,1.0047598915354905,0.4747682801235839,0.9513720984465186,1.0,13/87,12.65%,COA3;NUBPL;TMEM126A;FOXRED1;COX17;NDUFS1;NDUFA9;UQCC1;NDUFV2;NDUFAF7;IMMP2L;AIFM1;NDUFA10
prerank,cellular transition metal ion homeostasis (GO:0046916),0.40869078845088036,1.0046758167711958,0.4824380165289256,0.9509880422771272,1.0,23/91,15.52%,CP;HMOX2;ATP7A;ABCB7;GLRX3;MT1F;MT1M;MT1H;MT1X;MT1A;MT1E;MT1G;MT1B;ARF1;PRNP;SLC31A1;SLC39A10;FLVCR1;SLC22A17;NDFIP1;ATP6V0A2;SMAD4;ABCG2
prerank,carbohydrate derivative catabolic process (GO:1901136),0.47580697917557346,1.0042918511858412,0.4879356568364611,0.951403299341146,1.0,3/18,12.72%,FBXO17;BPGM;FUCA1
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.4130224292949505,1.0042067570872943,0.48693834900731453,0.9510255938839891,1.0,16/76,15.31%,PLK1;LRRK2;CDK5RAP3;FBXW7;DVL1;KEAP1;SUMO2;DAB2;RCHY1;USP5;SOCS5;RNF144B;HECTD1;CSNK1A1;PTEN;PIAS1
prerank,protein complex oligomerization (GO:0051259),0.4099096217849044,1.0041960361071858,0.47236704900938475,0.9504557759641801,1.0,16/85,14.06%,BLM;ADCY8;MICU1;EHD4;EHD1;UGDH;SLC9A1;LETM1;G3BP2;GSDMD;FUS;GLRA3;TMEM120B;PDCD6IP;PKD2;RNF135
prerank,negative regulation of hydrolase activity (GO:0051346),0.4213604032893609,1.0041556177868023,0.48180815876515987,0.9499597599601853,1.0,8/49,11.72%,URI1;LRRK2;TERF2;ARFGEF1;RRP1B;EGLN1;LRCH1;TMED2
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.4499844789589127,1.0039805069298466,0.4827175208581645,0.9498445114907582,1.0,4/29,11.10%,RAET1E;STX7;SLAMF6;CYRIB
prerank,macrophage differentiation (GO:0030225),-0.40029006743780793,-1.003974839788515,0.4533762057877814,0.9640324769795899,1.0,5/13,21.16%,CSF1R;CSF1;PARP1;SIRT1;CASP8
prerank,negative regulation of T cell activation (GO:0050868),0.4418953402870923,1.003926968498958,0.4888366627497062,0.9493690664719566,1.0,3/35,2.33%,DUSP3;TNFAIP8L2;GLMN
prerank,sphingolipid biosynthetic process (GO:0030148),0.4156852866002021,1.0037682431312929,0.4841101694915254,0.9491638245153594,1.0,20/71,17.64%,DEGS1;ST8SIA5;SGPP1;HACD1;SMPD1;CERS6;SGPP2;ACER3;CERS4;ASAH1;SGPL1;CERS5;PRKD2;HACD4;SPTLC1;VAPB;LARGE1;ST3GAL5;SGMS1;PLPP1
prerank,lipid homeostasis (GO:0055088),0.4209813746302133,1.0034988335548547,0.4961832061068702,0.9493148238126542,1.0,11/57,14.48%,FBXW7;ADCK1;TLCD3A;IRS2;PPARG;ABCG1;THADA;ABCA1;ABCD1;NR1D2;ACOX3
prerank,negative regulation of locomotion (GO:0040013),0.5146166811318204,1.003431870383615,0.4812680115273775,0.9488913528513437,1.0,1/12,1.73%,DUSP3
prerank,negative regulation of viral process (GO:0048525),0.4192189036756027,1.003287120608707,0.46688382193268185,0.9486699075649939,1.0,4/57,2.23%,BANF1;IFITM3;EIF2AK2;ILF3
prerank,cellular response to alkaloid (GO:0071312),0.4839776606210043,1.0031129135920396,0.47702702702702704,0.9485630636810225,1.0,1/17,1.16%,BLM
prerank,I-kappaB phosphorylation (GO:0007252),0.524978709292945,1.002773429942545,0.4903536977491961,0.9488529751487086,1.0,3/10,14.85%,TLR7;TLR3;TLR4
prerank,synaptic vesicle membrane organization (GO:0048499),-0.3834755335201576,-1.002357312928875,0.44483985765124556,0.9657571782128931,1.0,5/17,7.43%,SYNGR1;SNAP25;AP3D1;STX2;STX4
prerank,nuclear membrane reassembly (GO:0031468),0.4214250203012827,1.0022587675598882,0.4933481152993348,0.9496199762126242,1.0,8/54,7.70%,BANF1;KPNB1;VPS4A;PPP2R2A;NUP205;AHCTF1;NUP98;LEMD2
prerank,ruffle organization (GO:0031529),-0.3706675727964108,-1.002194366053819,0.4154929577464789,0.9632760621450651,1.0,5/16,10.07%,RAC1;PLEKHA1;PIP5K1A;CSF1R;INPP5K
prerank,regulation of gene silencing by RNA (GO:0060966),0.4199241041808167,1.0016788371353107,0.4850828729281768,0.9499291263462017,1.0,8/50,9.28%,POLR2D;POLR2A;NUP205;PUM2;NUP98;AGO2;NUP54;PUM1
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.4199241041808167,1.0016788371353107,0.4850828729281768,0.9499291263462017,1.0,8/50,9.28%,POLR2D;POLR2A;NUP205;PUM2;NUP98;AGO2;NUP54;PUM1
prerank,coenzyme A metabolic process (GO:0015936),0.5000168093453381,1.0016758848676992,0.49291784702549574,0.9493355607001843,1.0,4/14,11.12%,ACAT1;PANK1;CROT;SLC25A16
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.48970602656587686,1.0014738535251502,0.48514851485148514,0.9492817615066456,1.0,5/14,17.18%,PRKAR2A;PKIB;PKIA;PRKAR1A;RAPGEF2
prerank,extracellular matrix disassembly (GO:0022617),0.4166672359950739,1.0012546464393848,0.4746136865342163,0.9492448437512385,1.0,7/53,12.66%,SCUBE1;ADAM15;CD44;FURIN;CAPN2;LAMC1;ADAM10
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.42828631346030804,1.001152556170089,0.4922222222222222,0.9489048777810292,1.0,12/54,14.91%,KCNJ6;CACNA1D;FLNA;YWHAE;NEDD4;DLG1;CD63;KCNIP3;GNG2;GNB1;KCNMB2;KCNMB3
prerank,defense response to bacterium (GO:0042742),0.4018323523963159,1.0010583396499793,0.4959016393442623,0.9485627582062055,1.0,12/105,14.85%,ANG;RNASE6;PLA2G6;GSDMD;TLR3;LYZL4;MAVS;COLEC12;RNASE3;SYK;OPTN;TLR4
prerank,receptor metabolic process (GO:0043112),0.4247628785320725,1.0009699400714687,0.49719416386083054,0.9481991258685315,1.0,17/53,16.49%,CD36;LDLRAP1;GRB2;PIK3R4;ARRB2;NEDD4;KIF16B;SNX1;RAMP1;UVRAG;SH3GLB1;SYK;CALCRL;CLTC;BECN1;CD81;LGMN
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.42301819663093954,1.000670279793492,0.4807903402854007,0.9484203533259211,1.0,15/52,16.27%,SAP18;MBNL1;ZBTB7A;RNPS1;RBM15;RBM5;FXR2;MBNL2;RBFOX3;RBM7;WTAP;DDX5;HNRNPL;NSRP1;CELF2
prerank,cellular protein modification process (GO:0006464),0.3960563150988428,1.0006684297747384,0.511,0.9478290717589714,1.0,176/983,14.01%,SGK3;SGK2;PLK1;WDR45;WFS1;CP;FNTB;KLHL42;RSKR;SIRT7;FBXO17;LRRK2;IGFBP3;UST;PRKCZ;VWA1;ALG3;PARP9;UCHL3;ST8SIA5;FBXW7;FBXO30;ST8SIA4;MINK1;EIF2AK2;ILF3;GMFB;SEPHS1;LIPE;GGCX;DYRK2;KLHL11;NEK3;METAP1;BRAF;DAPP1;TGFB2;GAS6;FEM1C;FEM1A;FBXO21;BMPR1A;PSMD9;CPE;SCG3;THBS1;PPP2R2A;PIK3R4;PSMB8;MAP3K11;CDK7;PRKCB;WDR45B;PDGFB;COPS7B;COG3;QSOX1;PRKCA;PRKACA;CDK2;BTK;YES1;PARP8;PRKDC;STK19;MAPK1;MAP3K20;PTPRJ;ASB8;EGLN3;CDK6;ACVR1;UBXN7;CTDNEP1;STK11;FBXO9;CEL;PSMC5;KEAP1;IKBKB;CDC42BPB;MAPK8;SETD3;PKN2;PAK2;DUSP16;RPS6KA5;PARP2;CDK9;DUSP10;SSH2;CAMK2D;PTPN1;F13A1;MAP3K9;ABCA7;PTPRT;MAST2;STT3A;PPP4R1;TNKS2;BIRC6;GRK5;DAPK1;CHEK2;COPS4;PTPN3;RAB2A;BRD2;ASB13;FBXO11;NEK7;PROC;CTBP1;LYN;B4GALT5;DCAF17;GAN;CDK5;PARP4;SOCS5;TAOK1;ELOC;UBE2I;SDC2;ASB2;FBXW11;MIA3;B3GALNT1;TGFBR2;ATG3;BMP2K;MAN2A2;LAMC1;MTOR;B3GNT2;PPM1A;CUL4A;ABL1;ERN1;KLHL5;CDKL5;PIGU;ZDHHC6;PRKCSH;PSMD12;UBE2F;ADAM10;SRPK2;HIPK2;MAPKAPK2;PSMA2;TGFBR1;NRBP1;CTDP1;ACVR1B;RBBP7;DUSP12;CDK8;SYK;GPC3;FN1;NUS1;ASB7;PTPRU;PTPRO;INSR;CAMKK2;B3GALNT2;PPP2R3A;FYN;PRKD2;FBXL7;SPARCL1;CSNK1A1;CREB1
prerank,glucose transmembrane transport (GO:1904659),0.4898118480842449,1.0006287828532867,0.4636118598382749,0.9473422553082587,1.0,1/18,1.39%,SLC2A3
prerank,RNA stabilization (GO:0043489),-0.298875375054091,-1.0005915281037996,0.45751633986928103,0.9650234517493831,1.0,10/33,13.91%,TENT2;HNRNPU;PABPC1;SLC11A1;PAIP1;YBX1;ZCCHC17;NSUN2;TENT5A;LARP1
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.3952647009977943,0.9994575557076945,0.4929718875502008,0.9497918464786738,1.0,32/186,13.94%,MDFI;UBAC2;BICC1;NPHP4;DVL1;IGFBP2;SOX13;RBMS3;PSMD9;NFATC1;TLE2;PSMB8;STK11;PSMC5;TMEM170B;TLE1;HECW1;DAB2;NXN;APC;CHD8;HMGXB4;TCF7L2;PSMD12;CYLD;PSMA2;LRP6;WWOX;PTPRU;PTPRO;MCC;CSNK1A1
prerank,mRNA stabilization (GO:0048255),0.43237857629752546,0.9994144476197662,0.4903954802259887,0.9493166319150974,1.0,7/40,12.92%,ELAVL4;EIF4ENIF1;SYNCRIP;TARDBP;FUS;MAPK14;MAPKAPK2
prerank,phagosome-lysosome fusion (GO:0090385),-0.43273555591622614,-0.9990625874657006,0.49271137026239065,0.9668078499595749,1.0,4/10,16.54%,ARL8B;CLN3;RAB39A;RAB20
prerank,regulation of defense response to virus by host (GO:0050691),0.43836752800991374,0.9988150389861585,0.48148148148148145,0.9503652923366285,1.0,6/30,11.45%,PARP9;HSP90AA1;ZDHHC1;MAVS;RNF216;TRIM44
prerank,cellular response to catecholamine stimulus (GO:0071870),0.45742313350588126,0.9987010259360364,0.46547314578005117,0.9500676724017587,1.0,7/23,14.41%,LRRK2;SLC9A1;PRKACA;MAPK1;ABL1;GNG2;GNB1
prerank,regulation of embryonic development (GO:0045995),0.4403412702305737,0.9985651457782588,0.4835680751173709,0.949850701078533,1.0,8/34,15.10%,EHMT1;CFL1;B4GALT5;NR2C2;INSR;TRIP12;DAG1;CLASP1
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.44967602544842455,0.9985643391213038,0.4885954381752701,0.9492566283607953,1.0,5/29,7.41%,RAD50;TERF2;CDK2;HSP90AA1;MRE11
prerank,phospholipid dephosphorylation (GO:0046839),0.4325125269083975,0.9985444019489649,0.5,0.9487049918201379,1.0,4/37,5.74%,MTMR11;SGPP1;MTMR1;SGPP2
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.49516941636539846,0.9984071526585722,0.4950911640953717,0.948484796820175,1.0,5/14,16.20%,IL18;TGFBR2;SYK;LGALS9;CD81
prerank,positive regulation of protein polymerization (GO:0032273),-0.2625628369160245,-0.9983268404236004,0.4266666666666667,0.9660044748808139,1.0,14/65,12.97%,NAV3;PRKCE;HCK;PTK2B;RAC1;SLAIN2;TOGARAM1;FES;DRG1;NCK2;VASP;BAIAP2;PYCARD;PFN1
prerank,negative regulation of interferon-gamma production (GO:0032689),0.46118373359151976,0.998042495506519,0.4986737400530504,0.9488529352647425,1.0,7/23,14.85%,GAS6;AXL;PRNP;HMGB1;LGALS9;HAVCR2;TLR4
prerank,positive regulation of JNK cascade (GO:0046330),0.4152687145881613,0.9979879764569202,0.49626467449306294,0.9484088591138007,1.0,10/70,12.87%,UNC5CL;MINK1;TPD52L1;SH3RF3;MAP3K11;SDCBP;TAOK1;TRAF2;HMGB1;HIPK2
prerank,regulation of metal ion transport (GO:0010959),0.484872797750085,0.9979689243144999,0.4772727272727273,0.947870011418967,1.0,5/16,13.39%,IL16;DLG1;EPB41;BCL2;CAMK2G
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.5046611546687239,0.9979453237283379,0.45714285714285713,0.9473324775094899,1.0,4/12,12.92%,CDK2;PRKDC;RFWD3;TP53
prerank,protein autoubiquitination (GO:0051865),0.4118967317969635,0.9975674617441617,0.4788273615635179,0.9477528122777324,1.0,13/61,14.53%,BRCA1;SH3RF3;RAD18;UBE2A;RNF115;BFAR;RNF146;RNF11;RNF157;TRAF2;UBE3A;NFX1;UBE2D3
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.5278038366380604,0.9973302506243513,0.5149606299212598,0.9477996888598463,1.0,4/10,16.10%,MAPK1;LYN;MAP2K2;MAP2K1
prerank,regulation of secretion by cell (GO:1903530),0.41949429443148467,0.9969071621117941,0.4847161572052402,0.9483251453634929,1.0,11/54,13.05%,LLGL2;RAB8B;LLGL1;RAB12;VAMP3;LGI3;VAMP2;STXBP5;DNAJC1;STXBP5L;RAB3C
prerank,inflammatory response (GO:0006954),0.39879859411691776,0.996873496967008,0.5235235235235235,0.9478269366839133,1.0,20/195,10.28%,SCUBE1;C5AR1;RELA;CX3CL1;ADCY8;THBS1;HDAC9;SIGLEC1;LIAS;IL10RB;CMKLR1;HDAC5;IL1A;IKBKB;CCL25;IL18;ADGRE5;CD44;PARP4;LOXL3
prerank,peptidyl-lysine acetylation (GO:0018394),0.5251223050642182,0.996726571004197,0.4992343032159265,0.9476359334215474,1.0,3/10,11.99%,EP300;KAT2B;ESCO1
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.5177746754569921,0.9967057167465221,0.49842767295597484,0.9471024671444171,1.0,3/10,8.44%,NEDD4;CAMK2D;HECW1
prerank,positive regulation of chemotaxis (GO:0050921),0.425568946662606,0.9965179324680192,0.4898876404494382,0.9470146449333174,1.0,10/43,16.49%,THBS1;NRP1;PDGFB;STX3;F3;TMSB4X;PRKD2;P2RY12;AIF1;LGMN
prerank,regulation of epidermal cell differentiation (GO:0045604),0.46972412630323523,0.9963379563863417,0.47843137254901963,0.946938383649617,1.0,5/21,14.30%,SGPP1;RUNX1;MAFG;ZFP36L1;ROCK2
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.422615266238931,0.9962607868025043,0.48891352549889133,0.946560211387568,1.0,6/48,6.09%,POLR1C;ASF1A;WBP2;PADI2;EP300;POLR1A
prerank,regulation of myelination (GO:0031641),-0.3304406373594605,-0.9957649542729518,0.4306930693069307,0.9706482693659961,1.0,13/25,35.03%,SIRT2;PTPRZ1;EIF2AK3;RNF10;JAM2;ITGAX;TPPP;ZPR1;MYRF;DICER1;CST7;TNFRSF21;NSUN5
prerank,cochlea morphogenesis (GO:0090103),-0.4483306727244688,-0.9957173111310932,0.46684350132625996,0.9678086800894246,1.0,5/10,44.38%,TIFAB;HPN;PAX2;SOX9;MYO3B
prerank,positive regulation of mitochondrial fission (GO:0090141),0.47307586567652365,0.9956571656901154,0.48484848484848486,0.9475448209690956,1.0,6/18,17.12%,MIEF2;VPS35;BNIP3;DNM1L;MFF;RALBP1
prerank,cilium organization (GO:0044782),0.3987224343060033,0.9955865854957195,0.5251509054325956,0.9471381663544998,1.0,38/210,14.18%,CLUAP1;BBIP1;CCDC57;CEP89;ACTR3;ARL6;EHD4;TMEM67;RAB8B;EHD1;BBS4;IQCB1;DZIP1;CEP250;FLNA;TTC39C;FNBP1L;EXOC5;PCNT;DYNLL2;IFT52;IFT20;ABLIM3;CCDC66;SNX10;CCP110;ODF2;AHI1;PTPN23;POC1B;EXOC4;KIF3A;OCRL;PTPDC1;RPGR;ARMC9;PKD2;RFX3
prerank,nuclear pore complex assembly (GO:0051292),0.5162760601526506,0.9955724247459257,0.5069551777434312,0.9465835164880266,1.0,4/10,13.32%,NUP205;AHCTF1;NUP98;RTN4
prerank,tRNA modification (GO:0006400),0.41489917536586607,0.9955345489479389,0.4902173913043478,0.9461081988793927,1.0,6/62,8.31%,WDR6;NSUN6;TRMO;TARBP1;OSGEP;AARS1
prerank,protein modification by small protein conjugation (GO:0032446),0.39574573036007876,0.9955052771587325,0.522,0.9455948073780815,1.0,91/361,17.03%,TRIM55;PLK1;BRCA1;UBE2Z;CDK5RAP3;UCHL3;RNF182;FBXW7;EIPR1;UBA5;CTR9;RLIM;RAD18;NUP205;UBE2V2;CDC23;UFC1;PRKDC;TRAF7;ARRB2;UBE2A;UBE2J2;CBLL1;DCUN1D4;FBXO9;KEAP1;RNF34;SUMO3;SUMO2;NEDD4;NUP98;HECW1;TRPM4;NUP54;BIRC6;RCHY1;AREL1;CDC16;RNF38;TRPC4AP;USP5;FBXO11;UBE2Q2;GAN;RFWD3;ELOC;TRIM5;UBE2I;RNF157;MYLIP;ASB2;FBXW11;ATG3;CBL;TRIM44;BCL11A;DERL1;CUL4A;UBE2W;UBE2F;MIB1;VPS11;RNF138;RNF20;ANAPC16;NFX1;UVSSA;UBE2H;FBXL7;RNF135;UBA6;UBE2D3;DTX3;MSL2;ATG7;PEX14;TRIM26;PIAS1;VCPIP1;ZNRF3;UBE2G1;UBA2;UBE2E3;UBR3;NUP160;CNOT4;NSMCE2;HACE1;SAE1;NUP93;DCUN1D2
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.4461372046296888,0.9952962798899287,0.5081018518518519,0.9455571300680539,1.0,5/35,13.78%,PCDHB16;CDH11;PCDHGB4;CDH20;CDH18
prerank,autophagy of peroxisome (GO:0030242),0.5067821787714509,0.9948907210730381,0.48240469208211145,0.9460455593160012,1.0,4/12,12.19%,PIK3R4;SQSTM1;TRAPPC8;RB1CC1
prerank,generation of neurons (GO:0048699),0.39847841888399643,0.9946785120259217,0.5190380761523046,0.9460127107809349,1.0,30/190,16.27%,WNT4;IER2;WNT2B;CX3CL1;VXN;RUNX1;TGFB2;ELP3;NRP1;NAV1;CDK6;MAPT;ARTN;TUBGCP2;ADNP2;CEP85L;CDK5;SOX11;EML1;CDKL5;MYT1L;MYEF2;RELN;FZD3;TAFA1;LDB1;GPM6A;AUTS2;MAP2K1;MEF2C
prerank,regulation of membrane repolarization (GO:0060306),0.5026538867041338,0.994644942308768,0.4918518518518519,0.9455120298359879,1.0,2/13,4.70%,AKAP9;YWHAE
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.43466088832901734,0.9944236258663744,0.5011627906976744,0.9455060904154373,1.0,10/33,17.53%,ANKRD54;PRKDC;TAL1;MAPK14;ACVR1B;RAB7B;ARNT;FOXO3;NCKAP1L;MED1
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.42431372905992254,0.9939492207922853,0.47368421052631576,0.9462162559347125,1.0,7/39,9.16%,NEDD4;GPD1L;NETO1;SLMAP;CAMK2D;HECW1;PTPN3
prerank,cellular response to unfolded protein (GO:0034620),0.4491218572215841,0.9937980057341592,0.4899497487437186,0.946028766240325,1.0,9/26,17.68%,BAG3;HSPA9;PTPN1;TM7SF3;ERN1;OPTN;RHBDD1;HSPA5;TMBIM6
prerank,response to ketone (GO:1901654),0.4508539017491002,0.993328656947211,0.4796954314720812,0.9466595256024954,1.0,3/24,4.55%,TGFB2;WBP2;THBS1
prerank,long-term memory (GO:0007616),-0.3589174296190907,-0.9933242914546094,0.50199203187251,0.9719053197233988,1.0,3/19,3.51%,CPEB3;SGK1;EIF2AK4
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.48218642497763486,0.9926209649624443,0.5,0.9478958656026325,1.0,2/17,8.02%,CRLS1;PLA2G4A
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.40519183898430106,0.9925938062510415,0.5063291139240507,0.9473952458150456,1.0,17/73,16.07%,EIF2AK2;SETD1A;RUNX1;PSMD9;PSMB8;KITLG;PRKDC;METTL3;PSMC5;TAL1;TCF12;ABL1;PSMD12;PSMA2;LDB1;PSMB1;LMO2
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.4764950525817921,0.9925893312252569,0.4897959183673469,0.9468247351311245,1.0,5/17,18.26%,TGFB2;SYK;P2RY12;NCKAP1L;PIEZO1
prerank,neuropeptide signaling pathway (GO:0007218),0.4108655790359218,0.992186560576514,0.4897959183673469,0.9472961641922778,1.0,7/58,13.83%,CPE;GPR149;SORCS3;GLRB;SORL1;GLRA3;CYSLTR1
prerank,leukocyte tethering or rolling (GO:0050901),0.47729309860400015,0.9921697621856523,0.4885906040268456,0.946755968328457,1.0,2/17,7.03%,ITGA4;GOLPH3
prerank,eye photoreceptor cell development (GO:0042462),0.49459561914721645,0.9920425728707969,0.49793672627235214,0.9465230826696989,1.0,4/15,16.89%,BBS4;RPGRIP1L;CEP290;RORB
prerank,N-terminal protein amino acid modification (GO:0031365),0.4998827098041544,0.9918365420698195,0.4901129943502825,0.9465178143054434,1.0,4/14,13.16%,METAP1;NAA35;NAA16;NAA15
prerank,regulation of vacuole organization (GO:0044088),0.4654172420437939,0.9917721945158423,0.5019710906701709,0.9460914324795079,1.0,7/20,15.54%,IFT20;TBC1D14;ENO1;ANXA2;TBC1D12;SCARB2;MTM1
prerank,regulation of macrophage differentiation (GO:0045649),-0.3822827680585964,-0.9916837566215684,0.4948453608247423,0.9739074544226939,1.0,4/15,7.25%,C1QC;PTPN2;CSF1;RIPK1
prerank,amide biosynthetic process (GO:0043604),0.4199735836546707,0.9914234839938584,0.5099557522123894,0.946408196975212,1.0,9/47,14.77%,DEGS1;SMPD1;CERS6;SLC25A2;CERS4;FURIN;ASAH1;CERS5;SPTLC1
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.48483233640642454,0.991096985851388,0.5040760869565217,0.9466869629766865,1.0,3/15,12.68%,FBXW7;CTDNEP1;SLC27A1
prerank,negative regulation of gene expression (GO:0010629),0.3959303551111752,0.9905479255930337,0.527,0.9475899539182081,1.0,54/302,13.37%,WNT4;RGCC;PARP9;EIF4A3;CNOT10;FBXW7;ZC3H12D;EIF2AK2;ILF3;FLOT2;EIF4ENIF1;PPHLN1;SYNCRIP;RUNX1;TGFB2;MALSU1;OLFM1;TARDBP;BMPR1A;RBMS3;HDAC9;TERF2;PDGFB;TNRC6B;ESR1;METTL3;PTBP3;MAPT;SYT11;MECP2;AGO2;RPS6KA5;EZH2;ITGB8;NPTN;NCOR1;DAPK1;FXR2;CNOT9;NOTCH2;KAT2B;SOX11;LSM14A;NCOR2;DNMT3A;TASOR;ERN1;ERP29;ADAM10;SAMD4A;MAP2K2;RBBP7;EPC1;NDFIP1
prerank,negative regulation of B cell activation (GO:0050869),-0.35066324523802384,-0.9904855402710723,0.4533898305084746,0.9745181975032583,1.0,4/21,7.10%,LAPTM5;SAMSN1;FCGR2B;TYROBP
prerank,positive regulation of cell division (GO:0051781),0.43041550995354827,0.9902186519306573,0.5102272727272728,0.9478751669260397,1.0,7/38,10.69%,SVIL;FGF1;KIF20B;GIPC1;PKN2;TAL1;CDC42
prerank,glycosphingolipid metabolic process (GO:0006687),0.41771767112281943,0.9901711631984035,0.49716231555051077,0.9474411255897419,1.0,7/42,11.14%,ST8SIA5;GBA2;SMPD3;SMPD1;GALC;ASAH1;B3GALNT1
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.4947603865005658,0.9897980240808499,0.4940119760479042,0.9478592686228203,1.0,3/14,5.62%,THBS1;CMKLR1;MAPK1
prerank,synaptic vesicle localization (GO:0097479),-0.4047746454529111,-0.9896210465179643,0.4857142857142857,0.9741709145070049,1.0,9/13,31.58%,DNM2;KIF5C;RAB27A;SYNDIG1;KIF5A;SYNJ1;TMEM230;TOR1A;SNAPIN
prerank,cellular response to UV (GO:0034644),0.40130845428386214,0.9886876175349251,0.5095137420718816,0.9501653888323546,1.0,12/76,12.93%,ACTR5;PPID;IMPACT;SMPD1;EP300;METTL3;STK11;NEDD4;ERCC4;NOC2L;TP53;EIF2S1
prerank,organelle organization (GO:0006996),0.39342838934943386,0.9884774839400449,0.533,0.9501710382645091,1.0,92/388,15.81%,MIEF2;LMAN1;LRRK2;COG1;FGD6;MTX1;ADCK1;WDR73;TMED4;CFL1;FGD3;VPS4A;FGD1;CHMP5;PPID;RAB3GAP1;TFB2M;SSBP1;HCFC1;SIPA1L3;HPS3;STX7;TPM1;ATP7A;ATXN7;COG3;PRPF40A;FNBP1L;CAPZB;TMED9;RAB30;PYROXD2;PACSIN2;ABCD2;ARFGEF1;POLG2;GOLPH3;LYSMD3;CDC42BPB;VPS13C;RANBP9;REEP5;MAST2;YTHDF1;STX17;PI4K2A;ODF2;RAB2A;MICAL2;ATP8B4;MAST3;SEC61A1;CDC42;ABCD3;SEMA6A;DIAPH1;PALLD;MIA3;MCOLN1;KIF3A;VPS4B;TMED2;TRAPPC8;RAB18;DNAJA3;ZMYM6;VPS11;ABCD1;TMED5;MAST4;VPS13D;PDCD6IP;PKD2;CSNK1A1;SAR1B;LNPK;EPS15;TRIP11;OPTN;RAB7A;WASL;NIPSNAP2;CLASP1;PEX14;ATL2;PHIP;MICAL3;PITPNB;SH3KBP1;ATP5F1B;GOLGA5;GOLGA8B
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.3960852730903185,-0.9883005178855093,0.47648902821316613,0.9753146342406138,1.0,6/13,15.54%,ZFPM2;ERBB4;FGFR2;FGF2;TGFBR3;NOTCH1
prerank,regulation of mitotic cell cycle (GO:0007346),0.3929616787484862,0.9881231486463335,0.5135135135135135,0.9505262048150287,1.0,29/171,13.61%,PLK1;GAS1;CDK5RAP3;CCDC57;DUSP3;TFAP4;PSMD9;PSMB8;ANAPC10;SMAD3;CDC23;PRKCA;KIF20B;SDCBP;PSMC5;BUB3;PKN2;CDK9;CDC16;PTPN3;NEK7;TAL1;HECA;PSMD12;CYLD;PSMA2;RNF20;ANAPC16;TTC28
prerank,regulation of axon guidance (GO:1902667),0.5165934412692323,0.9877593342674947,0.4847094801223242,0.9508990270075449,1.0,3/10,8.77%,NRP1;ZSWIM6;YTHDF1
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.44955604710725483,0.9875263641207008,0.48533007334963324,0.9509129459235731,1.0,3/24,6.74%,RFC2;POLD3;POLB
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.4879687414846639,0.9870052787382287,0.49930651872399445,0.9517018701890342,1.0,2/15,4.23%,SMPD3;PLA2G6
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.444703539596169,0.9869418305406841,0.5117370892018779,0.9512943859354054,1.0,7/30,14.15%,ACSBG1;HACD1;ABCD2;TECR;ABCD3;ABCD1;HACD4
prerank,protein destabilization (GO:0031648),0.4385469797900201,0.9869194029706009,0.49759615384615385,0.9507673038631208,1.0,5/32,11.74%,PLK1;EP300;FBXW11;PRNP;DERL1
prerank,water transport (GO:0006833),-0.4075359368884298,-0.986600614732437,0.4952978056426332,0.9776926553279507,1.0,1/12,9.54%,AQP4
prerank,neuron projection regeneration (GO:0031102),0.5205285677800452,0.9856519600109118,0.5113464447806354,0.9534814317762992,1.0,3/10,11.57%,NREP;MTR;GAP43
prerank,regulation of Rho protein signal transduction (GO:0035023),0.4022197612965682,0.9854676091794509,0.5052521008403361,0.9533812474181376,1.0,16/72,14.97%,ARHGEF3;SCAI;NRP1;GPR65;EPS8L1;EPS8;ARHGAP35;AKAP13;RIT2;ABL1;RAF1;MYO9B;ABCA1;HEG1;LPAR6;ARHGDIB
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.4423099906136162,0.9851396145046669,0.5067155067155067,0.9536613070344847,1.0,10/27,16.10%,EIF4ENIF1;PUM2;TNRC6B;AGO2;PUM1;TP53;MAP2K2;DDX5;EIF4E2;MAP2K1
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.33435303018172957,-0.9849844088032942,0.4669811320754717,0.9796449061412343,1.0,4/23,6.96%,CACNA2D1;PTK2B;NOS1AP;ATP1A2
prerank,sterol biosynthetic process (GO:0016126),0.43449501852301403,0.9849720689669937,0.5029171528588098,0.9534816807512756,1.0,3/33,4.43%,INSIG1;INSIG2;GGPS1
prerank,intracellular lipid transport (GO:0032365),0.4617451685392155,0.9847203367136353,0.4930817610062893,0.9535808144216056,1.0,6/21,14.13%,SGPP1;ABCD2;SLC25A20;ABCD3;ABCD1;ACACA
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.4028404105213972,-0.9846186069204083,0.47840531561461797,0.9777918535952955,1.0,8/13,38.82%,UPP2;NT5M;TDG;SMUG1;NEIL2;NT5C;OGG1;NEIL1
prerank,protein ubiquitination (GO:0016567),0.39158268033088645,0.9844915635075152,0.569,0.9536110095615616,1.0,103/471,15.66%,TRIM55;PLK1;BRCA1;KLHL42;FBXO17;UBE2Z;UCHL3;RNF182;FBXW7;FBXO30;EIPR1;CTR9;RNF31;RLIM;SH3RF3;SASH1;FBXO21;RAD18;PELI1;PSMD9;PSMB8;UBE2V2;CDC23;AKTIP;PRKDC;TRAF7;RC3H2;ARRB2;NHLRC1;UBE2A;RNF166;UBE2J2;CBLL1;FBXO9;PSMC5;RNF115;KEAP1;RNF34;PPIL2;NEDD4;UNKL;TPP2;BFAR;LNPEP;HECW1;HERC6;RNF146;TNKS2;BIRC6;RCHY1;AREL1;CDC16;RNF38;TRPC4AP;USP5;FBXO11;UBE2Q2;GAN;RNF11;RFWD3;TRIM3;ELOC;TRIM5;RNF157;MYLIP;ASB2;TRAF2;FBXW11;ATG3;CBL;TRIM44;RNF144B;DERL1;CUL4A;UBE3A;UBE2W;UBE3C;PSMD12;MIB1;VPS11;UBR5;RNF138;NHLRC3;PSMA2;RNF20;BCL2;ANAPC16;NFX1;UVSSA;UBE2H;FBXL7;RNF135;UBA6;UBE2D3;DTX3;MSL2;TRIP12;PEX14;TRIM26;VCPIP1;FBXW4;PSMB1;ZNRF3
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.4381445629128845,0.9844722929481586,0.5006075334143378,0.953084760085323,1.0,9/29,18.00%,SMARCA4;TLE2;EP300;TLE1;TCF7L2;TRRAP;TLE4;CTNNB1;BCL9
prerank,carnitine metabolic process (GO:0009437),0.5052189705627854,0.9838950742389944,0.5111441307578009,0.9539697601015976,1.0,3/12,11.42%,CPT1C;CROT;ACADL
prerank,chromatin organization (GO:0006325),0.39560057859507636,0.9835797029440725,0.5555555555555556,0.9541946048818117,1.0,32/132,16.82%,EHMT1;SMARCA4;SUV39H1;HCFC1;ZBTB7A;KDM5A;PADI2;HMGN3;ESR1;HDAC11;HDAC5;NUDT5;SETD2;HP1BP3;KDM5B;GATAD1;EZH2;TADA2A;BAZ2B;KDM4B;KAT2B;KDM4C;ATRX;NPM1;SMARCA2;HDAC2;BAZ1B;PAK1;RB1;SMARCC2;ZBTB1;SETD5
prerank,cardiac cell development (GO:0055006),-0.4335772973759271,-0.9833524552158719,0.49295774647887325,0.978699914427951,1.0,4/11,32.19%,NOTCH1;VEGFA;JAG1;CXADR
prerank,cellular response to gamma radiation (GO:0071480),0.4793975918492335,0.9833073169884489,0.5013774104683195,0.9543486704119615,1.0,3/17,5.83%,TMEM109;WRN;MAP3K20
prerank,positive regulation of mitochondrial translation (GO:0070131),0.48752599247590356,0.983209752181764,0.511380880121396,0.9540160980218634,1.0,1/14,1.42%,COA3
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.4202225272671979,-0.9824522236583385,0.5141065830721003,0.9784977059079394,1.0,4/12,27.72%,SLC11A1;PRKCQ;CARD9;CCR2
prerank,RNA transport (GO:0050658),0.4095564231243359,0.9823974776742239,0.5100742311770944,0.9555463986541844,1.0,16/71,12.67%,EIF4A3;DHX38;SARNP;RFTN1;SIDT1;RNPS1;U2AF1;HNRNPA2B1;THOC5;SRSF5;U2AF2;ATXN2;TGFBR2;ZFP36L1;SRSF9;SRSF11
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.37978526985067895,-0.982317424870977,0.48120300751879697,0.9759802899661872,1.0,8/15,12.95%,CPEB3;CNOT1;TENT4B;TNRC6C;PABPC1;CNOT7;TNRC6A;TENT4A
prerank,regulation of mRNA 3'-end processing (GO:0031440),-0.4351144775456851,-0.9817297579314572,0.4891640866873065,0.9747398987506133,1.0,7/11,32.14%,AHCYL1;ZC3H3;NCBP1;CDC73;NCBP2;PAF1;LEO1
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.4771299669576715,0.9816787341963954,0.510840108401084,0.9567914809612622,1.0,3/16,12.05%,ZC3H12D;TARDBP;ZFP36L1
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.455788538279432,0.9814794437806553,0.5141388174807198,0.9567418508219152,1.0,7/23,15.88%,MTMR11;MTMR1;OCRL;PTEN;SYNJ2;MTM1;INPP5F
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.44710172949570504,0.9814741944258938,0.5036407766990292,0.9561780223901708,1.0,6/25,14.79%,AKAP9;DLG1;CAMK2D;TRPM4;CALM1;CACNA1C
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.4843335030035083,0.9811821500740326,0.528169014084507,0.9563864123761862,1.0,3/15,11.90%,DDR1;IGF1R;ABL1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.4926246795433279,0.980922912692058,0.5007518796992482,0.9564701447556905,1.0,3/13,9.77%,NFU1;GLRX3;YAE1
prerank,alanine transport (GO:0032328),-0.4376699501369399,-0.9808501080109551,0.5315315315315315,0.9745350159929493,1.0,2/10,11.71%,SLC36A1;SLC36A4
prerank,myoblast differentiation (GO:0045445),0.49362821521671324,0.9805208257108068,0.5170940170940171,0.9569729332338,1.0,5/14,16.57%,MBNL1;PLEKHM3;TCF7L2;DDX5;RB1
prerank,negative regulation of cell aging (GO:0090344),-0.3566682738478295,-0.9803038302545637,0.4781021897810219,0.9733862003264646,1.0,5/16,14.16%,AKT3;MAP3K3;YBX1;RBL1;SIRT1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.4072098739643777,-0.9801456932541796,0.4851190476190476,0.9682339570342912,1.0,5/11,24.53%,PTK2B;SHC1;JAK1;STAT5B;STAT5A
prerank,cellular response to interleukin-2 (GO:0071352),-0.4072098739643777,-0.9801456932541796,0.4851190476190476,0.9682339570342912,1.0,5/11,24.53%,PTK2B;SHC1;JAK1;STAT5B;STAT5A
prerank,nuclear migration (GO:0007097),0.49148768786295527,0.9801449069842217,0.5021337126600285,0.9573551656427248,1.0,3/13,11.05%,SYNE2;DCTN1;FBXW11
prerank,regulation of protein import into nucleus (GO:0042306),0.4277070772368933,0.9800362401935393,0.5125858123569794,0.9570674628132848,1.0,7/36,12.71%,DMAP1;BAG3;FLNA;SMAD3;MAVS;IPO5;UBR5
prerank,regulation of glycogen metabolic process (GO:0070873),-0.39833238284857453,-0.9800062399021812,0.4692556634304207,0.9657847789449987,1.0,8/12,52.66%,INPP5K;AKT1;PPP1R3B;PPP1R3F;KHK;PPP1R3D;PPP1R3C;PPP1R3E
prerank,cellular response to oxygen-containing compound (GO:1901701),0.3906181687382002,0.9795842628502759,0.577,0.9576463984660034,1.0,51/291,14.85%,HCN3;RORA;INSIG1;RELA;CTR9;RAPGEF1;PID1;CHMP5;IMPACT;JUN;AKAP9;IRS1;RAP1A;TPM1;PDGFB;CDK2;MAPK1;ESR1;AXL;IL1A;EZR;MAPT;RAP1B;MAPK8;TWF2;NCOA3;DAPK1;MTR;ADNP2;LYN;SETX;IPO5;PLAA;CAPN2;PXN;MTOR;HMGB1;ZFP36L1;SLC38A9;MAPK14;LCOR;CAMKK2;HTRA2;PKD2;CREB1;GNG2;ROCK2;GNB1;LARS1;P2RY12;TLR4
prerank,cell cycle G1/S phase transition (GO:0044843),0.4046615941249662,0.979559107492291,0.5098468271334792,0.9571292219602876,1.0,17/61,18.00%,MAX;MAP3K11;CDK7;CDK2;CDK6;ACVR1;USP29;MNAT1;CUL4A;ACVR1B;USP37;CRLF3;RB1;EIF4E;RPS6KB1;PPP6C;KHDRBS1
prerank,negative regulation of apoptotic process (GO:0043066),0.38849988592349566,0.9793615410231916,0.579,0.9570655432066607,1.0,64/444,13.16%,ISL1;PLK1;WFS1;UBE2Z;RELA;CX3CL1;CD38;WDR73;SMAD6;CFL1;BAG3;NUPR1;BRAF;GAS6;IGBP1;NAA35;THBS1;FLNA;TNFAIP8;YWHAE;PRKCA;PRKDC;SQSTM1;MAPK1;AXL;BIRC3;GOLPH3;TLE1;API5;IKBKB;MRE11;HSPA9;MAPK8;PAK2;BNIP3L;SET;BFAR;BABAM2;DAB2;BIRC6;ZFAND6;GRK5;FNIP1;AREL1;AHI1;MTDH;PROC;CD44;SETX;TMBIM4;RNF157;NAA16;BNIP3;NOTCH2;IGF1R;CBL;RNF144B;MAP2K5;RAF1;ADAM10;TP53;BCL2;FMN2;NAA15
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.443657249046716,0.9793501315026156,0.5060975609756098,0.9565168320832607,1.0,6/29,11.98%,LSM7;EXOSC5;DCP1B;EXOSC7;DCP1A;DCPS
prerank,microtubule depolymerization (GO:0007019),0.48274072800852413,0.979165501451788,0.516914749661705,0.9563996603420514,1.0,2/17,5.98%,STMN2;NCKAP5L
prerank,fluid transport (GO:0042044),-0.40520479627534267,-0.979064913326223,0.5045045045045045,0.9656641576918513,1.0,1/12,9.54%,AQP4
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.48839227009855146,0.978985172386485,0.5118881118881119,0.9562899796960476,1.0,3/13,10.01%,NEDD4;PTPN1;HGS
prerank,ephrin receptor signaling pathway (GO:0048013),0.39794310966721913,0.9789473486549689,0.5303347280334728,0.9558112840676785,1.0,22/82,14.75%,ACTR3;ITSN1;EPHB2;YES1;VAV3;SDCBP;AP2A1;ARPC1A;ARPC4;KALRN;LYN;ANKS1A;EPHA5;CDC42;SDC2;ARPC2;VAV2;ANKS1B;FYN;ARPC3;ROCK2;WASL
prerank,negative regulation of stress fiber assembly (GO:0051497),0.4472604035524572,0.9788024917289554,0.5186567164179104,0.9556097028003867,1.0,7/24,15.70%,CGNL1;PPFIA1;PAK2;WASF2;TMEFF2;CLASP1;PIK3R1
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.41392537797221085,0.9787955534349616,0.5072302558398221,0.9550580017269763,1.0,11/48,13.73%,SS18L1;FLNA;NRP1;DOCK1;PRKDC;CUX1;LIMS1;CDC42;ABL1;CDKL5;RREB1
prerank,mRNA export from nucleus (GO:0006406),0.3948384065753583,0.9785338450450108,0.5269582909460834,0.955152266021006,1.0,17/102,12.67%,POLR2D;EIF4A3;SMG6;DHX38;SARNP;RNPS1;NUP205;U2AF1;HNRNPA2B1;THOC5;NUP98;SRSF5;NUP54;U2AF2;CPSF3;SRSF9;SRSF11
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.3994652002807629,0.9781536265182414,0.5191082802547771,0.955559716694813,1.0,12/69,14.85%,ISL1;EPHB2;THBS1;PTPRJ;IL1A;TLR3;MAVS;HMGB1;SYK;LGALS9;HAVCR2;TLR4
prerank,polyol metabolic process (GO:0019751),0.41673892615297065,0.9780867476509475,0.52,0.9551811541921074,1.0,11/46,14.70%,INPP1;INPP4A;INPP5A;MINPP1;PLD4;IPMK;PLCB4;OCRL;CALM1;ITPK1;PTEN
prerank,secretion (GO:0046903),0.4820438517021891,0.9780413961109573,0.5196629213483146,0.9547286248981058,1.0,1/14,3.48%,TPD52
prerank,nucleotide catabolic process (GO:0009166),-0.3672068800773041,-0.9779838191961214,0.4580152671755725,0.9659205205898195,1.0,9/16,36.85%,VCP;XDH;DERA;NUDT3;PNP;GPX1;SAMHD1;ITPA;NT5C
prerank,negative regulation of gluconeogenesis (GO:0045721),0.5125860601194306,0.9778629335791283,0.5317829457364341,0.9546082723000802,1.0,2/11,11.56%,EP300;GCK
prerank,epidermal cell differentiation (GO:0009913),-0.29494239372841047,-0.9776597406701167,0.49586776859504134,0.9640081268597109,1.0,7/41,16.99%,PIP5K1A;ADAM9;UGCG;HDAC1;BCR;TXNIP;ST14
prerank,regulation of AMPA receptor activity (GO:2000311),0.44706633825357617,0.9770559725979258,0.5142503097893433,0.9560904242337346,1.0,2/25,3.10%,MINK1;CACNG7
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.45864865795447046,0.9765537564610033,0.5110533159947984,0.95682368972913,1.0,3/20,8.04%,EIF6;TNRC6B;AGO2
prerank,monocarboxylic acid metabolic process (GO:0032787),0.39795597213335576,0.9762166565370851,0.5304259634888439,0.9571106326911438,1.0,11/117,9.43%,ALDH1A2;PDZD11;BTD;CPT1C;CD36;GBA2;MCCC2;CKB;GPAM;CROT;PPARG
prerank,sensory perception of light stimulus (GO:0050953),0.3973586971993316,0.975058907179336,0.5311203319502075,0.9594644200904413,1.0,14/87,16.46%,WFS1;ATXN7;CRYBG3;COL11A1;MYO9A;DHRS3;PITPNA;EML2;ATF6;RPGR;ABLIM1;SLC4A10;DRAM2;RP2
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.3886961620740744,0.9749964886384893,0.5543259557344065,0.9590547204988724,1.0,38/172,15.88%,LCAT;PTDSS2;ARF3;MTMR1;PIP4K2A;PIK3R4;FAR1;CRLS1;INPP4A;HDHD5;CHKB;PITPNM1;PI4KA;GPD1L;GPAM;PLA2G4A;PI4K2A;CDS1;PIP4K2B;LCLAT1;DGKD;FIG4;AGPAT4;ARF1;OCRL;PLD1;SLC27A1;AGPAT5;PIK3C2A;CHKA;ETNK1;PTEN;SLC44A1;SYNJ2;MTM1;PIK3R1;DGKZ;INPP5F
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.47233706673119163,0.9746065374599817,0.5013513513513513,0.9594819689335952,1.0,1/16,0.58%,RORA
prerank,negative regulation of bone mineralization (GO:0030502),-0.3829307711533857,-0.9745678461086918,0.4738562091503268,0.9700812098519003,1.0,3/13,8.93%,PTK2B;BCOR;ENPP1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.4640546936974471,0.9743682870588931,0.5032258064516129,0.9595049943454106,1.0,5/19,12.92%,TMEM109;DYRK2;EP300;HIPK2;TP53
prerank,cellular response to hexose stimulus (GO:0071331),0.4572485557657923,0.9739602466535707,0.5225,0.959929041054981,1.0,5/23,12.18%,ADCY8;GAS6;PRKACA;IGF1R;ERN1
prerank,acute inflammatory response (GO:0002526),-0.340870167638805,-0.9737031056087798,0.48223350253807107,0.9697827260858569,1.0,4/23,22.08%,ANO6;IL22;CEBPB;CTNNBIP1
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.49313403993944904,0.9736164480327808,0.5013888888888889,0.960264054411147,1.0,3/13,10.70%,UBAC2;ERLEC1;EDEM2
prerank,positive regulation of mitochondrion organization (GO:0010822),0.4033501298865426,0.9731822702387891,0.5300546448087432,0.960777443442433,1.0,13/57,17.12%,MIEF2;ADCK1;BCL2L11;VPS35;BNIP3;ZDHHC6;MLLT11;TP53;CAMKK2;HTRA2;DNM1L;MFF;RALBP1
prerank,myeloid cell development (GO:0061515),-0.36155255819359866,-0.9731721510146463,0.5138339920948617,0.9686222770402741,1.0,2/18,0.16%,APP;FOXP1
prerank,response to peptide hormone (GO:0043434),0.425532066868039,0.9729020936404702,0.5299435028248588,0.9609195652849739,1.0,9/43,16.72%,EIF6;IRS1;ZFP36L1;SLC27A1;CREB1;ROCK2;TSC1;STAT2;STAT6
prerank,positive regulation of nervous system development (GO:0051962),0.4323736195833163,0.9728269150936929,0.541002277904328,0.9605421778377587,1.0,8/42,11.42%,NUMBL;EPHB2;SPEN;CLSTN3;RGS14;IL1RAP;CLSTN1;SOX11
prerank,lymphocyte chemotaxis (GO:0048247),0.43031847361285824,0.9726628998637566,0.5101311084624554,0.9603854332614451,1.0,3/34,7.28%,CX3CL1;GAS6;CCL25
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.44851275866148077,0.9720910395245652,0.5037783375314862,0.9612246110193949,1.0,5/24,14.29%,SELENON;PRKACA;CAMK2D;PKD2;CALM1
prerank,ion homeostasis (GO:0050801),0.43182098649692574,0.9719811988993775,0.5098265895953757,0.9609359286127916,1.0,2/30,8.39%,SLC4A3;CAMK2D
prerank,keratan sulfate biosynthetic process (GO:0018146),0.440968475187625,0.9718084238672395,0.5082382762991128,0.960796137360376,1.0,4/26,11.61%,B4GALT3;B4GALT5;B4GALT1;B3GNT2
prerank,regulation of actin filament bundle assembly (GO:0032231),0.4388751095422228,0.9716812193013806,0.5196560196560197,0.9605593469770016,1.0,8/26,16.52%,CX3CL1;ALMS1;SLC9A1;CDC42;ROCK2;TSC1;ACTG1;RDX
prerank,inositol phosphate metabolic process (GO:0043647),0.4148726801598896,0.9716005102685279,0.5298850574712644,0.9602106505306385,1.0,11/46,14.70%,INPP1;INPP4A;INPP5A;MINPP1;PLD4;IPMK;PLCB4;OCRL;CALM1;ITPK1;PTEN
prerank,sarcomere organization (GO:0045214),0.4342981167790803,0.9714976106681709,0.5376078914919852,0.9599160140749466,1.0,2/27,12.08%,TPM1;WDR1
prerank,regulation of interferon-alpha production (GO:0032647),0.443293101830228,0.9713177976079344,0.5317258883248731,0.9597831782562857,1.0,8/23,16.40%,TLR7;IRF3;SETD2;TLR3;MAVS;HAVCR2;TLR4;TBK1
prerank,regulation of calcium ion transport (GO:0051924),0.4066418543811219,0.971181356114834,0.5287610619469026,0.9595523595815252,1.0,9/54,14.08%,WFS1;IL16;HOMER2;CACNA1D;EPB41;BCL2;CAMK2G;PKD2;CD84
prerank,cellular response to reactive oxygen species (GO:0034614),0.3997860134639086,0.9711274409184885,0.5250544662309368,0.9591196322756532,1.0,12/59,13.91%,RELA;IMPACT;JUN;TPM1;MAPK1;MAPT;MAPK8;SETX;PXN;ABL1;CAMKK2;PKD2
prerank,protein modification by small protein removal (GO:0070646),0.3854788573711966,0.9708234346865092,0.563,0.9593501279791322,1.0,61/252,15.89%,BRCA1;ACTR5;KDM1B;USP11;UCHL3;USP32;USP24;DESI1;DESI2;HCFC1;USP19;PSMD9;AR;USP34;PSMB8;EP300;SMAD3;ATXN7;COPS7B;ESR1;ARRB2;USP29;BIRC3;POLB;PSMC5;KEAP1;USP33;USP1;UCHL5;USP48;SNX3;BABAM2;CCP110;COPS4;USP20;USP5;USP46;APC;HGS;TRAF2;KAT2B;USP3;PSMD12;CYLD;TP53;PSMA2;TGFBR1;USP37;ATXN3;USP45;OTULINL;PTEN;RAD23B;NFRKB;OTUD7A;BECN1;SMAD4;VCPIP1;PSMB1;TRRAP;FOXK1
prerank,regulation of glucose transmembrane transport (GO:0010827),0.4646663634420538,0.9707863292752543,0.5251989389920424,0.9588693461225545,1.0,2/18,4.96%,BRAF;PRKCB
prerank,protein mono-ADP-ribosylation (GO:0140289),0.5098914954032807,0.9700213640918218,0.5289017341040463,0.9602704168411619,1.0,3/11,10.02%,PARP9;PARP8;PARP4
prerank,autophagosome maturation (GO:0097352),0.4298014430223334,0.9698846410943003,0.5376344086021505,0.9600393896594561,1.0,10/32,15.96%,TSG101;VPS16;VAMP7;UBQLN1;STX17;UVRAG;VIPAS39;CALM1;SNX14;EPG5
prerank,negative regulation of cellular catabolic process (GO:0031330),0.39337831303175946,0.9698316135881978,0.5325379609544468,0.9596214459586825,1.0,10/63,13.04%,WDR6;CDK5RAP3;NUPR1;NELL1;TBC1D14;TAB3;PTPN3;MTOR;SORL1;BCL2
prerank,nuclear pore organization (GO:0006999),0.4801272807904477,0.9697490153559146,0.5447976878612717,0.9592603560412107,1.0,5/14,13.32%,NUP205;AHCTF1;NUP98;NUP54;RTN4
prerank,negative regulation of cell motility (GO:2000146),0.3909621398920356,0.9694486529643833,0.5482233502538071,0.9594887595656827,1.0,13/108,8.51%,VCL;DUSP3;CX3CL1;SCAI;ADAM15;ZMYND8;NF1;TPM1;PTPRJ;LDLRAD4;DUSP10;SLURP1;PTPRT
prerank,negative regulation of innate immune response (GO:0045824),-0.3008112774395853,-0.9692378240192873,0.5,0.9773360483855765,1.0,11/34,20.86%,GRN;PTPN2;NLRC5;CNOT7;NLRC3;RPS19;TNFAIP3;IRAK3;SUSD4;NMI;USP18
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.3174711557527932,-0.969149785830069,0.4603960396039604,0.9748079508612283,1.0,9/24,13.55%,B2M;FCER1G;IDE;CALR;BCAP31;MFSD6;SEC23A;CANX;SEC24C
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.4418023251909554,0.9690444639491521,0.5236318407960199,0.9599169299240985,1.0,7/24,16.32%,PRKCB;NEDD4;PTPN1;HGS;PRKD2;ARNT;EPN2
prerank,regulation of endocytosis (GO:0030100),0.40585292682518914,0.9686338214734255,0.5296610169491526,0.9603667451582348,1.0,13/61,13.37%,SMPD1;STON2;PACSIN2;CBLL1;RAB5B;SYT11;PTPN1;ABCA7;DAB2;RIT2;SCAMP5;ABL1;GPC3
prerank,protein localization to plasma membrane (GO:0072659),0.3903551987975296,0.9685646880916833,0.5567951318458418,0.9599564135375055,1.0,28/129,14.30%,FLOT2;ZFYVE27;EHD4;ITGB1BP1;RAB8B;EHD1;GAS6;RAB40C;RAB12;RAP1A;FLNA;MYO5A;EZR;PPIL2;IKBKB;DLG1;SLMAP;SPTBN1;EFR3B;RAMP1;TMED2;PACS2;EPB41L3;RAB3C;LRP6;PACS1;KCNIP3;ROCK2
prerank,establishment of protein localization to organelle (GO:0072594),0.40122101738169563,0.967910006567653,0.5373134328358209,0.961018480284936,1.0,11/72,9.84%,NEURL1B;KPNB1;EIF4ENIF1;HIKESHI;HEATR3;RANBP6;IPO7;IPO9;PTTG1IP;CSE1L;IPO5
prerank,sensory organ development (GO:0007423),0.41279958287135643,0.9679085529325543,0.5495594713656388,0.9604594686988338,1.0,13/51,18.35%,TGFB2;SIPA1L3;CHD7;AHI1;SMCHD1;RAB18;ATF6;HIPK2;SMG9;HIPK1;PBX3;MEIS1;MEIS2
prerank,prostaglandin metabolic process (GO:0006693),0.44109510441453587,0.9676973717970405,0.5327455919395466,0.9604283991354355,1.0,4/26,11.29%,HPGD;PLA2G4A;PLAA;PTGR2
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.5046962205858738,0.9675388566400328,0.5289514866979655,0.9602750204301369,1.0,3/10,17.53%,NCOA3;PRKCH;MED1
prerank,mitochondrial transport (GO:0006839),0.4040983630177144,0.9673770269559828,0.5487404162102957,0.9600800686978139,1.0,9/53,13.04%,SLC25A24;TIMM17A;TOMM40;TIMM23;HSP90AA1;BNIP3;SLC25A16;FLVCR1;BCL2
prerank,histone H3 acetylation (GO:0043966),-0.29442369735900215,-0.9672538005097049,0.45,0.9775018600662496,1.0,23/40,29.90%,KAT6A;MBIP;JADE2;ING4;KAT14;MEAF6;KAT6B;BRPF1;BRD1;BRPF3;WDR5;JADE1;TADA1;DR1;ING5;TAF12;TAF5L;SGF29;TADA3;TAF6L;NAA60;KAT2A;PER1
prerank,negative chemotaxis (GO:0050919),-0.2989285687797069,-0.967202143194226,0.5112781954887218,0.9748872266758977,1.0,14/33,26.17%,RHOA;SLIT2;SEMA4D;EPHA7;PDGFA;SEMA3A;SEMA3E;SEMA4C;SEMA3C;SLIT1;SLIT3;ITGB3;ITGAV;SEMA4G
prerank,regulation of muscle contraction (GO:0006937),0.43186774374612885,0.9671473959350461,0.5295566502463054,0.9600880220593542,1.0,6/26,17.25%,TPM1;PPP1R12B;ENO1;KCNA1;CHRM2;KCNB2
prerank,ribosomal large subunit assembly (GO:0000027),0.44266872438383414,0.9669791487340458,0.5098522167487685,0.9599386847038236,1.0,3/24,5.60%,BOP1;RPLP0;TRAF7
prerank,lung epithelium development (GO:0060428),-0.42143389912769547,-0.96625480522751,0.5255681818181818,0.9747392952524556,1.0,2/10,14.25%,PKD1;ERRFI1
prerank,regulation of axon extension (GO:0030516),0.41833792802822284,0.966046176233887,0.5249406175771971,0.9617198596084875,1.0,12/37,16.16%,ZFYVE27;OLFM1;MAPT;TWF2;DIP2B;DBNL;ABL1;CDKL5;RUFY3;RTN4;MACF1;GOLGA4
prerank,protein deubiquitination (GO:0016579),0.38342152515843586,0.9660064568918199,0.583,0.9612579296061865,1.0,59/242,15.89%,BRCA1;ACTR5;KDM1B;USP11;UCHL3;USP32;USP24;DESI2;HCFC1;USP19;PSMD9;AR;USP34;PSMB8;EP300;SMAD3;ATXN7;ESR1;ARRB2;USP29;BIRC3;POLB;PSMC5;KEAP1;USP33;USP1;UCHL5;USP48;SNX3;BABAM2;CCP110;USP20;USP5;USP46;APC;HGS;TRAF2;KAT2B;MINDY2;USP3;PSMD12;CYLD;TP53;PSMA2;TGFBR1;USP37;ATXN3;USP45;OTULINL;PTEN;RAD23B;NFRKB;OTUD7A;BECN1;SMAD4;VCPIP1;PSMB1;TRRAP;FOXK1
prerank,mitochondrion localization (GO:0051646),0.4636411520732863,0.9658753384708556,0.5351213282247765,0.9610278844899827,1.0,2/19,7.15%,LRRK2;MEF2A
prerank,lipid biosynthetic process (GO:0008610),-0.23053805446176184,-0.9654023188477162,0.509090909090909,0.9743594434536124,1.0,26/77,25.94%,PAM;PIP5K1A;LPCAT1;ACLY;AGPAT3;LPL;ACSL1;PRKAA1;PDSS1;ACSS2;GNPAT;PRKAA2;ACSL5;MBOAT1;HMGCR;LIPH;PCYT2;GPAT4;FDFT1;ACSL6;PRLR;SCP2;SREBF1;XBP1;NDUFAB1;CLN8
prerank,macrophage chemotaxis (GO:0048246),-0.4217927429722224,-0.96533501098679,0.5175202156334232,0.9718188572501356,1.0,6/10,49.22%,CKLF;EDNRB;CCL3;CXCL17;CCL2;CCL5
prerank,positive regulation of myoblast differentiation (GO:0045663),0.4648461370574897,0.9650556134416585,0.5292479108635098,0.9624902975925367,1.0,1/16,1.08%,IGFBP3
prerank,neutral amino acid transport (GO:0015804),0.4348936245414328,0.9648547235717237,0.532777115613826,0.9624005888646047,1.0,3/28,8.66%,LLGL2;SLC38A2;SLC7A8
prerank,phosphatidic acid metabolic process (GO:0046473),0.4072067906080702,0.9648535504829714,0.5365579302587177,0.9618449408766881,1.0,10/48,13.00%,PLA2G6;GPD1L;GPAM;PLA2G4A;LCLAT1;DGKD;AGPAT4;PLD1;SLC27A1;AGPAT5
prerank,mRNA catabolic process (GO:0006402),0.42438429884452017,0.9644564654205933,0.54421768707483,0.9622576777981606,1.0,8/44,13.71%,CNOT10;ZC3H12D;TUT4;METTL3;XRN1;XRN2;ERN1;DDX5
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.5005084243770518,0.9644373530699852,0.5286144578313253,0.9617430815180361,1.0,1/10,1.43%,EMC9
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.42641358052960066,0.9641784530686077,0.54,0.961836551446068,1.0,5/30,13.51%,LMAN1;UGGT2;STT3A;ST6GAL1;UGGT1
prerank,triglyceride metabolic process (GO:0006641),0.4090849687683894,0.9639532013233838,0.5411111111111111,0.9618369204369209,1.0,3/48,11.56%,MOGAT3;GPAM;GK
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.4195798852487657,0.9632116300158227,0.5253456221198156,0.9630958090784022,1.0,7/40,12.96%,BLM;WRN;BOD1L1;CDK9;EXD2;RFWD3;ATRX
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.40323601099313716,-0.9631711111142109,0.5264900662251656,0.9753636010685711,1.0,3/12,7.56%,FOXP1;MBP;LPL
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.3976645093910342,0.9631466891213071,0.5516506922257721,0.9626913697014042,1.0,10/63,12.92%,RGCC;CNOT10;EP300;CDK2;PRKDC;CHEK2;CNOT9;RFWD3;CNOT3;TP53
prerank,vesicle transport along actin filament (GO:0030050),0.45868903504486974,0.9629730708633579,0.5279583875162549,0.962580673813607,1.0,8/19,17.05%,MYO5A;FNBP1L;MYO1G;ACTN4;MYO1E;WASL;MYO1B;MYO1D
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.2592023166119581,-0.9628948282313973,0.5113636363636364,0.9734456047500315,1.0,27/53,27.10%,PSMD14;PSMA3;AZIN1;PSMB2;PSMB7;PSMC6;PSMD4;PSMD7;PSMA1;PSMA5;PSMC1;PSMD13;PSMC2;PSMA6;OAZ2;PSMA4;PSMD3;PSMF1;PSMD2;PSMD5;OAZ1;PSMD1;PSMC3;PSMD8;PSMB3;PSME1;PSMB9
prerank,dopamine metabolic process (GO:0042417),0.4598891460228608,0.9626842171138142,0.5378266850068776,0.9627171184930605,1.0,2/18,5.05%,TGFB2;ATP7A
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.4630908687879754,0.9626479458831345,0.5408022130013831,0.962263398568006,1.0,4/18,9.28%,DDX60;PUM2;BIRC3;PUM1
prerank,macroautophagy (GO:0016236),0.3834502749410653,0.9625462232758119,0.5672097759674134,0.9619554059150036,1.0,26/118,12.45%,TSG101;VPS16;TOMM40;VAMP7;VPS4A;UBQLN1;PIP4K2A;PIK3R4;EI24;ILRUN;SQSTM1;AMBRA1;DYNLL2;STX17;PIP4K2B;VPS41;HGS;PLAA;VPS37C;VPS37A;ATG3;VPS4B;UVRAG;RB1CC1;TBC1D5;VIPAS39
prerank,T cell proliferation (GO:0042098),0.48740139385047654,0.9625148740201861,0.5530973451327433,0.9614660749441091,1.0,2/13,4.01%,DOCK8;MSN
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.4077397125129954,0.9624064505962199,0.5383759733036707,0.9611925035979174,1.0,4/50,7.11%,BLM;CDK5RAP3;CDK7;MNAT1
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.44194707347126594,0.9623398095374144,0.5255474452554745,0.9607860806639638,1.0,6/27,14.69%,CD36;IL18;PPARG;ABCG1;ABCA1;ABCA5
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.3914444733117014,0.962323309124711,0.5522388059701493,0.9602705916749087,1.0,17/77,16.57%,URI1;RELA;CX3CL1;ITGA6;AR;THBS1;ACVR1;BIRC6;NOC2L;ZMYND11;TCF7L2;TGFBR1;BCL2;FZD9;PHIP;CFLAR;RB1
prerank,positive regulation of macroautophagy (GO:0016239),0.40809473510567773,0.9618596166793073,0.5512249443207127,0.9608674792799565,1.0,14/48,14.77%,BAG3;RAB3GAP1;PIP4K2A;EPM2A;BNIP3L;PIP4K2B;BNIP3;UVRAG;GNAI3;FYCO1;SH3GLB1;VPS13D;OPTN;SPTLC1
prerank,brain development (GO:0007420),0.3866561338774196,0.9616976900938636,0.5727272727272728,0.9606901737517711,1.0,37/136,18.35%,CDK5RAP3;UTP3;NNAT;RAB3GAP1;BBS4;SETD1A;NF1;ATXN1;UFC1;PITPNM1;TUBGCP2;AFF2;CHD8;FBXW11;TGFBR2;UGP2;EML1;RAB18;UBE3A;SOX6;NDRG4;RELN;GRIN2A;PTEN;SMG9;SYNJ2;CIC;NFIB;TBC1D23;CTNNA2;RAPGEF2;PBX3;APOD;MEIS1;CDK5RAP2;PROX1;MEIS2
prerank,axon guidance (GO:0007411),0.38262475633017873,0.9603037853105542,0.595,0.9635741579350859,1.0,36/201,15.94%,CXCL12;PLXNA1;GRB2;EPHB2;NRP1;PRKCA;SEMA6D;MAPK1;IRS2;EZR;USP33;RANBP9;ARTN;SPTBN1;RPS6KA5;NPTN;EPHA5;ARHGAP35;SEMA3D;SEMA6A;PALLD;NOTCH2;GAP43;FRS2;FEZ1;DOK6;PLXNC1;PTPRO;FYN;NRP2;RELN;DAG1;EVL;SH3KBP1;PIK3R1;NFIB
prerank,protein localization to mitochondrion (GO:0070585),0.5018539730782946,0.960233500041436,0.5620437956204379,0.9631892730137284,1.0,1/11,1.07%,LRRK2
prerank,negative regulation of translational initiation (GO:0045947),0.4785654985671388,0.9599209328078445,0.5489614243323442,0.9633750048194982,1.0,3/13,8.04%,EIF2AK1;EIF3E;AGO2
prerank,dendritic spine organization (GO:0097061),0.4420884169839823,0.9597996214271041,0.5179233621755254,0.9631415009784057,1.0,12/26,17.88%,EPHB2;CDC42;ARF1;IGF1R;PRNP;INSR;FYN;PTEN;WASL;LGMN;DOCK10;TREM2
prerank,negative regulation of viral release from host cell (GO:1902187),-0.38970705481629175,-0.9597743588796461,0.5128205128205128,0.9797105406965938,1.0,6/13,18.39%,CHMP3;TRIM8;TRIM35;PML;TRIM11;MID2
prerank,protein localization to cell surface (GO:0034394),0.4314347635484592,0.9597027315184907,0.5256410256410257,0.9628302568603587,1.0,7/26,17.61%,VCL;FLNA;PIGU;PTPRU;GGA1;GGA3;CTNNB1
prerank,positive regulation of glucose import (GO:0046326),-0.3353632201995492,-0.9596142784358971,0.5063829787234042,0.977488450255051,1.0,9/21,15.29%,APPL1;SORBS1;OSBPL8;IGF1;PRKCI;AKT1;ARPP19;RHOQ;CREBL2
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),-0.3117857496577009,-0.959395225124235,0.5287958115183246,0.9753540649437206,1.0,9/26,14.72%,PTPN12;PDE8A;EEF1A1;GAREM1;INPP5K;DUSP22;SYAP1;PDPK1;PLCG1
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.4997482577207758,0.9593651726600648,0.5351681957186545,0.9631208034320119,1.0,1/11,3.69%,TGFB2
prerank,peripheral nervous system development (GO:0007422),0.4504095801659408,0.9592793433619538,0.5545454545454546,0.9627771201531965,1.0,3/23,8.15%,NF1;SERPINI1;ARTN
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),-0.2938083580639664,-0.9590131926364153,0.5057471264367817,0.973705512855858,1.0,7/33,9.18%,PLCG2;APPL2;TAF1;APPL1;PKD1;PTPN6;STXBP4
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.38451084624357657,0.9587144109473846,0.5769230769230769,0.9635709119673753,1.0,23/136,15.59%,MDFI;WFS1;CDK5RAP3;NUPR1;GAS6;FLNA;CMKLR1;ESR1;ARRB2;KEAP1;PYDC1;EGLN1;IRAK2;PRNP;MAP2K5;TMSB4X;COMMD7;TCF7L2;CYLD;PKD2;HAVCR2;PEX14;HDAC2
prerank,regulation of sensory perception of pain (GO:0051930),-0.4121649932248715,-0.958520278069561,0.521865889212828,0.9724787618687851,1.0,8/11,53.10%,MGLL;ZFHX2;ATPSCKMT;CCL3;TMEM100;F2R;ACP3;CCN3
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.5016766707972087,0.9584829130850638,0.5539568345323741,0.9635843276348097,1.0,4/11,13.51%,UGGT2;POMT2;DERL1;UGGT1
prerank,regulation of exit from mitosis (GO:0007096),0.4190561905127652,0.9582629731856974,0.5421965317919075,0.9635585429684105,1.0,5/38,9.14%,RGCC;ANAPC10;CDC23;BUB3;CDC16
prerank,engulfment of apoptotic cell (GO:0043652),-0.36274295318418953,-0.9580538856725597,0.5261324041811847,0.9710341834440671,1.0,4/15,7.98%,XKR6;RAC1;RHOBTB1;MEGF10
prerank,regulation of immunoglobulin production (GO:0002637),-0.33571850353795774,-0.9573389147187125,0.5161290322580645,0.970455834291192,1.0,5/23,7.43%,CD86;PTPRC;GPI;FCGR2B;STX4
prerank,regulation of glycolytic process (GO:0006110),0.392853828140268,0.9572502194825246,0.5371549893842887,0.9654266189804406,1.0,9/68,8.99%,EIF6;NUPR1;PGAM1;ZBTB7A;NUP205;EP300;NUP98;NUP54;NCOR1
prerank,integrin-mediated signaling pathway (GO:0007229),0.3944428657654024,0.9572095416624327,0.5580168776371308,0.9649570008100785,1.0,14/73,13.49%,ADAM15;ITGB1BP1;ITGBL1;NRP1;DOCK1;ITGB5;FERMT3;ITGB8;DAB2;CDC42;ABL1;ADAM10;SYK;FN1
prerank,regulation of osteoblast proliferation (GO:0033688),0.4623325704788518,0.9569573050832401,0.5434782608695652,0.9650116308023196,1.0,2/17,4.64%,EIF2AK2;NELL1
prerank,autophagy of mitochondrion (GO:0000422),0.409171363246211,0.9564360826984374,0.5281030444964872,0.9657331552870237,1.0,10/38,15.16%,WDR45;WDR45B;SQSTM1;AMBRA1;BNIP3;ULK2;ATG3;RB1CC1;ATG7;BECN1
prerank,receptor catabolic process (GO:0032801),0.44245226338674426,0.9559518144893858,0.5521235521235521,0.9663733770964104,1.0,11/24,16.49%,PIK3R4;AP2A1;NEDD4;KIF16B;MYLIP;UVRAG;SH3GLB1;CLTC;BECN1;ZNRF3;LGMN
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.3960009575400622,0.9559257181230512,0.5604395604395604,0.9653390409188579,1.0,7/56,9.78%,NUBPL;TMEM126A;FOXRED1;NDUFS1;NDUFA9;NDUFV2;NDUFAF7
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.3960009575400622,0.9559257181230512,0.5604395604395604,0.9653390409188579,1.0,7/56,9.78%,NUBPL;TMEM126A;FOXRED1;NDUFS1;NDUFA9;NDUFV2;NDUFAF7
prerank,regulation of histone modification (GO:0031056),0.47445880585610944,0.9559008843197986,0.5416078984485191,0.9648512839133631,1.0,3/13,8.29%,PARG;MTHFR;CDK9
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.447692003480565,0.9550852819826922,0.5538261997405967,0.9663249265547245,1.0,3/22,8.61%,BTK;LACC1;TRPM4
prerank,granulocyte differentiation (GO:0030851),0.4577375862432742,0.9549806345359301,0.5288831835686778,0.9660290658040342,1.0,4/18,13.22%,EP300;CDK2;TAL1;RXRA
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.5058772168919334,0.9547874166739937,0.5291411042944786,0.9659538129940212,1.0,2/10,4.96%,PID1;PRKCB
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.4199854100504596,0.9545759123210115,0.5349397590361445,0.9659152399583417,1.0,5/31,12.97%,EIF4A3;HOXC4;TGFBR2;SOX11;TGFBR1
prerank,primary miRNA processing (GO:0031053),0.5172620703887223,0.9545673118397047,0.5506134969325154,0.9653925483518041,1.0,3/10,7.13%,SMAD3;METTL3;HNRNPA2B1
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.28624653106380826,-0.9545588297579214,0.5359477124183006,0.9754534713645665,1.0,6/35,5.41%,SGIP1;B2M;RAC1;PPT1;SMAP1;RAB21
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.3958444474119457,0.9543548579408586,0.5541264737406216,0.965374644871528,1.0,18/70,16.57%,ATRNL1;SIPA1L3;VAMP3;NRP1;METTL3;ITGA4;PARVB;FERMT3;LPXN;PXN;LAMC1;FN1;RELN;UNK;TMEFF2;PIK3R1;MEF2C;RB1
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.4263062969530748,0.9542390962619897,0.524330900243309,0.965099298760207,1.0,7/27,15.69%,BRD8;EP300;PHF20;MORF4L2;KAT2B;PHF20L1;TRRAP
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.38507117017292597,0.9540661771819892,0.5788934426229508,0.9649650938624221,1.0,20/104,15.19%,DAND5;SMAD6;PMEPA1;BMPR1A;ZBTB7A;SMAD3;CRIM1;SPRED2;ACVR1;LEMD2;LDLRAD4;PPARG;TGFBR2;PPM1A;SORL1;HIPK2;TGFBR1;SPRED1;UBE2D3;SMAD4
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.44358985849238675,0.9540107795327236,0.5384615384615384,0.9640204226726534,1.0,4/21,13.04%,EYA2;IL1A;MAP2K5;BCL2
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.44358985849238675,0.9540107795327236,0.5384615384615384,0.9640204226726534,1.0,4/21,13.04%,EYA2;IL1A;MAP2K5;BCL2
prerank,cell proliferation in forebrain (GO:0021846),-0.41672235885858,-0.9539532631050289,0.5396341463414634,0.9745000536178985,1.0,4/10,8.55%,PCM1;CEP120;DOCK7;AKNA
prerank,establishment of vesicle localization (GO:0051650),-0.34682856250574434,-0.9536391079412198,0.4845814977973568,0.9727892336745748,1.0,13/18,32.50%,DNM2;RAB11A;KIF5C;CCDC186;RAB27A;LIMK2;IKBKG;KIF5A;SYNJ1;TMEM230;TOR1A;SNAPIN;TESK1
prerank,carboxylic acid metabolic process (GO:0019752),0.4197417915344658,0.9534608953475153,0.5562060889929742,0.9648058069388213,1.0,4/33,10.61%,SLC2A3;LIAS;PLA2G4A;ST6GAL1
prerank,dendritic cell migration (GO:0036336),0.4690252952286774,0.9531451772303329,0.5604395604395604,0.9650427178053007,1.0,4/16,12.01%,ALOX5;TRPM4;EPS8;HMGB1
prerank,establishment of protein localization to membrane (GO:0090150),0.3924694030619212,0.9526274213100412,0.5531686358754028,0.9657572869714284,1.0,12/66,12.38%,ZDHHC24;ARL6;RAB3GAP1;BRAF;RFTN1;SDCBP;NACA;ZDHHC1;VPS37C;VPS37A;ATG3;ZDHHC6
prerank,regulation of cell development (GO:0060284),0.4182262253025025,0.9520928945843946,0.5478662053056517,0.9664161784488694,1.0,3/36,4.82%,CX3CL1;CLOCK;HDAC9
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.4203083588260645,0.9518382577450939,0.5516431924882629,0.9664745620145607,1.0,5/33,7.41%,RAD50;TERF2;CDK2;HSP90AA1;MRE11
prerank,covalent chromatin modification (GO:0016569),0.47292980112361804,0.9517607564423208,0.5441389290882779,0.9661192246510948,1.0,2/14,8.24%,SIRT7;PARP2
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.40201285718804125,0.9516425531129564,0.5618101545253863,0.9658634633912722,1.0,13/55,16.44%,TPD52L1;NUPR1;BCL2L11;TRAF7;PAK2;TRAF2;CYLD;TP53;TGFBR1;BCL2;WWOX;BECN1;DNM1L
prerank,cellular response to interferon-gamma (GO:0071346),0.38333537806429113,0.9515613270710604,0.5741127348643006,0.9655278885672771,1.0,16/88,15.45%,MID1;CX3CL1;IRF1;SYNCRIP;IRF3;CCL25;CAMK2D;DAPK1;CD44;TRIM5;CAMK2G;LGALS9;AIF1;TLR4;TRIM26;CD47
prerank,peptide biosynthetic process (GO:0043043),0.37686688935372137,0.9514834078668644,0.5963855421686747,0.9651713819541481,1.0,17/153,8.04%,GGTA1;RPL18;RPS6KB2;RPS23;MRPL37;RPL41;RPL31;RPS17;RPL4;MRPS21;RPLP0;HARS1;RPS15A;RPL38;DHPS;PABPC4;AGO2
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.34249997722100906,-0.9514518486814818,0.4980237154150198,0.9762979256258315,1.0,2/18,0.30%,AKT3;MAP3K3
prerank,response to interferon-beta (GO:0035456),0.4479983111198691,0.951327027290319,0.5686274509803921,0.9649747250442358,1.0,2/22,1.88%,IFITM3;IRF1
prerank,cytoskeleton organization (GO:0007010),0.38567319247705767,0.9512023550039576,0.5973496432212029,0.9647299643564947,1.0,22/114,13.14%,FGD6;CFL1;RHOF;FGD3;FGD1;SIPA1L3;TPM1;PRPF40A;CAPZB;PACSIN2;CDC42BPB;RANBP9;MAST2;MICAL2;MAST3;LRCH3;SEMA6A;DIAPH1;PALLD;EPB41L3;ZMYM6;MAST4
prerank,embryonic heart tube morphogenesis (GO:0003143),0.40795111914532606,0.9511809086190582,0.5551801801801802,0.964239964090748,1.0,8/44,16.27%,BBS4;ACVR1;AHI1;MICAL2;TGFBR2;NDRG4;PKD2;MEF2C
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.46119179729087467,0.950917577223436,0.5408299866131191,0.9643320641702782,1.0,6/18,15.70%,BCL2L11;TMEM259;NCK1;ERN1;ATXN3;PIK3R1
prerank,cellular response to DNA damage stimulus (GO:0006974),0.3773942331288265,0.9504820978005527,0.648,0.9648243689299915,1.0,73/336,15.69%,BRCA1;PCLAF;SIRT7;BLM;RFC2;POLE2;RAD50;SUV39H1;GRB2;DYRK2;BCL2L11;RAD18;ASF1A;IRF3;BCL6;POLA1;WRN;AKTIP;PRKDC;VAV3;UBE2A;METTL3;POLB;STK11;MNAT1;PDS5A;RBBP8;BOD1L1;MRE11;MAP2K6;SLF1;ERCC4;SMC5;KMT5B;NBN;PARP2;BABAM2;CHEK2;KMT5C;APC;LYN;SETX;RFWD3;PARP4;TAOK1;CBX1;TANK;RNF169;RAD51B;ZBTB38;CUL4A;ABL1;UVRAG;USP3;MAPK14;UBR5;MAPKAPK2;TP53;BCL2;FMN2;CHCHD6;GTF2H1;HTRA2;USP45;UBA6;MTREX;RECQL5;SPIDR;TRIP12;NPM1;VCPIP1;BAZ1B;TRRAP
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.42714318423115166,0.9504098737235542,0.5368956743002544,0.9644442029238702,1.0,5/26,13.81%,EYA2;IL1A;MAP2K5;BCL2;HTRA2
prerank,negative regulation of protein metabolic process (GO:0051248),0.40423481455623544,0.9503131049561121,0.5475113122171946,0.9641419113531049,1.0,8/48,14.08%,PFDN1;EIF2AK1;FLOT2;FLNA;SNX3;PRNP;FMN2;CD84
prerank,necroptotic process (GO:0070266),0.45755143477033033,0.9500933586857971,0.5451977401129944,0.9641490019366373,1.0,6/16,16.44%,TLR3;IPMK;CYLD;ITPK1;TLR4;DNM1L
prerank,protein insertion into membrane (GO:0051205),0.42250738597954973,0.9498143490148919,0.5479289940828402,0.9642580860150782,1.0,5/32,11.35%,TRAM1L1;SEC61G;UBE2J2;VAMP2;PRNP
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.3123899158312907,-0.9497630160476428,0.4918918918918919,0.9782929325071981,1.0,6/25,5.73%,LYST;CHMP4B;CHMP4A;VCP;CHMP3;DENND10
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.44390871985463354,0.9489452723739573,0.5492021276595744,0.9658120219601108,1.0,6/20,15.19%,RELA;EP300;CARF;RBPJ;CHD6;SMAD4
prerank,outer dynein arm assembly (GO:0036158),-0.3675216102288128,-0.9483546489718263,0.5265017667844523,0.9796579059566565,1.0,8/15,50.22%,LRRC49;DNAL1;DNAAF5;ODAD1;DNAH8;DNAH5;ODAD2;ODAD4
prerank,lipid transport (GO:0006869),0.38633409095542076,0.9482470601959155,0.5743589743589743,0.9668788217856965,1.0,23/97,16.25%,CD36;OSBP;SLCO1B1;ABCD2;PITPNM1;PRELID2;NCOA1;ABCA7;STARD5;ABCG1;ABCD3;PITPNA;SLC27A1;ABCA1;ABCD1;RXRA;CHKA;SLCO2B1;PPARD;NCOA2;ABCA5;PITPNB;OSBPL2
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.381110017733307,0.9481227360637515,0.5907258064516129,0.9666240679877399,1.0,16/140,14.79%,C5AR1;CD36;ADCY8;ADCY5;GPR65;CMKLR1;ESR1;SPPL3;TRPM4;NPTN;CACNA1A;ABL1;HMGB1;CYSLTR1;LPAR6;CACNA1C
prerank,iron ion transport (GO:0006826),0.40580152957550036,0.9473607752428714,0.5693673695893452,0.9679236406921403,1.0,11/47,14.68%,CP;STEAP3;ABCB7;ATP6V0E1;ARHGAP1;ATP6V1E1;MCOLN1;ATP6V0D2;ATP6V1H;ATP6V0A2;CLTC
prerank,retrograde axonal transport (GO:0008090),-0.36078859679439224,-0.9472269123977365,0.5405405405405406,0.9801561987061005,1.0,7/16,16.40%,DLG2;TMEM108;KIF1A;ACTR10;KIF1C;NEFL;DYNC1H1
prerank,regulation of protein polymerization (GO:0032271),0.4155580467678499,0.9470979744340684,0.5494761350407451,0.9680085939337079,1.0,7/35,11.90%,GBA2;PLEKHG2;CAMSAP3;HSP90AA1;MAPT;DBNL;ABL1
prerank,actin filament organization (GO:0007015),0.3800987714108555,0.9469307579053751,0.60262891809909,0.9678712865376048,1.0,33/151,17.40%,CGNL1;SVIL;RHOF;NEBL;TMOD1;FLNA;TMOD3;ALDOA;TPM1;PLS3;MYO5A;ABI1;DLG1;ARPC4;MYO1G;SHROOM3;EPS8;CD2AP;CDC42;RUFY3;PPP1R9A;ERMN;MYO1E;ELMO1;AIF1;WASL;HIP1;EVL;PPP1R9B;ARHGAP17;MYO1B;MYO1D;GSN
prerank,negative regulation of cytokine production (GO:0001818),0.37803351310160405,0.9469098522263026,0.5985915492957746,0.9673882272125083,1.0,31/163,14.85%,RGCC;CX3CL1;HOMER2;GAS6;THBS1;IRF3;HDAC9;ILRUN;CMKLR1;AXL;ABCD2;EZR;SYT11;RPS6KA5;NPTN;MAVS;CUEDC2;RNF216;MAPKBP1;PRNP;MAP2K5;TMSB4X;HMGB1;CYLD;ABCD1;FN1;LGALS9;RNF135;CD84;HAVCR2;TLR4
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.40997468729141934,0.9469067886978895,0.5391600454029511,0.96685778681282,1.0,9/39,13.10%,SOCS4;SOCS7;PIP4K2A;PI4KA;PI4K2A;PIP4K2B;SOCS5;EFR3B;PIK3C2A
prerank,hyaluronan metabolic process (GO:0030212),0.4308498430643417,0.9467949496620833,0.5604534005037783,0.9665862226442435,1.0,4/23,9.66%,SLC9A1;CEMIP2;ABCC5;CD44
prerank,endoderm formation (GO:0001706),0.4163974071999335,0.9463143713598294,0.5702380952380952,0.9671469363334528,1.0,4/35,7.49%,ITGA4;ITGB5;COL11A1;SETD2
prerank,B cell activation (GO:0042113),0.38804695240830916,0.94606440012652,0.5796178343949044,0.967185906610971,1.0,9/68,6.60%,TPD52;EPHB2;ZBTB7A;HDAC9;PRKCB;BTK;PTPRJ;HDAC5;ITGA4
prerank,positive regulation of T cell cytokine production (GO:0002726),0.44867320254075904,0.9460305983206417,0.5604249667994687,0.9667284815411248,1.0,3/20,10.87%,PRKCZ;IL18;TRAF2
prerank,positive regulation of metabolic process (GO:0009893),0.3831619478528471,0.9459935260078607,0.5757884028484231,0.9662698591713397,1.0,18/103,14.13%,EHMT1;CD36;ALMS1;CAMK1D;CMKLR1;DECR1;KDM3A;IL18;APC;CNOT3;IGF1R;ACADL;TRPV2;PPARGC1B;SYK;INSR;ADIPOR1;ACACA
prerank,negative regulation of cellular senescence (GO:2000773),-0.3738769140007313,-0.945797097345685,0.5311475409836065,0.9814237016007697,1.0,5/13,14.16%,AKT3;MAP3K3;YBX1;RBL1;SIRT1
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.3788986687629353,0.9457760931639972,0.6130653266331658,0.966225671588898,1.0,36/208,14.38%,RORA;UNC5CL;RIOK3;RELA;CX3CL1;IRAK4;TMED4;RNF31;PLEKHG5;PELI1;FLNA;PRKCB;SQSTM1;ESR1;BIRC3;TLE1;IKBKB;ZFAND6;TAB3;MAVS;MTDH;MAPKBP1;CANT1;TFG;WLS;TRIM5;AKAP13;TANK;TRAF2;ZMYND11;PPM1A;NDFIP1;S100B;TRIM59;LGALS9;OPTN
prerank,chloride transport (GO:0006821),-0.24130914115471427,-0.9456948718875019,0.5918367346938775,0.9790976594353366,1.0,28/74,33.82%,GABRB1;ANO6;GABRA2;ANO3;GABRA3;SLC12A9;PACC1;ANO10;TTYH3;CLCN4;GLRA1;CLCN6;CLCN3;SLC1A1;SLC12A2;GABRA5;SLC6A1;GLRA2;GABRA4;GABRB3;GABRG1;TTYH1;ANO5;GABRA1;SLC12A7;SLC4A8;SLC12A5;LRRC8A
prerank,connective tissue development (GO:0061448),0.4214785456528438,0.9456496901678844,0.5477326968973747,0.965974117825976,1.0,8/35,14.32%,ATP7A;ARID5B;LRP5;ITGB8;CD44;CREB3L2;SOX6;TRIP11
prerank,negative regulation of interleukin-6 production (GO:0032715),0.42550042571022606,0.9450246287050552,0.5569620253164557,0.9668587343396665,1.0,3/27,7.80%,CX3CL1;GAS6;SYT11
prerank,regulation of interleukin-8 production (GO:0032677),0.39028578332400155,0.9450012448452652,0.5633652822151225,0.9663721096490859,1.0,13/69,14.85%,RELA;TLR7;TLR3;MAVS;MAPKBP1;F3;MAP2K5;TMSB4X;HMGB1;SYK;PRKD2;LGALS9;TLR4
prerank,double-strand break repair via break-induced replication (GO:0000727),-0.39425145126080113,-0.9447212677875292,0.5648148148148148,0.97935853938672,1.0,10/12,51.82%,MCM3;CDC7;MCM6;MCMDC2;MCM4;GINS4;GINS2;MUS81;MCM2;MCM7
prerank,regulation of vesicle-mediated transport (GO:0060627),0.3867332728567695,0.9447188474771968,0.5876923076923077,0.9664635516239201,1.0,24/91,16.10%,GAS1;LRRK2;RAB8B;RAB12;NRP1;STON2;LGI3;MAPK1;PACSIN2;RAB5B;PTPN1;VAMP2;STXBP5;RIT2;ABL1;STXBP5L;PLD1;RAB3C;MAP2K2;SYK;HIP1;DNAJC13;INPP5F;MAP2K1
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.4619048634313831,0.9444494522247973,0.5364806866952789,0.9665690671039162,1.0,3/15,12.97%,EIF4A3;TGFBR2;TGFBR1
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.26802241878570854,-0.9444066296629607,0.512396694214876,0.977584112925187,1.0,14/47,18.44%,APP;EIF4G1;TGFB1;MTPN;CSF1;EIF2A;SSH1;WDR91;PUM3;AKT1;TCOF1;PCIF1;NFKBIA;GEMIN5
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.345436388570838,-0.9441479047453534,0.522633744855967,0.9757058170584332,1.0,3/17,1.88%,PRKN;DYRK1A;RFFL
prerank,negative regulation of anoikis (GO:2000811),-0.37229472249347595,-0.9440056493295663,0.4919093851132686,0.9734961986298782,1.0,4/14,7.53%,PTK2;MCL1;PIK3CA;ITGA5
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.3349175360822218,-0.9439829901846173,0.5138121546961326,0.9709890218729917,1.0,4/22,4.37%,RYR2;CALM2;ATP1B1;AKAP6
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.4925630413569948,0.9438993806151477,0.5666666666666667,0.9673550545942892,1.0,4/11,13.69%,PTPRT;HGS;SH2B3;ADIPOR1
prerank,insulin secretion (GO:0030073),-0.3473598389365205,-0.9438701429144533,0.531496062992126,0.9687459526772515,1.0,5/19,12.25%,RIMS2;RAB11FIP2;RAB11FIP5;RAB11B;SELENOT
prerank,protein import into nucleus (GO:0006606),0.3887792310784522,0.9438021388289337,0.5810234541577826,0.9670606672311503,1.0,12/66,9.84%,KPNB1;EIF4ENIF1;HIKESHI;HEATR3;RANBP6;IPO7;IPO9;PTTG1IP;KPNA6;CSE1L;NUP54;IPO5
prerank,negative regulation of platelet activation (GO:0010544),-0.34565728807870777,-0.9437477425432692,0.5412186379928315,0.9665145966365807,1.0,4/16,11.07%,PRKG1;SERPINE2;CD9;PDGFA
prerank,regulation of small molecule metabolic process (GO:0062012),0.42926870583822946,0.9435964209089611,0.5585042219541616,0.9670207658323539,1.0,6/28,15.89%,RORA;TTC39B;ACADL;NCOR2;ADIPOR1;FOXK1
prerank,microtubule anchoring (GO:0034453),0.4906602878285318,0.94353968567314,0.5522827687776142,0.9666114778086599,1.0,7/12,18.03%,CAMSAP3;BICD1;DAG1;CLASP1;PEX14;GCC2;CLASP2
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.38330507182115425,0.9435237072038963,0.5903866248693835,0.9661172627240528,1.0,16/87,11.44%,PRKCZ;SMAD6;ZFYVE9;HPGD;TGFB2;BMPR1A;JUN;SMAD3;ARRB2;ACVR1;ITGB5;LPXN;FURIN;PXN;TGFBR2;CBL
prerank,mRNA splice site selection (GO:0006376),0.4191006349478557,0.943391861430065,0.5541871921182266,0.9658829835670909,1.0,7/30,12.16%,PSIP1;LUC7L;SRSF5;SFSWAP;SETX;SF1;SRSF9
prerank,regulation of cartilage development (GO:0061035),0.4468125843289417,0.9432358545910785,0.5445945945945946,0.9657173049215327,1.0,4/18,15.86%,TAPT1;TRPS1;SOX6;MBOAT2
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.5030139050356913,0.9431904237402606,0.5521472392638037,0.9653017386340073,1.0,4/10,17.29%,TGFBR2;LGALS9;CD81;NCKAP1L
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.3742030176465745,0.9431444931655065,0.6212121212121212,0.9648911447382298,1.0,27/161,13.94%,UBAC2;BICC1;NPHP4;DVL1;IGFBP2;SOX13;RBMS3;PSMD9;TLE2;PSMB8;STK11;PSMC5;TMEM170B;TLE1;HECW1;DAB2;APC;CHD8;TCF7L2;PSMD12;CYLD;PSMA2;LRP6;PTPRU;PTPRO;MCC;CSNK1A1
prerank,negative regulation of ossification (GO:0030279),0.43718432421229414,0.9425828813788552,0.5451127819548872,0.9656279169299984,1.0,5/23,16.27%,SMAD6;CHSY1;TRPM4;RBPJ;MEF2C
prerank,histone mRNA catabolic process (GO:0071044),-0.36194203517095574,-0.9424838515484159,0.5638297872340425,0.967319481853113,1.0,8/15,17.60%,TENT2;TENT4B;SSB;MTPAP;EXOSC10;DCP2;ERI1;UPF1
prerank,digestive tract development (GO:0048565),-0.2833938577342603,-0.9423685331620233,0.5705521472392638,0.9651176524077207,1.0,14/33,32.83%,SALL1;FGFR2;NIPBL;PKD1;COBL;SMO;MEGF8;CLMP;BBS7;RARB;GLI3;EDNRB;KIT;PKDCC
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.38554944480572356,0.9422324023621278,0.5858480749219563,0.9658978125415711,1.0,13/79,12.87%,ADAMTS12;DAND5;SMAD6;BMPR1A;THBS1;CRIM1;NEDD4;LEMD2;PTPN1;PPARG;HGS;SORL1;HIPK2
prerank,protein dephosphorylation (GO:0006470),0.3734541848157963,0.9418455178096283,0.6170212765957447,0.9662851296158104,1.0,32/135,15.88%,EYA2;RPRD1B;DUSP3;DAPP1;PPP2R2A;PTPRJ;RPRD1A;CTDNEP1;STK11;DUSP16;DUSP10;SSH2;PTPN1;PTPRT;NCK1;PPP4R1;PTPN3;SSU72;FBXW11;PPM1A;RPAP2;CTDP1;DUSP12;PTPRU;PTPRO;PPP2R3A;PPP2R5C;PTEN;PTPN9;PTPN18;MTM1;PPP2R2D
prerank,positive regulation of phospholipase activity (GO:0010518),-0.31802593330258694,-0.9415686714299135,0.5205479452054794,0.9648504033623263,1.0,7/22,15.22%,FGFR2;FLT1;NTRK3;FGF2;PDPK1;PLCG1;ABL2
prerank,regulation of cell cycle phase transition (GO:1901987),0.38168818093962453,0.9413834691011214,0.6012396694214877,0.9668617302120543,1.0,14/91,13.15%,PLK1;FBXW7;TFAP4;PSMD9;PSMB8;ANAPC10;CDC23;PSMC5;BUB3;CDC16;PSMD12;TP53;PSMA2;ANAPC16
prerank,positive regulation of B cell activation (GO:0050871),0.40268790876820987,0.9411137636151481,0.5730088495575221,0.9669459583543468,1.0,13/50,17.29%,CD38;EPHB2;BTK;VAV3;IRS2;KMT5B;KMT5C;BCL2;SYK;SH3KBP1;CD81;MEF2C;NCKAP1L
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.4512301076634928,0.9410682948519175,0.5454545454545454,0.9665093863980201,1.0,2/18,7.03%,ITGA4;GOLPH3
prerank,iron ion transmembrane transport (GO:0034755),0.5025214260425519,0.9410079276659574,0.5805946791862285,0.9661008331935109,1.0,2/10,5.93%,ABCC5;ABCB7
prerank,erythrocyte development (GO:0048821),0.49851006232588224,0.9410066216809423,0.5746031746031746,0.9655719635405404,1.0,4/10,17.53%,ZBTB7A;SH2B3;NCKAP1L;MED1
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.45765579109283205,0.9409939419909915,0.5590659340659341,0.9650700604914042,1.0,2/17,4.71%,ALG3;MPDU1
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.4726330487564443,0.9409613986157468,0.5527065527065527,0.9646102288828182,1.0,3/14,8.42%,BCL2L11;BFAR;PTPN1
prerank,regulation of aerobic respiration (GO:1903715),0.46601985389192424,0.9409136541676737,0.5739484396200815,0.9641968856492273,1.0,2/15,5.05%,AK4;ATP7A
prerank,purine-containing compound catabolic process (GO:0072523),-0.38648970524005133,-0.9408949436097215,0.528052805280528,0.9641598411639254,1.0,2/13,3.58%,DPYD;XDH
prerank,peptidyl-asparagine modification (GO:0018196),0.4172557904456442,0.9406769685758017,0.5751479289940828,0.9642032261385026,1.0,5/31,13.51%,LMAN1;UGGT2;STT3A;ST6GAL1;UGGT1
prerank,stabilization of membrane potential (GO:0030322),0.4612079046418667,0.9404549975779822,0.5548037889039242,0.9641871532366699,1.0,3/16,12.84%,KCNK2;KCNK13;KCNK10
prerank,striated muscle contraction (GO:0006941),-0.25946840158386075,-0.9403840723527408,0.5517241379310345,0.9630233522032856,1.0,6/53,8.49%,RYR2;ATP1B1;GRK2;ATP1A2;PIK3CA;DTNA
prerank,plasma membrane invagination (GO:0099024),0.423239375928354,0.9400410881698684,0.5535055350553506,0.9645825906631609,1.0,9/29,17.40%,CD36;VAMP7;DOCK1;CDC42;ELMO1;AIF1;SNX9;GSN;FCGR1A
prerank,mitochondrial fusion (GO:0008053),0.44812222363415993,0.9394589010147861,0.5397489539748954,0.9654078869457721,1.0,1/18,0.55%,MIEF2
prerank,response to laminar fluid shear stress (GO:0034616),0.4987734179877763,0.9392515786118131,0.5795275590551181,0.9653531526714243,1.0,3/10,12.85%,SMAD6;MAP2K5;ABCA1
prerank,actin filament network formation (GO:0051639),-0.4055029277921832,-0.9391652447684163,0.5521126760563381,0.9639160634903505,1.0,5/11,14.96%,COBL;FHOD3;FHOD1;PLS1;ACTN1
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.39580436993893836,0.9389023697130275,0.5946524064171123,0.9656070105312651,1.0,8/59,14.67%,ALDH1A2;OSBP;ALOX5;SRR;ABCD3;HSD17B4;ACACA;OSBPL1A
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.28540859820775344,-0.9388164981761528,0.5633802816901409,0.9623880129769379,1.0,12/33,17.56%,PRKN;OPA1;BCL2L1;HUWE1;FLCN;IGF1;MPV17L;GHITM;AKT1;SLC35F6;HGF;OMA1
prerank,regulation of lipase activity (GO:0060191),-0.37290996508969754,-0.9386145360479075,0.5303514376996805,0.9604894639508723,1.0,4/13,15.17%,RHOA;LPL;SNCA;LMF1
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.42530383248249737,0.9385662179124592,0.5578144853875476,0.9658337765764516,1.0,4/26,6.12%,HOMER2;DYRK2;SLC9A1;SPPL3
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.37150665233299845,0.9384625966951134,0.674,0.9655455197142304,1.0,82/341,15.66%,PLK1;KLHL42;TSG101;FBXW7;UBXN1;VPS4A;RLIM;CLOCK;FEM1C;FEM1A;FBXO21;PELI1;PSMD9;GID4;UBQLN1;GID8;PSMB8;ANAPC10;CDC23;SQSTM1;RC3H2;ARRB2;NHLRC1;UBE2A;RNF166;PSMC5;RNF115;KEAP1;RNF34;BUB3;USP33;NEDD4;BFAR;HECW1;RNF146;BIRC6;RCHY1;AREL1;FAF1;CDC16;TRPC4AP;RNF216;FBXO11;PTPN23;RNF11;PLAA;TRIM3;ELOC;VPS37C;UBE2I;MYLIP;ASB2;FBXW11;VPS37A;RNF150;CBL;RNF144B;VPS4B;CUL4A;UBE2W;UBE3C;PSMD12;MIB1;NHLRC3;PSMA2;RNF20;APPBP2;ANAPC16;NDFIP1;ATXN3;UBE2H;FBXL7;PPP2R5C;UBA6;TBL1XR1;UBE2D3;RAD23B;OTUD7A;TRIP12;FBXW4;PSMB1;ZNRF3
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.4868392595297204,0.9384570491486809,0.5518796992481203,0.9650299057798213,1.0,4/12,15.05%,PPHLN1;APOBEC1;TASOR;RESF1
prerank,cellular response to insulin stimulus (GO:0032869),0.37961323731662283,0.9382748300948,0.6083844580777096,0.9648829465454675,1.0,32/124,15.70%,INSIG1;GRB2;RAB8B;INSIG2;RAB12;IRS1;HDAC9;MYO5A;PRKDC;HDAC5;PDE3B;IRS2;ATP6V0E1;ATP6V1E1;PPARG;APC;VAMP2;IGF1R;KAT2B;GCK;TBC1D4;ZFP36L1;SLC27A1;ATP6V0D2;PIK3C2A;ATP6V1H;INSR;ATP6V0A2;SH2B2;PHIP;ZNF106;PIK3R1
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.44599967933981916,0.9378506618408925,0.5752895752895753,0.9653113953875136,1.0,5/21,10.28%,STMN2;ATXN7;CAMSAP3;APC;TAOK1
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.45391122272843576,0.9377705938934697,0.5723771580345286,0.964949956866896,1.0,4/18,13.51%,MAN1B1;UGGT2;EDEM2;UGGT1
prerank,leukocyte cell-cell adhesion (GO:0007159),0.42817958959372315,0.9376766282700983,0.582089552238806,0.9646384677568155,1.0,4/24,7.73%,MSN;ITGA4;EZR;FERMT3
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),-0.3776708905987723,-0.937626194462879,0.5340136054421769,0.9606620479576702,1.0,3/13,7.85%,PTPRC;JAK2;DOT1L
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.3860574894408271,0.9375028469334249,0.615866388308977,0.964545465876234,1.0,13/78,13.94%,PLK1;LRRK2;DVL1;UBQLN1;KEAP1;SUMO2;DAB2;RCHY1;USP5;SOCS5;RNF144B;HECTD1;CSNK1A1
prerank,tyrosine metabolic process (GO:0006570),-0.3966573822068431,-0.9370470450465842,0.561046511627907,0.959797521231838,1.0,4/11,44.12%,GSTZ1;THAP4;FAH;IL4I1
prerank,regulation of myoblast differentiation (GO:0045661),0.41471017519964454,0.937010921986212,0.559074299634592,0.9650921916251127,1.0,4/32,12.55%,IGFBP3;FLOT2;ZFP36L1;MAPK14
prerank,aerobic respiration (GO:0009060),0.43871388897116265,0.9368779208473428,0.5595854922279793,0.9648511762187527,1.0,2/20,2.65%,UQCRH;UQCRC1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.4867974155839207,0.9364496407086104,0.553125,0.9652976901796819,1.0,3/10,8.44%,NEDD4;CAMK2D;HECW1
prerank,positive regulation of telomere capping (GO:1904355),0.4476457172581774,0.9361730168850199,0.5570652173913043,0.9653844461658154,1.0,4/17,9.59%,MAPK1;PKIB;TNKS2;NEK7
prerank,negative regulation of immune response (GO:0050777),0.3747213382882696,0.9361523463846703,0.6395582329317269,0.9649050197542175,1.0,22/154,14.64%,RXFP1;ADCY8;ADCY3;PRKAR2A;ADCY5;ILRUN;PRKACA;YES1;ADCY9;LYN;MAPKBP1;FURIN;RAMP1;MAPK14;SYK;FYN;CYSLTR1;CALCRL;CREB1;GNG2;GNB1;HAVCR2
prerank,signal transduction in response to DNA damage (GO:0042770),0.3950711460426825,0.9361387303449784,0.57,0.964418902960368,1.0,12/49,14.07%,GRB2;CLOCK;MAP3K20;NBN;CHEK2;CDC5L;ABL1;MAPK14;TP53;ATRX;TIPRL;NDRG1
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.4069070134041345,0.9356783599656087,0.597254004576659,0.9649727876599703,1.0,12/46,15.70%,ATRNL1;VAMP3;NRP1;ITGA4;PARVB;FERMT3;LPXN;PXN;LAMC1;FN1;TMEFF2;PIK3R1
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.3780133786046451,0.9354240526487324,0.5795574288724974,0.9650201915811696,1.0,12/72,14.07%,RGCC;CNOT10;TFAP4;EP300;NBN;CHEK2;CNOT9;CNOT3;HIPK2;TP53;ATRX;NDRG1
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.4137382693735686,-0.9352070393938405,0.5426997245179064,0.9623093370201664,1.0,3/10,18.79%,JAK2;IL33;TLR2
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.3072087077284883,-0.9350264275325422,0.5728643216080402,0.9604024734612083,1.0,12/23,27.68%,BTRC;VCP;MOSMO;SUFU;ENPP1;PTCH1;RACK1;MEGF8;IFT122;HHIP;KCTD21;GLI3
prerank,establishment of skin barrier (GO:0061436),-0.36096762191108156,-0.9348638104925749,0.5324232081911263,0.9560563699186827,1.0,9/15,56.33%,UGCG;STMN1;MET;HRNR;FA2H;LSR;ALOXE3;SFN;CLDN1
prerank,regulation of water loss via skin (GO:0033561),-0.36096762191108156,-0.9348638104925749,0.5324232081911263,0.9560563699186827,1.0,9/15,56.33%,UGCG;STMN1;MET;HRNR;FA2H;LSR;ALOXE3;SFN;CLDN1
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.45881198458328726,0.9347392867374014,0.5448179271708683,0.9660422059879222,1.0,2/14,4.64%,VEGFC;NRP1
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.3710160790704654,0.9345555946503207,0.855,0.9659539288543963,1.0,233/1645,13.73%,POU2F3;ISL1;GLIS1;WNT4;BRCA1;SRCAP;ACTR5;RORA;ANKRD49;ZNHIT3;ZIC4;URI1;SP8;BLM;EHMT1;PARP9;ELAVL2;THAP7;POLR3G;ZBTB8A;DMAP1;RELA;IRF1;DVL1;SMARCA4;CD38;SP1;SMAD6;CTR9;SUV39H1;HOPX;ILF3;PSIP1;ZFP90;CASZ1;TFAP4;POU5F2;SOX13;KLF9;RLIM;SS18L1;SNX5;ZBTB5;TGIF1;PCBD2;CLOCK;ZEB2;BBX;RUNX1;SAP18;MAX;GAS6;HCFC1;ZNF318;POLR2A;PSMD9;NFATC1;JUN;MYCBP;AR;TLE2;ELP3;ATXN1;ZBTB7A;ZNF569;KDM5A;ELK3;WBP2;IRF3;BCL6;HDAC9;TRPS1;POLA1;PRKCB;TARBP1;EP300;SMAD3;RBM15;SPEN;ARID5B;PDGFB;TEAD1;CIPC;RBAK;LRP5;LIN9;ZNF467;DPF2;ESR1;SPTY2D1;HDAC5;NR3C1;ACVR1;SCMH1;IKZF1;JUND;KDM3A;BRCA2;MAMLD1;PSMC5;TLE1;KMT2E;MNAT1;MEF2A;IKBKB;RBBP8;RGS14;HP1BP3;PHF10;WIZ;MECP2;SEC14L2;TFCP2;CUX1;DRGX;NCOA1;ZBTB11;SETD3;KDM5B;SET;RPS6KA5;CAMK2D;PHF20;EZH2;TADA2A;JMJD1C;LIMS1;CHD7;NACC1;MAFG;NCOR1;CHEK2;PCGF5;ZXDC;PHF6;BAZ2B;BRD2;PPARG;MTDH;NR6A1;PTP4A3;ASCC2;CTBP1;TAL1;HMBOX1;ENO1;FUS;CDK5;CDC5L;FADS1;DEAF1;HBP1;HIVEP1;LOXL3;HOXC4;ZBTB46;ELOC;TCF12;UBE2I;NAA16;TULP3;ZNF568;FOXN3;ARID4B;SP140;BCL7A;CHD8;FBXW11;PHC3;ZSCAN29;EPC2;NR5A1;ZNF711;PSPC1;CREB3L2;NR2C2;SOX11;TRIM44;ZBTB38;BCL11A;ZMYND11;TSHZ2;ZNF182;COMMD7;PRDM1;PPM1A;NCOR2;HIVEP2;GMEB2;ABL1;KDM4C;YEATS2;HMGB1;GPBP1;ZFP69;BACH2;TP53INP2;TCF7L2;MAPK14;ZBTB34;ATF6;SOX6;TGFA;BRD7;MLLT11;BRD3;HIPK2;TP53;ATRX;MAF;TGFBR1;RNF20;NR1D2;KLF13;MYT1L;LRP6;MAP2K2;NAA15;ACVR1B;LCOR;RXRA;EPC1;MED27;FUBP3;PPARGC1B;NFX1;SP4;INSR;TRIM56;GTF2H1;CAMKK2;DDX5;RREB1
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.398627994551748,-0.9341919996109608,0.5617647058823529,0.9555675833673223,1.0,6/11,26.94%,TYROBP;STX4;ITGB2;CAMK4;ITGAM;STAP1
prerank,regulation of neuroinflammatory response (GO:0150077),0.43629339723365856,0.9335860784719311,0.5590659340659341,0.9676602810577788,1.0,2/19,8.68%,NUPR1;IL18
prerank,regulation of double-strand break repair (GO:2000779),0.40711661474557614,0.9334006764053688,0.5834292289988493,0.9675734354251391,1.0,9/39,15.07%,SIRT7;SETD2;SLF1;RNF169;UBR5;PPP4C;FMN2;SPIDR;TRIP12
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.44907288224989317,0.9330417928700178,0.5858310626702997,0.9678707317883081,1.0,2/18,6.62%,POLA1;POLD3
prerank,protein glycosylation (GO:0006486),0.37917697458094896,0.9329529983133038,0.6268958543983822,0.9675408593730264,1.0,24/125,17.11%,MGAT3;ALG3;ST8SIA5;ST8SIA4;EOGT;GALNT1;POMT2;COG3;STT3A;B4GALT5;B4GALT1;FKTN;B3GALNT1;B3GNT2;MGAT4B;NUS1;B3GALNT2;TET2;MGAT4A;TET3;LARGE1;ST3GAL5;B3GALT1;ST3GAL2
prerank,membrane depolarization during action potential (GO:0086010),-0.3051531611756775,-0.9326580822405557,0.546875,0.9572003542724975,1.0,5/26,7.06%,SCN2A;SCN3A;SCN8A;ATP1A2;KCNJ2
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.4540308316363156,0.9326551919940257,0.5686015831134564,0.9676899187701404,1.0,3/18,9.50%,RELA;SP1;ABCG1
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.41718079362887034,0.932411760625634,0.5657894736842105,0.9677522015497749,1.0,6/31,11.98%,LSM7;EXOSC5;DCP1B;EXOSC7;DCP1A;DCPS
prerank,negative regulation of neuron death (GO:1901215),0.3738067112926099,0.9323896118568284,0.5915201654601862,0.9672850785921144,1.0,12/93,14.50%,ISL1;WFS1;LRRK2;INPP5A;SET;VPS35;CDK5;TRAF2;SORL1;BCL2;HTRA2;FZD9
prerank,neural tube closure (GO:0001843),0.4132248065391114,0.9323472141894797,0.5639187574671446,0.9668498720647065,1.0,6/34,13.13%,DVL1;BBS4;TGFB2;MTHFR;DEAF1;LRP6
prerank,cellular response to chemical stress (GO:0062197),0.38144756393262014,0.9320498064056418,0.609100310237849,0.9669918221425694,1.0,17/96,15.27%,MGAT3;PYCR2;SLC25A24;LRRK2;VKORC1L1;KEAP1;ADNP2;SETX;ABL1;TXNRD2;NCF4;EIF2S1;HTRA2;PKD2;AIF1;ATG7;MSRA
prerank,tryptophan metabolic process (GO:0006568),0.48612503307517063,0.9320015425060342,0.5895522388059702,0.9665957778038511,1.0,1/11,5.05%,ATP7A
prerank,regulation of neuron differentiation (GO:0045664),0.3861714489479857,0.9317051144566064,0.5983086680761099,0.9667355110048507,1.0,6/76,6.92%,LRRK2;CDK5RAP3;CASZ1;IMPACT;NREP;BEND6
prerank,plasma membrane organization (GO:0007009),0.3857383706208286,0.9316385826024822,0.6047774158523345,0.9663598277047637,1.0,9/61,8.50%,DEGS1;SMPD1;MYOF;FNBP1L;PACSIN2;ABCD2;SYT11;SPTBN1;ABCA7
prerank,camera-type eye development (GO:0043010),0.42958618198808807,0.9315683385140083,0.5515970515970516,0.9659944416459791,1.0,2/25,4.01%,RAB3GAP1;NF1
prerank,ncRNA 3'-end processing (GO:0043628),0.4731984017123201,0.9314854162542497,0.5659025787965616,0.9656651542198669,1.0,3/14,5.83%,INTS12;INTS2;PTCD1
prerank,regulation of cellular respiration (GO:0043457),0.46082526917679356,0.9310768649258504,0.5837837837837838,0.9660499518383098,1.0,2/17,5.19%,NOA1;IL10RB
prerank,regulation of cell-substrate adhesion (GO:0010810),0.4014124713887191,0.9310248916914706,0.5830508474576271,0.9656348378213716,1.0,9/42,14.87%,CX3CL1;MINK1;RSU1;NF1;PDGFB;LIMS1;PTPRO;ATXN3;TSC1
prerank,autophagosome assembly (GO:0000045),0.39176305297899683,0.9309606575436349,0.585792349726776,0.9652645926452537,1.0,14/52,15.16%,WDR45;UBQLN1;WDR45B;AMBRA1;STX17;ULK2;ATG3;TRAPPC8;PACS2;RB1CC1;TP53INP2;RAB7A;ATG7;BECN1
prerank,post-translational protein modification (GO:0043687),0.3705081990013628,0.9308490351634409,0.698,0.9650219132888159,1.0,53/332,13.92%,WFS1;CP;KLHL42;FBXO17;IGFBP3;VWA1;UCHL3;FBXW7;FBXO30;KLHL11;GAS6;FEM1C;FEM1A;FBXO21;PSMD9;SCG3;PSMB8;COPS7B;QSOX1;ASB8;UBXN7;FBXO9;PSMC5;KEAP1;STT3A;COPS4;RAB2A;ASB13;FBXO11;PROC;DCAF17;GAN;SOCS5;ELOC;SDC2;ASB2;FBXW11;MIA3;LAMC1;CUL4A;ESCO1;KLHL5;PRKCSH;PSMD12;UBE2F;ADAM10;PSMA2;RBBP7;GPC3;FN1;ASB7;FBXL7;SPARCL1
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.48331242032957167,0.9307345877446591,0.5701078582434514,0.9647603195529469,1.0,4/11,16.32%,THBS1;ALOX5;SEMA6A;EPN2
prerank,regulation of Ras protein signal transduction (GO:0046578),0.3730707838814888,0.9306887323860507,0.618848167539267,0.9643517144807268,1.0,21/86,16.60%,RAPGEF1;GRB2;TGFB2;EPHB2;SQSTM1;STK19;IRS2;EPS8L1;MAPKAP1;LYN;EPS8;AKAP13;NOTCH2;RAF1;MYO9B;SHOC2;ARHGDIB;VAV1;RALGPS1;RDX;ARHGAP17
prerank,regulation of chromatin organization (GO:1902275),0.46260871693332317,0.9306836088113092,0.5687943262411348,0.9638444931400144,1.0,3/14,8.29%,PARG;SETD1A;CDK9
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.4233249474012093,0.9303152902893029,0.5647798742138365,0.9641489663316285,1.0,8/24,16.64%,ACTR3;TWF2;CDC42;ARPC2;WASF2;AUTS2;PIK3R1;CYFIP1
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.3547587429846208,-0.9301959914143548,0.553030303030303,0.961345097210482,1.0,7/16,57.66%,CLDN14;CLDN11;CLDN12;CLDN10;CLDN18;CLDN1;CLDN5
prerank,'de novo' posttranslational protein folding (GO:0051084),0.41857401197055377,0.9300833544299277,0.5793357933579336,0.9641322161013686,1.0,4/30,7.55%,DNAJB1;DNAJC18;ST13;HSPA9
prerank,diterpenoid metabolic process (GO:0016101),0.38616943220067235,0.9300387832405972,0.5871459694989106,0.9637106150130409,1.0,7/55,15.11%,AKR1B1;ALDH1A1;LRP8;DHRS3;SDC2;GPC3;GPC6
prerank,global genome nucleotide-excision repair (GO:0070911),0.41926100620943746,0.9298180472386776,0.5695121951219512,0.9637017622292373,1.0,6/26,14.70%,CETN2;ERCC4;CUL4A;GTF2H1;USP45;RAD23B
prerank,melanosome localization (GO:0032400),0.44023887667054973,0.9297933837638755,0.574607329842932,0.963240452470453,1.0,3/21,5.36%,ARL6;BBS4;MYO5A
prerank,negative regulation of establishment of protein localization (GO:1904950),0.48684554132046365,0.9296762086560105,0.5709923664122137,0.9629918373159543,1.0,4/10,13.42%,MAPT;SNX3;NDFIP1;TERF1
prerank,regulation of acute inflammatory response (GO:0002673),-0.3387552596872449,-0.9294410166252799,0.5564516129032258,0.9610107253915007,1.0,12/18,66.13%,NLRP3;ADAM8;IL6ST;PTGES;OSM;OSMR;IL6;PLA2G2D;GSTP1;KLKB1;F12;DNASE1
prerank,vasculature development (GO:0001944),0.4505781745153997,0.9293085856986207,0.5659574468085107,0.9633219610038101,1.0,2/16,6.79%,FBXW7;STK11
prerank,chondrocyte differentiation (GO:0002062),0.40604192605890926,0.9290103126823592,0.5851318944844125,0.9634686378968108,1.0,7/32,16.27%,WNT2B;RUNX1;SNX19;CREB3L2;SOX6;NFIB;MEF2C
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.45864874857613247,0.9290057628547866,0.5691489361702128,0.9629643206438652,1.0,4/17,9.50%,FGF1;KPNB1;SEC14L2;ABCG1
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.37496232755529396,0.9289538744157347,0.610134436401241,0.9625666878280351,1.0,14/86,12.95%,DNAJB1;BAG3;IMPACT;PSMD9;PSMB8;EP300;EGLN3;EGLN2;PSMC5;EGLN1;ELOC;PSMD12;TP53;PSMA2
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.34410538335545127,-0.9289485238155715,0.5487804878048781,0.9600125042660189,1.0,6/17,11.76%,BCAS3;HCK;FES;HCLS1;NTRK3;BAIAP2
prerank,toll-like receptor signaling pathway (GO:0002224),0.379265879681722,0.9287388131114558,0.6075156576200418,0.9625171290497201,1.0,20/84,14.86%,CD36;IRAK4;TLR7;RFTN1;PIK3R4;BTK;BIRC3;IKBKB;TLR3;IRAK2;TAB3;COLEC12;CNPY3;HMGB1;MAPKAPK2;LGALS9;UNC93B1;UBE2D3;TLR4;PIK3AP1
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.37671448340330477,0.9287241908647502,0.5918153200419727,0.9620407678412123,1.0,12/73,14.85%,ISL1;EPHB2;THBS1;PTPRJ;IL1A;TLR3;MAVS;HMGB1;SYK;LGALS9;HAVCR2;TLR4
prerank,transport across blood-brain barrier (GO:0150104),0.3786839296549331,0.9287033379346834,0.6,0.9615698046778679,1.0,12/83,15.52%,SLC4A3;SLC2A3;CD36;SLC7A2;SLC38A2;ABCC5;SLC7A8;SLC27A1;INSR;SLCO2B1;SLC44A1;ABCG2
prerank,negative regulation of GTPase activity (GO:0034260),0.43264873943182247,0.9282506484057379,0.5632911392405063,0.9620629549385297,1.0,5/22,11.72%,LRRK2;ARFGEF1;RRP1B;LRCH1;TMED2
prerank,2-oxoglutarate metabolic process (GO:0006103),0.4635477194151941,0.9282416781524885,0.5730659025787965,0.9615675071806938,1.0,1/13,0.96%,D2HGDH
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.41692847540659556,0.9281438239804101,0.579136690647482,0.9612646694034599,1.0,5/29,11.91%,UTP3;UTP20;RRP36;UTP6;HEATR1
prerank,endomembrane system organization (GO:0010256),0.36817336151407304,0.9279934878271546,0.6395582329317269,0.9610711597213291,1.0,46/178,16.98%,LMAN1;LRRK2;COG1;TMED4;VPS4A;MYOF;COG3;AKTIP;SQSTM1;TMED9;RAB30;ARFGEF1;CTDNEP1;GOLPH3;LYSMD3;SNX10;LEMD2;SPTBN1;REEP5;STX17;PI4K2A;RAB2A;ATP8B4;SEC61A1;CDC42;MIA3;TMED2;TRAPPC8;VPS11;TMED5;CSNK1A1;WASHC5;LNPK;TRIP11;OPTN;CLASP1;ATL2;DNAJC13;GOLGA5;GOLGA8B;OSBPL2;VAPB;DNM1L;HACE1;HOOK2;NUP93
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.37116396631501625,0.9279484712954758,0.6381909547738693,0.9606588737213756,1.0,38/182,16.57%,WNT4;PARP9;FBXW7;FLOT2;RUNX1;TGFB2;RIN3;OLFM1;TARDBP;BMPR1A;RBMS3;TERF2;PDGFB;TNRC6B;ESR1;SDCBP;MAPT;MECP2;AGO2;ITGB8;APOBEC1;ATXN2;NOTCH2;SOX11;ERP29;ADAM10;MAP2K2;NDFIP1;LGALS9;ROCK2;OPTN;HAVCR2;ANKRD13A;SH3GL2;MAP2K1;MEF2C;LGMN;RB1
prerank,regulation of integrin activation (GO:0033623),0.4596035790703908,0.9278452195674766,0.5836791147994468,0.9603743353197052,1.0,3/15,13.07%,FARP2;RAP1B;FBLIM1
prerank,actin filament polymerization (GO:0030041),0.41673876839846036,0.9276560516615535,0.5592592592592592,0.9602514533529038,1.0,8/29,17.40%,ANG;WASF1;DIAPH1;WASHC5;AIF1;WASL;PREX1;GSN
prerank,regulation of ion transmembrane transport (GO:0034765),0.41076844305058013,0.9276207793118383,0.5792019347037485,0.9598148215291664,1.0,4/33,7.47%,KCNJ6;AKAP9;YWHAE;NEDD4
prerank,neuron development (GO:0048666),0.37268006308202956,0.9275541335288435,0.6538461538461539,0.9594403129956318,1.0,34/141,17.66%,GBA2;ZFYVE27;TDP2;EHD1;UGDH;STMN2;RUNX1;TGFB2;ATP7A;BICDL1;NEDD4;MAPT;TENM4;STX3;DTNBP1;LYN;B4GALT5;CDK5;EPHA5;HMGB1;PPP1R9A;MYT1L;TBC1D24;UNK;PLP1;GPM6A;PPP1R9B;SH3GL2;MEF2C;RB1;TBC1D23;RAPGEF2;PBX3;ARL3
prerank,regulation of protein sumoylation (GO:0033233),-0.3369201829359664,-0.9274658823018935,0.5343511450381679,0.9615387385720195,1.0,10/17,37.37%,ZMIZ1;CAPN3;GNL3;GNL3L;PIAS4;HDAC4;PARK7;EGR1;PIAS3;RWDD3
prerank,positive regulation of phospholipid transport (GO:2001140),0.49506582090613815,0.9271960804573957,0.5793413173652695,0.9597003243254071,1.0,2/10,8.50%,TMEM30A;ABCA7
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.3697421110174868,0.9270349107188748,0.7194388777555111,0.9595359142344798,1.0,60/314,14.70%,PLK1;WFS1;KLHL42;MAN1B1;FBXO17;FBXW7;UBXN1;TMEM67;DNAJC18;CLOCK;UBXN4;FEM1C;FEM1A;USP19;PELI1;PSMD9;GID4;UBQLN1;GID8;PSMB8;ANAPC10;CDC23;CDK2;ARRB2;NHLRC1;UBE2A;UBE2J2;RHBDD2;FBXO9;PSMC5;RNF34;BUB3;NEDD4;ECPAS;BFAR;HECW1;AREL1;FAF1;CDC16;RNF216;AMN1;PLAA;TRIM3;FBXW11;DERL1;CUL4A;UBE2W;FBXO38;PSMD12;DCAF12;NHLRC3;PSMA2;APPBP2;ANAPC16;ATXN3;FBXL7;PPP2R5C;TBL1XR1;UBE2D3;RAD23B
prerank,Golgi organization (GO:0007030),0.3694324510561801,0.9269478436249826,0.6381243628950051,0.9592177698630651,1.0,29/112,15.84%,LMAN1;LRRK2;COG1;GOSR2;TMED4;COG3;TMED9;RAB30;ARFGEF1;GOLPH3;LYSMD3;STX16;STX17;PI4K2A;RAB2A;ATP8B4;CDC42;TMED2;TRAPPC8;TMED5;CSNK1A1;TRIP11;OPTN;CLASP1;ATL2;VCPIP1;GOLGA5;GOLGA8B;VTI1A
prerank,cellular protein-containing complex assembly (GO:0034622),0.3695698692193476,0.926901164774804,0.6515609264853978,0.9588136027294393,1.0,32/160,15.24%,VAMP1;SPAG1;TBCA;HOPX;ARL6;TCP1;EIF4B;VAMP3;NUP205;SMAD3;AHCTF1;POMP;RPL38;GPX4;HSP90AA1;MAPT;NUP98;NCK1;VAMP2;DNAI4;IMMP2L;TRAF2;GTF2B;PXN;UVRAG;AIFM1;PIK3C2A;RTN4;EPS15;CLTC;SMAD4;HIP1
prerank,regulation of dendrite morphogenesis (GO:0048814),0.4082066482188243,0.9268497142387876,0.5702179176755447,0.9584168753377342,1.0,8/32,12.22%,SS18L1;NEDD4;CUX1;HECW1;ADGRB3;SDC2;LZTS1;CDKL5
prerank,response to retinoic acid (GO:0032526),0.3853011631340385,0.926816272617643,0.5928338762214984,0.9579752760893218,1.0,8/59,14.01%,OVCA2;TWF2;ADNP2;LYN;SETX;RXRA;HTRA2;CREB1
prerank,nitric oxide metabolic process (GO:0046209),-0.3784571449574965,-0.926781458639415,0.5833333333333334,0.9610074789197925,1.0,3/14,22.60%,CYB5B;AKT1;GCH1
prerank,regulation of MAPK cascade (GO:0043408),0.36986889608948864,0.926751797824028,0.6455823293172691,0.9576160537961963,1.0,31/157,16.23%,ROR2;DUSP3;CX3CL1;MINK1;NF1;STYX;PDGFB;TRAF7;MAPK1;PTPRJ;PAK2;ABCA7;PHLPP1;LYN;TAOK1;TRIM5;RIT2;IGF1R;HMGB1;MAP2K2;SYK;FN1;SPRED1;INSR;ROCK2;DAG1;STK3;MAP4K4;IQGAP1;MAP2K1;PAK1
prerank,peptide catabolic process (GO:0043171),-0.31276688528386454,-0.926583928793362,0.5416666666666666,0.9591306219269451,1.0,5/23,9.74%,CPQ;IDE;TRHDE;TPP1;LTA4H
prerank,regulation of hemopoiesis (GO:1903706),0.4947469379315418,0.9265317020083363,0.5768645357686454,0.9575599062175857,1.0,2/10,4.96%,RUNX1;PRKCB
prerank,regulation of transport (GO:0051049),0.39993303759106397,0.9262497023364663,0.5876887340301974,0.9576427046698234,1.0,6/36,9.89%,LRRK2;NRP1;EPB41;REEP5;VAMP2;CDK5
prerank,acute-phase response (GO:0006953),-0.3903365022584092,-0.9258531384470263,0.5331125827814569,0.9586461435852287,1.0,3/12,33.98%,IL22;CEBPB;PLSCR1
prerank,regulation of histone methylation (GO:0031060),0.4697796935175935,0.9257457945209383,0.5780089153046062,0.958248388573385,1.0,2/13,6.57%,CTR9;MTHFR
prerank,phagosome acidification (GO:0090383),-0.3053305554871546,-0.9256944229325839,0.6352201257861635,0.956701302855149,1.0,9/26,16.54%,ATP6V0A1;ATP6V1A;ATP6V1D;ATP6V0C;RAB39A;ATP6V0B;ATP6V1C1;ATP6V1G1;RAB20
prerank,negative regulation of cell development (GO:0010721),-0.30730994240597514,-0.925281630312707,0.5801886792452831,0.9553903899396087,1.0,7/25,15.54%,PCM1;B2M;APPL2;GSK3B;IGF1;LILRB1;NOTCH1
prerank,response to organonitrogen compound (GO:0010243),-0.27881906352275654,-0.925131318829808,0.5725806451612904,0.9534496247078885,1.0,9/38,12.82%,PRKN;VCP;IRF5;HLCS;RNF185;KYNU;CCDC47;GLRA1;DNAJB12
prerank,negative regulation of viral transcription (GO:0032897),0.48069430695772924,0.9250883955810064,0.5955882352941176,0.9591685590704635,1.0,1/13,1.47%,IFITM3
prerank,glycolytic process (GO:0006096),0.4156937057212623,0.9250374048563448,0.601907032181168,0.9587763306461763,1.0,5/28,11.56%,PGAM4;PGAM1;ALDOA;ENO1;GCK
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.38957709005007346,-0.9247847326526075,0.5416666666666666,0.9521151774700574,1.0,6/12,7.77%,GRN;PPT1;VPS33A;CLN3;ATP6AP2;TMEM165
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.4074694800539452,0.9245697734265009,0.5676959619952494,0.9593014964012814,1.0,11/30,17.03%,SYS1;KIF13A;GOLPH3;SPTBN1;VAMP2;GGA1;OPTN;MACF1;GGA3;GOLGA4;GCC2
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.44108818546916295,0.9245145768737394,0.5670241286863271,0.9589214222906771,1.0,4/17,17.13%,HDAC9;FURIN;PCSK6;PCSK5
prerank,transition metal ion homeostasis (GO:0055076),0.41554728484933046,0.9244142718331765,0.6019900497512438,0.9586238510112487,1.0,3/28,5.93%,CP;HMOX2;ABCB7
prerank,synaptic vesicle exocytosis (GO:0016079),-0.27663039640880693,-0.9240747708536515,0.5725190839694656,0.9515870131302421,1.0,15/40,24.89%,RIMS2;SYT1;SNAP25;STX2;PIP5K1C;STX4;SNCA;RIMS1;UNC13B;SYT2;SNAP29;SNPH;SYT10;CPLX1;SYT7
prerank,neuronal action potential (GO:0019228),-0.31603921032454435,-0.9238793628870667,0.5396039603960396,0.9498336132704924,1.0,3/22,6.36%,SCN2A;SCN3A;SCN8A
prerank,positive regulation of T cell differentiation (GO:0045582),0.39939776839339697,0.9234872833397418,0.5710928319623971,0.9601335320545593,1.0,3/36,8.29%,SART1;BCL6;DUSP10
prerank,adherens junction organization (GO:0034332),0.39480108688975973,0.9234372551794561,0.5854748603351956,0.9597359296005905,1.0,7/48,13.78%,ANG;VCL;CTNNA1;PAK2;CDH11;CDH20;CDH18
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.3054655140655151,-0.923210320438716,0.5402843601895735,0.9491698239102099,1.0,9/23,18.39%,JAK2;PARP14;PTPN2;IFNGR1;NLRC5;SUMO1;CDC37;IRGM;JAK1
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.4154152177183935,0.9231355813384023,0.591861898890259,0.9598782752065212,1.0,5/26,7.60%,STMN2;MAPRE1;AKAP9;DCTN1;MAPT
prerank,intestinal absorption (GO:0050892),0.4623523057160644,0.9227639147134561,0.5563380281690141,0.9601896895386385,1.0,1/13,1.63%,CD36
prerank,sulfur compound transport (GO:0072348),0.4233329934198347,0.9225884041509564,0.5965978128797084,0.9600902644220534,1.0,5/27,15.52%,SLC35F3;SLC26A11;SLC25A26;SLC27A1;ABCG2
prerank,neutrophil migration (GO:1990266),0.383875372761033,0.9224931881777159,0.6033149171270719,0.9597785726075853,1.0,4/58,7.28%,CX3CL1;IRAK4;TGFB2;CCL25
prerank,pyroptosis (GO:0070269),-0.36274340323702975,-0.9224313441432742,0.5755395683453237,0.9487805224301091,1.0,9/15,35.31%,DHX9;AIM2;CASP4;CASP8;CASP1;GSDME;APIP;NLRC4;ZBP1
prerank,long-chain fatty acid metabolic process (GO:0001676),0.3852346194526876,0.9218424930875531,0.6230031948881789,0.9607375571097618,1.0,10/64,12.99%,AIG1;ACSBG1;HPGD;GPX4;PLA2G4A;ALOX5;FADS1;ACADL;ABCD1;HSD17B4
prerank,monocyte differentiation (GO:0030224),0.4904450555447182,0.9216189540543515,0.5794392523364486,0.9607299147278562,1.0,3/10,10.60%,THOC5;PPARG;MT1G
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.4782062831385317,0.9212435467039611,0.5838323353293413,0.9610448768337887,1.0,4/11,17.18%,LYN;LGALS9;MEF2C;RAPGEF2
prerank,ceramide metabolic process (GO:0006672),0.390008676329056,0.9212182655850586,0.5891472868217055,0.9605956118131833,1.0,12/49,17.64%,DEGS1;SMPD1;CERS6;ACER3;CERS4;ASAH1;SGPL1;CERS5;SPTLC1;NSMAF;SGMS1;PLPP1
prerank,protein targeting to lysosome (GO:0006622),0.4276810193112211,0.9207037879893692,0.5727891156462585,0.9612437790809873,1.0,9/20,17.03%,VPS4A;AP3M1;NEDD4;HGS;SORL1;RAB7A;SCARB2;GGA3;GCC2
prerank,Golgi ribbon formation (GO:0090161),0.47357030340084283,0.9205744314974704,0.6038011695906432,0.9610273822659017,1.0,7/13,17.03%,GOLPH3;STX16;TMED5;TRIP11;OPTN;VTI1A;GCC2
prerank,organelle fusion (GO:0048284),0.42823623517330817,0.9205333870748317,0.5788770053475936,0.9606054787320631,1.0,7/22,18.19%,MIEF2;EEA1;VPS11;MIGA1;MFF;CHCHD3;MFN1
prerank,regulation of primary metabolic process (GO:0080090),0.37135707980756477,0.9204925234954677,0.6524390243902439,0.9601914730489066,1.0,27/126,14.57%,SP1;BBS4;PSMD9;GGPS1;PSMB8;TGS1;IRS2;PSMC5;GPAM;NCOA1;CHD9;ABCA7;NCOR1;PPARG;SIN3B;NCOR2;ZFP69;PSMD12;PSMA2;NR1D2;RXRA;ADIPOR1;ACACA;ROCK2;PPARD;TBL1XR1;NCOA2
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.3735581957166343,0.9204841121280218,0.6430041152263375,0.9597054883352132,1.0,13/95,11.61%,UST;B4GALT3;CHSY1;UGDH;DSE;ABCC5;GLCE;HS6ST2;B4GALT5;B4GALT1;BGN;SDC2;B3GNT2
prerank,protein polyubiquitination (GO:0000209),0.36605134358486224,0.9200947608569091,0.7047047047047047,0.960031010908574,1.0,61/297,14.06%,BRCA1;KLHL42;FBXO17;FBXW7;FBXO30;RNF31;RLIM;SASH1;FBXO21;PELI1;PSMD9;PSMB8;ANAPC10;UBE2V2;CDC23;AKTIP;RC3H2;NHLRC1;UBE2A;RNF166;UBE2J2;FBXO9;PSMC5;RNF115;RNF34;PPIL2;NEDD4;UNKL;TPP2;BFAR;LNPEP;HECW1;HERC6;RNF146;TNKS2;AREL1;CDC16;RNF216;FBXO11;UBE2Q2;TRIM3;TRIM5;MYLIP;TRAF2;FBXW11;RNF144B;UBE3A;UBE2W;FBXO38;UBE3C;PSMD12;UBR5;NHLRC3;HECTD1;PSMA2;RNF20;BCL2;TRIM56;UBE2H;FBXL7;RNF135
prerank,regulation of viral entry into host cell (GO:0046596),0.41265937733823765,0.920066661371741,0.5971563981042654,0.9595812513814714,1.0,7/30,17.40%,IFITM3;SNX3;TRIM5;LGALS9;TRIM26;TRIM25;GSN
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.43126093207872385,0.9198213487060711,0.5926395939086294,0.9596077411259866,1.0,4/22,13.71%,CDK5RAP3;SPRED2;SPRED1;DDX5
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.4254028630736307,0.9197316770589302,0.5974683544303797,0.9593106277774132,1.0,3/23,12.41%,SLC9A1;SLC9A7;SLC12A6
prerank,regulation of filopodium assembly (GO:0051489),0.4005580681484765,0.9194476946813178,0.5981416957026713,0.9594445020506939,1.0,11/38,15.70%,NRP1;FNBP1L;CAPZB;FXR2;CDC42;GAP43;PPP1R16B;DOCK11;WASL;GPM6A;PIK3R1
prerank,cardiac muscle cell contraction (GO:0086003),-0.33635538964403444,-0.9193903588545713,0.5689655172413793,0.9542676935913161,1.0,5/19,7.08%,FGF12;CACNA2D1;ATP1A1;KCNJ2;PIK3CA
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.42733639219833397,0.9193383981744409,0.5792922673656619,0.9591727284140397,1.0,2/19,7.52%,CX3CL1;PYDC1
prerank,regulation of macrophage cytokine production (GO:0010935),-0.36969509791276217,-0.9193307449091892,0.5538922155688623,0.9521537654876105,1.0,7/13,19.82%,PLCG2;LAPTM5;TGFB1;SIRT1;LILRB1;IRAK3;CD74
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.39931550291324897,-0.9190510766535867,0.56797583081571,0.9505864454674637,1.0,4/11,16.63%,PDK1;PDCD10;STK25;GSKIP
prerank,sensory perception of mechanical stimulus (GO:0050954),0.3724211007546207,0.9190260739509885,0.6339937434827946,0.9593394259659498,1.0,9/85,12.48%,WFS1;HOMER2;CACNA1D;ALDH7A1;COL11A1;PIEZO2;GRM7;WDR1;EML2
prerank,positive regulation of rRNA processing (GO:2000234),0.479841641585716,0.9190235271931537,0.5828025477707006,0.9588452965986971,1.0,1/10,1.00%,SIRT7
prerank,cellular response to starvation (GO:0009267),0.3668261468524697,0.9188438918828408,0.6555217831813577,0.9587687463859281,1.0,26/147,13.11%,WDR45;RIPOR1;LRRK2;EIF2AK2;IMPACT;PIK3R4;WRN;WDR45B;MAPK1;MIOS;EHMT2;USP33;ATP6V0E1;MAPK8;FNIP1;ATP6V1E1;VPS41;FADS1;XPR1;MTOR;SLC38A9;SH3GLB1;TP53;EIF2S1;ATP6V0D2;ATP6V1H
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.37485207710500046,0.9188129251661651,0.6161719549641761,0.9583320998774573,1.0,15/90,13.69%,EHMT1;CD36;ALMS1;CMKLR1;DECR1;KDM3A;IL18;APC;CNOT3;IGF1R;ACADL;TRPV2;PPARGC1B;SYK;ADIPOR1
prerank,neuron projection fasciculation (GO:0106030),0.4872099846735909,0.9187619456406549,0.5922480620155038,0.9579371987133393,1.0,3/10,13.32%,EPHB2;ARHGAP35;RTN4
prerank,termination of RNA polymerase II transcription (GO:0006369),0.40838305388464924,0.9183781509294676,0.5846153846153846,0.9582527876098196,1.0,6/33,11.07%,CSTF3;CSTF2;SSU72;SNRPD3;SETX;CPSF3
prerank,cytoplasmic microtubule organization (GO:0031122),0.38439577346284504,0.918343430465934,0.5958149779735683,0.9578361246977583,1.0,9/54,8.66%,WDR73;KPNB1;TUBGCP6;CAMSAP3;EZR;DCTN1;DLG1;MAPT;TUBGCP2
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.4610223924185281,0.9182492955573395,0.5820029027576198,0.9575657793243405,1.0,3/13,10.86%,BCL2L11;BNIP3L;BNIP3
prerank,cellular response to glucose starvation (GO:0042149),-0.26114189607590177,-0.918002661943057,0.6187050359712231,0.9511149418910475,1.0,20/41,25.93%,SESN1;CPEB4;EIF2AK3;SESN3;PIK3C3;PRKAA1;HNRNPA1;PRKAG1;MTMR3;PRKAA2;ATG14;NUAK2;SIK2;ZC3H12A;ATF4;NIM1K;SZT2;XBP1;PRKAG2;MYBBP1A
prerank,programmed necrotic cell death (GO:0097300),0.4345575723041225,0.917587525018785,0.5879120879120879,0.9584674845392568,1.0,6/18,16.44%,TLR3;IPMK;CYLD;ITPK1;TLR4;DNM1L
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.3880042108502043,0.9175724074261794,0.6058558558558559,0.958001194029703,1.0,10/50,12.03%,GAS6;IGBP1;THBS1;YWHAE;RNF34;PAK2;FNIP1;CD44;MAP2K5;RAF1
prerank,chondroitin sulfate metabolic process (GO:0030204),0.4135465377359723,0.9175348757063041,0.5908558030480656,0.9575818276620417,1.0,5/30,9.84%,CHSY1;UGDH;DSE;ARSB;BGN
prerank,regulation of gene silencing by miRNA (GO:0060964),0.3800025866051875,0.9175336819087192,0.6062231759656652,0.9570911566799086,1.0,9/62,9.43%,POLR2D;POLR2A;NUP205;PUM2;NUP98;AGO2;NUP54;PUM1;PPARG
prerank,purine nucleotide biosynthetic process (GO:0006164),0.4757681407172916,0.9174888126452704,0.5897058823529412,0.9566811280355938,1.0,2/12,6.83%,PRPSAP1;HPRT1
prerank,inositol phosphate-mediated signaling (GO:0048016),0.4332474759700986,0.9173860240950258,0.5602165087956699,0.9564053646796965,1.0,2/19,6.20%,NFATC1;INPP5A
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.4516572564497714,0.917201134440431,0.5800865800865801,0.9563073723306542,1.0,2/13,11.20%,NRP1;TGFBR2
prerank,cotranslational protein targeting to membrane (GO:0006613),0.3730090898758026,0.9168991202977259,0.6298969072164948,0.9564647827562498,1.0,11/91,5.94%,RPL18;RPS23;RPL41;RPL31;RPS17;SSR2;RPL4;SIL1;RPLP0;RPS15A;RPL38
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.3949963294810762,-0.9165461640236885,0.5945205479452055,0.952545291495934,1.0,6/10,20.04%,RENBP;NAGK;AMDHD2;ST3GAL1;GNPDA1;GNE
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.3646015809827561,0.9162086626158843,0.724,0.9574306842929659,1.0,55/327,14.18%,ACTR5;RORA;ZNHIT3;ELAVL2;THAP7;RELA;DVL1;SP1;CTR9;CASZ1;SOX13;CLOCK;HCFC1;POLR2A;MYCBP;ATXN1;EP300;RBAK;ESR1;SPTY2D1;NR3C1;BRCA2;HP1BP3;ZBTB11;RPS6KA5;EZH2;JMJD1C;CHD7;CHEK2;PTP4A3;ASCC2;FUS;FADS1;ACTN4;TULP3;FOXN3;PSPC1;NR2C2;SOX11;ZBTB38;ABL1;GPBP1;SOX6;TP53;ATRX;TGFBR1;RNF20;NR1D2;ACVR1B;PPARGC1B;NFX1;INSR;RREB1;NSD2;RFX3
prerank,axon extension (GO:0048675),0.43174052958736064,0.9161377438520973,0.5916561314791403,0.9570941038492664,1.0,9/23,16.64%,NRP1;HSP90AA1;SLC9A6;CDK5;ULK2;SPG11;NRP2;AUTS2;CYFIP1
prerank,translational elongation (GO:0006414),0.3674474441781549,0.9159856715507685,0.6358024691358025,0.9569024050432478,1.0,9/101,7.30%,MRPS22;MRPS31;MRPS30;MRPL37;MRPS21;MRPL48;MRPS35;MRPS28;MRPL1
prerank,nitric oxide biosynthetic process (GO:0006809),-0.3784713318284907,-0.9158925341536787,0.6058631921824105,0.952046987154804,1.0,3/13,22.60%,CYB5B;AKT1;GCH1
prerank,negative regulation of chemotaxis (GO:0050922),0.40250911814504997,0.915808047482486,0.5921521997621879,0.9567776180964004,1.0,5/31,10.93%,DUSP3;THBS1;SEMA6D;SEMA3D;SEMA6A
prerank,positive regulation of telomerase activity (GO:0051973),0.39815016782990553,0.9155643731272904,0.5973871733966746,0.9567815949256865,1.0,6/33,9.74%,TCP1;MAPK1;HSP90AA1;PKIB;NEK7;HMBOX1
prerank,snRNA metabolic process (GO:0016073),0.4451290212374027,0.915511072080121,0.5787234042553191,0.9564061565758637,1.0,6/17,16.04%,INTS12;INTS2;INTS4;RBM7;MTREX;INTS9
prerank,protein targeting to mitochondrion (GO:0006626),0.381340108131353,0.9154348287670699,0.6136363636363636,0.9560562798738759,1.0,7/52,12.19%,TIMM17A;TOMM40;DNAJC15;TIMM23;HSP90AA1;IMMP2L;AIFM1
prerank,positive regulation of interleukin-17 production (GO:0032740),0.4230677454779041,0.9152534284064394,0.5937904269081501,0.9559216984687194,1.0,3/22,9.94%,RFTN1;IL18;SLAMF6
prerank,synaptonemal complex organization (GO:0070193),-0.349461899135988,-0.9152114695094296,0.5591397849462365,0.9492485877572445,1.0,10/15,57.86%,RAD21;BAG6;SYCP2;SYCE2;STAG3;P3H4;TRIP13;TEX11;REC8;HORMAD1
prerank,synaptonemal complex assembly (GO:0007130),-0.349461899135988,-0.9152114695094296,0.5591397849462365,0.9492485877572445,1.0,10/15,57.86%,RAD21;BAG6;SYCP2;SYCE2;STAG3;P3H4;TRIP13;TEX11;REC8;HORMAD1
prerank,negative regulation of protein catabolic process (GO:0042177),0.3904892038287776,0.9151375734544399,0.5945017182130584,0.9556892734623993,1.0,6/40,9.16%,CDK5RAP3;FLNA;NELL1;SNX3;SNRNP70;PTPN3
prerank,glycogen metabolic process (GO:0005977),-0.29590064859207477,-0.9150420678998848,0.6022099447513812,0.9474038444099896,1.0,13/27,25.86%,PHKA2;GSK3B;PHKB;PYGB;PGM2L1;PGM1;GYG1;PHKG2;GYS1;PYGL;GAA;PGM2;PRKAG2
prerank,modification-dependent protein catabolic process (GO:0019941),0.364066319191351,0.914770925395826,0.6941649899396378,0.9559739760435382,1.0,51/193,16.71%,PLK1;RLIM;FEM1C;FEM1A;FBXO21;PSMD9;UBQLN1;ANAPC10;CDC23;SQSTM1;RC3H2;UBE2A;RNF166;KEAP1;RNF34;BUB3;USP33;NEDD4;BFAR;RNF146;BIRC6;RCHY1;AREL1;CDC16;TRPC4AP;FBXO11;RNF11;ELOC;UBE2I;MYLIP;ASB2;RNF150;CBL;RNF144B;UBE3C;MIB1;RNF20;ANAPC16;NDFIP1;ATXN3;UBE2H;FBXL7;UBA6;TRIP12;FBXW4;ZNRF3;UBE2G1;TRIM25;UBR3;CNOT4;HACE1
prerank,histone deacetylation (GO:0016575),0.39255341519652304,0.914295419278691,0.5988888888888889,0.956482938006618,1.0,11/43,16.96%,SIRT7;HDAC9;HDAC11;HDAC5;MORF4L2;SIN3B;MIER3;TBL1XR1;HDAC2;RCOR1;TBL1X
prerank,positive regulation of cell death (GO:0010942),0.37682462281114626,0.9139324203245603,0.6188436830835118,0.9567392151135945,1.0,9/59,13.79%,LRRK2;CD36;MAPT;FAF1;APC;BNIP3;PRNP;EIF2S1;FYN
prerank,microtubule-based transport (GO:0099111),-0.3712167744145348,-0.9136781037708683,0.5769230769230769,0.9486408765058092,1.0,1/13,0.91%,DYNC1I1
prerank,nucleotide biosynthetic process (GO:0009165),0.4436048184988661,0.9132592632736477,0.5943012211668928,0.9576268850796938,1.0,3/18,6.83%,PRPSAP1;NMNAT3;HPRT1
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.3538134010901714,-0.9130960872694353,0.5833333333333334,0.9478869162938146,1.0,1/15,0.56%,SAT1
prerank,B cell differentiation (GO:0030183),0.38109037488735603,0.9130164606228185,0.6133333333333333,0.9576507916032742,1.0,7/46,9.08%,TPD52;ZBTB7A;HDAC9;PTPRJ;HDAC5;ITGA4;FNIP1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.2575813211783482,-0.9129792597106406,0.6204379562043796,0.9459811977443163,1.0,13/40,21.52%,PRKN;OPA1;BCL2L1;IGF1;GHITM;PYCARD;AKT1;HGF;PLAUR;FAM162A;BMF;BAX;BID
prerank,regulation of response to biotic stimulus (GO:0002831),0.41469932825314965,0.9129202601546951,0.5929951690821256,0.9573628255408387,1.0,8/28,14.06%,CD36;CX3CL1;IRF1;BIRC3;LRP8;TRIM5;ERAP1;RNF135
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.3769993704545043,0.9127092532347708,0.6355841371918542,0.9573137497144367,1.0,11/65,13.58%,DAND5;SMAD6;PMEPA1;ZBTB7A;SMAD3;SPRED2;LDLRAD4;TGFBR2;PPM1A;TGFBR1;SPRED1
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.4667640032615007,0.9123422116499734,0.6,0.957557467916069,1.0,4/13,15.19%,CPE;TGFBR2;RBPJ;SMAD4
prerank,organophosphate biosynthetic process (GO:0090407),0.39572698889702707,0.9119628110365147,0.6023121387283237,0.9578786495538902,1.0,9/37,13.00%,TPK1;NFS1;GPAM;FADS1;TKT;AGPAT4;IPMK;GK;AGPAT5
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.32827626799512155,-0.9119619043485684,0.5404255319148936,0.9464302195766524,1.0,3/20,1.86%,PRKCE;HCK;TGFB1
prerank,regulation of macrophage activation (GO:0043030),-0.2868889671191569,-0.9119585339843382,0.6079545454545454,0.9442317343820268,1.0,8/30,19.82%,LRFN5;FCGR2B;GPR137B;TNIP2;IL33;HSPD1;ZC3H12A;CD74
prerank,protein O-linked glycosylation (GO:0006493),0.3721244979177242,0.9113536847336935,0.6444906444906445,0.9586446873854396,1.0,14/96,14.26%,POGLUT3;EOGT;GALNT1;POMT2;GALNT12;GALNT3;C1GALT1;B4GALT5;GALNTL6;ST6GAL1;FKTN;B3GNT2;B3GALNT2;TET2
prerank,carboxylic acid transport (GO:0046942),0.38731475026094764,0.9112220868527825,0.6149614961496149,0.9584455232853896,1.0,7/55,15.51%,SLC66A1;LLGL2;SLC38A2;SLC7A8;SLC15A4;SLC16A6;SLC38A6
prerank,positive regulation of DNA replication (GO:0045740),-0.3393605755749698,-0.9110884630892012,0.5645161290322581,0.9441697913563494,1.0,6/16,22.55%,DHX9;DNA2;STN1;BRPF3;ATAD5;EGFR
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.4272428157837151,0.9110413058519017,0.5864759427828349,0.9583142611718366,1.0,5/21,12.87%,CNOT10;TUT4;CNOT9;CNOT3;SAMD4A
prerank,ceramide transport (GO:0035627),-0.3844549922354109,-0.9110301128997786,0.6061538461538462,0.9421226906552791,1.0,7/12,20.01%,CERT1;PLEKHA8;PLEKHA3;ABCB4;GLTP;PLTP;ABCA2
prerank,miRNA metabolic process (GO:0010586),0.4422652564866154,0.910874201654244,0.5981675392670157,0.9581643949392135,1.0,4/20,11.02%,TUT4;AGO2;LIN28B;PRKRA
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.4639676144696823,0.9105039854128112,0.5851528384279476,0.9584485539424593,1.0,5/13,18.86%,CYFIP2;TBC1D10A;GRIN2A;LGMN;ASPH
prerank,epithelial structure maintenance (GO:0010669),-0.3955463378439263,-0.9103271785810532,0.5887573964497042,0.9416930645955528,1.0,4/11,42.16%,STRAP;CXADR;NOD2;RBP4
prerank,cellular copper ion homeostasis (GO:0006878),0.4566261538445778,0.9100655867083035,0.6059743954480796,0.9588317372721751,1.0,4/14,11.64%,ATP7A;ARF1;PRNP;SLC31A1
prerank,inorganic anion transport (GO:0015698),-0.239914465894218,-0.9095659725818921,0.6292134831460674,0.9413224958399123,1.0,9/53,12.67%,ANO6;SLC11A1;ENPP1;PACC1;ANO10;TTYH3;CLCN4;GLRA1;CLCN6
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.4192738820402905,0.9094904052242014,0.5926395939086294,0.9595195957099478,1.0,5/23,14.70%,CETN2;COPS7B;COPS4;CUL4A;RAD23B
prerank,membrane protein intracellular domain proteolysis (GO:0031293),-0.3245709250593451,-0.9093063186964139,0.6059322033898306,0.9397769511114487,1.0,8/20,14.79%,TGFB1;MBTPS2;ADAM9;HM13;NCSTN;MBTPS1;TRAF6;PSEN2
prerank,response to metal ion (GO:0010038),0.3764929086485014,0.9089910918114115,0.6385927505330491,0.960068584367777,1.0,12/67,14.29%,D2HGDH;PEF1;THBS1;HVCN1;IL1A;NEDD4;MAPT;MT1X;MT1A;BCL2;NDRG1;CALM1
prerank,ventricular septum development (GO:0003281),0.39862488448387573,0.9088429243459275,0.6146682188591386,0.9598740777139714,1.0,8/37,12.97%,DAND5;TGFB2;BMPR1A;ACVR1;TGFBR2;SOX11;HECTD1;TGFBR1
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.45153308765833755,0.9087885905094357,0.5808625336927223,0.9594960745214913,1.0,2/15,8.68%,CD36;IL18
prerank,lipid catabolic process (GO:0016042),0.4327603601903367,0.9087297919773214,0.6103038309114928,0.9591231229071205,1.0,3/18,11.42%,LIPE;CEL;ACADL
prerank,regulation of axonogenesis (GO:0050770),0.38552056281714375,0.9085487052273385,0.609271523178808,0.9589931531459879,1.0,10/51,14.70%,CHODL;PLXNA1;GDI1;PAK2;ARHGAP35;RUFY3;PLXNC1;RTN4;MAP6;PTEN
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.3857582028351023,0.9085405594863399,0.6169265033407573,0.9585218737958587,1.0,4/46,6.70%,TIMM17A;TOMM40;DNAJC15;TIMM23
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.2702971841912497,-0.9083099018738671,0.6143790849673203,0.9400857531371265,1.0,6/35,7.19%,PDE4D;RIMS2;CAP1;AKAP6;KSR1;ADCY2
prerank,positive regulation of hydrolase activity (GO:0051345),0.36252687828751473,0.9082532120913644,0.6747474747474748,0.958614501554921,1.0,28/137,17.18%,CX3CL1;RAPGEF1;DOCK8;ITGA6;NDEL1;RAB3GAP1;RSU1;NF1;RAP1A;WRN;EVI5;CCL25;MAPK8;EZH2;LIMS1;RAP1GDS1;CDKL5;DOCK9;DOCK11;CALM1;LARS1;PKP4;SNX13;MAP4K4;DOCK10;SNX9;RALBP1;RAPGEF2
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.414203102108538,0.9079869089492266,0.585427135678392,0.9586811556888465,1.0,7/26,16.80%,CD36;ABCB7;ABCD2;ALOX5;ABCD1;TLR4;COA8
prerank,regulation of T cell mediated immunity (GO:0002709),0.48909921559981073,0.9079554129683156,0.603030303030303,0.9582619661933516,1.0,3/10,16.68%,TRPM4;HMGB1;ZBTB1
prerank,regulation of platelet aggregation (GO:0090330),-0.33023036011913987,-0.9078994661736302,0.5661764705882353,0.9389909608267047,1.0,4/17,5.58%,F11R;PRKG1;SERPINE2;CD9
prerank,renal filtration (GO:0097205),-0.4037274844092199,-0.907686479184522,0.5919540229885057,0.9373587799199643,1.0,5/10,23.56%,SULF2;XPNPEP3;CD34;TBC1D8B;SULF1
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.3830440094871582,0.9076402982770061,0.608793686583991,0.9584419699667982,1.0,5/48,11.00%,SELENON;CX3CL1;PRKACA;CAMK2D;DIAPH1
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.39321019518416095,0.9074726212600535,0.6192129629629629,0.9583246258225285,1.0,7/39,11.49%,ITGB1BP1;TGFB2;EP300;MAML3;MAML2;KAT2B;BMP2K
prerank,regulation of tumor necrosis factor production (GO:0032680),0.36448857343897023,0.9073573522645012,0.6513292433537833,0.9580849782519224,1.0,18/112,15.45%,ISL1;CX3CL1;GAS6;EPHB2;THBS1;ILRUN;PTPRJ;IL1A;SYT11;TLR3;MAVS;HMGB1;MAPKAPK2;SYK;LGALS9;HAVCR2;TLR4;CD47
prerank,"phototransduction, visible light (GO:0007603)",0.4517421055266576,0.9071974516768251,0.6014598540145986,0.9579307603633778,1.0,2/14,14.41%,GNAQ;GNB1
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.37987620875358497,0.907187610156135,0.6204217536071032,0.9574645018696294,1.0,8/56,14.30%,PLK1;VPS4A;BBS4;SPTBN1;APC;PDCD6IP;IST1;ROCK2
prerank,nucleotide-sugar metabolic process (GO:0009225),0.463996547503841,0.9071789351535078,0.6079881656804734,0.9570043875387778,1.0,4/12,17.18%,PARG;UGP2;SLC35A3;GMDS
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.404094198030849,0.9054514932871357,0.5995085995085995,0.9600352310799295,1.0,6/28,14.25%,ADCY8;EPHB2;SQSTM1;YTHDF1;ABL1;RELN
prerank,negative regulation of TOR signaling (GO:0032007),-0.26908539052212777,-0.9053624624263362,0.59375,0.9411185996601465,1.0,14/36,22.93%,UBR1;SESN1;FLCN;SESN3;PRKAA1;DEPTOR;TMEM127;UBR2;SIRT1;PRKAA2;CASTOR2;RNF152;MINAR1;SZT2
prerank,positive regulation of GTPase activity (GO:0043547),0.3611439252689178,0.9053106459389795,0.7044088176352705,0.9598329381165494,1.0,45/188,17.18%,CX3CL1;RAPGEF1;DOCK8;ITGA6;NDEL1;RAB3GAP1;RSU1;SIPA1L3;NF1;TBC1D15;RAP1A;GPR65;EVI5;TBC1D17;CCL25;ARHGAP22;TBC1D14;EZH2;LIMS1;TBC1D10B;RAP1GDS1;SIPA1L2;TBC1D4;TBC1D12;CDKL5;TBC1D5;TBC1D10A;TBC1D13;RABGAP1;ARHGAP45;DOCK9;DOCK11;TBC1D22A;TBC1D8;LARS1;PKP4;TSC1;TBC1D1;SNX13;MAP4K4;DOCK10;TBCK;SNX9;RALBP1;RAPGEF2
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.4343540732605295,0.9049837830337477,0.5924479166666666,0.9600212089950771,1.0,4/19,11.59%,POLR3G;AR;CHD8;MTOR
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.394252757723619,0.9049746595333277,0.5910112359550562,0.9595545571059771,1.0,9/37,15.10%,STMN2;MAPRE1;CAMSAP3;MAPT;TAOK1;CYLD;BICD1;MAP6;CLASP1
prerank,regulation of B cell proliferation (GO:0030888),0.3888291056426571,0.9047710577744323,0.6148571428571429,0.9594793709003698,1.0,11/44,18.02%,CD38;EPHB2;VAV3;IRS2;LYN;BCL2;CD81;MEF2C;ATM;NCKAP1L;RC3H1
prerank,eye morphogenesis (GO:0048592),-0.31695908628727354,-0.9042438956900944,0.5910931174089069,0.9416779348982064,1.0,12/19,34.36%,AGTPBP1;NIPBL;FBN2;SHROOM2;IFT122;TENM3;STAT3;FBN1;VEGFA;COL5A2;RARG;EFEMP1
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.40156392163271065,0.904203939876179,0.6107226107226107,0.9601817446297433,1.0,3/37,5.92%,PLK1;MAPK1;SPRED2
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.32141029545981903,-0.9041489770601554,0.5583333333333333,0.9397699955687334,1.0,5/19,16.60%,DLST;ASPA;GOT1;GOT2;DLD
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),-0.3333145977494393,-0.904100803160864,0.6163793103448276,0.9377773442087666,1.0,11/19,20.98%,TENT4B;HNRNPU;EXOSC10;DCP2;HNRNPA1;PINX1;STN1;GNL3L;NAT10;TEN1;SRC
prerank,neuron projection development (GO:0031175),0.3620791620905167,0.9038194496789416,0.7017189079878665,0.9604671118341674,1.0,39/168,17.29%,VASH2;LRRK2;MINK1;ZFYVE27;EHD1;STMN2;EPHB2;NYAP1;ATP7A;KIF20B;BICDL1;NEDD4;MAPT;STX3;SLC9A6;DTNBP1;LYN;CDK5;TAOK1;CDC42;GRM7;DBNL;HMGB1;EPB41L3;PPP1R9A;TBC1D24;PLP1;PTEN;WASL;GPM6A;MAP4K4;PPP1R9B;SH3GL2;PAK1;RB1;DOCK10;TBC1D23;RAPGEF2;NCKAP1L
prerank,lymphocyte differentiation (GO:0030098),0.36798286037161443,0.9036612550835069,0.6588235294117647,0.9602986019586099,1.0,9/68,8.95%,TPD52;ZBTB7A;HDAC9;PTPRJ;AXL;HDAC5;IKZF1;ITGA4;CHD7
prerank,regulation of centrosome duplication (GO:0010824),0.4004542725529206,0.9036516403567335,0.6258992805755396,0.9598350369041442,1.0,7/30,16.45%,ALMS1;CHMP5;TMEM67;VPS4B;PDCD6IP;NPM1;CEP295
prerank,cardiac muscle cell differentiation (GO:0055007),0.418013392272625,0.9035192549540145,0.6013245033112583,0.9596290387350346,1.0,3/21,16.27%,ACVR1;AKAP13;MEF2C
prerank,positive regulation of chromatin organization (GO:1905269),0.4623833503936988,0.9034077698480752,0.597684515195369,0.9593822139130809,1.0,4/12,13.42%,TERF2;TAL1;ATRX;TERF1
prerank,midbody abscission (GO:0061952),0.43562626031228596,0.9033988696430956,0.6041666666666666,0.9589151925017252,1.0,4/17,13.31%,VPS4A;CHMP5;VPS4B;PDCD6IP
prerank,defense response to Gram-negative bacterium (GO:0050829),0.391162482693654,0.9033212988197162,0.6318807339449541,0.9585982614900473,1.0,7/42,17.88%,RNASE6;GSDMD;RNASE3;OPTN;TLR4;DROSHA;TREM2
prerank,regulation of establishment of cell polarity (GO:2000114),0.4347985045180454,0.9031087735435885,0.5983606557377049,0.9585428432619028,1.0,8/16,18.14%,KIF20B;ARFGEF1;RAP1B;CYRIB;RUFY3;ROCK2;GSN;ROCK1
prerank,negative regulation of macrophage activation (GO:0043031),-0.34604868420494406,-0.9030037719507314,0.5778546712802768,0.9382845473527028,1.0,4/16,4.56%,LRFN5;PTPRC;GRN;FCGR2B
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.3876658366687172,0.9029073825726434,0.6226851851851852,0.958479802204252,1.0,12/45,15.97%,GRB2;BRAF;AREG;REPS2;RPS6KA5;KIF16B;DGKD;CBL;TGFA;PIK3C2A;PIK3R1;IQGAP1
prerank,RNA interference (GO:0016246),-0.3383690220120994,-0.9028536979030245,0.5846153846153846,0.9365625008344473,1.0,6/17,16.94%,DHX9;AGO4;AGO3;AGO1;TSNAX;TSN
prerank,lymphocyte proliferation (GO:0046651),-0.3051015639865992,-0.9027370060914011,0.5848214285714286,0.9347307428227529,1.0,3/22,3.34%,ELF4;PTPRC;PIK3CG
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.45317313957312844,0.9026275662965998,0.5832147937411095,0.9585426863094392,1.0,4/13,17.17%,SPRED2;SPRED1;DDX5;ATM
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.4082352269183795,-0.9023231630554552,0.6442577030812325,0.933608507628827,1.0,6/10,29.89%,GABRA2;GABRA3;GABRA5;GABRA4;GABRG1;GABRA1
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.4254985855951882,0.9021318351931795,0.6046213093709885,0.9590488723524156,1.0,5/20,11.02%,PUM2;AGO2;PUM1;ZC3H7A;PRKRA
prerank,regulation of microglial cell activation (GO:1903978),0.44536633068911946,0.9021242542487881,0.5965909090909091,0.9585823972156018,1.0,2/15,7.80%,CX3CL1;SYT11
prerank,neurogenesis (GO:0022008),0.3881658466334909,0.9020400523186777,0.6103603603603603,0.9582696485954322,1.0,5/43,7.60%,VXN;TGFB2;CDK6;METTL3;MAPT
prerank,glycoprotein biosynthetic process (GO:0009101),0.3715189744752962,0.9016743979586463,0.6514522821576764,0.9585357353962655,1.0,13/79,13.74%,ALG3;ST8SIA5;ST8SIA4;ATP7A;COG3;GOLPH3;B4GALT5;CANT1;B3GALNT1;B3GNT2;CHST8;NUS1;B3GALNT2
prerank,long-chain fatty acid import into cell (GO:0044539),0.48592004557028595,0.9012725870506196,0.6121212121212121,0.9588929101804141,1.0,2/10,12.68%,CD36;SLC27A1
prerank,regulation of dendrite extension (GO:1903859),0.43869975167760633,0.9009738384929519,0.6063829787234043,0.9590043694298638,1.0,3/18,10.66%,CPNE5;PLAA;RNF157
prerank,positive regulation of protein kinase activity (GO:0045860),0.3630994434834596,0.900579036330195,0.714572864321608,0.9593007919437591,1.0,38/148,18.70%,CAMKK1;DDR2;MINK1;TGFB2;GAS6;RAP1A;PDGFB;STK11;HSP90AA1;PAK2;PTPN1;EZH2;LRP8;TAOK1;TGFBR2;PRNP;SLC27A1;MAP2K2;MMD;INSR;RELN;CALM1;STK3;MAP4K4;IQGAP1;MAP2K1;PAK1;SNX9;RAPGEF2;FCGR1A;CAMK1;LCP2;DDX3X;STK4;ALS2;CAB39;TNIK;AXIN1
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.3972940589761174,0.9001624959356135,0.6072684642438453,0.9597013853030572,1.0,7/32,13.71%,TMEM109;DYRK2;EP300;STK11;HIPK2;TP53;DDX5
prerank,regulation of neuron projection development (GO:0010975),0.3601334446874611,0.8999154177601577,0.7009063444108762,0.9597216125308417,1.0,32/163,14.93%,ROR2;LRRK2;CX3CL1;RAPGEF1;CFL1;ITGA6;NDEL1;CAMK1D;STMN2;RAP1A;EP300;SERPINI1;PAK2;SNX3;ARSB;TWF2;NPTN;LYN;SETX;CDK5;ARHGAP35;MYLIP;RIT2;CDKL5;RUFY3;CAMK2G;PTPRO;NDRG4;RELN;PTEN;PTPN9;SCARB2
prerank,regulation of proteolysis (GO:0030162),0.37907545990948704,0.899768531893771,0.62751677852349,0.9595300402388274,1.0,9/48,15.59%,PLK1;CDK5;FBXW11;CYFIP2;DNAJC1;PARL;TBC1D10A;IST1;HDAC2
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.35884026603743935,0.8996772514401784,0.6889564336372846,0.9592363836285682,1.0,21/124,14.68%,WNT4;ROR2;DVL1;PSMD9;NFATC1;PSMB8;TNRC6B;ARRB2;AP2A1;PSMC5;AGO2;CDC42;TCF7L2;PSMD12;PSMA2;GNG2;CALM1;GNB1;FZD9;FZD3;CLTC
prerank,mitochondrial transcription (GO:0006390),0.47048459742994403,0.8996496156326363,0.6059701492537314,0.9588163833868097,1.0,1/10,3.24%,TFB2M
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.39016349581105225,0.8995597280344969,0.6258823529411764,0.9585116825462227,1.0,8/35,13.07%,TCP1;MAPK1;HNRNPA2B1;PKIB;TNKS2;NEK7;HMBOX1;CCT3
prerank,mesenchymal to epithelial transition (GO:0060231),-0.38725761890802707,-0.8994489951237021,0.5971014492753624,0.9387147098917944,1.0,3/10,30.39%,SALL1;PAX8;PAX2
prerank,regulation of T cell activation (GO:0050863),0.38491346347545075,0.8991773500844121,0.6183908045977011,0.9588317057277305,1.0,5/42,11.90%,DUSP3;TNFAIP8L2;METTL3;CYRIB;ABL1
prerank,positive regulation of synaptic transmission (GO:0050806),0.37608595316276816,0.8991144367878537,0.6476793248945147,0.9584749947069772,1.0,11/72,10.25%,PRKCZ;ADCY8;CACNG7;EPHB2;CLSTN3;SQSTM1;RGS14;NPTN;DTNBP1;VAMP2;CLSTN1
prerank,embryonic organ morphogenesis (GO:0048562),-0.24864503031875002,-0.8987092809218825,0.7064220183486238,0.938399302539995,1.0,4/42,3.58%,RYR2;DSCAML1;FGFR2;NIPBL
prerank,regulation of defense response to virus (GO:0050688),-0.3565900050570935,-0.8978652455327923,0.6037735849056604,0.9383447309582844,1.0,6/14,16.37%,PCBP2;DHX9;ELMOD2;TRAF3;ZMPSTE24;TNFAIP3
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.4794284062428593,0.8975641063427239,0.6195652173913043,0.9611122718899578,1.0,3/10,13.52%,ACADS;ACADL;ETFA
prerank,aortic valve morphogenesis (GO:0003180),0.4032839314833392,0.8974168022246705,0.6239316239316239,0.9609384309897195,1.0,2/30,4.22%,SMAD6;NFATC1
prerank,regulation of protein dephosphorylation (GO:0035304),-0.2620405115106279,-0.8973554204914665,0.6349206349206349,0.937462912728729,1.0,11/37,14.35%,PPP6R3;CALM2;TGFB1;CAMTA1;PPP6R2;PPP1R2;CNEP1R1;PPP6R1;PPIA;ARPP19;SYMPK
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.42971247253626965,0.8970929316323322,0.615686274509804,0.961110580165836,1.0,5/20,14.80%,CTR9;CDK6;HSPA9;ZFP36L1;LDB1
prerank,response to UV-A (GO:0070141),0.44811868893274853,0.8965578883848281,0.5955555555555555,0.9617321010749692,1.0,1/14,2.94%,PPID
prerank,negative regulation of potassium ion transport (GO:0043267),-0.35681496991270584,-0.8962704798112794,0.5865384615384616,0.9379597455243707,1.0,1/13,2.26%,PTK2B
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.37855741494068706,0.8961071243813534,0.6359550561797753,0.9621280926015142,1.0,8/49,13.04%,URI1;NUPR1;BCL2L11;UBQLN1;NOC2L;CYLD;TP53;BCL2
prerank,regulation of stem cell differentiation (GO:2000736),0.3617636386344786,0.8960553896864922,0.6763185108583247,0.9617596698561968,1.0,18/89,16.33%,EIF2AK2;SETD1A;RUNX1;BMPR1A;PSMD9;PSMB8;PRKDC;METTL3;PSMC5;TAL1;TCF12;ABL1;PSMD12;PSMA2;LDB1;PSMB1;LMO2;OCIAD1
prerank,protein localization to cell-cell junction (GO:0150105),0.44185353316743237,0.8960522652449322,0.6019417475728155,0.9612888820403741,1.0,2/15,8.02%,CGNL1;PAK2
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.4007356224266948,0.8957543839735775,0.6269554753309265,0.9614073216986753,1.0,4/27,5.54%,IRS1;PIK3R4;PDGFB;AMBRA1
prerank,phasic smooth muscle contraction (GO:0014821),-0.3848070912085173,-0.8957412974185484,0.6340782122905028,0.9371070511491413,1.0,6/10,51.22%,TIFAB;HTR2B;EDNRB;DRD2;PTGER3;HTR1D
prerank,negative regulation of cell adhesion (GO:0007162),0.3614107490775136,0.8957040620710623,0.6473684210526316,0.9610312079923325,1.0,13/72,13.55%,PLXNA1;CX3CL1;ITGB1BP1;EPHB2;CBLL1;PDE3B;LPXN;SEMA6A;MIA3;ADAM10;PLXNC1;ADAM22;PTPRO
prerank,determination of left/right symmetry (GO:0007368),0.39578046511570986,0.8956920009161605,0.617169373549884,0.9605801753539992,1.0,2/37,2.69%,DAND5;ARL6
prerank,positive regulation of cellular catabolic process (GO:0031331),0.3609264111237183,0.8954683371790992,0.6804435483870968,0.9605402012872167,1.0,39/132,18.25%,LRRK2;MSN;IRS1;NRDC;ABCD2;IRS2;STK11;HSP90AA1;EZR;PTTG1IP;PTPN1;LIN28B;VPS35;DAPK1;FAF1;MTDH;TPCN1;FURIN;TRIM5;BNIP3;HMGB1;ATF6;VPS11;SH3GLB1;ABCD1;PIK3C2A;INSR;OPTN;ARNT;RDX;PFKFB3;SNX9;FOXO3;VGLL4;TFEB;PSEN1;RC3H1;ROCK1;ZBTB20
prerank,retina homeostasis (GO:0001895),0.4094409489584095,0.8953897907049865,0.5994865211810013,0.9602306986633034,1.0,3/23,10.98%,BBS4;CCDC66;POC1B
prerank,bone morphogenesis (GO:0060349),-0.3570785614986161,-0.8953269757815912,0.559322033898305,0.9360435309672451,1.0,2/14,3.13%,BMPR2;FGFR2
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.41983227483555086,0.895198088744846,0.6149936467598475,0.9601339213999227,1.0,4/22,8.16%,RAD50;PDGFB;MRE11;NBN
prerank,regulation of sodium ion transport (GO:0002028),0.38649669776203743,0.8948017280027519,0.6193317422434368,0.9604442184592652,1.0,6/34,10.04%,CNKSR3;NEDD4;DLG1;GPD1L;SLMAP;NKAIN1
prerank,positive regulation of type 2 immune response (GO:0002830),0.4507273400443403,0.894620023895427,0.6206415620641562,0.96032474855764,1.0,2/14,8.68%,PRKCZ;IL18
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.39204623068726224,0.8944740699653593,0.6343457943925234,0.9601444350529516,1.0,7/35,13.83%,FLNA;NRP1;FARP2;SEMA6D;SEMA3D;SEMA6A;NRP2
prerank,positive regulation of protein binding (GO:0032092),0.37391419428634703,0.8942899640477694,0.6403887688984882,0.9600448697023376,1.0,12/56,14.13%,LRRK2;NMD3;AKTIP;SPPL3;USP33;EPB41;ADD1;DERL1;ABL1;TCF7L2;HIPK2;NVL
prerank,membrane lipid biosynthetic process (GO:0046467),0.3778388171840724,0.8940933790125508,0.6442516268980477,0.9599549654696016,1.0,16/58,17.64%,DEGS1;SGPP1;HACD1;CERS6;SGPP2;ACER3;CERS4;SGPL1;CERS5;PRKD2;HACD4;SPTLC1;VAPB;ST3GAL2;SGMS1;PLPP1
prerank,vesicle transport along microtubule (GO:0047496),0.4143066613559491,0.8939483460194335,0.6265984654731458,0.9597615175070747,1.0,6/23,12.55%,NDEL1;KIF13A;BICDL1;FBXW11;KIF3A;FYCO1
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.3732775018364463,0.8938124283511485,0.6324972737186477,0.95957027123272,1.0,12/56,14.85%,CD36;IRAK4;TLR7;TLR3;LACC1;IRAK2;TAB3;CNPY3;HMGB1;MAPKAPK2;UNC93B1;TLR4
prerank,glucan biosynthetic process (GO:0009250),0.4599403009507263,0.8936267043130427,0.6142433234421365,0.9590034864072883,1.0,3/12,11.70%,NHLRC1;GBE1;UGP2
prerank,glycogen biosynthetic process (GO:0005978),0.4599403009507263,0.8936267043130427,0.6142433234421365,0.9590034864072883,1.0,3/12,11.70%,NHLRC1;GBE1;UGP2
prerank,TOR signaling (GO:0031929),0.399932094927712,0.8935889580868388,0.6131840796019901,0.9586115603257063,1.0,6/26,13.93%,RPS6KB2;MAPKAP1;FNIP1;MTOR;RPS6;TIPRL
prerank,interstrand cross-link repair (GO:0036297),-0.24455866877274865,-0.8934930956868917,0.627906976744186,0.9385239609472817,1.0,19/53,24.44%,VCP;ATR;ERCC6L2;FANCC;MCM9;FANCL;NUCKS1;XPA;WDR48;UBC;FANCE;RPA1;RNF168;RPS27A;FANCM;FAN1;UBB;DCLRE1C;RNF8
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.3673113271715888,0.893439522976438,0.6862745098039216,0.95844634628258,1.0,12/84,13.15%,PLK1;PSMD9;PSMB8;ANAPC10;CDC23;CDK2;PSMC5;BUB3;CDC16;PSMD12;PSMA2;ANAPC16
prerank,negative regulation of cell growth (GO:0030308),0.361388148662761,0.8934104591566059,0.7014314928425358,0.9580259864469013,1.0,23/121,15.95%,CGRRF1;SMARCA4;ADAM15;TGFB2;RERG;BCL6;EI24;SMAD3;DCBLD2;PTPRJ;STK11;DIP2B;ENO1;ULK2;TP53;ACVR1B;RBBP7;RTN4;SMAD4;SMARCA2;CRLF3;PPP1R9B;ST7L
prerank,protein stabilization (GO:0050821),0.3582742474241306,0.8932640101054488,0.7095477386934673,0.9578351521163571,1.0,35/168,15.92%,WFS1;CRTAP;FBXW7;DVL1;BAG3;FLOT2;TCP1;HCFC1;NAPG;USP19;FLNA;CDK7;EP300;COG3;HSP90AA1;USP33;WIZ;CHEK2;GNAQ;NAA16;HPS4;PRKRA;TRIM44;CAMLG;MFSD1;CCT3;NAA15;RTN4;CREB1;PTEN;TSC1;HIP1;STK3;PIK3R1;LAMP1
prerank,regulation of receptor binding (GO:1900120),0.4751700798181194,0.8931864278484271,0.594383775351014,0.957528751922517,1.0,1/10,3.00%,ADAM15
prerank,icosanoid metabolic process (GO:0006690),0.3910443446400566,0.8930882067561635,0.6393629124004551,0.9572737388015262,1.0,9/40,17.95%,HPGD;GPX4;PLA2G4A;ALOX5;FADS1;MAPKAPK2;PON3;ABCC1;PTGS1
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.4075060083915255,0.8923951908793059,0.6173285198555957,0.9581268131402526,1.0,6/28,12.73%,RELA;MAP2K6;LACC1;IRAK2;TAB3;CYLD
prerank,regulation of urine volume (GO:0035809),-0.3931956562676542,-0.8921545067880212,0.5873015873015873,0.9397477636503386,1.0,8/10,60.70%,INPP5K;ADCY6;NPR3;HAS2;NPR1;TFAP2B;HYAL2;ADM
prerank,eye development (GO:0001654),0.379489806864185,0.8920524509874949,0.6399560922063666,0.9583390924564857,1.0,13/54,18.35%,RAB3GAP1;TGFB2;SIPA1L3;RAB18;ATF6;HIPK2;CACNA1C;SMG9;CEP290;HIPK1;PBX3;MEIS1;MEIS2
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.40109624880719263,0.8916770382459878,0.6361416361416361,0.9586371836289578,1.0,6/29,14.70%,CETN2;CDK7;MNAT1;CUL4A;GTF2H1;RAD23B
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.4326664553157994,0.8913755031427802,0.6212534059945504,0.9587640276991881,1.0,3/17,17.18%,ADCY9;AKAP13;RAPGEF2
prerank,regulation of autophagy (GO:0010506),0.356892610722188,0.8911386598125733,0.7372116349047142,0.9587948196709979,1.0,45/216,14.45%,WDR6;LRRK2;FBXW7;NUPR1;SNX5;UBQLN1;PIP4K2A;EP300;PRKACA;STK11;KEAP1;USP33;NEDD4;ATP6V0E1;MAPT;MAPK8;TBC1D14;VPS35;DAPK1;TAB3;ATP6V1E1;PIP4K2B;MTDH;CDK5;TPCN1;TRIM5;BNIP3;EXOC4;MTOR;ABL1;HMGB1;ERN1;RB1CC1;SLC38A9;ATF6;DCAF12;SH3GLB1;ATP6V0D2;BCL2;PIK3C2A;ATP6V1H;HTRA2;ATP6V0A2;OPTN;TPCN2
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.3709704820927743,0.8908330140552699,0.6466739367502726,0.958910476320112,1.0,7/54,12.92%,RGCC;CNOT10;EP300;CHEK2;CNOT9;CNOT3;TP53
prerank,manganese ion transport (GO:0006828),-0.34921929653122435,-0.8905709008329338,0.597972972972973,0.9413684186378765,1.0,7/14,16.96%,SLC11A1;TRPC1;TMEM165;SLC39A14;SLC11A2;ATP2C1;TRPC4
prerank,purine-containing compound salvage (GO:0043101),0.45618839610572615,0.8905623055778575,0.6266471449487555,0.9589731114372458,1.0,2/12,7.65%,HPRT1;DGUOK
prerank,regulation of lymphocyte proliferation (GO:0050670),0.4300829945953645,0.8903619901585417,0.6191819464033851,0.9588840218045314,1.0,2/16,11.42%,LST1;SOX11
prerank,rRNA 3'-end processing (GO:0031125),0.4697688364001823,0.8901159669268046,0.6024279210925645,0.9588997356063585,1.0,2/10,6.89%,EXOSC7;ERI3
prerank,positive regulation of dendrite extension (GO:1903861),0.43870644048643875,0.8900225115150575,0.6288798920377868,0.9586119044344668,1.0,3/17,10.66%,CPNE5;PLAA;RNF157
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.3541092046916325,0.888976543510482,0.805,0.9601615814128472,1.0,63/366,14.87%,ACTR5;RORA;ZNHIT3;ELAVL2;THAP7;RELA;DVL1;SP1;CTR9;CASZ1;SOX13;CLOCK;METAP1;HCFC1;POLR2A;MYCBP;ATXN1;RBM3;EP300;RBAK;ESR1;SPTY2D1;NR3C1;EHMT2;BRCA2;HP1BP3;ZBTB11;RPS6KA5;EZH2;JMJD1C;CHD7;CHEK2;PTP4A3;ASCC2;FUS;FADS1;TULP3;ATXN2;FOXN3;PSPC1;NR2C2;SOX11;ZBTB38;ABL1;ESCO1;GPBP1;SOX6;TP53;ATRX;TGFBR1;RNF20;NR1D2;ACVR1B;PPARGC1B;NFX1;INSR;USP37;RREB1;NSD2;RFX3;NCOA2;LDB1;TSC1
prerank,gene expression (GO:0010467),0.3547953628325062,0.8887045094058159,0.803,0.9601950727207944,1.0,57/348,13.76%,POLR2D;ELAVL4;RPL18;EIF4A3;RPS6KB2;RPS23;MRPL37;RPL41;RPL31;SMG6;RPS17;SYNCRIP;DHX38;RPL4;SARNP;POLR2A;ATXN1;MRPS21;RNPS1;NUP205;RBM3;RPLP0;HARS1;U2AF1;RPS15A;RPL38;RBM5;DHPS;GOLPH3;HNRNPA2B1;MEF2A;THOC5;NUP98;PABPC4;SRSF5;AGO2;NUP54;SETX;APOBEC1;POLR3A;RNGTT;U2AF2;ADAR;XRN2;CPSF3;RBM6;SRSF9;RPL21;RPS6;SORL1;SRSF11;DHX8;HNRNPH3;EPC1;FUBP3;HNRNPH1;BICD1
prerank,mitochondrial gene expression (GO:0140053),0.3797497509881558,0.8883237033257552,0.6319365798414496,0.960498273056521,1.0,5/42,7.17%,NOA1;TFB2M;MRPS21;HARS1;MRPS28
prerank,positive regulation of cytokinesis (GO:0032467),0.3965747864218561,0.8882110762671417,0.6375442739079102,0.9602559882718553,1.0,5/32,10.69%,SVIL;KIF20B;GIPC1;PKN2;CDC42
prerank,regulation of pseudopodium assembly (GO:0031272),0.47394468830646247,0.887813500649328,0.6263399693721287,0.9601090593135749,1.0,2/10,10.69%,APC;CDC42
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.47394468830646247,0.887813500649328,0.6263399693721287,0.9601090593135749,1.0,2/10,10.69%,APC;CDC42
prerank,cellular response to amyloid-beta (GO:1904646),0.3842398428027816,0.8875255095065034,0.6267441860465116,0.960198126328807,1.0,14/35,18.37%,CD36;ITGA4;CDK5;CACNA1A;IGF1R;PRNP;FYN;GRIN2A;TLR4;LGMN;ABCC1;TREM2;PSEN1;SNX6
prerank,regulation of osteoclast differentiation (GO:0045670),-0.2673959643696121,-0.8870358627181755,0.6477987421383647,0.9475735017944623,1.0,9/33,24.67%,MAFB;GPR137B;CSF1;TRAF6;CAMK4;LILRB3;CEBPB;FBN1;TCTA
prerank,membrane assembly (GO:0071709),0.39000123537885223,0.8870182759843069,0.6257309941520468,0.960713077359293,1.0,6/34,10.14%,FLOT2;VPS4A;RFTN1;CEL;SPTBN1;ANXA2
prerank,positive regulation of growth (GO:0045927),0.36862016136263537,0.8869926248176336,0.6623655913978495,0.9603005741471202,1.0,11/64,13.60%,WFS1;DDX49;TGFB2;RFTN1;SDCBP;ADNP2;CDC42;ADAM10;TGFBR1;BCL2;INSR
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.34958704664282514,0.8867733301588379,0.7607607607607607,0.9602773253799493,1.0,43/248,14.50%,LRRK2;UBAC2;BICC1;NPHP4;DVL1;IGFBP2;SOX13;ZEB2;RBMS3;PSMD9;TLE2;GID8;USP34;PSMB8;LRRK1;STK11;PSMC5;TMEM170B;TLE1;HECW1;TRPM4;CSNK1G1;RNF146;TNKS2;DAB2;APC;GNAQ;WLS;CHD8;PPM1A;TCF7L2;PSMD12;UBR5;CYLD;PSMA2;LRP6;GPC3;PTPRU;PTPRO;MCC;CSNK1A1;TBL1XR1;FZD9
prerank,cellular response to interleukin-1 (GO:0071347),0.3520420535165795,0.8866707585493816,0.7142857142857143,0.9599938322422095,1.0,20/143,12.95%,ADAMTS12;RELA;CX3CL1;IRAK4;PELI1;PSMD9;PSMB8;SQSTM1;IL1A;PSMC5;IKBKB;CCL25;RPS6KA5;IL1RAP;IRAK2;TAB3;TANK;FBXW11;PSMD12;PSMA2
prerank,autophagosome organization (GO:1905037),0.3737125595344398,0.8863686469237441,0.6331491712707182,0.9601213886432702,1.0,12/50,15.16%,WDR45;UBQLN1;WDR45B;AMBRA1;ULK2;ATG3;PACS2;RB1CC1;TP53INP2;RAB7A;ATG7;BECN1
prerank,mitotic DNA replication (GO:1902969),0.4680324317347171,0.8862736384372365,0.622848200312989,0.9598332932694239,1.0,1/10,4.91%,POLA1
prerank,microtubule polymerization or depolymerization (GO:0031109),0.4104240876386024,0.8862016755782066,0.5977722772277227,0.9595038948759569,1.0,3/25,7.60%,STMN2;NCKAP5L;MAPT
prerank,mismatch repair (GO:0006298),0.40443065640160986,0.8861231628265505,0.6268292682926829,0.9591960913212402,1.0,5/27,12.67%,RNASEH2A;POLD3;SETD2;ABL1;MLH3
prerank,mRNA modification (GO:0016556),0.4141165799105503,0.8861199527550978,0.6378865979381443,0.9587372544279146,1.0,5/22,12.81%,METTL8;METTL3;CBLL1;ZC3H13;WTAP
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.4107063130266757,0.8859627565737143,0.6357786357786358,0.9585873093809644,1.0,3/22,11.72%,FLOT2;CD44;MAP2K5
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.45238664737159295,0.885749949494293,0.6233766233766234,0.9585457103449885,1.0,1/12,1.99%,PFDN1
prerank,mitotic cytokinesis (GO:0000281),0.3800807628216175,0.8856469460178577,0.6570438799076213,0.9582705700816169,1.0,4/47,9.63%,PLK1;BBS4;SPTBN1;APC
prerank,regulation of macroautophagy (GO:0016241),0.3595329091173563,0.8853938564613978,0.6996904024767802,0.9583180106529744,1.0,24/105,13.11%,LRRK2;SNX5;UBQLN1;QSOX1;PRKACA;EPM2A;NEDD4;ATP6V0E1;MAPK8;BNIP3L;VPS35;ATP6V1E1;CDK5;BNIP3;EXOC4;MTOR;LZTS1;ERN1;RB1CC1;SLC38A9;GNAI3;SH3GLB1;ATP6V0D2;ATP6V1H
prerank,adipose tissue development (GO:0060612),0.462687809448875,0.8845812595835717,0.6199095022624435,0.959443874590062,1.0,2/11,5.48%,ARID5B;LRP5
prerank,maintenance of protein location in nucleus (GO:0051457),-0.3194650609673363,-0.8842465117277278,0.6483050847457628,0.952019296874541,1.0,14/20,33.19%,HNRNPU;MORC3;PML;SUN1;SUN2;SKP1;SYNE1;RANGAP1;TOPORS;TAF8;BCL3;ARL2BP;PARK7;ARL2
prerank,piRNA metabolic process (GO:0034587),-0.32037432483356365,-0.8840136331132682,0.6166666666666667,0.9504915517482488,1.0,12/19,67.96%,TDRKH;TEX15;MYBL1;EXD1;DDX4;PIWIL2;TDRD12;GPAT2;TDRD9;MOV10L1;PIWIL4;PIWIL1
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.4064384989446608,0.8836081115967757,0.6490765171503958,0.9608729035414,1.0,2/24,3.19%,PID1;NDUFS1
prerank,positive regulation of integrin activation (GO:0033625),0.4522436868522842,0.8835936246602681,0.6212121212121212,0.9604369865991044,1.0,4/11,18.67%,RAP1B;P2RY12;PIEZO1;PLEK
prerank,positive regulation of dephosphorylation (GO:0035306),-0.2860437345717527,-0.8834452474573081,0.6107784431137725,0.949718097577314,1.0,11/27,20.98%,CALM2;TGFB1;CAMTA1;CNEP1R1;PPIA;SYMPK;PPP1R7;NSMF;MTMR9;PTBP1;SRC
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.3583818367335118,0.8831166198645447,0.6817248459958932,0.9608522778431353,1.0,18/94,13.81%,BRCA1;BCL2L11;APAF1;PRKDC;STK11;CHEK2;BNIP3;TRAF2;CUL4A;ABL1;ERN1;AIFM1;MLLT11;HIPK2;TP53;BCL2;DDX5;HTRA2
prerank,vasculogenesis (GO:0001570),0.3924778709228234,0.8830802669598351,0.6327272727272727,0.960461599560164,1.0,5/32,13.58%,GLMN;ITGB8;TGFBR2;AGGF1;SPRED1
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.4494805010789126,0.8830515542859062,0.6098981077147017,0.960056532716626,1.0,3/13,12.01%,SP1;ITGA4;HMGB1
prerank,regulation of chromosome organization (GO:0033044),0.4182984919875787,0.882843750381566,0.6397435897435897,0.9599986648758675,1.0,3/22,7.60%,SMG6;TERF2;MAPT
prerank,positive regulation of isotype switching (GO:0045830),-0.35808935657550695,-0.882810902340944,0.610738255033557,0.949198666478612,1.0,7/15,22.92%,TGFB1;RIF1;SHLD1;SHLD2;PAXIP1;HMCES;TFRC
prerank,second-messenger-mediated signaling (GO:0019932),0.36348370286187226,0.8827947567068472,0.6853582554517134,0.9596315791789781,1.0,13/82,15.82%,LRRK2;CD36;BTK;INPP5A;TRPM4;RCAN2;DGKD;RCAN3;PPP1R9A;CAMKK2;TPCN2;P2RY12;PPP1R9B
prerank,mitochondrial membrane organization (GO:0007006),0.3950409389689123,0.8827469812504616,0.6488095238095238,0.9592520688055771,1.0,8/32,13.42%,MTX1;HSPA9;MICOS10;DNAJC11;BNIP3;APOOL;BCL2;CHCHD6
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.46512736977217484,0.8826670439826071,0.6099071207430341,0.9589436587497695,1.0,4/10,18.02%,PRNP;LGALS9;PRKAR1A;RC3H1
prerank,nuclear envelope organization (GO:0006998),0.41395443102284923,0.8826559165337076,0.6086956521739131,0.9584995430765316,1.0,3/20,7.70%,VPS4A;CTDNEP1;LEMD2
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.4081605108827514,0.8825117432387203,0.6218375499334221,0.9583164402651012,1.0,3/21,8.59%,LRRK2;BCL2L11;NCK1
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.4002760024945505,0.8823777664809526,0.6375757575757576,0.9581148738571469,1.0,2/26,7.10%,RGCC;KMT2E
prerank,histone monoubiquitination (GO:0010390),-0.2914277758086765,-0.8821729429061652,0.6051502145922747,0.9485623947264952,1.0,12/24,26.99%,WAC;BCOR;DDB1;RNF168;DDB2;CUL4B;DTX3L;SKP1;CDC73;ATXN7L3;RNF40;PAF1
prerank,regulation of postsynapse organization (GO:0099175),0.39639440912312135,0.8819335958220947,0.625615763546798,0.9584979089827798,1.0,6/28,12.22%,LRRK2;CFL1;ARHGAP22;VPS35;CDK5;CDKL5
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.4230764974717602,0.8815978933399061,0.6264900662251656,0.9586943614503455,1.0,3/18,6.09%,ILRUN;CTNNA1;POLR1A
prerank,glucose catabolic process to pyruvate (GO:0061718),0.4004258898692883,0.8810914712948534,0.6383763837638377,0.9586974930578317,1.0,7/24,16.86%,PGAM1;ALDOA;ENO1;GCK;PFKP;FOXK1;HK2
prerank,canonical glycolysis (GO:0061621),0.4004258898692883,0.8810914712948534,0.6383763837638377,0.9586974930578317,1.0,7/24,16.86%,PGAM1;ALDOA;ENO1;GCK;PFKP;FOXK1;HK2
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.2671714194361831,-0.8804935039566983,0.6442953020134228,0.9504918811389569,1.0,7/35,12.33%,PPP6R3;CALM2;PPP6R2;GSK3B;PPP1R2;PPP6R1;FKBP1A
prerank,histone mRNA metabolic process (GO:0008334),-0.28445211308229135,-0.8804692689112306,0.6473988439306358,0.9484938311394874,1.0,15/27,25.32%,TENT2;TENT4B;SSB;MTPAP;EXOSC10;DCP2;ERI1;CPSF2;SNRPB;UPF1;NCBP1;SLBP;TUT1;LSM1;NCBP2
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.2841915788537428,-0.8803948488265108,0.6432748538011696,0.9466266836199158,1.0,7/29,8.89%,PRKN;TJP1;SLIT2;PLEKHH2;PIK3CA;SSH1;CORO1A
prerank,potassium ion transmembrane transport (GO:0071805),0.35122374509724863,0.8795194333196675,0.717479674796748,0.9612002976787969,1.0,20/135,17.25%,HCN3;TMEM175;KCNJ6;SLC9A9;SLC9A1;KCNH8;KCNH7;KCNK2;SLC9A7;SLC9A6;KCNK13;SLC12A6;KCNK10;PKD2;KCNQ5;HCN1;KCND2;KCNA1;KCNA5;KCNB2
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.4386390100227235,0.8795088665154043,0.6368715083798883,0.9607582698405455,1.0,2/15,13.36%,HSPH1;SYK
prerank,glucose homeostasis (GO:0042593),0.3592336365459901,0.8792685420694663,0.6989473684210527,0.9607610457856494,1.0,15/83,15.89%,WFS1;ADCY8;IRS1;STK11;ALOX5;PPARG;IGF1R;GCK;RPS6;TCF7L2;CYB5R4;INSR;ADIPOR1;PIK3R1;FOXK1
prerank,regulation of cilium movement (GO:0003352),-0.3846588412529031,-0.879172625074628,0.6291208791208791,0.947457665482758,1.0,10/10,61.56%,CCDC39;CFAP43;DNAH11;CFAP298;ODAD2;CCDC40;CFAP206;DRC1;DNAAF1;CCDC65
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.386884546805488,0.8789708487948741,0.6184971098265896,0.9608586140638277,1.0,5/36,7.46%,UBXN1;MAP1A;SDCBP;GIPC1;UCHL5
prerank,P-body assembly (GO:0033962),0.4503537794972408,0.8787712065367812,0.6397608370702541,0.9607509609018641,1.0,5/12,18.02%,EIF4ENIF1;ATXN2;LSM14A;PATL1;RC3H1
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.3057417932749288,-0.8783965741188476,0.6286919831223629,0.9450646737354788,1.0,9/21,19.44%,PARP1;DDB1;ERCC5;XPA;RBX1;RPA1;DDB2;CUL4B;CHD1L
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.3057417932749288,-0.8783965741188476,0.6286919831223629,0.9450646737354788,1.0,9/21,19.44%,PARP1;DDB1;ERCC5;XPA;RBX1;RPA1;DDB2;CUL4B;CHD1L
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.45195741581665794,0.878304574889886,0.6466049382716049,0.9612052908700924,1.0,2/12,7.47%,SIRT7;NEDD4
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.3575025095834976,-0.8781367343167688,0.6190476190476191,0.943633415530433,1.0,4/13,25.90%,JAK2;IL33;TLR2;SELENOS
prerank,artery development (GO:0060840),0.411207143953024,0.8774487860621218,0.6367088607594936,0.9623300960311969,1.0,5/23,13.91%,NF1;NRP1;HECTD1;TGFBR1;PKD2
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.45457061099740925,0.8773801583445622,0.6466973886328725,0.9620004783912169,1.0,2/11,10.11%,RC3H2;SOCS5
prerank,protein catabolic process (GO:0030163),0.36634987473828956,0.8773021488408471,0.6615720524017468,0.9616745875501638,1.0,7/59,9.06%,FBXO17;USE1;UCHL3;RAB12;HSP90AA1;CLPX;CHEK2
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.39792790539036194,0.8772692439376258,0.6411837237977805,0.9612637412488928,1.0,4/24,10.93%,NRP1;SEMA6D;SEMA3D;SEMA6A
prerank,positive regulation of cell development (GO:0010720),0.39671603804388234,0.8771168200469626,0.6542168674698795,0.9610797432895073,1.0,5/31,14.18%,NUMBL;SPEN;RGS14;SOX11;RFX3
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.31400557643294763,-0.8770398787990125,0.5833333333333334,0.9441105502984479,1.0,11/19,60.36%,RIC3;CHRNA7;CHRFAM7A;SLC5A7;CHRNA4;ACHE;CHRNB2;COLQ;RAPSN;CHRNA5;NQO1
prerank,peptidyl-lysine modification (GO:0018205),0.3543087258695815,0.8769483286556095,0.7003089598352215,0.9609285343476504,1.0,17/99,12.45%,SIRT7;NNAT;NUP205;HDAC9;EP300;ATP7A;SUMO3;SUMO2;NUP98;TRPM4;NUP54;LOXL3;UBE2I;KAT2B;BCL11A;ESCO1;VIPAS39
prerank,positive regulation of protein localization to membrane (GO:1905477),0.3541604173559136,0.8766697359732614,0.6919875130072841,0.9609939796316771,1.0,22/98,17.22%,MIEF2;ITGB1BP1;EPHB2;YWHAE;SQSTM1;ZDHHC5;DLG1;MAPK8;STX3;SPTBN1;NMT1;PRNP;TP53;BCL2;FYN;PTPN9;PIK3R1;CD81;YWHAB;TFDP2;MFF;PRKCH
prerank,protein K63-linked deubiquitination (GO:0070536),-0.2724358632007657,-0.8765373673491655,0.6444444444444445,0.9432130909682506,1.0,11/31,18.46%,PSMD14;ZRANB1;OTUD4;OTUD5;BRCC3;ABRAXAS2;USP50;USP13;USP8;TNFAIP3;STAMBP
prerank,retinal metabolic process (GO:0042574),-0.36433249643788373,-0.8764461054393419,0.6321070234113713,0.9414102434020293,1.0,4/12,35.26%,BCO2;RDH10;RDH11;RDH13
prerank,melanocyte differentiation (GO:0030318),0.456142581666802,0.8764302963152193,0.6493108728943339,0.9609873889971624,1.0,2/11,11.31%,SLC24A5;LRMDA
prerank,regulation of rRNA processing (GO:2000232),0.42569891542841554,0.876335369488823,0.6163793103448276,0.960714920577953,1.0,3/16,11.91%,SIRT7;KAT2B;HEATR1
prerank,synaptic vesicle transport (GO:0048489),-0.3741001598622667,-0.8760933422732303,0.6390532544378699,0.9402780612347694,1.0,8/11,31.58%,DNM2;KIF5C;RAB27A;KIF5A;SYNJ1;TMEM230;TOR1A;SNAPIN
prerank,establishment of endothelial barrier (GO:0061028),0.3936154840156208,0.875740285293083,0.6372549019607843,0.9614158603174545,1.0,5/29,7.63%,RAPGEF1;MSN;RAP1A;EZR;RAP1B
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.36245534146565356,0.875569453439223,0.674892703862661,0.9612964159251861,1.0,13/67,14.25%,DDR1;DDR2;EPHB2;PDGFB;BTK;ABI1;LYN;IGF1R;ABL1;SYK;INSR;FYN;RELN
prerank,positive regulation of lipid kinase activity (GO:0090218),0.383787109409612,0.8755538946443259,0.6536180308422301,0.9608581876407473,1.0,4/29,5.54%,IRS1;PIK3R4;PDGFB;AMBRA1
prerank,response to hexose (GO:0009746),0.4022852992649081,0.8754415793419167,0.655940594059406,0.9606192885285258,1.0,4/25,12.47%,THBS1;IRS2;VAMP2;TCF7L2
prerank,tetrahydrofolate metabolic process (GO:0046653),0.45675815237349504,0.8752244158814715,0.6292307692307693,0.9605774950849826,1.0,2/10,6.57%,MTHFD2L;MTHFR
prerank,fatty acid elongation (GO:0030497),0.44122408806567337,0.8749557196677747,0.616361071932299,0.9606094146848998,1.0,4/13,14.15%,HACD1;TECR;ABCD1;HACD4
prerank,negative regulation of actin filament polymerization (GO:0030837),0.40769010273792755,0.8743814515396789,0.6454431960049938,0.9612430077340736,1.0,5/22,11.73%,ARFGEF1;SSH2;TWF2;CYRIB;TMSB4X
prerank,negative regulation of lipid metabolic process (GO:0045833),0.4040694385628535,0.8743611442461804,0.6380208333333334,0.9608261810426377,1.0,5/22,18.29%,PDE3B;NCOR1;ASXL3;APOD;ALK
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.351853684247137,0.874094530359578,0.7247983870967742,0.9608739096261523,1.0,25/158,14.00%,UNC5CL;RELA;CX3CL1;IRAK4;TMED4;RNF31;PLEKHG5;PELI1;FLNA;PRKCB;BIRC3;IKBKB;TAB3;MAVS;MTDH;CANT1;TFG;WLS;TRIM5;AKAP13;TRAF2;PPM1A;NDFIP1;S100B;LGALS9
prerank,bone development (GO:0060348),0.37938570847261904,0.8737227031087987,0.6383219954648526,0.9611194571440153,1.0,6/39,13.13%,SBDS;PLS3;LRP5;AKAP13;TP53;LRP6
prerank,negative regulation of insulin secretion (GO:0046676),0.42324687191563626,0.8735706698884684,0.6324900133155792,0.9609431197574769,1.0,2/17,4.54%,PSMD9;IRS1
prerank,supramolecular fiber organization (GO:0097435),0.34780749090596585,0.8732515332718462,0.827,0.9610854555610032,1.0,42/334,12.97%,COL14A1;CGNL1;CRTAP;DDR2;CD36;ADAMTS2;WDR73;RHOF;ITGA6;STMN2;TGFB2;NF1;TMOD1;TMOD3;ALDOA;TPM1;ATP7A;MYO5A;NCKAP5L;TUBGCP6;CAMSAP3;DCTN1;COL11A1;DLG1;MAPT;TUBGCP2;MYO1G;ITM2B;SHROOM3;LOXL3;FURIN;CD2AP;CDC42;PXDN;VPS4B;SORL1;P4HA1;RUFY3;ADAM10;PPP1R9A;ERMN;TGFBR1
prerank,regulation of execution phase of apoptosis (GO:1900117),-0.3706209946795507,-0.8727069552776194,0.653179190751445,0.9461458951985015,1.0,2/11,3.46%,BCL2L1;SIRT2
prerank,protein localization to cell junction (GO:1902414),0.40723862864129795,0.8722706157980803,0.649810366624526,0.9624373120680557,1.0,4/22,13.87%,CGNL1;PAK2;KIF3A;HEG1
prerank,cellular amino acid catabolic process (GO:0009063),0.3560949058556958,0.8722163447695039,0.7157676348547718,0.962087737689475,1.0,6/87,6.67%,CBS;ALDH6A1;ACAT1;ECHS1;MCCC2;ALDH7A1
prerank,early endosome to late endosome transport (GO:0045022),0.4176478940985364,0.8722074133543196,0.6543046357615894,0.9616429322735616,1.0,8/20,16.87%,EEA1;AKTIP;KIF16B;PTPN23;RAB7A;BECN1;STX8;HOOK2
prerank,cytoplasmic translation (GO:0002181),0.35356550986221447,0.8721580063377694,0.7067901234567902,0.961272837238564,1.0,10/91,5.94%,RPL18;RPS23;RPL41;RPL31;RPS17;RPL4;RPLP0;ETF1;RPS15A;RPL38
prerank,regulation of microtubule polymerization (GO:0031113),0.37597137590801044,0.8721095876400345,0.660092807424594,0.9608953766784645,1.0,12/40,16.23%,GBA2;STMN2;MAPRE1;AKAP9;CAMSAP3;DCTN1;MAPT;ABL1;EML2;CLASP1;CLIP1;PAK1
prerank,vitamin transport (GO:0051180),0.3952619520260492,0.8718062779098321,0.6658767772511849,0.9610031137281909,1.0,4/29,15.52%,SLC35F3;SLC25A32;SLC27A1;ABCG2
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.38704247175405254,0.8714432307555071,0.6619552414605419,0.9612085388725616,1.0,7/34,16.27%,LRRK2;RAB3GAP1;ARRB2;GABRG2;GRIN2A;GRID2;MEF2C
prerank,protein localization to centrosome (GO:0071539),0.4098025901344395,0.8712702161530878,0.6509695290858726,0.9610757605086646,1.0,6/17,17.19%,BBS4;SNX10;DCTN2;C2CD3;CEP83;PIBF1
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.3908555034169017,0.8712139614635633,0.6654366543665436,0.960722686131261,1.0,5/28,16.24%,BAG3;DELE1;BCL2;CASP8AP2;DEDD
prerank,proteolysis (GO:0006508),0.34683820308395547,0.8711847583595279,0.8038038038038038,0.9603285745873272,1.0,29/252,13.24%,TYSND1;ADAMTS12;VASH2;NLN;CPD;CTSC;DESI1;DESI2;FBXO3;CPE;FOLH1;SPPL3;DPP3;CLPX;LNPEP;LRP8;PROC;F3;CTSZ;FURIN;CAPN2;UBE3A;PARL;XPNPEP1;ERAP1;ADAM10;ATG4C;NAPSA;PCSK6
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.3816021598663517,-0.8711300857831976,0.6325966850828729,0.9478423574602735,1.0,6/10,19.94%,MTMR2;ABCA3;MTMR3;DNAJC19;MTMR4;MTMR9
prerank,cation transport (GO:0006812),-0.19479336798384808,-0.870908765081221,0.8888888888888888,0.9463435425823586,1.0,24/167,14.79%,ANO6;KCNN2;SGK1;SCN2A;KCNAB1;ATP1B1;SLC36A1;CLN3;SCN3A;SCN8A;SLC8B1;ATP1A2;KCNJ2;CHP1;KCND3;SLC38A7;ANO10;SLC7A6;SLC11A2;SLC36A4;KCNK6;SLC3A2;SLC7A1;KCNMA1
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.38085196077212574,0.8707786448917064,0.6378048780487805,0.9606651931971599,1.0,6/32,13.10%,ITGB1BP1;THBS1;HDAC9;HDAC5;MAP2K5;PIK3C2A
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.3775876127986903,0.8705788682144282,0.6462984723854289,0.9605761732923579,1.0,12/36,17.03%,SYS1;KIF13A;GOLPH3;SPTBN1;VAMP2;GGA1;OPTN;RAB7A;MACF1;GGA3;GOLGA4;GCC2
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.37448646307617944,-0.8701060607336195,0.6277173913043478,0.9461409021045413,1.0,6/11,13.71%,GIGYF1;GHR;EIF2AK3;GIGYF2;IGF1;AKT1
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.45125317195126174,0.8700819688442487,0.6439393939393939,0.961071839726644,1.0,2/10,10.97%,RC3H2;NFKBIZ
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.3759405141990896,0.8698938556431565,0.6406429391504018,0.9609755103242523,1.0,7/36,14.75%,NOSTRIN;TERF2;IL1A;HSP90AA1;NUS1;CALM1;WASL
prerank,regulation of protein localization to centrosome (GO:1904779),0.4712420571211078,0.8697984865324214,0.660377358490566,0.9606959448578707,1.0,3/10,13.76%,CEP250;APC;BICD1
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.3974964213260078,0.8697062969525857,0.6477987421383647,0.9603979340957806,1.0,6/25,14.80%,EAF1;EAPP;NELFA;ZMYND11;RECQL5;LDB1
prerank,regulation of gluconeogenesis (GO:0006111),0.39597144019058683,0.8696874161668927,0.6404907975460122,0.9599803375143623,1.0,2/27,5.03%,SIRT7;EP300
prerank,acylglycerol catabolic process (GO:0046464),0.3812758379400579,0.8688213214430126,0.65311004784689,0.9611273627417464,1.0,3/30,10.19%,LIPE;ABHD6;ABHD16A
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.376641608583739,0.8687859032333439,0.6458333333333334,0.9607399935311438,1.0,5/39,9.16%,CACNA1D;YWHAE;NEDD4;GPD1L;PTPN3
prerank,positive regulation of endocytosis (GO:0045807),0.3701935985702074,0.8687570598735296,0.6740088105726872,0.9603448479695808,1.0,12/45,15.62%,LDLRAP1;SMPD1;AXL;CBLL1;DAB2;CDC42;CBL;ANKFY1;GPC3;BICD1;HIP1;HNRNPK
prerank,neural crest cell development (GO:0014032),0.3671231316921657,0.8683234415810133,0.6677704194260485,0.9606602611754358,1.0,6/44,11.42%,TAPT1;PEF1;SEMA6D;SEMA3D;SEMA6A;SOX11
prerank,regulation of lipid storage (GO:0010883),0.4051600330892825,0.8678981388098136,0.6384615384615384,0.9610021660740582,1.0,2/22,5.34%,FBXW7;FTO
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.35590452748010165,0.8678883899246086,0.6992639327024185,0.9605711157440244,1.0,14/80,13.81%,UACA;DELE1;GAS6;IGBP1;THBS1;YWHAE;DAPK1;FNIP1;CD44;MAP2K5;HMGB1;RAF1;SYK;HTRA2
prerank,dendrite self-avoidance (GO:0070593),-0.3395456361134388,-0.8676407490315073,0.6311787072243346,0.9496509500305649,1.0,5/16,17.90%,CNTN6;DSCAML1;CNTN2;EMB;BSG
prerank,anterograde trans-synaptic signaling (GO:0098916),0.34775740935072386,0.8674581783796947,0.8,0.9609160877478407,1.0,32/224,14.58%,CAMKK1;PCDHB16;MINK1;GAD2;PRKAR2A;AKAP9;PRKACA;MAPK1;SDCBP;CEL;GIPC1;DLG1;PDE7B;APBA1;GRIA4;GLRB;CDK5;CACNA1A;RIT2;GABRG2;GRM7;EXOC4;GLRA3;SLC12A6;AMPH;LRP6;SPG11;CAMKK2;ATXN3;CALM1;GRIN2A;PLP1
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.38237032087338446,0.8674278545237677,0.6710369487485102,0.9605299038996775,1.0,5/35,10.44%,SCAI;TGFB2;EPHB2;MAPKAP1;ARHGAP35
prerank,cellular protein metabolic process (GO:0044267),0.34337230337467084,0.8668378120502488,0.854,0.9611720213740068,1.0,55/396,13.92%,WFS1;CP;RPL18;D2HGDH;IGFBP3;VWA1;RPS6KB2;ST8SIA4;RPS23;MRPL37;RPL41;RPL31;IGFBP2;SEPHS1;RPS17;GGCX;GAS6;RPL4;RAB12;CPE;SCG3;MRPS21;QSOX1;RPLP0;YES1;PRKDC;HARS1;RPS15A;RPL38;SPPL3;DHPS;PABPC4;AGO2;CHEK2;FBXO11;PROC;PARP4;FURIN;UBE2I;SDC2;MIA3;ATG3;LAMC1;ABL1;RPL21;RPS6;PARL;PRKCSH;ADAM10;DUSP12;NAPSA;GPC3;FN1;HTRA2;SPARCL1
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.3559245258214956,-0.8665635186537428,0.6298507462686567,0.950251949156569,1.0,5/12,19.38%,CNOT1;ASXL1;CALR;SNW1;CTBP2
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.3927697000811123,0.8664795611536329,0.6487148102815178,0.9613573142027704,1.0,6/29,13.81%,THBS1;PAK2;TRAF2;CYLD;WWOX;HTRA2
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.34902151305314344,0.866333508835307,0.7238193018480493,0.9611732361632629,1.0,19/105,13.79%,NRAS;RELA;PSMD9;PSMB8;EP300;PRKACA;PSMC5;IKBKB;PAK2;RPS6KA5;KRAS;TAB3;LYN;FBXW11;RAF1;PSMD12;PSMA2;SYK;FYN
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.3490302014334082,0.8661991762470024,0.7297019527235354,0.9605201388696104,1.0,19/104,13.79%,NRAS;RELA;PSMD9;PSMB8;EP300;PRKACA;PSMC5;IKBKB;PAK2;RPS6KA5;KRAS;TAB3;LYN;FBXW11;RAF1;PSMD12;PSMA2;SYK;FYN
prerank,cellular response to lectin (GO:1990858),0.3490302014334082,0.8661991762470024,0.7297019527235354,0.9605201388696104,1.0,19/104,13.79%,NRAS;RELA;PSMD9;PSMB8;EP300;PRKACA;PSMC5;IKBKB;PAK2;RPS6KA5;KRAS;TAB3;LYN;FBXW11;RAF1;PSMD12;PSMA2;SYK;FYN
prerank,membrane organization (GO:0061024),0.344806068853387,0.8661112426816181,0.805,0.9602347733787746,1.0,59/227,17.09%,ACTR3;LDLRAP1;VAMP7;VPS4A;GRB2;CHMP5;NAPG;ITSN1;FNBP1;MTCH1;VAMP3;AREG;MYOF;RABEP1;STON2;FNBP1L;ARRB2;PACSIN2;AP2A1;CTDNEP1;ARPC1A;ARPC4;LEMD2;REPS2;SNX3;SPTBN1;DAB2;VAMP2;HGS;REPS1;ARPC2;CBL;VPS4B;OCRL;TGFA;SH3GLB1;AMPH;PIK3C2A;NAPA;PDCD6IP;SAR1B;EPS15;ARPC3;CLTC;WASL;SCARB2;HIP1;SYNJ2;SH3KBP1;SH3GL2;OSBPL2;VAPB;EPN2;ACTG1;DNM1L;HACE1;NUP93;SNX9;CHRM2
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.42265375373942476,0.8659887986118029,0.6507936507936508,0.9600139487865125,1.0,4/18,12.01%,SP1;ITGA4;PPARG;HMGB1
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.40827297336041296,0.8659022900342264,0.6495507060333762,0.9597224224435686,1.0,5/22,14.79%,MAN1B1;UGGT2;EDEM2;UGGT1;MAN1A2
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.3833322244050449,-0.8656760823623334,0.6620111731843575,0.9501436463955669,1.0,3/10,6.20%,APP;SYNGR1;RAB5A
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.41028254196709524,0.8656579937237247,0.6448230668414154,0.9597056276395843,1.0,5/20,14.79%,SLC9A1;PRKACA;CAMK2D;CALM1;CACNA1C
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.40447468614872056,0.8656266394455636,0.6210526315789474,0.9593103933921416,1.0,4/19,14.48%,SLC35D1;UGDH;UGP2;UAP1
prerank,regulation of cell size (GO:0008361),0.3971074766558895,0.8650638073457495,0.6406052963430012,0.9598840352218047,1.0,9/23,16.52%,MSN;VAV3;EZR;MTOR;VAV2;LARS1;PTEN;VAV1;RDX
prerank,regulation of cellular biosynthetic process (GO:0031326),0.3889136830820502,0.8648116757031976,0.6586599241466498,0.9598980639679305,1.0,1/28,0.30%,EIF6
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.39436728716160513,0.8647704579920902,0.643312101910828,0.9595265556560392,1.0,5/24,13.60%,DYRK2;IRS1;IRS2;GCK;INSR
prerank,response to gamma radiation (GO:0010332),0.39385612722672014,0.8645758231199784,0.6369346733668342,0.9594292151609722,1.0,3/24,5.83%,TMEM109;WRN;MAP3K20
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.4265821055142091,0.8644299134497728,0.6384839650145773,0.959261288023887,1.0,2/14,7.80%,CX3CL1;SYT11
prerank,zymogen activation (GO:0031638),0.3760132290626333,0.8643081697835847,0.6578341013824884,0.9590389926682952,1.0,9/39,18.86%,CD5L;FURIN;CYFIP2;TBC1D10A;GRIN2A;LGMN;KLK2;CTSH;ASPH
prerank,response to UV (GO:0009411),0.3454590810921034,0.8640143430776773,0.7120901639344263,0.9591154620460256,1.0,18/95,15.57%,PCLAF;RELA;SMPD1;WRN;EP300;UBE2A;METTL3;USP1;NEDD4;MAPK8;ERCC4;NOC2L;TP53;EIF2S1;UVSSA;NPM1;SDF4;RHBDD1
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.3828355352150513,0.8636692338715155,0.6495828367103695,0.959293702303406,1.0,7/34,13.73%,FLNA;NRP1;DOCK1;LIMS1;CDC42;ABL1;RREB1
prerank,negative regulation of endopeptidase activity (GO:0010951),-0.24047605327772265,-0.8635213433845653,0.7608695652173914,0.952910417572828,1.0,11/47,29.56%,TIMP2;SERPINE2;SERPINA2;AKT1;SPOCK1;SPOCK2;TIMP3;RECK;GAPDH;SERPINB8;SERPINE1
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.42427783387418205,0.8634615148357616,0.6515151515151515,0.9592137399203826,1.0,2/16,11.10%,STX7;CYRIB
prerank,negative regulation of protein depolymerization (GO:1901880),0.40211661843163704,0.8634462481247565,0.6566791510611736,0.9587983216759605,1.0,7/24,15.10%,STMN2;ATXN7;CAMSAP3;APC;TAOK1;LIMA1;CLASP1
prerank,positive regulation of response to stimulus (GO:0048584),0.364247088018699,0.8631663889243327,0.6625,0.9588227281353464,1.0,4/40,9.31%,SELENON;TGFB2;FXR2;MAVS
prerank,protein maturation (GO:0051604),0.3530779509412886,0.8631254452637496,0.7133956386292835,0.9584475909975962,1.0,14/95,13.24%,TYSND1;CPD;NNAT;NAA35;CPE;NFU1;GLRX3;F3;FURIN;NAA16;SORL1;ADAM10;NAA15;PCSK6
prerank,sphingolipid metabolic process (GO:0006665),0.3492648962327626,0.8630456624802332,0.7053388090349076,0.9581484148459162,1.0,21/108,14.77%,DEGS1;GBA2;SGPP1;SMPD3;HACD1;SMPD1;CERS6;SGPP2;ACER3;TECR;PDXDC1;CERS4;GALC;ASAH1;SERINC1;B3GALNT1;SGPL1;CERS5;PRKD2;HACD4;SPTLC1
prerank,positive regulation of hormone secretion (GO:0046887),0.41627382924015366,0.862918642373113,0.650472334682861,0.9579255666940147,1.0,2/17,11.42%,VAMP7;SOX11
prerank,chromatin disassembly (GO:0031498),0.43114909829492787,0.8628333881402518,0.6377410468319559,0.9572091268627907,1.0,2/14,8.22%,SMARCA4;SET
prerank,nucleosome disassembly (GO:0006337),0.43114909829492787,0.8628333881402518,0.6377410468319559,0.9572091268627907,1.0,2/14,8.22%,SMARCA4;SET
prerank,regulation of stem cell proliferation (GO:0072091),0.4146182832323955,0.8623966029644928,0.6419753086419753,0.957547417843474,1.0,3/17,12.05%,EIF2AK2;SOX11;ZFP36L1
prerank,positive regulation of catalytic activity (GO:0043085),0.3711061596362113,0.8622940685093297,0.6601382488479263,0.9572922536033893,1.0,7/37,12.55%,SSBP1;XRCC4;WRN;ATP7A;MAPK8;ABL1;MAPK14
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.44741444498908184,0.8621954796346039,0.6486902927580893,0.9570293130058827,1.0,1/11,6.07%,ARRB2
prerank,positive regulation of protein metabolic process (GO:0051247),0.34732722791661297,0.8619446157088647,0.7415730337078652,0.9570445414775898,1.0,18/110,15.14%,ISL1;WFS1;EGLN2;NEDD4;MAPK8;RANBP9;HECW1;IL18;AREL1;APC;PAEP;MAP2K5;SORL1;GPC3;ROCK2;RAB7A;LDB1;ATG7
prerank,"phagocytosis, engulfment (GO:0006911)",0.37632190517281283,0.8618196619591825,0.6577726218097448,0.9568238625780624,1.0,10/36,17.40%,CD36;VAMP7;THBS1;DOCK1;CDC42;ELMO1;AIF1;XKR4;GSN;FCGR1A
prerank,cellular response to dsRNA (GO:0071359),0.41758802513850124,0.8617855727553604,0.6390041493775933,0.9564353727430267,1.0,3/15,10.41%,RIOK3;MAVS;COLEC12
prerank,positive regulation of neuron differentiation (GO:0045666),-0.26062098668771927,-0.8617685385172804,0.736,0.954666965382223,1.0,4/40,1.49%,RHOA;ARHGEF2;BRINP1;NRCAM
prerank,non-motile cilium assembly (GO:1905515),0.37590324376442685,0.8613676513839518,0.6556372549019608,0.9567011125109559,1.0,6/30,13.68%,CEP89;BBS4;CEP250;DCTN1;RPGRIP1L;C2CD3
prerank,positive regulation of DNA repair (GO:0045739),0.36253177819825577,0.8612485409725483,0.6700680272108843,0.9564790155402023,1.0,8/46,13.05%,BRCA1;EYA2;FAM168A;SLF1;BABAM2;SMCHD1;HMGB1;FMN2
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.44993762763401085,0.8611280804305672,0.6521739130434783,0.9562547729971815,1.0,2/10,11.20%,LRP5;TGFBR2
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.3740787349417074,-0.8610512305558228,0.6482558139534884,0.9542578177444763,1.0,5/11,21.41%,CORO1C;ENPP2;ARHGEF7;SRC;KANK1
prerank,regulation of protein autophosphorylation (GO:0031952),0.3800341274658027,0.8610065698933053,0.6869965477560415,0.9560213414026136,1.0,9/36,15.90%,RAD50;IMPACT;PDGFB;MRE11;NBN;MVP;PPP2R5C;CALM1;PDGFC
prerank,axonemal dynein complex assembly (GO:0070286),0.3861406821531595,0.8605866168509488,0.671267252195734,0.9563219989522627,1.0,2/28,10.04%,SPAG1;DNAI4
prerank,amide transport (GO:0042886),-0.27774971751065936,-0.860428851581401,0.6810810810810811,0.9536154642952936,1.0,7/26,17.06%,CERT1;DISP1;PLEKHA8;PLEKHA3;GLTP;PLTP;TAP2
prerank,organic substance transport (GO:0071702),0.3455402595312157,0.8600239193937156,0.7335390946502057,0.956854699139429,1.0,26/121,17.01%,SLCO1B1;HIKESHI;SLC35F3;SCAMP1;ABCD2;TAP1;ABCA7;ABCG1;VAMP2;ABCD3;MIA3;KIF3A;RAMP1;SCAMP5;ABCA1;ABCD1;FLVCR1;CALCRL;CHKA;SLCO2B1;RAB7A;ABCA5;ABCG2;ARL6IP5;CEP290;SCAMP2
prerank,negative regulation of secretion by cell (GO:1903531),-0.245717882138071,-0.85985768951296,0.7183098591549296,0.9528944808673284,1.0,8/38,15.96%,IL1RAPL1;STXBP6;SNCA;RHBDF2;LILRB1;SYT4;NOTCH1;HMGCR
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.45322853684479025,0.8596992437620786,0.656298600311042,0.9569792487721842,1.0,1/10,7.73%,FERMT3
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.38718474536778597,0.8596267890392554,0.6670716889428918,0.956662917866751,1.0,7/25,16.86%,PGAM1;ALDOA;ENO1;GCK;PFKP;FOXK1;HK2
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.3968404876214228,0.8595740594336085,0.6545682102628285,0.956320630805193,1.0,4/23,8.72%,ACSBG1;HACD1;FAR1;TECR
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.3484268857121787,0.8591380537101394,0.7162303664921466,0.9566794891149134,1.0,14/80,13.23%,USE1;ERGIC1;ARF3;COPB2;COG3;TMED9;KDELR2;GOLPH3;KIF11;RAB6A;KIF3A;TMED2;UVRAG;NAPA
prerank,myotube differentiation (GO:0014902),0.4100612412953165,0.8589500392848359,0.6630727762803235,0.9565683581819665,1.0,4/17,16.27%,ADAM12;ADGRB3;MYEF2;MEF2C
prerank,nuclear export (GO:0051168),0.35705845009723863,0.8588661325908162,0.7170010559662091,0.9562799415063065,1.0,14/80,12.67%,EIF4A3;PHAX;DESI1;DHX38;SARNP;ATXN1;RNPS1;U2AF1;THOC5;SRSF5;CSE1L;U2AF2;SRSF9;SRSF11
prerank,camera-type eye morphogenesis (GO:0048593),0.4515936770076017,0.8587117115356533,0.6454689984101749,0.956119037822993,1.0,2/10,13.13%,NF1;LRP6
prerank,regulation of chemokine production (GO:0032642),0.37642160571135913,0.8582463316811676,0.6717289719626168,0.9564768638334609,1.0,7/36,14.85%,EIF2AK2;TLR7;TLR3;IL18;LGALS9;AIF1;TLR4
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.3516677289121367,0.8575180264766892,0.7049525816649105,0.957312511358595,1.0,18/72,16.83%,RNF31;RUNX1;GAS6;LIFR;AXL;BIRC3;IKBKB;PTPN1;IRAK2;TRAF2;IFNAR2;TRIM44;CYLD;SYK;PIAS1;CFLAR;ABCE1;HIPK1
prerank,phospholipid biosynthetic process (GO:0008654),0.37398070132251315,0.8574952936421897,0.6674259681093394,0.9569149606403076,1.0,8/36,13.50%,FAR1;CRLS1;HDHD5;GPAM;FADS1;AGPAT4;AGPAT5;NUS1
prerank,ventricular septum morphogenesis (GO:0060412),0.3835570065625745,0.8573617477581649,0.6334563345633456,0.9566994252217215,1.0,7/27,15.19%,TGFB2;BMPR1A;ACVR1;TGFBR2;SOX11;TGFBR1;SMAD4
prerank,positive regulation of interleukin-4 production (GO:0032753),0.41095361964276567,0.857258473572523,0.6580027359781122,0.9564341436060416,1.0,4/17,14.64%,PRKCZ;SYK;LGALS9;HAVCR2
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.37492692342350753,-0.8571553758101199,0.6538461538461539,0.9567287343873965,1.0,5/11,22.41%,PPIP5K1;IP6K2;FGF2;IPPK;ITPKB
prerank,smooth muscle contraction (GO:0006939),0.4289862529605777,0.8568416497852752,0.6493688639551192,0.9567410884602944,1.0,4/14,18.14%,PIK3C2A;ROCK2;TPCN2;ROCK1
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.38243055121781266,0.8564732686263928,0.6549210206561361,0.9569353670937665,1.0,4/30,14.23%,ARHGEF3;GPR65;AKAP13;LPAR6
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.46202424684762333,0.8561573563445858,0.6666666666666666,0.9570353123574864,1.0,3/10,17.29%,RUNX1;HMGB1;NCKAP1L
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.36880234360127173,0.8561030098238094,0.6498237367802585,0.9566995436148567,1.0,8/38,15.45%,CD36;SMAD3;HSP90AA1;INSR;PKD2;ROCK2;TLR4;CD47
prerank,centromere complex assembly (GO:0034508),-0.25893656307887813,-0.8557727970810786,0.6666666666666666,0.9578022504181736,1.0,8/36,15.51%,SMARCA5;POGZ;RBBP4;HJURP;NASP;CENPV;CENPO;ITGB3BP
prerank,positive regulation of microtubule polymerization (GO:0031116),0.3792573629260485,0.8551264577175121,0.6552147239263804,0.9580019283107101,1.0,5/28,7.80%,MAPRE1;AKAP9;DCTN1;MAPT;MECP2
prerank,proteoglycan biosynthetic process (GO:0030166),0.3795227755877943,0.8550851924035301,0.6670506912442397,0.9576399581281575,1.0,6/31,11.86%,NDST3;UGDH;GLCE;EXTL3;CANT1;CHST8
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.3120145667595392,-0.8550220721461234,0.622568093385214,0.9574735277444518,1.0,7/18,20.05%,NXF1;POLDIP3;ENY2;MCM3AP;DDX19B;NUP133;DDX19A
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.3589353704185575,0.8545015928785149,0.6959385290889133,0.9582102540481986,1.0,7/52,8.18%,EPHB2;SQSTM1;ZDHHC5;DLG1;EPB41;STX3;SPTBN1
prerank,protein polymerization (GO:0051258),0.35871437049067967,0.854331654109754,0.6787280701754386,0.9580591900741033,1.0,10/56,14.75%,ANG;ARL6;WASF1;GPX4;MAPT;DIAPH1;WASHC5;RNF135;AIF1;WASL
prerank,positive regulation of cell growth (GO:0030307),0.3458460466733146,0.8542856080786343,0.7195876288659794,0.9577023363541917,1.0,17/96,13.04%,CPNE5;ZFYVE27;DDX49;TGFB2;SDCBP;MAPT;TWF2;ADNP2;PLAA;RNF157;CDC42;DBNL;CDKL5;RUFY3;ADAM10;TGFBR1;BCL2
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.36389149952209154,0.854095342436479,0.6711864406779661,0.957591134773228,1.0,6/45,10.54%,MID1;IRF1;IRF3;CAMK2D;CD44;TRIM5
prerank,response to exogenous dsRNA (GO:0043330),0.4064823361873815,0.8540159658394207,0.6595744680851063,0.9572928712642241,1.0,4/18,10.41%,RFTN1;TLR3;MAVS;COLEC12
prerank,negative regulation of protein ubiquitination (GO:0031397),0.359456584767871,0.8537442897772397,0.6840354767184036,0.9573393250953727,1.0,8/50,12.11%,SIRT7;UBXN1;SQSTM1;ARRB2;NXN;U2AF2;ABL1;CAMLG
prerank,response to muramyl dipeptide (GO:0032495),-0.34826704393429764,-0.8534970610996422,0.6785714285714286,0.9588335953928441,1.0,6/12,21.34%,ARHGEF2;IRF5;TRIM41;VIM;NOD1;PTPN22
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.43716971104988356,0.8534755746440493,0.6842857142857143,0.9573648566194753,1.0,1/13,2.01%,DAND5
prerank,mitotic recombination (GO:0006312),0.4214413604160811,0.8533756269343317,0.6528150134048257,0.9571000312198653,1.0,2/15,7.92%,RAD50;SMC5
prerank,sensory perception of sound (GO:0007605),0.3445318667335101,0.8531391767257606,0.733402489626556,0.9570843893952988,1.0,8/88,12.48%,WFS1;HOMER2;CACNA1D;ALDH7A1;COL11A1;GRM7;WDR1;EML2
prerank,visual system development (GO:0150063),0.3709567671210403,0.8530985863760169,0.6658986175115207,0.956713819379508,1.0,10/37,18.35%,TGFB2;SIPA1L3;RAB18;ATF6;HIPK2;SMG9;HIPK1;PBX3;MEIS1;MEIS2
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.44336066977943167,0.8530924216895774,0.6333830104321908,0.9562954165643457,1.0,3/11,12.96%,CABIN1;ASF1A;ATRX
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.35464259820676886,0.8527031292443938,0.6990077177508269,0.9565315431540912,1.0,10/59,10.87%,RELA;RNF31;TLR7;BIRC3;IKBKB;TLR3;IRAK2;TAB3;TANK;TRAF2
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.3198317048075474,-0.8525479639975684,0.6484375,0.9589681372542612,1.0,3/18,1.30%,NAV3;PTPRC;LAPTM5
prerank,oligosaccharide biosynthetic process (GO:0009312),0.39733152373500913,0.8524730559994302,0.6653386454183267,0.9564837952165991,1.0,8/20,19.07%,MPDU1;B4GALT1;B3GALT1;ST3GAL2;ST3GAL4;B3GALT5;ST3GAL3;FUT8
prerank,phosphatidylinositol metabolic process (GO:0046488),0.3439458452217648,0.8523797922685057,0.7446153846153846,0.9562131499933809,1.0,24/109,15.88%,MTMR11;ARF3;MTMR1;PIP4K2A;PIK3R4;INPP4A;PITPNM1;PI4KA;PLA2G4A;PI4K2A;CDS1;PIP4K2B;LCLAT1;FIG4;ARF1;OCRL;SLC27A1;PIK3C2A;PTEN;SYNJ2;MTM1;PGAP1;PIK3R1;INPP5F
prerank,apoptotic process (GO:0006915),0.3392236357847001,0.8523626770946823,0.8132530120481928,0.9558109876713311,1.0,32/203,13.79%,MRPS30;IRF1;TRPC5;ADAM15;NDUFS1;TNFRSF25;BCL2L11;IRF3;APAF1;EP300;AKAP1;PRUNE2;TRAF7;DPF2;EGLN3;IL1A;STK11;DAPK1;CDK5;BNIP3;SEMA6A;PAEP;NOTCH2;TGFBR2;MTOR;CYFIP2;MAGI3;RAF1;AIFM1;BCL2;RTN4;ELMO1
prerank,transepithelial transport (GO:0070633),-0.33076257937463194,-0.852152689936007,0.6204379562043796,0.957890273687597,1.0,5/15,33.56%,SLC1A2;SLC1A1;SLC12A2;CXADR;GPLD1
prerank,smooth muscle tissue development (GO:0048745),0.4535711735625975,0.8519609351919651,0.6631259484066768,0.9560542999961714,1.0,1/10,4.01%,NF1
prerank,dicarboxylic acid metabolic process (GO:0043648),0.36184705360098346,0.8516556500649085,0.6954595791805094,0.9561745256280086,1.0,7/52,12.20%,D2HGDH;ALDH1L1;MTHFD2L;MTHFR;SDHA;IDH2;SLC25A32
prerank,endochondral bone morphogenesis (GO:0060350),-0.3686179618349863,-0.8516453462640914,0.6666666666666666,0.9570217895608137,1.0,2/11,10.68%,BMPR2;INPPL1
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.35302072012459773,0.8514770725223951,0.6843853820598007,0.956057330777772,1.0,8/53,13.71%,BRCA1;EYA2;SPRED2;BABAM2;FXR2;SMCHD1;SPRED1;DDX5
prerank,embryonic digit morphogenesis (GO:0042733),-0.3059870646690871,-0.8512498206429946,0.6173913043478261,0.9559225259766794,1.0,7/18,27.68%,WDPCP;SALL1;HDAC1;CREBBP;ECE1;INTU;GLI3
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.4198544992646534,0.851112985548519,0.6743554952510177,0.9562498999934991,1.0,3/16,15.92%,RAET1E;SLAMF6;LAMP1
prerank,ganglioside biosynthetic process (GO:0001574),0.41591685065014317,0.8508467445159252,0.6619718309859155,0.9562573223396725,1.0,4/15,17.11%,ST8SIA4;B4GALT5;ST3GAL5;ST3GAL2
prerank,positive regulation of binding (GO:0051099),0.34755744073283057,0.8506362333932709,0.7233820459290188,0.9561633023397704,1.0,15/84,14.13%,LRRK2;PARP9;NMD3;AKTIP;SPPL3;USP33;EPB41;ADD1;PPARG;HMBOX1;DERL1;HMGB1;TCF7L2;HIPK2;NVL
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.41539177724121107,0.8503212811444605,0.6853333333333333,0.9562334344396328,1.0,3/17,15.92%,RAET1E;SLAMF6;LAMP1
prerank,in utero embryonic development (GO:0001701),0.38684554952432604,0.8502308767589829,0.6670792079207921,0.9559543265301995,1.0,5/25,12.97%,MBNL1;CHD7;ZNF568;ADAM10;TGFBR1
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.4376997632900693,0.8500485288003253,0.6613924050632911,0.9558205112313947,1.0,2/10,6.71%,IRS1;IRS2
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.36168917395990696,0.8499698465680089,0.683371298405467,0.9555280335610268,1.0,9/46,13.00%,GPD1L;GPAM;PLA2G4A;LCLAT1;DGKD;AGPAT4;PLD1;SLC27A1;AGPAT5
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.4390238141676467,0.8498345165200528,0.6891117478510028,0.9553121847671152,1.0,2/12,5.17%,TPM1;PDGFB
prerank,negative regulation of secretion (GO:0051048),0.45693597396090996,0.8497209766237024,0.662015503875969,0.9550836551255467,1.0,1/10,4.13%,VAMP3
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.38361836372410163,0.8495219148145746,0.6800976800976801,0.9550042477282153,1.0,7/27,15.70%,CGNL1;PPFIA1;PAK2;WASF2;TMEFF2;CLASP1;PIK3R1
prerank,endosome organization (GO:0007032),0.3626898271812133,0.849326906300262,0.6583427922814983,0.9549203176144697,1.0,10/41,16.87%,EEA1;AKTIP;SQSTM1;SNX10;SNX3;PI4K2A;VPS11;WASHC5;DNAJC13;HOOK2
prerank,regulation of T cell proliferation (GO:0042129),-0.22904184671431252,-0.8487816780591723,0.7866666666666666,0.9593300946047946,1.0,12/61,20.11%,CD86;PTPRC;NCK2;CCDC88B;CD274;CD46;TNFSF8;LILRB1;SLC7A1;CD80;DLG5;CEBPB
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.3460899109692685,0.8481063591844958,0.7321613236814891,0.9565869566610559,1.0,9/87,5.94%,RPL18;RPS23;RPL41;RPL31;RPS17;RPL4;RPLP0;RPS15A;RPL38
prerank,regulation of viral release from host cell (GO:1902186),0.38826161787480734,0.8480089514972432,0.6640926640926641,0.9563422000070527,1.0,2/21,2.78%,TSG101;VPS4A
prerank,embryonic organ development (GO:0048568),0.3557633197470325,0.8478448840881319,0.7158469945355191,0.9561976801919805,1.0,12/61,17.49%,TGFB2;BMPR1A;KITLG;TEAD1;TAL1;TGFBR2;SH2B3;NDRG4;RBPJ;TBC1D23;PCSK5;PBX3
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.32808011336667475,-0.8478346710129655,0.6729323308270677,0.9593974408202336,1.0,4/16,3.61%,CDK13;DHX9;RSRC1;CELF4
prerank,small GTPase mediated signal transduction (GO:0007264),0.34340406648162564,0.8477207652180253,0.7405128205128205,0.9559854191135971,1.0,27/103,17.18%,NRAS;GRB2;NF1;RERG;RASSF1;JUN;CDK2;G3BP2;RAPGEF5;ARHGAP1;KRAS;RIT2;RAB18;PLD1;MAPK14;ARHGAP32;TP53;RREB1;SHOC2;GNB1;ARHGAP31;G3BP1;RRAS2;RB1;RIN2;RALBP1;RAPGEF2
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.2934211168282439,-0.847555844423668,0.6502463054187192,0.958093026943911,1.0,6/23,10.40%,SLIT2;MCU;RAC1;RIPOR2;MOSPD2;JAM3
prerank,glycosaminoglycan metabolic process (GO:0030203),-0.23106690475289715,-0.8468795541220693,0.8072289156626506,0.9576405693967377,1.0,19/54,22.64%,HEXA;GUSB;GCNT2;HS6ST1;NDST1;XYLT1;HS3ST5;HPSE;HGSNAT;SDC3;NDST2;NAGLU;IDS;HS3ST1;B3GAT3;SLC35D2;CHST9;IDUA;GPC5
prerank,vascular transport (GO:0010232),0.3457404817225595,0.8465405843739152,0.7309697601668405,0.9575005320885225,1.0,11/81,15.52%,SLC4A3;SLC2A3;SLC7A2;SLC38A2;ABCC5;SLC7A8;SLC27A1;INSR;SLCO2B1;SLC44A1;ABCG2
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.4447293228698293,0.8464739018165933,0.6552287581699346,0.9571792893082011,1.0,1/10,1.70%,RIOK3
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.36661148093152557,0.845696747224726,0.7104677060133631,0.9580417319308068,1.0,4/44,7.78%,INSIG1;OSBP;INSIG2;PSAT1
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.30800322475015307,-0.8455672688473592,0.6779661016949152,0.9585540526061792,1.0,4/19,8.56%,MCU;RAC1;RIPOR2;MOSPD2
prerank,regulation of fat cell differentiation (GO:0045598),0.35150610864200854,0.8452718861529928,0.7510416666666667,0.958342638461317,1.0,12/74,14.37%,RORA;SMAD3;FTO;LRP5;CMKLR1;ALOX5;TRPM4;CDS1;PPARG;ZFP36L1;CREB1;PPARD
prerank,embryonic axis specification (GO:0000578),0.41742923111182384,0.8447605035797888,0.6638655462184874,0.9587901525492681,1.0,2/15,11.94%,SMAD6;TASOR
prerank,regulation of lymphocyte migration (GO:2000401),0.451451586831369,0.84462265964604,0.6904761904761905,0.9585777584483792,1.0,3/10,14.75%,MSN;MIA3;WASL
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.4122818033404497,0.844417875259217,0.6680731364275668,0.9584802994366736,1.0,15/15,58.81%,NCOA3;PRKCH;MED1;CYP27B1;VDR;KDF1;SULT2B1;TRIM16;SFN;SFRP4;BMP4;NME2;FOXC1;ETV4;NUMA1
prerank,melanosome organization (GO:0032438),0.38859149059795506,0.8443627318070365,0.6628787878787878,0.9581466859713131,1.0,4/26,10.76%,AP1M1;KIF13A;DTNBP1;HPS4
prerank,positive regulation of neuron death (GO:1901216),0.3629497057285739,0.8437254982887854,0.7070135746606335,0.9587784682792947,1.0,10/46,14.85%,NUPR1;TGFB2;NF1;MAPT;CDK5;PRNP;SRPK2;EIF2S1;FYN;TLR4
prerank,positive regulation of double-strand break repair (GO:2000781),0.3624697410959604,0.8435475784414352,0.6787741203178207,0.9586833329205177,1.0,9/39,14.72%,PARP9;PRKDC;SLF1;KMT5B;KMT5C;FUS;SMCHD1;FMN2;SPIDR
prerank,negative regulation of phagocytosis (GO:0050765),-0.3128900163045754,-0.843545797263564,0.6503496503496503,0.9609501616470864,1.0,6/17,13.43%,APPL1;FCGR2B;PIP4P2;CD300LF;SIRPA;RACK1
prerank,myoblast fusion (GO:0007520),0.4287106090885636,0.8433601284507077,0.6725925925925926,0.9585636404629355,1.0,2/12,8.60%,ADAM12;ADGRB3
prerank,negative regulation of RNA metabolic process (GO:0051253),0.40174756304192866,0.8432419273243694,0.6923076923076923,0.9583272853181847,1.0,5/18,11.85%,ESR1;PTBP3;NCOR1;KAT2B;NCOR2
prerank,regulation of T cell cytokine production (GO:0002724),-0.3213349412474449,-0.843213764769267,0.6231884057971014,0.959763118247564,1.0,2/15,1.91%,B2M;SMAD7
prerank,actin filament bundle organization (GO:0061572),0.37821762104291373,0.8431385020800549,0.6949352179034158,0.9580555787627715,1.0,7/33,16.91%,PLS3;EZR;ADD1;EPS8;LIMA1;AIF1;MYO1B
prerank,protein targeting (GO:0006605),0.3368980204279566,0.8429381860219426,0.7659574468085106,0.9579591126709488,1.0,19/118,12.58%,TIMM17A;ZDHHC24;TOMM40;ARL6;SEC61G;SDCBP;TIMM23;GIPC1;NACA;ZDHHC1;ZFAND6;SEC61A1;VPS37C;HPS4;VPS37A;ATG3;SORL1;ZDHHC6;SRPRA
prerank,regulation of regulated secretory pathway (GO:1903305),0.37734201438087345,0.8429207845584346,0.6830102622576967,0.9575625442532949,1.0,5/34,9.40%,LRRK2;UNC13D;SYT12;SYT11;DTNBP1
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.36286151772042785,0.8429029868894329,0.6874279123414071,0.9571640526933886,1.0,7/41,14.85%,CX3CL1;GAS6;ILRUN;SYT11;LGALS9;HAVCR2;TLR4
prerank,translation (GO:0006412),0.33440794662503226,0.8424471437710987,0.8248248248248248,0.9574963760231258,1.0,23/208,8.31%,RPL18;RPS6KB2;RPS23;MRPL37;RPL41;RPL31;TARS1;NOA1;RPS17;FARSA;RPL4;MRPS21;WARS2;RPLP0;HARS1;ETF1;RPS15A;RPL38;DHPS;MRPS28;PABPC4;AGO2;AARS1
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.45442707367790414,0.8421424775344925,0.6641221374045801,0.9575822957332296,1.0,2/10,10.65%,IMPACT;MVP
prerank,protein ADP-ribosylation (GO:0006471),0.3811990197402223,0.8420468808182008,0.6670716889428918,0.9573198310264582,1.0,5/28,10.02%,PARP9;PARP8;PARP2;TNKS2;PARP4
prerank,transferrin transport (GO:0033572),0.3732759560247761,0.841649606615445,0.6962616822429907,0.9575375601015491,1.0,9/33,14.68%,STEAP3;ATP6V0E1;ARHGAP1;ATP6V1E1;MCOLN1;ATP6V0D2;ATP6V1H;ATP6V0A2;CLTC
prerank,cellular response to osmotic stress (GO:0071470),-0.30366795587971873,-0.8415713011190352,0.6900826446280992,0.9612908331535718,1.0,3/21,7.55%,ARHGEF2;SCN2A;CAPN3
prerank,tRNA wobble uridine modification (GO:0002098),-0.34111662360896716,-0.8413793111804159,0.7093425605536332,0.9597827955788768,1.0,4/14,8.88%,ELP4;ALKBH8;MTO1;ELP1
prerank,regulation of stem cell population maintenance (GO:2000036),-0.3103210260855845,-0.8413720724228716,0.6888888888888889,0.9578852868594141,1.0,3/18,6.34%,CNOT2;CNOT1;WDR43
prerank,protein K63-linked ubiquitination (GO:0070534),0.36902298286685675,0.8408971586094434,0.6904487917146145,0.9583738599719882,1.0,14/41,17.85%,PELI1;UBE2V2;RNF115;NEDD4;BFAR;TRIM5;TRAF2;HECTD1;TRIM56;RNF135;UBE2G1;UBE2E3;UBE2B;TRAF5
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.3785572884724383,0.8407445334423967,0.6606498194945848,0.958201760073342,1.0,4/27,8.61%,AKAP9;DLG1;CAMK2D;TRPM4
prerank,import into cell (GO:0098657),0.3560784708805556,0.8405140418438937,0.6931155192532089,0.9581564517682104,1.0,4/41,12.68%,NEURL1B;SLC7A8;SLC12A6;SLC27A1
prerank,organophosphate catabolic process (GO:0046434),-0.3642874714180526,-0.8405111951677972,0.6789772727272727,0.9578506259178347,1.0,1/11,2.45%,ENPP2
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.34068120003117014,0.8404653949620137,0.72829417773238,0.9578062969402796,1.0,16/96,12.67%,EIF4A3;SMG6;DHX38;SARNP;RNPS1;NUP205;U2AF1;HNRNPA2B1;THOC5;NUP98;SRSF5;NUP54;U2AF2;CPSF3;SRSF9;SRSF11
prerank,cellular response to hydrogen peroxide (GO:0070301),0.3655837135722746,0.8403950531061506,0.6818727490996399,0.957490918882886,1.0,4/33,11.90%,RELA;IMPACT;SETX;ABL1
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.44358653566141615,0.8401889192142055,0.6661786237188873,0.95739703007031,1.0,3/11,14.29%,HSP90AA1;PTS;CALM1
prerank,energy reserve metabolic process (GO:0006112),0.402286624266272,0.8399573694424005,0.676985195154778,0.9573612209383155,1.0,3/19,11.70%,PID1;GBE1;UGP2
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.3855914788312628,0.8397704986142412,0.653416149068323,0.9572407519806052,1.0,3/22,6.89%,UTP20;EXOSC7;ERI3
prerank,negative regulation of peptidase activity (GO:0010466),-0.23991500711893574,-0.8392696218402708,0.7403846153846154,0.9584877614486608,1.0,4/47,3.59%,CST3;TIMP2;SERPINE2;SERPINA2
prerank,DNA damage checkpoint signaling (GO:0000077),0.37948532948698815,0.8391839381887568,0.7019950124688279,0.9577749873817993,1.0,5/28,9.93%,CLOCK;MAP3K20;NBN;CHEK2;CDC5L
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.35567753220316206,0.8390437229294178,0.7133479212253829,0.957579327720902,1.0,7/52,12.58%,WFS1;GOSR2;DCTN1;EXTL3;ADD1;ERN1;SRPRA
prerank,endothelial cell proliferation (GO:0001935),0.403484568175912,0.8386650292085478,0.669024045261669,0.9577633164965488,1.0,3/17,12.18%,ITGB1BP1;DLG1;ERN1
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.35087491754014166,-0.838562658345216,0.6878787878787879,0.9580516587566141,1.0,4/12,4.93%,CHMP4B;CHMP4A;SEC62;SEC61A2
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.42391610302208493,0.8383441123091386,0.6834532374100719,0.9578815887452009,1.0,2/14,7.52%,GAS6;PYDC1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.3363034294239171,0.8381499620375027,0.7727272727272727,0.9577701939357358,1.0,17/114,12.95%,TNFRSF11A;RELA;TNFRSF25;PSMD9;PSMB8;BIRC3;PSMC5;IKBKB;PYDC1;LIMS1;ACTN4;TRAF2;TMSB4X;COMMD7;PSMD12;TP53;PSMA2
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.42131007919753605,0.8381113235671026,0.6681159420289855,0.957411368874861,1.0,5/13,16.20%,CD36;PPARG;ABCA1;SYK;CD81
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.40064157573400794,0.8380272082944307,0.6717032967032966,0.9571255516625677,1.0,4/17,14.85%,IL18;MYO1G;BACH2;TLR4
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.36550923645536315,0.8379449465457961,0.7104337631887456,0.9568345713898081,1.0,6/36,13.04%,CX3CL1;TPD52L1;TRAF7;CYLD;TGFBR1;BCL2
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.35720656360330594,0.8377552273841347,0.6968325791855203,0.9567215800808034,1.0,8/44,12.03%,GAS6;IGBP1;THBS1;YWHAE;FNIP1;CD44;MAP2K5;RAF1
prerank,sprouting angiogenesis (GO:0002040),0.3524534570243597,0.8370100467677669,0.7267699115044248,0.9575235594149627,1.0,4/51,4.64%,ITGB1BP1;VEGFC;THBS1;NRP1
prerank,cGMP metabolic process (GO:0046068),-0.35220091877631104,-0.8366857120269807,0.6636636636636637,0.9600636484324999,1.0,10/12,61.85%,GUCY1B1;GUCY1A1;PDE9A;NPPC;NPR2;PDE2A;NPR1;GUCY2F;GUCY2D;GUCY2C
prerank,negative regulation of protein polymerization (GO:0032272),0.38009465729381875,0.8366849467512665,0.7091584158415841,0.9576487834011983,1.0,7/27,12.48%,STMN2;MAPRE1;ARFGEF1;SSH2;TWF2;CYRIB;EML2
prerank,ether lipid biosynthetic process (GO:0008611),0.44341267771082127,0.8365964295687266,0.677570093457944,0.9573702491146925,1.0,4/10,17.26%,FAR1;PLA2G4A;PEDS1;PEX7
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.27419692736447054,-0.8365735518659811,0.7216981132075472,0.9584153147288125,1.0,15/25,32.50%,SLIT2;ABI3;ARHGAP24;LIMK2;CEP97;EVI5L;TBC1D30;CDK10;KANK1;STAP1;RAP1GAP;TCHP;PFN2;PRKCD;TESK1
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.32273106482502295,-0.8365140239844758,0.6751824817518248,0.9566384104411947,1.0,3/17,5.43%,TGFB1;SERPINE2;PTPRZ1
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.3351254499823573,0.8364555405316006,0.734504132231405,0.9571865236103301,1.0,19/83,18.00%,MAX;CDK7;POLA1;CDK2;CDK6;ACVR1;USP29;MNAT1;CDK5;CUL4A;ACVR1B;USP37;CRLF3;RB1;TFDP2;EIF4E;RPS6KB1;PPP6C;KHDRBS1
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.35474186561149335,-0.8357099963098134,0.7109144542772862,0.9563711504773525,1.0,9/11,46.97%,TOMM70;AGK;TIMM22;TIMM10B;NDUFA13;TIMM13;TIMM8B;ROMO1;TIMM29
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.35412034612135207,0.8354318818386773,0.7086614173228346,0.9584153829162523,1.0,7/46,8.27%,NRDC;ALDH1A1;STK11;ACOT13;MAP2K6;ABHD6;LNPEP
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.36033568044119946,0.8353888543652568,0.6971751412429379,0.9580684934974774,1.0,9/47,13.73%,ITGB1BP1;FLNA;NRP1;DOCK1;LIMS1;ACTN4;CDC42;ABL1;RREB1
prerank,respiratory system development (GO:0060541),0.36522330408547343,0.8350286172544837,0.6780258519388954,0.9582161370964325,1.0,4/32,10.28%,FGF1;CHD7;SMCHD1;LOXL3
prerank,positive regulation of vasculogenesis (GO:2001214),0.44482759152594215,0.8347826548332452,0.6846275752773375,0.9581995800553231,1.0,3/10,17.18%,RAP1A;RIN2;RAPGEF2
prerank,cytosolic calcium ion transport (GO:0060401),-0.26628354189149883,-0.8347619987100845,0.7068965517241379,0.9564583380269677,1.0,4/28,6.96%,RYR2;CACNA2D1;MCU;AFG3L2
prerank,clathrin coat assembly (GO:0048268),-0.3160423755374701,-0.8346639731111675,0.690566037735849,0.9547906133537485,1.0,4/15,14.43%,SGIP1;CLTA;FCHO2;NSG2
prerank,negative regulation of kinase activity (GO:0033673),0.3483379716178434,0.8344190877042821,0.7162740899357601,0.9583699510247079,1.0,11/62,13.58%,DVL1;ITGB1BP1;NF1;IRS2;PYDC1;MAPT;PAK2;DTNBP1;GNAQ;LRP6;SPRED1
prerank,epithelial tube morphogenesis (GO:0060562),-0.25848809593168964,-0.8341764068006132,0.793939393939394,0.9540067712075984,1.0,4/32,5.82%,RYR2;SLIT2;PKD1;CSF1R
prerank,protein modification process (GO:0036211),0.33765724256300667,0.8341337428367787,0.7398119122257053,0.9583995996372202,1.0,14/76,15.27%,ST8SIA4;SEPHS1;GGCX;CPE;YES1;PRKDC;FBXO11;PARP4;UBE2I;ATG3;ABL1;DUSP12;UBE2D3;MSRA
prerank,protein K48-linked ubiquitination (GO:0070936),0.348711218343604,0.8334912167442222,0.7397563676633444,0.9590325657693646,1.0,16/54,16.71%,PELI1;UBE2A;RNF115;RNF34;BFAR;RNF146;RNF216;UBE2Q2;UBE3A;FBXO38;UBR5;UBE2H;UBE2D3;UBE2G1;UBE2E3;HACE1
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.34079143991575594,0.8329397587692142,0.7677286742034943,0.9595415781575349,1.0,16/104,14.29%,BLM;CDK5RAP3;TSG101;CDK7;LRP5;MNAT1;EZH2;HGS;CCNI;ABL1;UVRAG;SLC27A1;LRP6;MAP2K2;GTF2H1;CALM1
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.3736384523237196,-0.8328645207641913,0.7226890756302521,0.9549719240812252,1.0,4/10,21.66%,EIF2AK3;HERPUD1;DDIT3;ATF4
prerank,presynapse assembly (GO:0099054),0.4081670731899786,0.8326183153835953,0.6791946308724832,0.9596505103563593,1.0,2/16,6.94%,DVL1;CEL
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.3886931867753775,0.8314245499346976,0.6914893617021277,0.9607208771516974,1.0,4/22,14.15%,ZDHHC24;ZDHHC1;ZDHHC6;ZDHHC20
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.3886931867753775,0.8314245499346976,0.6914893617021277,0.9607208771516974,1.0,4/22,14.15%,ZDHHC24;ZDHHC1;ZDHHC6;ZDHHC20
prerank,histone acetylation (GO:0016573),0.3466927847439172,0.831260421504704,0.7290322580645161,0.9605594938183687,1.0,14/69,14.24%,DMAP1;BRD8;EP300;BRCA2;ING3;PHF20;TADA2A;MORF4L2;JADE3;KAT2B;YEATS2;EPC1;EP400;PHF20L1
prerank,regulation of mRNA stability (GO:0043488),0.33299046337224975,0.831244448114961,0.813953488372093,0.9601672201361711,1.0,32/145,16.77%,EIF4ENIF1;CARHSP1;PSMD9;PSMB8;EXOSC5;PRKCA;FTO;PUM2;RC3H2;METTL3;EXOSC7;PSMC5;XRN1;SET;YTHDF1;FXR2;PUM1;FUS;DCP1A;ZFP36L1;PSMD12;SAMD4A;MAPKAPK2;PSMA2;ROCK2;ANP32A;NPM1;PSMB1;SERBP1;YWHAB;YTHDF3;HNRNPD
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.40521068412685635,0.8310469418357825,0.6730245231607629,0.9600612681027628,1.0,2/17,9.95%,PLA2G4A;LCLAT1
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.39622414863531186,0.8310364494192582,0.6984993178717599,0.9596565830801048,1.0,2/18,7.91%,FBXW7;TLR3
prerank,fatty acid metabolic process (GO:0006631),0.3398116181389115,0.8309088913419705,0.7783452502553626,0.9594369244692612,1.0,16/115,14.37%,CPT1C;CD36;ACSBG1;HPGD;GPX4;ABCD2;CEL;GPAM;ALOX5;CROT;PPARG;ABCD3;SGPL1;ADIPOR1;ACACA;PPARD
prerank,positive regulation of fat cell differentiation (GO:0045600),0.3563777503403225,0.8308904469436007,0.723568281938326,0.9590413587170624,1.0,10/47,14.37%,SOX13;LRP5;CMKLR1;TRPM4;CDS1;PPARG;ZFP36L1;RREB1;CREB1;PPARD
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.35185336271674983,0.8306769107352585,0.7320837927232635,0.9589597624120694,1.0,13/51,15.61%,SMG6;TCP1;TERF2;MAPK1;XRN1;PKIB;TNKS2;NEK7;HMBOX1;CCT3;TERF1;CTC1;HNRNPC
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.3392440622147444,0.8304884426864502,0.7476340694006309,0.9584446002780553,1.0,24/78,16.86%,AP1M1;ACTR1B;CAPZB;DYNLL2;AP2A1;KIF11;DCTN1;DCTN2;DCTN4;ARF1;SEC24B;SEC24D;KIF3A;SAR1B;RAB7A;OSBPL1A;CLTC;DYNC1I2;DYNC1LI2;CAPZA1;SH3GL2;LGMN;SEC24A;KIF2A
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.3392440622147444,0.8304884426864502,0.7476340694006309,0.9584446002780553,1.0,24/78,16.86%,AP1M1;ACTR1B;CAPZB;DYNLL2;AP2A1;KIF11;DCTN1;DCTN2;DCTN4;ARF1;SEC24B;SEC24D;KIF3A;SAR1B;RAB7A;OSBPL1A;CLTC;DYNC1I2;DYNC1LI2;CAPZA1;SH3GL2;LGMN;SEC24A;KIF2A
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.2736179867011095,-0.8302352498697899,0.7475728155339806,0.958371787892069,1.0,4/26,5.34%,MAFB;C1QC;PTPN2;GPR137B
prerank,positive regulation of reproductive process (GO:2000243),0.3656417022829372,0.8301226672015848,0.7061668681983071,0.9586261666995572,1.0,4/31,13.18%,PGAM4;AGO2;LHFPL2;ACVR1B
prerank,carboxylic acid catabolic process (GO:0046395),-0.34579693283971685,-0.8299298396924961,0.698051948051948,0.9571165719632736,1.0,4/12,15.66%,RENBP;NAGK;AMDHD2;GNPDA1
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.3555484684274638,0.8298771480698077,0.6979405034324943,0.9585970734105456,1.0,4/40,3.07%,CDK5RAP3;FBXW7;GLMN;DESI1
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.38265474552850876,0.8295727596090493,0.6934487021013597,0.9586856921021756,1.0,2/26,1.24%,LRRK2;PRKCZ
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.37596950977170596,0.8294539047165207,0.7127403846153846,0.9584614306230084,1.0,4/31,11.42%,GLMN;LST1;LYN;SOX11
prerank,vesicle organization (GO:0016050),0.35104788070598786,0.8294344244747032,0.6902654867256637,0.9580819221922504,1.0,11/46,15.39%,AKTIP;FNBP1L;SQSTM1;SNX10;PI4K2A;VPS11;SAR1B;WASHC5;EPS15;WASL;DNAJC13
prerank,sodium ion transmembrane transport (GO:0035725),0.33778780537212183,0.8292217663046494,0.7696280991735537,0.9580361991605293,1.0,6/84,8.80%,HCN3;SLC9A9;SLC9A1;TRPM4;SLC9A7;SLC9A6
prerank,positive regulation of ATPase activity (GO:0032781),0.35673148564108054,0.8290989685856275,0.7108294930875576,0.9578191886750597,1.0,4/41,5.96%,DNAJB1;SSBP1;TPM1;DYNLL2
prerank,acyl-CoA biosynthetic process (GO:0071616),-0.3221965672564754,-0.8286164664466634,0.6971830985915493,0.9578360287253153,1.0,4/16,6.34%,ACSS1;PPT1;DIP2A;ACLY
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.4190347314123558,0.828389120059702,0.6869688385269122,0.9585418104949436,1.0,1/14,1.76%,RELA
prerank,bicellular tight junction assembly (GO:0070830),-0.22825490015219096,-0.8282949942147175,0.839622641509434,0.9566203378983952,1.0,3/46,2.17%,F11R;STRN;TBCD
prerank,somite development (GO:0061053),0.4404604670912826,0.8282784483776217,0.6951219512195121,0.9583016486874175,1.0,3/11,13.78%,LOXL3;SOX11;PPP2R3A
prerank,negative regulation of DNA metabolic process (GO:0051053),0.3829046196250972,0.8282465200574874,0.6966292134831461,0.9579354790409879,1.0,3/24,7.85%,BLM;TERF2;ERCC4
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.42654619173325325,0.8279547155796749,0.6933534743202417,0.9580014213111937,1.0,5/11,16.79%,RTN4;ATL2;VCPIP1;VAPB;ARL6IP1
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.3825316109051534,0.8277290429651577,0.6992084432717678,0.9579518561397857,1.0,6/21,13.26%,RPIA;RBKS;TKT;TALDO1;GCK;RPE
prerank,regulation of synapse maturation (GO:0090128),-0.35463485100723985,-0.8276904689087893,0.7032640949554896,0.9559939412099496,1.0,5/10,32.49%,NRXN1;YWHAZ;ADGRL1;CAMK2B;DAB2IP
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.2670489138762249,-0.8276867268182323,0.7472527472527473,0.9541607321516093,1.0,10/27,17.58%,RHOA;ETS1;ITGB2;IRAK1;CCDC88B;PYCARD;SIRPA;TRAF6;HSPD1;PRKCQ
prerank,positive regulation of protein processing (GO:0010954),-0.2935071660663391,-0.8272651468348148,0.6889763779527559,0.9531473983368746,1.0,2/19,3.23%,PLGRKT;LPCAT3
prerank,regulation of brown fat cell differentiation (GO:0090335),0.4004692993599749,0.8271178905324802,0.6965986394557823,0.9584837723582597,1.0,2/16,5.34%,SOX13;FTO
prerank,stress-activated MAPK cascade (GO:0051403),0.34893140711625414,0.8270053859506102,0.7311827956989247,0.9582565794557513,1.0,13/61,14.00%,MINK1;MAP3K11;MAPK1;MAP3K20;IKBKB;MAPK8;IRAK2;TAB3;FBXW11;ZFP36L1;MAPK14;MAP3K8;LGALS9
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.40404893900395894,0.8269096962510706,0.6919945725915875,0.9579825769278695,1.0,2/16,8.48%,RELA;ALOX5
prerank,calcium ion transmembrane transport (GO:0070588),0.33919905027293606,0.8268455246622234,0.7515592515592515,0.9576569497460526,1.0,15/86,14.79%,SLC24A5;TRPC5;MICU1;CACNA1D;GAS6;LETM1;TRPM4;TRPC4AP;CACNA1A;MCOLN1;PARL;TRPV2;PKD2;GRIN2A;CACNA1C
prerank,defense response to tumor cell (GO:0002357),0.43806433679374757,0.8266885272781151,0.6866359447004609,0.9574853524068424,1.0,2/10,9.02%,RBMS3;DAPK1
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.385017280491652,0.8265928531686526,0.6973180076628352,0.95724127083817,1.0,6/22,17.88%,IFI35;WDFY1;LYN;RAB7B;MFHAS1;TREM2
prerank,regulation of protein modification process (GO:0031399),0.3491226922059497,0.8265199913333027,0.7337016574585635,0.9569553450191433,1.0,14/50,16.44%,PARG;SPRED2;CDK9;FNIP1;LYN;ASPSCR1;FKTN;KAT2B;PPP1R16B;FN1;SPRED1;ATG7;PHIP;STAT2
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.26501433144471864,-0.8262026614125938,0.7054794520547946,0.9534619463934524,1.0,7/32,14.72%,CALM2;AKAP6;TRPC1;CAPN3;SNCA;PDPK1;PLCG1
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.41907357688121644,0.8261556783951354,0.6808510638297872,0.9571431423765531,1.0,5/12,18.51%,DLG1;TRPM4;CACNA1C;BIN1;CTNNA3
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.41150255940798863,0.8261090715751672,0.6971428571428572,0.9568097372286147,1.0,2/14,10.26%,SLC9A1;ACTN4
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.3918595785123995,0.8259422222522628,0.6977950713359273,0.9566596572753353,1.0,3/21,9.84%,CHSY1;UGDH;BGN
prerank,cellular senescence (GO:0090398),-0.2636762101318768,-0.8255806221528185,0.7257142857142858,0.9529042561114969,1.0,6/27,14.16%,KAT6A;OPA1;SMC6;CALR;PML;SIRT1
prerank,microglial cell activation (GO:0001774),0.385526812383934,0.8250516746880827,0.7051114023591087,0.9575924265887209,1.0,3/21,7.60%,C5AR1;CX3CL1;MAPT
prerank,protein monoubiquitination (GO:0006513),-0.24515959759143952,-0.8248459054966386,0.8,0.9524536557592961,1.0,18/36,28.16%,WAC;PRKN;HUWE1;FANCL;CUL3;RBX1;UBE2O;KLHL22;DTX3L;OBI1;KLHL12;TOPORS;CDC73;ATXN7L3;RNF40;UBE3D;PAF1;UBE2R2
prerank,cellular iron ion homeostasis (GO:0006879),0.34288587494741213,0.8246911891387912,0.7238403451995685,0.9577367754242221,1.0,13/55,17.72%,CP;HMOX2;ABCB7;GLRX3;FLVCR1;SLC22A17;NDFIP1;ATP6V0A2;SMAD4;ABCG2;FTH1;FRRS1;FTL
prerank,mitochondrion transport along microtubule (GO:0047497),-0.3322066634438895,-0.8244995483133982,0.6824324324324325,0.9512907156005336,1.0,4/13,15.24%,OPA1;RHOT1;NEFL;MAP1S
prerank,epithelial cell development (GO:0002064),0.3923983536921076,0.8243606544221429,0.7090663058186739,0.9578372866084418,1.0,1/20,3.84%,SIPA1L3
prerank,regulation of cation channel activity (GO:2001257),0.33251722948499074,0.8241516626306842,0.7612095933263816,0.9577792650115052,1.0,11/89,9.86%,SELENON;MINK1;CACNG7;PRKACA;DLG1;NETO1;SLMAP;CAMK2D;DAPK1;GRIA4;VAMP2
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.3819697018563203,0.8238930811717557,0.7242744063324539,0.9573767398508861,1.0,8/23,18.07%,YWHAE;MAPK8;NMT1;TP53;BCL2;YWHAB;TFDP2;PPP3CC
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.3819697018563203,0.8238930811717557,0.7242744063324539,0.9573767398508861,1.0,8/23,18.07%,YWHAE;MAPK8;NMT1;TP53;BCL2;YWHAB;TFDP2;PPP3CC
prerank,protein deneddylation (GO:0000338),0.4378833721658101,0.8237528067792881,0.6819620253164557,0.957174415401254,1.0,2/10,9.10%,COPS7B;COPS4
prerank,embryonic limb morphogenesis (GO:0030326),0.3711848118108244,0.8230257290079676,0.7074910820451843,0.9579213013202926,1.0,7/34,15.59%,TGFB2;MBNL1;MAP3K20;LRP6;CACNA1C;FBXW4;HDAC2
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.3833659554680699,0.822834370570642,0.6988416988416989,0.9577933445721813,1.0,8/22,19.59%,IKBKB;BOD1L1;TIPRL;ROCK2;NCKAP1L;ROCK1;PTPA;MGAT5
prerank,protein K11-linked ubiquitination (GO:0070979),0.3731138571079324,0.8227905435712393,0.7184822521419829,0.957450234087828,1.0,10/27,17.58%,ANAPC10;CDC23;UBE2A;CDC16;UBE2W;UBE2H;UBE2D3;UBE2E3;ANAPC1;UBE2B
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.30801394487057426,-0.8227370935115468,0.6973180076628352,0.9529342238434961,1.0,4/17,8.56%,MCU;RAC1;RIPOR2;MOSPD2
prerank,actin filament bundle assembly (GO:0051017),0.36787786005905787,0.8224290290990119,0.7129411764705882,0.9576099254999629,1.0,7/33,16.91%,PLS3;EZR;ADD1;EPS8;LIMA1;AIF1;MYO1B
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.30577842613848294,-0.8222805838298287,0.6941580756013745,0.9520339429731923,1.0,8/17,17.76%,CPEB3;ZC3H14;CCNT1;CPSF6;ZC3H3;NUDT21;HSF1;NCBP1
prerank,regulation of interleukin-17 production (GO:0032660),0.36434878218591826,0.8222332499173779,0.7148058252427184,0.9574866663765462,1.0,6/31,17.29%,RFTN1;IL18;SLAMF6;PRNP;TLR4;NCKAP1L
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.4014139896180161,0.8221874789625702,0.6890982503364738,0.9571445704116673,1.0,2/17,5.17%,NRP1;PDGFB
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.36213331583897196,0.8215801353218897,0.7208182912154031,0.9576834371764529,1.0,7/32,13.07%,TCP1;MAPK1;PKIB;TNKS2;NEK7;HMBOX1;CCT3
prerank,clathrin-dependent endocytosis (GO:0072583),0.36928790223167074,0.8212410198973408,0.6986469864698647,0.9578172762592156,1.0,5/26,8.57%,ITSN1;SIGLEC1;FNBP1L;AP2A1;LMBRD1
prerank,hippo signaling (GO:0035329),0.37076514376162234,0.8209241287744966,0.7009925558312655,0.957896993763894,1.0,3/26,5.25%,NPHP4;YWHAE;TEAD1
prerank,production of siRNA involved in RNA interference (GO:0030422),0.4334693978652536,0.8209218979058844,0.6895522388059702,0.9574890370951297,1.0,3/10,16.49%,AGO2;PRKRA;DROSHA
prerank,peptidyl-glutamic acid modification (GO:0018200),0.37469546981098456,0.8207963288184387,0.6926889714993805,0.9572801621089286,1.0,3/24,11.18%,GGCX;VKORC1L1;TTLL4
prerank,mRNA transport (GO:0051028),0.334356383937188,0.8207175460128374,0.7761806981519507,0.9569920956920639,1.0,17/101,12.67%,EIF4A3;SMG6;DHX38;SARNP;RNPS1;NUP205;U2AF1;HNRNPA2B1;THOC5;NUP98;SRSF5;NUP54;U2AF2;CPSF3;ZFP36L1;SRSF9;SRSF11
prerank,maturation of SSU-rRNA (GO:0030490),0.35749984333754575,0.8193325881816601,0.7028639618138425,0.9587486203048462,1.0,5/34,11.91%,UTP3;RIOK3;RRP36;UTP6;HEATR1
prerank,negative regulation of lipid storage (GO:0010888),0.3905504088759001,0.8192745937290185,0.6779431664411367,0.9584356356171733,1.0,5/19,14.37%,TTC39B;PPARG;ABCG1;ABCA1;PPARD
prerank,inorganic cation transmembrane transport (GO:0098662),0.3263256544435857,0.8191946913030684,0.8828828828828829,0.9581483202474419,1.0,26/268,13.11%,HCN3;SLC24A5;SLC30A6;TRPC5;TMEM175;SLC9A9;SLC39A11;SLC9A1;CACNA1D;GAS6;KCNH8;KCNH7;HVCN1;ABCB7;KCNK2;ATP6V0E1;TRPM4;SLC9A7;SLC9A6;TRPC4AP;CACNA1A;MCOLN1;KCNK13;TRPV2;KCNK10;ATP6V1H
prerank,macrophage activation involved in immune response (GO:0002281),-0.34312869290543235,-0.8191362681610971,0.7023411371237458,0.9562632502067788,1.0,3/13,7.10%,PLCG2;GRN;TYROBP
prerank,muscle cell development (GO:0055001),0.36319214234235364,0.819010428596679,0.7083839611178615,0.958024535840559,1.0,2/30,4.50%,NEBL;MYOF
prerank,hemopoiesis (GO:0030097),0.3320857110173707,0.8187253902636938,0.7628336755646817,0.9580461317880017,1.0,13/87,12.92%,WNT2B;SBDS;RUNX1;TGFB2;PDGFB;KITLG;TAL1;PRRC2C;NOTCH2;TGFBR2;PLD4;SH2B3;TP53
prerank,nucleoside catabolic process (GO:0009164),-0.3479283130860946,-0.8186908739218827,0.6932515337423313,0.9552907640743599,1.0,4/11,16.32%,DPYD;UPP2;DERA;NT5M
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.3569467194951106,-0.8186720509136114,0.7245989304812834,0.9517360391809266,1.0,1/10,1.58%,MBP
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.3569467194951106,-0.8186720509136114,0.7245989304812834,0.9517360391809266,1.0,1/10,1.58%,MBP
prerank,nucleosome assembly (GO:0006334),0.36505856808563847,0.8185921089679005,0.7049576783555018,0.957844205018565,1.0,7/31,15.24%,CABIN1;ASF1A;SPTY2D1;BRD2;ATRX;ANP32B;NPM1
prerank,maintenance of protein localization in organelle (GO:0072595),0.3897886513748471,0.817985830223115,0.7100671140939597,0.9583839402329468,1.0,2/19,3.53%,TAPT1;BBS4
prerank,endocytic recycling (GO:0032456),0.34912454616654265,0.817240964276428,0.7569060773480663,0.959092337310742,1.0,8/50,9.83%,EIPR1;EHD4;EHD1;CCDC93;SNX3;VPS35;ARL4C;PTPN23
prerank,glycine metabolic process (GO:0006544),-0.3397288723920705,-0.8168182362114148,0.6946778711484594,0.9535547796946597,1.0,6/12,46.28%,DLD;RIDA;AMT;GCSH;SHMT2;SHMT1
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.28959078823305184,-0.8167183046136609,0.7063829787234043,0.951961917473221,1.0,2/21,0.26%,MED13;MITF
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.38028910586818715,0.8160432743926977,0.7083333333333334,0.9604933698930238,1.0,1/22,1.07%,LRRK2
prerank,muscle tissue morphogenesis (GO:0060415),-0.3199352152385627,-0.8160015926342455,0.7052238805970149,0.9516914759945687,1.0,2/16,15.54%,TGFBR3;NOTCH1
prerank,response to interferon-gamma (GO:0034341),0.3327270690181006,0.8159796791766748,0.751345532831001,0.960175906597745,1.0,9/67,15.45%,IFITM3;CX3CL1;SYNCRIP;CCL25;DAPK1;LGALS9;AIF1;TLR4;CD47
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.3332585608549042,0.8157599574882085,0.7710084033613446,0.9601026910660752,1.0,24/79,16.86%,AP1M1;ACTR1B;CAPZB;DYNLL2;AP2A1;KIF11;DCTN1;DCTN2;DCTN4;ARF1;SEC24B;SEC24D;KIF3A;SAR1B;RAB7A;OSBPL1A;CLTC;DYNC1I2;DYNC1LI2;CAPZA1;SH3GL2;LGMN;SEC24A;KIF2A
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.3292293952373807,0.8151762386254033,0.8087934560327198,0.9605700709118243,1.0,30/109,17.83%,RELA;GRB2;PSMD9;NFATC1;JUN;PSMB8;BTK;MAPK1;VAV3;PSMC5;IKBKB;MAPK8;PAK2;TAB3;LYN;FBXW11;VAV2;PSMD12;PSMA2;SYK;CALM1;VAV1;PSMB1;PIK3R1;PAK1;MAP2K4;FER;PSME4;LCP2;PPP3CA
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.3855911882839082,0.8149479189782313,0.7096774193548387,0.9605141928155584,1.0,3/21,9.57%,MICU1;LETM1;RAP1GDS1
prerank,regulation of Wnt signaling pathway (GO:0030111),0.3281021707260662,0.8148864589794206,0.7916241062308478,0.9601937752375911,1.0,14/108,13.43%,MDFI;LRRK2;SMARCA4;RUNX1;NFATC1;ESR1;TLE1;SNX3;NXN;GNAQ;WLS;HMGXB4;GPC3;WWOX
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.3661064043481157,0.8145111652410576,0.7051442910915935,0.9603468090607626,1.0,6/27,13.98%,MAPK1;MAP3K20;IKBKB;MAPK8;FBXW11;MAP3K8
prerank,cellular response to peptide (GO:1901653),0.3385129015049552,0.8143822046847973,0.7198697068403909,0.9601164534361547,1.0,17/56,18.37%,CD36;CHMP5;ITGA4;CDK5;CACNA1A;IGF1R;PRNP;ZFP36L1;TP53;FYN;GRIN2A;TLR4;LGMN;ABCC1;TREM2;PSEN1;SNX6
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.400826180601933,0.8139846822422762,0.69432918395574,0.9603194534371322,1.0,4/15,12.58%,SEC61G;RAB3GAP1;SEC61A1;SRPRA
prerank,cellular glucose homeostasis (GO:0001678),0.35367867276177795,0.8130315017937183,0.7301587301587301,0.9613864896176487,1.0,9/41,16.86%,ADCY8;GAS6;PRKACA;IGF1R;GCK;ERN1;PIK3R1;FOXK1;HK2
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.3290293044788046,0.812573226581286,0.7846790890269151,0.9616883831735508,1.0,17/94,13.98%,RELA;IRAK4;PELI1;PSMD9;PSMB8;SQSTM1;IL1A;PSMC5;IKBKB;RPS6KA5;IL1RAP;IRAK2;TAB3;FBXW11;PSMD12;PSMA2;MAP3K8
prerank,positive regulation of cholesterol efflux (GO:0010875),0.38211169576388876,0.8121094240477188,0.7128072445019404,0.9620178457353813,1.0,4/21,13.22%,EEPD1;ABCA7;PPARG;RXRA
prerank,regulation of DNA damage checkpoint (GO:2000001),0.43647268869801714,0.8120584207841265,0.7101226993865031,0.9616916582720824,1.0,2/10,9.90%,THOC5;RFWD3
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.42038349909932393,0.8118690473667708,0.7168141592920354,0.9611491058108064,1.0,2/12,6.12%,SLC9A1;SPPL3
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.42038349909932393,0.8118690473667708,0.7168141592920354,0.9611491058108064,1.0,2/12,6.12%,SLC9A1;SPPL3
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.4368452374695415,0.8113848200721461,0.7039764359351989,0.9614869184573082,1.0,3/10,13.22%,PPARG;ACTN4;RXRA
prerank,ncRNA metabolic process (GO:0034660),0.352901198101107,0.8113697024021469,0.727061556329849,0.9610972996151743,1.0,6/37,16.49%,TUT4;MAPT;AGO2;PRKRA;DTD1;DROSHA
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.37671402649816194,0.8112795013700678,0.7045751633986929,0.9608255369046227,1.0,7/21,17.22%,RUNX1;PRKCB;LPXN;LYN;SLC39A10;CD81;PRKCH
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.40515972438444386,0.8106203110408824,0.7195467422096318,0.9614058107104775,1.0,4/14,12.96%,TERF2;BRCA2;TNKS2;ATRX
prerank,protein targeting to ER (GO:0045047),0.3297591435039175,0.8105658126252986,0.8028747433264887,0.9610808511298198,1.0,10/99,5.94%,RPL18;RPS23;RPL41;RPL31;SEC61G;RPS17;RPL4;RPLP0;RPS15A;RPL38
prerank,inorganic cation import across plasma membrane (GO:0098659),0.3322860628354686,0.8104466163318624,0.7678571428571429,0.9608492881771069,1.0,9/75,12.80%,KCNJ6;SLC9A9;SLC9A1;TRPM4;SLC9A7;SLC9A6;SLC12A6;SLC39A10;TRPV2
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.3498555028388967,0.8103285364099007,0.7242178447276941,0.960613592084481,1.0,4/39,4.55%,CX3CL1;ADAM15;ITGB1BP1;THBS1
prerank,epithelial cell morphogenesis (GO:0003382),0.39063817127647743,0.8102072038739542,0.7142857142857143,0.9603772301405061,1.0,1/17,3.84%,SIPA1L3
prerank,RNA export from nucleus (GO:0006405),0.3292569994310211,0.810076903043652,0.778118609406953,0.9601704831877977,1.0,16/100,12.67%,EIF4A3;SMG6;DHX38;SARNP;RNPS1;NUP205;U2AF1;HNRNPA2B1;THOC5;NUP98;SRSF5;NUP54;U2AF2;CPSF3;SRSF9;SRSF11
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.3353380345909777,0.8097972560757644,0.7738478027867095,0.9601878883738582,1.0,11/63,17.29%,CD38;EPHB2;VAV3;IRS2;NCK1;IL18;BCL2;AIF1;CD81;MEF2C;NCKAP1L
prerank,regulation of keratinocyte proliferation (GO:0010837),0.37520610079676053,0.809699627439972,0.7278562259306803,0.959936014858805,1.0,4/22,12.05%,KLF9;AREG;NOTCH2;ZFP36L1
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.3476524305480494,0.8092882902801118,0.7226697353279632,0.9601721079368919,1.0,7/43,14.85%,CX3CL1;GAS6;ILRUN;SYT11;LGALS9;HAVCR2;TLR4
prerank,protein-DNA complex disassembly (GO:0032986),0.39324581205579967,0.8091953619336579,0.7110215053763441,0.9599066351200404,1.0,2/16,8.22%,SMARCA4;SET
prerank,Fc receptor signaling pathway (GO:0038093),0.3275177327321524,0.8091460144661169,0.8112820512820513,0.9595800912313709,1.0,30/110,17.83%,RELA;GRB2;PSMD9;NFATC1;JUN;PSMB8;BTK;MAPK1;VAV3;PSMC5;IKBKB;MAPK8;PAK2;TAB3;LYN;FBXW11;VAV2;PSMD12;PSMA2;SYK;CALM1;VAV1;PSMB1;PIK3R1;PAK1;MAP2K4;FER;PSME4;LCP2;PPP3CA
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.3808369390049866,0.808838352388248,0.7114624505928854,0.9596374047190154,1.0,6/19,17.42%,RUNX1;BMPR1A;TGFBR1;RBPJ;MEF2C;VGLL4
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.27656264433927097,-0.8084215173371551,0.7385892116182573,0.9644092085097484,1.0,3/23,5.53%,IL10RA;ERBB4;GHR
prerank,modulation by symbiont of host process (GO:0044003),-0.3528175857727863,-0.8084121118133477,0.7329545454545454,0.9626271375162456,1.0,6/10,22.23%,B2M;UBC;RPS27A;TLR2;PGK1;UBB
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.3256875370322437,0.8083156551467289,0.8008255933952528,0.9600379792140997,1.0,21/100,15.90%,ROR2;TGFB2;PIP4K2A;PDGFB;MAPK1;IRS2;NEDD4;IL18;PIP4K2B;LYN;IGF1R;CBL;PPP1R16B;FN1;INSR;PPP2R5C;PTEN;PIK3AP1;BECN1;PIK3R1;PDGFC
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.3717313147725048,0.8082629440492592,0.7338308457711443,0.9597221399221445,1.0,5/26,14.29%,UBQLN1;YWHAE;THADA;PKD2;CALM1
prerank,protein localization to vacuole (GO:0072665),0.40945853929607867,0.8080756390126027,0.7085798816568047,0.9595987615617231,1.0,5/13,16.20%,LMBRD1;MFSD1;SH3GLB1;RTN4;CD81
prerank,regulation of cholesterol efflux (GO:0010874),0.36180910284010454,0.8078935738566182,0.7345238095238096,0.9594711797529965,1.0,6/30,14.69%,EEPD1;TTC39B;ABCA7;PPARG;RXRA;ABCA5
prerank,amino acid transport (GO:0006865),0.34067523902396135,0.8078487303096755,0.732824427480916,0.959140047656054,1.0,6/49,12.25%,SLC7A2;SLC38A2;SLC7A11;SLC7A7;SLC7A8;SLC38A9
prerank,transport along microtubule (GO:0010970),0.4160082018760478,0.8078031575885447,0.6948424068767909,0.9587915487462141,1.0,6/13,15.38%,BAG3;CAMSAP3;APBA1;CDC42;SPG11;DYNC1I2
prerank,cytoplasmic translational initiation (GO:0002183),0.393398118586576,0.8069452375113554,0.7240437158469946,0.9596745860847041,1.0,2/17,3.90%,DENR;EIF4B
prerank,response to amyloid-beta (GO:1904645),0.34253461398707646,0.8063795190603524,0.7567567567567568,0.9601393282169501,1.0,14/44,18.37%,CD36;ITGA4;CDK5;CACNA1A;IGF1R;PRNP;FYN;GRIN2A;TLR4;LGMN;ABCC1;TREM2;PSEN1;SNX6
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.3424103054284115,0.8052306142044268,0.7837541163556532,0.9614543359487017,1.0,11/56,16.70%,RGCC;CDC23;KMT2E;MECP2;CDC16;RAD51B;VPS4B;AIF1;RDX;RB1;NSMCE2
prerank,Notch signaling pathway (GO:0007219),0.33686639007037883,0.8049628264582912,0.7510964912280702,0.961451327057128,1.0,10/59,14.67%,EP300;TRAF7;MAML3;MAML2;NOTCH2;KAT2B;MIB1;ADAM10;RBPJ;DTX3
prerank,positive regulation of interleukin-10 production (GO:0032733),0.3570153570579533,0.8042586990953935,0.7224242424242424,0.9621286174745509,1.0,6/30,17.19%,PRKCZ;HMGB1;SYK;LGALS9;TLR4;PIBF1
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.3725431013555716,0.8041754181699419,0.7257653061224489,0.9618419899080294,1.0,1/22,0.51%,CETN2
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.3632586295125681,0.8041165957355939,0.7192546583850932,0.9615182697044055,1.0,6/25,16.98%,BCL2L11;BNIP3;MLLT11;TP53;DNM1L;MFF
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.2864796234920012,-0.8040600618625308,0.7689243027888446,0.9690439621553386,1.0,4/21,8.76%,LPIN2;ACOX1;PLA2G15;LPIN1
prerank,cellular response to interferon-beta (GO:0035458),0.39966653680117054,0.8037746013984992,0.7156862745098039,0.961622473870902,1.0,1/14,1.88%,IRF1
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.346607238478799,0.803747274275492,0.7387173396674585,0.9612613866503918,1.0,5/36,11.45%,PARP9;GAS6;AXL;MAVS;TRIM44
prerank,positive regulation of histone deacetylation (GO:0031065),-0.3324514098337074,-0.8030856197380078,0.7142857142857143,0.9689515002143622,1.0,5/12,18.16%,AKAP8;NIPBL;PRKD1;SAP30BP;ING2
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.3337187884181392,-0.8030382332910758,0.7147435897435898,0.9672253377647803,1.0,3/12,11.23%,PTK2B;FCGR2B;GPR183
prerank,hyaluronan catabolic process (GO:0030214),0.3813815446941089,0.8029669935828441,0.710455764075067,0.9619947659067687,1.0,3/18,9.66%,SLC9A1;CEMIP2;CD44
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.40716384284737867,0.8025428754791117,0.7132867132867133,0.9617969008305187,1.0,1/13,2.87%,GRB2
prerank,cellular response to interleukin-15 (GO:0071350),0.40716384284737867,0.8025428754791117,0.7132867132867133,0.9617969008305187,1.0,1/13,2.87%,GRB2
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.32926227708130285,0.8024202420876785,0.7728706624605678,0.9615771710794803,1.0,4/76,6.00%,C5AR1;GPR65;CMKLR1;ESR1
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.32491062351476846,-0.8020668221774488,0.7232704402515723,0.9672757701560017,1.0,3/13,8.08%,TGFB1;TYROBP;ITGB2
prerank,muscle tissue development (GO:0060537),0.40567229304040126,0.8020631175457453,0.7172619047619048,0.9617204520323045,1.0,1/13,4.01%,NF1
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.29248003730917344,-0.8019314812833915,0.7615384615384615,0.9657353028772715,1.0,7/19,13.62%,PRKN;CSNK2A2;FBXO7;SREBF2;ATP13A2;VDAC1;USP36
prerank,negative regulation of cell activation (GO:0050866),0.4041315574166637,0.8018380820214801,0.7162726008344924,0.9616715835699685,1.0,1/14,5.17%,PDGFB
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.42360582077440934,0.8014890516513352,0.7253086419753086,0.9617903374139355,1.0,3/10,14.95%,PRKCB;PRKD2;ARNT
prerank,positive regulation of protein catabolic process (GO:0045732),0.3264814101118948,0.801274068214876,0.8052083333333333,0.961702166717981,1.0,22/84,17.42%,MSN;NRDC;EGLN2;HSP90AA1;EZR;PTTG1IP;NEDD4;HECW1;VPS35;AREL1;FAF1;APC;FURIN;SORL1;VPS11;GPC3;RAB7A;ATG7;RDX;HACE1;SNX9;VGLL4
prerank,negative regulation of leukocyte activation (GO:0002695),0.39401254019544546,0.8011623145036573,0.7079276773296245,0.9614752472419786,1.0,1/15,0.91%,MILR1
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.34242940671459654,0.8011440912695504,0.7414187643020596,0.9610969438994423,1.0,7/41,16.17%,CX3CL1;DENND6A;CD44;PTPN23;PTPRU;CD47;ADAM19
prerank,sensory perception (GO:0007600),0.33975313368498894,0.7996582998861292,0.7609427609427609,0.9629591736921769,1.0,3/45,3.99%,C5AR1;BBS4;NIPSNAP1
prerank,negative regulation of cell junction assembly (GO:1901889),0.3668166888423356,0.7992635428037972,0.7383419689119171,0.963131321610939,1.0,8/25,18.14%,ITGB1BP1;THBS1;IKBKB;ROCK2;PTEN;APOD;CLASP2;ROCK1
prerank,aorta morphogenesis (GO:0035909),0.38501186370264395,0.7990934441704205,0.7148648648648649,0.9629677230159502,1.0,4/17,19.14%,BMPR1A;RBPJ;PROX1;LRP1
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.3272128103943907,0.7990729641955217,0.7873931623931624,0.9625936908764582,1.0,15/72,15.90%,ROR2;TGFB2;PDGFB;IRS2;NEDD4;IL18;LYN;IGF1R;CBL;FN1;INSR;PIK3AP1;BECN1;PIK3R1;PDGFC
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.25458757498991486,-0.7990213381804749,0.775,0.9692090236538714,1.0,10/28,24.57%,ITPR1;ERO1A;DNAJC10;CASP4;DDIT3;CEBPB;BAX;ATF4;SELENOK;BAG6
prerank,bile acid metabolic process (GO:0008206),0.36899917771524293,0.7989882144221377,0.7312722948870393,0.9623158381058318,1.0,2/27,2.58%,GBA2;OSBP
prerank,regulation of lamellipodium assembly (GO:0010591),0.35110225697648983,0.7988489784970425,0.7410926365795725,0.9621195638366897,1.0,11/34,18.34%,ACTR3;CAPZB;TWF2;CDC42;ARPC2;WASF2;AUTS2;PIK3R1;CYFIP1;FER;NCKAP1
prerank,tRNA aminoacylation (GO:0043039),0.35352989497675796,0.7985765234202742,0.7363420427553444,0.962093742064447,1.0,8/37,15.43%,TARS1;FARSA;WARS2;HARS1;AARS1;GATB;LARS1;NARS1
prerank,regulation of cell morphogenesis (GO:0022604),0.3545797911188394,0.7984960450446958,0.7301587301587301,0.9618113381500486,1.0,7/30,15.63%,CFL1;CAPZB;CD44;MYO9A;ZMYM6;PHIP;MACF1
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.34077770960198495,0.7982008675352006,0.736780258519389,0.961829053720627,1.0,11/36,17.83%,NFATC1;TNRC6B;AGO2;TCF7L2;GNG2;CALM1;GNB1;FZD3;GNAO1;CTNNB1;PPP3CA
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.4136303198789809,0.7980995984515811,0.7157434402332361,0.9611708178297433,1.0,2/12,10.26%,ITGB1BP1;ACTN4
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.4136303198789809,0.7980995984515811,0.7157434402332361,0.9611708178297433,1.0,2/12,10.26%,ITGB1BP1;ACTN4
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.32804472144369157,0.7976624338073367,0.7771911298838438,0.9614181897508562,1.0,11/76,12.73%,CDK5RAP3;CMKLR1;ARRB2;G3BP2;PYDC1;IRAK2;FAF1;MAP2K5;TMSB4X;COMMD7;CYLD
prerank,heterochromatin assembly (GO:0031507),-0.2769608532189152,-0.7976582797787171,0.75,0.9698816786206693,1.0,7/20,15.12%,ZNFX1;SIRT2;EZH1;H3-3A;HDAC1;SIRT1;CENPV
prerank,regulation of complement activation (GO:0030449),0.34419047626811666,0.7975903392762854,0.7334851936218679,0.9611328315427733,1.0,5/40,16.20%,C5AR1;CFH;C1QB;PROS1;CD81
prerank,ribosomal small subunit biogenesis (GO:0042274),0.34445089848888216,0.7974606907348727,0.7420091324200914,0.9609147789544676,1.0,4/39,7.38%,RIOK3;EMG1;RPS17;RRP36
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.42767457974930245,0.7969122939483392,0.7068702290076336,0.9613503417584601,1.0,2/10,12.94%,ABCD2;ABCD1
prerank,heart process (GO:0003015),-0.30195606146320075,-0.7965467505807265,0.7703180212014135,0.9701374219319635,1.0,2/14,6.05%,SGCZ;SGCD
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.33375912999040425,0.7965142299979138,0.7686486486486487,0.9615247018659859,1.0,4/59,11.07%,SDK2;PTPRT;NPTN;PALLD
prerank,snRNA processing (GO:0016180),0.39238058517722196,0.7957968126875489,0.7355371900826446,0.9621894342003219,1.0,3/16,9.20%,INTS12;INTS2;INTS4
prerank,steroid biosynthetic process (GO:0006694),0.33916668694821533,0.7956486277892758,0.7866379310344828,0.9619988508332311,1.0,3/56,3.75%,INSIG1;OSBP;INSIG2
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.35489282916032033,-0.7953625093883989,0.7255434782608695,0.970459486093883,1.0,7/10,53.77%,NAF1;DKC1;GAR1;RPUSD4;TSR3;RPUSD1;NOP10
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.40539769453997576,0.7953462845118007,0.7105263157894737,0.9620532687900804,1.0,1/12,4.27%,AKR1B1
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.33859082357066445,0.7950567022168081,0.7721796276013143,0.962092398207404,1.0,10/51,15.19%,DAND5;SMAD6;BMPR1A;CRIM1;LEMD2;PPARG;SORL1;HIPK2;UBE2D3;SMAD4
prerank,limb development (GO:0060173),0.36197576736252335,0.7950312681872027,0.7198067632850241,0.9617239022207039,1.0,7/28,17.13%,MAP3K20;IQCE;CHD7;KAT2B;LNPK;ZNRF3;PCSK5
prerank,smoothened signaling pathway (GO:0007224),0.3484345811123627,0.7935238962320323,0.7426556991774383,0.9635366790090687,1.0,2/32,3.31%,DYRK2;DISP2
prerank,nitrogen compound transport (GO:0071705),0.3194410037135342,0.7934817631511899,0.8520770010131712,0.9631945331583807,1.0,27/141,17.27%,SLC7A2;HIKESHI;SLC35F3;SLC38A2;SLC7A11;SCAMP1;TMEM30A;SLC7A7;SLC15A3;SLC7A8;VAMP2;MIA3;KIF3A;RAMP1;SCAMP5;FLVCR1;CALCRL;SLC15A4;RAB7A;SCARB2;SLC44A1;ABCG2;ARL6IP5;CEP290;SCAMP2;RALBP1;ABCC1
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.37226926551576667,0.7931997854656595,0.7391304347826086,0.9631891619230427,1.0,2/20,6.93%,HOPX;HSP90AA1
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.41974834751953316,0.7930382639497168,0.7123493975903614,0.9630177317272918,1.0,3/11,14.00%,RUNX1;HMGB1;LGALS9
prerank,regulation of interleukin-2 production (GO:0032663),0.3368848080775047,0.7929768982983932,0.7448512585812357,0.9626964988977347,1.0,10/43,14.64%,GLMN;HOMER2;RUNX1;IL1A;EZR;SPTBN1;TRAF2;PRNP;PRKD2;HAVCR2
prerank,chromatin remodeling at centromere (GO:0031055),-0.2490446450494827,-0.7927551434239947,0.825136612021858,0.9733081559491051,1.0,7/31,15.51%,SMARCA5;RBBP4;HJURP;NASP;CENPV;CENPO;ITGB3BP
prerank,negative regulation of epithelial cell migration (GO:0010633),0.34717256735491075,0.7927017899906078,0.7503001200480192,0.9626803628169859,1.0,7/33,15.32%,THBS1;DUSP10;PTPN23;MCC;ADIPOR1;PTEN;EVL
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.3404087796673736,0.7920049191909656,0.770345596432553,0.9632955963160783,1.0,7/45,10.78%,PARP9;METAP1;RBM3;PUM2;PUM1;ZC3H7A;ATXN2
prerank,positive regulation of vasoconstriction (GO:0045907),0.3986097034291437,0.7919619281014599,0.7228739002932552,0.9629598817183744,1.0,1/13,8.61%,TRPM4
prerank,sensory perception of pain (GO:0019233),-0.2724031076237355,-0.7918968229944915,0.7565217391304347,0.9731340037174846,1.0,8/21,27.72%,P2RX7;OPRM1;P2RX4;RETREG1;SCN9A;MME;KCNA2;CCR2
prerank,regulation of neurogenesis (GO:0050767),0.33612982927594226,0.7917048202300941,0.7686486486486487,0.9629339582469489,1.0,6/55,12.31%,CX3CL1;NUMBL;SPEN;RGS14;SOX11;SORL1
prerank,purine-containing compound biosynthetic process (GO:0072522),0.36438771498614564,0.7911374396768013,0.7433962264150943,0.9633717141558855,1.0,3/25,7.65%,PRPSAP1;HPRT1;DGUOK
prerank,protein alkylation (GO:0008213),0.36523103840077614,0.7910692989850266,0.7351421188630491,0.9630776741642593,1.0,3/22,9.48%,FAM98A;ETF1;SNRPD3
prerank,amyloid precursor protein metabolic process (GO:0042982),0.38084760829107434,0.7903715052259216,0.7269129287598944,0.9636847373349909,1.0,5/18,17.99%,LDLRAP1;ABCG1;ADAM10;ADAM19;PSEN1
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.2748417648087026,-0.7900471009130899,0.7836734693877551,0.9745926844385353,1.0,4/21,15.93%,LPCAT3;OSBPL8;PLAAT3;MBOAT1
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.4195593496955622,0.7896286770153745,0.740495867768595,0.9643380297205452,1.0,10/10,58.07%,GNB1;GRK1;RHO;CNGA1;GNAT1;CNGB1;PDE6A;PDE6B;PDE6G;SAG
prerank,negative regulation of fat cell differentiation (GO:0045599),0.3452660794430751,0.7894738132381056,0.7599067599067599,0.9641432668855837,1.0,2/34,5.09%,RORA;SMAD3
prerank,kinetochore organization (GO:0051383),-0.32769664173904106,-0.789432470822219,0.7913043478260869,0.9739778016630514,1.0,12/13,56.11%,POGZ;MIS12;CENPE;CENPA;CENPF;DLGAP5;CENPT;NDC80;CENPH;CDT1;CENPW;NUF2
prerank,cellular response to glucose stimulus (GO:0071333),0.35931405437032504,0.7893952758757734,0.7697841726618705,0.9638599094577649,1.0,5/30,12.18%,ADCY8;GAS6;PRKACA;IGF1R;ERN1
prerank,central nervous system development (GO:0007417),0.31702940243481176,0.7893783085213874,0.9209209209209209,0.9634872258801167,1.0,43/250,16.09%,ZIC4;BTD;CDK5RAP3;UTP3;GBA2;NNAT;RAB3GAP1;SETD1A;NF1;ELP3;ATXN1;UFC1;PITPNM1;SERPINI1;TUBGCP2;CHD7;AHI1;CDK5;LOXL3;AFF2;CHD8;TGFBR2;SOX11;UGP2;EML1;CHST8;RAB18;UBE3A;PTS;SOX6;S100B;ADAM22;NDRG4;PKD2;RELN;GRIN2A;PTEN;SMG9;SYNJ2;CIC;PDGFC;NFIB;SH3GL2
prerank,negative regulation of metabolic process (GO:0009892),0.32880423864581027,0.7885352567971411,0.7769230769230769,0.9642731779242101,1.0,7/54,8.27%,NRDC;ALDH1A1;STK11;ACOT13;MAP2K6;ABHD6;LNPEP
prerank,regulation of interleukin-4 production (GO:0032673),0.36835379279048797,0.7882656953332172,0.7270375161707633,0.9642665560542274,1.0,4/21,14.64%,PRKCZ;SYK;LGALS9;HAVCR2
prerank,detection of mechanical stimulus (GO:0050982),-0.2785888843451905,-0.7873057913071911,0.782608695652174,0.975874501717917,1.0,2/19,4.89%,PTK2;PKD1
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.3977459342208014,0.7870596988685469,0.7040358744394619,0.9655638783284888,1.0,2/12,9.65%,RUNX1;LYN
prerank,T cell activation (GO:0042110),-0.2003183209502593,-0.7870542627341288,0.9583333333333334,0.9745393617541421,1.0,17/69,22.77%,PTPRC;PTPN2;PIK3CG;EIF2AK4;KIF13B;NCK2;NLRC3;FKBP1A;HSPD1;GPR89B;GPR89A;NHEJ1;CD74;LMBR1L;CASP8;PTPN22;SCRIB
prerank,iron ion homeostasis (GO:0055072),0.3275179989556161,0.7869487569336449,0.7688172043010753,0.9653157804729543,1.0,13/58,17.72%,CP;HMOX2;ABCB7;GLRX3;FLVCR1;SLC22A17;NDFIP1;ATP6V0A2;SMAD4;ABCG2;FTH1;FRRS1;FTL
prerank,regulation of multicellular organismal development (GO:2000026),0.3597098065800625,0.7867493829751676,0.7326732673267327,0.9651975437596032,1.0,1/25,1.20%,EHMT1
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.3915296389089656,0.7865377615899946,0.7503467406380028,0.9650840178603479,1.0,2/15,11.22%,HOMER2;GRM7
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.347841684129847,0.7861881330607962,0.7508896797153025,0.9651885996874054,1.0,4/33,12.05%,RUNX1;PRKCA;ACIN1;ZFP36L1
prerank,positive regulation of potassium ion transport (GO:0043268),0.34464384626338024,0.7861033697872665,0.7525655644241733,0.9649180130383972,1.0,7/38,14.91%,KCNJ6;FLNA;DLG1;GNG2;GNB1;KCNMB2;KCNMB3
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.345024732980141,0.7853277772534356,0.7427578215527231,0.9656174364265204,1.0,3/33,8.54%,RGCC;KMT2E;EZH2
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.31698883181672965,-0.7852621482726626,0.7350157728706624,0.9758387838576518,1.0,6/13,34.38%,SYT1;SYT4;SYT10;STX1A;KCNB1;CACNA1G
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.29527948801127946,-0.7852137271082984,0.7630522088353414,0.9741489522044208,1.0,4/18,12.84%,PLCG2;FCER1G;TYROBP;PYCARD
prerank,positive regulation of immune response (GO:0050778),0.3264019739689497,0.7851024426555416,0.775880469583778,0.9655361677809143,1.0,5/64,7.87%,POLR3G;RIOK3;IFI35;TGFB2;AKIRIN2
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.3930251018429288,0.7849883900305947,0.7346041055718475,0.9653172556201851,1.0,5/13,16.98%,BMPR1A;DAB2;TGFBR1;SMAD4;NUP93
prerank,selective autophagy (GO:0061912),0.32492052139049277,0.7847794359053638,0.7841648590021691,0.9652169300425706,1.0,13/56,15.48%,UBA5;UBQLN1;UFC1;SQSTM1;AMBRA1;PCNT;DYNLL2;ULK2;RB1CC1;RAB7A;BECN1;DYNC1I2;DYNC1LI2
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.3699589080333384,0.7846949840011477,0.7444589308996089,0.9649289017470857,1.0,3/20,13.90%,THBS1;NPTN;PRKD2
prerank,positive regulation of neutrophil migration (GO:1902624),-0.28773873420313245,-0.7841518897467473,0.7944664031620553,0.9742087208819872,1.0,4/18,8.56%,MCU;RAC1;RIPOR2;MOSPD2
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.39760625312004105,0.7839626386477547,0.7163120567375887,0.9655566560467729,1.0,3/13,14.15%,HACD1;TECR;HACD4
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.2953831012835235,-0.7834424775513376,0.7531380753138075,0.9736309247774615,1.0,11/18,27.40%,EXOSC10;DCP2;CCT4;SHQ1;CCT6A;CCT8;CCT2;CCT7;NAF1;CCT5;DKC1
prerank,regulation of response to interferon-gamma (GO:0060330),0.39178184521861376,0.783181529398089,0.724233983286908,0.9662578628374127,1.0,1/14,1.34%,PARP9
prerank,cellular response to exogenous dsRNA (GO:0071360),-0.3259933191662999,-0.7831752921538362,0.7483870967741936,0.9723069400458544,1.0,4/12,14.17%,DHX9;RALB;IFIH1;CGAS
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.3815424593267974,0.7831129296162133,0.7351724137931035,0.9659530535965842,1.0,1/16,2.34%,FGF1
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.3707021125855129,0.7829913358135036,0.7540322580645161,0.9657219814762504,1.0,3/20,8.83%,PID1;PPFIA1;DAB2
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.29391956221594934,-0.782892347653673,0.7589928057553957,0.9710453088537269,1.0,12/16,35.63%,PIGN;PIGV;PIGB;PIGL;PIGG;PIGX;PIGM;PIGZ;PIGF;PIGA;DPM2;PIGC
prerank,axonal fasciculation (GO:0007413),0.40171100141532734,0.7828067210902764,0.7306002928257687,0.9655950244756645,1.0,3/12,13.32%,EPHB2;ARHGAP35;RTN4
prerank,lytic vacuole organization (GO:0080171),0.35505412940384357,0.7827513739472439,0.7733175914994097,0.9652837668047475,1.0,7/32,14.45%,LRRK2;AKTIP;ARSB;HPS4;MTOR;ABCA1;TPCN2
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.34281774702916445,0.7827146052315966,0.7630057803468208,0.9649435708328665,1.0,12/39,17.68%,NDEL1;MYO5A;FNBP1L;BICDL1;MYO1G;ACTN4;FBXW11;MYO1E;WASL;MYO1B;MYO1D;RAB1A
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.3252339660553332,0.782404391274612,0.7758433079434167,0.9649880010463834,1.0,7/57,9.10%,MINK1;CACNG7;AKAP9;DLG1;NETO1;DAPK1;GRIA4
prerank,response to cholesterol (GO:0070723),-0.2851448467592739,-0.7823555244074157,0.7859649122807018,0.9702891030928746,1.0,6/17,20.01%,TGFB1;SMAD2;PTCH1;SMO;OSBPL7;ABCA2
prerank,negative regulation of JUN kinase activity (GO:0043508),0.4172000395794223,0.7820909482438879,0.7412140575079872,0.9650282280802397,1.0,2/10,12.26%,DUSP10;AIDA
prerank,phospholipid transport (GO:0015914),0.32942481278920194,0.7820467285236316,0.777535441657579,0.9646923010562309,1.0,13/52,17.27%,ATP11C;TMEM30A;PITPNM1;PRELID2;ABCA7;ABCG1;ATP8B4;PITPNA;ABCA1;SCARB2;PITPNB;OSBPL2;ABCC1
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.3778234680210434,0.7819919519158782,0.7489655172413793,0.9643737183403152,1.0,2/16,13.44%,THBS1;PPP1R16B
prerank,lipid phosphorylation (GO:0046834),0.4113783992265388,0.781991894960283,0.7391304347826086,0.9639808980884454,1.0,4/10,17.83%,DGKI;DGKD;DGKZ;DGKH
prerank,cyclooxygenase pathway (GO:0019371),-0.3398113452602211,-0.781526402198357,0.7264957264957265,0.9699241278247619,1.0,6/10,50.89%,PTGES3;PTGES;CBR1;PTGDS;PTGIS;PTGES2
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.3261708267387316,0.7814020091673844,0.7716794731064764,0.964410443982326,1.0,7/54,12.11%,SIRT7;UBXN1;SQSTM1;ARRB2;NXN;U2AF2;CAMLG
prerank,tight junction assembly (GO:0120192),-0.21450301668425187,-0.7811443786101409,0.8901098901098901,0.9688977321298592,1.0,3/49,2.17%,F11R;STRN;TBCD
prerank,protein neddylation (GO:0045116),-0.31730238499255226,-0.7809872811757349,0.7597402597402597,0.9674405137690966,1.0,6/13,18.02%,DCUN1D1;UBA3;NAE1;RBX1;DCUN1D3;NEDD8
prerank,apoptotic mitochondrial changes (GO:0008637),0.3478698740150033,0.7808602619672408,0.7746650426309378,0.9647548076424913,1.0,9/32,16.98%,NDUFS1;VPS35;BNIP3;ATG3;BCL2;FZD9;DNM1L;HK2;MFF
prerank,regulation of DNA replication (GO:0006275),0.32317726195758184,0.7807388434565697,0.7654867256637168,0.9645302452221569,1.0,9/49,15.16%,BLM;EHMT2;PDS5A;FAF1;ZBTB38;ESCO1;TERF1;USP37;CTC1
prerank,tube closure (GO:0060606),0.34881122412111293,0.7807308363997459,0.7796610169491526,0.9641508810483828,1.0,5/31,13.13%,BBS4;TGFB2;MTHFR;DEAF1;LRP6
prerank,protein palmitoylation (GO:0018345),0.3471212449308894,0.7806702615853621,0.7426470588235294,0.9638445096022942,1.0,5/30,14.15%,ZDHHC24;ZDHHC5;ZDHHC1;ZDHHC6;ZDHHC20
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.402209667074548,0.7806630747346852,0.7472868217054264,0.9634619958395224,1.0,3/11,15.19%,MLIP;GLRX3;SMAD4
prerank,primary neural tube formation (GO:0014020),0.3508308640251407,0.7805548220047022,0.7785977859778598,0.9632105182728073,1.0,5/30,13.13%,BBS4;TGFB2;MTHFR;DEAF1;LRP6
prerank,histone H4-K8 acetylation (GO:0043982),0.38713795789710814,0.7805445696968822,0.7391304347826086,0.9624427901503219,1.0,3/15,10.82%,HCFC1;PHF20;JADE3
prerank,histone H4-K5 acetylation (GO:0043981),0.38713795789710814,0.7805445696968822,0.7391304347826086,0.9624427901503219,1.0,3/15,10.82%,HCFC1;PHF20;JADE3
prerank,proteoglycan metabolic process (GO:0006029),0.35607924295659044,0.7805113930538033,0.7708830548926014,0.9620983559274274,1.0,4/26,11.86%,ADAMTS12;CANT1;HS3ST4;CHST8
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.39880115301591323,0.7804769260338579,0.7426470588235294,0.9617500577679334,1.0,5/13,16.20%,TMEM30A;EDEM2;SORL1;SAR1B;CD81
prerank,positive regulation of heart contraction (GO:0045823),0.37370632823041494,0.7804725007656194,0.744429882044561,0.961365595862446,1.0,2/19,8.61%,TGFB2;TRPM4
prerank,RNA modification (GO:0009451),0.3292492368057003,0.780351356905839,0.775974025974026,0.9611536664146539,1.0,6/54,10.36%,NSUN6;RBM15;METTL3;NSUN3;AARS1;ADAR
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.33728768878396487,-0.7802575532356175,0.7507082152974505,0.9670124680161224,1.0,5/11,21.16%,TGFB1;CSF1;RIPK1;HSF1;CASP8
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.38122022240514886,0.7801249233326777,0.7464985994397759,0.9610726772988469,1.0,2/15,8.52%,COL11A1;PIEZO2
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.3511874094534745,0.7797884529154206,0.755688622754491,0.9611427386874529,1.0,5/27,13.71%,SPRED2;PTTG1IP;CD44;SPRED1;DDX5
prerank,regulation of cation transmembrane transport (GO:1904062),0.3484131992930851,0.7795339822877815,0.7527675276752768,0.9611085439074998,1.0,5/29,13.72%,CACNA1D;DLG1;SLMAP;CD63;KCNIP3
prerank,positive regulation of filopodium assembly (GO:0051491),0.3607304838937892,0.7794658835825111,0.7537128712871287,0.9608044770976909,1.0,7/24,15.70%,NRP1;FNBP1L;CDC42;DOCK11;WASL;GPM6A;PIK3R1
prerank,presynaptic endocytosis (GO:0140238),0.3526458931326051,0.7792036274927893,0.7392900856793145,0.9607782967090602,1.0,6/24,15.36%,STON2;CEL;VAMP2;CDK5;AMPH;SYNJ2
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.29517153770069715,-0.7790149241854827,0.7857142857142857,0.9673899906974268,1.0,1/17,0.51%,RYR2
prerank,receptor-mediated endocytosis (GO:0006898),0.31130899304946,0.7786795291580159,0.8690355329949239,0.961114328420992,1.0,28/132,16.20%,CD36;LDLRAP1;GRB2;WASF1;HSPH1;FNBP1L;ARRB2;AP2A1;HSP90AA1;NEDD4;LMBRD1;DAB2;COLEC12;SNX1;RAMP1;SORL1;LRP6;SYK;COLEC11;INSR;CALCRL;EPS15;TPCN2;CLTC;SCARB2;DNAJC13;INPP5F;CD81
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.2916564293178057,-0.7786312316504161,0.8,0.9662795509631144,1.0,3/16,3.71%,PARP14;PTPN2;NF2
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.3294944422440231,-0.7782629778880036,0.7799442896935933,0.9651746777868504,1.0,1/11,14.45%,RTP4
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.391852096097532,0.7780146810822448,0.7181688125894135,0.9616218224029667,1.0,2/13,8.20%,PRPF3;PRPF6
prerank,cGMP biosynthetic process (GO:0006182),-0.34422040362084566,-0.7776277321215584,0.7808988764044944,0.9644687485259699,1.0,8/10,61.85%,GUCY1B1;GUCY1A1;NPPC;NPR2;NPR1;GUCY2F;GUCY2D;GUCY2C
prerank,mesoderm development (GO:0007498),0.3814106185091486,0.7775268444082216,0.7443708609271523,0.9619056601365567,1.0,2/18,6.56%,BTK;IKZF1
prerank,respiratory electron transport chain (GO:0022904),-0.306770357761022,-0.777347816872131,0.7589928057553957,0.9632368556216123,1.0,10/14,39.24%,SLC25A13;GPD2;SDHB;PPARGC1A;ETFDH;SLC25A12;UQCRFS1;ETFRF1;NDUFA5;SLC25A22
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.37984855278917956,0.7772959302148336,0.7657295850066934,0.9618304038385718,1.0,4/17,16.27%,TPM1;PPARG;PTEN;MEF2C
prerank,C21-steroid hormone metabolic process (GO:0008207),0.3678877270206656,0.7772209461088829,0.7639257294429708,0.9615337914324347,1.0,1/20,4.27%,AKR1B1
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.37548345632452074,0.7771834193045778,0.7333333333333333,0.9611912569046707,1.0,2/18,7.87%,NF1;TENM4
prerank,positive regulation of interleukin-2 production (GO:0032743),0.35165430119004126,0.7769236940281564,0.7328339575530587,0.9611575786442386,1.0,6/25,13.90%,GLMN;RUNX1;IL1A;SPTBN1;TRAF2;PRKD2
prerank,negative regulation of double-strand break repair (GO:2000780),-0.24866397187139916,-0.7768286230682113,0.8181818181818182,0.9624126251978365,1.0,5/30,7.31%,RIF1;ERCC6;SHLD1;SHLD2;KLHL15
prerank,regulation of monooxygenase activity (GO:0032768),0.3596683975466358,0.7767064117129859,0.7506361323155216,0.9610646249773871,1.0,5/23,14.75%,NOSTRIN;IL1A;HSP90AA1;CALM1;WASL
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.33405058195196097,0.7764922667533306,0.7617370892018779,0.9609523983160398,1.0,8/37,14.85%,ABCD2;ALOX5;CUEDC2;PLD4;IL17RA;MAPK14;ABCD1;TLR4
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.4017160835221777,0.7761325300654784,0.7250384024577573,0.9610571181169636,1.0,2/11,11.20%,LRP5;TGFBR2
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.37174273533228686,0.7760710113258461,0.7477003942181341,0.9607537182798956,1.0,3/18,8.72%,ACSBG1;HACD1;TECR
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.35845230900345165,0.7754873410884916,0.7540777917189461,0.9611425455918775,1.0,3/25,11.54%,EAF1;THOC5;ZMYND11
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.35604154822834416,0.775401541972108,0.7623888182973316,0.9608866199049925,1.0,7/24,17.58%,PRKAR2A;PDE3B;RNF157;PEX5L;PRKAR1A;RAPGEF2;UBE2B
prerank,inorganic anion transmembrane transport (GO:0098661),-0.20201980086172855,-0.7753390432672103,0.9295774647887324,0.9631646558697494,1.0,27/63,33.82%,GABRB1;ANO6;GABRA2;ANO3;GABRA3;SLC12A9;GLRA1;CLCN3;SLC20A1;SLC1A1;SLC12A2;GABRA5;SLC6A1;SLC25A30;SLC26A2;GLRA2;GABRA4;GABRB3;GABRG1;SLC25A11;ANO5;SLC25A14;GABRA1;SLC12A7;SLC4A8;SLC12A5;LRRC8A
prerank,neuron cell-cell adhesion (GO:0007158),-0.30504435326948526,-0.7749698139070152,0.7670250896057348,0.9620814228903621,1.0,8/14,34.24%,ASTN2;NRXN1;NINJ2;NRXN2;CDK5R1;NCAM2;NLGN2;NLGN3
prerank,regulation of peptidase activity (GO:0052547),0.36813540535612077,0.7743044662117452,0.7420212765957447,0.9620022497636327,1.0,3/19,10.43%,PSMB8;NRDC;FURIN
prerank,regulation of catecholamine secretion (GO:0050433),-0.24282724321810878,-0.774245218998627,0.832258064516129,0.9615540253400834,1.0,13/29,31.82%,PRKN;SYT1;GRK2;SNCA;SYT4;SYT2;SYT9;SYT10;SYT7;KCNA2;STX1A;KCNB1;SYT6
prerank,embryonic skeletal system development (GO:0048706),-0.22804761552778446,-0.7736689425676865,0.8506493506493507,0.9607994041708043,1.0,4/35,8.34%,KIAA1217;DSCAML1;XYLT1;SULF2
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.37688741803237347,0.7731692970010109,0.7521489971346705,0.9631461400027376,1.0,2/15,9.37%,TGFB2;CUEDC2
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.33160149128698596,0.7730651687529221,0.7741573033707865,0.9628905388035465,1.0,8/44,12.05%,EIF4ENIF1;FTO;TNRC6B;METTL3;AGO2;YTHDF1;PUM1;ZFP36L1
prerank,carbohydrate transport (GO:0008643),-0.339533222701031,-0.7725324879639199,0.7666666666666667,0.9608837615148953,1.0,7/11,65.97%,SLC2A5;SLC50A1;SLC26A6;AQP11;AQP1;SLC2A2;SLC5A1
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.3827467053952423,0.7720573208829071,0.7555555555555555,0.9638505545342215,1.0,4/15,14.75%,DAB2;DGKD;BMP2K;WASL
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.3211207355197522,0.7719954293701892,0.8122941822173436,0.9635345807726818,1.0,12/59,14.70%,MED10;RELA;JUN;TNRC6B;MECP2;SETX;TCF7L2;TP53;CDK8;MED27;MED15;PTEN
prerank,response to lipopolysaccharide (GO:0032496),0.3094864043412866,0.7712330448009618,0.8668012108980827,0.964163923190391,1.0,15/138,12.92%,TNFRSF11A;RELA;SMAD6;CTR9;CHMP5;PELI1;LIAS;AXL;IL1A;MAPK8;PLAA;SRR;HMGB1;MAPK14;MAPKAPK2
prerank,protein-DNA complex assembly (GO:0065004),0.30958046588888827,0.7712267143948437,0.8603465851172273,0.9637861912273867,1.0,20/116,15.65%,CETN2;PSMD9;ORC4;ASF1A;PSMB8;CDK7;SPTY2D1;PSMC5;MNAT1;BRD2;ORC2;CUL4A;PSMD12;PSMA2;ATRX;GTF2H1;RAD23B;ANP32B;NPM1;PSMB1
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.3600390276736488,0.771173655037392,0.7486702127659575,0.9634693943238106,1.0,5/21,18.31%,CX3CL1;FZD9;FZD3;CTNNB1;PROX1
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.3128400693414173,0.7705103205245003,0.8864321608040201,0.9639866187524467,1.0,13/159,12.29%,SDK2;PCDHB16;MILR1;TGFB2;ACVR1;TENM4;PTPRT;NPTN;CDH11;PALLD;TGFBR2;PCDHGB4;CDH20
prerank,positive regulation of signaling (GO:0023056),0.3407587153095056,0.7699326743618516,0.770663562281723,0.9643863550956132,1.0,7/37,11.42%,VAMP3;CLSTN3;PTPN23;ANXA2;CLSTN1;WLS;SOX11
prerank,protein acylation (GO:0043543),0.3330256821384454,0.7694725021473572,0.7699530516431925,0.9645864984308579,1.0,8/38,14.15%,CLOCK;EP300;ZDHHC5;ZDHHC1;GTF2B;KAT2B;ZDHHC6;ZDHHC20
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.4038114760506072,0.7694650904713585,0.7496159754224271,0.9642109894538485,1.0,4/10,17.54%,PTPRJ;HGS;NDRG4;APOD
prerank,negative regulation of cellular protein localization (GO:1903828),0.33784640211201367,0.7692036801125752,0.7755581668625147,0.9641640931646439,1.0,4/34,7.60%,MAP1A;ILRUN;CTNNA1;MAPT
prerank,positive regulation of glucose metabolic process (GO:0010907),0.38120673394786564,0.7691948321489965,0.7542613636363636,0.9637878274765905,1.0,2/14,6.71%,IRS1;IRS2
prerank,rRNA modification (GO:0000154),0.3581562952675552,0.7687595001461089,0.7717678100263852,0.9640066824073332,1.0,2/21,6.76%,TFB2M;NSUN3
prerank,dephosphorylation (GO:0016311),0.3027571892667947,0.7682755444135265,0.856710393541877,0.9642731413039091,1.0,26/147,14.87%,DUSP3;SGPP1;DAPP1;PPP2R2A;SGPP2;PTPRJ;CTDNEP1;STK11;DUSP16;DUSP10;SSH2;PTPN1;PTPRT;PPP4R1;PTPN3;FBXW11;PPM1A;CTDP1;DUSP12;PTPRU;PTPRO;PPP2R3A;PPP2R5C;PTEN;PTPN9;PTPN18
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.305467034105805,0.7672242887802397,0.8837675350701403,0.9652598666423328,1.0,32/163,16.52%,RELA;CD38;RNF31;RFTN1;PSMD9;PSMB8;PRKCB;BTK;VAV3;PTPRJ;RC3H2;SPPL3;PSMC5;IKBKB;PAK2;NCK1;ICOSLG;NFKBIZ;FBXW11;PSMD12;PSMA2;BCL2;SYK;FYN;PRKD2;SH2B2;THEMIS2;PSMB1;PIK3R1;PAK1;MEF2C;FYB1
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.34535761737300946,0.7664896589715399,0.792814371257485,0.9658353150389084,1.0,7/32,12.48%,STMN2;MAPRE1;ATXN7;CAMSAP3;APC;TAOK1;EML2
prerank,negative regulation of coagulation (GO:0050819),-0.301878355460386,-0.7664275642553697,0.7484472049689441,0.9688839546074111,1.0,4/14,20.97%,SERPINE2;HS3ST5;CD34;TFPI
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.3781907781279346,0.7663979145639507,0.7352941176470589,0.9655712995901085,1.0,1/14,1.07%,LRRK2
prerank,regulation of protein localization (GO:0032880),0.3231416575903807,0.7663122174590712,0.8091684434968017,0.9652903708209875,1.0,7/58,10.54%,FBXW7;DVL1;VPS4A;HSP90AA1;DLG1;MAPK8;TRIM5
prerank,oligodendrocyte differentiation (GO:0048709),0.3695043757474412,0.7662006689112011,0.7522935779816514,0.965046345874141,1.0,3/19,12.64%,SOX13;CDK5;SOX6
prerank,magnesium ion transport (GO:0015693),0.39197442300892543,0.7653764866915105,0.7587253414264037,0.9657570298181405,1.0,2/12,12.14%,NIPAL3;NIPA2
prerank,skeletal system morphogenesis (GO:0048705),0.32849506129370154,0.7652472231292482,0.7779043280182233,0.9655545505943398,1.0,7/42,13.43%,LRP5;HOXC4;ANKRD11;SOX11;TGFBR1;LRP6;WWOX
prerank,sphingoid biosynthetic process (GO:0046520),0.3986429111172223,0.7649804947356665,0.75,0.9651394964882287,1.0,3/11,14.77%,ACER3;ASAH1;SPTLC1
prerank,sphingosine biosynthetic process (GO:0046512),0.3986429111172223,0.7649804947356665,0.75,0.9651394964882287,1.0,3/11,14.77%,ACER3;ASAH1;SPTLC1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.32024284013422283,-0.7644327964839092,0.7645348837209303,0.9702048294286837,1.0,5/11,21.66%,MBTPS2;ATF3;DDIT3;CEBPB;ATF4
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.3300757005378285,0.7643906965370587,0.7640718562874251,0.9655028750227763,1.0,8/33,15.70%,NF1;IRS1;NYAP1;IGF1R;ZFP36L1;PIK3C2A;PTEN;PIK3R1
prerank,pinocytosis (GO:0006907),0.40535157998857574,0.7641911106905805,0.7565084226646248,0.9653723771706668,1.0,2/10,12.92%,SNX5;MAPKAPK2
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.3435809818002662,-0.7636253446707766,0.7645348837209303,0.9698301305507376,1.0,4/10,12.33%,SESTD1;ATP1A2;VDAC1;FKBP1A
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.3569103496460274,0.7635100900722005,0.7623261694058154,0.9658833099599109,1.0,4/24,12.68%,CRLS1;GPAM;PLA2G4A;SLC27A1
prerank,cellular respiration (GO:0045333),0.3265887998369189,0.7632944849229714,0.7878440366972477,0.9657885151370066,1.0,3/41,3.19%,UQCRH;UQCRC1;NDUFS1
prerank,histone H3-K4 methylation (GO:0051568),0.3459993673614222,0.7632060633596764,0.7653562653562653,0.9655248603808214,1.0,2/26,3.61%,CTR9;SETD1A
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.3707886187852835,0.7619929741985824,0.7852257181942545,0.9667231802131553,1.0,3/17,14.85%,EMC9;CAMLG;EMC2
prerank,negative regulation of interleukin-8 production (GO:0032717),0.369007595150888,0.7619634750717236,0.7751724137931034,0.9663765862147087,1.0,3/17,11.73%,MAPKBP1;MAP2K5;TMSB4X
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.39013740662018015,0.7619013040433491,0.7797356828193832,0.9660732621450681,1.0,2/13,11.20%,RUNX1;TGFBR2
prerank,proteasomal protein catabolic process (GO:0010498),0.30426313780064396,0.7618560969582997,0.9169169169169169,0.9657458518181005,1.0,37/201,14.70%,KLHL42;FBXW7;UBXN1;CLOCK;FEM1C;PELI1;PSMD9;GID4;GID8;PSMB8;ARRB2;NHLRC1;UBE2A;PSMC5;RNF34;NEDD4;ERLEC1;BFAR;HECW1;AREL1;FAF1;RNF216;PLAA;TRIM3;FBXW11;DERL1;CUL4A;UBE2W;PSMD12;NHLRC3;PSMA2;APPBP2;ATXN3;PPP2R5C;TBL1XR1;UBE2D3;RAD23B
prerank,response to organic cyclic compound (GO:0014070),0.3223312365625367,0.7617331212366665,0.7978021978021979,0.9655179970465141,1.0,4/52,8.68%,LRRK2;ESR1;TLR3;IL18
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.30648334486017126,0.7615869537988722,0.8555442522889115,0.9653437999062007,1.0,27/119,15.91%,ARF3;SOCS4;SOCS7;MTMR1;PIP4K2A;PIK3R4;PIGP;INPP4A;PITPNM1;PI4KA;PI4K2A;CDS1;PIP4K2B;SOCS5;FIG4;ARF1;EFR3B;OCRL;PIGU;SLC27A1;PIK3C2A;PTEN;SYNJ2;MTM1;PIK3R1;INPP5F;PIGQ
prerank,cellular response to light stimulus (GO:0071482),0.3133114396463609,0.7613642992740844,0.8358369098712446,0.9652341307239841,1.0,12/66,16.68%,SMPD1;EP300;METTL3;NEDD4;ERCC4;NOC2L;TP53;EIF2S1;GNB1;NPM1;RHBDD1;ZBTB1
prerank,ion transport (GO:0006811),0.3079228807149575,0.7613568611024449,0.8700102354145343,0.9648638525455282,1.0,14/111,14.42%,SLC24A5;SLC9A9;SLC9A1;SLC26A11;SLC15A3;PIEZO2;SLC25A26;SLC9A7;SLC9A6;GLRB;MCOLN1;SLC12A6;SLC15A4;SLC20A2
prerank,membrane fusion (GO:0061025),0.3316149033805438,0.7607136503258844,0.7815533980582524,0.9652934500778906,1.0,4/33,4.77%,NAPG;VAMP3;MYOF;RABEP1
prerank,ketone body metabolic process (GO:1902224),0.39844783973173536,0.7605509813098611,0.7781065088757396,0.9651143593503242,1.0,1/10,3.78%,ACAT1
prerank,DNA integrity checkpoint signaling (GO:0031570),0.3298198773823983,0.7601603143916994,0.7793263646922184,0.96525644577663,1.0,5/36,9.93%,CLOCK;MAP3K20;NBN;CHEK2;CDC5L
prerank,glycerolipid catabolic process (GO:0046503),0.3606943023895766,0.7600915376992666,0.7677165354330708,0.9649663655091081,1.0,4/19,12.07%,ABHD6;PLA2G4A;PNPLA6;GPCPD1
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.40042079245437384,0.7599200999731148,0.7589424572317263,0.9648183210888233,1.0,3/11,13.42%,TCP1;CCT3;TERF1
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.3750969235225886,0.759770133199615,0.7659574468085106,0.9642428276156014,1.0,2/16,4.55%,ITGB1BP1;THBS1
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.3750969235225886,0.759770133199615,0.7659574468085106,0.9642428276156014,1.0,2/16,4.55%,ITGB1BP1;THBS1
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.33342284022164126,-0.7597199806851098,0.7904191616766467,0.9742889804081196,1.0,5/10,35.36%,UFL1;MLLT3;LMBR1L;BATF;HOXB4
prerank,mitotic cytokinetic process (GO:1902410),0.36140662235805127,0.7593947231098849,0.7526737967914439,0.9643514848199362,1.0,4/20,13.31%,VPS4A;CHMP5;VPS4B;PDCD6IP
prerank,keratan sulfate metabolic process (GO:0042339),0.33710663838388366,0.7589209236900564,0.7681159420289855,0.9645665456400008,1.0,4/31,11.61%,B4GALT3;B4GALT5;B4GALT1;B3GNT2
prerank,cellular response to amino acid starvation (GO:0034198),0.31450677595271787,0.7587235667968191,0.8293991416309013,0.9644508046913673,1.0,14/71,14.53%,EIF2AK2;IMPACT;MAPK1;MIOS;ATP6V0E1;MAPK8;ATP6V1E1;MTOR;SLC38A9;SH3GLB1;EIF2S1;ATP6V0D2;ATP6V1H;LARS1
prerank,protein deacylation (GO:0035601),0.3489018866912306,0.7582435237831326,0.7759699624530664,0.9646741207241737,1.0,2/23,6.16%,SIRT7;HDAC5
prerank,glycolipid metabolic process (GO:0006664),0.3208661973595068,0.7579919001081772,0.8080357142857143,0.9646293375918579,1.0,7/47,12.72%,GBA2;SMPD3;SMPD1;GALC;ASAH1;B3GALNT1;FUCA1
prerank,negative regulation of catabolic process (GO:0009895),0.31950050756277426,0.7572832850590611,0.8055865921787709,0.9651685526072904,1.0,5/47,8.99%,NUPR1;FLNA;PDE3B;SNX3;NCOR1
prerank,positive regulation of monooxygenase activity (GO:0032770),0.3421829085436626,0.7572195790353102,0.7866831072749692,0.964867170115156,1.0,2/26,5.11%,ATP7A;TERF2
prerank,embryonic digestive tract development (GO:0048566),-0.2807284841169019,-0.7568970141546543,0.7890625,0.9769505491736534,1.0,3/18,3.58%,SALL1;FGFR2;NIPBL
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.37793860660187945,0.7567895994956922,0.7719546742209632,0.9650356442153462,1.0,2/13,11.65%,SOAT1;RAMP1
prerank,regulation of adenylate cyclase activity (GO:0045761),0.3516667705803977,0.7557532639249664,0.7767741935483871,0.9659779287555113,1.0,4/22,14.79%,CACNA1D;NF1;GNAI3;CACNA1C
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.33044192924237004,0.7553571149313733,0.8165887850467289,0.9660851161646515,1.0,4/34,5.54%,IRS1;PIK3R4;PDGFB;AMBRA1
prerank,ERK1 and ERK2 cascade (GO:0070371),0.3520408361847926,0.7551194473076693,0.783748361730013,0.9660185807986696,1.0,6/21,18.24%,MAPK1;ZFP36L1;MAP2K2;LGALS9;MAP2K1;CTSH
prerank,linoleic acid metabolic process (GO:0043651),0.36939430512846627,0.7546677191132113,0.7737127371273713,0.9662337474898555,1.0,3/17,12.94%,ALOX5;FADS1;ABCD1
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.3420016380649617,0.7538118580214105,0.7804265997490589,0.966920654219731,1.0,3/26,6.71%,BRAF;IRS1;IRS2
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.3375655281505269,0.7533623830973215,0.7838479809976246,0.9671348959048605,1.0,7/31,16.57%,CDK6;DLG1;APC;BRD7;PKD2;PTEN;RB1
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.3229502701415552,0.7531302584876086,0.802646085997795,0.9670431715671193,1.0,11/46,18.29%,LRRK2;CACNG7;DGKI;CDK5;GRM7;RELN;DGKZ;MEF2C;ATAD1;TSHZ3;HOMER1
prerank,calcium ion import (GO:0070509),0.3402740031093439,0.752884904769816,0.7843601895734598,0.9669719779960795,1.0,3/28,9.91%,MICU1;CACNA1D;CACNA1A
prerank,DNA conformation change (GO:0071103),-0.28351674020735584,-0.7526751150115912,0.8091603053435115,0.9817265846342472,1.0,8/17,31.13%,KAT6A;HAT1;TOP3B;TOP3A;TOP1;HHEX;ERCC3;HMGB2
prerank,regulation of hippo signaling (GO:0035330),-0.2763353113484079,-0.7523745222969224,0.8305785123966942,0.9804783231091857,1.0,10/17,31.79%,NF2;LIMD1;MARK3;DLG5;CIT;MAP2K3;SHANK2;WWC1;WTIP;WWC2
prerank,positive regulation of wound healing (GO:0090303),0.32238890891282923,0.7522771850527625,0.7887323943661971,0.9673788255750874,1.0,5/36,13.73%,THBS1;ENPP4;ARFGEF1;MTOR;RREB1
prerank,regulation of exocytosis (GO:0017157),0.3215383198805208,0.7522131825229936,0.8129175946547884,0.967079079071684,1.0,9/46,13.05%,UNC13D;RAB8B;RAB12;CADPS;LGI3;VAMP2;STXBP5;STXBP5L;RAB3C
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.34505214134102646,0.7522010501290878,0.8118556701030928,0.9667190650066686,1.0,2/25,4.31%,COX17;AKAP9
prerank,female gamete generation (GO:0007292),-0.24399810499562444,-0.7521513838967369,0.8522727272727273,0.9790987499256598,1.0,3/29,6.79%,USP9X;KMT2D;MCM9
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.32813430292195883,0.7521041643417914,0.7858823529411765,0.966463869640341,1.0,1/39,0.38%,RGCC
prerank,organelle transport along microtubule (GO:0072384),0.3375916999715534,0.7520582174911928,0.7788697788697788,0.9661436146393328,1.0,9/31,16.29%,NDEL1;BICDL1;MAPT;RAB6A;CDC42;FBXW11;BICD1;PEX14;LRPPRC
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.2387861754093497,-0.7517820337225403,0.9119496855345912,0.9780057331937869,1.0,9/34,17.40%,OTUD4;CD300LF;PTPRS;LGR4;GPS2;LY96;TNFAIP3;IRAK3;GRAMD4
prerank,positive regulation of lipid metabolic process (GO:0045834),0.35124022007454914,0.7516359164626297,0.788235294117647,0.9663018602940285,1.0,4/22,14.37%,PPARG;MTOR;CREB1;PPARD
prerank,positive regulation of ERAD pathway (GO:1904294),0.3804736274861697,0.7511882310037663,0.7711864406779662,0.9664807847491991,1.0,3/13,13.77%,UBQLN1;TMEM259;ATXN3
prerank,anion transport (GO:0006820),0.3309769178559187,0.7511705004448685,0.7835909631391201,0.9661225091702376,1.0,4/33,15.52%,SLCO1B1;LRRC8B;SLCO2B1;ABCG2
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.2978808620175085,-0.7510274087968705,0.7971014492753623,0.977501109788293,1.0,3/15,6.69%,PTPN2;NLRC5;CNOT7
prerank,neutrophil activation (GO:0042119),0.3820053056030449,0.7506650767172409,0.755072463768116,0.9663737166010077,1.0,3/12,16.65%,KMT2E;SYK;PREX1
prerank,aortic valve development (GO:0003176),0.33261937223168425,0.7503859185465565,0.8048192771084337,0.9663470173935901,1.0,2/34,4.22%,SMAD6;NFATC1
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.30884285052036403,-0.7500355362458341,0.7916666666666666,0.9772633625258826,1.0,3/13,5.07%,SYNGR1;SHISA9;CLN3
prerank,response to molecule of bacterial origin (GO:0002237),0.3104472796568761,0.7497470791197892,0.8202127659574469,0.9667465273966253,1.0,9/69,14.85%,TNFRSF11A;SMAD6;PELI1;LIAS;SRR;CYRIB;MAPKAPK2;LGALS9;TLR4
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.3654887272860095,0.749203070814189,0.7905405405405406,0.9670119694905659,1.0,6/18,19.21%,CTR9;CBL;SMAD4;FER;PTPN11;SPI1
prerank,regulation of B cell differentiation (GO:0045577),0.3691274407108677,0.7489133800801826,0.7755102040816326,0.9670034115295526,1.0,4/17,17.29%,BTK;ZFP36L1;SYK;NCKAP1L
prerank,positive regulation of ATP metabolic process (GO:1903580),0.33383677951138213,0.7488682077136231,0.793144208037825,0.9666852681856899,1.0,10/32,18.25%,PID1;NUPR1;ENO1;TMSB4X;INSR;ARNT;PFKFB3;TREM2;PSEN1;ZBTB20
prerank,neuromuscular process (GO:0050905),0.3653932522049096,0.7487145529475645,0.7861975642760487,0.9665069542915562,1.0,2/16,7.27%,UBA5;DCTN1
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.3036398526757254,0.7479183552817698,0.8756423432682425,0.9671328516027519,1.0,22/108,17.43%,UACA;MTCH1;APAF1;SMAD3;EGLN3;MAPT;DAPK1;PPARG;F3;TRAF2;HMGB1;AIFM1;SYK;HTRA2;LGALS9;CASP8AP2;ANP32B;HIP1;ARL6IP5;CFLAR;GSN;SENP1
prerank,carbohydrate catabolic process (GO:0016052),0.32571339458597964,0.7476925731946976,0.8055878928987195,0.9670338021519767,1.0,5/38,11.56%,PGAM4;PGAM1;ALDOA;ENO1;GCK
prerank,calcium-mediated signaling (GO:0019722),0.3042997386956434,0.7474185874000541,0.8605371900826446,0.966981435325481,1.0,14/93,14.79%,LRRK2;SLC9A1;PRKACA;BTK;PTPRJ;TRPM4;RCAN2;RCAN3;PRNP;PPP1R9A;CAMKK2;TPCN2;P2RY12;CACNA1C
prerank,organelle disassembly (GO:1903008),0.3271121876712706,0.7472247746208985,0.7912735849056604,0.9668462875725483,1.0,5/33,12.19%,DENR;UBA5;UFC1;ULK2;RB1CC1
prerank,positive regulation of lamellipodium organization (GO:1902745),0.33149676489677604,0.7471964362232519,0.7932285368802902,0.9664979029986258,1.0,9/32,16.64%,ACTR3;TWF2;CDC42;ARPC2;WASF2;RREB1;AUTS2;PIK3R1;CYFIP1
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.30007642449140903,0.7467878079764431,0.8796296296296297,0.9666355906626392,1.0,16/121,12.92%,PARP9;GAS6;NRP1;PDGFB;PTPRJ;ACVR1;PAK2;PTPN1;IL18;LRP8;LYN;CD44;PRNP;ABL1;BANK1;TP53
prerank,regulation of cellular amide metabolic process (GO:0034248),0.3322276769133694,0.7467009298986524,0.801909307875895,0.966367102619689,1.0,9/32,18.14%,PGAM1;METAP1;RBM3;ATXN2;TSC1;CYFIP1;EIF4E;FOXO3;ROCK1
prerank,negative regulation of interleukin-17 production (GO:0032700),0.39623618283203044,0.7462393925435934,0.7651632970451011,0.9665762951377334,1.0,3/10,17.29%,PRNP;TLR4;NCKAP1L
prerank,chromatin assembly (GO:0031497),0.3242737858461857,0.7461341389506473,0.7995226730310262,0.9663283067780671,1.0,9/38,15.24%,ASF1A;SPTY2D1;BRD2;NOC2L;TP53;ATRX;ANP32B;CTCF;NPM1
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.3453701559489657,0.7458924669977778,0.8002594033722439,0.9662560968913255,1.0,5/21,16.98%,BMPR1A;DAB2;TGFBR1;SMAD4;NUP93
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.3485548760586702,0.7457671992951291,0.7827225130890052,0.9660342371207067,1.0,4/22,11.91%,SMARCA4;UBTF;MTOR;HEATR1
prerank,carbohydrate biosynthetic process (GO:0016051),0.34324182895726835,0.7457671210032267,0.7940026075619296,0.9656589324442807,1.0,8/21,19.07%,MPDU1;B4GALT1;B3GALT1;ST3GAL2;ST3GAL4;B3GALT5;ST3GAL3;FUT8
prerank,polyamine metabolic process (GO:0006595),-0.3033256998814453,-0.7456930236862173,0.8246753246753247,0.9819991055853804,1.0,5/13,19.01%,SAT1;SMS;AMD1;PAOX;OAZ2
prerank,negative regulation of developmental process (GO:0051093),0.30520905375247287,0.7456417541043471,0.8372844827586207,0.9654354929516961,1.0,10/69,15.94%,ADCK1;HOPX;GAS6;CDK6;MAPT;BNIP3;BCL11A;ROCK2;ANP32B;NFIB
prerank,regulation of superoxide anion generation (GO:0032928),-0.2976285742427304,-0.7454993182299228,0.8258064516129032,0.9805880883486159,1.0,3/14,8.08%,TGFB1;TYROBP;ITGB2
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.35485663279626833,0.7451793051671197,0.8002717391304348,0.9656219516338659,1.0,3/20,8.83%,PID1;PPFIA1;DAB2
prerank,response to amino acid starvation (GO:1990928),0.30873833833713704,0.7451053008007383,0.8485499462943072,0.9653416065223246,1.0,13/72,13.11%,EIF2AK2;IMPACT;MAPK1;MIOS;ATP6V0E1;MAPK8;ATP6V1E1;MTOR;SLC38A9;SH3GLB1;EIF2S1;ATP6V0D2;ATP6V1H
prerank,regulation of protein neddylation (GO:2000434),-0.32697228942380324,-0.7436090845796166,0.7900874635568513,0.981577787947108,1.0,4/10,13.44%,DCUN1D1;RPL5;DCUN1D3;RPL11
prerank,T cell homeostasis (GO:0043029),-0.3263029980170532,-0.7435213475370549,0.8015873015873016,0.9800367438948109,1.0,3/10,23.35%,AKT1;PPP2R3C;ZC3H8
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.2655060730864426,-0.7425913194708758,0.8471615720524017,0.9797080372074871,1.0,4/20,7.45%,ACSL4;PPT1;ACLY;ACSL3
prerank,response to axon injury (GO:0048678),0.35659857889960805,0.7423399878458479,0.7906976744186046,0.9683601169292743,1.0,6/18,17.88%,NREP;MTR;GAP43;P2RY12;APOD;TREM2
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.3404316728218897,0.7421724493150521,0.7984790874524715,0.9681902524960391,1.0,1/25,1.82%,CX3CL1
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.3750718503635564,0.7419750597167726,0.7908689248895434,0.9680438849666255,1.0,1/14,4.55%,THBS1
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.36480074837946824,0.7418316293829537,0.7718309859154929,0.96785646065287,1.0,4/15,17.88%,EHD1;MAPK14;CAMK1;TREM2
prerank,regulation of trans-synaptic signaling (GO:0099177),0.32988286376598536,0.7416389708301343,0.7925659472422062,0.9677194371977916,1.0,8/33,15.72%,CEL;PSMC5;NRG3;LRP8;CACNA1A;RELN;IQSEC2;GRID2
prerank,regulation of humoral immune response (GO:0002920),0.32114664833323764,0.7415739637719363,0.8130630630630631,0.9674365578947849,1.0,5/44,16.20%,C5AR1;CFH;C1QB;PROS1;CD81
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.32212441692253124,0.7409946731295515,0.7993079584775087,0.967733960698802,1.0,8/38,15.09%,PTPRJ;ARRB2;PHLPP1;BANK1;SH2B3;PPP2R5C;PTEN;DAG1
prerank,tRNA wobble base modification (GO:0002097),-0.2950713426565133,-0.7409528171035817,0.8114478114478114,0.9803525506759267,1.0,3/14,7.21%,ELP4;ALKBH8;MTO1
prerank,lipid translocation (GO:0034204),0.341593869846142,0.7404420234310132,0.7854406130268199,0.9680248093274348,1.0,5/21,12.85%,ATP11C;TMEM30A;ABCA7;ATP8B4;ABCA1
prerank,oogenesis (GO:0048477),0.3693673842967158,0.7404075479081316,0.7752489331436699,0.9676927523618307,1.0,2/15,13.05%,METTL3;FMN2
prerank,calcium import into the mitochondrion (GO:0036444),0.39855874112756934,0.7401519632542906,0.7888563049853372,0.967642155946782,1.0,1/10,2.55%,MICU1
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.36120718166058974,0.7400768526409524,0.7943548387096774,0.9673677489582914,1.0,2/17,11.81%,UNC13D;SCAMP5
prerank,estrogen metabolic process (GO:0008210),0.3678739926782424,0.7398500753813899,0.7804878048780488,0.9672735116647251,1.0,2/15,12.99%,HSD17B11;HSD17B4
prerank,calcineurin-mediated signaling (GO:0097720),0.39644681610515087,0.7394268116157607,0.7830940988835726,0.9670446383365376,1.0,1/10,4.22%,NFATC1
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.39644681610515087,0.7394268116157607,0.7830940988835726,0.9670446383365376,1.0,1/10,4.22%,NFATC1
prerank,anterograde synaptic vesicle transport (GO:0048490),0.3565328783339728,0.7393546440299814,0.7745504840940526,0.9663937121982225,1.0,3/15,10.36%,AP3M1;DTNBP1;AP3M2
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.3565328783339728,0.7393546440299814,0.7745504840940526,0.9663937121982225,1.0,3/15,10.36%,AP3M1;DTNBP1;AP3M2
prerank,macrophage activation (GO:0042116),0.32493064988220216,0.7386864638421091,0.807185628742515,0.9667939618631107,1.0,4/34,7.60%,C5AR1;CX3CL1;IFI35;MAPT
prerank,modulation by symbiont of entry into host (GO:0052372),-0.2796696715861344,-0.7384733689770661,0.8211382113821138,0.9822769260230604,1.0,5/16,19.88%,HS3ST5;EXOC2;EXOC7;FUCA2;TRIM27
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.30560040200642563,0.7378996138078288,0.8717139852786541,0.9673651763145277,1.0,15/72,15.19%,PFDN1;STMN2;MAPRE1;ATXN7;ARFGEF1;CAMSAP3;SSH2;TWF2;APC;TAOK1;CYRIB;EML2;LIMA1;CLASP1;SMAD4
prerank,positive regulation of viral genome replication (GO:0045070),0.3300148319648326,0.7375402495077494,0.8029197080291971,0.9674246903081796,1.0,9/29,18.60%,PPID;PKN2;ADAR;SRPK2;TMEM39A;VAPB;TOP2B;DDX3X;STAU1
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.38093474087002777,0.7371539502014419,0.7879234167893961,0.9675294027373991,1.0,3/12,15.97%,PTPRO;MYO1E;IQGAP1
prerank,protein auto-ADP-ribosylation (GO:0070213),0.3841045872231796,0.7368935450405184,0.7826725403817915,0.967449980927064,1.0,3/12,8.76%,PARP8;PARP2;TNKS2
prerank,regulation of mRNA catabolic process (GO:0061013),0.2971511791122384,0.7368814315329764,0.899492385786802,0.9670903216329488,1.0,20/121,12.95%,CARHSP1;PSMD9;PSMB8;EXOSC5;PRKCA;PUM2;RC3H2;EXOSC7;PSMC5;XRN1;SET;YTHDF1;FXR2;PUM1;DCP1A;ZFP36L1;PSMD12;SAMD4A;MAPKAPK2;PSMA2
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.3428967864861789,0.7367869069723159,0.7924528301886793,0.9668283966672493,1.0,6/21,17.22%,RELA;PRKCB;SLC39A10;PRKD2;CD81;PRKCH
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.3214738697938988,0.7365281559805078,0.8173302107728337,0.9667784049063742,1.0,4/37,6.46%,CLUAP1;DYNLL2;IFT52;IFT20
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.326597633834537,0.7360384857037371,0.8190830235439901,0.9669872226891365,1.0,8/29,16.40%,IRF3;BIRC3;IKBKB;TLR3;TANK;UBE2D3;TLR4;TBK1
prerank,arachidonic acid metabolic process (GO:0019369),0.3237918018334262,0.7359841879872842,0.8157589803012746,0.9666730413154824,1.0,3/35,8.48%,GPX4;PLA2G4A;ALOX5
prerank,regulation of immune effector process (GO:0002697),0.3168011874658003,0.7358866643018789,0.809255079006772,0.9664163873879935,1.0,5/41,16.20%,C5AR1;CFH;C1QB;PROS1;CD81
prerank,actin crosslink formation (GO:0051764),0.38368642606038794,0.7357496121698668,0.793400286944046,0.966210134692728,1.0,3/12,14.65%,FLNA;EPS8;AIF1
prerank,cardiac muscle cell development (GO:0055013),-0.2682689233836716,-0.735109591622689,0.8613445378151261,0.9852703703273186,1.0,10/20,57.04%,FHOD3;VEGFA;PDGFRA;CXADR;PDGFRB;SLC8A1;MYH11;HEY2;OBSL1;MYL2
prerank,calcium ion import across plasma membrane (GO:0098703),-0.2902164693048857,-0.7343926065493512,0.8402777777777778,0.9846090386618481,1.0,1/14,1.07%,CACNA2D1
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.37575344333204846,0.7339910071401267,0.781733746130031,0.9678753889146379,1.0,1/12,1.63%,CD36
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.24551483685269154,-0.7336653791956202,0.8502415458937198,0.9839653650883694,1.0,9/25,25.59%,BMPR2;SMAD2;ACVR2B;UBE2O;NOTCH1;BMPR1B;ENG;SULF1;ZNF423
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.2972165055987399,0.73360194530451,0.882414151925078,0.9679865813523276,1.0,15/88,15.65%,FBXO17;FBXW7;PSMD9;PSMB8;FBXO9;PSMC5;AMN1;FBXW11;CUL4A;FBXO38;PSMD12;PSMA2;FBXL7;FBXW4;PSMB1
prerank,activation of GTPase activity (GO:0090630),0.29941563352548295,0.7335084483608576,0.8765432098765432,0.9677063112665066,1.0,20/89,15.01%,SIPA1L3;TBC1D15;GPR65;EVI5;TBC1D17;ARHGAP22;TBC1D14;TBC1D10B;SIPA1L2;TBC1D4;TBC1D12;TBC1D5;TBC1D10A;TBC1D13;RABGAP1;ARHGAP45;TBC1D22A;TBC1D8;TSC1;TBC1D1
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.3451815735607448,0.7331115778625965,0.820580474934037,0.9678018185176769,1.0,8/20,19.38%,RGS14;RNF157;RPGRIP1L;BICD1;YWHAB;GPRASP1;PLEK;GRK3
prerank,regulation of BMP signaling pathway (GO:0030510),0.30502485173278193,0.7325793356254602,0.8560924369747899,0.9680745879569124,1.0,13/73,15.19%,DAND5;SMAD6;BMPR1A;CRIM1;LEMD2;PPARG;SOX11;SORL1;HIPK2;PCSK6;RBPJ;UBE2D3;SMAD4
prerank,regulation of anoikis (GO:2000209),-0.2630920458830207,-0.7324267132521766,0.8464566929133859,0.983984430336036,1.0,11/19,32.65%,PTK2;MCL1;PIK3CA;ITGA5;NOTCH1;SRC;TLE5;MYBBP1A;PTRH2;ITGB1;SIK1
prerank,peptidyl-arginine modification (GO:0018195),0.36319297871205136,0.7323946933554217,0.8017118402282454,0.9679241327422442,1.0,1/15,4.60%,PADI2
prerank,negative regulation of chemokine production (GO:0032682),0.36297508781890797,0.7323139809688735,0.7857142857142857,0.967647053952068,1.0,3/14,17.54%,MAP2K5;LGALS9;APOD
prerank,membrane protein proteolysis (GO:0033619),0.3165895270006279,0.7317829638206943,0.8106235565819861,0.9679234796455508,1.0,12/37,18.24%,RELA;SPPL3;PARL;ERAP1;ADAM10;NAPSA;DAG1;RHBDD1;ADAM19;PSEN1;SPPL2A;CTSH
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.3736084498565605,0.7315392668057734,0.7929078014184398,0.9678553375648022,1.0,3/13,8.04%,EIF4ENIF1;TNRC6B;AGO2
prerank,dendritic spine morphogenesis (GO:0060997),0.3640815407991835,0.7308964819735719,0.7933884297520661,0.9682385295581528,1.0,5/15,16.64%,EPHB2;CDC42;PTEN;WASL;DOCK10
prerank,axonal transport (GO:0098930),0.3198591891473297,0.7307589482947318,0.8198307134220073,0.9680312758830125,1.0,7/36,11.52%,AP3M1;DCTN1;MAPT;DTNBP1;AP3M2;FBXW11;KIF3A
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.3234812710777608,0.7307138411658453,0.8114086146682189,0.9677125199896359,1.0,7/37,12.87%,UBXN1;MAP1A;SDCBP;GIPC1;UCHL5;CAMLG;HIPK2
prerank,peptidyl-tyrosine modification (GO:0018212),0.30489992369112867,0.730049838207064,0.8469055374592834,0.9681210854206712,1.0,11/56,14.25%,DDR2;EPHB2;PDGFB;BTK;ABI1;LYN;ABL1;SYK;INSR;FYN;RELN
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.3285964991231009,0.7299664814320926,0.8226950354609929,0.967854034964017,1.0,4/31,11.81%,RAB3GAP1;SYT12;SYT11;SCAMP5
prerank,cell projection assembly (GO:0030031),-0.2603645889109519,-0.7296598777271474,0.8431372549019608,0.9859172368243486,1.0,12/22,32.24%,RAC1;PDGFA;PARVG;RHOQ;CAPG;RHOJ;NEFH;RHOH;RHOG;RAC2;PARVA;RHOU
prerank,protein processing (GO:0016485),0.29536445208805456,0.7296559651315745,0.884102564102564,0.9678519811570334,1.0,16/102,17.13%,TYSND1;CD5L;CPD;CPE;SPPL3;F3;FURIN;PARL;ADAM10;PCSK6;HTRA2;ADAM19;LGMN;KLK2;FAM111A;PCSK5
prerank,inner dynein arm assembly (GO:0036159),-0.309353421217828,-0.7296187400055979,0.8034682080924855,0.984321617449034,1.0,9/11,69.08%,DNAAF5;CCDC39;CCDC40;DNAI3;DNAAF1;DNAH1;CFAP100;DNAAF4;CFAP73
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.2975111869511456,0.729093087347477,0.8652849740932642,0.9681454169280858,1.0,14/87,14.70%,RGCC;PSMD9;PSMB8;CDK6;PSMC5;DLG1;APC;ZFP36L1;PSMD12;BRD7;PSMA2;PKD2;FBXL7;PTEN
prerank,CENP-A containing chromatin organization (GO:0061641),-0.2342298184870825,-0.7289080235010774,0.9116022099447514,0.9819325618987935,1.0,6/29,15.51%,SMARCA5;RBBP4;HJURP;NASP;CENPO;ITGB3BP
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.2342298184870825,-0.7289080235010774,0.9116022099447514,0.9819325618987935,1.0,6/29,15.51%,SMARCA5;RBBP4;HJURP;NASP;CENPO;ITGB3BP
prerank,calcium ion import into cytosol (GO:1902656),-0.2837400363823651,-0.7288957249335216,0.8551236749116607,0.9803103840448935,1.0,1/15,1.07%,CACNA2D1
prerank,transcription preinitiation complex assembly (GO:0070897),-0.30179078900225736,-0.7284009048260551,0.810126582278481,0.9792957453850912,1.0,7/12,31.89%,TAF1;GTF2A2;TBP;DR1;TAF12;TAF11;TAF7
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.3390969572547172,0.7283909431106731,0.805699481865285,0.9685968378151327,1.0,2/23,5.65%,LMAN1;TMED9
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.32183495572323845,0.728345111245221,0.8247549019607843,0.9682758687453008,1.0,8/30,16.40%,IRF3;BIRC3;IKBKB;TLR3;TANK;UBE2D3;TLR4;TBK1
prerank,positive regulation of cartilage development (GO:0061036),0.35057179059917043,0.7279013420631137,0.8111111111111111,0.9684492677735228,1.0,1/17,2.21%,TAPT1
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.3872982812501137,0.7276800450610018,0.7907692307692308,0.968339563132197,1.0,4/10,17.83%,DGKD;GAP43;PLPP1;DGKH
prerank,regulation of macromolecule metabolic process (GO:0060255),0.2944482895933109,0.7276116766932466,0.9354187689202825,0.9680575779958334,1.0,29/170,15.66%,C1D;TARDBP;MTMR1;PRDM10;NELL1;CDK2;CDK6;PRDM4;ADNP2;KIF16B;AFF2;TRIM5;ARF1;NFKBIZ;ZNF711;TRIM44;AFF1;PRDM1;ZFP36L1;FUBP3;COQ7;PCBP3;ROCK2;AIF1;SCARB2;CTCF;TRIM26;HNRNPK;AFF4
prerank,regulation of receptor recycling (GO:0001919),0.3608847322126574,0.7275559196545078,0.796875,0.9677493599263861,1.0,5/16,15.88%,VAMP3;KIF16B;ANXA2;OPTN;INPP5F
prerank,Notch signaling involved in heart development (GO:0061314),0.3854633822197294,0.7270614824624418,0.7972136222910217,0.9679654620024816,1.0,3/11,18.39%,NOTCH2;RBPJ;GALNT11
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.2411233840353644,-0.7267825750472172,0.8731707317073171,0.9798732701744313,1.0,13/24,32.36%,SUCLA2;ALAS1;CPOX;COX10;ATP5IF1;ABCB10;PGRMC1;SLC25A38;NFE2L1;PPOX;COX15;RSAD1;TSPO
prerank,negative regulation of DNA replication (GO:0008156),-0.2929583306398453,-0.7261877959200799,0.8493589743589743,0.979029857121282,1.0,2/13,3.59%,WAPL;ATR
prerank,cardiac ventricle development (GO:0003231),0.3470823730160228,0.7261670478630599,0.7997364953886693,0.9686225056697731,1.0,1/20,2.01%,DAND5
prerank,response to reactive oxygen species (GO:0000302),0.3030104890847416,0.7261272134654858,0.8379272326350606,0.9682911148664595,1.0,14/54,17.54%,JUN;TPM1;MAPK1;MAPT;MAPK8;PXN;TXNRD2;CAMKK2;FYN;PKD2;STK24;COA8;FER;APOD
prerank,steroid catabolic process (GO:0006706),-0.3247831182397315,-0.725681657784834,0.8115577889447236,0.9780663881152576,1.0,1/10,5.39%,SPP1
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.379829240082202,0.7245259835818715,0.7975460122699386,0.9697525728376034,1.0,2/10,10.69%,APC;CDC42
prerank,cellular response to acid chemical (GO:0071229),-0.2305992729136645,-0.7242332832917909,0.8870056497175142,0.9784038268917934,1.0,11/27,24.03%,CPEB3;CPEB4;GLRA1;LAMTOR1;LAMTOR3;RRAGD;RRAGB;RPTOR;NSMF;GLRA2;XBP1
prerank,regulation of autophagosome maturation (GO:1901096),-0.289010568128228,-0.7241770758545205,0.8277027027027027,0.9768413992364867,1.0,7/13,27.58%,CLEC16A;CLN3;IRGM;SMCR8;UBQLN4;PHF23;TBC1D25
prerank,histone H4-K16 acetylation (GO:0043984),0.34525185728673,0.7240860143325045,0.7941176470588235,0.969882570323343,1.0,8/19,18.80%,HCFC1;PHF20;JADE3;MSL2;KANSL1;KANSL3;KAT7;KMT2A
prerank,ear morphogenesis (GO:0042471),0.33802760589075675,0.7239399520429193,0.8234536082474226,0.9696694335492058,1.0,2/20,8.95%,EPHB2;CHD7
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.31637700505329047,-0.7234018288991978,0.8306709265175719,0.9745667550295438,1.0,4/11,26.04%,CALM2;FKBP1A;SRI;CALM3
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.31637700505329047,-0.7234018288991978,0.8306709265175719,0.9745667550295438,1.0,4/11,26.04%,CALM2;FKBP1A;SRI;CALM3
prerank,regulation of establishment of planar polarity (GO:0090175),0.2930693630960663,0.7231600738943407,0.8605619146722164,0.9701663190909151,1.0,7/88,6.95%,ROR2;DVL1;PSMD9;PSMB8;ARRB2;AP2A1;PSMC5
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.3450830640330577,0.7229344457293361,0.8118279569892473,0.9700649097568065,1.0,3/18,11.58%,MECP2;RAD51B;VPS4B
prerank,pteridine-containing compound metabolic process (GO:0042558),0.3733512993058834,0.722834134360639,0.7779390420899854,0.9698112475812403,1.0,3/13,14.29%,HSP90AA1;PTS;CALM1
prerank,calcium-ion regulated exocytosis (GO:0017156),0.3293042991290007,0.7226317360547101,0.8049645390070922,0.9696747908947096,1.0,4/27,9.86%,VAMP7;SYT12;SYT11;VAMP2
prerank,copper ion homeostasis (GO:0055070),0.35262063071657945,0.7218866742845967,0.8276797829036635,0.9701720829191021,1.0,4/17,11.64%,ATP7A;ARF1;PRNP;SLC31A1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.37933962146988587,0.7216769522153882,0.819935691318328,0.9696751215571107,1.0,3/10,14.68%,AP2A1;MYLIP;CLTC
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.37933962146988587,0.7216769522153882,0.819935691318328,0.9696751215571107,1.0,3/10,14.68%,AP2A1;MYLIP;CLTC
prerank,determination of bilateral symmetry (GO:0009855),0.33628650100219365,0.721169559543326,0.815365551425031,0.9699052925424798,1.0,1/25,2.69%,ARL6
prerank,neutrophil chemotaxis (GO:0030593),0.3022943778709097,0.7207092525441118,0.8587443946188341,0.970067612004863,1.0,3/53,7.28%,CX3CL1;TGFB2;CCL25
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.2922620205586645,0.7199390569756277,0.8730489073881373,0.9705769583847264,1.0,7/85,6.95%,ROR2;DVL1;PSMD9;PSMB8;ARRB2;AP2A1;PSMC5
prerank,adrenergic receptor signaling pathway (GO:0071875),0.3388980250707421,0.7194838477192118,0.8194993412384717,0.9707458568562675,1.0,3/20,10.68%,ADCY9;LMBRD2;AKAP13
prerank,negative regulation of cation channel activity (GO:2001258),0.3295505049159582,0.7194553389925742,0.8182941903584673,0.9704058853991209,1.0,4/26,14.29%,EPHB2;UBQLN1;PKD2;CALM1
prerank,tRNA processing (GO:0008033),0.29928415379340706,0.7191253984184076,0.8627027027027027,0.970418719206105,1.0,5/61,8.31%,NSUN6;CSTF2;PTCD1;POP1;AARS1
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.34771010007619485,0.719075873046598,0.8,0.9701150259152974,1.0,2/20,4.25%,MICU1;LETM1
prerank,regulation of epithelial cell migration (GO:0010632),0.3022957544986517,0.7183667688988793,0.8351648351648352,0.9705527818886467,1.0,13/51,15.63%,TGFB2;SASH1;DOCK1;DUSP10;ARSB;PTPN23;RTN4;MCC;ADIPOR1;RREB1;CLASP1;EVL;MACF1
prerank,positive regulation of autophagy (GO:0010508),0.294732351902284,0.7181924627365915,0.8891191709844559,0.9703904354552106,1.0,16/81,14.38%,LRRK2;EPM2A;STK11;BNIP3L;DAPK1;MTDH;TPCN1;TRIM5;BNIP3;HMGB1;GNAI3;ATF6;SH3GLB1;PIK3C2A;CAMKK2;OPTN
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.36852568762288085,0.7180706994827586,0.7894736842105263,0.9701653652913703,1.0,4/11,16.10%,TP53;MAP2K2;DDX5;MAP2K1
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.35421597053106957,0.7179278445326008,0.8007968127490039,0.9699570377475071,1.0,3/16,8.78%,RBM3;NUP98;TRA2A
prerank,mitochondrial RNA metabolic process (GO:0000959),0.3557689894821525,0.7175134119231132,0.8195592286501377,0.9700828956089991,1.0,1/14,3.24%,TFB2M
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.37586719735008356,0.7173251491627386,0.8069381598793364,0.9699433082488371,1.0,3/11,16.27%,FRS2;SOX6;MEF2C
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.3612311287217921,0.7170711534490025,0.8076379066478077,0.9698650377005509,1.0,4/14,14.61%,CHKB;SLC27A1;CHKA;ETNK1
prerank,cardiac conduction system development (GO:0003161),0.329542330925907,0.716591739082003,0.820480404551201,0.9700358135503059,1.0,3/24,15.19%,BMPR1A;NOTCH2;SMAD4
prerank,JNK cascade (GO:0007254),0.3155200068272312,0.7161974764524123,0.8569794050343249,0.9700899000794491,1.0,5/40,9.05%,MINK1;MAP3K11;MAPK8;IRAK2;TAB3
prerank,GPI anchor biosynthetic process (GO:0006506),-0.23085213070952243,-0.7161563365188648,0.9207317073170732,0.9819597597296337,1.0,17/30,35.63%,PIGN;PGAP2;PIGV;PIGB;DPM1;PIGL;PIGG;PIGX;PIGM;PIGT;MPPE1;PIGZ;PIGF;PIGA;PIGS;DPM2;PIGC
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.35172963647517236,0.7159810454826702,0.8181818181818182,0.9699693628855884,1.0,4/16,14.79%,PRKACA;CAMK2D;CALM1;CACNA1C
prerank,phosphate ion homeostasis (GO:0055062),0.3797369216081399,0.7153721739272495,0.8049921996879875,0.970284440911658,1.0,1/10,11.18%,XPR1
prerank,calcium ion transport (GO:0006816),0.2890753616526153,0.7152499226737988,0.9035897435897436,0.9700486447672674,1.0,16/113,14.79%,SLC24A5;TRPC5;MICU1;CACNG7;CACNA1D;GAS6;TRPM4;TRPC4AP;CACNA1A;MCOLN1;RAMP1;TRPV2;FYN;CALCRL;PKD2;CACNA1C
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.3613094148688566,0.7151608172496727,0.806312769010043,0.9690571396855099,1.0,4/12,16.70%,CDC23;CDC16;RB1;NSMCE2
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.3613094148688566,0.7151608172496727,0.806312769010043,0.9690571396855099,1.0,4/12,16.70%,CDC23;CDC16;RB1;NSMCE2
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.3613094148688566,0.7151608172496727,0.806312769010043,0.9690571396855099,1.0,4/12,16.70%,CDC23;CDC16;RB1;NSMCE2
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.3584109790462352,0.7148424513682964,0.8283261802575107,0.9690688633297282,1.0,2/15,10.43%,NRDC;FURIN
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.3288164997068865,0.7148210973764499,0.8085106382978723,0.9687254260241738,1.0,6/25,17.14%,NDST3;B3GALNT1;B3GNT2;EXT1;B3GALT1;EXT2
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.2633439746450436,-0.7144466835939254,0.8492063492063492,0.9825012751504473,1.0,5/18,23.22%,CHRM3;GRK2;OPRM1;CDK5R1;GNA11
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.2927967384103475,0.7144214347901717,0.879746835443038,0.9687786714305903,1.0,12/70,12.95%,CD36;VAMP3;PSMD9;PSMB8;PSMC5;ITGB5;IKBKB;TAP1;LNPEP;PSMD12;NCF4;PSMA2
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.3577785631240059,0.7143991573741649,0.810966810966811,0.9684424990430746,1.0,2/14,10.87%,TLR3;TRAF2
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.3305039469329891,0.7137226610324959,0.803129074315515,0.96881838267065,1.0,3/22,10.43%,NRDC;PTPN3;FURIN
prerank,acetyl-CoA metabolic process (GO:0006084),-0.27416738717834543,-0.7131858806714515,0.8766666666666667,0.9823738098027244,1.0,3/15,6.34%,ACSS1;DIP2A;ACLY
prerank,prostanoid biosynthetic process (GO:0046457),-0.27169196374108723,-0.7128317618329041,0.8428571428571429,0.9811600323586095,1.0,2/15,6.68%,PNPLA8;PTGES3
prerank,genitalia development (GO:0048806),-0.29693994895867387,-0.7125482100676361,0.8520710059171598,0.9799233283777643,1.0,3/12,19.47%,PKD1;DNAJC19;TIFAB
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.33046007252879755,0.7120577366906419,0.8225602027883396,0.970273927847358,1.0,3/20,10.93%,SEMA6D;SEMA3D;SEMA6A
prerank,glutamine family amino acid metabolic process (GO:0009064),0.3170983752649049,0.7115936012556651,0.8240850059031877,0.9704375296657137,1.0,1/33,0.82%,PYCR2
prerank,negative regulation of complement activation (GO:0045916),-0.3158388172294561,-0.7113809270563133,0.8363095238095238,0.979726101113662,1.0,6/10,50.60%,CD46;SUSD4;CD55;A2M;SERPING1;VSIG4
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.29082100019303825,-0.7111473373501968,0.8380281690140845,0.9783825656369499,1.0,6/14,22.92%,RIF1;SHLD1;SHLD2;PAXIP1;HMCES;TFRC
prerank,protein lipidation (GO:0006497),0.2922082385251594,0.7110534534839849,0.8614393125671321,0.9706599403875569,1.0,10/59,15.91%,WDR45;WDR45B;PIGP;ZDHHC5;ZDHHC1;PIGU;ZDHHC6;ZDHHC20;ATG7;PIGQ
prerank,heterochromatin organization (GO:0070828),-0.2887244847963291,-0.7102817289471617,0.8535714285714285,0.9777631733914265,1.0,5/14,17.93%,SETDB1;EZH1;SETD7;SIRT1;SETDB2
prerank,aerobic electron transport chain (GO:0019646),0.2871152504576482,0.7098525938591717,0.8686974789915967,0.9716311753651222,1.0,8/68,12.65%,UQCRH;UQCRC1;NDUFS1;NDUFA9;NDUFV2;COX7C;SDHA;NDUFA10
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.37441261766204165,0.7097286345004783,0.8449275362318841,0.9714040525071218,1.0,2/12,7.84%,KPNB1;SEC14L2
prerank,synaptic vesicle recycling (GO:0036465),0.31201233820142477,0.7096178206725657,0.8317865429234339,0.9711621921388048,1.0,7/31,15.36%,STON2;CEL;VAMP2;CDK5;AMPH;TBC1D24;SYNJ2
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.3556779265081789,0.7094463521065808,0.8034934497816594,0.9709942578391029,1.0,1/13,2.70%,SOX13
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.28953964169632046,-0.7091745555545729,0.8401360544217688,0.977557058326289,1.0,5/13,22.93%,SESN1;SESN3;CASTOR2;RNF152;SZT2
prerank,alcohol catabolic process (GO:0046164),0.3804281637159508,0.7091745166373637,0.7945619335347432,0.9709249938721083,1.0,1/10,6.94%,CEL
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.371654238368369,0.7088065642623372,0.825,0.9709833074662836,1.0,1/10,6.68%,PDE3B
prerank,L-amino acid transport (GO:0015807),0.32256452908616506,0.7078054027537061,0.8177399756986634,0.9716873650429081,1.0,3/28,8.66%,SLC7A2;SLC38A2;SLC7A8
prerank,regulation of gastrulation (GO:0010470),0.3588300043319937,0.7075362893458197,0.8128654970760234,0.971652638956127,1.0,4/14,18.03%,TENM4;DAG1;CLASP1;CLASP2
prerank,myelination in peripheral nervous system (GO:0022011),0.35563774093875883,0.7069359403509645,0.8175287356321839,0.971964618843108,1.0,1/13,4.01%,NF1
prerank,regulation of RNA metabolic process (GO:0051252),0.2882676544299258,0.7069114982072282,0.8596300326441785,0.971629395037541,1.0,12/59,13.88%,MBNL1;RC3H2;PTBP3;RRP1B;SNRNP70;MBNL2;FUS;AFF2;HNRNPH3;CLK1;HNRNPH1;PCBP3
prerank,regulation of oxidoreductase activity (GO:0051341),0.35649225287332215,0.7065337945816498,0.8270893371757925,0.9716804773097778,1.0,2/13,11.90%,ATP7A;ABL1
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.28956009521369375,0.7059091001401505,0.880675818373812,0.9720080981488871,1.0,11/67,12.95%,CD36;VAMP3;PSMD9;PSMB8;PSMC5;ITGB5;IKBKB;TAP1;PSMD12;NCF4;PSMA2
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.34399719712117516,0.7056002633799786,0.8089887640449438,0.9719847417623033,1.0,5/16,17.88%,ABCD2;CUEDC2;ABCD1;APOD;TREM2
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.28516462267339715,0.7055051929882015,0.8706624605678234,0.97172919059578,1.0,8/69,12.65%,UQCRH;UQCRC1;NDUFS1;NDUFA9;NDUFV2;COX7C;SDHA;NDUFA10
prerank,amino sugar metabolic process (GO:0006040),-0.3145597646624811,-0.7054146747913568,0.8338192419825073,0.9803176814891515,1.0,4/10,20.04%,GFPT1;CSGALNACT1;ST3GAL1;GNE
prerank,modulation of chemical synaptic transmission (GO:0050804),0.2848822306137789,0.7050703178246199,0.9069529652351738,0.9718437087667994,1.0,20/107,16.27%,LRRK2;AKAP9;CLSTN3;CEL;PSMC5;NRG3;SYN3;DGKI;LRP8;USP46;CDK5;CACNA1A;CLSTN1;GRM7;RELN;PTEN;IQSEC2;GRID2;DGKZ;MEF2C
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.3284301629107642,0.7048288409736871,0.8268506900878294,0.9717359925876284,1.0,5/24,12.73%,RNF34;MAP2K6;IRAK2;TAB3;CYLD
prerank,aggrephagy (GO:0035973),0.3204434419400188,0.704646838487999,0.8306748466257668,0.9715785437435679,1.0,4/27,5.96%,UBQLN1;SQSTM1;PCNT;DYNLL2
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.31137502564208863,-0.7038001196229329,0.8542857142857143,0.980663053440762,1.0,2/10,4.56%,PTPRC;FCGR2B
prerank,cellular response to retinoic acid (GO:0071300),0.29709148735002394,0.7030934746719019,0.8312284730195177,0.9728743696349648,1.0,8/42,17.17%,TWF2;ADNP2;LYN;SETX;HTRA2;CREB1;RORB;ATM
prerank,response to interleukin-4 (GO:0070670),-0.3126608499152595,-0.7028471201268086,0.8688046647230321,0.9801193324080724,1.0,9/10,68.75%,XBP1;JAK3;SHPK;LEF1;TCF7;GATA3;DCSTAMP;CITED1;RUFY4
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.2805365035989027,0.7028200097185595,0.9201213346814965,0.9728123664548586,1.0,20/113,14.85%,CD36;BCL2L11;ESR1;HSP90AA1;PSMC5;RAP1B;SLF1;ERCC4;FNIP1;FAF1;TAL1;CUL4A;SH3GLB1;ABCA1;TP53;SYK;TERF1;GTF2H1;SPIDR;TLR4
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.29756857889299343,0.7025399747211709,0.8612334801762115,0.9727450918010794,1.0,6/52,8.18%,EPHB2;SQSTM1;ZDHHC5;DLG1;STX3;SPTBN1
prerank,histone H2B ubiquitination (GO:0033523),0.37056692332794544,0.7022780121042537,0.8102893890675241,0.9726490110510326,1.0,1/10,2.15%,CTR9
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.3663667239981593,0.7019622327197426,0.8133535660091047,0.9726330855584971,1.0,3/11,15.05%,PPHLN1;TASOR;RESF1
prerank,T cell differentiation in thymus (GO:0033077),-0.2800443711061327,-0.7018991719377721,0.8378378378378378,0.9796083454449047,1.0,1/14,1.20%,PTPRC
prerank,prostaglandin biosynthetic process (GO:0001516),-0.24762471390810065,-0.7017273691762487,0.8658536585365854,0.9782109505270702,1.0,2/18,6.68%,PNPLA8;PTGES3
prerank,positive regulation of immunoglobulin production (GO:0002639),0.3153111943844239,0.7011442241431767,0.8705035971223022,0.9731468191712773,1.0,4/31,9.33%,VAMP3;EPHB2;KMT5B;KMT5C
prerank,regulation of store-operated calcium entry (GO:2001256),0.37388746568567194,0.7008114318818253,0.8206785137318255,0.9731489253254184,1.0,1/10,2.77%,HOMER2
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.35170778362709987,0.7006999247332932,0.836231884057971,0.9729136995863503,1.0,1/14,4.31%,AKAP9
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.31243673448065673,0.7003850896416354,0.8500604594921403,0.9728965625999738,1.0,3/32,4.55%,ADAM15;ITGB1BP1;THBS1
prerank,catecholamine metabolic process (GO:0006584),0.3496654350564303,0.7000761761542368,0.8321167883211679,0.9728737557099347,1.0,1/14,5.05%,ATP7A
prerank,ameboidal-type cell migration (GO:0001667),0.2962198249775435,0.7000710382040178,0.8687089715536105,0.9725188454980893,1.0,8/51,13.37%,SEMA6D;ITGA4;PKN2;PDXDC1;SEMA3D;SEMA6A;SGPL1;GPC3
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.3369489804962086,0.6998403127930314,0.8209150326797385,0.9723996626392911,1.0,4/18,15.51%,HDAC5;FRS2;SOX6;TMEM119
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.30752843002373786,-0.6997903389562085,0.8297872340425532,0.9787883366478684,1.0,2/10,5.56%,ADAM9;EPB41L4B
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.3048630795128817,0.6997036759865737,0.845223700120919,0.9721859631001987,1.0,3/34,8.10%,VAMP3;EPHB2;LACC1
prerank,actomyosin structure organization (GO:0031032),0.28292911190084713,0.6992405070018168,0.8866736621196223,0.9723238436880275,1.0,9/75,12.11%,TMOD1;TMOD3;TPM1;ITGB5;EPB41;CDC42BPB;FRMD6;WDR1;EPB41L3
prerank,regulation of interleukin-1 production (GO:0032652),0.3415594471591115,0.6991207406266073,0.8184480234260615,0.9720849950246404,1.0,3/15,14.85%,GAS6;HMGB1;TLR4
prerank,regulation of macrophage migration (GO:1905521),0.3716124721204218,0.6990917484102483,0.8184615384615385,0.9717593831230051,1.0,3/10,16.20%,MTUS1;P2RY12;CD81
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.33937121349378196,0.6971657806592848,0.8232984293193717,0.9734139987881101,1.0,3/15,13.04%,PTTG1IP;CD44;BCL2
prerank,negative regulation of microtubule polymerization (GO:0031115),0.35507539622574424,0.6970105809068899,0.8258928571428571,0.9732207161719341,1.0,2/12,3.87%,STMN2;MAPRE1
prerank,protein mannosylation (GO:0035268),-0.23664392032479087,-0.6970038103845071,0.8672985781990521,0.980291638881608,1.0,6/22,17.96%,TMTC2;DPY19L4;TMTC1;TMTC3;RXYLT1;DPM1
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.31688004779197954,0.6969555866717047,0.8611449451887941,0.9729180779823353,1.0,3/27,9.84%,CHSY1;UGDH;BGN
prerank,cellular response to increased oxygen levels (GO:0036295),-0.29422364119590316,-0.696418829428683,0.8296529968454258,0.9793205144290884,1.0,3/11,16.45%,ATP6V1A;ATP6AP1;ATP6V1G1
prerank,cellular response to lipopolysaccharide (GO:0071222),0.2800724949704803,0.6962406596871418,0.9001040582726326,0.9733063809758805,1.0,12/101,12.55%,RELA;CTR9;CHMP5;AXL;IL1A;MAPK8;IL18;MTDH;LYN;PLAA;HMGB1;MAPK14
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.31070673745604294,0.6957309883283131,0.86810551558753,0.9734642430136953,1.0,4/30,12.92%,SBDS;PRRC2C;PLD4;TP53
prerank,membrane lipid catabolic process (GO:0046466),0.36528754867263863,0.6957253471354037,0.8215434083601286,0.9731131960946875,1.0,3/10,12.72%,PDXDC1;SGPL1;FUCA1
prerank,granulocyte chemotaxis (GO:0071621),0.28883997427584973,0.6952290580926714,0.8837209302325582,0.9732811925488407,1.0,3/55,7.28%,CX3CL1;TGFB2;CCL25
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.32500291116066704,0.6946641936260228,0.846553966189857,0.9734976831537826,1.0,2/23,8.02%,PLA2G6;PLA2G4A
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.334951945242447,0.6945134182034925,0.831275720164609,0.9732931894579739,1.0,4/16,13.60%,ETF1;BNIP3;IGF1R;INSR
prerank,cation transmembrane transport (GO:0098655),0.2982284257062959,0.6945013853286919,0.8641975308641975,0.9729487488710679,1.0,4/44,8.66%,SLC7A2;SLC25A20;TRPM4;SLC7A8
prerank,regulation of protein kinase C signaling (GO:0090036),0.3451947677699343,0.6944768410108317,0.8325859491778774,0.9726143502720156,1.0,2/14,10.16%,GPD1L;DGKD
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.30531917538433556,0.6938741682056684,0.8568102444703143,0.9728796903241633,1.0,7/37,16.44%,NUPR1;BCL2L11;NCK1;TP53;BCL2;BECN1;DNM1L
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.27797124539844836,-0.6937312519455263,0.8619528619528619,0.9805620698567555,1.0,7/13,28.34%,HEXA;VCAN;CSPG4;IDS;IDUA;DCN;CSPG5
prerank,ganglioside metabolic process (GO:0001573),0.32324025438085174,0.6930619915525075,0.8270967741935484,0.9733697969516814,1.0,1/20,1.79%,ST8SIA4
prerank,respiratory tube development (GO:0030323),0.30872536519787586,0.6930586345403194,0.8446601941747572,0.9730126734345221,1.0,3/28,12.45%,FGF1;LOXL3;HECA
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.3377641257770651,0.6926053160086153,0.8285322359396433,0.9731148034070265,1.0,3/15,15.59%,ANKRD11;LRP6;HDAC2
prerank,polyol biosynthetic process (GO:0046173),-0.26416211791170785,-0.6920264437923126,0.8586206896551725,0.9808237388156111,1.0,5/16,14.89%,CYP27A1;PPIP5K1;IP6K2;FGF2;IPPK
prerank,amino acid transmembrane transport (GO:0003333),0.29489607487867303,0.6917797195773975,0.8512763596004439,0.9736065374595885,1.0,5/45,12.25%,SLC38A2;SLC7A11;SLC7A7;SLC7A8;SLC38A9
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.27448656431378154,0.691628365617489,0.9321862348178138,0.9734123717671335,1.0,20/129,14.50%,LRRK2;ZEB2;PSMD9;GID8;USP34;PSMB8;LRRK1;PSMC5;TRPM4;CSNK1G1;RNF146;TNKS2;WLS;PPM1A;PSMD12;UBR5;PSMA2;GPC3;TBL1XR1;FZD9
prerank,negative regulation of catalytic activity (GO:0043086),0.3163716428706574,0.6913696640160482,0.8515723270440252,0.9733325005799486,1.0,1/24,1.34%,PARP9
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.31150939883754053,0.6909239635113327,0.8555691554467564,0.9734456238152251,1.0,7/29,17.50%,CTR9;IFNAR2;PKD2;PIAS1;STAT2;STAT6;FER
prerank,regulation of leukocyte activation (GO:0002694),-0.2744753282506862,-0.6908007603361946,0.8586206896551725,0.9805405085415704,1.0,2/14,5.34%,CD33;GPR137B
prerank,positive regulation of neuron migration (GO:2001224),0.36145677426443146,0.6903462039175412,0.8587301587301587,0.9736959957669201,1.0,3/11,10.93%,KIF20B;PLAA;SEMA6A
prerank,ribosomal small subunit assembly (GO:0000028),-0.25994662153858317,-0.6901356582612194,0.8846153846153846,0.9796465406617418,1.0,10/16,35.93%,XRCC5;RPS14;RPS19;RPS15;RPS28;RPS27;RRP7A;RPS5;ERAL1;MRPS7
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.31094767542394647,0.6900104099615662,0.8442521631644005,0.9736839989457342,1.0,6/26,17.11%,GOLPH3;B4GALT5;TKT;GK;LARGE1;ST3GAL2
prerank,negative regulation of blood coagulation (GO:0030195),0.2981228774835917,0.6892653044748265,0.8584795321637427,0.9740840789065985,1.0,3/38,10.13%,PDGFB;PROC;F3
prerank,receptor recycling (GO:0001881),-0.29899391341749504,-0.6890274039768228,0.8579545454545454,0.979289026542038,1.0,2/10,9.12%,RAB11B;LMTK2
prerank,plasma membrane tubulation (GO:0097320),0.34669272661388084,0.6888978422583131,0.8371428571428572,0.9741146769284237,1.0,2/13,6.28%,FNBP1L;PACSIN2
prerank,aminoglycan catabolic process (GO:0006026),0.3109452774027549,0.6888720975834098,0.8573141486810552,0.9737803208863572,1.0,6/28,16.08%,CTBS;SDC2;FUCA1;GPC3;GPC6;GNS
prerank,regulation of endothelial cell migration (GO:0010594),0.2787927822807002,0.6885112111259177,0.906054279749478,0.9737986481430961,1.0,7/85,5.26%,FGF1;ITGB1BP1;SASH1;NF1;THBS1;NRP1;PRKCA
prerank,negative regulation of nuclear division (GO:0051784),0.3619373057791762,0.6884825116227663,0.8141025641025641,0.9734650273426857,1.0,1/11,9.33%,TOM1L2
prerank,regulation of cytoskeleton organization (GO:0051493),0.2787743103235186,0.6882758734937358,0.9305413687436159,0.9733000685811484,1.0,23/108,16.60%,RHOF;IQGAP2;MAPK1;CAMSAP3;EZR;MAPT;PAK2;TWF2;EPHA5;TAOK1;ARHGAP35;CAPN2;DIAPH1;MTOR;ABL1;CYLD;BICD1;MAP6;ROCK2;CLASP1;IQGAP1;PAK1;ARHGAP17
prerank,synaptic vesicle endocytosis (GO:0048488),0.30109514077087596,0.6880206131301273,0.8637951105937136,0.9731973352669898,1.0,6/33,12.72%,ITSN1;STON2;CEL;VAMP2;CDK5;AMPH
prerank,regulation of nuclear division (GO:0051783),-0.25208069656257587,-0.687174379787901,0.9181034482758621,0.9795786368824873,1.0,2/20,5.72%,CDK13;CUL9
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.2838421103154724,0.6869841603991981,0.8926673751328374,0.9738849125621518,1.0,13/73,16.32%,MTCH1;APAF1;SMAD3;EGLN3;MAPT;PPARG;F3;TRAF2;AIFM1;CASP8AP2;ANP32B;HIP1;CFLAR
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.2883715015915791,0.6864650412106198,0.8896034297963559,0.9740930841093942,1.0,11/66,16.57%,RGCC;CDK6;KMT2E;DLG1;APC;BRD7;PKD2;AIF1;PTEN;RDX;RB1
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.2324209978198048,-0.6847713494140737,0.9166666666666666,0.9804630121186206,1.0,12/22,34.42%,PSMA3;PSMB2;PSMB7;PSMA1;PSMA5;PSMA6;PSMA4;PSMB3;PSMB9;PSMB4;PSMA8;PSMB6
prerank,protein sumoylation (GO:0016925),0.288565388585855,0.6839330457524001,0.8910891089108911,0.9762929980847539,1.0,14/49,16.98%,NUP205;SUMO3;SUMO2;NUP98;TRPM4;NUP54;UBE2I;BCL11A;PIAS1;UBA2;NUP160;NSMCE2;SAE1;NUP93
prerank,positive regulation of cell communication (GO:0010647),0.31075872763774054,0.6838316486617364,0.8523409363745498,0.9760410105697043,1.0,5/28,11.42%,CLSTN3;PTPN23;CLSTN1;WLS;SOX11
prerank,negative regulation of phosphate metabolic process (GO:0045936),-0.22537385055853582,-0.6836248332885291,0.933920704845815,0.9800914332505398,1.0,6/22,26.94%,INPP5K;SIRT1;CDKN1B;DYNLL1;PRKRIP1;STAP1
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.3552047935211446,0.6835236754868098,0.8281481481481482,0.9759860104769963,1.0,1/12,2.57%,ADSS1
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.3486799401004095,0.6834817560856872,0.8563218390804598,0.975668617717982,1.0,2/13,9.66%,PTTG1IP;CD44
prerank,acidic amino acid transport (GO:0015800),-0.25737694128390154,-0.6832456002284448,0.8740458015267175,0.9789278532090532,1.0,2/17,3.26%,SLC1A2;SLC25A13
prerank,regulation of keratinocyte migration (GO:0051547),0.34684645087304156,0.6826904106478583,0.8378378378378378,0.9761343629792028,1.0,5/12,18.36%,MTOR;PTEN;MAP4K4;IQSEC1;MAPRE2
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.3631967477987807,0.6826876154280834,0.8390625,0.9757828289061656,1.0,1/10,4.31%,AKAP9
prerank,lysosome organization (GO:0007040),0.30450484435842196,0.6824167652125408,0.875,0.9757022735444579,1.0,7/36,14.45%,LRRK2;AKTIP;ARSB;HPS4;MTOR;ABCA1;TPCN2
prerank,negative regulation of neurogenesis (GO:0050768),0.2965197085379469,0.6821786232148369,0.8656361474435196,0.9755912106872009,1.0,6/34,14.70%,GDI1;NF1;SORL1;RUFY3;RTN4;PTEN
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.3142383585140103,0.6821451378295122,0.8435544430538173,0.9752700691901358,1.0,6/24,13.26%,PPHLN1;EZH2;DNMT3A;TASOR;RBBP7;EPC1
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.27340842535479076,0.6819805505438032,0.9094693028095734,0.9750888447133997,1.0,22/86,18.67%,CX3CL1;STMN2;MAPRE1;AKAP9;DCTN1;MAPT;NCK1;WDR1;CLASP1;EVL;CLIP1;PAK1;RB1;SNX9;NCKAP1L;FER;BIN1;PSEN1;CDK5RAP2;PROX1;NCKAP1;PLEK
prerank,regulation of neuron death (GO:1901214),0.27813341828343247,0.6816025088724498,0.90625,0.9751225993700285,1.0,19/82,16.40%,LRRK2;INPP5A;EGLN3;EGLN2;MAPT;VPS35;CDK5;CTSZ;TRAF2;PRNP;SORL1;EIF2S1;FYN;HTRA2;TSC1;GRID2;RRAS2;MEF2C;TBK1
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.276724558243237,0.6813587452845105,0.9507186858316222,0.9750063262837925,1.0,25/124,17.18%,ZFYVE27;EHD1;STMN2;TPM1;BICDL1;NEDD4;MAPT;STX3;ODF2;DTNBP1;LYN;CDK5;HMGB1;PPP1R9A;TBC1D24;LIMA1;PKD2;PLP1;GPM6A;PPP1R9B;SH3GL2;RB1;CYFIP1;TBC1D23;RAPGEF2
prerank,receptor signaling pathway via STAT (GO:0097696),0.3154466798651812,0.6811509318488805,0.8627700127064803,0.9748514414898826,1.0,6/25,16.72%,CTR9;IFNAR2;PKD2;PIAS1;STAT2;STAT6
prerank,regulation of neuron projection arborization (GO:0150011),0.34051334767019514,0.6809012452361143,0.8628318584070797,0.9747305164805019,1.0,2/15,9.82%,DVL1;MYO9A
prerank,regulation of cell-cell adhesion (GO:0022407),0.2974599193898049,0.6807709108578581,0.8494749124854143,0.9745107780467201,1.0,3/39,7.73%,MINK1;FLOT2;FERMT3
prerank,signal peptide processing (GO:0006465),0.3557025573170155,0.6807159402793563,0.837138508371385,0.9742176079003438,1.0,3/11,12.32%,SPPL3;FURIN;PARL
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.3567482736974262,0.6806913266414959,0.8592814371257484,0.973886753940174,1.0,11/11,64.35%,BIN1;CAB39;CAV3;KCNE5;CASQ2;KCNE3;STK39;KCNH2;NEDD4L;CAV1;ACTN2
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.3469124618820869,0.6806798407475404,0.8670605612998523,0.9735435127626935,1.0,1/12,3.77%,SOAT1
prerank,regulation of glucose import (GO:0046324),0.303626424591319,0.6806318762636138,0.843065693430657,0.9732317076700964,1.0,3/30,6.71%,PID1;IRS1;IRS2
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.3149840429693545,0.6802528298445928,0.8542199488491049,0.9732404182751595,1.0,4/24,12.10%,CTSC;PRKACA;UCHL5;UBE3A
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.22052908332568083,-0.6795158005535314,0.9176470588235294,0.9809572828801878,1.0,7/29,15.29%,SORBS1;CHP1;ELOVL5;CNEP1R1;AKT1;SCARB1;CREBL2
prerank,negative regulation of defense response to virus (GO:0050687),0.3618091016217456,0.6793455668782926,0.8398133748055988,0.9737644413577642,1.0,1/10,4.92%,ILRUN
prerank,replicative senescence (GO:0090399),0.3512662644596826,0.678293962469604,0.8382789317507419,0.9744253041461959,1.0,3/12,17.17%,CHEK2;TP53;ATM
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.34508805204851467,0.6781452422848436,0.8573446327683616,0.9742118752639218,1.0,2/14,13.58%,SPRED2;SPRED1
prerank,action potential (GO:0001508),0.2876495883321689,0.6777771800142772,0.8709315375982043,0.9742202177115623,1.0,6/44,16.61%,SLC4A3;GNAQ;KCNMB2;KCNMB3;KCND2;KCNA1
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.2802912350025687,0.6769191236842809,0.9081196581196581,0.9747157113601893,1.0,10/70,14.32%,BAG3;DELE1;TGFB2;SMAD3;TLR3;TRAF2;MLLT11;BCL2;ACVR1B;CASP8AP2
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.3298729576659086,0.6766383509631855,0.8584656084656085,0.9746468370220808,1.0,3/18,13.87%,SCAI;ARHGAP35;HEG1
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.3497858241692645,0.6765954728797786,0.8509984639016898,0.9743373869238793,1.0,2/12,8.14%,SNAP47;STX3
prerank,neuron apoptotic process (GO:0051402),0.320940685813872,0.6764922744140862,0.851006711409396,0.9740955117685338,1.0,4/19,13.04%,TRPC5;CDK5;BNIP3;BCL2
prerank,regulation of amyloid fibril formation (GO:1905906),0.33255829602850634,0.6764216742959969,0.8484005563282336,0.9738068312481754,1.0,1/15,1.99%,PFDN1
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.32463760196302716,0.6759661770624653,0.8569482288828338,0.9739255000096505,1.0,3/19,11.35%,PRKACA;PTPRJ;PRNP
prerank,histone deubiquitination (GO:0016578),0.33008902252799277,0.6755220252817521,0.8597475455820477,0.9740115530347988,1.0,6/18,17.61%,ATXN7;USP3;TRRAP;UIMC1;USP21;USP16
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.2804953008824982,0.6752606986305411,0.8970747562296858,0.9739079780498182,1.0,10/60,14.70%,MED10;RELA;TNRC6B;MECP2;TCF7L2;TP53;CDK8;MED27;MED15;PTEN
prerank,peptide hormone secretion (GO:0030072),0.3093469935702192,0.6750171267512726,0.86489898989899,0.9737926574663013,1.0,3/26,13.39%,SNX19;CYB5R4;CAMK2G
prerank,cellular response to leucine starvation (GO:1990253),0.35563322171508566,0.6746049470994845,0.8459119496855346,0.9738602023609707,1.0,4/10,16.99%,IMPACT;MTOR;LARS1;GCN1
prerank,negative regulation of lipid catabolic process (GO:0050995),0.3223801483648248,0.6745209436041315,0.8418079096045198,0.9735844136764727,1.0,2/17,12.31%,PDE3B;SORL1
prerank,macrophage migration (GO:1905517),-0.2762518013910742,-0.6744774327109694,0.8741935483870967,0.9841972874456061,1.0,8/13,49.22%,CKLF;P2RX4;CCR2;EDNRB;CCL3;CXCL17;CCL2;CCL5
prerank,regulation of adaptive immune response (GO:0002819),0.31908130427008585,0.6742273135602321,0.85359477124183,0.9735209935015983,1.0,1/18,1.88%,IRF1
prerank,regulation of ion transport (GO:0043269),0.27659760785217863,0.6736710362158875,0.8995771670190275,0.9737416389296437,1.0,8/76,10.04%,KCNJ6;VAMP3;NEDD4;SYT12;SYT11;DTNBP1;VAMP2;NKAIN1
prerank,positive regulation of cholesterol transport (GO:0032376),0.30652319959510965,0.673088811543378,0.8836633663366337,0.9739234091069093,1.0,5/27,14.69%,EEPD1;ABCA7;PPARG;RXRA;ABCA5
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.3258469816141803,0.6728160807606218,0.8537859007832899,0.9738345025128432,1.0,2/18,11.90%,ATP7A;ABL1
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.3278250981249381,0.6722734508268329,0.8358620689655173,0.9739947375464663,1.0,1/17,4.31%,AKAP9
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.30720096374352623,0.6718572563962469,0.8614232209737828,0.9740384663469086,1.0,2/27,8.39%,AK4;AK2
prerank,hexose biosynthetic process (GO:0019319),0.28762267967085076,0.6718424275294183,0.8834285714285715,0.9737018209935556,1.0,4/42,9.86%,PGAM1;AKR1B1;ALDOA;ENO1
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.3566126011911808,0.6715226741985654,0.838006230529595,0.9736539769517968,1.0,1/10,3.35%,TUT4
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.31125231439074413,0.6713996536619851,0.8794871794871795,0.973410798067095,1.0,4/21,15.24%,MECP2;RAD51B;VPS4B;NPM1
prerank,regulation of potassium ion transport (GO:0043266),0.2993457848839633,0.6712191166462199,0.8688327316486161,0.9732431921657729,1.0,6/31,17.73%,CACNA1D;DLG1;CD63;KCNIP3;KCNA5;DPP6
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.30541416915584435,0.6711466371583023,0.8667466986794717,0.9729628345528705,1.0,6/25,13.77%,UGGT2;POMT2;DERL1;UBE2W;UGGT1;ATXN3
prerank,negative regulation of B cell proliferation (GO:0030889),-0.29191439178564166,-0.6707335983320614,0.8558558558558559,0.9860926777643919,1.0,2/11,7.10%,FCGR2B;TYROBP
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.2743427944200129,0.6706139497895084,0.9045120671563484,0.9731266549673657,1.0,13/71,15.57%,ADAMTS12;VPS4A;CTSC;CLPX;CTSZ;CAPN2;VPS4B;UBE2W;PDCD6IP;ATXN3;RSPRY1;OTUD7A;RHBDD1
prerank,positive regulation of epithelial cell migration (GO:0010634),0.27186276610698323,0.6704709871407708,0.9286463798530955,0.9729104681205807,1.0,19/92,16.78%,FGF1;ITGB1BP1;TGFB2;SASH1;THBS1;NRP1;PRKCA;DOCK1;MTOR;ABL1;RTN4;RREB1;NRP2;PRKD2;ROCK2;CLASP1;MAP4K4;IQSEC1;RIN2
prerank,regulation of T cell differentiation (GO:0045580),0.2976075384321775,0.6703850691098402,0.8855491329479769,0.972640815877184,1.0,4/33,11.90%,RUNX1;METTL3;PRDM1;ABL1
prerank,positive regulation of synapse assembly (GO:0051965),0.31203991283518173,0.6700510031899369,0.8782287822878229,0.9726044874379083,1.0,4/27,10.25%,EPHB2;CLSTN3;IL1RAP;CLSTN1
prerank,B cell proliferation (GO:0042100),-0.24845992108842335,-0.6699241693938086,0.8869257950530035,0.9853074352143278,1.0,4/17,28.95%,PTPRC;HSPD1;CD180;CTPS1
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.3367266689740751,0.6699146905631017,0.8638968481375359,0.9723835830830518,1.0,2/14,8.59%,PPP2R2A;NCK1
prerank,response to histamine (GO:0034776),0.35107777565771164,0.6697263084111741,0.8446153846153847,0.9722097967572064,1.0,2/10,11.00%,GABRG2;DIAPH1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.3472888217498037,0.6689242846841436,0.8514285714285714,0.9726177825340859,1.0,2/11,13.04%,CD44;BCL2
prerank,stem cell differentiation (GO:0048863),0.2854339890373318,0.6687065373544182,0.8833333333333333,0.9724843636536322,1.0,7/39,16.27%,TGFB2;SETD2;PUM1;TP53;LRP6;GPM6A;MEF2C
prerank,purine nucleotide metabolic process (GO:0006163),0.3071741873854533,0.6683511822239543,0.8725247524752475,0.9724650143536973,1.0,3/24,11.13%,PRPSAP1;HPRT1;GDA
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.28724883109923677,-0.6680297019442306,0.8910256410256411,0.9854678527743489,1.0,2/12,10.18%,WAPL;RAD21
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.2921831816397532,-0.6678063784793652,0.863768115942029,0.9840892491723281,1.0,5/10,33.08%,XDH;CADM4;DCN;DAB2IP;PIK3CB
prerank,histone lysine methylation (GO:0034968),0.29616876996673935,0.6677071337799348,0.8903456495828367,0.9727248331102191,1.0,4/33,8.54%,SUV39H1;EHMT2;SETD3;EZH2
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.31728141017863853,0.6674974902559115,0.8700787401574803,0.9725841950662759,1.0,3/21,8.59%,CNKSR3;GPD1L;NCK1
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.2789183753917841,0.6670153428103173,0.9004282655246253,0.9726973523171563,1.0,11/57,16.49%,UACA;DAPK1;CYFIP2;HMGB1;TBC1D10A;SYK;FYN;HTRA2;GRIN2A;ARL6IP5;LGMN
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.2925346338123915,0.6668952039111473,0.8840749414519906,0.972467532953739,1.0,6/38,11.35%,GAS6;PDGFB;PTPN1;LRP8;MVP;PRNP
prerank,proton transmembrane transport (GO:1902600),0.29200720026292626,0.666587136836469,0.8790322580645161,0.972399570337321,1.0,3/36,7.57%,SLC9A1;HVCN1;ATP6V0E1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.29636849614275934,0.6660785251354917,0.8687943262411347,0.9725145006093273,1.0,7/33,16.57%,CDK6;DLG1;APC;BRD7;PKD2;PTEN;RB1
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.31175451654136566,0.664656093538344,0.8588390501319261,0.9734946235805985,1.0,2/20,7.02%,PPID;PPIL2
prerank,regulation of neurotransmitter secretion (GO:0046928),0.29842352905474046,0.6644180295641959,0.8816425120772947,0.9733565700048468,1.0,3/32,9.40%,LRRK2;SYT11;DTNBP1
prerank,regulation of neuron migration (GO:2001222),0.29758403139772693,0.6640534306408938,0.8671679197994987,0.9733450076469101,1.0,4/26,10.93%,CX3CL1;KIF20B;PLAA;SEMA6A
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.3211912939605953,0.6628305833393758,0.8514442916093535,0.9740893465389805,1.0,2/16,10.06%,CHMP5;TMEM50B
prerank,photoreceptor cell development (GO:0042461),0.33139546779518736,0.6627582378307095,0.8427762039660056,0.9738176255593312,1.0,4/14,17.66%,AHI1;CEP290;RORB;ARL3
prerank,glycerol metabolic process (GO:0006071),-0.28971728121517143,-0.6627327704177807,0.9067796610169492,0.9869874912956333,1.0,5/10,27.37%,GOT1;COQ2;TPI1;COQ3;GK5
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.3084418293569256,0.6625578595369209,0.89625,0.9736511912659868,1.0,7/24,15.61%,TERF2;XRN1;ERCC4;TNKS2;TERF1;CTC1;HNRNPC
prerank,maintenance of blood-brain barrier (GO:0035633),0.29483431462996496,0.661885009096587,0.8785276073619632,0.9739255235094246,1.0,1/30,0.78%,VCL
prerank,metal ion transport (GO:0030001),0.27039431623471955,0.6607285546335705,0.930890052356021,0.974660205818889,1.0,12/86,14.79%,TRPC5;NIPAL3;CACNG7;CACNA1D;CACNA1A;RAMP1;NIPA2;NDFIP1;FYN;CALCRL;PKD2;CACNA1C
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.33886283217714774,0.6602995241164207,0.8768996960486323,0.9746999641569783,1.0,2/12,9.65%,MAPK1;LYN
prerank,neural crest cell migration (GO:0001755),0.29105610630331075,0.6596416690355303,0.8875878220140515,0.9749612397982895,1.0,5/36,13.49%,NRP1;SEMA6D;SEMA3D;SEMA6A;FN1
prerank,positive regulation of protein maturation (GO:1903319),-0.28170733689200034,-0.6593802609281187,0.8789808917197452,0.9882644970912614,1.0,4/11,34.27%,ADAM8;CCBE1;SOX4;NLRC4
prerank,positive regulation of immune effector process (GO:0002699),0.29895813545182437,0.6593004326389109,0.8746898263027295,0.9748955929442362,1.0,2/27,5.98%,DDX60;PTPRJ
prerank,cellular biogenic amine metabolic process (GO:0006576),0.33687819577484834,0.6586310830129442,0.8440366972477065,0.9751810089888987,1.0,1/12,5.05%,ATP7A
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.28541578689348446,0.6582975438188081,0.8976744186046511,0.9751539140718538,1.0,8/38,17.90%,CABIN1;ASF1A;CENPP;ATRX;RBBP7;NPM1;CENPC;UBN1
prerank,positive regulation of T cell proliferation (GO:0042102),0.27498335015375336,0.6578950598909243,0.9089912280701754,0.9751592224600543,1.0,7/55,14.65%,IGFBP2;NCK1;IL18;ICOSLG;HMGB1;SYK;AIF1
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.2659173816137483,0.6574877879847505,0.9227557411273486,0.9751787127613964,1.0,10/95,12.55%,RELA;CTR9;CHMP5;AXL;IL1A;MAPK8;PLAA;CYRIB;HMGB1;MAPK14
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.35416697373030737,0.6573722501361904,0.8507936507936508,0.9749393015285898,1.0,2/10,13.07%,TCP1;CCT3
prerank,negative regulation of stem cell differentiation (GO:2000737),0.3353447428605339,0.6569817202241952,0.8647058823529412,0.9749421362604788,1.0,1/12,4.94%,N4BP2L2
prerank,negative regulation of response to biotic stimulus (GO:0002832),-0.2232180975360209,-0.656711896047449,0.9468599033816425,0.9889107465604865,1.0,17/26,42.27%,PCBP2;SIRT2;NLRC3;TNFAIP3;IRAK3;CARD16;NMI;TRAF3IP1;DHX58;NFKBIL1;PPM1B;TRIB1;CACTIN;TRIM21;C1QBP;LYAR;TYRO3
prerank,GPI anchor metabolic process (GO:0006505),-0.2164945576152138,-0.6561931365912654,0.9489795918367347,0.9877572426217355,1.0,15/26,35.63%,PIGN;PGAP2;PIGV;PIGB;DPM1;PIGL;PIGG;PIGM;MPPE1;PIGZ;PIGF;PIGA;DPM2;GPLD1;PIGC
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.3367714635308415,0.6552561788590711,0.8706395348837209,0.9761458329808994,1.0,1/14,2.57%,ADSS1
prerank,negative regulation of axonogenesis (GO:0050771),0.29371236609911955,0.6545469661887857,0.879415347137637,0.9764297311137384,1.0,6/27,14.70%,GDI1;DIP2B;ULK2;RUFY3;RTN4;PTEN
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.28600606105054244,0.6545461782760472,0.9025821596244131,0.9760834673383676,1.0,5/37,13.65%,RFC2;POLD3;ERCC4;CUL4A;GTF2H1
prerank,regulation of protein localization to cell surface (GO:2000008),0.28792159654259647,0.6543098899203398,0.8929804372842347,0.9759428851796358,1.0,4/33,8.50%,MAP1A;GPD1L;STX3;ABCA7
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.33583847109223935,0.6531087644177171,0.887624466571835,0.9766938799542175,1.0,1/12,3.40%,ALDH6A1
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.29918393240256436,0.6527525083885457,0.8795944233206591,0.9766576393046785,1.0,7/29,16.59%,METTL3;PTPN1;MAVS;IFNAR2;ABCE1;STAT2;YTHDF3
prerank,T cell receptor signaling pathway (GO:0050852),0.2601978793905322,0.6520734615369873,0.9628140703517588,0.9769071327097948,1.0,24/138,16.52%,RELA;RNF31;RFTN1;PSMD9;PSMB8;PTPRJ;RC3H2;SPPL3;PSMC5;IKBKB;PAK2;NCK1;ICOSLG;NFKBIZ;FBXW11;PSMD12;PSMA2;FYN;PRKD2;THEMIS2;PSMB1;PIK3R1;PAK1;FYB1
prerank,regulation of synapse organization (GO:0050807),0.29362041777898945,0.651509821335965,0.8895781637717122,0.977067649981079,1.0,8/26,17.37%,ARHGAP22;NEDD4;ABL1;CDKL5;MEF2C;SETD5;CTNNA2;GRIPAP1
prerank,positive regulation of stem cell proliferation (GO:2000648),0.3161061166451268,0.6510046134750919,0.8926630434782609,0.9771711696596965,1.0,2/17,11.42%,N4BP2L2;SOX11
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.26618889364167153,0.6501821364350632,0.9298429319371728,0.9775527766737131,1.0,14/86,14.25%,PRKCZ;NRP1;PDGFB;PTPRJ;ACVR1;PAK2;LRP8;CD44;PRNP;ABL1;BANK1;TP53;FYN;RELN
prerank,negative regulation of cilium assembly (GO:1902018),-0.261855691412203,-0.6501801841459695,0.9074074074074074,0.9909924436674499,1.0,8/12,32.50%,LIMK2;CEP97;EVI5L;TBC1D30;CDK10;TCHP;MAP4;TESK1
prerank,sulfate transport (GO:0008272),0.3294013942535975,0.6501468713186475,0.882768361581921,0.9772447508005706,1.0,1/14,6.52%,SLC26A11
prerank,regulation of cell communication (GO:0010646),0.2828586638245173,0.650011648029823,0.8968347010550997,0.9770067960002178,1.0,4/35,9.00%,MTCH1;CAMK2D;PTPN1;GRK5
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.3056253766899548,0.6488264497206047,0.8835078534031413,0.9776731571351045,1.0,2/21,6.42%,DELE1;BIRC3
prerank,embryonic heart tube development (GO:0035050),0.3252793790796664,0.6483437558006868,0.8577524893314367,0.977743366773346,1.0,2/14,13.74%,ACVR1;NDRG4
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.28897275758350593,0.6476328636628456,0.8899521531100478,0.9780470864939712,1.0,3/29,7.66%,RAB3GAP1;EPHB2;NETO1
prerank,regulation of actin filament-based process (GO:0032970),0.2686432448784793,0.6474381725811817,0.9309978768577495,0.9778735172847387,1.0,13/70,16.60%,RHOF;IQGAP2;EZR;TWF2;EPHA5;TAOK1;ARHGAP35;MTOR;ABL1;ROCK2;IQGAP1;PAK1;ARHGAP17
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.27975643148652746,0.6469262912071219,0.9157894736842105,0.9779623687754055,1.0,7/39,17.61%,NRP1;LRP5;TGFBR2;LRP6;PKD2;PAK1;CTNNB1
prerank,regulation of nervous system development (GO:0051960),0.28338999449451685,0.6466924460420774,0.9060710194730813,0.9778214570002633,1.0,2/37,7.87%,CX3CL1;TENM4
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.2896416656311967,0.6461313554155366,0.8992628992628993,0.9779759727574786,1.0,8/31,18.07%,YWHAE;MAPK8;NMT1;TP53;BCL2;YWHAB;TFDP2;PPP3CC
prerank,amino acid import across plasma membrane (GO:0089718),0.29692145322145647,0.6455770626458657,0.89,0.978126770264035,1.0,2/24,8.66%,SLC7A2;SLC7A8
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.23843443009153975,-0.644138456689473,0.9288389513108615,0.994119766142862,1.0,4/16,16.32%,DPYD;UPP2;DPYSL3;NT5M
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.34137316970807724,0.644100347076079,0.8709677419354839,0.9790628829097392,1.0,1/10,5.29%,NT5C3A
prerank,androgen metabolic process (GO:0008209),0.30265966278485773,0.6435146402934898,0.881491344873502,0.9792286984325564,1.0,3/18,17.53%,HSD17B11;HSD17B4;MED1
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.29198495209851055,0.6422393405663198,0.8910891089108911,0.980010898162198,1.0,5/27,14.61%,PLA2G6;CHKB;SLC27A1;CHKA;ETNK1
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.27221915556032034,-0.6421401963711975,0.8980263157894737,0.9941059789660728,1.0,2/12,13.71%,FUT9;AKT1
prerank,negative regulation of T cell proliferation (GO:0042130),0.29022991022790406,0.6415692035408596,0.8907766990291263,0.9802652810766852,1.0,5/28,18.02%,GLMN;PRNP;LGALS9;PRKAR1A;RC3H1
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.32464615519611045,0.6410904606400153,0.8814814814814815,0.9803393482045526,1.0,4/13,19.15%,SOX11;TMSB4X;PSEN1;SIN3A
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.2437595990248792,-0.6403315098244463,0.903114186851211,0.9939254466410528,1.0,3/16,15.96%,IFNGR1;HDAC1;HMGCR
prerank,regulation of vasculogenesis (GO:2001212),0.32209377456658195,0.6402840996414164,0.8833819241982507,0.9806723079412918,1.0,1/14,4.54%,RAP1A
prerank,cilium-dependent cell motility (GO:0060285),0.29423958791381366,0.6400555930315118,0.8773087071240105,0.9805247678347331,1.0,22/22,70.62%,RFX3;TEKT3;TEKT4;TEKT1;TEKT2;TEKT5;DNAH1;CCDC65;DNAH17;DNAAF2;GAS8;DRC1;DNAH3;RSPH9;DNAI3;DNAH2;EFHC1;EFHC2;DNAH8;CFAP44;CCDC39;CFAP54
prerank,cellular response to superoxide (GO:0071451),0.3354712389467143,0.6397358116731929,0.8703976435935199,0.9804514694343679,1.0,1/10,5.05%,ATP7A
prerank,negative regulation of ATPase activity (GO:0032780),-0.24692276462740112,-0.639731868104491,0.9277566539923955,0.9928281458482251,1.0,4/16,16.30%,PXK;SIRT1;OXA1L;ATP5IF1
prerank,pyruvate metabolic process (GO:0006090),0.27056608885743,0.6389094756706666,0.9303590859630033,0.9807944711690831,1.0,6/52,11.56%,PGAM4;PGAM1;ALDOA;ENO1;SRR;GCK
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.29335570716233944,0.6386163196033413,0.9003880983182406,0.9807006300294338,1.0,3/25,10.78%,RIN3;SDCBP;ATXN2
prerank,regulation of microtubule-based movement (GO:0060632),0.3348939034444624,0.6383479960175545,0.8813559322033898,0.9805881602953286,1.0,1/11,3.82%,IGBP1
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.31569387640739627,0.63826295324157,0.8786127167630058,0.9803129679492344,1.0,2/15,9.52%,SYN3;USP46
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.31322001993160886,0.637711725938084,0.894878706199461,0.9804396210886284,1.0,2/17,8.61%,CACNA1D;TRPM4
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.3021610234151305,0.6374153868410302,0.8875816993464052,0.9803216155655539,1.0,1/20,1.88%,PTDSS2
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.33197130875213277,0.6365720280395137,0.8786039453717754,0.9803252267010142,1.0,2/11,13.07%,TCP1;CCT3
prerank,regulation of protein localization to Cajal body (GO:1904869),0.33197130875213277,0.6365720280395137,0.8786039453717754,0.9803252267010142,1.0,2/11,13.07%,TCP1;CCT3
prerank,histone ubiquitination (GO:0016574),0.29486070927523206,0.6363097533612473,0.8855263157894737,0.9802106144410884,1.0,2/21,6.14%,CTR9;UBE2A
prerank,glycosaminoglycan catabolic process (GO:0006027),0.2683450813785836,0.6360038445910403,0.9251626898047722,0.9801107864221353,1.0,10/55,16.08%,SLC9A1;CEMIP2;ARSB;CD44;BGN;SDC2;FUCA1;GPC3;GPC6;GNS
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.22737001179850252,-0.6357990433527789,0.9557522123893806,0.9941339183447311,1.0,2/20,4.41%,CHRM3;GRK2
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.25917013575673614,0.635186329740136,0.9361924686192469,0.9804656102886495,1.0,13/74,15.65%,PSMD9;PSMB8;EP300;EGLN3;EGLN2;PSMC5;EGLN1;ELOC;PSMD12;PSMA2;RBPJ;ARNT;PSMB1
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.30748638928731703,0.6349863597067141,0.8995983935742972,0.9802847695949576,1.0,1/18,1.24%,PRKCZ
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.3146158918987512,0.6345734501312739,0.8989071038251366,0.9803082591393847,1.0,5/14,17.68%,SEC24B;MIA3;SEC24D;SEC24A;RAB1A
prerank,meiosis I (GO:0007127),0.2892332867258149,0.6342731818811624,0.8908629441624365,0.9802336056805723,1.0,1/23,3.73%,BCL2L11
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.3336871252457105,0.6342092845206903,0.8870728083209509,0.9799434881971164,1.0,2/11,12.68%,CTDNEP1;SLC27A1
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.3237103626179374,0.6340928628729832,0.8827160493827161,0.9796925823418435,1.0,3/12,14.60%,EAPP;NELFA;RECQL5
prerank,retinol metabolic process (GO:0042572),0.3177389978250468,0.6335429568113006,0.8972895863052782,0.9797835033105581,1.0,1/14,10.20%,DHRS3
prerank,epithelial cell differentiation (GO:0030855),0.2579749089344594,0.6335307876527458,0.9572025052192067,0.9794491449288047,1.0,1/88,0.19%,SCUBE1
prerank,regulation of monocyte differentiation (GO:0045655),0.31828633131222267,0.6334340079219491,0.8852691218130312,0.9791858054314297,1.0,3/14,12.05%,CDK6;ACIN1;ZFP36L1
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.3178143765537072,0.6331117560279175,0.8837876614060258,0.9791002652636069,1.0,1/13,4.51%,UTP20
prerank,histone H4 deacetylation (GO:0070933),0.3350125463967807,0.6327326745738325,0.8940092165898618,0.9790687295906978,1.0,3/10,16.15%,HDAC9;HDAC2;RCOR1
prerank,negative regulation of transferase activity (GO:0051348),0.2865227995243904,0.632316084574801,0.8943488943488943,0.9790440013312585,1.0,6/28,13.42%,IRS2;MAPT;ERCC4;ABL1;TP53;TERF1
prerank,myeloid dendritic cell activation (GO:0001773),0.32840583728845985,0.6312877387805511,0.8740629685157422,0.9795569321470302,1.0,2/12,12.01%,TGFBR2;HMGB1
prerank,positive regulation of mRNA processing (GO:0050685),0.29974814370063935,0.6310965871441739,0.8908629441624365,0.9793664605620229,1.0,3/21,8.78%,RBM3;NUP98;TRA2A
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.19286828900206954,-0.6304022512540037,0.963855421686747,0.9963740842071018,1.0,7/32,18.83%,CDK17;NPAT;CDK16;TFDP1;CDK18;HINFP;CDK14
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.27310683524783785,0.6299228956441849,0.9232505643340858,0.9799677514853506,1.0,5/48,9.43%,GAS6;PADI2;METTL3;PYDC1;PPARG
prerank,regulation of centrosome cycle (GO:0046605),0.29187661862145325,0.6295218589633103,0.896640826873385,0.9799605752578991,1.0,4/21,15.24%,CHMP5;VPS4B;PDCD6IP;NPM1
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.3265162320365727,0.6295028622757002,0.9072463768115943,0.9796329090922131,1.0,1/11,4.60%,PADI2
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.265838890228409,0.6294748778669632,0.9206703910614525,0.9793115299177035,1.0,3/49,9.65%,PARP9;IL18;LYN
prerank,cell differentiation in hindbrain (GO:0021533),0.3286016466679609,0.6292959578868047,0.880466472303207,0.979109363359688,1.0,1/11,5.05%,ATP7A
prerank,ethanol metabolic process (GO:0006067),0.31996180110707173,0.6289444954964581,0.8893740902474527,0.9790615415163008,1.0,1/12,6.51%,ALDH1A1
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.26046179628122934,-0.62887759986827,0.9245901639344263,0.995887745725303,1.0,7/11,42.88%,PRDX1;CAT;PRDX2;PRDX3;GPX1;PRDX5;PRDX4
prerank,regulation of biosynthetic process (GO:0009889),0.3326407582892585,0.6287779122255734,0.874051593323217,0.978853906869002,1.0,1/11,8.48%,ALOX5
prerank,purine nucleotide catabolic process (GO:0006195),-0.2609523953104153,-0.6278259441569748,0.9295302013422819,0.9950508487274521,1.0,7/13,41.25%,XDH;HINT1;PNP;GPX1;ITPA;NT5C;NT5E
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.27964522755210586,0.627249961922778,0.9064837905236908,0.979734700173228,1.0,1/26,1.07%,LRRK2
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.2597242291826214,0.6269722272372605,0.9404888416578109,0.9796255203729423,1.0,5/65,6.95%,CDK5RAP3;VPS4A;PSMD9;PSMB8;PSMC5
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.26159961680146016,0.6267951932745568,0.9251925192519251,0.9794196844005949,1.0,8/54,13.36%,RNF31;GAS6;BIRC3;IKBKB;PYDC1;TRAF2;CYLD;SYK
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.316055871982892,0.6259665792954469,0.9167842031029619,0.9797447669918348,1.0,1/13,4.60%,PADI2
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.24796505449858205,0.6256470183433466,0.9707661290322581,0.9796538222825733,1.0,21/152,14.50%,LRRK2;SMARCA4;ZEB2;PSMD9;GID8;USP34;PSMB8;LRRK1;PSMC5;TRPM4;CSNK1G1;RNF146;TNKS2;WLS;PPM1A;PSMD12;UBR5;PSMA2;GPC3;TBL1XR1;FZD9
prerank,odontogenesis (GO:0042476),0.2747657583615438,0.6254362904861461,0.9229857819905213,0.9794748358327438,1.0,4/35,15.59%,TGFB2;ANKRD11;LRP6;HDAC2
prerank,ceramide catabolic process (GO:0046514),0.3159871894664507,0.6253865391256642,0.8790560471976401,0.9791738061472669,1.0,2/14,10.83%,ACER3;ASAH1
prerank,positive regulation of T cell activation (GO:0050870),0.2579239048052104,0.6252655687866077,0.9255663430420712,0.9789155874738041,1.0,10/62,17.29%,FLOT2;DOCK8;NCK1;CYRIB;LGALS9;AIF1;CD47;CD81;ZBTB1;NCKAP1L
prerank,organophosphate ester transport (GO:0015748),0.2885664067361003,0.6245504070013749,0.905940594059406,0.9791508478400485,1.0,6/24,16.25%,PITPNM1;PRELID2;PITPNA;PITPNB;EPG5;OSBPL2
prerank,regulation of phospholipase C activity (GO:1900274),0.3074673387872269,0.6243784349544335,0.8906882591093117,0.9789509985095379,1.0,3/15,13.76%,ESR1;ABL1;BICD1
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.2719268488884653,0.6240626921269655,0.9291521486643438,0.9788658384031533,1.0,5/39,13.65%,RFC2;POLD3;ERCC4;CUL4A;GTF2H1
prerank,regulation of myotube differentiation (GO:0010830),0.27898535076084796,0.6237462942757975,0.9121706398996235,0.9787881823654795,1.0,4/24,15.51%,HDAC9;HDAC5;MAPK14;TMEM119
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.3196396711274405,0.623369671117548,0.9021084337349398,0.9787598417228359,1.0,1/11,4.75%,EXOSC5
prerank,error-free translesion synthesis (GO:0070987),0.28988647068418205,0.6228954170277168,0.9066834804539723,0.9787889135372357,1.0,2/22,8.93%,RFC2;RCHY1
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.2690290574443608,0.6225341278735664,0.9354120267260579,0.978736155678308,1.0,7/44,14.91%,KCNJ6;AKAP9;FLNA;GNG2;GNB1;KCNMB2;KCNMB3
prerank,signal transduction by p53 class mediator (GO:0072331),0.27706573103661625,0.6223519154383377,0.9090909090909091,0.9785460703332466,1.0,6/30,14.07%,STK11;NBN;TP53;ATRX;DDX5;NDRG1
prerank,T-helper cell differentiation (GO:0042093),0.31673100953874267,0.6223013466151064,0.9066091954022989,0.9782421581604241,1.0,2/14,12.01%,ATP7A;HMGB1
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.30851721611673655,0.6220282424799944,0.8931082981715893,0.9781224251086447,1.0,2/15,9.06%,MRE11;CHEK2
prerank,C-terminal protein amino acid modification (GO:0018410),-0.2599144794765781,-0.6215443831980747,0.9311377245508982,0.9976056053476651,1.0,2/11,3.44%,AGTPBP1;ATG5
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.3083940389375782,0.6215017224360948,0.8956043956043956,0.9781912775467441,1.0,1/16,2.57%,ADSS1
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.29304228772826474,0.6214929306977179,0.8958333333333334,0.9778630557464482,1.0,5/20,17.72%,UBQLN1;HSP90AA1;TGFBR1;DCUN1D2;DCUN1D5
prerank,substantia nigra development (GO:0021762),0.2656291695465447,0.6209160580843739,0.9162790697674419,0.9779697660748142,1.0,7/37,14.58%,PADI2;YWHAE;CKB;MAPKAP1;CDC42;CALM1;PLP1
prerank,cellular response to drug (GO:0035690),-0.20833031515401867,-0.620812889777453,0.976303317535545,0.9965057596581857,1.0,3/25,4.82%,RAP2A;AIM2;PDE4B
prerank,tRNA metabolic process (GO:0006399),0.297324264528909,0.6204900405659819,0.9002732240437158,0.9779584015600222,1.0,3/17,15.00%,POP1;AARS1;DTD1
prerank,spermatid development (GO:0007286),0.2733283973175122,0.6198388916762673,0.9134615384615384,0.9781165686255461,1.0,2/32,10.50%,BBS4;YTHDC2
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.27230159341294785,-0.6194501537102152,0.9046242774566474,0.995826731113212,1.0,5/10,38.19%,FMR1;GNB5;CALM3;CBARP;GPR35
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.2876552374648904,0.6192062420441591,0.9054916985951469,0.9782693305983672,1.0,2/23,6.93%,BCL2L11;HSP90AA1
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.3253283939106381,0.6192005909382489,0.8956127080181543,0.9779335313137597,1.0,2/10,17.61%,LRP6;CTNNB1
prerank,regulation of actin filament polymerization (GO:0030833),0.2526105493577279,0.6189972189055337,0.9505907626208379,0.9777563749813215,1.0,16/69,18.66%,GBA2;PLEKHG2;ARFGEF1;SSH2;NCK1;TWF2;CYRIB;DBNL;WASHC5;EVL;SNX9;NCKAP1L;FER;BIN1;NCKAP1;ARHGAP18
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.3344079420169227,0.6186951309132772,0.9080118694362018,0.9776414138259748,1.0,1/10,3.92%,DSE
prerank,positive regulation of TOR signaling (GO:0032008),0.2698456344181418,0.6184876615862394,0.9294797687861271,0.9774665959448178,1.0,7/40,14.53%,GAS6;MIOS;GOLPH3;GPR137C;FNIP1;SLC38A9;LARS1
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.2511323848446835,0.6178632529172997,0.9575129533678757,0.9776073355720283,1.0,10/93,9.66%,CNKSR3;BRAF;GAS6;AKAP9;HSP90AA1;GPD1L;NCK1;FNIP1;CNOT9;CD44
prerank,purine ribonucleotide catabolic process (GO:0009154),0.29300917960587874,0.6174134944107981,0.9130998702983139,0.9776429862009458,1.0,2/21,6.83%,ACAT1;HPRT1
prerank,positive regulation of protein acetylation (GO:1901985),0.31439296752042845,0.6173119957271112,0.8820960698689956,0.9773764242346614,1.0,5/12,18.25%,DIP2B;TAOK1;CEP295;CAMK1;DDX3X
prerank,diol biosynthetic process (GO:0034312),0.30593869356577175,0.6172340665415734,0.8976486860304288,0.977097723208274,1.0,3/15,14.77%,ACER3;ASAH1;SPTLC1
prerank,peroxisome organization (GO:0007031),0.28431326892937486,0.6167337049441354,0.9004854368932039,0.9771342164578245,1.0,8/25,17.26%,ABCD2;ABCD3;ABCD1;PEX14;DNM1L;TMEM135;MFF;PEX7
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.2749821405565359,-0.6165741070529911,0.9090909090909091,0.9960126834023066,1.0,7/10,41.80%,FGR;LILRB1;BAG6;KIT;BTLA;CD40;CD24
prerank,basement membrane organization (GO:0071711),0.3079655645294962,0.6161520558832275,0.8991228070175439,0.9772389408829433,1.0,2/14,11.03%,FLRT2;PXDN
prerank,negative regulation of axon extension (GO:0030517),0.27155644161168935,0.6159874782693566,0.9314903846153846,0.9770238837932992,1.0,5/30,13.32%,SEMA6D;DIP2B;SEMA3D;SEMA6A;RTN4
prerank,regulation of trophoblast cell migration (GO:1901163),0.3050957813051809,0.6156040472260451,0.9067431850789096,0.9769693018035736,1.0,4/14,16.59%,AGO2;ACVR1B;ARHGDIB;YTHDF3
prerank,T cell mediated immunity (GO:0002456),-0.24722506464859872,-0.6145688842130155,0.948220064724919,0.9957415224072893,1.0,6/13,36.76%,CADM1;CD46;BTN3A3;GNL1;JAG1;CD55
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.2873667635912969,0.614335091153337,0.9051948051948052,0.9776120808892927,1.0,8/21,18.97%,SPPL3;ERAP1;ADAM10;DAG1;ADAM19;PSEN1;SPPL2A;MYH9
prerank,protein heterotetramerization (GO:0051290),0.3123384083216294,0.6136287784018135,0.9047619047619048,0.9777765782460438,1.0,1/13,2.89%,FARSA
prerank,lung development (GO:0030324),0.267686765928583,0.6129039176029208,0.9327830188679245,0.9779701147553972,1.0,3/33,11.42%,FGF1;LOXL3;SOX11
prerank,regulation of leukocyte migration (GO:0002685),-0.23516316123976755,-0.6128480161697142,0.9413680781758957,0.9952043469847712,1.0,6/16,29.30%,RAC1;RHOH;RHOG;HMOX1;RAC2;VEGFA
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.21369892288968095,-0.6127101855391615,0.9570815450643777,0.9937834651793915,1.0,12/19,41.74%,XDH;MYO1C;ADAMTS3;CADM4;CCBE1;DCN;DAB2IP;PIK3CB;ROBO1;TSPAN12;JCAD;SMOC2
prerank,response to hydrogen peroxide (GO:0042542),0.25578455397924443,0.6122072652787955,0.9302587176602924,0.9781522826913692,1.0,6/45,15.64%,RELA;IMPACT;SETX;ABL1;FYN;STK24
prerank,protein import into peroxisome matrix (GO:0016558),-0.2557097296904467,-0.6119731138177446,0.9238095238095239,0.9927063610344784,1.0,5/12,27.00%,PEX13;PEX1;PEX6;PEX5;PEX2
prerank,aorta development (GO:0035904),0.3058956488980975,0.6112011683766544,0.905367231638418,0.9785866877038628,1.0,14/14,69.44%,HECTD1;PKD2;LRP1;ROBO2;TBX1;APLNR;TBX2;TFAP2B;PDGFRB;PDE2A;EFEMP2;ROBO1;JAG1;ADAMTS9
prerank,glucose metabolic process (GO:0006006),0.2542703116089131,0.6107430665430432,0.9478260869565217,0.9785762419972771,1.0,8/58,15.71%,PGAM1;ALDOA;LRP5;IRS2;ENO1;PPARD;MDH1;SLC25A1
prerank,protein heterooligomerization (GO:0051291),0.29703218080427657,0.6097529482483856,0.9320652173913043,0.9789923149866181,1.0,3/17,13.91%,FARSA;TMEM120B;PKD2
prerank,glial cell development (GO:0021782),0.28072806316397264,0.609643003828673,0.9238329238329238,0.9787468156579997,1.0,3/25,11.42%,NF1;CDK6;SOX11
prerank,positive regulation of leukocyte migration (GO:0002687),-0.19513607991242019,-0.6095865612385668,0.98,0.9925165606043691,1.0,4/27,18.18%,CSF1;JAM3;ICAM1;ADAM8
prerank,NIK/NF-kappaB signaling (GO:0038061),0.24943410321954962,0.609104792648504,0.9390115667718192,0.9787969638188941,1.0,10/72,12.95%,RELA;PSMD9;PSMB8;BIRC3;PSMC5;TLR3;TRAF2;FBXW11;PSMD12;PSMA2
prerank,aminoglycan biosynthetic process (GO:0006023),0.2584675842910066,0.6083929862531267,0.9490586932447398,0.9789928393067636,1.0,10/49,17.14%,UGDH;HS6ST2;SDC2;B3GALNT1;B3GNT2;GPC3;GPC6;EXT1;B3GALT1;EXT2
prerank,striated muscle cell differentiation (GO:0051146),0.2924231790230168,0.6083191577448499,0.9178082191780822,0.9787045092409598,1.0,3/16,16.27%,AKAP13;MYEF2;MEF2C
prerank,cellular glucan metabolic process (GO:0006073),0.3185387574888441,0.6082630239600636,0.8861911987860395,0.9784090236762937,1.0,2/11,11.70%,GBE1;UGP2
prerank,aspartate family amino acid metabolic process (GO:0009066),0.2868828990657416,0.6079600889409628,0.8976377952755905,0.9782971555774707,1.0,2/18,6.57%,FOLH1;MTHFR
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.32039943809343874,0.6076469968355689,0.9093655589123867,0.9781937619111267,1.0,2/10,10.66%,PDE3B;RNF157
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.3202770645170856,0.6070213251382538,0.913946587537092,0.978289468967635,1.0,2/11,9.28%,PUM2;PUM1
prerank,carbohydrate derivative transport (GO:1901264),0.2925524966563311,0.6069083036891993,0.9140211640211641,0.9780343922373557,1.0,3/18,14.14%,SLC15A3;ABCG1;SLC15A4
prerank,steroid hormone biosynthetic process (GO:0120178),0.2746781650496747,0.6062761907982662,0.9184914841849149,0.9781692378911565,1.0,2/29,12.06%,AKR1B1;HSD17B11
prerank,dicarboxylic acid transport (GO:0006835),-0.187851891255073,-0.6054338174324714,0.9887640449438202,0.9932929196403856,1.0,2/28,3.26%,SLC1A2;SLC25A13
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.30628263472022893,0.605307084131331,0.8998505231689088,0.9785332174563408,1.0,1/12,8.68%,IL18
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.2175526816131919,-0.6049442760892979,0.9675090252707581,0.9920310950477487,1.0,14/19,58.97%,AQP4;OFD1;SPEF2;NPHP3;CCDC39;NEK10;CCDC40;CABYR;ODAD4;CFAP53;ADCY10;SPAG17;DNAAF2;SPA17
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),-0.2457542529937072,-0.6048255164401596,0.9399293286219081,0.9906064340010186,1.0,1/14,2.26%,PTK2B
prerank,negative regulation of hemostasis (GO:1900047),-0.25163802432140137,-0.6040912534074344,0.9248554913294798,0.9895147224730435,1.0,3/12,20.97%,SERPINE2;CD34;TFPI
prerank,response to amino acid (GO:0043200),0.2738040547229692,0.6036078215029289,0.937424789410349,0.9794048458112286,1.0,7/31,14.53%,GLRB;IPO5;CAPN2;MTOR;SLC38A9;GLRA3;LARS1
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.3034419152175428,0.6034617033318151,0.9046898638426626,0.9791654501959628,1.0,3/13,14.60%,EAPP;NELFA;RECQL5
prerank,cell junction maintenance (GO:0034331),0.30366993458890207,0.6018100071108032,0.910948905109489,0.9800038032808867,1.0,1/14,7.27%,DCTN1
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.29906530619112837,0.6001044986108173,0.9013062409288825,0.9808405368620539,1.0,1/13,3.95%,CSTF2
prerank,response to peptide (GO:1901652),0.2660053402009372,0.5991965236508785,0.9346016646848989,0.9811157746726088,1.0,8/33,18.75%,IRS1;CACNA1A;PRNP;FYN;STAT2;STAT6;ERBIN;KAT7
prerank,regulation of endopeptidase activity (GO:0052548),0.25018049183411006,0.5990968714728654,0.9568965517241379,0.9808545016408845,1.0,5/59,10.43%,PSMB8;BIRC3;NRDC;SERPINI1;FURIN
prerank,anterior/posterior pattern specification (GO:0009952),-0.16610251404110193,-0.5990791484262974,1.0,0.9906808780991698,1.0,4/53,7.04%,BMPR2;SMAD2;ATP6AP2;BHLHE41
prerank,cell projection organization (GO:0030030),0.2692650761220551,0.5989595036549779,0.9334945586457074,0.9806143226257644,1.0,9/30,18.67%,PACSIN2;PARVB;CDC42;P2RY12;CYFIP1;NCKAP1L;GSN;NCKAP1;PLEK
prerank,protein kinase B signaling (GO:0043491),0.2768197907325321,0.5982038564667996,0.9106217616580311,0.9807781919094432,1.0,4/23,14.70%,GAS6;SETX;ZFP36L1;PTEN
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.2957712734116963,0.5980255066351309,0.9107142857142857,0.9805639811707992,1.0,2/15,13.18%,ACVR1;ACVR1B
prerank,lysine metabolic process (GO:0006553),0.31011434094556,0.5974659576892297,0.9042709867452136,0.9802856894096117,1.0,1/12,6.67%,ALDH7A1
prerank,lysine catabolic process (GO:0006554),0.31011434094556,0.5974659576892297,0.9042709867452136,0.9802856894096117,1.0,1/12,6.67%,ALDH7A1
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.2461645731465063,0.5971760217951911,0.9606801275239107,0.9801421616832111,1.0,9/73,13.90%,BRAF;GAS6;AKAP9;HSP90AA1;FNIP1;CNOT9;CD44;RAF1;PRKD2
prerank,endothelial tube morphogenesis (GO:0061154),-0.2658827606136954,-0.5968943469432296,0.9237536656891495,0.9902956613769386,1.0,1/10,0.80%,RHOA
prerank,regulation of interleukin-10 production (GO:0032653),0.2540587495629745,0.5968234842496944,0.9236031927023945,0.9800505663243114,1.0,7/44,17.19%,PRKCZ;HMGB1;SYK;LGALS9;TLR4;CD47;PIBF1
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.2975101034092648,0.5965442071088113,0.9240687679083095,0.979903390915415,1.0,1/14,3.95%,CSTF2
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.30785838552316713,0.5932484577724111,0.9256559766763849,0.981734772949735,1.0,3/12,12.99%,FADS1;ABCD1;HSD17B4
prerank,response to estradiol (GO:0032355),0.2651719994319619,0.5922782567787293,0.9410377358490566,0.9820472524537294,1.0,3/31,13.20%,ESR1;NCOA3;LCOR
prerank,regulation of NMDA receptor activity (GO:2000310),0.2645671027149743,0.591784234315587,0.9338942307692307,0.9820346908545599,1.0,7/32,16.27%,EPHB2;DLG1;DAPK1;GRIA4;RELN;GRIN2A;MEF2C
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.28024518515077657,0.5910809937838212,0.9218543046357616,0.9821871015830492,1.0,2/17,11.09%,NRP1;MIA3
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.3000188335739843,0.5910456314696597,0.9398496240601504,0.9818762783811058,1.0,12/12,70.02%,TLR4;MUC4;MUC13;MUC2;VSIG1;MUC6;INAVA;TLR9;SOX9;RBP4;NOD2;STRAP
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.27555562132703143,0.5900945835035821,0.9212598425196851,0.9821740559484631,1.0,3/22,11.84%,DUSP16;DUSP10;PPM1A
prerank,regulation of histone deacetylation (GO:0031063),0.3036932550641218,0.5883794178313667,0.9101283880171184,0.9829424267089285,1.0,3/13,15.39%,CAMK2D;CTBP1;AKAP8L
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.30005595599365353,0.5878551543851479,0.9152798789712556,0.9829507386277337,1.0,2/11,13.79%,UBQLN1;FYN
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.30152997539024656,0.5877321331997023,0.9161931818181818,0.9827076852628187,1.0,2/12,13.04%,CD44;BCL2
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.29234322352093484,0.5872730831519579,0.9165467625899281,0.9826630436114988,1.0,2/14,12.18%,CSTF2;ERN1
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.2906524294284266,0.5870712410912586,0.929676511954993,0.9824420801140572,1.0,2/15,12.18%,CSTF2;ERN1
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.26773020062132086,0.5865610955470805,0.9319640564826701,0.9824342719037938,1.0,1/24,3.74%,GAS6
prerank,secretory granule organization (GO:0033363),0.3106408924126922,0.5855967012141862,0.913961038961039,0.9827197283442024,1.0,2/10,12.85%,DTNBP1;ABCA1
prerank,glial cell differentiation (GO:0010001),-0.19134111472284798,-0.5855609560610894,0.9942196531791907,0.9942881475576667,1.0,21/28,47.27%,PTPRZ1;TPPP;GPR157;STAT3;SOX2;CDH2;MYRF;FGF10;EIF2B5;PAX2;SOX4;PICK1;ADGRG6;SOX8;ERBB3;SOX10;SOX9;SLC8A3;EGR2;GPC1;METRN
prerank,regulation of isotype switching (GO:0045191),0.2984229498539996,0.5855193730999613,0.8977272727272727,0.9824394382969067,1.0,3/14,14.14%,KMT5B;KMT5C;SLC15A4
prerank,glycolipid biosynthetic process (GO:0009247),0.2538133929475411,0.5852058241857045,0.9485380116959065,0.9823119234281166,1.0,7/38,17.11%,ST8SIA5;PIGP;PIGU;PIGQ;LARGE1;ST3GAL5;ST3GAL2
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.2575244385422138,-0.5846157353219176,0.9349593495934959,0.9932275335929204,1.0,4/10,32.83%,ZBTB16;BMPR1B;ACVRL1;PKDCC
prerank,regulation of smooth muscle contraction (GO:0006940),-0.20864380245834596,-0.5831421938193561,0.9652173913043478,0.9924171304038792,1.0,3/20,12.55%,CHRM3;ZDHHC21;PLCE1
prerank,innate immune response in mucosa (GO:0002227),0.3108715011947737,0.583044540513666,0.9288956127080181,0.9833023835279858,1.0,1/10,12.02%,RNASE3
prerank,negative regulation of protein secretion (GO:0050709),0.25389436088582906,0.5823547060261212,0.9559164733178654,0.9833897283512287,1.0,2/38,4.54%,PSMD9;IRS1
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.2361560617785789,0.5814830114071801,0.9761163032191069,0.9835824365240721,1.0,16/87,16.60%,RHOF;IQGAP2;EZR;TWF2;EPHA5;EPS8;TAOK1;ARHGAP35;NOTCH2;MTOR;ABL1;ROCK2;ARHGDIB;IQGAP1;PAK1;ARHGAP17
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.3055231140258431,0.5808929882395899,0.933920704845815,0.9836057044245887,1.0,1/11,4.64%,NRP1
prerank,carnitine shuttle (GO:0006853),0.30271685318408337,0.5806173024325856,0.9150227617602428,0.9834514139710259,1.0,2/11,14.13%,SLC25A20;ACACA
prerank,peptidyl-proline modification (GO:0018208),0.26178944453556685,0.5795237776374023,0.9390862944162437,0.9837872041438802,1.0,2/25,7.02%,PPID;PPIL2
prerank,regulation of wound healing (GO:0061041),0.24660465678552063,0.5791950951481804,0.9693181818181819,0.9836564288817603,1.0,3/42,8.48%,EPHB2;ARFGEF1;ALOX5
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.24685896817594818,0.5790432219918082,0.9484536082474226,0.9834125610584882,1.0,4/38,12.65%,NDUFS1;NDUFA9;NDUFV2;NDUFA10
prerank,protein oxidation (GO:0018158),0.30145516582406484,0.5787128185231687,0.9240121580547113,0.9832775162679008,1.0,1/11,10.28%,LOXL3
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.2618140550821396,0.5776666515937176,0.9436619718309859,0.9835770494179966,1.0,5/32,14.29%,SMPD1;SPPL3;MTOR;PPP1R16B;CALM1
prerank,lipid droplet formation (GO:0140042),0.309810560549041,0.5776455506145286,0.9306184012066365,0.9832579627426099,1.0,2/10,17.24%,CDS1;CDS2
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.20791973009643133,-0.5773609708132189,0.9552238805970149,0.9933494737829378,1.0,1/17,1.09%,KLF7
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.27831016048985135,0.5770050958121251,0.918848167539267,0.9832957504212713,1.0,1/18,3.10%,CACNG7
prerank,regulation of spindle organization (GO:0090224),-0.20715261926947032,-0.5766100462724894,0.9484126984126984,0.9921793331938707,1.0,12/18,42.31%,GNAI1;RNF4;DYNC1H1;RAE1;GPSM2;BORA;SENP6;MAP9;TACC3;PARP3;NUMA1;TPX2
prerank,regulation of immune response (GO:0050776),0.2305550318332556,0.5753589468299554,0.9909365558912386,0.9839170651262535,1.0,14/135,14.06%,IRF1;RAET1E;TGFB2;BCL6;BIRC3;ITGA4;LAIR1;LRP8;LYN;SLAMF6;COLEC12;ERAP1;SYK;RNF135
prerank,negative regulation of biomineral tissue development (GO:0070168),0.2673736869390766,0.5737642094935808,0.9326287978863936,0.9845259082081276,1.0,3/21,14.30%,GAS6;TRPM4;ROCK2
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.24865414284586224,-0.5725219336631189,0.9318885448916409,0.9924081308447238,1.0,5/12,28.90%,RAB10;SCRIB;ZDHHC7;TRAF3IP1;LAMA3
prerank,cellular response to fluid shear stress (GO:0071498),0.2966496248842371,0.5711060385561468,0.9350850077279753,0.9857236967934525,1.0,4/12,18.62%,MAP2K5;PKD2;MEF2C;NFE2L2
prerank,metanephros development (GO:0001656),0.2579498184880658,0.5708143439685416,0.9362745098039216,0.9855482724403974,1.0,1/26,4.01%,NF1
prerank,mucosal immune response (GO:0002385),0.28132550167405246,0.570219093272513,0.9384404924760602,0.9855460072976323,1.0,1/15,12.02%,RNASE3
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.2906265552353727,0.5701510614217908,0.9352409638554217,0.985250738955447,1.0,4/11,19.17%,HTRA2;LGALS9;GSN;CAAP1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.15219491842158053,-0.5693355066099387,1.0,0.9922142993291825,1.0,7/53,22.26%,CHRM3;CNR2;OPRM1;HTR4;HTR1F;HTR7;HTR2B
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.281631125496503,0.5693006380767539,0.9376731301939059,0.9854153119232624,1.0,1/15,3.17%,TCP1
prerank,positive regulation of cell killing (GO:0031343),0.2819816490449363,0.5690450334397296,0.9446022727272727,0.9852209817512094,1.0,2/13,13.36%,MAPK8;SYK
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.2958050134629999,0.5676188613545416,0.9346879535558781,0.9857042734148536,1.0,1/12,4.17%,EPHB2
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.27956776254163807,0.5672240365840012,0.9457579972183588,0.9855886244850036,1.0,2/16,12.68%,CTDNEP1;SLC27A1
prerank,positive regulation of leukocyte activation (GO:0002696),0.2726825942429202,0.5664440991725774,0.934228187919463,0.9856890043651608,1.0,1/18,4.55%,THBS1
prerank,regulation of dopamine secretion (GO:0014059),0.2600120701833,0.5663168148007309,0.9414634146341463,0.9854296336295664,1.0,3/25,9.40%,SYT12;SYT11;DTNBP1
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.2994830278940045,0.5661357682783993,0.9385826771653544,0.9851978845965493,1.0,3/10,19.22%,WDR1;PLEK;SEMA5A
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.2930259869127387,0.5655826675406078,0.9409158050221565,0.9851751651931349,1.0,1/12,3.17%,TCP1
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.21475596220362914,-0.5651355345477853,0.9712230215827338,0.9923719198546606,1.0,2/15,10.84%,PTPN12;RHBDF2
prerank,myelin assembly (GO:0032288),0.2969443915303076,0.5650635845782678,0.9287878787878788,0.9851205747202816,1.0,2/10,12.11%,TENM4;EPB41L3
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.2931763274228967,0.5646034315944398,0.9294117647058824,0.9850516254313676,1.0,2/11,17.61%,LRP6;CTNNB1
prerank,nucleoside salvage (GO:0043174),0.2986387605710003,0.5645191983049007,0.9236641221374046,0.9847648073706852,1.0,1/10,6.83%,HPRT1
prerank,chromatin assembly or disassembly (GO:0006333),0.2950299217626307,0.5630351717809804,0.9271137026239067,0.9852553567915063,1.0,2/11,12.92%,NOC2L;TP53
prerank,ncRNA export from nucleus (GO:0097064),0.24432266714885892,0.5628632937579957,0.9634433962264151,0.9850316650341115,1.0,4/36,8.68%,PHAX;NUP205;NUP98;NUP54
prerank,growth hormone receptor signaling pathway (GO:0060396),0.28411980760450667,0.562831480141643,0.9338129496402877,0.9847194702209419,1.0,5/14,16.72%,PTPN1;LYN;PXN;PIK3R1;STAT6
prerank,dendritic cell chemotaxis (GO:0002407),0.28399162740303296,0.5618934928751457,0.9381294964028777,0.9848916616930526,1.0,2/14,12.01%,TRPM4;HMGB1
prerank,inhibitory synapse assembly (GO:1904862),-0.23746491293586222,-0.5618756752575464,0.9481268011527377,0.9920880833943244,1.0,5/11,34.94%,GABRA2;LGI2;GABRB3;GABRA1;FGF13
prerank,positive regulation of myelination (GO:0031643),-0.23424613147298837,-0.561865546787582,0.9628482972136223,0.9906231989298735,1.0,6/11,32.56%,RNF10;ITGAX;TPPP;MYRF;DICER1;CST7
prerank,regulation of cholesterol esterification (GO:0010872),0.29881885549454373,0.5616854916649601,0.9265785609397944,0.984667632240027,1.0,1/10,9.50%,ABCG1
prerank,regulation of cell projection organization (GO:0031344),0.28366457744811,0.5604043050245554,0.9535211267605633,0.9850230086753317,1.0,4/13,17.88%,MYO9A;ERMN;MACF1;TREM2
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.29671925238073316,0.559707988479569,0.9412698412698413,0.9850499893198974,1.0,2/10,13.49%,FURIN;FN1
prerank,protein localization to condensed chromosome (GO:1903083),0.28012815991807266,0.5595151266004076,0.9418604651162791,0.9848104127145874,1.0,1/12,7.07%,BUB3
prerank,blood vessel endothelial cell migration (GO:0043534),0.25676131048040535,0.5589918812832754,0.9435173299101413,0.9847674178474886,1.0,2/22,11.09%,NRP1;MIA3
prerank,amyloid precursor protein catabolic process (GO:0042987),0.27779452604637817,0.5585276523061782,0.9492242595204513,0.9847066943179605,1.0,5/14,17.99%,ABCA7;ABCG1;ADAM10;ADAM19;PSEN1
prerank,regulation of T cell chemotaxis (GO:0010819),0.2886432854489897,0.5576183122855196,0.9489953632148377,0.9848699529786268,1.0,10/11,54.72%,ADAM10;CXCL13;XCL1;WNK1;CXCL10;STK39;OXSR1;CCL5;WNT5A;ADAM17
prerank,regulation of actin nucleation (GO:0051125),0.28640157329992594,0.5569568629431005,0.9340175953079178,0.9848662262509712,1.0,3/12,17.40%,ARF1;WASHC5;GSN
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.26337997030335164,0.5524414725919096,0.9516778523489933,0.9868312581600615,1.0,4/18,18.82%,CAMK2D;BIN1;CAB39;SLC43A2
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.2486670230604613,0.552357359797099,0.9586877278250304,0.9865407529442356,1.0,2/27,8.66%,SLC7A2;SLC7A8
prerank,positive regulation of macrophage activation (GO:0043032),0.2679037239643153,0.5504453980909984,0.9508196721311475,0.9871255801232813,1.0,1/17,4.55%,THBS1
prerank,negative regulation of lyase activity (GO:0051350),-0.20797943705291633,-0.5484458297428966,0.9854014598540146,0.993630996779224,1.0,6/16,34.05%,GRM3;CCR2;EDNRB;MTRR;PALM;ADGRV1
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.2724432033444277,0.5472448964067209,0.9457917261055635,0.9883040404003789,1.0,1/14,5.29%,NT5C3A
prerank,response to prostaglandin E (GO:0034695),0.29318421997113403,0.5452457728225608,0.9502332814930016,0.9889308167268245,1.0,2/10,14.41%,GNG2;GNB1
prerank,anion transmembrane transport (GO:0098656),0.22468374505647923,0.5448951135268569,0.9797008547008547,0.9887619258758966,1.0,9/67,17.27%,SLC7A2;ABCC5;LRRC8B;SLC7A8;SLC27A1;SLC25A1;ARL6IP5;SLC35A3;ABCC1
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.26228007951015175,0.5448566215439988,0.9547270306258322,0.988450833469721,1.0,2/16,13.50%,TERF2;NUS1
prerank,negative regulation of developmental growth (GO:0048640),0.23887687458553958,0.5434153965500079,0.9697336561743342,0.9888107800809408,1.0,5/30,14.70%,DUSP10;DIP2B;ULK2;RTN4;PTEN
prerank,apoptotic cell clearance (GO:0043277),0.2432921321728553,0.5430231239070666,0.9607843137254902,0.9886618317070631,1.0,2/30,4.55%,GAS6;THBS1
prerank,regulation of TOR signaling (GO:0032006),0.22821230325245095,0.543004004439239,0.9796791443850268,0.9883446209363057,1.0,9/67,14.87%,GAS6;MIOS;EPM2A;FBXO9;GOLPH3;FNIP1;SLC38A9;LARS1;TSC1
prerank,negative regulation of neuron projection development (GO:0010977),0.22772218537620856,0.5426559573919358,0.9749727965179543,0.9881609056719315,1.0,10/56,15.59%,STMN2;GDI1;MYLIP;BCL11A;RUFY3;RTN4;PTPRO;PTEN;PTPN9;HDAC2
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.24025367405218745,0.5414961250615983,0.9567307692307693,0.9883647964441459,1.0,2/29,8.02%,PLA2G6;PLA2G4A
prerank,negative regulation of endocytosis (GO:0045806),0.24992039660728235,0.5412502267637256,0.9702072538860104,0.9881499364384667,1.0,3/24,11.81%,SYT11;ABCA7;SCAMP5
prerank,positive regulation of cation channel activity (GO:2001259),0.23804896495740674,0.5408058522712049,0.969248291571754,0.9880133438697298,1.0,5/40,14.29%,EPHB2;TMSB4X;PKD2;RELN;CALM1
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.2600100935079539,0.5384887451776836,0.9557867360208062,0.9886904259154224,1.0,3/18,16.34%,NF1;TP53;FTH1
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.28731325380587114,0.5382117940986443,0.9405144694533762,0.9884858552648418,1.0,2/10,9.65%,PTPN1;LYN
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.2849899305063863,0.538149468492098,0.9634146341463414,0.9881860677417529,1.0,1/11,10.97%,NFKBIZ
prerank,photoperiodism (GO:0009648),0.24349783858347884,0.5378163472025087,0.969097651421508,0.9880069027308201,1.0,3/28,12.92%,CLOCK;CRTC1;TP53
prerank,regulation of neutrophil migration (GO:1902622),0.28528740491315485,0.537348328916905,0.947452229299363,0.9878627848131024,1.0,1/10,6.01%,MPP1
prerank,positive regulation of establishment of protein localization (GO:1904951),0.25443770246003794,0.5372412477948117,0.964095744680851,0.9875879101144809,1.0,5/19,17.88%,TCP1;PTP4A3;CCT3;CEP295;TREM2
prerank,bile acid biosynthetic process (GO:0006699),0.25344950556277096,0.5358646147851612,0.9638854296388543,0.9878544146280143,1.0,4/24,16.25%,OSBP;HSD17B4;OSBPL1A;OSBPL2
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.25582863088641716,0.5344537658088742,0.9639175257731959,0.9881410686798686,1.0,2/20,10.90%,EP300;GTF2B
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.28149190515280453,0.5326641499104844,0.9648562300319489,0.988573494650128,1.0,9/10,54.72%,ADAM10;CXCL13;XCL1;WNK1;STK39;OXSR1;CCL5;WNT5A;ADAM17
prerank,gluconeogenesis (GO:0006094),0.2271586312731837,0.5325085956180093,0.9665513264129181,0.9883122906385043,1.0,3/39,9.86%,PGAM1;ALDOA;ENO1
prerank,acylglycerol metabolic process (GO:0006639),0.2279783088609161,0.5310170999958368,0.9800235017626322,0.9885738024605808,1.0,7/37,17.83%,ABHD6;DGKI;DGKD;GK;DGKZ;ABHD12;DGKH
prerank,neuromuscular synaptic transmission (GO:0007274),0.25508395439393716,0.5281394994497502,0.9608355091383812,0.9894082592203329,1.0,3/18,16.39%,TBC1D24;KIF1B;ERC2
prerank,positive regulation of dendritic spine development (GO:0060999),0.25428239916798867,0.5278834143377493,0.9613333333333334,0.9891778154225388,1.0,6/20,17.99%,LRP8;DBNL;RELN;CAPRIN1;CAMK1;PSEN1
prerank,oxoacid metabolic process (GO:0043436),0.23830721690504,0.5268880081953008,0.9624242424242424,0.9892349078445124,1.0,3/27,15.81%,LIAS;MINPP1;TPST2
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.20218875714056067,-0.5258219430544109,0.9826989619377162,0.9982177337328447,1.0,9/15,43.56%,APPL1;CARD9;STAT3;MYD88;TICAM1;NOD2;GBP5;TNF;TLR6
prerank,pre-replicative complex assembly (GO:0036388),0.21789765860627003,0.5241722622682934,0.9946409431939979,0.9899067601910105,1.0,7/64,12.95%,PSMD9;ORC4;PSMB8;PSMC5;ORC2;PSMD12;PSMA2
prerank,glycine transport (GO:0015816),0.2823402849628626,0.5235541558997245,0.9666160849772383,0.989812881607794,1.0,1/10,8.66%,SLC7A8
prerank,sulfur compound catabolic process (GO:0044273),0.22872863793951326,0.5200161072756885,0.9817559863169898,0.9907826813370451,1.0,3/38,9.84%,ACAT1;ARSB;BGN
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.24571471792550115,0.5176668699549234,0.9662162162162162,0.9913095165492359,1.0,3/17,16.57%,BUB3;CTCF;RB1
prerank,histone H3-K36 demethylation (GO:0070544),0.2706687167574061,0.5165302424865476,0.968,0.9913725612371377,1.0,2/10,11.95%,KDM4B;KDM4C
prerank,protein hydroxylation (GO:0018126),0.252627880955223,0.5159600954119753,0.9739507959479016,0.9912479540173237,1.0,2/15,12.45%,EGLN3;VIPAS39
prerank,oligodendrocyte development (GO:0014003),-0.1968851088347842,-0.5150893628775219,0.9966996699669967,0.9992421361607029,1.0,9/15,39.83%,EIF2B3;TPPP;MYRF;EIF2B5;EIF2B4;NSUN5;EIF2B2;SOX10;CNTNAP1
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.23777748962449038,0.5102564676159776,0.9742599742599742,0.9928845618495107,1.0,3/22,12.92%,ESR1;PSMC5;TP53
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.24514157036996168,0.5079711771973612,0.9715447154471545,0.9933014276083031,1.0,4/17,18.62%,UBQLN1;HTRA2;TREM2;NFE2L2
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.19880911664209883,-0.5075576600232132,0.9932432432432432,0.999288664890987,1.0,6/15,31.67%,GOT2;GGT5;GGACT;HOGA1;GGT7;CHAC2
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.27010130974646107,0.5063007808414367,0.9559543230016313,0.9935039632536348,1.0,2/10,12.90%,MAP2K5;SH2B3
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.1932365260527156,-0.5059120360611743,0.992,0.9981082143412789,1.0,11/17,45.24%,BCL2L1;SOD2;BAX;BID;FIS1;CLU;BBC3;BAD;GGCT;BAK1;TIMM50
prerank,thymus development (GO:0048538),0.2552109492717226,0.5053281703242345,0.9518248175182482,0.9934657591664908,1.0,13/13,74.50%,TGFBR1;ZBTB1;SIX1;AIRE;TBX1;RIPK3;FADD;SHH;HES1;EPHB3;FGF10;FOXE1;SOD1
prerank,electron transport chain (GO:0022900),0.255081216739849,0.5043267182968818,0.979108635097493,0.993439033928973,1.0,3/15,13.52%,SDHA;ENOX2;ETFA
prerank,xenobiotic transport (GO:0042908),0.24509441746074326,0.5033177743275845,0.9633802816901409,0.993407948412465,1.0,3/17,17.27%,ABCC5;ABCG2;ABCC1
prerank,protein O-linked mannosylation (GO:0035269),0.24246930584723583,0.5032170838077809,0.9715025906735751,0.9931166527115962,1.0,2/18,10.73%,POMT2;FKTN
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.2623695842040099,0.497997801101233,0.9673405909797823,0.994333245404807,1.0,1/11,8.83%,DAB2
prerank,negative regulation of myotube differentiation (GO:0010832),0.2529680073209178,0.49299956543611956,0.9655688622754491,0.995404709054851,1.0,1/12,6.16%,HDAC5
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.22405169567214694,0.4874108681163875,0.9825436408977556,0.996510444386312,1.0,3/26,14.77%,ACER3;ASAH1;SPTLC1
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.24480552496102334,0.4870355920193079,0.9801980198019802,0.9962729767643038,1.0,2/15,14.37%,PPARG;PPARD
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.23301227291318033,0.48236638765585543,0.967479674796748,0.9970950417982567,1.0,1/16,7.85%,ERCC4
prerank,positive regulation of lymphocyte activation (GO:0051251),0.21355823201549867,0.4819195491265363,0.9875311720698254,0.9968743374180554,1.0,5/28,17.29%,PRKDC;CYRIB;CD47;SH3KBP1;NCKAP1L
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.22059329251574064,0.4815697879923943,0.9826302729528535,0.996631274476673,1.0,1/27,4.83%,GPR65
prerank,steroid metabolic process (GO:0008202),0.2007516732222162,0.4815364482874207,0.9957492029755579,0.9963091306920144,1.0,2/72,6.93%,GBA2;LIPA
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.1965782268787093,-0.48103199367895283,0.9871794871794872,1.0,1.0,5/13,34.05%,GRM3;CCR2;EDNRB;PALM;ADGRV1
prerank,embryonic eye morphogenesis (GO:0048048),-0.20560572188246384,-0.47903726233154525,0.9786585365853658,0.9993672737511815,1.0,5/11,38.73%,FBN2;FBN1;RARG;EFEMP1;KDM2B
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.24915155399579697,0.47790621204274053,0.9774774774774775,0.9968390907805085,1.0,4/11,18.73%,LYN;MFHAS1;TREM2;PJA2
prerank,positive regulation of phosphatase activity (GO:0010922),-0.16332231950813278,-0.477466264466652,0.9954954954954955,0.9981131247697973,1.0,1/21,1.34%,CALM2
prerank,T cell differentiation (GO:0030217),0.2039885213890014,0.4764405931599736,0.9953216374269006,0.9968365288901138,1.0,3/40,12.05%,SOX13;CHD7;ZFP36L1
prerank,acyl-CoA metabolic process (GO:0006637),0.20988996584241942,0.47559779282527187,0.9881235154394299,0.9966893963949419,1.0,4/35,15.80%,ACOT9;ACOT13;ACACA;SUCLG2
prerank,negative regulation of protein transport (GO:0051224),0.22027071119080344,0.4749382481335894,0.9872611464968153,0.996503462838472,1.0,3/25,13.37%,SNX3;ERP29;NDFIP1
prerank,regulation of cholesterol transport (GO:0032374),0.22609462714355674,0.4747299796090072,0.9832474226804123,0.9962140700239994,1.0,3/20,14.69%,TTC39B;NUS1;ABCA5
prerank,negative regulation of cyclase activity (GO:0031280),-0.18808961737106775,-0.4739036801579018,0.9865771812080537,0.9970612518645741,1.0,5/14,34.05%,GRM3;CCR2;EDNRB;PALM;ADGRV1
prerank,skin development (GO:0043588),0.1975811695662935,0.4723398905098435,0.9957401490947817,0.9963916676012711,1.0,2/65,5.05%,ITGA6;ATP7A
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.211201806011013,0.46922410252024066,0.9873737373737373,0.9966860618456748,1.0,7/24,18.62%,ATF6;TP53;RBPJ;CHD6;GCN1;HSPA5;NFE2L2
prerank,protein localization to kinetochore (GO:0034501),0.23133003933600477,0.4662918345861511,0.9814020028612304,0.9969213233782276,1.0,1/14,7.07%,BUB3
prerank,negative regulation of vascular permeability (GO:0043116),0.23701106512709783,0.46569499508926426,0.9851411589895989,0.9967085016560908,1.0,1/12,5.98%,PTPRJ
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.22216150480761634,0.46033500503258856,0.9803646563814866,0.9973421882678096,1.0,2/17,14.18%,AHI1;RFX3
prerank,regulation of protein acetylation (GO:1901983),0.23212561653164374,0.45937719305607017,0.96602658788774,0.9971708530375527,1.0,4/12,18.25%,TAOK1;CEP295;CAMK1;DDX3X
prerank,cellular response to interleukin-4 (GO:0071353),0.24034900508442672,0.4585640324249916,0.9803625377643505,0.9969815698712952,1.0,10/10,75.98%,STAT6;XCL1;RUFY4;DCSTAMP;GATA3;TCF7;LEF1;SHPK;JAK3;XBP1
prerank,hexose metabolic process (GO:0019318),0.19874217233658056,0.455378605648224,0.9931584948688712,0.9971845877819095,1.0,4/39,14.37%,ALDOA;IRS2;FUCA1;PPARD
prerank,lymphocyte mediated immunity (GO:0002449),0.23224642832515136,0.4547370896546053,0.9880774962742176,0.996965677707014,1.0,1/12,8.96%,MYO1G
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.2352330270489857,0.45355769028900966,0.9806547619047619,0.9968224215287899,1.0,1/12,9.06%,CHEK2
prerank,negative regulation of wound healing (GO:0061045),0.20395974048337073,0.4523779065138952,0.9937578027465668,0.9966645626155262,1.0,4/28,15.10%,ALOX5;PROC;PTEN;CLASP1
prerank,tRNA 5'-leader removal (GO:0001682),0.22645777446884285,0.4479723222126738,0.9852507374631269,0.9969802768973205,1.0,1/13,7.52%,POP1
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.2256483840211749,0.44295203957673146,0.9883720930232558,0.9973602065199108,1.0,1/12,9.66%,CD44
prerank,organic cation transport (GO:0015695),0.20415122983768327,0.4337033957150389,0.993514915693904,0.9981806816159271,1.0,4/20,18.87%,SLC25A26;SLC44A1;RALBP1;SLC44A2
prerank,heme biosynthetic process (GO:0006783),0.19745102323943098,0.4268382637661326,0.9948652118100129,0.9986076721729845,1.0,3/22,15.52%,FECH;FLVCR1;ABCG2
prerank,vasoconstriction (GO:0042310),0.22266164469554292,0.4230358822434533,0.9984962406015038,0.9986605709030251,1.0,11/11,77.75%,PIK3C2A;EDN1;EDN2;CRP;EDN3;KEL;ACTA2;SLC8A1;EDNRA;EDNRB;HTR2B
prerank,tRNA 5'-end processing (GO:0099116),0.20617466070853668,0.4159101675787068,0.9956647398843931,0.998991786685898,1.0,1/15,7.52%,POP1
prerank,modified amino acid transport (GO:0072337),-0.16114515229248316,-0.41518456165263273,0.9963369963369964,0.9999443346728042,1.0,9/15,51.00%,CTNS;SLC6A8;SLC1A4;MGST1;PDPN;SLC46A1;SLC5A6;SLC19A1;SLC16A12
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.1692881277539128,-0.39567279359534824,0.9972067039106145,0.9991546914623838,1.0,1/12,4.52%,MAD1L1
prerank,positive regulation of protein sumoylation (GO:0033235),0.20954273957482566,0.39429623137898173,0.9925925925925926,1.0,1.0,3/10,16.92%,PIAS1;UBA2;SAE1
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.18162696145035517,0.37842506993133496,0.997364953886693,1.0,1.0,2/18,13.04%,BNIP3;BCL2
prerank,toxin transport (GO:1901998),0.19763186145032705,0.376920243233622,0.9969183359013868,1.0,1.0,1/10,12.66%,ADAM10
prerank,vitamin D metabolic process (GO:0042359),0.18307383224510307,0.3685051249601087,0.998546511627907,1.0,1.0,13/13,81.71%,LGMN;CYP27B1;GC;CYP11A1;CYP24A1;VDR;FGF23;UGT1A4;CUBN;LRP2;CYP1A1;CYP2R1;PIAS4
prerank,negative regulation of reproductive process (GO:2000242),0.1733703661359819,0.3547680025551463,0.9985994397759104,1.0,1.0,2/17,14.97%,PAEP;ARHGDIB
prerank,skeletal muscle contraction (GO:0003009),0.16250000957848726,0.3521492357158654,1.0,1.0,1.0,18/19,62.46%,RCSD1;TCAP;MYH8;MYH3;JSRP1;CHRNA1;TNNC2;TNNT1;MYH7;TNNI3;TNNC1;CCDC78;TNNT3;TNNI2;STAC3;TNNI1;MYH14;STAC2
prerank,negative regulation of immune system process (GO:0002683),0.17266814956703838,0.3457850611277678,0.9986033519553073,1.0,1.0,1/16,9.65%,LYN
prerank,protein polyglutamylation (GO:0018095),0.17527456392207724,0.33886456029490136,1.0,0.9998852016597116,1.0,1/11,11.18%,TTLL4
prerank,dopaminergic neuron differentiation (GO:0071542),0.14491782308068057,0.3020583246957839,1.0,0.9999169052041273,1.0,2/19,17.61%,LRP6;CTNNB1
